archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,2.8267e-05,0.37482,0.39329,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,4.5779e-05,0.26399,0.29881,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0017696,0.23345,0.1917,1,1
1,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0172,0.16968,0.15484,1,1
1,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.045233,0.15438,0.091879,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0015882,0.088582,0.13856,1,1
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.037377,-0.10996,-0.24695,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0080134,-0.11039,-0.27049,1,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.046961,-0.12433,-0.15651,1,0
1,GO BASE EXCISION REPAIR AP SITE FORMATION,0.024086,-0.12846,-0.18506,1,0
1,GO CELLULAR RESPIRATION,0.018736,-0.1324,-0.15604,1,0
1,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.0063209,-0.14447,-0.24924,1,0
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.016475,-0.15082,-0.20203,1,0
1,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.0015041,-0.15882,-0.30844,1,0
1,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.056456,-0.16494,-0.26488,1,0
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.00029789,-0.16833,-0.29757,1,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.0024341,-0.17081,-0.27406,1,0
1,GO QUINONE METABOLIC PROCESS,0.0013481,-0.17235,-0.22366,1,0
1,GO OTIC VESICLE DEVELOPMENT,0.035953,-0.17519,-0.21115,1,0
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.0172,-0.18344,-0.19913,1,0
1,GO DNA DEAMINATION,0.035953,-0.1836,-0.29326,1,0
1,GO RETINOL METABOLIC PROCESS,0.0020776,-0.18583,-0.26951,1,0
1,GO PROTEIN TARGETING,6.2007e-06,-0.18841,-0.2404,1,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,3.7287e-05,-0.1906,-0.27889,1,0
1,GO CENTROMERE COMPLEX ASSEMBLY,0.0038653,-0.19171,-0.27283,1,0
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00081392,-0.1942,-0.22323,1,0
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,6.4139e-05,-0.19588,-0.28599,1,0
1,GO NEGATIVE REGULATION OF BEHAVIOR,0.0080134,-0.19612,-0.20557,1,0
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0010209,-0.1982,-0.25536,1,0
1,GO CYTIDINE TO URIDINE EDITING,0.069906,-0.20207,-0.34947,1,0
1,GO SPERM EGG RECOGNITION,0.0042727,-0.20301,-0.20333,1,0
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0013481,-0.2058,-0.24971,1,0
1,GO GROOMING BEHAVIOR,0.045233,-0.20633,-0.25682,1,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00012367,-0.20633,-0.30103,1,0
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00040321,-0.20787,-0.28835,1,0
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.043559,-0.20818,-0.41448,1,0
1,GO HYPERSENSITIVITY,0.037377,-0.20957,-0.52225,1,0
1,GO RNA SURVEILLANCE,0.00017019,-0.20969,-0.30944,1,0
1,GO CELLULAR RESPONSE TO LITHIUM ION,0.0010798,-0.21001,-0.29282,1,0
1,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.0023095,-0.21379,-0.27752,1,0
1,GO T CELL MEDIATED CYTOTOXICITY,0.045233,-0.21519,-0.38974,1,0
1,GO PROTEIN K11 LINKED UBIQUITINATION,5.2428e-05,-0.21638,-0.31131,1,0
1,GO SEQUESTERING OF METAL ION,0.026142,-0.21725,-0.22809,1,0
1,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00017019,-0.2211,-0.26129,1,0
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00031664,-0.22171,-0.28892,1,0
1,GO MEIOSIS I CELL CYCLE PROCESS,0.00076864,-0.22305,-0.33098,1,0
1,GO FOREBRAIN REGIONALIZATION,0.016475,-0.2238,-0.35787,1,0
1,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.02951,-0.22409,-0.41727,1,0
1,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.062884,-0.22571,-0.2246,1,0
1,GO KINETOCHORE ORGANIZATION,0.0027019,-0.22861,-0.33303,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.00010866,-0.22949,-0.27793,1,0
1,GO TRNA WOBBLE BASE MODIFICATION,5.9985e-05,-0.23007,-0.34471,1,0
1,GO DEFENSE RESPONSE TO FUNGUS,0.015104,-0.23042,-0.28335,1,0
1,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.019548,-0.2312,-0.2908,1,0
1,GO TERPENOID BIOSYNTHETIC PROCESS,0.00057531,-0.23395,-0.25874,1,0
1,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.00045436,-0.2344,-0.25888,1,0
1,GO RETINAL METABOLIC PROCESS,0.033245,-0.23468,-0.30471,1,0
1,GO SPERM AXONEME ASSEMBLY,0.008797,-0.23728,-0.22807,1,0
1,GO AMIDE BIOSYNTHETIC PROCESS,7.1973e-06,-0.2382,-0.2857,1,0
1,GO MITOCHONDRIAL RNA PROCESSING,0.00054254,-0.24073,-0.39106,1,0
1,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.0012071,-0.24088,-0.22297,1,0
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,9.6689e-06,-0.24159,-0.33593,1,0
1,GO CELL REDOX HOMEOSTASIS,5.2428e-05,-0.24193,-0.3524,1,0
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.00019306,-0.24273,-0.24486,1,0
1,GO SENSORY PERCEPTION OF TASTE,0.00033648,-0.24312,-0.32251,1,0
1,GO MUCUS SECRETION,0.045233,-0.24314,-0.22892,1,0
1,GO STEROID ESTERIFICATION,0.0028457,-0.24378,-0.37076,1,0
1,GO PEPTIDE METABOLIC PROCESS,5.7533e-06,-0.24428,-0.28078,1,0
1,GO STARTLE RESPONSE,0.015104,-0.24578,-0.36679,1,0
1,GO HISTONE MRNA METABOLIC PROCESS,8.9327e-05,-0.24587,-0.29055,1,0
1,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.015104,-0.24641,-0.23537,1,0
1,GO REGULATION OF FERTILIZATION,0.0034935,-0.24644,-0.2478,1,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.00072571,-0.24645,-0.34287,1,0
1,GO UBIQUINONE METABOLIC PROCESS,0.0011418,-0.24836,-0.27596,1,0
1,GO LACTATE METABOLIC PROCESS,0.0010209,-0.24901,-0.27928,1,0
1,GO SENSORY PERCEPTION OF SMELL,0.00011593,-0.24954,-0.25177,1,0
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,3.0304e-05,-0.2505,-0.3056,1,0
1,GO RNA CAPPING,9.6689e-06,-0.25121,-0.32135,1,0
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,8.9327e-05,-0.25142,-0.30236,1,0
1,GO URONIC ACID METABOLIC PROCESS,0.00026348,-0.25175,-0.22375,1,0
1,GO POSITIVE REGULATION OF BEHAVIOR,0.0025648,-0.25599,-0.34347,1,0
1,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.058535,-0.25745,-0.17428,1,0
1,GO GASTRIC ACID SECRETION,0.00057531,-0.26032,-0.28085,1,0
1,GO DRUG CATABOLIC PROCESS,0.0015041,-0.26055,-0.28752,1,0
1,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,3.248e-05,-0.26344,-0.39339,1,0
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0042727,-0.26413,-0.46607,1,0
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.00060992,-0.26452,-0.35253,1,0
1,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.0024341,-0.26692,-0.32621,1,0
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.00017019,-0.26729,-0.27836,1,0
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.006955,-0.26828,-0.4508,1,0
1,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.0052065,-0.26839,-0.23134,1,0
1,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.0016767,-0.27023,-0.33943,1,0
1,GO REGULATION OF GASTRIC ACID SECRETION,0.0013481,-0.27027,-0.30923,1,0
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.00028019,-0.27045,-0.34885,1,0
1,GO POSITIVE REGULATION OF ACROSOME REACTION,0.012106,-0.27358,-0.25418,1,0
1,GO KETONE BODY METABOLIC PROCESS,0.0042727,-0.27403,-0.21673,1,0
1,GO OUTER DYNEIN ARM ASSEMBLY,0.018736,-0.27473,-0.33022,1,0
1,GO AMINE CATABOLIC PROCESS,0.00091199,-0.27644,-0.37447,1,0
1,GO NEUROPEPTIDE SIGNALING PATHWAY,0.016475,-0.27706,-0.25736,1,0
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.00076864,-0.27777,-0.3447,1,0
1,GO AMP METABOLIC PROCESS,0.00040321,-0.27835,-0.28401,1,0
1,GO NEGATIVE REGULATION OF RNA SPLICING,0.00086166,-0.27854,-0.2956,1,0
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.0028457,-0.27889,-0.38801,1,0
1,GO REGULATION OF T CELL CHEMOTAXIS,0.035953,-0.27911,-0.42201,1,0
1,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.008797,-0.27951,-0.33622,1,0
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00045436,-0.27971,-0.37826,1,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,1.6059e-05,-0.28131,-0.32141,1,0
1,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,3.0304e-05,-0.28148,-0.31254,1,0
1,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.00054254,-0.28159,-0.35654,1,0
1,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0031545,-0.2833,-0.41581,1,0
1,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,5.2428e-05,-0.28338,-0.35677,1,0
1,GO T CELL MEDIATED IMMUNITY,0.0029965,-0.28479,-0.46114,1,0
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,2.8267e-05,-0.28563,-0.2986,1,0
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0003797,-0.28583,-0.32707,1,0
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.0034935,-0.28774,-0.28514,1,0
1,GO LIPOXYGENASE PATHWAY,0.037377,-0.28809,-0.24242,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.016475,-0.28859,-0.43926,1,0
1,GO RESPONSE TO INSECTICIDE,0.0057394,-0.29186,-0.35847,1,0
1,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00014989,-0.29241,-0.31148,1,0
1,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.0013481,-0.29332,-0.36965,1,0
1,GO TOLERANCE INDUCTION,0.028348,-0.29431,-0.59652,1,0
1,GO OOCYTE DIFFERENTIATION,4.8997e-05,-0.29436,-0.38007,1,0
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,7.7514e-06,-0.29466,-0.39422,1,0
1,GO AMINO ACID ACTIVATION,0.00010181,-0.29467,-0.34891,1,0
1,GO TRANSLESION SYNTHESIS,2.636e-05,-0.2963,-0.36879,1,0
1,GO PROTEIN TARGETING TO MITOCHONDRION,1.8524e-05,-0.29659,-0.32641,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.013834,-0.29692,-0.38915,1,0
1,GO ETHANOL METABOLIC PROCESS,0.00064645,-0.29697,-0.4246,1,0
1,GO INTERLEUKIN 5 PRODUCTION,0.030713,-0.29833,-0.36032,1,0
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,5.9985e-05,-0.29954,-0.3866,1,0
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,3.248e-05,-0.30088,-0.37383,1,0
1,GO PHOTOTRANSDUCTION,6.2007e-06,-0.30095,-0.36511,1,0
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00014989,-0.30105,-0.38457,1,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.00013188,-0.30106,-0.31369,1,0
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.2035e-05,-0.30132,-0.35594,1,0
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.008797,-0.3014,-0.32312,1,0
1,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.00011593,-0.30142,-0.39458,1,0
1,GO GTP METABOLIC PROCESS,2.636e-05,-0.30158,-0.33965,1,0
1,GO REGULATION OF FEEDING BEHAVIOR,3.0304e-05,-0.30161,-0.33911,1,0
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,8.3461e-06,-0.30164,-0.35094,1,0
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,5.2428e-05,-0.30205,-0.39721,1,0
1,GO DORSAL SPINAL CORD DEVELOPMENT,0.0015041,-0.30218,-0.40673,1,0
1,GO BEHAVIORAL RESPONSE TO COCAINE,0.0066311,-0.30271,-0.42264,1,0
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,2.2907e-05,-0.30271,-0.37732,1,0
1,GO OOGENESIS,3.7287e-05,-0.30284,-0.37068,1,0
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.00013188,-0.3033,-0.38314,1,0
1,GO DETOXIFICATION,0.00018128,-0.30406,-0.299,1,0
1,GO DOPAMINE BIOSYNTHETIC PROCESS,0.0049572,-0.30478,-0.36307,1,0
1,GO METHIONINE BIOSYNTHETIC PROCESS,0.0015882,-0.30482,-0.31895,1,0
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,1.6059e-05,-0.3049,-0.41916,1,0
1,GO POSITIVE REGULATION OF CELL KILLING,0.024086,-0.30519,-0.41368,1,0
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,2.1347e-05,-0.30541,-0.39477,1,0
1,GO CELL KILLING,0.0092139,-0.30627,-0.39062,1,0
1,GO HEPATOCYTE DIFFERENTIATION,0.0016767,-0.30641,-0.32462,1,0
1,GO NUCLEOSIDE METABOLIC PROCESS,1.2939e-05,-0.3065,-0.33117,1,0
1,GO SNRNA PROCESSING,0.00010866,-0.30675,-0.33894,1,0
1,GO POSITIVE REGULATION OF ATPASE ACTIVITY,3.4805e-05,-0.30677,-0.32641,1,0
1,GO CELLULAR AMIDE METABOLIC PROCESS,5.337e-06,-0.30725,-0.32705,1,0
1,GO IMMUNOLOGICAL MEMORY PROCESS,0.0040644,-0.30754,-0.45607,1,0
1,GO METHIONINE METABOLIC PROCESS,0.00042807,-0.30795,-0.32849,1,0
1,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,8.3461e-06,-0.30908,-0.36009,1,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00035748,-0.30916,-0.30325,1,0
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.00051151,-0.30918,-0.35698,1,0
1,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.00017019,-0.30931,-0.41428,1,0
1,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,4.5779e-05,-0.30969,-0.37269,1,0
1,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,7.1973e-06,-0.30993,-0.36044,1,0
1,GO OPSONIZATION,0.0029965,-0.31029,-0.47286,1,0
1,GO EMBRYONIC AXIS SPECIFICATION,1.7249e-05,-0.31032,-0.3827,1,0
1,GO NUCLEOSIDE CATABOLIC PROCESS,0.0012071,-0.3105,-0.33949,1,0
1,GO TRIPARTITE REGIONAL SUBDIVISION,7.8298e-05,-0.31152,-0.36022,1,0
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,7.7514e-06,-0.31162,-0.38194,1,0
1,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0029965,-0.31193,-0.35518,1,0
1,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.00010181,-0.31229,-0.33846,1,0
1,GO NUCLEOTIDE EXCISION REPAIR,1.3909e-05,-0.31241,-0.37956,1,0
1,GO INTERLEUKIN 17 PRODUCTION,0.0027019,-0.31279,-0.51519,1,0
1,GO PROTEIN LOCALIZATION TO MITOCHONDRION,1.7249e-05,-0.31393,-0.34829,1,0
1,GO GLYCOSIDE METABOLIC PROCESS,0.00068502,-0.31409,-0.32103,1,0
1,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0016767,-0.31424,-0.36661,1,0
1,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,5.2428e-05,-0.31439,-0.36683,1,0
1,GO REGULATION OF MICROTUBULE BASED MOVEMENT,3.4805e-05,-0.31518,-0.30851,1,0
1,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.016475,-0.31535,-0.52249,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.008797,-0.31548,-0.30379,1,0
1,GO PEROXISOME ORGANIZATION,1.2035e-05,-0.31553,-0.35708,1,0
1,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.0049572,-0.31633,-0.25561,1,0
1,GO DRUG METABOLIC PROCESS,1.2939e-05,-0.31709,-0.35625,1,0
1,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,7.7514e-06,-0.31715,-0.36213,1,0
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.00014989,-0.31729,-0.38656,1,0
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.0304e-05,-0.31746,-0.42058,1,0
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0036751,-0.31818,-0.29522,1,0
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.0031545,-0.3183,-0.29002,1,0
1,GO RESPONSE TO INTERLEUKIN 12,2.636e-05,-0.31837,-0.38107,1,0
1,GO SALIVA SECRETION,0.0083971,-0.31843,-0.2839,1,0
1,GO FEAR RESPONSE,4.2763e-05,-0.31859,-0.38619,1,0
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.006955,-0.31875,-0.4838,1,0
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.00091199,-0.3191,-0.37255,1,0
1,GO MEIOTIC CELL CYCLE PROCESS,5.9985e-05,-0.31915,-0.4054,1,0
1,GO CELL CELL RECOGNITION,0.00024771,-0.31938,-0.33087,1,0
1,GO SKELETAL MUSCLE TISSUE REGENERATION,3.7287e-05,-0.3195,-0.44435,1,0
1,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.010101,-0.31957,-0.42088,1,0
1,GO NEPHRON TUBULE FORMATION,0.0019699,-0.31962,-0.29391,1,0
1,GO REGULATION OF CELL CYCLE CHECKPOINT,7.8298e-05,-0.3199,-0.3935,1,0
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.034576,-0.32003,-0.41395,1,0
1,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0096484,-0.3205,-0.49155,1,0
1,GO RETINOIC ACID METABOLIC PROCESS,0.0020776,-0.32127,-0.28937,1,0
1,GO REGULATION OF CELL KILLING,0.0076456,-0.32146,-0.47641,1,0
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00060992,-0.32207,-0.33065,1,0
1,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.0020776,-0.32242,-0.40124,1,0
1,GO REGULATION OF CHROMOSOME SEPARATION,4.2763e-05,-0.32247,-0.41249,1,0
1,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00035748,-0.32258,-0.33517,1,0
1,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,8.3641e-05,-0.32269,-0.39266,1,0
1,GO NEURON FATE SPECIFICATION,0.024086,-0.32286,-0.40068,1,0
1,GO ALPHA BETA T CELL PROLIFERATION,0.011063,-0.32291,-0.53409,1,0
1,GO CELLULAR OXIDANT DETOXIFICATION,0.00013188,-0.32349,-0.31621,1,0
1,GO ATP METABOLIC PROCESS,3.248e-05,-0.32418,-0.32305,1,0
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.015104,-0.32464,-0.38542,1,0
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.01266,-0.32471,-0.50877,1,0
1,GO REGULATION OF SPINDLE CHECKPOINT,0.00014062,-0.32475,-0.38597,1,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0020776,-0.32514,-0.39607,1,0
1,GO EATING BEHAVIOR,0.0015882,-0.32548,-0.34368,1,0
1,GO INTERLEUKIN 4 PRODUCTION,0.010572,-0.32557,-0.49188,1,0
1,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,1.2035e-05,-0.32619,-0.38769,1,0
1,GO ACROSOME REACTION,0.00072571,-0.32626,-0.39221,1,0
1,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.00014062,-0.32747,-0.40255,1,0
1,GO ESTROGEN METABOLIC PROCESS,2.4576e-05,-0.32821,-0.33307,1,0
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,1.2035e-05,-0.32884,-0.33219,1,0
1,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.00015974,-0.329,-0.38701,1,0
1,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.034576,-0.32954,-0.41112,1,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00081392,-0.32959,-0.39104,1,0
1,GO REGULATION OF PROTON TRANSPORT,3.248e-05,-0.32978,-0.3919,1,0
1,GO PROTON TRANSMEMBRANE TRANSPORT,1.7249e-05,-0.33003,-0.34675,1,0
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00017019,-0.33032,-0.32475,1,0
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.00013188,-0.33036,-0.36111,1,0
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00040321,-0.33114,-0.30785,1,0
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0052065,-0.33195,-0.51967,1,0
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.00024771,-0.33214,-0.40754,1,0
1,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,2.8267e-05,-0.3324,-0.40502,1,0
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0042727,-0.33241,-0.37554,1,0
1,GO PRIMARY ALCOHOL METABOLIC PROCESS,4.2763e-05,-0.33284,-0.37448,1,0
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,4.2763e-05,-0.33385,-0.34552,1,0
1,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,6.8565e-05,-0.33389,-0.39137,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.006955,-0.3342,-0.4165,1,0
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,7.7514e-06,-0.33445,-0.3688,1,0
1,GO TRICARBOXYLIC ACID CYCLE,1.7249e-05,-0.33456,-0.38528,1,0
1,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,1.0403e-05,-0.33485,-0.37443,1,0
1,GO REGULATION OF TOLERANCE INDUCTION,0.030713,-0.3351,-0.58081,1,0
1,GO IMMUNE RESPONSE TO TUMOR CELL,0.0042727,-0.33539,-0.45644,1,0
1,GO PROTEIN ADP RIBOSYLATION,3.248e-05,-0.33572,-0.47808,1,0
1,GO PEROXISOMAL TRANSPORT,1.7249e-05,-0.33576,-0.35407,1,0
1,GO MITOCHONDRION ORGANIZATION,6.2007e-06,-0.3359,-0.37988,1,0
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00026348,-0.33596,-0.44702,1,0
1,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0047188,-0.33643,-0.50255,1,0
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,5.6086e-05,-0.33691,-0.31083,1,0
1,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.00021879,-0.33729,-0.36673,1,0
1,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,2.8267e-05,-0.33739,-0.44368,1,0
1,GO GERM CELL DEVELOPMENT,2.1347e-05,-0.33791,-0.38813,1,0
1,GO REGULATION OF LIGASE ACTIVITY,4.5779e-05,-0.33809,-0.39248,1,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,1.2939e-05,-0.3384,-0.3532,1,0
1,GO T CELL CYTOKINE PRODUCTION,0.0015041,-0.33847,-0.51844,1,0
1,GO MIDDLE EAR MORPHOGENESIS,0.00015974,-0.33896,-0.37189,1,0
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.012106,-0.33918,-0.38848,1,0
1,GO PROTEIN HETEROTETRAMERIZATION,4.8997e-05,-0.33978,-0.41972,1,0
1,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00057531,-0.33991,-0.36501,1,0
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.028348,-0.33992,-0.47895,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,5.9985e-05,-0.34069,-0.53388,1,0
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,1.0403e-05,-0.34072,-0.41273,1,0
1,GO PLASMA MEMBRANE FUSION,0.00026348,-0.34114,-0.36848,1,0
1,GO HYDROGEN PEROXIDE METABOLIC PROCESS,6.4139e-05,-0.34126,-0.33698,1,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.007293,-0.34132,-0.3497,1,0
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.016475,-0.34136,-0.34028,1,0
1,GO POSITIVE REGULATION OF FERTILIZATION,0.0015041,-0.34161,-0.33035,1,0
1,GO DETECTION OF LIGHT STIMULUS,5.337e-06,-0.34171,-0.37878,1,0
1,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.00068502,-0.34178,-0.39438,1,0
1,GO MEIOTIC CELL CYCLE,2.1347e-05,-0.34184,-0.43641,1,0
1,GO SPERMATID DIFFERENTIATION,3.4805e-05,-0.34197,-0.37131,1,0
1,GO INTERFERON GAMMA PRODUCTION,0.0052065,-0.34218,-0.51221,1,0
1,GO AXONAL TRANSPORT OF MITOCHONDRION,0.00045436,-0.34232,-0.4799,1,0
1,GO RESPONSE TO INTERFERON BETA,0.010101,-0.34238,-0.50761,1,0
1,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.0025648,-0.3428,-0.35355,1,0
1,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,4.2763e-05,-0.34321,-0.38954,1,0
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,8.3461e-06,-0.34324,-0.38469,1,0
1,GO BASE EXCISION REPAIR,3.9936e-05,-0.34433,-0.37881,1,0
1,GO INTERLEUKIN 13 PRODUCTION,0.013834,-0.34434,-0.45021,1,0
1,GO CELLULAR HORMONE METABOLIC PROCESS,5.9985e-05,-0.34458,-0.33778,1,0
1,GO SPERM CAPACITATION,0.0083971,-0.34514,-0.2401,1,0
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.00072571,-0.34539,-0.28989,1,0
1,GO BICARBONATE TRANSPORT,0.00015974,-0.34548,-0.37364,1,0
1,GO FEEDING BEHAVIOR,0.00018128,-0.34549,-0.3916,1,0
1,GO PREPULSE INHIBITION,0.0047188,-0.34559,-0.47726,1,0
1,GO REGULATION OF SISTER CHROMATID SEGREGATION,2.8267e-05,-0.3459,-0.43873,1,0
1,GO PHOTORECEPTOR CELL DEVELOPMENT,1.7249e-05,-0.34643,-0.40406,1,0
1,GO PEPTIDYL ARGININE METHYLATION,5.2428e-05,-0.34668,-0.39786,1,0
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,8.3461e-06,-0.34668,-0.36656,1,0
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.030713,-0.34729,-0.5568,1,0
1,GO PH REDUCTION,8.3461e-06,-0.34752,-0.41937,1,0
1,GO NODAL SIGNALING PATHWAY,0.00054254,-0.34773,-0.3031,1,0
1,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.00035748,-0.34816,-0.36574,1,0
1,GO POSITIVE REGULATION OF MRNA PROCESSING,3.248e-05,-0.34827,-0.38165,1,0
1,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00029789,-0.3486,-0.45063,1,0
1,GO NUCLEAR CHROMOSOME SEGREGATION,2.4576e-05,-0.3489,-0.4292,1,0
1,GO SECRETION BY TISSUE,9.5377e-05,-0.34892,-0.34119,1,0
1,GO TERPENOID METABOLIC PROCESS,5.6086e-05,-0.349,-0.36531,1,0
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0063209,-0.35021,-0.44861,1,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.0016767,-0.35049,-0.38697,1,0
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,1.2939e-05,-0.35063,-0.39944,1,0
1,GO DETECTION OF VISIBLE LIGHT,4.5891e-06,-0.35065,-0.37957,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0052065,-0.35131,-0.42737,1,0
1,GO REGULATION OF BEHAVIOR,7.7514e-06,-0.35166,-0.43407,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,7.8298e-05,-0.35172,-0.38941,1,0
1,GO GLUTATHIONE METABOLIC PROCESS,5.2428e-05,-0.35247,-0.3332,1,0
1,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,5.6086e-05,-0.35259,-0.35656,1,0
1,GO EPOXYGENASE P450 PATHWAY,0.019548,-0.35275,-0.22756,1,0
1,GO LIPOPROTEIN CATABOLIC PROCESS,0.00017019,-0.35314,-0.43649,1,0
1,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00035748,-0.3534,-0.50582,1,0
1,GO HOMOCYSTEINE METABOLIC PROCESS,0.00011593,-0.35345,-0.37671,1,0
1,GO SEMINIFEROUS TUBULE DEVELOPMENT,2.636e-05,-0.35384,-0.49268,1,0
1,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.00029789,-0.35393,-0.39882,1,0
1,GO INTERLEUKIN 10 PRODUCTION,0.0076456,-0.35417,-0.52957,1,0
1,GO MUSCLE CELL FATE COMMITMENT,0.00010181,-0.35432,-0.40095,1,0
1,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,1.9888e-05,-0.35449,-0.39307,1,0
1,GO OOCYTE MATURATION,5.6086e-05,-0.3546,-0.40753,1,0
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0019699,-0.35478,-0.62401,1,0
1,GO ISOPRENOID METABOLIC PROCESS,5.9985e-05,-0.35519,-0.3489,1,0
1,GO INTERSTRAND CROSS LINK REPAIR,3.248e-05,-0.35519,-0.41836,1,0
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,3.0304e-05,-0.35564,-0.41121,1,0
1,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.00096503,-0.35578,-0.41804,1,0
1,GO RESPONSE TO SALT,0.00013188,-0.35581,-0.36757,1,0
1,GO ETHANOL OXIDATION,0.0057394,-0.35595,-0.45123,1,0
1,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,5.337e-06,-0.35629,-0.37022,1,0
1,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.00014062,-0.35649,-0.46385,1,0
1,GO MACROPHAGE APOPTOTIC PROCESS,0.012106,-0.35664,-0.3107,1,0
1,GO CHROMOSOME SEGREGATION,2.4576e-05,-0.35757,-0.42771,1,0
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,1.1191e-05,-0.35766,-0.40182,1,0
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00013188,-0.35794,-0.50076,1,0
1,GO CHROMATIN SILENCING AT TELOMERE,0.00021879,-0.35811,-0.3742,1,0
1,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,5.6086e-05,-0.35813,-0.427,1,0
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,3.7287e-05,-0.35921,-0.40544,1,0
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,6.6813e-06,-0.35923,-0.39922,1,0
1,GO KERATINOCYTE DIFFERENTIATION,0.00024771,-0.35984,-0.35907,1,0
1,GO HEART FIELD SPECIFICATION,0.00028019,-0.36004,-0.48913,1,0
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,7.3279e-05,-0.36022,-0.4398,1,0
1,GO SLEEP,3.9936e-05,-0.36027,-0.38682,1,0
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00081392,-0.36036,-0.45016,1,0
1,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.00068502,-0.36041,-0.46465,1,0
1,GO GLUTAMATE METABOLIC PROCESS,0.00011593,-0.36043,-0.40294,1,0
1,GO TRANSCRIPTION BY RNA POLYMERASE III,6.2007e-06,-0.36051,-0.41663,1,0
1,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0025648,-0.36112,-0.42759,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.0047188,-0.36122,-0.56955,1,0
1,GO PROSTATE GLAND GROWTH,0.00086166,-0.36147,-0.2998,1,0
1,GO REGULATION OF ACROSOME REACTION,0.013235,-0.36154,-0.30387,1,0
1,GO NEGATIVE REGULATION OF DNA BINDING,1.2939e-05,-0.36183,-0.43581,1,0
1,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,8.3461e-06,-0.36206,-0.36797,1,0
1,GO EXPLORATION BEHAVIOR,0.00014989,-0.36227,-0.45627,1,0
1,GO ARACHIDONIC ACID METABOLIC PROCESS,9.5377e-05,-0.36291,-0.42508,1,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00026348,-0.36351,-0.34703,1,0
1,GO DNA PACKAGING,2.636e-05,-0.36371,-0.44455,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0057394,-0.36397,-0.4751,1,0
1,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.00068502,-0.36479,-0.40255,1,0
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0076456,-0.36514,-0.50503,1,0
1,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,7.8298e-05,-0.36529,-0.34224,1,0
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0063209,-0.36555,-0.45748,1,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,2.1347e-05,-0.36607,-0.46071,1,0
1,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0042727,-0.36616,-0.4624,1,0
1,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,4.5779e-05,-0.36674,-0.42267,1,0
1,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0054671,-0.36679,-0.41305,1,0
1,GO NEURAL NUCLEUS DEVELOPMENT,7.8298e-05,-0.36749,-0.476,1,0
1,GO ICOSANOID METABOLIC PROCESS,9.5377e-05,-0.36757,-0.40373,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.012106,-0.36768,-0.64459,1,0
1,GO T CELL CHEMOTAXIS,0.019548,-0.36802,-0.51976,1,0
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.0017696,-0.36819,-0.40656,1,0
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,1.2939e-05,-0.36837,-0.37559,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0027019,-0.36847,-0.55638,1,0
1,GO CELLULAR KETONE METABOLIC PROCESS,7.1973e-06,-0.36891,-0.39873,1,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,4.9495e-06,-0.369,-0.40758,1,0
1,GO ACID SECRETION,0.00028019,-0.36902,-0.35197,1,0
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.012106,-0.36931,-0.47086,1,0
1,GO PROTEIN AUTOPROCESSING,0.00057531,-0.36952,-0.34206,1,0
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,1.8524e-05,-0.37035,-0.41575,1,0
1,GO PHOTOTRANSDUCTION VISIBLE LIGHT,4.9495e-06,-0.37036,-0.41549,1,0
1,GO RNA 3 END PROCESSING,1.1191e-05,-0.37036,-0.41044,1,0
1,GO SINGLE FERTILIZATION,4.2763e-05,-0.37039,-0.35221,1,0
1,GO T CELL APOPTOTIC PROCESS,0.0015882,-0.37067,-0.47587,1,0
1,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,2.8267e-05,-0.37069,-0.4134,1,0
1,GO NUCLEOTIDE SALVAGE,0.00014062,-0.37075,-0.35987,1,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,9.6689e-06,-0.37105,-0.34614,1,0
1,GO INNATE IMMUNE RESPONSE,0.00019306,-0.37141,-0.50842,1,0
1,GO RESPONSE TO L GLUTAMATE,2.2907e-05,-0.3717,-0.43408,1,0
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0023095,-0.37193,-0.49405,1,0
1,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,5.2428e-05,-0.37194,-0.39679,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.010101,-0.37197,-0.49429,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.011063,-0.37212,-0.48671,1,0
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.0076456,-0.37225,-0.53061,1,0
1,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.0049572,-0.37243,-0.58166,1,0
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,5.9985e-05,-0.37253,-0.42162,1,0
1,GO AMINO SUGAR CATABOLIC PROCESS,0.0029965,-0.37254,-0.48824,1,0
1,GO CILIUM MOVEMENT,0.00018128,-0.37262,-0.36615,1,0
1,GO TISSUE REGENERATION,4.5779e-05,-0.37289,-0.43147,1,0
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0172,-0.37334,-0.48671,1,0
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,4.9495e-06,-0.37346,-0.38607,1,0
1,GO SPERM MOTILITY,6.8565e-05,-0.3735,-0.35948,1,0
1,GO MITOCHONDRION MORPHOGENESIS,9.6689e-06,-0.37353,-0.40368,1,0
1,GO UNSATURATED FATTY ACID METABOLIC PROCESS,3.7287e-05,-0.37353,-0.40213,1,0
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00031664,-0.37418,-0.49875,1,0
1,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,1.8524e-05,-0.37466,-0.41693,1,0
1,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0042727,-0.37551,-0.39797,1,0
1,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00060992,-0.37568,-0.37508,1,0
1,GO ACUTE PHASE RESPONSE,0.00028019,-0.37615,-0.46752,1,0
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,7.3279e-05,-0.37617,-0.45359,1,0
1,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,1.2035e-05,-0.37645,-0.41687,1,0
1,GO REGULATION OF DNA CATABOLIC PROCESS,1.2035e-05,-0.37658,-0.40595,1,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,3.7287e-05,-0.37659,-0.40218,1,0
1,GO RESPONSE TO TOXIC SUBSTANCE,9.6689e-06,-0.37694,-0.39167,1,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.00013188,-0.37698,-0.39517,1,0
1,GO SISTER CHROMATID SEGREGATION,3.9936e-05,-0.37704,-0.43796,1,0
1,GO HEME METABOLIC PROCESS,1.9888e-05,-0.37743,-0.4124,1,0
1,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,8.9843e-06,-0.3776,-0.41053,1,0
1,GO COENZYME A METABOLIC PROCESS,8.9843e-06,-0.37781,-0.43439,1,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,4.9495e-06,-0.37788,-0.39521,1,0
1,GO EOSINOPHIL CHEMOTAXIS,0.067497,-0.37798,-0.40896,1,0
1,GO REGULATION OF ATPASE ACTIVITY,8.9843e-06,-0.37803,-0.3707,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,6.8565e-05,-0.37803,-0.44205,1,0
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,5.337e-06,-0.37816,-0.42397,1,0
1,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,1.4947e-05,-0.37816,-0.44866,1,0
1,GO REGULATION OF OOGENESIS,7.1973e-06,-0.37819,-0.45551,1,0
1,GO ETHANOL CATABOLIC PROCESS,0.00035748,-0.3783,-0.40222,1,0
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,3.9422e-06,-0.37844,-0.48297,1,0
1,GO COENZYME A BIOSYNTHETIC PROCESS,6.4139e-05,-0.37863,-0.41514,1,0
1,GO SECONDARY METABOLIC PROCESS,4.8997e-05,-0.37874,-0.36691,1,0
1,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0015041,-0.37883,-0.50421,1,0
1,GO MITOTIC SISTER CHROMATID SEGREGATION,4.8997e-05,-0.37897,-0.42998,1,0
1,GO MALE GAMETE GENERATION,1.0403e-05,-0.37905,-0.40582,1,0
1,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.00029789,-0.37912,-0.43238,1,0
1,GO HISTONE H3 K9 ACETYLATION,1.6059e-05,-0.37936,-0.44052,1,0
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,1.3909e-05,-0.38012,-0.42362,1,0
1,GO OXIDATIVE DEMETHYLATION,2.1347e-05,-0.38015,-0.43979,1,0
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,7.3279e-05,-0.38017,-0.43019,1,0
1,GO NEGATIVE REGULATION OF ERAD PATHWAY,1.4947e-05,-0.38033,-0.45088,1,0
1,GO RESPONSE TO INTERFERON GAMMA,0.0027019,-0.38038,-0.55562,1,0
1,GO PROSTANOID METABOLIC PROCESS,0.00021879,-0.38049,-0.43003,1,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.0010798,-0.38059,-0.36809,1,0
1,GO PROTEIN CONTAINING COMPLEX REMODELING,0.00023283,-0.38063,-0.45247,1,0
1,GO DIGESTION,4.8997e-05,-0.38095,-0.34738,1,0
1,GO NEUTROPHIL MIGRATION,0.007293,-0.3811,-0.47331,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.0017696,-0.38169,-0.57069,1,0
1,GO EXTRACELLULAR VESICLE BIOGENESIS,1.4947e-05,-0.38174,-0.49031,1,0
1,GO FERTILIZATION,3.0304e-05,-0.38175,-0.36462,1,0
1,GO NON MOTILE CILIUM ASSEMBLY,9.6689e-06,-0.38216,-0.4829,1,0
1,GO PROTEIN LOCALIZATION TO MEMBRANE,4.9495e-06,-0.38234,-0.39962,1,0
1,GO DETECTION OF STIMULUS,4.9495e-06,-0.38237,-0.38647,1,0
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,1.1191e-05,-0.3825,-0.4812,1,0
1,GO OXIDATION REDUCTION PROCESS,7.7514e-06,-0.38258,-0.38162,1,0
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0010209,-0.38267,-0.51167,1,0
1,GO RESPONSE TO MINERALOCORTICOID,2.636e-05,-0.38305,-0.47295,1,0
1,GO ALPHA AMINO ACID METABOLIC PROCESS,5.337e-06,-0.38326,-0.4097,1,0
1,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0013481,-0.38352,-0.43835,1,0
1,GO TETRAPYRROLE METABOLIC PROCESS,1.0403e-05,-0.38355,-0.41488,1,0
1,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,9.5377e-05,-0.38392,-0.46783,1,0
1,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,2.2907e-05,-0.38394,-0.35651,1,0
1,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,1.4947e-05,-0.38397,-0.46998,1,0
1,GO REGULATION OF STEM CELL DIFFERENTIATION,1.2035e-05,-0.38426,-0.40705,1,0
1,GO INSEMINATION,0.00051151,-0.38478,-0.38325,1,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,3.4805e-05,-0.38479,-0.36549,1,0
1,GO PYROPTOSIS,0.00064645,-0.38485,-0.39933,1,0
1,GO ACTIVATED T CELL PROLIFERATION,0.00019306,-0.38494,-0.51921,1,0
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00068502,-0.38528,-0.53619,1,0
1,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,5.6086e-05,-0.38566,-0.41,1,0
1,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,8.9327e-05,-0.38623,-0.3539,1,0
1,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.0019699,-0.38627,-0.39303,1,0
1,GO CHEMOSENSORY BEHAVIOR,3.7287e-05,-0.38658,-0.41131,1,0
1,GO REGULATION OF MYOBLAST DIFFERENTIATION,6.4139e-05,-0.38683,-0.43214,1,0
1,GO FEMALE GAMETE GENERATION,5.7533e-06,-0.38713,-0.44649,1,0
1,GO REGULATION OF DOPAMINE SECRETION,0.0025648,-0.38725,-0.43877,1,0
1,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.00026348,-0.38742,-0.43827,1,0
1,GO TRIGLYCERIDE METABOLIC PROCESS,9.6689e-06,-0.38781,-0.43994,1,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.00013188,-0.38801,-0.5323,1,0
1,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,6.2007e-06,-0.3881,-0.41967,1,0
1,GO T CELL PROLIFERATION,0.00072571,-0.38815,-0.54601,1,0
1,GO ATP TRANSPORT,3.248e-05,-0.3884,-0.46051,1,0
1,GO PHOTORECEPTOR CELL MAINTENANCE,1.7249e-05,-0.38868,-0.37288,1,0
1,GO DEFENSE RESPONSE TO BACTERIUM,0.0016767,-0.38873,-0.40085,1,0
1,GO RESPONSE TO AMPHETAMINE,0.00068502,-0.38876,-0.3441,1,0
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,5.7533e-06,-0.38895,-0.44105,1,0
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.023112,-0.38895,-0.4707,1,0
1,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.019548,-0.3892,-0.34054,1,0
1,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,1.9888e-05,-0.38933,-0.45017,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00026348,-0.38934,-0.56717,1,0
1,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.00028019,-0.38939,-0.40116,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0012758,-0.38963,-0.51046,1,0
1,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.00021879,-0.38967,-0.42352,1,0
1,GO RESPONSE TO DIETARY EXCESS,0.00051151,-0.38972,-0.42733,1,0
1,GO HUMORAL IMMUNE RESPONSE,0.0066311,-0.38977,-0.41593,1,0
1,GO POSTSYNAPSE ASSEMBLY,0.0014241,-0.3901,-0.51484,1,0
1,GO CELLULAR AMINO ACID CATABOLIC PROCESS,5.337e-06,-0.3902,-0.40803,1,0
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00072571,-0.39042,-0.53728,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.00068502,-0.39066,-0.62557,1,0
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,1.4947e-05,-0.39072,-0.40525,1,0
1,GO CHROMOSOME SEPARATION,2.8267e-05,-0.39079,-0.46326,1,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,1.3909e-05,-0.39102,-0.43197,1,0
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,5.2428e-05,-0.39127,-0.39728,1,0
1,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,1.1191e-05,-0.39148,-0.42303,1,0
1,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,3.9936e-05,-0.39152,-0.42302,1,0
1,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,5.2428e-05,-0.39155,-0.43727,1,0
1,GO RESPONSE TO BACTERIUM,0.00010181,-0.3917,-0.48839,1,0
1,GO FUCOSE METABOLIC PROCESS,1.2035e-05,-0.39184,-0.41599,1,0
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,3.4805e-05,-0.39229,-0.48248,1,0
1,GO SKELETAL MUSCLE CELL PROLIFERATION,2.636e-05,-0.39258,-0.42357,1,0
1,GO REGULATION OF HISTONE H4 ACETYLATION,6.8565e-05,-0.39285,-0.45463,1,0
1,GO REGULATION OF MEIOTIC CELL CYCLE,8.3641e-05,-0.39296,-0.41973,1,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00033648,-0.39307,-0.55211,1,0
1,GO CARDIOLIPIN METABOLIC PROCESS,7.1973e-06,-0.39308,-0.42995,1,0
1,GO INTRACELLULAR PROTEIN TRANSPORT,4.9495e-06,-0.3931,-0.42879,1,0
1,GO RESPONSE TO BIOTIC STIMULUS,3.9936e-05,-0.39337,-0.5004,1,0
1,GO PHOTORECEPTOR CELL DIFFERENTIATION,2.8267e-05,-0.39351,-0.43032,1,0
1,GO INTERLEUKIN 1 PRODUCTION,0.00076864,-0.39352,-0.54078,1,0
1,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00332,-0.39355,-0.49468,1,0
1,GO TRANSPOSITION,6.4139e-05,-0.39357,-0.42021,1,0
1,GO RESPONSE TO CHEMOKINE,0.01266,-0.39432,-0.45102,1,0
1,GO RESPONSE TO FUNGUS,0.00064645,-0.3944,-0.3949,1,0
1,GO REGULATION OF T CELL MIGRATION,0.0017696,-0.39453,-0.51231,1,0
1,GO MANNOSYLATION,3.0304e-05,-0.39483,-0.44312,1,0
1,GO RNA SPLICING,1.6059e-05,-0.395,-0.4122,1,0
1,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.00011593,-0.39529,-0.38879,1,0
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0083971,-0.39562,-0.46202,1,0
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,6.4139e-05,-0.39567,-0.43737,1,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00091199,-0.39586,-0.48157,1,0
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00064645,-0.39598,-0.58476,1,0
1,GO GLUTAMATE SECRETION,0.00031664,-0.39599,-0.50406,1,0
1,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,5.7533e-06,-0.39613,-0.42849,1,0
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0013481,-0.39639,-0.54422,1,0
1,GO ESTABLISHMENT OF TISSUE POLARITY,4.9495e-06,-0.39664,-0.46133,1,0
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00045436,-0.3967,-0.54257,1,0
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00076864,-0.39696,-0.5252,1,0
1,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,1.1191e-05,-0.39719,-0.45456,1,0
1,GO CHROMOSOME CONDENSATION,7.3279e-05,-0.39725,-0.47892,1,0
1,GO STEROID HORMONE SECRETION,0.00068502,-0.39726,-0.3819,1,0
1,GO RIBONUCLEOTIDE CATABOLIC PROCESS,1.0403e-05,-0.39766,-0.42131,1,0
1,GO LIPOPROTEIN METABOLIC PROCESS,9.6689e-06,-0.39766,-0.45237,1,0
1,GO HISTONE H2B UBIQUITINATION,5.7533e-06,-0.39798,-0.49346,1,0
1,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.00054254,-0.39801,-0.42952,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0014241,-0.39813,-0.55131,1,0
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00015974,-0.3992,-0.54841,1,0
1,GO REGULATION OF TRANSPOSITION,5.9985e-05,-0.39964,-0.44769,1,0
1,GO ALPHA AMINO ACID CATABOLIC PROCESS,3.9422e-06,-0.39975,-0.40919,1,0
1,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,4.2763e-05,-0.40004,-0.43426,1,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0015882,-0.40049,-0.39693,1,0
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,3.9422e-06,-0.40063,-0.49138,1,0
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,4.2763e-05,-0.40077,-0.37922,1,0
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00014062,-0.40083,-0.40548,1,0
1,GO REGULATION OF CHROMOSOME SEGREGATION,2.4576e-05,-0.40108,-0.46456,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,4.8997e-05,-0.40131,-0.49371,1,0
1,GO THYROID GLAND DEVELOPMENT,8.9327e-05,-0.40151,-0.53511,1,0
1,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,1.2035e-05,-0.40152,-0.43715,1,0
1,GO ZYMOGEN INHIBITION,0.0015041,-0.40153,-0.46746,1,0
1,GO SYMBIOTIC PROCESS,4.5891e-06,-0.40154,-0.42976,1,0
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.00054254,-0.40169,-0.50767,1,0
1,GO CELL CYCLE DNA REPLICATION,7.3279e-05,-0.40171,-0.41448,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00054254,-0.40171,-0.53283,1,0
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00011593,-0.40177,-0.3437,1,0
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,6.2007e-06,-0.40189,-0.46626,1,0
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,5.6086e-05,-0.40227,-0.48549,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,3.9422e-06,-0.40249,-0.43435,1,0
1,GO MEIOTIC CHROMOSOME SEPARATION,0.00023283,-0.40267,-0.49168,1,0
1,GO RESPONSE TO INTERLEUKIN 1,3.0304e-05,-0.40277,-0.45259,1,0
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00017019,-0.40315,-0.54079,1,0
1,GO CELLULAR RESPONSE TO ALKALOID,1.0403e-05,-0.40317,-0.43316,1,0
1,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0013481,-0.4034,-0.4167,1,0
1,GO MYELOID LEUKOCYTE MIGRATION,0.00040321,-0.40343,-0.51978,1,0
1,GO NEURAL RETINA DEVELOPMENT,4.8997e-05,-0.40393,-0.45387,1,0
1,GO ADHESION OF SYMBIONT TO HOST,0.0023095,-0.40427,-0.63493,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0015882,-0.40428,-0.48812,1,0
1,GO GAMETE GENERATION,7.1973e-06,-0.40429,-0.4313,1,0
1,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,3.0304e-05,-0.4043,-0.55139,1,0
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,6.2007e-06,-0.40438,-0.45418,1,0
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,3.7287e-05,-0.40452,-0.56866,1,0
1,GO MRNA PROCESSING,1.2035e-05,-0.40478,-0.43273,1,0
1,GO ETHER METABOLIC PROCESS,1.3909e-05,-0.40481,-0.46622,1,0
1,GO DNA REPAIR,8.9843e-06,-0.40487,-0.45747,1,0
1,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,8.3461e-06,-0.40491,-0.44808,1,0
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00086166,-0.40507,-0.56682,1,0
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,7.8298e-05,-0.40527,-0.56745,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0096484,-0.40538,-0.46714,1,0
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00040321,-0.40539,-0.53892,1,0
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,5.337e-06,-0.40549,-0.44609,1,0
1,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.00014062,-0.40554,-0.43359,1,0
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,9.5377e-05,-0.40556,-0.43471,1,0
1,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,8.3641e-05,-0.40574,-0.4833,1,0
1,GO NECROTIC CELL DEATH,4.2763e-05,-0.40589,-0.45886,1,0
1,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,2.2907e-05,-0.40595,-0.49857,1,0
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.00021879,-0.40639,-0.47891,1,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00072571,-0.40679,-0.55982,1,0
1,GO DENDRITIC CELL MIGRATION,0.0096484,-0.4068,-0.55608,1,0
1,GO LEUKOCYTE MEDIATED IMMUNITY,2.4576e-05,-0.40712,-0.53467,1,0
1,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,1.6059e-05,-0.40743,-0.50873,1,0
1,GO FATTY ACID METABOLIC PROCESS,8.3461e-06,-0.40772,-0.42628,1,0
1,GO DEFENSE RESPONSE,3.248e-05,-0.40784,-0.52249,1,0
1,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0020776,-0.40818,-0.40233,1,0
1,GO CELLULAR RESPONSE TO LIGHT STIMULUS,3.9422e-06,-0.40838,-0.44306,1,0
1,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.00013188,-0.40858,-0.39499,1,0
1,GO FAT CELL PROLIFERATION,0.00031664,-0.40869,-0.43542,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,7.8298e-05,-0.40892,-0.55238,1,0
1,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,1.6059e-05,-0.40892,-0.38473,1,0
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,2.4576e-05,-0.40905,-0.46091,1,0
1,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,2.4576e-05,-0.40909,-0.47114,1,0
1,GO REGULATION OF INNATE IMMUNE RESPONSE,8.3641e-05,-0.40935,-0.47235,1,0
1,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00057531,-0.40943,-0.54602,1,0
1,GO PROTEIN MANNOSYLATION,3.9936e-05,-0.40974,-0.46109,1,0
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00014062,-0.40975,-0.54891,1,0
1,GO SENSORY PERCEPTION,6.2007e-06,-0.41008,-0.40693,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0060238,-0.41014,-0.50312,1,0
1,GO CELLULAR RESPONSE TO INTERFERON BETA,0.0024341,-0.41018,-0.46203,1,0
1,GO PIGMENT BIOSYNTHETIC PROCESS,4.9495e-06,-0.41019,-0.44328,1,0
1,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.00040321,-0.41024,-0.54578,1,0
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00057531,-0.41029,-0.51239,1,0
1,GO CELLULAR DEFENSE RESPONSE,0.012106,-0.41071,-0.4818,1,0
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00015974,-0.41087,-0.57431,1,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,1.2035e-05,-0.41088,-0.44146,1,0
1,GO CYSTEINE METABOLIC PROCESS,5.9985e-05,-0.41117,-0.43172,1,0
1,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.0012071,-0.41124,-0.50167,1,0
1,GO NIK NF KAPPAB SIGNALING,1.9888e-05,-0.41134,-0.4674,1,0
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,2.1347e-05,-0.41134,-0.52664,1,0
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.00017019,-0.41137,-0.59344,1,0
1,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,5.9985e-05,-0.41156,-0.3832,1,0
1,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,7.3279e-05,-0.41165,-0.41092,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.00026348,-0.41174,-0.45938,1,0
1,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.0042727,-0.41181,-0.4654,1,0
1,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,9.5377e-05,-0.41189,-0.43726,1,0
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00017019,-0.41195,-0.5712,1,0
1,GO POSITIVE REGULATION OF TRANSLATION,3.9422e-06,-0.41207,-0.44604,1,0
1,GO PROTEIN FOLDING,8.3461e-06,-0.41225,-0.42729,1,0
1,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,3.4805e-05,-0.41241,-0.46499,1,0
1,GO GRANULOCYTE MIGRATION,0.0031545,-0.41255,-0.4952,1,0
1,GO HISTONE H2A UBIQUITINATION,8.9843e-06,-0.41256,-0.51194,1,0
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.00091199,-0.41256,-0.4443,1,0
1,GO EPITHELIAL STRUCTURE MAINTENANCE,0.00017019,-0.41266,-0.34838,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.00042807,-0.41289,-0.5235,1,0
1,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,1.3909e-05,-0.41296,-0.42666,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0010209,-0.41297,-0.5223,1,0
1,GO ALPHA BETA T CELL ACTIVATION,0.00045436,-0.41306,-0.57732,1,0
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0012071,-0.41343,-0.58586,1,0
1,GO RESPONSE TO TUMOR CELL,0.00091199,-0.41345,-0.47349,1,0
1,GO T CELL TOLERANCE INDUCTION,0.031957,-0.41351,-0.57584,1,0
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.031957,-0.41366,-0.38576,1,0
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00018128,-0.41401,-0.55001,1,0
1,GO AMMONIUM ION METABOLIC PROCESS,0.00042807,-0.41428,-0.42025,1,0
1,GO RESPONSE TO AMINE,0.00011593,-0.41431,-0.38598,1,0
1,GO IRON ION TRANSMEMBRANE TRANSPORT,1.7249e-05,-0.41448,-0.49319,1,0
1,GO MISMATCH REPAIR,1.0403e-05,-0.41448,-0.46808,1,0
1,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.01266,-0.41465,-0.6325,1,0
1,GO PHOTOPERIODISM,0.00013188,-0.4148,-0.41448,1,0
1,GO AXONEME ASSEMBLY,0.0029965,-0.41486,-0.34475,1,0
1,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,1.1191e-05,-0.41514,-0.44039,1,0
1,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,1.6059e-05,-0.41526,-0.40528,1,0
1,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.00035748,-0.41553,-0.4295,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00029789,-0.41579,-0.53703,1,0
1,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.00076864,-0.41584,-0.43993,1,0
1,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0034935,-0.41596,-0.51701,1,0
1,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,8.3461e-06,-0.41614,-0.43979,1,0
1,GO GLYCEROL ETHER METABOLIC PROCESS,6.2007e-06,-0.41631,-0.48634,1,0
1,GO ORGANIC ACID CATABOLIC PROCESS,6.6813e-06,-0.41652,-0.43206,1,0
1,GO REGULATION OF T CELL ACTIVATION,0.00020554,-0.41662,-0.56118,1,0
1,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.050584,-0.41673,-0.29235,1,0
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,4.5891e-06,-0.41688,-0.44275,1,0
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,5.2428e-05,-0.41704,-0.53965,1,0
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00076864,-0.41742,-0.55635,1,0
1,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.0019699,-0.41749,-0.40672,1,0
1,GO PROSTANOID BIOSYNTHETIC PROCESS,0.00048214,-0.41758,-0.48003,1,0
1,GO NEURON CELL CELL ADHESION,0.011063,-0.41764,-0.39659,1,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,3.4805e-05,-0.4177,-0.54737,1,0
1,GO REGULATION OF GONAD DEVELOPMENT,1.1191e-05,-0.41771,-0.44752,1,0
1,GO INTERLEUKIN 2 PRODUCTION,0.00057531,-0.41777,-0.59648,1,0
1,GO TRANSITION METAL ION TRANSPORT,6.2007e-06,-0.41783,-0.4402,1,0
1,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,2.636e-05,-0.4179,-0.47287,1,0
1,GO SEXUAL REPRODUCTION,7.1973e-06,-0.41792,-0.42704,1,0
1,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,1.3909e-05,-0.41793,-0.46454,1,0
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,1.3909e-05,-0.418,-0.41232,1,0
1,GO ACUTE INFLAMMATORY RESPONSE,0.00015974,-0.41801,-0.47518,1,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,2.8267e-05,-0.41805,-0.42407,1,0
1,GO METHYLATION,4.5891e-06,-0.4181,-0.47183,1,0
1,GO PHARYNGEAL SYSTEM DEVELOPMENT,9.5377e-05,-0.4185,-0.45419,1,0
1,GO T CELL SELECTION,0.0012758,-0.41876,-0.57554,1,0
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.4947e-05,-0.41917,-0.55051,1,0
1,GO PROTEIN HETEROOLIGOMERIZATION,7.7514e-06,-0.41938,-0.49111,1,0
1,GO EPIDERMAL CELL DIFFERENTIATION,4.8997e-05,-0.41944,-0.40903,1,0
1,GO ETHER BIOSYNTHETIC PROCESS,4.8997e-05,-0.41946,-0.50296,1,0
1,GO SMALL MOLECULE CATABOLIC PROCESS,6.6813e-06,-0.41946,-0.43639,1,0
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,6.6813e-06,-0.41947,-0.45158,1,0
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,5.2428e-05,-0.41969,-0.53531,1,0
1,GO RESPONSE TO ISOQUINOLINE ALKALOID,7.7514e-06,-0.4197,-0.43391,1,0
1,GO HISTONE H2A ACETYLATION,8.3461e-06,-0.41975,-0.46858,1,0
1,GO RESPONSE TO PROTOZOAN,0.0063209,-0.41976,-0.53624,1,0
1,GO TRANSITION METAL ION HOMEOSTASIS,1.0403e-05,-0.41984,-0.43125,1,0
1,GO DENDRITIC CELL CHEMOTAXIS,0.012106,-0.41998,-0.54692,1,0
1,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,2.4576e-05,-0.42012,-0.43074,1,0
1,GO REGULATION OF REPRODUCTIVE PROCESS,6.6813e-06,-0.42032,-0.43842,1,0
1,GO THIOESTER METABOLIC PROCESS,1.1191e-05,-0.4204,-0.41085,1,0
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00010866,-0.42056,-0.57935,1,0
1,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,5.7533e-06,-0.42134,-0.4444,1,0
1,GO EPIDERMIS DEVELOPMENT,1.7249e-05,-0.42138,-0.45401,1,0
1,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.00015974,-0.42141,-0.42047,1,0
1,GO MONOSACCHARIDE CATABOLIC PROCESS,2.636e-05,-0.42144,-0.45308,1,0
1,GO SYNAPTIC TRANSMISSION CHOLINERGIC,4.5779e-05,-0.42161,-0.40166,1,0
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,1.2035e-05,-0.42168,-0.46606,1,0
1,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,7.8298e-05,-0.42181,-0.44884,1,0
1,GO MYELOID LEUKOCYTE ACTIVATION,1.9888e-05,-0.4219,-0.54177,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00048214,-0.42208,-0.52683,1,0
1,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.0016767,-0.42221,-0.46927,1,0
1,GO LINOLEIC ACID METABOLIC PROCESS,7.8298e-05,-0.42252,-0.46842,1,0
1,GO POTASSIUM ION HOMEOSTASIS,7.1973e-06,-0.42269,-0.50196,1,0
1,GO NEUTROPHIL CHEMOTAXIS,0.0092139,-0.42274,-0.47787,1,0
1,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.00013188,-0.42314,-0.45479,1,0
1,GO HORMONE METABOLIC PROCESS,5.2428e-05,-0.42335,-0.38319,1,0
1,GO INTERLEUKIN 1 BETA PRODUCTION,0.00048214,-0.42356,-0.57127,1,0
1,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,3.4805e-05,-0.42395,-0.43179,1,0
1,GO INNER EAR RECEPTOR CELL DEVELOPMENT,1.9888e-05,-0.42399,-0.48787,1,0
1,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,7.1973e-06,-0.42417,-0.5011,1,0
1,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00018128,-0.42431,-0.43153,1,0
1,GO REGULATION OF DEFENSE RESPONSE,1.8524e-05,-0.42437,-0.50828,1,0
1,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00021879,-0.42438,-0.39432,1,0
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0042727,-0.42446,-0.56437,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00042807,-0.42452,-0.4688,1,0
1,GO DOPAMINE METABOLIC PROCESS,7.8298e-05,-0.42473,-0.47076,1,0
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00091199,-0.42474,-0.55289,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00017019,-0.42477,-0.57082,1,0
1,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,6.2007e-06,-0.42481,-0.45398,1,0
1,GO RESPONSE TO INTERLEUKIN 18,0.00332,-0.42494,-0.58371,1,0
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,1.4947e-05,-0.42496,-0.4744,1,0
1,GO EMBRYONIC PATTERN SPECIFICATION,6.2007e-06,-0.42498,-0.46489,1,0
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00045436,-0.42498,-0.56118,1,0
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00040321,-0.42518,-0.57502,1,0
1,GO REGULATION OF STEROL TRANSPORT,1.7249e-05,-0.42518,-0.50818,1,0
1,GO BRAIN MORPHOGENESIS,1.3909e-05,-0.42534,-0.51274,1,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,6.6813e-06,-0.42535,-0.46502,1,0
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00028019,-0.4257,-0.5097,1,0
1,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,6.2007e-06,-0.42588,-0.51243,1,0
1,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0012758,-0.42601,-0.44085,1,0
1,GO MYOTUBE CELL DEVELOPMENT,8.9843e-06,-0.42614,-0.43854,1,0
1,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,3.0304e-05,-0.42618,-0.45559,1,0
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,4.9495e-06,-0.4262,-0.47082,1,0
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0024341,-0.42621,-0.56097,1,0
1,GO LEUKOCYTE PROLIFERATION,0.00033648,-0.42651,-0.56049,1,0
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,4.2539e-06,-0.42656,-0.4648,1,0
1,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.00010181,-0.42679,-0.43581,1,0
1,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.034576,-0.42686,-0.63935,1,0
1,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.00051151,-0.42688,-0.47892,1,0
1,GO PIGMENT METABOLIC PROCESS,7.1973e-06,-0.4269,-0.43517,1,0
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.00068502,-0.42699,-0.46859,1,0
1,GO GLUCOCORTICOID METABOLIC PROCESS,0.00033648,-0.42701,-0.49497,1,0
1,GO SUPEROXIDE METABOLIC PROCESS,2.2907e-05,-0.42702,-0.52172,1,0
1,GO PRESYNAPSE ORGANIZATION,7.8298e-05,-0.42735,-0.50025,1,0
1,GO NEGATIVE REGULATION OF MRNA PROCESSING,6.8565e-05,-0.42738,-0.46841,1,0
1,GO DOPAMINE TRANSPORT,0.0017696,-0.42738,-0.44257,1,0
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,4.5891e-06,-0.4274,-0.48522,1,0
1,GO LEUKOTRIENE METABOLIC PROCESS,0.00029789,-0.42757,-0.47032,1,0
1,GO ORGANOPHOSPHATE CATABOLIC PROCESS,5.337e-06,-0.42766,-0.44951,1,0
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,4.9495e-06,-0.42769,-0.5095,1,0
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,3.9422e-06,-0.4277,-0.48841,1,0
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0024341,-0.42771,-0.52946,1,0
1,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,1.9888e-05,-0.42775,-0.44344,1,0
1,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,6.6813e-06,-0.42821,-0.44247,1,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,1.0403e-05,-0.42825,-0.51403,1,0
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00057531,-0.42846,-0.56813,1,0
1,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.020391,-0.4285,-0.48062,1,0
1,GO TYPE 2 IMMUNE RESPONSE,0.0018673,-0.42881,-0.53432,1,0
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.00064645,-0.42885,-0.38061,1,0
1,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,2.2907e-05,-0.42935,-0.40528,1,0
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.0042727,-0.42943,-0.60734,1,0
1,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,2.2907e-05,-0.42961,-0.43297,1,0
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,1.0403e-05,-0.4299,-0.51367,1,0
1,GO LEUKOCYTE APOPTOTIC PROCESS,0.00017019,-0.43,-0.56065,1,0
1,GO LYMPHOCYTE CHEMOTAXIS,0.020391,-0.43016,-0.48296,1,0
1,GO EOSINOPHIL MIGRATION,0.038848,-0.43032,-0.48453,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0015041,-0.43033,-0.53179,1,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,8.9843e-06,-0.43036,-0.45761,1,0
1,GO LIVER REGENERATION,1.2035e-05,-0.43039,-0.43731,1,0
1,GO THYMIC T CELL SELECTION,0.0047188,-0.43054,-0.54885,1,0
1,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,7.1973e-06,-0.43082,-0.55613,1,0
1,GO T CELL ACTIVATION,0.00010866,-0.43084,-0.56945,1,0
1,GO SENSORY PERCEPTION OF LIGHT STIMULUS,6.6813e-06,-0.43122,-0.41695,1,0
1,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,3.7287e-05,-0.43128,-0.47427,1,0
1,GO REGULATION OF MRNA PROCESSING,1.1191e-05,-0.43137,-0.49696,1,0
1,GO CELLULAR LIPID CATABOLIC PROCESS,7.1973e-06,-0.43142,-0.4823,1,0
1,GO TRIGLYCERIDE CATABOLIC PROCESS,0.00012367,-0.43144,-0.34693,1,0
1,GO EXTRACELLULAR TRANSPORT,0.00035748,-0.43151,-0.42942,1,0
1,GO ACROSOME ASSEMBLY,0.00014989,-0.43167,-0.44541,1,0
1,GO REGULATION OF B CELL APOPTOTIC PROCESS,6.4139e-05,-0.43198,-0.52857,1,0
1,GO CYTOKINE PRODUCTION,2.636e-05,-0.43203,-0.55417,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,6.8565e-05,-0.43207,-0.46888,1,0
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,8.3461e-06,-0.43244,-0.46981,1,0
1,GO REGULATION OF RNA SPLICING,1.0403e-05,-0.4325,-0.47474,1,0
1,GO URETER DEVELOPMENT,8.9327e-05,-0.4325,-0.45811,1,0
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0054671,-0.43257,-0.53556,1,0
1,GO REGULATION OF PH,4.9495e-06,-0.43266,-0.48635,1,0
1,GO ACETYL COA METABOLIC PROCESS,3.9422e-06,-0.43274,-0.52368,1,0
1,GO CATECHOLAMINE METABOLIC PROCESS,7.3279e-05,-0.43274,-0.45481,1,0
1,GO REGULATION OF SYNAPSE ASSEMBLY,6.6813e-06,-0.43283,-0.55313,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00040321,-0.43294,-0.58043,1,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,5.337e-06,-0.43314,-0.44329,1,0
1,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,2.8267e-05,-0.43325,-0.41878,1,0
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0049572,-0.43326,-0.48648,1,0
1,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,9.6689e-06,-0.43365,-0.44025,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.021265,-0.43371,-0.45557,1,0
1,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,1.1191e-05,-0.43372,-0.46745,1,0
1,GO SYNAPTIC SIGNALING,1.6059e-05,-0.43388,-0.52847,1,0
1,GO CRISTAE FORMATION,7.7514e-06,-0.434,-0.55277,1,0
1,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00332,-0.43403,-0.56809,1,0
1,GO MITOCHONDRIAL DEPOLARIZATION,0.00023283,-0.43434,-0.47943,1,0
1,GO DNA MODIFICATION,7.1973e-06,-0.4344,-0.44293,1,0
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,2.636e-05,-0.4345,-0.51965,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,7.3279e-05,-0.43451,-0.58507,1,0
1,GO POSITIVE REGULATION OF RNA SPLICING,1.7249e-05,-0.43453,-0.47103,1,0
1,GO C21 STEROID HORMONE METABOLIC PROCESS,0.00012367,-0.43459,-0.41749,1,0
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,1.2035e-05,-0.4346,-0.49372,1,0
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,2.2907e-05,-0.43475,-0.38555,1,0
1,GO RESPONSE TO NITRIC OXIDE,4.5779e-05,-0.43509,-0.47625,1,0
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00010181,-0.43515,-0.57549,1,0
1,GO PIGMENT GRANULE LOCALIZATION,1.6059e-05,-0.43522,-0.43986,1,0
1,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,6.6813e-06,-0.4353,-0.45432,1,0
1,GO SECONDARY HEART FIELD SPECIFICATION,0.00096503,-0.43539,-0.5113,1,0
1,GO POSITIVE REGULATION OF HORMONE SECRETION,3.0304e-05,-0.43546,-0.43786,1,0
1,GO MALE SEX DETERMINATION,0.00014062,-0.43561,-0.4569,1,0
1,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,4.9495e-06,-0.43575,-0.4552,1,0
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0054671,-0.43576,-0.56053,1,0
1,GO ADAPTIVE IMMUNE RESPONSE,0.0015041,-0.43582,-0.58293,1,0
1,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.00042807,-0.43585,-0.38996,1,0
1,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.00096503,-0.43585,-0.49473,1,0
1,GO MRNA 3 END PROCESSING,1.1191e-05,-0.43601,-0.46706,1,0
1,GO REGULATION OF HISTONE H3 K4 METHYLATION,2.636e-05,-0.43607,-0.44796,1,0
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00011593,-0.43643,-0.58557,1,0
1,GO VESICLE FUSION TO PLASMA MEMBRANE,0.00054254,-0.43647,-0.60279,1,0
1,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.00015974,-0.43661,-0.45903,1,0
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,4.9495e-06,-0.43667,-0.48522,1,0
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00021879,-0.43684,-0.57466,1,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,3.9422e-06,-0.43686,-0.49041,1,0
1,GO TUMOR NECROSIS FACTOR SECRETION,7.3279e-05,-0.43694,-0.50464,1,0
1,GO INTERLEUKIN 12 PRODUCTION,0.0044907,-0.43707,-0.53204,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,4.8997e-05,-0.43709,-0.59441,1,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,3.4805e-05,-0.4371,-0.49303,1,0
1,GO REGULATION OF INFLAMMATORY RESPONSE,3.248e-05,-0.43715,-0.54163,1,0
1,GO DENDRITIC CELL DIFFERENTIATION,0.0092139,-0.43739,-0.56444,1,0
1,GO COPPER ION TRANSPORT,3.248e-05,-0.43792,-0.45212,1,0
1,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.00014062,-0.43816,-0.41031,1,0
1,GO IMMUNE EFFECTOR PROCESS,2.2907e-05,-0.43823,-0.55017,1,0
1,GO RESPONSE TO VIRUS,0.00013188,-0.43823,-0.49668,1,0
1,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,1.1191e-05,-0.43828,-0.42605,1,0
1,GO LEARNING,8.3461e-06,-0.4383,-0.52106,1,0
1,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,1.8524e-05,-0.43841,-0.45924,1,0
1,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,4.5891e-06,-0.43871,-0.50057,1,0
1,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,7.1973e-06,-0.43892,-0.44107,1,0
1,GO INTRACELLULAR TRANSPORT,4.9495e-06,-0.43894,-0.46872,1,0
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,1.7249e-05,-0.43904,-0.49057,1,0
1,GO SENSORY PERCEPTION OF PAIN,6.6813e-06,-0.43908,-0.49028,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.00019306,-0.43911,-0.54416,1,0
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,4.9495e-06,-0.43927,-0.49288,1,0
1,GO LEUKOCYTE CELL CELL ADHESION,0.00013188,-0.43942,-0.57943,1,0
1,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00014989,-0.43946,-0.56234,1,0
1,GO NEUROTRANSMITTER SECRETION,0.00020554,-0.43952,-0.54765,1,0
1,GO REGULATION OF IMMUNE RESPONSE,5.2428e-05,-0.44001,-0.55129,1,0
1,GO RRNA TRANSCRIPTION,8.9843e-06,-0.44004,-0.49547,1,0
1,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00024771,-0.44012,-0.50181,1,0
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,4.2539e-06,-0.44015,-0.4929,1,0
1,GO REGULATION OF RIBOSOME BIOGENESIS,3.9422e-06,-0.44021,-0.51539,1,0
1,GO FATTY ACID BIOSYNTHETIC PROCESS,8.9843e-06,-0.44031,-0.43602,1,0
1,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,8.3461e-06,-0.44032,-0.49374,1,0
1,GO POSITIVE REGULATION OF VIRAL PROCESS,3.9422e-06,-0.44032,-0.51602,1,0
1,GO IMMUNOGLOBULIN SECRETION,0.00051151,-0.44046,-0.50548,1,0
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00020554,-0.44051,-0.55927,1,0
1,GO DETECTION OF BIOTIC STIMULUS,0.0012758,-0.44052,-0.53321,1,0
1,GO POSITIVE REGULATION OF LYASE ACTIVITY,4.8997e-05,-0.4407,-0.44139,1,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,8.3461e-06,-0.44079,-0.45513,1,0
1,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.0016767,-0.44082,-0.42742,1,0
1,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0015882,-0.44095,-0.5208,1,0
1,GO CELL FATE SPECIFICATION,1.7249e-05,-0.44102,-0.48203,1,0
1,GO RESPONSE TO ALKALOID,6.6813e-06,-0.4413,-0.47194,1,0
1,GO CELLULAR IRON ION HOMEOSTASIS,1.3909e-05,-0.44134,-0.4404,1,0
1,GO NON CANONICAL WNT SIGNALING PATHWAY,5.337e-06,-0.44176,-0.5004,1,0
1,GO CYTOKINE METABOLIC PROCESS,5.9985e-05,-0.44236,-0.57074,1,0
1,GO CELLULAR COPPER ION HOMEOSTASIS,1.2939e-05,-0.44241,-0.51089,1,0
1,GO NEUTRAL LIPID METABOLIC PROCESS,6.6813e-06,-0.4426,-0.48351,1,0
1,GO REGULATION OF SENSORY PERCEPTION,2.2907e-05,-0.44263,-0.41349,1,0
1,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,1.2035e-05,-0.44296,-0.44493,1,0
1,GO AXIS SPECIFICATION,7.1973e-06,-0.44307,-0.45376,1,0
1,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,4.5779e-05,-0.44314,-0.40431,1,0
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,5.7533e-06,-0.44351,-0.47248,1,0
1,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,3.7287e-05,-0.44405,-0.4292,1,0
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,4.8997e-05,-0.4443,-0.53101,1,0
1,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,6.2007e-06,-0.4444,-0.44661,1,0
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,4.9495e-06,-0.44441,-0.48953,1,0
1,GO DIGESTIVE SYSTEM PROCESS,2.8267e-05,-0.44443,-0.38338,1,0
1,GO CARNITINE METABOLIC PROCESS,0.00014062,-0.44455,-0.39855,1,0
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,9.6689e-06,-0.4447,-0.45039,1,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,8.3461e-06,-0.4447,-0.42419,1,0
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00014062,-0.44471,-0.59466,1,0
1,GO T CELL MIGRATION,0.0018673,-0.44481,-0.59239,1,0
1,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,6.4139e-05,-0.44489,-0.42933,1,0
1,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0034935,-0.44495,-0.50933,1,0
1,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.00015974,-0.4451,-0.37385,1,0
1,GO CYTOKINE SECRETION,0.00010181,-0.44513,-0.5311,1,0
1,GO INTERACTION WITH SYMBIONT,2.636e-05,-0.44515,-0.45139,1,0
1,GO RENAL ABSORPTION,0.00033648,-0.44521,-0.52118,1,0
1,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.00014989,-0.44532,-0.44892,1,0
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00072571,-0.44549,-0.5805,1,0
1,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.9888e-05,-0.4456,-0.46139,1,0
1,GO DETECTION OF OTHER ORGANISM,0.0024341,-0.44581,-0.56133,1,0
1,GO LEUKOCYTE CHEMOTAXIS,0.00033648,-0.44594,-0.52878,1,0
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00018128,-0.44608,-0.56657,1,0
1,GO NAD BIOSYNTHETIC PROCESS,0.00024771,-0.44609,-0.47963,1,0
1,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,5.337e-06,-0.44615,-0.49262,1,0
1,GO BILE ACID BIOSYNTHETIC PROCESS,1.3909e-05,-0.44617,-0.43882,1,0
1,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.0066311,-0.44618,-0.53589,1,0
1,GO MICROTUBULE SEVERING,0.00010866,-0.44624,-0.4895,1,0
1,GO CELL DIFFERENTIATION IN SPINAL CORD,3.7287e-05,-0.4463,-0.48372,1,0
1,GO DNA DEMETHYLATION,2.636e-05,-0.44635,-0.4586,1,0
1,GO ORGANIC ACID METABOLIC PROCESS,5.337e-06,-0.44635,-0.44674,1,0
1,GO RESPONSE TO DEXAMETHASONE,8.9843e-06,-0.4464,-0.47623,1,0
1,GO VENTRAL SPINAL CORD DEVELOPMENT,4.5779e-05,-0.44645,-0.48265,1,0
1,GO RESPONSE TO LEAD ION,9.6689e-06,-0.44654,-0.51579,1,0
1,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,9.6689e-06,-0.44663,-0.49448,1,0
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,3.9422e-06,-0.44669,-0.47134,1,0
1,GO T CELL DIFFERENTIATION,5.9985e-05,-0.44724,-0.58785,1,0
1,GO REGULATORY T CELL DIFFERENTIATION,0.00028019,-0.44729,-0.59189,1,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00033648,-0.44738,-0.59765,1,0
1,GO REGULATION OF CYTOPLASMIC TRANSLATION,4.5891e-06,-0.44741,-0.47881,1,0
1,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,3.7287e-05,-0.44747,-0.53578,1,0
1,GO DORSAL VENTRAL PATTERN FORMATION,4.8997e-05,-0.44754,-0.46446,1,0
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,4.2539e-06,-0.4476,-0.4647,1,0
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0016767,-0.44775,-0.52287,1,0
1,GO NEGATIVE REGULATION OF CELL KILLING,0.0080134,-0.44778,-0.63237,1,0
1,GO DIOL BIOSYNTHETIC PROCESS,0.00021879,-0.44793,-0.47262,1,0
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,2.8267e-05,-0.44799,-0.55561,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,6.6813e-06,-0.44801,-0.49043,1,0
1,GO PANCREATIC JUICE SECRETION,0.00024771,-0.44808,-0.46125,1,0
1,GO REGULATION OF CILIUM ASSEMBLY,1.8524e-05,-0.4481,-0.49531,1,0
1,GO DICARBOXYLIC ACID METABOLIC PROCESS,1.1191e-05,-0.44813,-0.41104,1,0
1,GO REGULATION OF NEUTROPHIL MIGRATION,0.00091199,-0.44816,-0.6018,1,0
1,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00013188,-0.44825,-0.58113,1,0
1,GO LYMPHOCYTE MIGRATION,0.0021907,-0.44847,-0.54771,1,0
1,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,8.9843e-06,-0.44866,-0.47264,1,0
1,GO REGULATION OF LIPID TRANSPORT,1.4947e-05,-0.44869,-0.45451,1,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,3.0304e-05,-0.4487,-0.46336,1,0
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,4.5891e-06,-0.44878,-0.50243,1,0
1,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,5.6086e-05,-0.44887,-0.49723,1,0
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,5.7533e-06,-0.44888,-0.47291,1,0
1,GO SHORT TERM MEMORY,0.00029789,-0.44896,-0.48884,1,0
1,GO LIPID OXIDATION,7.7514e-06,-0.44898,-0.44661,1,0
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00011593,-0.44907,-0.57314,1,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,6.2007e-06,-0.44933,-0.49127,1,0
1,GO REFLEX,0.0042727,-0.44945,-0.4488,1,0
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,5.2428e-05,-0.44955,-0.54431,1,0
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.00048214,-0.44969,-0.52027,1,0
1,GO LYMPHOCYTE ACTIVATION,3.9936e-05,-0.44974,-0.57922,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00029789,-0.44974,-0.55789,1,0
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,4.5891e-06,-0.44982,-0.52075,1,0
1,GO MONOVALENT INORGANIC CATION TRANSPORT,1.2939e-05,-0.44986,-0.45507,1,0
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,3.9422e-06,-0.45014,-0.49105,1,0
1,GO PROGRAMMED NECROTIC CELL DEATH,6.4139e-05,-0.45016,-0.50651,1,0
1,GO WALKING BEHAVIOR,5.9985e-05,-0.4503,-0.50489,1,0
1,GO AMINE TRANSPORT,0.00042807,-0.45043,-0.435,1,0
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,9.6689e-06,-0.4507,-0.45366,1,0
1,GO UV DAMAGE EXCISION REPAIR,7.7514e-06,-0.45071,-0.51745,1,0
1,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.00020554,-0.45073,-0.42784,1,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.00018128,-0.45081,-0.47098,1,0
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,7.3279e-05,-0.45082,-0.65229,1,0
1,GO MACROMOLECULE CATABOLIC PROCESS,4.2539e-06,-0.45086,-0.4755,1,0
1,GO T CELL LINEAGE COMMITMENT,0.00014062,-0.45087,-0.55368,1,0
1,GO DETECTION OF ABIOTIC STIMULUS,7.7514e-06,-0.45092,-0.45368,1,0
1,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,5.9985e-05,-0.45099,-0.5736,1,0
1,GO ZYMOGEN ACTIVATION,7.3279e-05,-0.45106,-0.53957,1,0
1,GO HISTONE MONOUBIQUITINATION,9.6689e-06,-0.45116,-0.52827,1,0
1,GO REGULATION OF LYASE ACTIVITY,7.1973e-06,-0.45127,-0.46844,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00014062,-0.45129,-0.58271,1,0
1,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.0010798,-0.45137,-0.59275,1,0
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,8.3641e-05,-0.45144,-0.52111,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,5.337e-06,-0.45151,-0.51971,1,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,3.9422e-06,-0.45178,-0.50826,1,0
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,4.5891e-06,-0.4519,-0.49093,1,0
1,GO RESPONSE TO CORTICOSTEROID,1.2035e-05,-0.45192,-0.49812,1,0
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,3.9422e-06,-0.45215,-0.47476,1,0
1,GO REGULATION OF CELL ACTIVATION,5.9985e-05,-0.45232,-0.58956,1,0
1,GO REGULATION OF CALCIUM MEDIATED SIGNALING,6.6813e-06,-0.45242,-0.51165,1,0
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,1.2939e-05,-0.45249,-0.52644,1,0
1,GO COCHLEA DEVELOPMENT,2.1347e-05,-0.45271,-0.49876,1,0
1,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,6.8565e-05,-0.45272,-0.53416,1,0
1,GO VACUOLAR ACIDIFICATION,1.0403e-05,-0.45272,-0.46664,1,0
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,8.9843e-06,-0.45277,-0.53367,1,0
1,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0003797,-0.45282,-0.48953,1,0
1,GO STEROID METABOLIC PROCESS,1.2939e-05,-0.45292,-0.44664,1,0
1,GO REGULATION OF VIRAL TRANSCRIPTION,5.7533e-06,-0.45299,-0.48969,1,0
1,GO CELL DIVISION,8.9843e-06,-0.45299,-0.48643,1,0
1,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.00014062,-0.45323,-0.43305,1,0
1,GO SULFUR COMPOUND METABOLIC PROCESS,6.6813e-06,-0.45331,-0.43624,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,1.1191e-05,-0.4534,-0.43191,1,0
1,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,7.8298e-05,-0.4534,-0.49427,1,0
1,GO BILE ACID METABOLIC PROCESS,1.6059e-05,-0.4534,-0.43936,1,0
1,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.00023283,-0.45342,-0.50043,1,0
1,GO NEUROTRANSMITTER TRANSPORT,7.8298e-05,-0.45429,-0.53832,1,0
1,GO BLASTOCYST FORMATION,4.5891e-06,-0.45444,-0.48792,1,0
1,GO REGULATION OF CELL MATURATION,1.7249e-05,-0.45453,-0.42307,1,0
1,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,7.7514e-06,-0.45467,-0.47866,1,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,1.1191e-05,-0.45491,-0.39927,1,0
1,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,8.9843e-06,-0.45491,-0.51778,1,0
1,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,6.2007e-06,-0.45491,-0.49836,1,0
1,GO SYNAPTIC MEMBRANE ADHESION,0.00014062,-0.45493,-0.58049,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,2.8267e-05,-0.45497,-0.48209,1,0
1,GO RESPONSE TO INTERLEUKIN 4,3.7287e-05,-0.45508,-0.5233,1,0
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00057531,-0.45508,-0.6246,1,0
1,GO IRON ION TRANSPORT,1.1191e-05,-0.45511,-0.47838,1,0
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00013188,-0.45514,-0.50524,1,0
1,GO PROTEIN O LINKED MANNOSYLATION,2.4576e-05,-0.45516,-0.4811,1,0
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0042727,-0.45528,-0.52503,1,0
1,GO GLYCOLIPID BIOSYNTHETIC PROCESS,3.9936e-05,-0.45528,-0.43748,1,0
1,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,5.337e-06,-0.45548,-0.47991,1,0
1,GO CELLULAR MACROMOLECULE LOCALIZATION,4.9495e-06,-0.45558,-0.48736,1,0
1,GO NADH METABOLIC PROCESS,5.9985e-05,-0.45565,-0.50469,1,0
1,GO MRNA CLEAVAGE,1.1191e-05,-0.4557,-0.50409,1,0
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,6.2007e-06,-0.45572,-0.46605,1,0
1,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,3.7287e-05,-0.45576,-0.52066,1,0
1,GO IMP BIOSYNTHETIC PROCESS,0.00023283,-0.45576,-0.43348,1,0
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.037377,-0.4558,-0.43038,1,0
1,GO NEGATIVE REGULATION OF LYASE ACTIVITY,4.5779e-05,-0.45583,-0.48596,1,0
1,GO NERVOUS SYSTEM PROCESS,6.2007e-06,-0.45599,-0.47276,1,0
1,GO MULTI ORGANISM PROCESS,6.2007e-06,-0.4561,-0.45773,1,0
1,GO NEUTRAL LIPID CATABOLIC PROCESS,4.8997e-05,-0.45617,-0.39929,1,0
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.248e-05,-0.45629,-0.58972,1,0
1,GO PROTEIN TRIMERIZATION,3.4805e-05,-0.45633,-0.54341,1,0
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,2.1347e-05,-0.45642,-0.43172,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,8.9327e-05,-0.45643,-0.55642,1,0
1,GO MULTICELLULAR ORGANISM REPRODUCTION,5.7533e-06,-0.45645,-0.45834,1,0
1,GO SUPEROXIDE ANION GENERATION,0.00014062,-0.45655,-0.53592,1,0
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.012106,-0.45657,-0.63837,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,6.8565e-05,-0.45679,-0.57456,1,0
1,GO MRNA EXPORT FROM NUCLEUS,9.6689e-06,-0.4568,-0.49867,1,0
1,GO MICROTUBULE BASED MOVEMENT,1.2939e-05,-0.45686,-0.48017,1,0
1,GO SARCOMERE ORGANIZATION,1.6059e-05,-0.45694,-0.43246,1,0
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,4.9495e-06,-0.45694,-0.50136,1,0
1,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,5.9985e-05,-0.45704,-0.45075,1,0
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0024341,-0.45705,-0.75725,1,0
1,GO INFLAMMATORY RESPONSE,3.4805e-05,-0.45714,-0.56109,1,0
1,GO PEROXISOMAL MEMBRANE TRANSPORT,4.2539e-06,-0.45715,-0.51683,1,0
1,GO POSITIVE REGULATION OF NUCLEAR DIVISION,7.7514e-06,-0.45727,-0.48874,1,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,5.7533e-06,-0.45753,-0.59958,1,0
1,GO DIET INDUCED THERMOGENESIS,2.636e-05,-0.45784,-0.47625,1,0
1,GO MATING,2.8267e-05,-0.45808,-0.45929,1,0
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,1.1191e-05,-0.45815,-0.51867,1,0
1,GO REGULATION OF T CELL DIFFERENTIATION,8.3641e-05,-0.45817,-0.59086,1,0
1,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,1.8524e-05,-0.45849,-0.54302,1,0
1,GO NUCLEUS ORGANIZATION,6.6813e-06,-0.45859,-0.50329,1,0
1,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,5.337e-06,-0.4586,-0.48634,1,0
1,GO MACROPHAGE MIGRATION,0.00054254,-0.45861,-0.54468,1,0
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,6.4139e-05,-0.45874,-0.48457,1,0
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.8267e-05,-0.45883,-0.52931,1,0
1,GO FLUID TRANSPORT,0.00014062,-0.459,-0.4905,1,0
1,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,7.7514e-06,-0.45933,-0.52028,1,0
1,GO PROTEIN MATURATION,9.6689e-06,-0.45951,-0.46943,1,0
1,GO FUCOSYLATION,8.3461e-06,-0.45955,-0.51321,1,0
1,GO MONOCYTE CHEMOTAXIS,0.023112,-0.45961,-0.45653,1,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,7.1973e-06,-0.45969,-0.43698,1,0
1,GO ORGANIC ACID BIOSYNTHETIC PROCESS,4.9495e-06,-0.45975,-0.46137,1,0
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,4.8997e-05,-0.45976,-0.59307,1,0
1,GO PLASMINOGEN ACTIVATION,7.8298e-05,-0.45978,-0.58327,1,0
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,7.7514e-06,-0.45988,-0.53162,1,0
1,GO LEUKOCYTE TETHERING OR ROLLING,0.00013188,-0.45992,-0.57537,1,0
1,GO FATTY ACID CATABOLIC PROCESS,1.6059e-05,-0.45993,-0.44943,1,0
1,GO RESPONSE TO PARATHYROID HORMONE,4.2763e-05,-0.46008,-0.47888,1,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,1.8524e-05,-0.46021,-0.54701,1,0
1,GO HEXOSE CATABOLIC PROCESS,1.9888e-05,-0.46022,-0.4987,1,0
1,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00019306,-0.46026,-0.3992,1,0
1,GO INTERMEDIATE FILAMENT BASED PROCESS,1.3909e-05,-0.46031,-0.4948,1,0
1,GO POSITIVE REGULATION OF CHEMOTAXIS,5.6086e-05,-0.46032,-0.57307,1,0
1,GO MECHANOSENSORY BEHAVIOR,0.0038653,-0.46037,-0.4639,1,0
1,GO REGULATION OF NEUROTRANSMITTER UPTAKE,2.1347e-05,-0.46055,-0.49776,1,0
1,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.0038653,-0.46055,-0.4795,1,0
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0054671,-0.46073,-0.52022,1,0
1,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0010798,-0.46077,-0.54136,1,0
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,4.5891e-06,-0.46121,-0.4825,1,0
1,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,8.3461e-06,-0.46132,-0.47543,1,0
1,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,6.6813e-06,-0.46176,-0.47692,1,0
1,GO ACTIN NUCLEATION,6.6813e-06,-0.46193,-0.49937,1,0
1,GO KETONE BIOSYNTHETIC PROCESS,0.00013188,-0.46237,-0.44833,1,0
1,GO METENCEPHALON DEVELOPMENT,9.6689e-06,-0.46257,-0.52669,1,0
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,1.4947e-05,-0.46274,-0.56636,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,4.5779e-05,-0.46281,-0.60746,1,0
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,4.5891e-06,-0.46282,-0.50142,1,0
1,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.0012071,-0.46288,-0.507,1,0
1,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00012367,-0.46289,-0.52174,1,0
1,GO HEART FORMATION,3.0304e-05,-0.46306,-0.49525,1,0
1,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,9.5377e-05,-0.46315,-0.51395,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00018128,-0.46318,-0.56328,1,0
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.00020554,-0.46326,-0.48527,1,0
1,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,1.2035e-05,-0.46337,-0.51149,1,0
1,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,4.5891e-06,-0.46343,-0.46602,1,0
1,GO COPPER ION HOMEOSTASIS,7.7514e-06,-0.46359,-0.49805,1,0
1,GO MYOBLAST PROLIFERATION,3.0304e-05,-0.46383,-0.48559,1,0
1,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,4.5779e-05,-0.4639,-0.49047,1,0
1,GO DENDRITE EXTENSION,0.00024771,-0.46405,-0.50109,1,0
1,GO AMINE BIOSYNTHETIC PROCESS,0.00076864,-0.46407,-0.37582,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00031664,-0.46421,-0.56265,1,0
1,GO RESPONSE TO NICOTINE,2.8267e-05,-0.46439,-0.46378,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00014989,-0.46443,-0.59205,1,0
1,GO DICARBOXYLIC ACID TRANSPORT,5.6086e-05,-0.46452,-0.47652,1,0
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,9.6689e-06,-0.46458,-0.5033,1,0
1,GO CELLULAR RESPONSE TO VIRUS,2.1347e-05,-0.46478,-0.52459,1,0
1,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,1.1191e-05,-0.46503,-0.51866,1,0
1,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00013188,-0.46525,-0.58758,1,0
1,GO ANTIGEN PROCESSING AND PRESENTATION,4.5779e-05,-0.4653,-0.5085,1,0
1,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.010101,-0.46536,-0.44416,1,0
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,2.2907e-05,-0.46551,-0.49286,1,0
1,GO REGULATION OF POTASSIUM ION TRANSPORT,8.9843e-06,-0.46563,-0.49421,1,0
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,1.9888e-05,-0.46565,-0.53655,1,0
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0020776,-0.46571,-0.60277,1,0
1,GO ARACHIDONIC ACID SECRETION,0.00010181,-0.46572,-0.43759,1,0
1,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,5.6086e-05,-0.46591,-0.49796,1,0
1,GO POTASSIUM ION TRANSPORT,2.2907e-05,-0.46592,-0.48946,1,0
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.6059e-05,-0.46598,-0.59643,1,0
1,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,2.8267e-05,-0.46605,-0.55885,1,0
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,2.2907e-05,-0.46614,-0.60997,1,0
1,GO ANIMAL ORGAN FORMATION,8.9843e-06,-0.46627,-0.50784,1,0
1,GO REGULATION OF CELL CELL ADHESION,2.8267e-05,-0.46631,-0.59175,1,0
1,GO FEVER GENERATION,1.7249e-05,-0.46649,-0.49961,1,0
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,4.2539e-06,-0.46665,-0.50048,1,0
1,GO FOLIC ACID METABOLIC PROCESS,7.7514e-06,-0.46673,-0.47082,1,0
1,GO DETECTION OF CALCIUM ION,0.00051151,-0.46713,-0.42168,1,0
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00054254,-0.46736,-0.58845,1,0
1,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,1.2939e-05,-0.46737,-0.46018,1,0
1,GO CHLORIDE TRANSPORT,6.6813e-06,-0.46743,-0.48664,1,0
1,GO REGULATION OF PROTEIN ACETYLATION,5.337e-06,-0.46752,-0.50802,1,0
1,GO CHROMATIN REMODELING,9.6689e-06,-0.4677,-0.50599,1,0
1,GO CELLULAR PIGMENTATION,1.8524e-05,-0.46776,-0.42112,1,0
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,4.9495e-06,-0.46777,-0.52677,1,0
1,GO ALCOHOL CATABOLIC PROCESS,2.1347e-05,-0.46781,-0.46215,1,0
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,1.2035e-05,-0.46789,-0.56286,1,0
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,6.8565e-05,-0.46793,-0.55295,1,0
1,GO RESPONSE TO AUDITORY STIMULUS,0.0014241,-0.46803,-0.47386,1,0
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,1.0403e-05,-0.46807,-0.44499,1,0
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00010181,-0.46816,-0.58463,1,0
1,GO RESPONSE TO ELECTRICAL STIMULUS,1.7249e-05,-0.46822,-0.46489,1,0
1,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,4.8997e-05,-0.46826,-0.49723,1,0
1,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,6.2007e-06,-0.46829,-0.50247,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,1.7249e-05,-0.46832,-0.54303,1,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,6.6813e-06,-0.46835,-0.45131,1,0
1,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,7.1973e-06,-0.46837,-0.55188,1,0
1,GO IMMUNOGLOBULIN PRODUCTION,1.4947e-05,-0.46852,-0.56838,1,0
1,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,4.5779e-05,-0.46862,-0.52149,1,0
1,GO MITOTIC CYTOKINESIS,8.9843e-06,-0.46867,-0.5201,1,0
1,GO REGULATION OF AMYLOID BETA CLEARANCE,4.8997e-05,-0.46877,-0.62512,1,0
1,GO POSITIVE REGULATION OF CYTOKINE SECRETION,6.4139e-05,-0.46878,-0.53883,1,0
1,GO IRON ION HOMEOSTASIS,1.2939e-05,-0.46882,-0.46679,1,0
1,GO STEROID BIOSYNTHETIC PROCESS,3.7287e-05,-0.46907,-0.42738,1,0
1,GO REGULATION OF HORMONE LEVELS,1.9888e-05,-0.46909,-0.45463,1,0
1,GO ORGANELLE ASSEMBLY,5.7533e-06,-0.46914,-0.49646,1,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,7.7514e-06,-0.46938,-0.53283,1,0
1,GO ALCOHOL METABOLIC PROCESS,6.2007e-06,-0.46948,-0.48825,1,0
1,GO ORGANELLE DISASSEMBLY,4.9495e-06,-0.46948,-0.51708,1,0
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00091199,-0.46958,-0.56667,1,0
1,GO MONONUCLEAR CELL MIGRATION,0.0038653,-0.46961,-0.51594,1,0
1,GO REGULATION OF DNA REPAIR,7.7514e-06,-0.46963,-0.516,1,0
1,GO C4 DICARBOXYLATE TRANSPORT,3.4805e-05,-0.4697,-0.45881,1,0
1,GO RESPONSE TO CAFFEINE,3.7287e-05,-0.46972,-0.46418,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0028457,-0.46978,-0.52655,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0012071,-0.4698,-0.61528,1,0
1,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0015041,-0.46987,-0.52097,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,5.6086e-05,-0.46988,-0.52512,1,0
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.033245,-0.46992,-0.40575,1,0
1,GO ACTIVATION OF IMMUNE RESPONSE,2.8267e-05,-0.46993,-0.55826,1,0
1,GO REGULATION OF MICROTUBULE BASED PROCESS,8.9843e-06,-0.46995,-0.52998,1,0
1,GO RESPONSE TO X RAY,7.7514e-06,-0.47,-0.54744,1,0
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.9495e-06,-0.47013,-0.49888,1,0
1,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,3.7287e-05,-0.47018,-0.53507,1,0
1,GO LIPID CATABOLIC PROCESS,6.2007e-06,-0.47045,-0.48252,1,0
1,GO SINGLE STRAND BREAK REPAIR,3.7287e-05,-0.4705,-0.47035,1,0
1,GO GRANULOCYTE CHEMOTAXIS,0.00332,-0.47054,-0.49602,1,0
1,GO PROTEIN TETRAMERIZATION,4.9495e-06,-0.47061,-0.48181,1,0
1,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,7.7514e-06,-0.47108,-0.47789,1,0
1,GO MITOCHONDRIAL FUSION,7.7514e-06,-0.47117,-0.5253,1,0
1,GO VIRAL RNA GENOME REPLICATION,1.0403e-05,-0.47123,-0.52011,1,0
1,GO NATURAL KILLER CELL ACTIVATION,0.00015974,-0.47129,-0.57491,1,0
1,GO FEMALE GENITALIA DEVELOPMENT,9.6689e-06,-0.47133,-0.47076,1,0
1,GO HISTONE H3 K4 METHYLATION,1.2939e-05,-0.47136,-0.51863,1,0
1,GO POSITIVE REGULATION OF HEART RATE,5.9985e-05,-0.4714,-0.4547,1,0
1,GO SUCKLING BEHAVIOR,0.00020554,-0.47146,-0.56311,1,0
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.00031664,-0.47158,-0.74513,1,0
1,GO ANIMAL ORGAN REGENERATION,6.2007e-06,-0.47169,-0.50375,1,0
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,4.5779e-05,-0.47185,-0.55712,1,0
1,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00021879,-0.47189,-0.52473,1,0
1,GO PROTEIN TRANSPORT ALONG MICROTUBULE,3.0304e-05,-0.47193,-0.49983,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,1.2939e-05,-0.47213,-0.47516,1,0
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,3.9422e-06,-0.47221,-0.48483,1,0
1,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,2.8267e-05,-0.4723,-0.54124,1,0
1,GO HEAT GENERATION,2.2907e-05,-0.47236,-0.49165,1,0
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.9888e-05,-0.4724,-0.52979,1,0
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0172,-0.47254,-0.61513,1,0
1,GO INNER DYNEIN ARM ASSEMBLY,0.00060992,-0.47273,-0.49998,1,0
1,GO TRANSPORT ALONG MICROTUBULE,8.9843e-06,-0.47277,-0.53329,1,0
1,GO CELL ACTIVATION,9.6689e-06,-0.47295,-0.56682,1,0
1,GO DEVELOPMENTAL INDUCTION,3.7287e-05,-0.47299,-0.46613,1,0
1,GO PROTEIN POLYUBIQUITINATION,4.5891e-06,-0.473,-0.50465,1,0
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,4.5779e-05,-0.47302,-0.47258,1,0
1,GO DEFENSE RESPONSE TO VIRUS,0.00020554,-0.47306,-0.52999,1,0
1,GO LENS FIBER CELL DEVELOPMENT,3.0304e-05,-0.47353,-0.51867,1,0
1,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,4.9495e-06,-0.47356,-0.45794,1,0
1,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,1.4947e-05,-0.47369,-0.47499,1,0
1,GO NADP METABOLIC PROCESS,9.6689e-06,-0.47372,-0.45806,1,0
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,4.9495e-06,-0.47401,-0.50764,1,0
1,GO PARTURITION,1.4947e-05,-0.47404,-0.47755,1,0
1,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,1.6059e-05,-0.47422,-0.53457,1,0
1,GO REGULATION OF AMINO ACID TRANSPORT,0.00021879,-0.47437,-0.49078,1,0
1,GO CELLULAR LIPID METABOLIC PROCESS,5.337e-06,-0.47457,-0.48593,1,0
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,4.5891e-06,-0.47467,-0.51338,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,1.3909e-05,-0.47467,-0.50087,1,0
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,5.7533e-06,-0.47493,-0.4951,1,0
1,GO LYMPHOCYTE DIFFERENTIATION,2.636e-05,-0.47493,-0.59745,1,0
1,GO SYNAPSE MATURATION,7.8298e-05,-0.47506,-0.59967,1,0
1,GO RESPONSE TO IMMOBILIZATION STRESS,0.0024341,-0.47508,-0.35961,1,0
1,GO INTERFERON ALPHA PRODUCTION,3.9936e-05,-0.47524,-0.59036,1,0
1,GO RESPONSE TO LIGHT STIMULUS,4.9495e-06,-0.4753,-0.47554,1,0
1,GO POSITIVE REGULATION OF DNA REPAIR,7.7514e-06,-0.47534,-0.53446,1,0
1,GO VAGINA DEVELOPMENT,0.00015974,-0.47569,-0.50186,1,0
1,GO ADULT LOCOMOTORY BEHAVIOR,0.00010181,-0.47586,-0.51334,1,0
1,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,3.9936e-05,-0.47595,-0.50582,1,0
1,GO POSITIVE REGULATION OF TORC1 SIGNALING,1.7249e-05,-0.47601,-0.54392,1,0
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,4.2539e-06,-0.47605,-0.47611,1,0
1,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,5.337e-06,-0.47613,-0.51548,1,0
1,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,1.7249e-05,-0.47614,-0.47063,1,0
1,GO CHEMOKINE PRODUCTION,0.00010181,-0.47626,-0.54506,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0018673,-0.4763,-0.55351,1,0
1,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00029789,-0.47638,-0.51793,1,0
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,6.2007e-06,-0.47647,-0.49422,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,2.4576e-05,-0.47647,-0.62027,1,0
1,GO REGULATION OF PEPTIDASE ACTIVITY,1.0403e-05,-0.47664,-0.49388,1,0
1,GO EXECUTION PHASE OF APOPTOSIS,4.5891e-06,-0.47678,-0.49791,1,0
1,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,1.2939e-05,-0.47679,-0.48557,1,0
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0057394,-0.47679,-0.4987,1,0
1,GO MIDBRAIN DEVELOPMENT,4.9495e-06,-0.47701,-0.48645,1,0
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,6.8565e-05,-0.47721,-0.57028,1,0
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,4.5891e-06,-0.47732,-0.51652,1,0
1,GO POLYOL BIOSYNTHETIC PROCESS,1.6059e-05,-0.47736,-0.473,1,0
1,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,3.248e-05,-0.47748,-0.51451,1,0
1,GO REPLICATION FORK PROCESSING,1.7249e-05,-0.47753,-0.5863,1,0
1,GO REGULATION OF LIPID LOCALIZATION,1.0403e-05,-0.47756,-0.49163,1,0
1,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.0003797,-0.47766,-0.61517,1,0
1,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,1.2939e-05,-0.47768,-0.51225,1,0
1,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00012367,-0.4777,-0.60587,1,0
1,GO COGNITION,6.2007e-06,-0.47773,-0.50826,1,0
1,GO REGULATION OF CELLULAR PH,4.5891e-06,-0.47786,-0.50581,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0027019,-0.4779,-0.57149,1,0
1,GO WATER TRANSPORT,0.00017019,-0.47799,-0.5201,1,0
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00024771,-0.47802,-0.59215,1,0
1,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,5.7533e-06,-0.47802,-0.4857,1,0
1,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,3.4805e-05,-0.47825,-0.57916,1,0
1,GO EXCITATORY SYNAPSE ASSEMBLY,0.00010181,-0.47831,-0.54201,1,0
1,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,8.3641e-05,-0.47832,-0.53139,1,0
1,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,9.6689e-06,-0.47844,-0.50808,1,0
1,GO REGULATION OF NEUROTRANSMITTER LEVELS,5.2428e-05,-0.47845,-0.53816,1,0
1,GO PROTEIN K63 LINKED UBIQUITINATION,4.9495e-06,-0.4785,-0.51553,1,0
1,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,1.2035e-05,-0.47877,-0.49909,1,0
1,GO MICROTUBULE BASED PROCESS,8.9843e-06,-0.47879,-0.51163,1,0
1,GO REGULATION OF POSTSYNAPSE ORGANIZATION,8.3461e-06,-0.47882,-0.56753,1,0
1,GO T CELL HOMEOSTASIS,1.7249e-05,-0.47895,-0.49571,1,0
1,GO REGULATION OF SYMBIOTIC PROCESS,3.4805e-05,-0.47899,-0.50353,1,0
1,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,8.9843e-06,-0.47899,-0.54588,1,0
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.1191e-05,-0.47902,-0.54765,1,0
1,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,3.248e-05,-0.47912,-0.55342,1,0
1,GO SULFATION,3.4805e-05,-0.47928,-0.48959,1,0
1,GO MECHANORECEPTOR DIFFERENTIATION,1.0403e-05,-0.4793,-0.49909,1,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,3.9422e-06,-0.47942,-0.57297,1,0
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00028019,-0.47954,-0.57702,1,0
1,GO POSITIVE REGULATION OF HEART CONTRACTION,3.4805e-05,-0.47962,-0.49878,1,0
1,GO REGULATION OF LIPASE ACTIVITY,1.3909e-05,-0.47975,-0.50903,1,0
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00014062,-0.47979,-0.53599,1,0
1,GO RESPONSE TO GAMMA RADIATION,6.6813e-06,-0.47982,-0.48804,1,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,1.2939e-05,-0.47997,-0.51475,1,0
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,4.9495e-06,-0.48006,-0.52774,1,0
1,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00021879,-0.4803,-0.59694,1,0
1,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,4.9495e-06,-0.4803,-0.50649,1,0
1,GO HETEROTYPIC CELL CELL ADHESION,2.4576e-05,-0.48035,-0.58324,1,0
1,GO POSITIVE REGULATION OF HEMOPOIESIS,1.0403e-05,-0.48037,-0.59747,1,0
1,GO RESPONSE TO UV B,8.3641e-05,-0.48041,-0.46497,1,0
1,GO LIPID METABOLIC PROCESS,5.7533e-06,-0.48045,-0.48923,1,0
1,GO ALPHA BETA T CELL DIFFERENTIATION,0.00024771,-0.48048,-0.60098,1,0
1,GO REGULATION OF MAST CELL ACTIVATION,1.3909e-05,-0.48051,-0.62389,1,0
1,GO NUCLEOTIDE PHOSPHORYLATION,7.1973e-06,-0.48052,-0.52471,1,0
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00023283,-0.4808,-0.61435,1,0
1,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,7.1973e-06,-0.48086,-0.45894,1,0
1,GO MESODERMAL CELL FATE COMMITMENT,1.9888e-05,-0.48089,-0.45225,1,0
1,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0012758,-0.48092,-0.48367,1,0
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,3.7287e-05,-0.48094,-0.62976,1,0
1,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,4.5779e-05,-0.48094,-0.55805,1,0
1,GO REGULATION OF TRANS SYNAPTIC SIGNALING,1.2035e-05,-0.481,-0.57102,1,0
1,GO CHROMOSOME ORGANIZATION,7.7514e-06,-0.48103,-0.51645,1,0
1,GO LONG TERM SYNAPTIC DEPRESSION,1.8524e-05,-0.48103,-0.52173,1,0
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00020554,-0.48129,-0.69937,1,0
1,GO BROWN FAT CELL DIFFERENTIATION,1.2035e-05,-0.48131,-0.47574,1,0
1,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,5.337e-06,-0.48136,-0.50407,1,0
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,1.3909e-05,-0.48141,-0.54464,1,0
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0042727,-0.4816,-0.49179,1,0
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,6.6813e-06,-0.4816,-0.46877,1,0
1,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,1.2035e-05,-0.48168,-0.49584,1,0
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,3.7287e-05,-0.48175,-0.47651,1,0
1,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,2.636e-05,-0.48175,-0.46761,1,0
1,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.00024771,-0.48177,-0.5532,1,0
1,GO RESPONSE TO EXTRACELLULAR STIMULUS,5.7533e-06,-0.48192,-0.50629,1,0
1,GO POSITIVE T CELL SELECTION,0.0015882,-0.4821,-0.60536,1,0
1,GO BILE ACID AND BILE SALT TRANSPORT,1.2939e-05,-0.48212,-0.50272,1,0
1,GO CHEMOKINE SECRETION,0.00332,-0.48212,-0.55684,1,0
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.028348,-0.48222,-0.51263,1,0
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,9.5377e-05,-0.48222,-0.60531,1,0
1,GO MACROPHAGE CHEMOTAXIS,0.0011418,-0.48223,-0.52332,1,0
1,GO SYNAPSE ASSEMBLY,1.4947e-05,-0.48228,-0.57229,1,0
1,GO REGULATION OF SISTER CHROMATID COHESION,1.3909e-05,-0.48229,-0.55098,1,0
1,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,5.7533e-06,-0.48235,-0.48375,1,0
1,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,7.3279e-05,-0.48241,-0.56015,1,0
1,GO CEREBELLAR CORTEX DEVELOPMENT,8.3461e-06,-0.48242,-0.56835,1,0
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,2.1347e-05,-0.48246,-0.56154,1,0
1,GO LIPID DROPLET ORGANIZATION,1.9888e-05,-0.48251,-0.4693,1,0
1,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.00028019,-0.48263,-0.48688,1,0
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,1.0403e-05,-0.48267,-0.51802,1,0
1,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,8.9843e-06,-0.48281,-0.52604,1,0
1,GO ALCOHOL BIOSYNTHETIC PROCESS,1.1191e-05,-0.48294,-0.49002,1,0
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,4.2539e-06,-0.48298,-0.49344,1,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION,2.4576e-05,-0.48315,-0.45542,1,0
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,1.3909e-05,-0.48316,-0.50888,1,0
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,1.0403e-05,-0.48318,-0.55301,1,0
1,GO ASYMMETRIC CELL DIVISION,4.2539e-06,-0.4832,-0.54574,1,0
1,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,3.248e-05,-0.48321,-0.49919,1,0
1,GO DIOL METABOLIC PROCESS,0.00020554,-0.4833,-0.49679,1,0
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.3909e-05,-0.48331,-0.5748,1,0
1,GO RESPONSE TO WATER,0.00081392,-0.48345,-0.44749,1,0
1,GO NEUROMUSCULAR PROCESS,1.3909e-05,-0.48353,-0.55443,1,0
1,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,1.9888e-05,-0.48356,-0.55228,1,0
1,GO MITOTIC SPINDLE ORGANIZATION,1.9888e-05,-0.48368,-0.50389,1,0
1,GO HYPOTONIC RESPONSE,1.3909e-05,-0.48378,-0.54779,1,0
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,4.5891e-06,-0.48394,-0.5023,1,0
1,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.00096503,-0.48397,-0.58023,1,0
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,3.4805e-05,-0.48426,-0.6715,1,0
1,GO RESPONSE TO RADIATION,4.2539e-06,-0.48433,-0.48515,1,0
1,GO FC RECEPTOR SIGNALING PATHWAY,3.9422e-06,-0.48434,-0.5479,1,0
1,GO CILIUM ORGANIZATION,1.4947e-05,-0.48438,-0.49412,1,0
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,3.9936e-05,-0.48468,-0.6224,1,0
1,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,1.1191e-05,-0.4849,-0.52754,1,0
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,4.8997e-05,-0.48496,-0.50065,1,0
1,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,1.3909e-05,-0.48508,-0.50951,1,0
1,GO ARGININE METABOLIC PROCESS,3.9422e-06,-0.48512,-0.53535,1,0
1,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,4.9495e-06,-0.48536,-0.48553,1,0
1,GO REGULATION OF MEMBRANE POTENTIAL,1.7249e-05,-0.48554,-0.5076,1,0
1,GO REGULATION OF ACTIN NUCLEATION,7.7514e-06,-0.48558,-0.51186,1,0
1,GO PEPTIDE HORMONE SECRETION,2.1347e-05,-0.48568,-0.49907,1,0
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION,1.0403e-05,-0.48585,-0.53298,1,0
1,GO CALCIUM MEDIATED SIGNALING,7.1973e-06,-0.48597,-0.50555,1,0
1,GO REGULATION OF SYNAPTIC PLASTICITY,1.7249e-05,-0.48623,-0.56205,1,0
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,4.5891e-06,-0.48644,-0.47442,1,0
1,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,1.2939e-05,-0.48645,-0.50479,1,0
1,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,6.6813e-06,-0.48652,-0.48809,1,0
1,GO REGULATION OF HEART MORPHOGENESIS,1.2035e-05,-0.4868,-0.58684,1,0
1,GO HISTONE H2A MONOUBIQUITINATION,3.248e-05,-0.48682,-0.52058,1,0
1,GO RESPONSE TO CYTOKINE,1.0403e-05,-0.48704,-0.55775,1,0
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,4.5891e-06,-0.48704,-0.52546,1,0
1,GO SKELETAL MUSCLE CONTRACTION,9.6689e-06,-0.48741,-0.47965,1,0
1,GO CATECHOLAMINE SECRETION,0.00064645,-0.48743,-0.47405,1,0
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,6.8565e-05,-0.48749,-0.5932,1,0
1,GO INTERLEUKIN 8 PRODUCTION,0.00014062,-0.48758,-0.58914,1,0
1,GO LEUKOCYTE DIFFERENTIATION,1.3909e-05,-0.48758,-0.5967,1,0
1,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,1.0403e-05,-0.48762,-0.56886,1,0
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,8.3461e-06,-0.48787,-0.5388,1,0
1,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,1.7249e-05,-0.48801,-0.48294,1,0
1,GO EXOCYTIC PROCESS,1.8524e-05,-0.48809,-0.58421,1,0
1,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00011593,-0.48813,-0.59401,1,0
1,GO REGULATION OF MITOCHONDRION ORGANIZATION,4.9495e-06,-0.48814,-0.518,1,0
1,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,2.2907e-05,-0.48819,-0.54196,1,0
1,GO APOPTOTIC PROCESS,4.5891e-06,-0.48822,-0.52276,1,0
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,7.1973e-06,-0.4884,-0.54339,1,0
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,4.2539e-06,-0.48848,-0.54704,1,0
1,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,2.636e-05,-0.48859,-0.55956,1,0
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.00015974,-0.4886,-0.50872,1,0
1,GO BEHAVIOR,7.7514e-06,-0.48864,-0.52553,1,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,5.7533e-06,-0.48865,-0.52273,1,0
1,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,1.2035e-05,-0.48866,-0.51432,1,0
1,GO OLIGODENDROCYTE DIFFERENTIATION,1.0403e-05,-0.48878,-0.48088,1,0
1,GO CELLULAR COMPONENT DISASSEMBLY,3.9422e-06,-0.48904,-0.50692,1,0
1,GO ADULT BEHAVIOR,5.6086e-05,-0.48909,-0.51785,1,0
1,GO PROTEIN LOCALIZATION TO CHROMATIN,1.6059e-05,-0.48914,-0.51799,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,1.8524e-05,-0.48934,-0.47908,1,0
1,GO FATTY ACID TRANSPORT,4.5891e-06,-0.48935,-0.51603,1,0
1,GO PROTEIN AUTOUBIQUITINATION,7.1973e-06,-0.48942,-0.48877,1,0
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,1.6059e-05,-0.48949,-0.60092,1,0
1,GO STEROL METABOLIC PROCESS,8.9843e-06,-0.48968,-0.4937,1,0
1,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.0017696,-0.48974,-0.40049,1,0
1,GO RESPONSE TO OXIDATIVE STRESS,4.5891e-06,-0.48975,-0.50993,1,0
1,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,2.4576e-05,-0.48976,-0.52613,1,0
1,GO RESPONSE TO HYDROPEROXIDE,0.00010866,-0.48978,-0.55011,1,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.00026348,-0.48979,-0.54688,1,0
1,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,4.9495e-06,-0.4901,-0.50852,1,0
1,GO TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.49021,-0.47729,1,0
1,GO PARAXIAL MESODERM DEVELOPMENT,3.4805e-05,-0.49022,-0.48353,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,6.2007e-06,-0.49028,-0.47731,1,0
1,GO WATER HOMEOSTASIS,3.248e-05,-0.49033,-0.48383,1,0
1,GO PROTEIN HOMOOLIGOMERIZATION,4.9495e-06,-0.49042,-0.50826,1,0
1,GO RESPONSE TO FATTY ACID,8.9843e-06,-0.49042,-0.50532,1,0
1,GO EAR MORPHOGENESIS,1.2035e-05,-0.49056,-0.46911,1,0
1,GO STEM CELL DIFFERENTIATION,3.9422e-06,-0.4906,-0.49866,1,0
1,GO CELLULAR HOMEOSTASIS,4.5891e-06,-0.49076,-0.50389,1,0
1,GO MICROTUBULE BASED TRANSPORT,1.1191e-05,-0.49082,-0.52165,1,0
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00081392,-0.49083,-0.58133,1,0
1,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,2.2907e-05,-0.49088,-0.49251,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00040321,-0.49097,-0.60739,1,0
1,GO POSITIVE REGULATION OF GLUCONEOGENESIS,1.3909e-05,-0.49105,-0.50212,1,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00012367,-0.49113,-0.50423,1,0
1,GO RIG I SIGNALING PATHWAY,1.6059e-05,-0.49119,-0.51168,1,0
1,GO MONOSACCHARIDE METABOLIC PROCESS,6.6813e-06,-0.49138,-0.51088,1,0
1,GO RESPONSE TO CORTICOSTERONE,0.0010798,-0.49148,-0.4929,1,0
1,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.025096,-0.49151,-0.51776,1,0
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.2007e-06,-0.49159,-0.50246,1,0
1,GO POSITIVE REGULATION OF PEPTIDE SECRETION,8.3461e-06,-0.49174,-0.51313,1,0
1,GO REPRODUCTION,6.2007e-06,-0.49174,-0.4828,1,0
1,GO DNA METHYLATION OR DEMETHYLATION,8.9843e-06,-0.49176,-0.48572,1,0
1,GO MODULATION BY HOST OF VIRAL PROCESS,8.9843e-06,-0.49208,-0.52666,1,0
1,GO PROTEIN IMPORT,3.9422e-06,-0.49212,-0.49802,1,0
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,5.337e-06,-0.49219,-0.51064,1,0
1,GO MAINTENANCE OF LOCATION IN CELL,5.337e-06,-0.49222,-0.52601,1,0
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,1.0403e-05,-0.49244,-0.53851,1,0
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,4.9495e-06,-0.49248,-0.53484,1,0
1,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,6.2007e-06,-0.49266,-0.50949,1,0
1,GO PONS DEVELOPMENT,0.023112,-0.49276,-0.44496,1,0
1,GO GLYCOSYLATION,7.7514e-06,-0.49276,-0.49409,1,0
1,GO PROTEIN COMPLEX OLIGOMERIZATION,4.9495e-06,-0.49278,-0.519,1,0
1,GO THYMOCYTE APOPTOTIC PROCESS,6.8565e-05,-0.49282,-0.55485,1,0
1,GO VITAMIN BIOSYNTHETIC PROCESS,2.2907e-05,-0.49285,-0.57638,1,0
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,3.248e-05,-0.49288,-0.60546,1,0
1,GO WHITE FAT CELL DIFFERENTIATION,3.9422e-06,-0.49289,-0.53954,1,0
1,GO LONG CHAIN FATTY ACID TRANSPORT,8.3461e-06,-0.49295,-0.49188,1,0
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,5.337e-06,-0.49298,-0.50379,1,0
1,GO PROTEIN PROCESSING,1.0403e-05,-0.49298,-0.50683,1,0
1,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,8.9843e-06,-0.49316,-0.56216,1,0
1,GO CELL CHEMOTAXIS,9.5377e-05,-0.49316,-0.55874,1,0
1,GO COPII COATED VESICLE BUDDING,5.7533e-06,-0.4932,-0.50779,1,0
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,6.6813e-06,-0.4932,-0.53447,1,0
1,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,7.1973e-06,-0.49339,-0.48242,1,0
1,GO FATTY ACID BETA OXIDATION,1.1191e-05,-0.49354,-0.47472,1,0
1,GO HORMONE TRANSPORT,1.6059e-05,-0.49356,-0.48504,1,0
1,GO REGULATION OF B CELL DIFFERENTIATION,7.3279e-05,-0.49381,-0.67011,1,0
1,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00024771,-0.49395,-0.58595,1,0
1,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,1.0403e-05,-0.49408,-0.49634,1,0
1,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,7.1973e-06,-0.49446,-0.52444,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,5.337e-06,-0.49456,-0.53087,1,0
1,GO SPINDLE ASSEMBLY,9.6689e-06,-0.49466,-0.52131,1,0
1,GO VESICLE BUDDING FROM MEMBRANE,6.2007e-06,-0.49488,-0.51028,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.0063209,-0.49489,-0.52781,1,0
1,GO REGULATION OF PEPTIDE HORMONE SECRETION,2.2907e-05,-0.49531,-0.49215,1,0
1,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,8.9843e-06,-0.49556,-0.47916,1,0
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,3.0304e-05,-0.49572,-0.544,1,0
1,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00048214,-0.49574,-0.57009,1,0
1,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,1.4947e-05,-0.49578,-0.49836,1,0
1,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,2.8267e-05,-0.49581,-0.52104,1,0
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,5.337e-06,-0.49582,-0.48991,1,0
1,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,6.6813e-06,-0.49585,-0.57464,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.9495e-06,-0.4959,-0.5062,1,0
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,8.9843e-06,-0.4959,-0.55127,1,0
1,GO REGULATION OF PEPTIDE TRANSPORT,4.9495e-06,-0.49594,-0.53114,1,0
1,GO NEGATIVE REGULATION OF TRANSPORT,4.2539e-06,-0.49598,-0.50707,1,0
1,GO LYMPHOCYTE COSTIMULATION,0.00031664,-0.49598,-0.60166,1,0
1,GO NEURON CELLULAR HOMEOSTASIS,2.4576e-05,-0.49613,-0.55098,1,0
1,GO BIOLOGICAL PHASE,0.00024771,-0.49617,-0.46638,1,0
1,GO CELL PROLIFERATION IN HINDBRAIN,1.6059e-05,-0.49632,-0.50624,1,0
1,GO AMINO SUGAR METABOLIC PROCESS,8.3461e-06,-0.49636,-0.52617,1,0
1,GO BLASTODERM SEGMENTATION,1.1191e-05,-0.49668,-0.48924,1,0
1,GO CELL DIFFERENTIATION IN HINDBRAIN,3.0304e-05,-0.49671,-0.49973,1,0
1,GO ENDOSOME ORGANIZATION,4.9495e-06,-0.49685,-0.5133,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,9.6689e-06,-0.49685,-0.56091,1,0
1,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.49685,-0.51884,1,0
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,5.6086e-05,-0.49686,-0.61241,1,0
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,4.5891e-06,-0.49687,-0.53147,1,0
1,GO CELL RECOGNITION,9.6689e-06,-0.49694,-0.48403,1,0
1,GO REGULATION OF LEUKOCYTE MIGRATION,0.00013188,-0.49696,-0.57699,1,0
1,GO LOCOMOTORY BEHAVIOR,1.8524e-05,-0.49697,-0.55985,1,0
1,GO REGULATION OF CATION CHANNEL ACTIVITY,6.2007e-06,-0.49702,-0.51201,1,0
1,GO GANGLION DEVELOPMENT,0.00091199,-0.49705,-0.51646,1,0
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00026348,-0.49706,-0.60914,1,0
1,GO REPRODUCTIVE BEHAVIOR,0.00015974,-0.49714,-0.4806,1,0
1,GO NEGATIVE REGULATION OF CELL DEATH,3.9422e-06,-0.49725,-0.51526,1,0
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,4.5891e-06,-0.49729,-0.51236,1,0
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,6.8565e-05,-0.49736,-0.45132,1,0
1,GO CATION TRANSMEMBRANE TRANSPORT,6.6813e-06,-0.49741,-0.49575,1,0
1,GO POSITIVE REGULATION OF ORGAN GROWTH,5.337e-06,-0.49744,-0.54952,1,0
1,GO VIRAL GENOME REPLICATION,5.9985e-05,-0.49756,-0.51374,1,0
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,5.7533e-06,-0.49763,-0.53415,1,0
1,GO RESPONSE TO ALCOHOL,4.9495e-06,-0.49776,-0.52698,1,0
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,7.7514e-06,-0.49781,-0.53659,1,0
1,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,6.6813e-06,-0.4979,-0.5678,1,0
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.2907e-05,-0.4979,-0.58063,1,0
1,GO RESPONSE TO TYPE I INTERFERON,0.0028457,-0.49792,-0.59973,1,0
1,GO 2 OXOGLUTARATE METABOLIC PROCESS,2.8267e-05,-0.49811,-0.50596,1,0
1,GO NEURAL TUBE PATTERNING,2.8267e-05,-0.49813,-0.49306,1,0
1,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,8.3461e-06,-0.49823,-0.51485,1,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,5.337e-06,-0.49826,-0.5963,1,0
1,GO REGULATION OF NECROTIC CELL DEATH,0.00014062,-0.49846,-0.47396,1,0
1,GO ORGANOPHOSPHATE METABOLIC PROCESS,5.337e-06,-0.49858,-0.49664,1,0
1,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00017019,-0.49859,-0.52222,1,0
1,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,8.3461e-06,-0.49876,-0.59841,1,0
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,2.8267e-05,-0.49876,-0.59557,1,0
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.4947e-05,-0.49882,-0.56402,1,0
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,6.2007e-06,-0.49897,-0.51456,1,0
1,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,3.4805e-05,-0.49931,-0.52788,1,0
1,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,2.8267e-05,-0.49947,-0.49895,1,0
1,GO T HELPER CELL LINEAGE COMMITMENT,0.0011418,-0.49949,-0.60362,1,0
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.010101,-0.49952,-0.47317,1,0
1,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,6.4139e-05,-0.49952,-0.54625,1,0
1,GO MATING BEHAVIOR,0.00040321,-0.49952,-0.45603,1,0
1,GO INTRA S DNA DAMAGE CHECKPOINT,1.3909e-05,-0.49955,-0.61977,1,0
1,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,6.2007e-06,-0.4996,-0.53194,1,0
1,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.00017019,-0.49962,-0.47647,1,0
1,GO INORGANIC ANION TRANSPORT,5.337e-06,-0.49973,-0.50212,1,0
1,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.00096503,-0.49974,-0.46549,1,0
1,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,1.3909e-05,-0.49974,-0.4554,1,0
1,GO MYOBLAST FUSION,5.2428e-05,-0.4998,-0.63673,1,0
1,GO REGULATION OF PROTEOLYSIS,4.9495e-06,-0.49988,-0.51839,1,0
1,GO REGULATION OF RESPONSE TO STRESS,3.9422e-06,-0.49991,-0.53772,1,0
1,GO PROTEIN KINASE A SIGNALING,8.9843e-06,-0.49995,-0.48346,1,0
1,GO NUCLEAR BODY ORGANIZATION,1.7249e-05,-0.50003,-0.52082,1,0
1,GO CATION TRANSPORT,7.1973e-06,-0.5001,-0.49048,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,9.5377e-05,-0.50011,-0.4664,1,0
1,GO SYNCYTIUM FORMATION,3.0304e-05,-0.50013,-0.60779,1,0
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,1.6059e-05,-0.50019,-0.69715,1,0
1,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00042807,-0.50037,-0.50914,1,0
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,3.9422e-06,-0.50047,-0.57043,1,0
1,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,4.2763e-05,-0.50048,-0.55071,1,0
1,GO T CELL RECEPTOR SIGNALING PATHWAY,5.9985e-05,-0.50057,-0.52991,1,0
1,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.6059e-05,-0.50057,-0.53058,1,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00028019,-0.50067,-0.60493,1,0
1,GO HORMONE MEDIATED SIGNALING PATHWAY,4.5891e-06,-0.50071,-0.51622,1,0
1,GO REGENERATION,5.337e-06,-0.50079,-0.52279,1,0
1,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,6.2007e-06,-0.50082,-0.49782,1,0
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.0013481,-0.50096,-0.60061,1,0
1,GO CD40 SIGNALING PATHWAY,4.5779e-05,-0.5011,-0.60949,1,0
1,GO EMBRYONIC BRAIN DEVELOPMENT,0.00013188,-0.50118,-0.44472,1,0
1,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,7.3279e-05,-0.50129,-0.46924,1,0
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,7.7514e-06,-0.50134,-0.52567,1,0
1,GO ION TRANSMEMBRANE TRANSPORT,6.2007e-06,-0.50136,-0.49825,1,0
1,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.00010181,-0.50138,-0.56818,1,0
1,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,9.6689e-06,-0.5014,-0.58982,1,0
1,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.00031664,-0.50143,-0.42951,1,0
1,GO HINDBRAIN MORPHOGENESIS,4.5891e-06,-0.50143,-0.56597,1,0
1,GO TRANSFERRIN TRANSPORT,9.6689e-06,-0.50164,-0.48776,1,0
1,GO REGULATION OF TRANSPORTER ACTIVITY,6.2007e-06,-0.50165,-0.51315,1,0
1,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,4.9495e-06,-0.50165,-0.55668,1,0
1,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,5.7533e-06,-0.50171,-0.56484,1,0
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,4.9495e-06,-0.50174,-0.50323,1,0
1,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,8.3461e-06,-0.50185,-0.52455,1,0
1,GO PROTEIN HOMOTETRAMERIZATION,7.1973e-06,-0.50191,-0.48414,1,0
1,GO SKELETAL MUSCLE CELL DIFFERENTIATION,5.337e-06,-0.50196,-0.51031,1,0
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,1.9888e-05,-0.50215,-0.59918,1,0
1,GO DETECTION OF TEMPERATURE STIMULUS,3.4805e-05,-0.50216,-0.54685,1,0
1,GO PROTEOLYSIS,4.9495e-06,-0.50221,-0.51424,1,0
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,6.2007e-06,-0.50247,-0.51573,1,0
1,GO POSITIVE REGULATION OF BINDING,4.5891e-06,-0.50249,-0.53529,1,0
1,GO RECEPTOR LOCALIZATION TO SYNAPSE,2.636e-05,-0.50257,-0.56949,1,0
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,4.5779e-05,-0.50285,-0.58638,1,0
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,1.7249e-05,-0.50292,-0.50344,1,0
1,GO HISTONE H3 K9 TRIMETHYLATION,8.3461e-06,-0.50297,-0.5704,1,0
1,GO STEROL HOMEOSTASIS,6.2007e-06,-0.503,-0.54648,1,0
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.00021879,-0.50302,-0.65772,1,0
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.1191e-05,-0.50312,-0.62147,1,0
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,1.6059e-05,-0.50327,-0.61572,1,0
1,GO CARBOHYDRATE HOMEOSTASIS,8.3461e-06,-0.5033,-0.51323,1,0
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0031545,-0.50341,-0.54977,1,0
1,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,8.9843e-06,-0.50346,-0.51701,1,0
1,GO CENTRIOLE ASSEMBLY,8.9843e-06,-0.50351,-0.5813,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0080134,-0.50371,-0.58901,1,0
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,4.5891e-06,-0.5039,-0.53423,1,0
1,GO FATTY ACYL COA METABOLIC PROCESS,7.3279e-05,-0.50391,-0.4723,1,0
1,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,6.2007e-06,-0.50396,-0.50082,1,0
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00023283,-0.504,-0.56576,1,0
1,GO GOLGI VESICLE BUDDING,6.2007e-06,-0.50403,-0.52595,1,0
1,GO GLIAL CELL PROLIFERATION,2.2907e-05,-0.50406,-0.5348,1,0
1,GO CELLULAR ION HOMEOSTASIS,5.337e-06,-0.50408,-0.50718,1,0
1,GO CARBOHYDRATE METABOLIC PROCESS,5.7533e-06,-0.5041,-0.51263,1,0
1,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.00015974,-0.50422,-0.53185,1,0
1,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00019306,-0.50431,-0.45545,1,0
1,GO METAL ION HOMEOSTASIS,5.7533e-06,-0.50431,-0.50864,1,0
1,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,7.7514e-06,-0.5044,-0.51993,1,0
1,GO ADAPTATION OF SIGNALING PATHWAY,8.3461e-06,-0.5045,-0.55899,1,0
1,GO INTERLEUKIN 6 PRODUCTION,3.9936e-05,-0.50469,-0.59006,1,0
1,GO AMYLOID BETA FORMATION,8.3461e-06,-0.50471,-0.55612,1,0
1,GO PROTEIN LOCALIZATION TO CILIUM,1.1191e-05,-0.5049,-0.52406,1,0
1,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,5.337e-06,-0.50491,-0.52375,1,0
1,GO PROTEIN METHYLATION,7.1973e-06,-0.50499,-0.54423,1,0
1,GO REGULATION OF HEMOPOIESIS,6.2007e-06,-0.50503,-0.56026,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.012106,-0.50508,-0.6548,1,0
1,GO REGULATION OF CELL DEATH,4.2539e-06,-0.50512,-0.52788,1,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,5.337e-06,-0.50512,-0.52641,1,0
1,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,1.2035e-05,-0.50516,-0.51508,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,6.4139e-05,-0.50528,-0.62001,1,0
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,3.9422e-06,-0.5053,-0.51585,1,0
1,GO SPINDLE ORGANIZATION,1.4947e-05,-0.50531,-0.52541,1,0
1,GO CARBOHYDRATE CATABOLIC PROCESS,5.337e-06,-0.50533,-0.54575,1,0
1,GO CATECHOLAMINE UPTAKE,0.00040321,-0.50533,-0.49151,1,0
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,4.9495e-06,-0.50543,-0.58066,1,0
1,GO REGULATION OF CAMP MEDIATED SIGNALING,1.9888e-05,-0.50546,-0.50044,1,0
1,GO PROTEIN LOCALIZATION TO SYNAPSE,3.0304e-05,-0.50547,-0.57206,1,0
1,GO INSULIN SECRETION,1.6059e-05,-0.50556,-0.5078,1,0
1,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,3.0304e-05,-0.50557,-0.5633,1,0
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.4805e-05,-0.50558,-0.57545,1,0
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,5.7533e-06,-0.50561,-0.54667,1,0
1,GO REGULATION OF MEMBRANE DEPOLARIZATION,3.0304e-05,-0.50562,-0.48666,1,0
1,GO CELL MATURATION,1.4947e-05,-0.50567,-0.49487,1,0
1,GO MACROPHAGE DIFFERENTIATION,3.0304e-05,-0.50571,-0.6746,1,0
1,GO CHOLESTEROL EFFLUX,7.1973e-06,-0.50572,-0.55251,1,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,1.1191e-05,-0.50587,-0.48733,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,1.2035e-05,-0.5059,-0.59617,1,0
1,GO REGULATION OF INSULIN SECRETION,1.3909e-05,-0.50596,-0.50275,1,0
1,GO INNER EAR MORPHOGENESIS,1.7249e-05,-0.506,-0.47145,1,0
1,GO SYNAPTIC VESICLE LOCALIZATION,3.7287e-05,-0.506,-0.58099,1,0
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00035748,-0.50602,-0.54147,1,0
1,GO CELL CYCLE ARREST,4.5891e-06,-0.50603,-0.51996,1,0
1,GO STEROL TRANSPORT,5.337e-06,-0.50603,-0.56188,1,0
1,GO REGULATION OF HORMONE SECRETION,1.6059e-05,-0.50604,-0.47752,1,0
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00064645,-0.50613,-0.60811,1,0
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,4.9495e-06,-0.50626,-0.54861,1,0
1,GO RESPONSE TO CATECHOLAMINE,4.8997e-05,-0.50632,-0.50132,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,5.7533e-06,-0.50634,-0.54872,1,0
1,GO REGULATION OF VIRAL LIFE CYCLE,6.8565e-05,-0.50639,-0.51872,1,0
1,GO LIPID BIOSYNTHETIC PROCESS,6.2007e-06,-0.50646,-0.49303,1,0
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,5.7533e-06,-0.50655,-0.51757,1,0
1,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,2.636e-05,-0.50678,-0.53006,1,0
1,GO NON RECOMBINATIONAL REPAIR,7.1973e-06,-0.50686,-0.51919,1,0
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00332,-0.50689,-0.5033,1,0
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,5.337e-06,-0.50695,-0.49621,1,0
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00035748,-0.50741,-0.60352,1,0
1,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,1.3909e-05,-0.50756,-0.50776,1,0
1,GO GLYCEROLIPID CATABOLIC PROCESS,1.3909e-05,-0.50757,-0.46251,1,0
1,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,7.1973e-06,-0.50765,-0.52549,1,0
1,GO PROGESTERONE METABOLIC PROCESS,0.00031664,-0.50789,-0.47422,1,0
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,2.4576e-05,-0.5079,-0.51694,1,0
1,GO B CELL PROLIFERATION,0.00024771,-0.50797,-0.6377,1,0
1,GO POSITIVE REGULATION OF ANION TRANSPORT,7.3279e-05,-0.50807,-0.43409,1,0
1,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,3.0304e-05,-0.50813,-0.51614,1,0
1,GO PROTEIN STABILIZATION,4.2539e-06,-0.50828,-0.50285,1,0
1,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,4.5779e-05,-0.50841,-0.54575,1,0
1,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00023283,-0.50861,-0.44884,1,0
1,GO T CELL DIFFERENTIATION IN THYMUS,1.9888e-05,-0.50866,-0.59281,1,0
1,GO COPULATION,9.5377e-05,-0.50868,-0.47609,1,0
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,1.4947e-05,-0.50876,-0.56756,1,0
1,GO POSITIVE REGULATION OF GLIOGENESIS,9.6689e-06,-0.50877,-0.52905,1,0
1,GO NEURONAL ACTION POTENTIAL,5.9985e-05,-0.50877,-0.48192,1,0
1,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,1.3909e-05,-0.50882,-0.48923,1,0
1,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,5.6086e-05,-0.50885,-0.50395,1,0
1,GO NEGATIVE REGULATION OF ION TRANSPORT,4.9495e-06,-0.50886,-0.51804,1,0
1,GO TRANSMISSION OF NERVE IMPULSE,5.6086e-05,-0.50896,-0.49779,1,0
1,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,1.7249e-05,-0.50896,-0.51118,1,0
1,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,3.248e-05,-0.50897,-0.48557,1,0
1,GO SIGNAL RELEASE,1.0403e-05,-0.50897,-0.51634,1,0
1,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,3.4805e-05,-0.50907,-0.6273,1,0
1,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.0010209,-0.50908,-0.41853,1,0
1,GO PHOSPHOLIPID HOMEOSTASIS,1.8524e-05,-0.50913,-0.52353,1,0
1,GO RESPONSE TO IONIZING RADIATION,4.2539e-06,-0.50913,-0.52379,1,0
1,GO HOMEOSTATIC PROCESS,4.9495e-06,-0.50917,-0.5206,1,0
1,GO RECEPTOR BIOSYNTHETIC PROCESS,8.9843e-06,-0.50925,-0.55182,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,4.9495e-06,-0.50938,-0.51487,1,0
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,1.8524e-05,-0.50944,-0.58178,1,0
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,4.2539e-06,-0.50957,-0.50107,1,0
1,GO GLUCOSE METABOLIC PROCESS,8.3461e-06,-0.50971,-0.53836,1,0
1,GO REGULATION OF ATP METABOLIC PROCESS,4.2539e-06,-0.50981,-0.52063,1,0
1,GO LIVER MORPHOGENESIS,1.8524e-05,-0.50991,-0.57838,1,0
1,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,6.6813e-06,-0.50994,-0.53986,1,0
1,GO VESICLE TARGETING,5.7533e-06,-0.51012,-0.53103,1,0
1,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,3.7287e-05,-0.51013,-0.47972,1,0
1,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,3.248e-05,-0.51016,-0.53287,1,0
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00014062,-0.51022,-0.60651,1,0
1,GO ORGANELLE LOCALIZATION,5.337e-06,-0.51049,-0.55688,1,0
1,GO POSITIVE REGULATION OF TOR SIGNALING,6.2007e-06,-0.51054,-0.54948,1,0
1,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,5.7533e-06,-0.5106,-0.59077,1,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,1.3909e-05,-0.51068,-0.53697,1,0
1,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,1.4947e-05,-0.51079,-0.52161,1,0
1,GO REGULATION OF PROTEIN STABILITY,4.5891e-06,-0.5108,-0.50669,1,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,2.1347e-05,-0.51082,-0.56225,1,0
1,GO ACIDIC AMINO ACID TRANSPORT,3.248e-05,-0.51087,-0.52851,1,0
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,1.1191e-05,-0.51088,-0.52969,1,0
1,GO TYPE I INTERFERON PRODUCTION,1.3909e-05,-0.51088,-0.56712,1,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,1.9888e-05,-0.51106,-0.53532,1,0
1,GO SODIUM ION HOMEOSTASIS,3.0304e-05,-0.5111,-0.4746,1,0
1,GO ION HOMEOSTASIS,5.337e-06,-0.51119,-0.5106,1,0
1,GO REGULATION OF GLUCOSE IMPORT,6.2007e-06,-0.51126,-0.50413,1,0
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,4.5891e-06,-0.51131,-0.54833,1,0
1,GO SYNAPTIC VESICLE DOCKING,0.0017696,-0.51143,-0.64323,1,0
1,GO REGULATION OF HEART RATE,1.8524e-05,-0.51153,-0.5096,1,0
1,GO REGULATION OF CYCLASE ACTIVITY,6.6813e-06,-0.51153,-0.49889,1,0
1,GO MEMBRANE DOCKING,8.3461e-06,-0.51168,-0.55217,1,0
1,GO REGULATION OF VIRAL GENOME REPLICATION,0.00014989,-0.51172,-0.50889,1,0
1,GO KIDNEY MESENCHYME DEVELOPMENT,1.7249e-05,-0.51183,-0.57123,1,0
1,GO PROTEIN DEPHOSPHORYLATION,4.5891e-06,-0.51194,-0.54665,1,0
1,GO GLUCOSE CATABOLIC PROCESS,5.2428e-05,-0.51206,-0.54776,1,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,6.4139e-05,-0.51216,-0.61606,1,0
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,7.8298e-05,-0.51235,-0.58951,1,0
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,4.9495e-06,-0.51245,-0.57273,1,0
1,GO RESPONSE TO DOPAMINE,7.3279e-05,-0.51251,-0.49075,1,0
1,GO POSITIVE REGULATION OF PROTEOLYSIS,4.2539e-06,-0.51251,-0.55003,1,0
1,GO REGULATION OF SYNAPTIC VESICLE CYCLE,5.9985e-05,-0.51272,-0.61424,1,0
1,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,7.7514e-06,-0.51275,-0.52031,1,0
1,GO REGULATION OF BINDING,4.5891e-06,-0.51304,-0.53768,1,0
1,GO REGULATION OF CHROMOSOME ORGANIZATION,8.3461e-06,-0.51321,-0.5287,1,0
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.1347e-05,-0.51322,-0.61821,1,0
1,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,2.4576e-05,-0.51334,-0.57446,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION,4.9495e-06,-0.51348,-0.54615,1,0
1,GO NEGATIVE REGULATION OF BINDING,4.9495e-06,-0.51363,-0.5284,1,0
1,GO LEUKOCYTE MIGRATION,3.0304e-05,-0.51372,-0.59893,1,0
1,GO REGULATION OF AMYLOID BETA FORMATION,1.0403e-05,-0.51373,-0.57278,1,0
1,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,1.9888e-05,-0.51375,-0.4413,1,0
1,GO B CELL APOPTOTIC PROCESS,3.4805e-05,-0.51389,-0.51758,1,0
1,GO RESPONSE TO DRUG,5.7533e-06,-0.51389,-0.51301,1,0
1,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,5.337e-06,-0.51404,-0.55224,1,0
1,GO SPLEEN DEVELOPMENT,8.9843e-06,-0.5141,-0.53645,1,0
1,GO REGULATION OF MYELINATION,4.9495e-06,-0.51418,-0.53698,1,0
1,GO SPINAL CORD DEVELOPMENT,9.6689e-06,-0.51419,-0.55995,1,0
1,GO RESPONSE TO ABIOTIC STIMULUS,4.2539e-06,-0.51423,-0.51113,1,0
1,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,4.2539e-06,-0.51424,-0.50231,1,0
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,1.0403e-05,-0.51433,-0.5356,1,0
1,GO REGULATION OF PROTEIN TARGETING,4.5891e-06,-0.51453,-0.56043,1,0
1,GO REGULATION OF B CELL PROLIFERATION,0.00014062,-0.51456,-0.66372,1,0
1,GO TOR SIGNALING,5.337e-06,-0.51492,-0.56824,1,0
1,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,1.4947e-05,-0.51492,-0.51734,1,0
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,7.7514e-06,-0.51494,-0.56246,1,0
1,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,1.4947e-05,-0.51494,-0.47261,1,0
1,GO AUTOPHAGOSOME MATURATION,4.2539e-06,-0.51497,-0.56245,1,0
1,GO NEUROINFLAMMATORY RESPONSE,0.00010181,-0.51533,-0.66609,1,0
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1.2035e-05,-0.51537,-0.5937,1,0
1,GO OSTEOBLAST DEVELOPMENT,1.8524e-05,-0.51542,-0.51723,1,0
1,GO HISTONE H3 ACETYLATION,4.5891e-06,-0.51548,-0.57679,1,0
1,GO MAINTENANCE OF LOCATION,4.9495e-06,-0.51552,-0.54087,1,0
1,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,1.4947e-05,-0.51564,-0.55713,1,0
1,GO MONOCARBOXYLIC ACID TRANSPORT,4.2539e-06,-0.51576,-0.52694,1,0
1,GO CELLULAR RESPONSE TO NITRIC OXIDE,4.9495e-06,-0.51589,-0.55389,1,0
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,4.5891e-06,-0.51591,-0.52674,1,0
1,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,3.4805e-05,-0.51606,-0.55658,1,0
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,3.9936e-05,-0.5161,-0.55455,1,0
1,GO FIBROBLAST APOPTOTIC PROCESS,2.4576e-05,-0.51611,-0.53573,1,0
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,1.9888e-05,-0.51614,-0.49451,1,0
1,GO L GLUTAMATE IMPORT,4.2763e-05,-0.51615,-0.4349,1,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00020554,-0.51622,-0.62362,1,0
1,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,1.2035e-05,-0.51637,-0.58597,1,0
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,3.9422e-06,-0.51645,-0.52442,1,0
1,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.0019699,-0.51651,-0.53788,1,0
1,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,1.0403e-05,-0.51652,-0.54903,1,0
1,GO RESPONSE TO INORGANIC SUBSTANCE,5.7533e-06,-0.51661,-0.49539,1,0
1,GO RESPIRATORY BURST,0.00010866,-0.51689,-0.59793,1,0
1,GO ION TRANSPORT,6.6813e-06,-0.517,-0.49409,1,0
1,GO MEMBRANE LIPID METABOLIC PROCESS,1.2939e-05,-0.51708,-0.49927,1,0
1,GO NEUTROPHIL EXTRAVASATION,6.8565e-05,-0.51713,-0.6501,1,0
1,GO DIVALENT INORGANIC CATION HOMEOSTASIS,5.337e-06,-0.51716,-0.51391,1,0
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.00017019,-0.51733,-0.65312,1,0
1,GO SODIUM ION TRANSPORT,1.2939e-05,-0.51747,-0.49384,1,0
1,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0027019,-0.51774,-0.58083,1,0
1,GO RESPONSE TO SALT STRESS,5.6086e-05,-0.51783,-0.45901,1,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.0010798,-0.51806,-0.61683,1,0
1,GO SECRETION,5.337e-06,-0.51808,-0.53588,1,0
1,GO HORMONE BIOSYNTHETIC PROCESS,0.00024771,-0.51814,-0.43902,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.0034935,-0.51816,-0.5714,1,0
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,6.6813e-06,-0.51816,-0.50778,1,0
1,GO DEPHOSPHORYLATION,4.5891e-06,-0.5182,-0.54431,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00014989,-0.51821,-0.5874,1,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,4.2539e-06,-0.51835,-0.55629,1,0
1,GO MANGANESE ION TRANSPORT,4.9495e-06,-0.51838,-0.50713,1,0
1,GO MAINTENANCE OF PROTEIN LOCATION,5.7533e-06,-0.51843,-0.51348,1,0
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,4.2539e-06,-0.51849,-0.55586,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,4.9495e-06,-0.51853,-0.50033,1,0
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.00035748,-0.51856,-0.51701,1,0
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,1.7249e-05,-0.51859,-0.60247,1,0
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.4947e-05,-0.51881,-0.55508,1,0
1,GO PROTEIN POLYGLUTAMYLATION,0.00012367,-0.51894,-0.47907,1,0
1,GO CELLULAR SODIUM ION HOMEOSTASIS,6.4139e-05,-0.51895,-0.50076,1,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,5.9985e-05,-0.5192,-0.57519,1,0
1,GO THIOESTER BIOSYNTHETIC PROCESS,2.636e-05,-0.5192,-0.50707,1,0
1,GO PROTEIN CATABOLIC PROCESS,4.5891e-06,-0.51922,-0.54217,1,0
1,GO LIMBIC SYSTEM DEVELOPMENT,5.337e-06,-0.51931,-0.5233,1,0
1,GO POSTSYNAPSE ORGANIZATION,6.6813e-06,-0.51935,-0.58182,1,0
1,GO CHEMICAL HOMEOSTASIS,6.2007e-06,-0.51945,-0.51144,1,0
1,GO VIRAL LIFE CYCLE,6.6813e-06,-0.51955,-0.53963,1,0
1,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,0.0027019,-0.5196,-0.58073,1,0
1,GO LIPOSACCHARIDE METABOLIC PROCESS,1.7249e-05,-0.51964,-0.48728,1,0
1,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.0018673,-0.51966,-0.54245,1,0
1,GO PROTEIN O LINKED GLYCOSYLATION,1.2035e-05,-0.51979,-0.50217,1,0
1,GO SECOND MESSENGER MEDIATED SIGNALING,6.6813e-06,-0.51988,-0.50857,1,0
1,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,9.6689e-06,-0.51992,-0.58186,1,0
1,GO REGULATION OF CELL POPULATION PROLIFERATION,4.5891e-06,-0.52002,-0.54477,1,0
1,GO RESPONSE TO ANTIBIOTIC,4.2539e-06,-0.52017,-0.50474,1,0
1,GO CELLULAR POTASSIUM ION HOMEOSTASIS,4.5779e-05,-0.52025,-0.50076,1,0
1,GO REGULATION OF COAGULATION,1.2939e-05,-0.52026,-0.61032,1,0
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,1.0403e-05,-0.52037,-0.56116,1,0
1,GO REGULATION OF CELL DIVISION,4.2539e-06,-0.52038,-0.54822,1,0
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,2.2907e-05,-0.5204,-0.57571,1,0
1,GO REGIONALIZATION,1.0403e-05,-0.52041,-0.51637,1,0
1,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,4.9495e-06,-0.52042,-0.55002,1,0
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,2.2907e-05,-0.52044,-0.56694,1,0
1,GO RETINA LAYER FORMATION,0.00068502,-0.5206,-0.51653,1,0
1,GO TOXIN TRANSPORT,3.9422e-06,-0.52073,-0.57547,1,0
1,GO LONG TERM SYNAPTIC POTENTIATION,1.4947e-05,-0.52083,-0.54317,1,0
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,6.6813e-06,-0.5209,-0.49605,1,0
1,GO REGULATION OF PLATELET AGGREGATION,3.0304e-05,-0.52093,-0.61555,1,0
1,GO REGULATION OF PROTEIN GLYCOSYLATION,6.4139e-05,-0.52099,-0.59382,1,0
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.00081392,-0.52105,-0.64814,1,0
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,4.5891e-06,-0.52113,-0.55818,1,0
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,1.6059e-05,-0.52113,-0.60069,1,0
1,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,5.337e-06,-0.52116,-0.52037,1,0
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,4.5891e-06,-0.52117,-0.53098,1,0
1,GO T HELPER 1 CELL DIFFERENTIATION,0.0021907,-0.52122,-0.60621,1,0
1,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,1.8524e-05,-0.52124,-0.51291,1,0
1,GO CEREBELLAR CORTEX MORPHOGENESIS,6.6813e-06,-0.52144,-0.5855,1,0
1,GO POSITIVE REGULATION OF TRANSPORT,5.337e-06,-0.52152,-0.54482,1,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,5.7533e-06,-0.52157,-0.54084,1,0
1,GO RESPONSE TO OSMOTIC STRESS,5.7533e-06,-0.52158,-0.52783,1,0
1,GO PATTERN SPECIFICATION PROCESS,6.2007e-06,-0.52161,-0.53077,1,0
1,GO NEGATIVE REGULATION OF DNA RECOMBINATION,7.1973e-06,-0.52164,-0.56111,1,0
1,GO SODIUM ION TRANSMEMBRANE TRANSPORT,1.2035e-05,-0.52165,-0.50266,1,0
1,GO PROTEIN ACYLATION,6.2007e-06,-0.52167,-0.56538,1,0
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,3.9422e-06,-0.52176,-0.57729,1,0
1,GO PROTEIN ACETYLATION,4.9495e-06,-0.52176,-0.57009,1,0
1,GO EAR DEVELOPMENT,7.7514e-06,-0.52176,-0.49823,1,0
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.00081392,-0.52181,-0.51235,1,0
1,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,9.6689e-06,-0.5219,-0.51677,1,0
1,GO SEROTONIN SECRETION,4.2763e-05,-0.52193,-0.51684,1,0
1,GO GRANULOCYTE DIFFERENTIATION,1.7249e-05,-0.5221,-0.63178,1,0
1,GO CELLULAR RESPONSE TO MANGANESE ION,6.6813e-06,-0.52218,-0.52932,1,0
1,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,2.2907e-05,-0.52222,-0.5601,1,0
1,GO MITOTIC CHROMOSOME CONDENSATION,4.8997e-05,-0.52235,-0.59296,1,0
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,4.9495e-06,-0.52255,-0.52735,1,0
1,GO TISSUE HOMEOSTASIS,5.337e-06,-0.52257,-0.55225,1,0
1,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,1.8524e-05,-0.52266,-0.52712,1,0
1,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,1.1191e-05,-0.52278,-0.55064,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,7.7514e-06,-0.52286,-0.54513,1,0
1,GO DNA METHYLATION,8.9843e-06,-0.52294,-0.51013,1,0
1,GO EXOCYTOSIS,4.5891e-06,-0.52305,-0.56398,1,0
1,GO CELL CELL SIGNALING,6.2007e-06,-0.52311,-0.52375,1,0
1,GO GLYCEROLIPID METABOLIC PROCESS,5.337e-06,-0.52312,-0.52918,1,0
1,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.52322,-0.51872,1,0
1,GO RESPONSE TO GLUCAGON,3.0304e-05,-0.52323,-0.53364,1,0
1,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,1.7249e-05,-0.52323,-0.54436,1,0
1,GO REGULATION OF ORGANELLE ASSEMBLY,4.2539e-06,-0.52323,-0.56776,1,0
1,GO ENDOCRINE HORMONE SECRETION,2.8267e-05,-0.52338,-0.48151,1,0
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,9.5377e-05,-0.52351,-0.61125,1,0
1,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,9.6689e-06,-0.52354,-0.54462,1,0
1,GO POSITIVE REGULATION OF ION TRANSPORT,5.337e-06,-0.52356,-0.50537,1,0
1,GO STRIATED MUSCLE CELL PROLIFERATION,4.5891e-06,-0.52375,-0.54107,1,0
1,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.0010798,-0.52383,-0.44146,1,0
1,GO METAL ION TRANSPORT,6.2007e-06,-0.52388,-0.50594,1,0
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,8.9327e-05,-0.52389,-0.64172,1,0
1,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,0.0016767,-0.52414,-0.54041,1,0
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,3.9422e-06,-0.52431,-0.5119,1,0
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,5.337e-06,-0.52442,-0.52157,1,0
1,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,3.9422e-06,-0.52454,-0.52443,1,0
1,GO REGULATION OF TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.5246,-0.52396,1,0
1,GO RESPONSE TO THYROID HORMONE,1.6059e-05,-0.52498,-0.55855,1,0
1,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,1.0403e-05,-0.52511,-0.49107,1,0
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,4.5891e-06,-0.52511,-0.5198,1,0
1,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,8.9843e-06,-0.52527,-0.49379,1,0
1,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,8.9843e-06,-0.52533,-0.56166,1,0
1,GO MICROTUBULE BUNDLE FORMATION,0.00010866,-0.52544,-0.45696,1,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,6.6813e-06,-0.5255,-0.52997,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,4.2763e-05,-0.52551,-0.55258,1,0
1,GO DIVALENT INORGANIC CATION TRANSPORT,5.7533e-06,-0.52554,-0.53162,1,0
1,GO GLYCOPROTEIN METABOLIC PROCESS,4.5891e-06,-0.52571,-0.54438,1,0
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,1.6059e-05,-0.52575,-0.56727,1,0
1,GO ANTEROGRADE AXONAL TRANSPORT,7.7514e-06,-0.52577,-0.61335,1,0
1,GO RESPONSE TO STARVATION,5.7533e-06,-0.52595,-0.53585,1,0
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,6.6813e-06,-0.52599,-0.56545,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,4.5891e-06,-0.52619,-0.56218,1,0
1,GO G2 DNA DAMAGE CHECKPOINT,9.6689e-06,-0.52632,-0.57393,1,0
1,GO NEGATIVE REGULATION OF SECRETION,3.9422e-06,-0.52638,-0.51223,1,0
1,GO REGULATION OF GENE EXPRESSION EPIGENETIC,6.2007e-06,-0.52659,-0.52866,1,0
1,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,5.337e-06,-0.52667,-0.56096,1,0
1,GO CRANIAL NERVE DEVELOPMENT,2.8267e-05,-0.52672,-0.57265,1,0
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,9.5377e-05,-0.52679,-0.60919,1,0
1,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,4.5891e-06,-0.52682,-0.5511,1,0
1,GO MITOCHONDRION LOCALIZATION,8.9843e-06,-0.52684,-0.59643,1,0
1,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00012367,-0.52699,-0.44813,1,0
1,GO REGULATION OF B CELL ACTIVATION,5.2428e-05,-0.52703,-0.64754,1,0
1,GO HINDBRAIN DEVELOPMENT,8.9843e-06,-0.52706,-0.54089,1,0
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,2.8267e-05,-0.52711,-0.55848,1,0
1,GO ER NUCLEUS SIGNALING PATHWAY,7.1973e-06,-0.52713,-0.53736,1,0
1,GO REGULATION OF EXCRETION,6.4139e-05,-0.52726,-0.48928,1,0
1,GO PYRUVATE METABOLIC PROCESS,6.6813e-06,-0.52726,-0.54809,1,0
1,GO REGULATION OF ION TRANSPORT,6.2007e-06,-0.52731,-0.51261,1,0
1,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,3.9936e-05,-0.52741,-0.50948,1,0
1,GO NEURON APOPTOTIC PROCESS,5.337e-06,-0.52745,-0.53335,1,0
1,GO MYOTUBE DIFFERENTIATION,1.0403e-05,-0.52747,-0.56804,1,0
1,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,5.337e-06,-0.52751,-0.56858,1,0
1,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.00048214,-0.52752,-0.49803,1,0
1,GO AMINO ACID TRANSPORT,1.3909e-05,-0.52753,-0.52933,1,0
1,GO MULTICELLULAR ORGANISMAL SIGNALING,1.3909e-05,-0.52778,-0.52748,1,0
1,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,6.6813e-06,-0.52785,-0.5288,1,0
1,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,1.0403e-05,-0.52785,-0.56037,1,0
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00019306,-0.52794,-0.66737,1,0
1,GO CELLULAR RESPONSE TO FATTY ACID,9.6689e-06,-0.528,-0.50221,1,0
1,GO CHROMATIN ORGANIZATION,6.2007e-06,-0.52813,-0.56552,1,0
1,GO REGULATION OF SPINDLE ORGANIZATION,1.3909e-05,-0.52818,-0.52056,1,0
1,GO NEGATIVE REGULATION OF HORMONE SECRETION,7.7514e-06,-0.52825,-0.52411,1,0
1,GO ENDODERMAL CELL FATE COMMITMENT,3.4805e-05,-0.52828,-0.50167,1,0
1,GO REGULATION OF PROTEIN IMPORT,3.9422e-06,-0.52841,-0.55394,1,0
1,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,4.5891e-06,-0.52841,-0.54201,1,0
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.1191e-05,-0.52844,-0.54577,1,0
1,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,1.9888e-05,-0.52863,-0.45646,1,0
1,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,4.8997e-05,-0.52866,-0.60461,1,0
1,GO HISTONE METHYLATION,5.337e-06,-0.52885,-0.58752,1,0
1,GO ERK1 AND ERK2 CASCADE,8.9843e-06,-0.52886,-0.60596,1,0
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,5.6086e-05,-0.52889,-0.55898,1,0
1,GO RESPONSE TO AMINO ACID STARVATION,5.337e-06,-0.52892,-0.56872,1,0
1,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,4.9495e-06,-0.529,-0.547,1,0
1,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,8.9843e-06,-0.52909,-0.62033,1,0
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,1.1191e-05,-0.52912,-0.58971,1,0
1,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,1.0403e-05,-0.52922,-0.54475,1,0
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,6.2007e-06,-0.52925,-0.57332,1,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,7.7514e-06,-0.52931,-0.61562,1,0
1,GO REGULATION OF CIRCADIAN RHYTHM,1.2035e-05,-0.52948,-0.53627,1,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,4.5891e-06,-0.52959,-0.5748,1,0
1,GO REGULATION OF GENE SILENCING,5.337e-06,-0.52985,-0.54259,1,0
1,GO ANION TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.52991,-0.51621,1,0
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00033648,-0.52995,-0.62346,1,0
1,GO PHOSPHOLIPID CATABOLIC PROCESS,1.0403e-05,-0.53014,-0.58627,1,0
1,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.00018128,-0.53052,-0.51453,1,0
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,7.7514e-06,-0.53052,-0.50398,1,0
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,6.2007e-06,-0.53052,-0.52923,1,0
1,GO REGULATION OF MACROPHAGE MIGRATION,0.00014989,-0.53057,-0.60429,1,0
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,6.2007e-06,-0.53058,-0.5527,1,0
1,GO SEX DETERMINATION,9.5377e-05,-0.53066,-0.47031,1,0
1,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,3.7287e-05,-0.53069,-0.55655,1,0
1,GO MONOAMINE TRANSPORT,0.00015974,-0.53076,-0.49319,1,0
1,GO CALCINEURIN MEDIATED SIGNALING,3.9422e-06,-0.53079,-0.5773,1,0
1,GO AGING,4.2539e-06,-0.53084,-0.53748,1,0
1,GO B CELL MEDIATED IMMUNITY,0.00031664,-0.53092,-0.62001,1,0
1,GO EPITHELIAL CELL DIFFERENTIATION,6.6813e-06,-0.53103,-0.51156,1,0
1,GO AMYLOID FIBRIL FORMATION,1.8524e-05,-0.53113,-0.61844,1,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,4.8997e-05,-0.53117,-0.51116,1,0
1,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,3.9422e-06,-0.53133,-0.54765,1,0
1,GO RNA POLYADENYLATION,6.2007e-06,-0.53134,-0.58513,1,0
1,GO ENTRAINMENT OF CIRCADIAN CLOCK,2.2907e-05,-0.53135,-0.5146,1,0
1,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,1.4947e-05,-0.53138,-0.67055,1,0
1,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,4.2539e-06,-0.53143,-0.54773,1,0
1,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,2.2907e-05,-0.53148,-0.56947,1,0
1,GO NOREPINEPHRINE TRANSPORT,0.00015974,-0.53153,-0.59628,1,0
1,GO MEMBRANE ORGANIZATION,4.9495e-06,-0.53161,-0.55759,1,0
1,GO CELLULAR RESPONSE TO RETINOIC ACID,1.0403e-05,-0.5318,-0.55141,1,0
1,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,7.3279e-05,-0.53182,-0.52046,1,0
1,GO REGULATION OF STEROID METABOLIC PROCESS,2.4576e-05,-0.53193,-0.50211,1,0
1,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,1.8524e-05,-0.53195,-0.53755,1,0
1,GO REGULATION OF CYTOKINESIS,1.2939e-05,-0.53196,-0.54447,1,0
1,GO REGULATION OF PHAGOCYTOSIS,6.4139e-05,-0.53202,-0.64619,1,0
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,7.1973e-06,-0.5322,-0.54192,1,0
1,GO RENAL SODIUM EXCRETION,6.4139e-05,-0.53237,-0.50331,1,0
1,GO LAYER FORMATION IN CEREBRAL CORTEX,1.2035e-05,-0.53245,-0.67608,1,0
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,4.8997e-05,-0.53259,-0.6088,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,1.4947e-05,-0.53265,-0.57243,1,0
1,GO AXONAL FASCICULATION,1.0403e-05,-0.53269,-0.64473,1,0
1,GO ASTROCYTE DIFFERENTIATION,8.3461e-06,-0.53296,-0.58097,1,0
1,GO REGULATION OF INTEGRIN ACTIVATION,0.00020554,-0.53302,-0.55544,1,0
1,GO SYNAPTIC VESICLE MATURATION,0.0012758,-0.5331,-0.58792,1,0
1,GO NERVE DEVELOPMENT,2.2907e-05,-0.53318,-0.59902,1,0
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.00011593,-0.5333,-0.50504,1,0
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.0044907,-0.53336,-0.51604,1,0
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.00051151,-0.53341,-0.73774,1,0
1,GO RESPONSE TO NITROGEN COMPOUND,4.5891e-06,-0.5335,-0.55159,1,0
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,3.9936e-05,-0.53383,-0.57065,1,0
1,GO POSITIVE REGULATION OF DNA REPLICATION,1.3909e-05,-0.53396,-0.50973,1,0
1,GO RESPONSE TO LIPID,4.5891e-06,-0.53405,-0.54138,1,0
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,6.6813e-06,-0.53414,-0.52087,1,0
1,GO MUSCLE FIBER DEVELOPMENT,8.3461e-06,-0.53421,-0.54117,1,0
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00040321,-0.53424,-0.55418,1,0
1,GO RESPONSE TO REDOX STATE,0.00029789,-0.53451,-0.4916,1,0
1,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.00091199,-0.53451,-0.45551,1,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,7.1973e-06,-0.53452,-0.54187,1,0
1,GO POSITIVE REGULATION OF HEAT GENERATION,5.9985e-05,-0.53457,-0.50365,1,0
1,GO SULFATE TRANSPORT,0.00045436,-0.5346,-0.45149,1,0
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,3.9422e-06,-0.53484,-0.58749,1,0
1,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,1.8524e-05,-0.53488,-0.6345,1,0
1,GO CERAMIDE BIOSYNTHETIC PROCESS,1.4947e-05,-0.53496,-0.54402,1,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,9.6689e-06,-0.5351,-0.5019,1,0
1,GO AXO DENDRITIC TRANSPORT,1.0403e-05,-0.5352,-0.62141,1,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,3.9422e-06,-0.53525,-0.59611,1,0
1,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,4.8997e-05,-0.53539,-0.64092,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,5.337e-06,-0.53542,-0.51328,1,0
1,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,1.0403e-05,-0.53547,-0.57501,1,0
1,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00012367,-0.53549,-0.70202,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,6.6813e-06,-0.53563,-0.52971,1,0
1,GO LABYRINTHINE LAYER DEVELOPMENT,8.3461e-06,-0.53578,-0.59084,1,0
1,GO SERTOLI CELL DIFFERENTIATION,6.6813e-06,-0.53578,-0.62173,1,0
1,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,3.4805e-05,-0.53579,-0.50802,1,0
1,GO MEMORY,9.6689e-06,-0.53589,-0.52935,1,0
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,1.8524e-05,-0.53591,-0.63094,1,0
1,GO VITAMIN D METABOLIC PROCESS,3.9936e-05,-0.53616,-0.57253,1,0
1,GO SENSORY ORGAN MORPHOGENESIS,6.6813e-06,-0.5362,-0.53257,1,0
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,4.2539e-06,-0.53623,-0.58224,1,0
1,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,6.2007e-06,-0.53631,-0.59778,1,0
1,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,7.7514e-06,-0.53632,-0.5037,1,0
1,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.2939e-05,-0.5365,-0.55307,1,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,4.2539e-06,-0.53663,-0.55218,1,0
1,GO LYMPHOCYTE HOMEOSTASIS,1.2035e-05,-0.53667,-0.57079,1,0
1,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,9.6689e-06,-0.53672,-0.56765,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,5.7533e-06,-0.53689,-0.57805,1,0
1,GO RESPONSE TO HYDROGEN PEROXIDE,6.2007e-06,-0.53696,-0.50939,1,0
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0015882,-0.53703,-0.57664,1,0
1,GO POSITIVE REGULATION OF CELL ADHESION,1.8524e-05,-0.53708,-0.62672,1,0
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,3.0304e-05,-0.53709,-0.66747,1,0
1,GO MELANOCYTE DIFFERENTIATION,3.9422e-06,-0.53714,-0.55931,1,0
1,GO CELLULAR RESPONSE TO LIPID,4.5891e-06,-0.53721,-0.55373,1,0
1,GO REGULATION OF GLUCONEOGENESIS,6.2007e-06,-0.53727,-0.58953,1,0
1,GO POLYOL METABOLIC PROCESS,6.2007e-06,-0.53729,-0.52407,1,0
1,GO RESPONSE TO PAIN,1.0403e-05,-0.5373,-0.5393,1,0
1,GO POSITIVE REGULATION OF TELOMERE CAPPING,4.2763e-05,-0.5373,-0.51491,1,0
1,GO AMELOGENESIS,1.2939e-05,-0.53742,-0.57667,1,0
1,GO AUTOPHAGY OF MITOCHONDRION,4.9495e-06,-0.53747,-0.55995,1,0
1,GO PHOSPHOLIPID TRANSPORT,6.2007e-06,-0.53749,-0.57571,1,0
1,GO VISUAL BEHAVIOR,7.1973e-06,-0.53752,-0.53139,1,0
1,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0017696,-0.53768,-0.52637,1,0
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00026348,-0.5377,-0.63112,1,0
1,GO REGULATION OF NMDA RECEPTOR ACTIVITY,3.7287e-05,-0.53774,-0.50903,1,0
1,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,1.6059e-05,-0.53777,-0.54966,1,0
1,GO POSITIVE REGULATION OF SIGNALING,4.5891e-06,-0.53783,-0.55104,1,0
1,GO RESPONSE TO ESTRADIOL,6.6813e-06,-0.5379,-0.53031,1,0
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0010209,-0.5379,-0.57855,1,0
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,5.7533e-06,-0.53807,-0.62122,1,0
1,GO POSITIVE THYMIC T CELL SELECTION,0.0083971,-0.53811,-0.60531,1,0
1,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,4.2539e-06,-0.53839,-0.54086,1,0
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,1.9888e-05,-0.53842,-0.59706,1,0
1,GO CELLULAR RESPONSE TO ATP,6.6813e-06,-0.53847,-0.53835,1,0
1,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,9.6689e-06,-0.53851,-0.55724,1,0
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,4.2539e-06,-0.53858,-0.56541,1,0
1,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,1.2035e-05,-0.53865,-0.61067,1,0
1,GO RESPONSE TO STEROID HORMONE,4.9495e-06,-0.53877,-0.55423,1,0
1,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,8.9843e-06,-0.53878,-0.57099,1,0
1,GO RESPONSE TO PEPTIDOGLYCAN,0.00072571,-0.53891,-0.6033,1,0
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,4.5891e-06,-0.53892,-0.54099,1,0
1,GO COLLECTING DUCT DEVELOPMENT,0.00023283,-0.539,-0.53078,1,0
1,GO GLIAL CELL ACTIVATION,0.00028019,-0.53908,-0.67187,1,0
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,9.6689e-06,-0.53908,-0.56186,1,0
1,GO RESPONSE TO TEMPERATURE STIMULUS,4.5891e-06,-0.53911,-0.53813,1,0
1,GO FATTY ACID DERIVATIVE TRANSPORT,1.8524e-05,-0.53913,-0.51965,1,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.010572,-0.5392,-0.67942,1,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,6.6813e-06,-0.53921,-0.53986,1,0
1,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,2.4576e-05,-0.53937,-0.54606,1,0
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,3.9422e-06,-0.53938,-0.55937,1,0
1,GO PEPTIDYL LYSINE MODIFICATION,4.5891e-06,-0.5394,-0.57569,1,0
1,GO REGULATION OF TOR SIGNALING,4.9495e-06,-0.53956,-0.58963,1,0
1,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,2.636e-05,-0.53956,-0.51731,1,0
1,GO CELLULAR RESPONSE TO SALT STRESS,0.00029789,-0.53964,-0.54237,1,0
1,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2035e-05,-0.53964,-0.66759,1,0
1,GO RESPONSE TO MURAMYL DIPEPTIDE,1.4947e-05,-0.53983,-0.6914,1,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,4.5891e-06,-0.53983,-0.56053,1,0
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,1.8524e-05,-0.53983,-0.55116,1,0
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,3.7287e-05,-0.53992,-0.53905,1,0
1,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00035748,-0.53994,-0.6658,1,0
1,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00014989,-0.54015,-0.46351,1,0
1,GO CELLULAR RESPONSE TO CAMP,4.9495e-06,-0.54017,-0.51415,1,0
1,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,5.337e-06,-0.5402,-0.56346,1,0
1,GO ANION TRANSPORT,6.2007e-06,-0.54022,-0.50802,1,0
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,1.0403e-05,-0.54033,-0.51432,1,0
1,GO REGULATION OF LIPID KINASE ACTIVITY,5.337e-06,-0.54045,-0.65941,1,0
1,GO GOLGI VESICLE TRANSPORT,4.2539e-06,-0.54058,-0.57154,1,0
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,4.9495e-06,-0.54069,-0.58554,1,0
1,GO REGULATION OF CARDIAC CONDUCTION,1.7249e-05,-0.5407,-0.49651,1,0
1,GO EMBRYONIC ORGAN MORPHOGENESIS,4.9495e-06,-0.54084,-0.56787,1,0
1,GO BODY FLUID SECRETION,4.9495e-06,-0.54097,-0.50033,1,0
1,GO HEAD DEVELOPMENT,4.9495e-06,-0.54104,-0.57269,1,0
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,4.5891e-06,-0.54105,-0.54447,1,0
1,GO MEMBRANE BIOGENESIS,9.6689e-06,-0.54106,-0.57655,1,0
1,GO MUSCLE CELL APOPTOTIC PROCESS,6.2007e-06,-0.54108,-0.54767,1,0
1,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.00010866,-0.54112,-0.57022,1,0
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,3.4805e-05,-0.54121,-0.68546,1,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0021907,-0.54126,-0.52166,1,0
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,7.7514e-06,-0.54133,-0.58009,1,0
1,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,5.7533e-06,-0.54135,-0.56462,1,0
1,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,2.636e-05,-0.54137,-0.5509,1,0
1,GO REGULATION OF CATABOLIC PROCESS,4.5891e-06,-0.54154,-0.54081,1,0
1,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,1.8524e-05,-0.54164,-0.51079,1,0
1,GO SOMITE DEVELOPMENT,5.337e-06,-0.5418,-0.54899,1,0
1,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,5.337e-06,-0.54181,-0.54428,1,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,9.6689e-06,-0.54183,-0.68069,1,0
1,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,4.9495e-06,-0.54183,-0.53963,1,0
1,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,4.8997e-05,-0.54186,-0.59444,1,0
1,GO STORE OPERATED CALCIUM ENTRY,1.4947e-05,-0.54188,-0.59409,1,0
1,GO PIGMENTATION,6.2007e-06,-0.5419,-0.48096,1,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,1.6059e-05,-0.54194,-0.49861,1,0
1,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,6.6813e-06,-0.54195,-0.5064,1,0
1,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.00024771,-0.54212,-0.47515,1,0
1,GO OSTEOCLAST DIFFERENTIATION,9.6689e-06,-0.54216,-0.6321,1,0
1,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00018128,-0.54219,-0.51264,1,0
1,GO MRNA METHYLATION,5.7533e-06,-0.54221,-0.59695,1,0
1,GO REGULATION OF CELLULAR LOCALIZATION,4.5891e-06,-0.54226,-0.57246,1,0
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,4.9495e-06,-0.54229,-0.54182,1,0
1,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,7.1973e-06,-0.54231,-0.6129,1,0
1,GO REGULATION OF HEART GROWTH,4.9495e-06,-0.54242,-0.53163,1,0
1,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,1.4947e-05,-0.54242,-0.57639,1,0
1,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,8.9843e-06,-0.54242,-0.60707,1,0
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00014989,-0.54243,-0.60331,1,0
1,GO MESONEPHROS DEVELOPMENT,2.1347e-05,-0.54244,-0.49993,1,0
1,GO AXONAL TRANSPORT,8.9843e-06,-0.5425,-0.63922,1,0
1,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,6.2007e-06,-0.54251,-0.55322,1,0
1,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,8.9843e-06,-0.54258,-0.539,1,0
1,GO ANION HOMEOSTASIS,4.5891e-06,-0.54265,-0.567,1,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.00033648,-0.5427,-0.48114,1,0
1,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,5.7533e-06,-0.54271,-0.55671,1,0
1,GO REGULATION OF RECEPTOR BINDING,1.7249e-05,-0.54288,-0.63827,1,0
1,GO RESPONSE TO METAL ION,8.3461e-06,-0.5429,-0.48909,1,0
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,4.9495e-06,-0.54293,-0.53252,1,0
1,GO REGULATION OF TRANSFERASE ACTIVITY,4.5891e-06,-0.54294,-0.5601,1,0
1,GO SULFUR COMPOUND CATABOLIC PROCESS,5.337e-06,-0.54302,-0.56,1,0
1,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,4.2539e-06,-0.54303,-0.54411,1,0
1,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00014989,-0.54314,-0.52909,1,0
1,GO ANATOMICAL STRUCTURE HOMEOSTASIS,4.5891e-06,-0.54316,-0.52004,1,0
1,GO SENSORY ORGAN DEVELOPMENT,5.337e-06,-0.54321,-0.55304,1,0
1,GO INTERACTION WITH HOST,4.5891e-06,-0.54324,-0.5627,1,0
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,4.9495e-06,-0.54327,-0.58253,1,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,4.2763e-05,-0.5434,-0.50375,1,0
1,GO MICROVILLUS ORGANIZATION,1.1191e-05,-0.54341,-0.54428,1,0
1,GO MODULATION BY VIRUS OF HOST PROCESS,4.5891e-06,-0.54344,-0.56436,1,0
1,GO CEREBELLAR CORTEX FORMATION,1.2035e-05,-0.54349,-0.56521,1,0
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,4.5891e-06,-0.5435,-0.52719,1,0
1,GO AMYLOID BETA METABOLIC PROCESS,1.2035e-05,-0.54359,-0.55877,1,0
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,4.5891e-06,-0.54372,-0.55428,1,0
1,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,6.2007e-06,-0.54376,-0.52854,1,0
1,GO MOTILE CILIUM ASSEMBLY,0.00011593,-0.54382,-0.52146,1,0
1,GO POSITIVE REGULATION OF CELL DIVISION,6.2007e-06,-0.54383,-0.52266,1,0
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,5.9985e-05,-0.54383,-0.6374,1,0
1,GO MEMBRANE INVAGINATION,1.7249e-05,-0.54409,-0.67785,1,0
1,GO SEGMENTATION,3.9422e-06,-0.54417,-0.55525,1,0
1,GO LIPID LOCALIZATION,6.6813e-06,-0.5443,-0.52324,1,0
1,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,7.7514e-06,-0.54436,-0.49683,1,0
1,GO POSITIVE REGULATION OF BIOMINERALIZATION,2.2907e-05,-0.5444,-0.57821,1,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,5.9985e-05,-0.54453,-0.54984,1,0
1,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,5.2428e-05,-0.54474,-0.56214,1,0
1,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,2.636e-05,-0.54495,-0.55123,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,3.9936e-05,-0.54497,-0.5876,1,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,1.7249e-05,-0.54503,-0.46816,1,0
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,4.9495e-06,-0.54516,-0.5459,1,0
1,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,4.2539e-06,-0.54526,-0.57297,1,0
1,GO B CELL ACTIVATION,1.2939e-05,-0.54535,-0.61775,1,0
1,GO REGULATION OF FATTY ACID METABOLIC PROCESS,4.9495e-06,-0.5455,-0.5561,1,0
1,GO SECRETORY GRANULE ORGANIZATION,9.6689e-06,-0.54562,-0.54937,1,0
1,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00011593,-0.54564,-0.57803,1,0
1,GO CLATHRIN COAT ASSEMBLY,0.00028019,-0.54565,-0.54337,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,3.7287e-05,-0.54581,-0.62384,1,0
1,GO RENAL TUBULE DEVELOPMENT,1.0403e-05,-0.54585,-0.55299,1,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,4.2539e-06,-0.54587,-0.56465,1,0
1,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,1.2035e-05,-0.5459,-0.6352,1,0
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,3.9422e-06,-0.5459,-0.56193,1,0
1,GO REGULATION OF CHEMOTAXIS,1.3909e-05,-0.54595,-0.60082,1,0
1,GO REGULATION OF ORGANELLE ORGANIZATION,4.2539e-06,-0.54606,-0.56807,1,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,8.9843e-06,-0.54611,-0.57037,1,0
1,GO PEPTIDYL LYSINE METHYLATION,7.1973e-06,-0.54625,-0.58296,1,0
1,GO ACYLGLYCEROL HOMEOSTASIS,5.337e-06,-0.54648,-0.54198,1,0
1,GO REGULATION OF LIPID CATABOLIC PROCESS,1.7249e-05,-0.54655,-0.53761,1,0
1,GO CERAMIDE TRANSPORT,1.1191e-05,-0.54677,-0.5929,1,0
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,4.5891e-06,-0.54686,-0.55988,1,0
1,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,6.2007e-06,-0.54722,-0.51973,1,0
1,GO PSEUDOPODIUM ORGANIZATION,0.00024771,-0.54738,-0.57753,1,0
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,4.5891e-06,-0.54739,-0.55796,1,0
1,GO PEPTIDYL LYSINE ACETYLATION,5.337e-06,-0.54741,-0.58159,1,0
1,GO CELL AGGREGATION,0.00028019,-0.54751,-0.48085,1,0
1,GO MYELOID CELL APOPTOTIC PROCESS,4.5779e-05,-0.54753,-0.52852,1,0
1,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,7.1973e-06,-0.54755,-0.59335,1,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.2939e-05,-0.54759,-0.61555,1,0
1,GO CELL PROJECTION ASSEMBLY,6.2007e-06,-0.5476,-0.55131,1,0
1,GO REGULATION OF CHOLESTEROL EFFLUX,1.0403e-05,-0.5477,-0.59725,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00010181,-0.54772,-0.49616,1,0
1,GO ORGANIC ANION TRANSPORT,7.1973e-06,-0.54777,-0.50597,1,0
1,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,4.5891e-06,-0.54778,-0.55087,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS,0.00072571,-0.54794,-0.5753,1,0
1,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,7.1973e-06,-0.54797,-0.56105,1,0
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,5.337e-06,-0.54798,-0.58958,1,0
1,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.00045436,-0.54799,-0.59515,1,0
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.0040644,-0.54809,-0.57774,1,0
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,2.636e-05,-0.54816,-0.53571,1,0
1,GO MACROPHAGE ACTIVATION,4.8997e-05,-0.5482,-0.66199,1,0
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,3.9422e-06,-0.54822,-0.55672,1,0
1,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,4.2539e-06,-0.54831,-0.55003,1,0
1,GO INOSITOL PHOSPHATE METABOLIC PROCESS,3.9422e-06,-0.54845,-0.5657,1,0
1,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,2.636e-05,-0.54847,-0.51675,1,0
1,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,4.2539e-06,-0.54853,-0.55843,1,0
1,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00028019,-0.54855,-0.57058,1,0
1,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,5.337e-06,-0.54856,-0.52912,1,0
1,GO SMOOTHENED SIGNALING PATHWAY,8.3461e-06,-0.54861,-0.55278,1,0
1,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,1.7249e-05,-0.54872,-0.58198,1,0
1,GO HISTONE H4 K5 ACETYLATION,2.636e-05,-0.5488,-0.59486,1,0
1,GO RESPONSE TO DSRNA,1.4947e-05,-0.5488,-0.54647,1,0
1,GO SEQUESTERING OF CALCIUM ION,1.2035e-05,-0.54884,-0.56981,1,0
1,GO RESPONSE TO HEAT,3.9422e-06,-0.54896,-0.54158,1,0
1,GO INOSITOL METABOLIC PROCESS,0.00013188,-0.54933,-0.55094,1,0
1,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,8.3461e-06,-0.54939,-0.61196,1,0
1,GO SYNAPSE ORGANIZATION,5.337e-06,-0.54939,-0.60587,1,0
1,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,4.2539e-06,-0.54939,-0.54875,1,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,1.0403e-05,-0.54948,-0.54216,1,0
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,5.7533e-06,-0.54981,-0.56405,1,0
1,GO VITAMIN D BIOSYNTHETIC PROCESS,9.5377e-05,-0.54982,-0.65345,1,0
1,GO ENSHEATHMENT OF NEURONS,4.9495e-06,-0.54984,-0.55367,1,0
1,GO AUDITORY RECEPTOR CELL DEVELOPMENT,4.8997e-05,-0.54989,-0.55962,1,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,1.0403e-05,-0.54992,-0.51485,1,0
1,GO PROTEIN AUTO ADP RIBOSYLATION,9.6689e-06,-0.54995,-0.64034,1,0
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,4.5891e-06,-0.55,-0.58997,1,0
1,GO LIPID MODIFICATION,5.337e-06,-0.55006,-0.53185,1,0
1,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,4.5779e-05,-0.55014,-0.63892,1,0
1,GO HISTONE H4 ACETYLATION,6.2007e-06,-0.55018,-0.60445,1,0
1,GO PROTEIN SUMOYLATION,5.337e-06,-0.5502,-0.57923,1,0
1,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00028019,-0.55028,-0.51563,1,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,1.9888e-05,-0.5503,-0.65557,1,0
1,GO MESONEPHRIC TUBULE MORPHOGENESIS,1.3909e-05,-0.55035,-0.50023,1,0
1,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,7.8298e-05,-0.55045,-0.53054,1,0
1,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0003797,-0.55046,-0.65431,1,0
1,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00014989,-0.55053,-0.61697,1,0
1,GO REGULATION OF TRANSPORT,5.337e-06,-0.55062,-0.53629,1,0
1,GO REGULATION OF EPIDERMIS DEVELOPMENT,1.0403e-05,-0.55063,-0.58662,1,0
1,GO LEFT RIGHT AXIS SPECIFICATION,2.1347e-05,-0.55067,-0.58686,1,0
1,GO CELLULAR GLUCOSE HOMEOSTASIS,7.7514e-06,-0.55082,-0.55565,1,0
1,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,7.8298e-05,-0.55083,-0.47272,1,0
1,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00048214,-0.55083,-0.67505,1,0
1,GO ORGANOPHOSPHATE ESTER TRANSPORT,6.2007e-06,-0.55083,-0.54827,1,0
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,5.2428e-05,-0.55089,-0.64239,1,0
1,GO RESPONSE TO KETONE,4.2539e-06,-0.55097,-0.55707,1,0
1,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,3.9422e-06,-0.55101,-0.63629,1,0
1,GO NEGATIVE REGULATION OF SIGNALING,4.5891e-06,-0.55106,-0.57262,1,0
1,GO FORELIMB MORPHOGENESIS,1.6059e-05,-0.55107,-0.53629,1,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,3.9422e-06,-0.55123,-0.59196,1,0
1,GO REGULATION OF MITOCHONDRIAL FISSION,5.7533e-06,-0.55131,-0.58837,1,0
1,GO PHOSPHOLIPID METABOLIC PROCESS,5.337e-06,-0.55147,-0.54933,1,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,4.9495e-06,-0.55151,-0.58352,1,0
1,GO RESPONSE TO FORSKOLIN,8.3641e-05,-0.55158,-0.62112,1,0
1,GO REGULATION OF HAIR CYCLE,1.8524e-05,-0.55168,-0.54732,1,0
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,4.9495e-06,-0.55169,-0.55544,1,0
1,GO OLIGODENDROCYTE DEVELOPMENT,1.9888e-05,-0.55185,-0.54773,1,0
1,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.0029965,-0.55188,-0.60418,1,0
1,GO ASSOCIATIVE LEARNING,8.9843e-06,-0.55188,-0.53358,1,0
1,GO CYTOSOLIC CALCIUM ION TRANSPORT,7.7514e-06,-0.55189,-0.57009,1,0
1,GO RHYTHMIC BEHAVIOR,1.4947e-05,-0.55195,-0.54806,1,0
1,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,2.1347e-05,-0.55208,-0.53608,1,0
1,GO REGULATION OF SPINDLE ASSEMBLY,1.6059e-05,-0.55212,-0.48621,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,7.7514e-06,-0.55226,-0.58028,1,0
1,GO RESPONSE TO ATP,4.5891e-06,-0.5523,-0.5513,1,0
1,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.00054254,-0.55253,-0.62587,1,0
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,2.636e-05,-0.55266,-0.53623,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.00024771,-0.5527,-0.76238,1,0
1,GO POLYSACCHARIDE CATABOLIC PROCESS,4.2539e-06,-0.55274,-0.57235,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,3.9936e-05,-0.55277,-0.60592,1,0
1,GO MEMBRANE DISASSEMBLY,7.1973e-06,-0.55288,-0.63488,1,0
1,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,8.9843e-06,-0.55297,-0.52527,1,0
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,4.5891e-06,-0.55329,-0.54329,1,0
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,6.4139e-05,-0.55335,-0.59881,1,0
1,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,4.5779e-05,-0.55336,-0.5145,1,0
1,GO LIPID HOMEOSTASIS,5.337e-06,-0.55367,-0.53582,1,0
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,3.0304e-05,-0.55369,-0.61972,1,0
1,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,8.9327e-05,-0.55375,-0.64345,1,0
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,6.8565e-05,-0.55375,-0.50058,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,1.6059e-05,-0.55389,-0.63648,1,0
1,GO REGULATION OF ORGAN GROWTH,4.5891e-06,-0.55397,-0.55141,1,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,4.2539e-06,-0.55402,-0.5574,1,0
1,GO NOREPINEPHRINE SECRETION,0.00020554,-0.55403,-0.55469,1,0
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,7.7514e-06,-0.55406,-0.55683,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00018128,-0.5541,-0.57552,1,0
1,GO ACTIN MEDIATED CELL CONTRACTION,4.2539e-06,-0.55411,-0.5477,1,0
1,GO OVARIAN FOLLICLE DEVELOPMENT,2.1347e-05,-0.55416,-0.48156,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,4.9495e-06,-0.55429,-0.57506,1,0
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,3.4805e-05,-0.55437,-0.64196,1,0
1,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,4.2539e-06,-0.55452,-0.55883,1,0
1,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,7.1973e-06,-0.55455,-0.56484,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.2035e-05,-0.55455,-0.66226,1,0
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,4.2539e-06,-0.55456,-0.58457,1,0
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.008797,-0.5546,-0.53319,1,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,5.7533e-06,-0.55474,-0.56566,1,0
1,GO MICROTUBULE DEPOLYMERIZATION,1.7249e-05,-0.55474,-0.65715,1,0
1,GO REGULATION OF ENDOCRINE PROCESS,1.7249e-05,-0.55479,-0.49856,1,0
1,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.00076864,-0.55487,-0.57161,1,0
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,8.3461e-06,-0.55494,-0.59295,1,0
1,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,1.6059e-05,-0.55495,-0.59167,1,0
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,3.9422e-06,-0.55509,-0.55983,1,0
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,6.6813e-06,-0.55522,-0.5579,1,0
1,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,6.2007e-06,-0.55532,-0.56905,1,0
1,GO IMMUNE SYSTEM DEVELOPMENT,4.5891e-06,-0.55535,-0.57203,1,0
1,GO REGULATION OF ERAD PATHWAY,4.9495e-06,-0.55552,-0.58966,1,0
1,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,2.4576e-05,-0.55563,-0.52535,1,0
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.6059e-05,-0.55571,-0.5521,1,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,4.5891e-06,-0.55575,-0.58247,1,0
1,GO EPITHELIUM DEVELOPMENT,4.5891e-06,-0.55577,-0.54091,1,0
1,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,4.5891e-06,-0.5558,-0.57607,1,0
1,GO REGULATION OF PHOSPHORYLATION,4.5891e-06,-0.55601,-0.57348,1,0
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,5.2428e-05,-0.55622,-0.57238,1,0
1,GO AMINO ACID TRANSMEMBRANE TRANSPORT,8.9843e-06,-0.55622,-0.51072,1,0
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,3.9422e-06,-0.55629,-0.60955,1,0
1,GO ANATOMICAL STRUCTURE MATURATION,8.3461e-06,-0.55631,-0.54412,1,0
1,GO NEURON MIGRATION,9.6689e-06,-0.5564,-0.61762,1,0
1,GO REGULATION OF SECRETION,6.2007e-06,-0.55652,-0.52622,1,0
1,GO POSITIVE REGULATION OF B CELL PROLIFERATION,5.6086e-05,-0.5566,-0.65341,1,0
1,GO FOREGUT MORPHOGENESIS,3.248e-05,-0.55661,-0.57509,1,0
1,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,1.9888e-05,-0.55668,-0.67947,1,0
1,GO POSITIVE REGULATION OF HEART GROWTH,7.7514e-06,-0.5567,-0.52894,1,0
1,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,3.7287e-05,-0.55674,-0.53175,1,0
1,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,3.9422e-06,-0.55675,-0.58457,1,0
1,GO NEURONAL ION CHANNEL CLUSTERING,0.00011593,-0.55689,-0.58221,1,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,1.6059e-05,-0.55706,-0.54474,1,0
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,4.9495e-06,-0.55708,-0.56039,1,0
1,GO TRANSEPITHELIAL TRANSPORT,8.9843e-06,-0.55715,-0.55872,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,8.3461e-06,-0.55716,-0.53832,1,0
1,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,6.6813e-06,-0.5572,-0.55286,1,0
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,5.337e-06,-0.55733,-0.58518,1,0
1,GO LEUKOCYTE HOMEOSTASIS,8.3461e-06,-0.55734,-0.61308,1,0
1,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,5.7533e-06,-0.5574,-0.5338,1,0
1,GO DENDRITIC CELL APOPTOTIC PROCESS,0.0080134,-0.55741,-0.78584,1,0
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,4.5891e-06,-0.55751,-0.59593,1,0
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.8524e-05,-0.55755,-0.62249,1,0
1,GO CIRCADIAN RHYTHM,7.1973e-06,-0.55756,-0.54923,1,0
1,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,4.8997e-05,-0.55773,-0.57763,1,0
1,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,6.2007e-06,-0.55779,-0.54782,1,0
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,6.6813e-06,-0.55786,-0.61441,1,0
1,GO POSITIVE REGULATION OF MYELINATION,8.9843e-06,-0.55796,-0.61442,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,6.2007e-06,-0.55812,-0.61374,1,0
1,GO REGULATION OF CALCIUM ION TRANSPORT,5.337e-06,-0.55817,-0.55369,1,0
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,1.8524e-05,-0.55826,-0.61177,1,0
1,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,5.337e-06,-0.55834,-0.54469,1,0
1,GO MEMBRANE FISSION,4.8997e-05,-0.55844,-0.60611,1,0
1,GO POLYOL CATABOLIC PROCESS,3.9936e-05,-0.55854,-0.50138,1,0
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.1973e-06,-0.55862,-0.63992,1,0
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,4.2539e-06,-0.55874,-0.57946,1,0
1,GO NEUROBLAST PROLIFERATION,1.8524e-05,-0.55886,-0.56848,1,0
1,GO RESPONSE TO INTERLEUKIN 7,1.6059e-05,-0.55888,-0.60745,1,0
1,GO SYNAPSE PRUNING,0.0049572,-0.55893,-0.70313,1,0
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,4.2539e-06,-0.55903,-0.60189,1,0
1,GO SYNAPTIC VESICLE RECYCLING,2.8267e-05,-0.55906,-0.60839,1,0
1,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0018673,-0.55914,-0.58566,1,0
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,1.1191e-05,-0.5592,-0.53872,1,0
1,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,4.5891e-06,-0.55957,-0.60287,1,0
1,GO DEVELOPMENTAL PIGMENTATION,3.9422e-06,-0.55966,-0.52098,1,0
1,GO REGULATION OF STRIATED MUSCLE CONTRACTION,1.2939e-05,-0.55972,-0.5239,1,0
1,GO DOSAGE COMPENSATION,1.2035e-05,-0.55972,-0.61984,1,0
1,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,6.2007e-06,-0.55974,-0.60954,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,8.3461e-06,-0.5598,-0.55345,1,0
1,GO ADAPTIVE THERMOGENESIS,5.337e-06,-0.55987,-0.55153,1,0
1,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00011593,-0.56009,-0.63051,1,0
1,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,5.2428e-05,-0.56013,-0.54541,1,0
1,GO POSITIVE CHEMOTAXIS,2.8267e-05,-0.56026,-0.54003,1,0
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,4.9495e-06,-0.56032,-0.58274,1,0
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,6.2007e-06,-0.56045,-0.56069,1,0
1,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,1.0403e-05,-0.56046,-0.55233,1,0
1,GO REGULATION OF NERVOUS SYSTEM PROCESS,6.6813e-06,-0.5605,-0.55308,1,0
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,3.7287e-05,-0.56061,-0.61795,1,0
1,GO REGULATION OF EXOCYTOSIS,9.6689e-06,-0.56061,-0.5862,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,3.9422e-06,-0.56077,-0.59769,1,0
1,GO RESPONSE TO ACETYLCHOLINE,8.3641e-05,-0.56077,-0.59135,1,0
1,GO NEGATIVE REGULATION OF CELL AGING,5.7533e-06,-0.56078,-0.55595,1,0
1,GO CERAMIDE METABOLIC PROCESS,1.2035e-05,-0.56082,-0.5643,1,0
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,9.5377e-05,-0.56087,-0.61778,1,0
1,GO SYNAPTIC TRANSMISSION GABAERGIC,5.337e-06,-0.56097,-0.55354,1,0
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,3.9422e-06,-0.56102,-0.57152,1,0
1,GO REGULATION OF RECEPTOR RECYCLING,3.9422e-06,-0.56104,-0.57775,1,0
1,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,5.7533e-06,-0.56115,-0.54772,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0080134,-0.56124,-0.56291,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,4.2539e-06,-0.56124,-0.57143,1,0
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,4.2539e-06,-0.56125,-0.55484,1,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,4.2539e-06,-0.5615,-0.57685,1,0
1,GO VESICLE DOCKING,8.3461e-06,-0.56176,-0.60896,1,0
1,GO PROTEIN DESTABILIZATION,5.337e-06,-0.56177,-0.59532,1,0
1,GO REGULATION OF HYDROLASE ACTIVITY,4.5891e-06,-0.56185,-0.56827,1,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,4.5891e-06,-0.5619,-0.58435,1,0
1,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,3.248e-05,-0.56207,-0.60018,1,0
1,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,6.6813e-06,-0.56208,-0.59314,1,0
1,GO VESICLE LOCALIZATION,4.9495e-06,-0.56218,-0.58476,1,0
1,GO MUSCLE ORGAN DEVELOPMENT,4.5891e-06,-0.5622,-0.5639,1,0
1,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,3.7287e-05,-0.56229,-0.70227,1,0
1,GO MITOCHONDRIAL FISSION,7.1973e-06,-0.5624,-0.58544,1,0
1,GO DENDRITIC SPINE MORPHOGENESIS,8.3461e-06,-0.56256,-0.61455,1,0
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,8.3461e-06,-0.56263,-0.6288,1,0
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,3.9422e-06,-0.56265,-0.62443,1,0
1,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,7.7514e-06,-0.56273,-0.54275,1,0
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,9.5377e-05,-0.56273,-0.58156,1,0
1,GO VESICLE CARGO LOADING,4.5891e-06,-0.56273,-0.59679,1,0
1,GO CALCIUM ION IMPORT,1.3909e-05,-0.56277,-0.54532,1,0
1,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,3.7287e-05,-0.56291,-0.53356,1,0
1,GO RESPONSE TO MONOSACCHARIDE,5.7533e-06,-0.56297,-0.54901,1,0
1,GO RESPONSE TO ORGANOPHOSPHORUS,5.7533e-06,-0.56301,-0.54129,1,0
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,4.9495e-06,-0.56301,-0.58128,1,0
1,GO NEPHRON MORPHOGENESIS,1.3909e-05,-0.56305,-0.53563,1,0
1,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.00012367,-0.56312,-0.44525,1,0
1,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,4.2539e-06,-0.56319,-0.51939,1,0
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,4.5891e-06,-0.56319,-0.57289,1,0
1,GO IRON COORDINATION ENTITY TRANSPORT,0.00010866,-0.56342,-0.53709,1,0
1,GO CELLULAR RESPONSE TO KETONE,5.337e-06,-0.56349,-0.55934,1,0
1,GO GENETIC IMPRINTING,6.4139e-05,-0.56351,-0.52683,1,0
1,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,7.1973e-06,-0.56355,-0.53626,1,0
1,GO FOAM CELL DIFFERENTIATION,1.9888e-05,-0.56387,-0.59066,1,0
1,GO RECEPTOR RECYCLING,4.5891e-06,-0.56393,-0.57283,1,0
1,GO HEART PROCESS,6.2007e-06,-0.5641,-0.52965,1,0
1,GO NEURON DEATH,4.9495e-06,-0.56419,-0.56856,1,0
1,GO PIGMENT CELL DIFFERENTIATION,3.9422e-06,-0.56427,-0.56555,1,0
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,4.2539e-06,-0.5643,-0.55999,1,0
1,GO SKELETAL MUSCLE ADAPTATION,3.4805e-05,-0.56443,-0.51557,1,0
1,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00096503,-0.56446,-0.539,1,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,9.6689e-06,-0.5646,-0.57101,1,0
1,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,1.3909e-05,-0.56487,-0.5317,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.00035748,-0.56507,-0.62815,1,0
1,GO PEPTIDE SECRETION,7.1973e-06,-0.5651,-0.53857,1,0
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,3.9422e-06,-0.56518,-0.55729,1,0
1,GO CALCIUM ION IMPORT INTO CYTOSOL,5.2428e-05,-0.56519,-0.58893,1,0
1,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,5.7533e-06,-0.56522,-0.57394,1,0
1,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,5.337e-06,-0.56528,-0.54574,1,0
1,GO RHYTHMIC PROCESS,4.9495e-06,-0.56529,-0.56402,1,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,4.5891e-06,-0.56532,-0.57149,1,0
1,GO MESODERM DEVELOPMENT,4.9495e-06,-0.56551,-0.53708,1,0
1,GO REGULATION OF RESPONSE TO WOUNDING,4.9495e-06,-0.56575,-0.60646,1,0
1,GO MIDGUT DEVELOPMENT,1.2035e-05,-0.56577,-0.58705,1,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,4.2539e-06,-0.5659,-0.58537,1,0
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,4.5891e-06,-0.56621,-0.56939,1,0
1,GO INTERMEMBRANE LIPID TRANSFER,4.2539e-06,-0.56622,-0.61304,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,4.5891e-06,-0.56636,-0.56363,1,0
1,GO PROTEIN PALMITOYLATION,4.8997e-05,-0.56658,-0.53715,1,0
1,GO NEGATIVE REGULATION OF WOUND HEALING,7.7514e-06,-0.56674,-0.61121,1,0
1,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,8.9843e-06,-0.56677,-0.60244,1,0
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,4.2539e-06,-0.56677,-0.58899,1,0
1,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,4.2539e-06,-0.56679,-0.59254,1,0
1,GO REGULATION OF LIPID METABOLIC PROCESS,5.7533e-06,-0.56679,-0.56398,1,0
1,GO NEGATIVE REGULATION OF PROTEIN BINDING,5.337e-06,-0.56686,-0.57152,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,1.2035e-05,-0.56686,-0.6103,1,0
1,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,5.337e-06,-0.56695,-0.59291,1,0
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,5.7533e-06,-0.56696,-0.57784,1,0
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,3.9422e-06,-0.56699,-0.63751,1,0
1,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,4.2539e-06,-0.56699,-0.58293,1,0
1,GO PRESYNAPTIC ENDOCYTOSIS,2.2907e-05,-0.56702,-0.61458,1,0
1,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,7.1973e-06,-0.56707,-0.59282,1,0
1,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,0.023112,-0.56708,-0.74591,1,0
1,GO REGULATION OF SYNAPSE MATURATION,2.4576e-05,-0.56717,-0.65865,1,0
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,4.5891e-06,-0.56741,-0.61692,1,0
1,GO MOLTING CYCLE,1.1191e-05,-0.56744,-0.54402,1,0
1,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,4.2763e-05,-0.56768,-0.64144,1,0
1,GO PEPTIDYL SERINE DEPHOSPHORYLATION,7.7514e-06,-0.56781,-0.55242,1,0
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.00017019,-0.56802,-0.6345,1,0
1,GO ORGANIC HYDROXY COMPOUND TRANSPORT,1.3909e-05,-0.56809,-0.49313,1,0
1,GO PROTEIN POLYMERIZATION,4.2539e-06,-0.56813,-0.59658,1,0
1,GO COVALENT CHROMATIN MODIFICATION,4.5891e-06,-0.56815,-0.59267,1,0
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00045436,-0.56815,-0.75161,1,0
1,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,3.9422e-06,-0.56819,-0.58895,1,0
1,GO GERMINAL CENTER FORMATION,8.3641e-05,-0.56827,-0.78257,1,0
1,GO NEURON DIFFERENTIATION,6.6813e-06,-0.56841,-0.59073,1,0
1,GO RESPONSE TO PROSTAGLANDIN,3.0304e-05,-0.56842,-0.56393,1,0
1,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,3.248e-05,-0.56848,-0.64843,1,0
1,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,7.7514e-06,-0.56877,-0.57251,1,0
1,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,7.3279e-05,-0.56878,-0.53494,1,0
1,GO NATURAL KILLER CELL DIFFERENTIATION,2.636e-05,-0.56888,-0.62594,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00072571,-0.56897,-0.58655,1,0
1,GO REGULATION OF NEURON DIFFERENTIATION,5.7533e-06,-0.56909,-0.61721,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,2.8267e-05,-0.56915,-0.58941,1,0
1,GO RESPONSE TO MISFOLDED PROTEIN,1.2035e-05,-0.56917,-0.63787,1,0
1,GO RESPONSE TO RETINOIC ACID,8.3461e-06,-0.56917,-0.5694,1,0
1,GO CELL CELL ADHESION,5.337e-06,-0.5692,-0.58968,1,0
1,GO CELLULAR RESPONSE TO HEAT,4.2539e-06,-0.56921,-0.55352,1,0
1,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.3909e-05,-0.56921,-0.53421,1,0
1,GO ORGANIC ACID TRANSPORT,7.7514e-06,-0.56927,-0.51331,1,0
1,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,5.7533e-06,-0.56929,-0.61333,1,0
1,GO ASTROCYTE DEVELOPMENT,1.8524e-05,-0.56954,-0.64579,1,0
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,4.9495e-06,-0.5696,-0.5739,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,8.3461e-06,-0.56962,-0.61463,1,0
1,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,1.4947e-05,-0.56965,-0.56742,1,0
1,GO KIDNEY MORPHOGENESIS,1.6059e-05,-0.5697,-0.54139,1,0
1,GO CARDIAC MUSCLE CELL PROLIFERATION,5.337e-06,-0.56978,-0.57678,1,0
1,GO POSITIVE REGULATION OF HISTONE METHYLATION,7.1973e-06,-0.5699,-0.59711,1,0
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,4.5891e-06,-0.5699,-0.57581,1,0
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,2.8267e-05,-0.56995,-0.56791,1,0
1,GO MAST CELL MEDIATED IMMUNITY,4.5891e-06,-0.56996,-0.67534,1,0
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,5.337e-06,-0.57,-0.54034,1,0
1,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.00010866,-0.57014,-0.57892,1,0
1,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,9.6689e-06,-0.57028,-0.55909,1,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,4.5891e-06,-0.57029,-0.57144,1,0
1,GO SOMITOGENESIS,4.5891e-06,-0.5703,-0.57494,1,0
1,GO ERBB2 SIGNALING PATHWAY,4.2539e-06,-0.57039,-0.55807,1,0
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,1.4947e-05,-0.5704,-0.63386,1,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,8.9843e-06,-0.57053,-0.61042,1,0
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.4576e-05,-0.57055,-0.64847,1,0
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,5.7533e-06,-0.57074,-0.59533,1,0
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,3.9422e-06,-0.57074,-0.62379,1,0
1,GO IMPORT INTO CELL,7.7514e-06,-0.57085,-0.54792,1,0
1,GO RESPONSE TO PURINE CONTAINING COMPOUND,5.337e-06,-0.57091,-0.55377,1,0
1,GO REGULATION OF MRNA POLYADENYLATION,6.2007e-06,-0.57103,-0.63283,1,0
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,7.8298e-05,-0.57131,-0.61814,1,0
1,GO CELLULAR RESPONSE TO STARVATION,5.7533e-06,-0.57131,-0.55853,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,3.9422e-06,-0.57137,-0.56616,1,0
1,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,4.5891e-06,-0.57139,-0.5962,1,0
1,GO MYELOID CELL DIFFERENTIATION,3.9422e-06,-0.57142,-0.60531,1,0
1,GO RESPONSE TO LEPTIN,1.9888e-05,-0.57151,-0.52286,1,0
1,GO TELOMERE CAPPING,7.7514e-06,-0.57157,-0.5782,1,0
1,GO TEMPERATURE HOMEOSTASIS,5.337e-06,-0.57161,-0.55315,1,0
1,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,8.9327e-05,-0.57184,-0.72464,1,0
1,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,5.337e-06,-0.57187,-0.55051,1,0
1,GO DIGESTIVE TRACT MORPHOGENESIS,1.8524e-05,-0.57187,-0.53685,1,0
1,GO ANIMAL ORGAN MORPHOGENESIS,4.9495e-06,-0.5719,-0.58134,1,0
1,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,6.2007e-06,-0.57209,-0.56468,1,0
1,GO REGULATION OF MRNA 3 END PROCESSING,5.7533e-06,-0.57213,-0.58959,1,0
1,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,9.6689e-06,-0.57216,-0.639,1,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.5891e-06,-0.57238,-0.54206,1,0
1,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,1.3909e-05,-0.57244,-0.58836,1,0
1,GO NEUROGENESIS,5.337e-06,-0.57249,-0.58666,1,0
1,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,4.2539e-06,-0.57265,-0.57724,1,0
1,GO EMBRYONIC ORGAN DEVELOPMENT,4.9495e-06,-0.57276,-0.58129,1,0
1,GO NEGATIVE REGULATION OF KINASE ACTIVITY,7.1973e-06,-0.57279,-0.56667,1,0
1,GO REGULATION OF HISTONE MODIFICATION,4.9495e-06,-0.5729,-0.58551,1,0
1,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,2.1347e-05,-0.573,-0.63819,1,0
1,GO CELL ADHESION MOLECULE PRODUCTION,0.00015974,-0.57303,-0.59418,1,0
1,GO RESPONSE TO AXON INJURY,1.2035e-05,-0.57306,-0.56443,1,0
1,GO PROTEIN DNA COMPLEX DISASSEMBLY,8.3641e-05,-0.57306,-0.53229,1,0
1,GO MIRNA METABOLIC PROCESS,6.2007e-06,-0.57321,-0.5987,1,0
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,4.2539e-06,-0.57322,-0.56896,1,0
1,GO RESPONSE TO VITAMIN D,2.1347e-05,-0.57326,-0.57355,1,0
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,7.1973e-06,-0.57326,-0.61598,1,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,7.1973e-06,-0.57331,-0.61063,1,0
1,GO DIACYLGLYCEROL METABOLIC PROCESS,7.7514e-06,-0.57337,-0.63588,1,0
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,4.5891e-06,-0.57338,-0.58975,1,0
1,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,3.7287e-05,-0.57348,-0.58661,1,0
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,3.248e-05,-0.57362,-0.66599,1,0
1,GO SEGMENT SPECIFICATION,3.248e-05,-0.5737,-0.51523,1,0
1,GO ORGANIC CATION TRANSPORT,2.636e-05,-0.57379,-0.5144,1,0
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,4.9495e-06,-0.57381,-0.5908,1,0
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,6.2007e-06,-0.57385,-0.54681,1,0
1,GO RESPONSE TO POTASSIUM ION,0.00020554,-0.57386,-0.54004,1,0
1,GO ENDOCARDIAL CUSHION DEVELOPMENT,3.9422e-06,-0.5741,-0.66826,1,0
1,GO IMPORT ACROSS PLASMA MEMBRANE,7.7514e-06,-0.57412,-0.54985,1,0
1,GO REGULATION OF REGULATED SECRETORY PATHWAY,1.2035e-05,-0.57413,-0.60896,1,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,1.2035e-05,-0.57418,-0.5555,1,0
1,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,4.5891e-06,-0.57425,-0.57755,1,0
1,GO PROSTAGLANDIN SECRETION,4.5779e-05,-0.57433,-0.51696,1,0
1,GO MODIFIED AMINO ACID TRANSPORT,1.4947e-05,-0.57434,-0.51723,1,0
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,4.2539e-06,-0.57434,-0.60079,1,0
1,GO RESPONSE TO NERVE GROWTH FACTOR,6.2007e-06,-0.57437,-0.60105,1,0
1,GO PROTEIN LOCALIZATION TO CELL JUNCTION,9.6689e-06,-0.57462,-0.6125,1,0
1,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,6.6813e-06,-0.5747,-0.58343,1,0
1,GO CYCLOOXYGENASE PATHWAY,0.0012071,-0.57498,-0.56109,1,0
1,GO HYPEROSMOTIC RESPONSE,1.2035e-05,-0.575,-0.56623,1,0
1,GO NEURON RECOGNITION,2.1347e-05,-0.57501,-0.59693,1,0
1,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00042807,-0.57515,-0.56901,1,0
1,GO ACTION POTENTIAL,8.3461e-06,-0.57556,-0.55126,1,0
1,GO RESPONSE TO HORMONE,4.5891e-06,-0.5756,-0.56177,1,0
1,GO INTEGRIN ACTIVATION,9.5377e-05,-0.57577,-0.69029,1,0
1,GO MEMBRANE HYPERPOLARIZATION,1.7249e-05,-0.57582,-0.55161,1,0
1,GO CARBOHYDRATE TRANSPORT,5.337e-06,-0.57587,-0.55123,1,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,5.337e-06,-0.57595,-0.58917,1,0
1,GO MUSCLE TISSUE DEVELOPMENT,4.2539e-06,-0.57613,-0.56358,1,0
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,1.0403e-05,-0.57615,-0.64221,1,0
1,GO MUSCLE CELL PROLIFERATION,5.337e-06,-0.57628,-0.5991,1,0
1,GO NEGATIVE REGULATION OF NEURON DEATH,6.2007e-06,-0.57636,-0.56396,1,0
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,2.636e-05,-0.57642,-0.62919,1,0
1,GO MUSCLE SYSTEM PROCESS,4.9495e-06,-0.57658,-0.55852,1,0
1,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,2.636e-05,-0.57662,-0.54984,1,0
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,9.6689e-06,-0.57665,-0.5756,1,0
1,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,4.8997e-05,-0.57669,-0.49904,1,0
1,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.0057394,-0.57677,-0.7163,1,0
1,GO HEART GROWTH,4.9495e-06,-0.57682,-0.55838,1,0
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,4.5891e-06,-0.57688,-0.63603,1,0
1,GO SPECIFICATION OF SYMMETRY,6.2007e-06,-0.57712,-0.5362,1,0
1,GO REGULATION OF MACROPHAGE ACTIVATION,4.2763e-05,-0.57713,-0.67608,1,0
1,GO RAB PROTEIN SIGNAL TRANSDUCTION,2.1347e-05,-0.57717,-0.6288,1,0
1,GO SEQUESTERING OF TRIGLYCERIDE,7.1973e-06,-0.5772,-0.57495,1,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.6059e-05,-0.57723,-0.64897,1,0
1,GO CARBOHYDRATE PHOSPHORYLATION,1.2035e-05,-0.57725,-0.58334,1,0
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,4.9495e-06,-0.57729,-0.60006,1,0
1,GO REGULATION OF GROWTH,4.5891e-06,-0.57751,-0.5728,1,0
1,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,7.7514e-06,-0.57755,-0.62319,1,0
1,GO CHLORIDE ION HOMEOSTASIS,1.2939e-05,-0.57764,-0.57428,1,0
1,GO ENERGY RESERVE METABOLIC PROCESS,8.9843e-06,-0.57775,-0.53303,1,0
1,GO NEGATIVE T CELL SELECTION,0.010101,-0.57776,-0.57663,1,0
1,GO GLIAL CELL DIFFERENTIATION,6.6813e-06,-0.57779,-0.56185,1,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,7.7514e-06,-0.57795,-0.57249,1,0
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,6.2007e-06,-0.57803,-0.60362,1,0
1,GO SPHINGOLIPID METABOLIC PROCESS,1.4947e-05,-0.57824,-0.55052,1,0
1,GO POSITIVE REGULATION OF CELL DEVELOPMENT,4.5891e-06,-0.5783,-0.58738,1,0
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,7.3279e-05,-0.57833,-0.62617,1,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,4.5891e-06,-0.57838,-0.59354,1,0
1,GO REGULATION OF FIBRINOLYSIS,2.4576e-05,-0.57848,-0.60703,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,1.1191e-05,-0.57849,-0.58399,1,0
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,4.5891e-06,-0.57867,-0.58245,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,4.2539e-06,-0.57876,-0.56384,1,0
1,GO REGULATION OF MUSCLE CONTRACTION,5.337e-06,-0.57885,-0.52449,1,0
1,GO EMBRYO IMPLANTATION,7.1973e-06,-0.57887,-0.6498,1,0
1,GO REGULATION OF CALCIUM ION IMPORT,1.8524e-05,-0.57891,-0.59067,1,0
1,GO REGULATION OF SYSTEM PROCESS,5.7533e-06,-0.57892,-0.53573,1,0
1,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00018128,-0.57892,-0.56527,1,0
1,GO DENDRITE MORPHOGENESIS,7.7514e-06,-0.57909,-0.63172,1,0
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.00042807,-0.57913,-0.65735,1,0
1,GO POSITIVE REGULATION OF CELL GROWTH,4.9495e-06,-0.57919,-0.6022,1,0
1,GO MAGNESIUM ION TRANSPORT,9.6689e-06,-0.57924,-0.59928,1,0
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,4.5891e-06,-0.57927,-0.58746,1,0
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,2.4576e-05,-0.57929,-0.63359,1,0
1,GO REGULATION OF TELOMERE CAPPING,8.3461e-06,-0.57938,-0.60287,1,0
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,2.2907e-05,-0.57939,-0.52831,1,0
1,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,4.2539e-06,-0.57942,-0.6224,1,0
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,6.2007e-06,-0.57945,-0.52057,1,0
1,GO DENDRITE DEVELOPMENT,6.2007e-06,-0.5795,-0.62371,1,0
1,GO NEURON DEVELOPMENT,6.6813e-06,-0.57951,-0.60825,1,0
1,GO NEPHRON EPITHELIUM DEVELOPMENT,8.9843e-06,-0.57954,-0.56537,1,0
1,GO MITOPHAGY,5.337e-06,-0.57964,-0.64981,1,0
1,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,3.9422e-06,-0.57991,-0.58372,1,0
1,GO REGULATION OF GLUCOSE METABOLIC PROCESS,1.2939e-05,-0.58003,-0.5629,1,0
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,5.337e-06,-0.5801,-0.5799,1,0
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0003797,-0.58012,-0.51866,1,0
1,GO LIPID STORAGE,6.2007e-06,-0.58014,-0.56923,1,0
1,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,3.9422e-06,-0.58023,-0.62589,1,0
1,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,6.6813e-06,-0.58036,-0.64287,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,9.6689e-06,-0.58065,-0.63058,1,0
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,7.1973e-06,-0.58086,-0.55233,1,0
1,GO HETEROCHROMATIN ORGANIZATION,7.1973e-06,-0.58095,-0.59582,1,0
1,GO VESICLE TRANSPORT ALONG MICROTUBULE,5.7533e-06,-0.58107,-0.63401,1,0
1,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,3.9422e-06,-0.58108,-0.60424,1,0
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,4.5779e-05,-0.58139,-0.6051,1,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,4.9495e-06,-0.58143,-0.59061,1,0
1,GO RESPONSE TO ENDOGENOUS STIMULUS,4.5891e-06,-0.58144,-0.57154,1,0
1,GO RECEPTOR METABOLIC PROCESS,4.2539e-06,-0.58148,-0.58829,1,0
1,GO MAINTENANCE OF CELL POLARITY,4.5779e-05,-0.5816,-0.52982,1,0
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,1.1191e-05,-0.58166,-0.62303,1,0
1,GO REGULATION OF MICROTUBULE BINDING,3.248e-05,-0.58177,-0.68558,1,0
1,GO RESPONSE TO HYPEROXIA,4.2539e-06,-0.58183,-0.61675,1,0
1,GO REGULATION OF COLLATERAL SPROUTING,6.8565e-05,-0.58191,-0.66103,1,0
1,GO NEURAL PRECURSOR CELL PROLIFERATION,8.3461e-06,-0.58197,-0.55438,1,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,8.9843e-06,-0.58226,-0.5144,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,5.7533e-06,-0.58232,-0.54176,1,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION,1.7249e-05,-0.58237,-0.61738,1,0
1,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,4.5779e-05,-0.58238,-0.52036,1,0
1,GO POLYSACCHARIDE METABOLIC PROCESS,7.7514e-06,-0.58241,-0.56264,1,0
1,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,1.3909e-05,-0.58255,-0.65677,1,0
1,GO GROWTH,4.5891e-06,-0.58257,-0.5793,1,0
1,GO NOTCH RECEPTOR PROCESSING,0.00018128,-0.58282,-0.56014,1,0
1,GO MUSCLE CONTRACTION,5.337e-06,-0.58286,-0.54948,1,0
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,7.1973e-06,-0.58286,-0.59371,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,2.8267e-05,-0.58305,-0.64347,1,0
1,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,4.5891e-06,-0.58319,-0.59619,1,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,5.337e-06,-0.58344,-0.60084,1,0
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,4.2539e-06,-0.58356,-0.53789,1,0
1,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,6.2007e-06,-0.58362,-0.58354,1,0
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,4.2539e-06,-0.58383,-0.59728,1,0
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,3.4805e-05,-0.58388,-0.56469,1,0
1,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00015974,-0.58392,-0.58837,1,0
1,GO POSITIVE REGULATION OF COAGULATION,7.7514e-06,-0.58396,-0.61084,1,0
1,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,4.2539e-06,-0.58399,-0.60222,1,0
1,GO RESPONSE TO COCAINE,5.6086e-05,-0.58412,-0.52326,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,6.2007e-06,-0.58434,-0.55272,1,0
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,6.6813e-06,-0.58434,-0.56643,1,0
1,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,4.8997e-05,-0.58438,-0.57755,1,0
1,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,6.2007e-06,-0.58449,-0.56766,1,0
1,GO B CELL HOMEOSTASIS,5.7533e-06,-0.58451,-0.68219,1,0
1,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,4.9495e-06,-0.58466,-0.58036,1,0
1,GO RESPONSE TO CALCIUM ION,7.1973e-06,-0.58482,-0.5362,1,0
1,GO STRIATED MUSCLE CONTRACTION,6.6813e-06,-0.58487,-0.54027,1,0
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,4.2539e-06,-0.58492,-0.57127,1,0
1,GO PEPTIDYL AMINO ACID MODIFICATION,4.2539e-06,-0.58497,-0.57798,1,0
1,GO CARDIAC CONDUCTION,1.1191e-05,-0.58501,-0.54699,1,0
1,GO REGULATION OF WOUND HEALING,5.337e-06,-0.58521,-0.60167,1,0
1,GO PEPTIDYL LYSINE DIMETHYLATION,4.9495e-06,-0.58529,-0.6018,1,0
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,4.2539e-06,-0.5853,-0.65535,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,1.0403e-05,-0.58538,-0.591,1,0
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,4.5891e-06,-0.58549,-0.5902,1,0
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,9.6689e-06,-0.58551,-0.65896,1,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,4.5779e-05,-0.58555,-0.54593,1,0
1,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,4.2539e-06,-0.58576,-0.62212,1,0
1,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,2.636e-05,-0.58577,-0.51603,1,0
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,6.2007e-06,-0.58581,-0.55536,1,0
1,GO MAGNESIUM ION HOMEOSTASIS,3.248e-05,-0.58585,-0.54957,1,0
1,GO MICROTUBULE POLYMERIZATION,8.3461e-06,-0.58587,-0.6259,1,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0031545,-0.58608,-0.55092,1,0
1,GO DEVELOPMENTAL GROWTH,4.2539e-06,-0.5861,-0.59579,1,0
1,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,8.9843e-06,-0.5861,-0.57048,1,0
1,GO HINDLIMB MORPHOGENESIS,8.3461e-06,-0.58612,-0.57541,1,0
1,GO REGULATION OF CHROMATIN ORGANIZATION,4.9495e-06,-0.58614,-0.58109,1,0
1,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,6.6813e-06,-0.58641,-0.60749,1,0
1,GO ENDOSOME TO LYSOSOME TRANSPORT,4.5891e-06,-0.58645,-0.61963,1,0
1,GO NEGATIVE REGULATION OF GENE SILENCING,1.4947e-05,-0.58663,-0.55292,1,0
1,GO POSITIVE REGULATION OF BONE MINERALIZATION,2.636e-05,-0.58665,-0.62281,1,0
1,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,7.7514e-06,-0.58677,-0.55676,1,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,5.7533e-06,-0.58687,-0.60914,1,0
1,GO RESPONSE TO ACID CHEMICAL,4.5891e-06,-0.58688,-0.56368,1,0
1,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.00026348,-0.58697,-0.62507,1,0
1,GO REGULATION OF WNT SIGNALING PATHWAY,4.9495e-06,-0.58703,-0.56418,1,0
1,GO REGULATION OF MAPK CASCADE,4.5891e-06,-0.58708,-0.60757,1,0
1,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,4.5891e-06,-0.58726,-0.63247,1,0
1,GO REGULATION OF HORMONE METABOLIC PROCESS,9.5377e-05,-0.58726,-0.63966,1,0
1,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,8.9843e-06,-0.58733,-0.57242,1,0
1,GO NEUROTRANSMITTER UPTAKE,1.8524e-05,-0.58743,-0.50557,1,0
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,6.6813e-06,-0.5875,-0.60032,1,0
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,1.6059e-05,-0.58751,-0.60686,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,6.2007e-06,-0.58763,-0.58122,1,0
1,GO RESPONSE TO CAMP,6.2007e-06,-0.58768,-0.56418,1,0
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,5.337e-06,-0.58783,-0.6228,1,0
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,4.2539e-06,-0.58794,-0.55868,1,0
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,3.9422e-06,-0.58803,-0.6272,1,0
1,GO MITOCHONDRIAL GENOME MAINTENANCE,7.7514e-06,-0.58809,-0.58001,1,0
1,GO REGULATION OF SODIUM ION TRANSPORT,1.0403e-05,-0.58813,-0.53412,1,0
1,GO MEMBRANE DEPOLARIZATION,4.2763e-05,-0.58815,-0.55443,1,0
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,8.9843e-06,-0.58819,-0.60457,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,2.8267e-05,-0.58824,-0.69822,1,0
1,GO INTERFERON BETA PRODUCTION,1.0403e-05,-0.58832,-0.64041,1,0
1,GO GOLGI ORGANIZATION,4.2539e-06,-0.58836,-0.63801,1,0
1,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,2.4576e-05,-0.58857,-0.6194,1,0
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,4.2539e-06,-0.58863,-0.54042,1,0
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,3.9422e-06,-0.58869,-0.57058,1,0
1,GO NEUROTRANSMITTER REUPTAKE,2.2907e-05,-0.58871,-0.52489,1,0
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,3.248e-05,-0.58876,-0.62393,1,0
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,4.9495e-06,-0.58879,-0.58,1,0
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,6.6813e-06,-0.58881,-0.62839,1,0
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,2.2907e-05,-0.58883,-0.68056,1,0
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,4.5891e-06,-0.5889,-0.588,1,0
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,1.2939e-05,-0.58891,-0.5489,1,0
1,GO B CELL DIFFERENTIATION,7.7514e-06,-0.58893,-0.64365,1,0
1,GO DETERMINATION OF ADULT LIFESPAN,2.4576e-05,-0.589,-0.57114,1,0
1,GO REGULATION OF BLOOD PRESSURE,5.7533e-06,-0.58917,-0.54851,1,0
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,1.2035e-05,-0.58923,-0.5893,1,0
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,8.3641e-05,-0.58931,-0.59593,1,0
1,GO CELL PART MORPHOGENESIS,4.5891e-06,-0.58938,-0.63644,1,0
1,GO GAMMA DELTA T CELL DIFFERENTIATION,1.3909e-05,-0.58955,-0.73576,1,0
1,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,4.5779e-05,-0.5896,-0.6546,1,0
1,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,2.636e-05,-0.58967,-0.58097,1,0
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,4.2539e-06,-0.58981,-0.59464,1,0
1,GO REGULATION OF HISTONE METHYLATION,6.2007e-06,-0.58984,-0.63097,1,0
1,GO HISTONE H3 K27 METHYLATION,4.5779e-05,-0.58994,-0.62922,1,0
1,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,1.4947e-05,-0.59,-0.58597,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,1.0403e-05,-0.59003,-0.5587,1,0
1,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,4.5891e-06,-0.59005,-0.55673,1,0
1,GO REGULATION OF URINE VOLUME,1.6059e-05,-0.59006,-0.5472,1,0
1,GO MULTICELLULAR ORGANISMAL MOVEMENT,1.0403e-05,-0.59007,-0.58347,1,0
1,GO REGULATION OF PROTEIN MATURATION,5.337e-06,-0.59008,-0.58018,1,0
1,GO EMBRYO DEVELOPMENT,4.2539e-06,-0.59015,-0.5851,1,0
1,GO CELL FATE DETERMINATION,2.2907e-05,-0.59017,-0.53281,1,0
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,7.1973e-06,-0.59033,-0.63411,1,0
1,GO REGULATION OF MYOBLAST FUSION,0.0010798,-0.59043,-0.61249,1,0
1,GO AMINOGLYCAN METABOLIC PROCESS,6.2007e-06,-0.59051,-0.61518,1,0
1,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,5.7533e-06,-0.59054,-0.57061,1,0
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,6.2007e-06,-0.59072,-0.60157,1,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.00076864,-0.5908,-0.52574,1,0
1,GO FOREBRAIN NEURON DEVELOPMENT,0.00010866,-0.59082,-0.57357,1,0
1,GO REGULATION OF GLIAL CELL MIGRATION,3.7287e-05,-0.59092,-0.7084,1,0
1,GO MOVEMENT IN HOST ENVIRONMENT,7.7514e-06,-0.59092,-0.57741,1,0
1,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,4.5891e-06,-0.59136,-0.64018,1,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,6.2007e-06,-0.59138,-0.57533,1,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.00010866,-0.59146,-0.58486,1,0
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,1.0403e-05,-0.59146,-0.63556,1,0
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,4.2539e-06,-0.59152,-0.59108,1,0
1,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,5.2428e-05,-0.59182,-0.50914,1,0
1,GO MATURE B CELL DIFFERENTIATION,2.4576e-05,-0.59187,-0.7405,1,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.0403e-05,-0.59207,-0.54185,1,0
1,GO REGULATION OF RECEPTOR INTERNALIZATION,4.5891e-06,-0.59218,-0.62078,1,0
1,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,1.6059e-05,-0.59224,-0.60305,1,0
1,GO REGULATION OF TUBULIN DEACETYLATION,7.7514e-06,-0.5924,-0.64195,1,0
1,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,8.3641e-05,-0.5924,-0.72215,1,0
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,5.7533e-06,-0.59257,-0.62662,1,0
1,GO COMPLEMENT ACTIVATION,0.0020776,-0.59261,-0.62208,1,0
1,GO HOMEOSTASIS OF NUMBER OF CELLS,3.9422e-06,-0.59271,-0.59443,1,0
1,GO MACROMOLECULE DEACYLATION,5.7533e-06,-0.59273,-0.57358,1,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,6.6813e-06,-0.59274,-0.6113,1,0
1,GO NEGATIVE REGULATION OF BLOOD PRESSURE,5.6086e-05,-0.5928,-0.50416,1,0
1,GO POSITIVE REGULATION OF B CELL ACTIVATION,2.1347e-05,-0.59305,-0.65578,1,0
1,GO PRIMARY MIRNA PROCESSING,2.1347e-05,-0.59305,-0.6158,1,0
1,GO CELL GROWTH,4.2539e-06,-0.59312,-0.60465,1,0
1,GO POSITIVE REGULATION OF MAPK CASCADE,4.5891e-06,-0.59325,-0.60976,1,0
1,GO REGULATION OF MUSCLE SYSTEM PROCESS,4.9495e-06,-0.59327,-0.54997,1,0
1,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,3.9422e-06,-0.59334,-0.60304,1,0
1,GO L AMINO ACID TRANSPORT,6.6813e-06,-0.59339,-0.54034,1,0
1,GO POSITIVE REGULATION OF URINE VOLUME,3.7287e-05,-0.5934,-0.56116,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,1.4947e-05,-0.59356,-0.64909,1,0
1,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,4.5891e-06,-0.59361,-0.60198,1,0
1,GO AXON DEVELOPMENT,4.5891e-06,-0.59374,-0.63389,1,0
1,GO IN UTERO EMBRYONIC DEVELOPMENT,4.2539e-06,-0.5939,-0.57292,1,0
1,GO PLACENTA DEVELOPMENT,4.9495e-06,-0.59393,-0.61026,1,0
1,GO CELLULAR RESPONSE TO DSRNA,3.7287e-05,-0.59396,-0.58268,1,0
1,GO DIGESTIVE SYSTEM DEVELOPMENT,7.1973e-06,-0.59401,-0.59141,1,0
1,GO REGULATION OF ACTIN FILAMENT LENGTH,4.5891e-06,-0.59403,-0.61666,1,0
1,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,6.2007e-06,-0.59408,-0.63842,1,0
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,4.9495e-06,-0.5942,-0.58985,1,0
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,4.2539e-06,-0.59424,-0.62613,1,0
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,5.337e-06,-0.59429,-0.62233,1,0
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,1.9888e-05,-0.59447,-0.62327,1,0
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,6.8565e-05,-0.59447,-0.64106,1,0
1,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,5.7533e-06,-0.5945,-0.64877,1,0
1,GO REGULATION OF CELL DEVELOPMENT,4.5891e-06,-0.59456,-0.60198,1,0
1,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,1.4947e-05,-0.59457,-0.58593,1,0
1,GO REGULATION OF BODY FLUID LEVELS,4.5891e-06,-0.59462,-0.59916,1,0
1,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0003797,-0.5947,-0.51706,1,0
1,GO ADIPOSE TISSUE DEVELOPMENT,8.3461e-06,-0.59481,-0.59327,1,0
1,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.00010181,-0.59486,-0.56633,1,0
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,3.9422e-06,-0.59488,-0.59371,1,0
1,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,7.1973e-06,-0.59516,-0.53523,1,0
1,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,5.337e-06,-0.5955,-0.59231,1,0
1,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,4.9495e-06,-0.5955,-0.57782,1,0
1,GO AMYLOID BETA CLEARANCE,2.4576e-05,-0.59585,-0.68527,1,0
1,GO NEGATIVE REGULATION OF AUTOPHAGY,3.9422e-06,-0.59587,-0.61602,1,0
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,6.6813e-06,-0.59628,-0.61245,1,0
1,GO LONG TERM MEMORY,1.6059e-05,-0.59646,-0.57328,1,0
1,GO REGULATION OF CHROMATIN ASSEMBLY,7.1973e-06,-0.59659,-0.62973,1,0
1,GO ENTRY INTO HOST,1.0403e-05,-0.59669,-0.60854,1,0
1,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,6.6813e-06,-0.59681,-0.56435,1,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,6.6813e-06,-0.59687,-0.62672,1,0
1,GO MESENCHYME DEVELOPMENT,4.9495e-06,-0.59702,-0.59978,1,0
1,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.2939e-05,-0.59705,-0.60123,1,0
1,GO CELL CELL SIGNALING BY WNT,4.5891e-06,-0.59715,-0.57557,1,0
1,GO POSITIVE REGULATION OF GROWTH,4.5891e-06,-0.5972,-0.60935,1,0
1,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,8.9843e-06,-0.59724,-0.57807,1,0
1,GO REGULATION OF LIPID STORAGE,4.5891e-06,-0.59731,-0.62575,1,0
1,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,1.3909e-05,-0.59737,-0.61596,1,0
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,3.0304e-05,-0.59747,-0.53931,1,0
1,GO SPINDLE LOCALIZATION,8.3461e-06,-0.59749,-0.60364,1,0
1,GO MEGAKARYOCYTE DIFFERENTIATION,4.2539e-06,-0.59767,-0.61896,1,0
1,GO CELLULAR HYPEROSMOTIC RESPONSE,4.5779e-05,-0.59773,-0.56877,1,0
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,4.2539e-06,-0.59774,-0.65638,1,0
1,GO BIOMINERALIZATION,7.7514e-06,-0.59779,-0.61026,1,0
1,GO NEURAL CREST CELL DIFFERENTIATION,4.5891e-06,-0.59792,-0.58938,1,0
1,GO REGULATION OF CELL DIFFERENTIATION,4.5891e-06,-0.59797,-0.59233,1,0
1,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,6.2007e-06,-0.59807,-0.6587,1,0
1,GO MAINTENANCE OF ORGANELLE LOCATION,7.7514e-06,-0.59814,-0.62293,1,0
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,4.2539e-06,-0.59816,-0.61756,1,0
1,GO DEVELOPMENTAL MATURATION,7.7514e-06,-0.59822,-0.55799,1,0
1,GO REGULATION OF PROTEIN BINDING,4.5891e-06,-0.59828,-0.5953,1,0
1,GO MUSCLE CELL DEVELOPMENT,4.9495e-06,-0.59853,-0.55824,1,0
1,GO KIDNEY EPITHELIUM DEVELOPMENT,8.9843e-06,-0.59877,-0.5711,1,0
1,GO NEURON MATURATION,3.0304e-05,-0.5989,-0.58301,1,0
1,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,5.2428e-05,-0.59892,-0.62156,1,0
1,GO CELLULAR GLUCAN METABOLIC PROCESS,9.6689e-06,-0.59896,-0.53451,1,0
1,GO REGULATION OF BIOMINERALIZATION,7.7514e-06,-0.59907,-0.63361,1,0
1,GO INFLAMMATORY RESPONSE TO WOUNDING,7.8298e-05,-0.59928,-0.74947,1,0
1,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,2.8267e-05,-0.59931,-0.70058,1,0
1,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,4.9495e-06,-0.59931,-0.61717,1,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,4.9495e-06,-0.59932,-0.61396,1,0
1,GO INTRACELLULAR STEROL TRANSPORT,4.2539e-06,-0.59933,-0.63785,1,0
1,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,4.5891e-06,-0.59934,-0.58207,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,7.8298e-05,-0.59943,-0.64505,1,0
1,GO SENSORY SYSTEM DEVELOPMENT,4.5891e-06,-0.59948,-0.59947,1,0
1,GO SYNAPTIC VESICLE PRIMING,0.00026348,-0.5995,-0.63003,1,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,7.1973e-06,-0.59962,-0.55029,1,0
1,GO STRIATED MUSCLE CELL DIFFERENTIATION,4.9495e-06,-0.59962,-0.57905,1,0
1,GO MORPHOGENESIS OF AN EPITHELIUM,4.5891e-06,-0.59962,-0.5926,1,0
1,GO OVULATION CYCLE PROCESS,3.9422e-06,-0.59971,-0.59869,1,0
1,GO RAC PROTEIN SIGNAL TRANSDUCTION,4.9495e-06,-0.5998,-0.63138,1,0
1,GO LENS FIBER CELL DIFFERENTIATION,1.4947e-05,-0.59982,-0.55305,1,0
1,GO MYELOID CELL HOMEOSTASIS,4.2539e-06,-0.59989,-0.60077,1,0
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,6.6813e-06,-0.59995,-0.67287,1,0
1,GO CIRCULATORY SYSTEM PROCESS,4.9495e-06,-0.60007,-0.56389,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,5.7533e-06,-0.60007,-0.58129,1,0
1,GO REGULATION OF BLOOD CIRCULATION,7.1973e-06,-0.6003,-0.54982,1,0
1,GO N ACETYLNEURAMINATE METABOLIC PROCESS,7.1973e-06,-0.60042,-0.60914,1,0
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,1.0403e-05,-0.60045,-0.6256,1,0
1,GO CAMERA TYPE EYE DEVELOPMENT,4.5891e-06,-0.60054,-0.58957,1,0
1,GO HAIR CELL DIFFERENTIATION,1.0403e-05,-0.6006,-0.59048,1,0
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,7.1973e-06,-0.60068,-0.60088,1,0
1,GO DIVALENT METAL ION EXPORT,7.7514e-06,-0.60091,-0.62065,1,0
1,GO NEGATIVE REGULATION OF LIPID STORAGE,5.7533e-06,-0.60099,-0.62864,1,0
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,9.6689e-06,-0.6012,-0.63162,1,0
1,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,4.9495e-06,-0.60128,-0.65444,1,0
1,GO CELLULAR RESPONSE TO CALCIUM ION,1.6059e-05,-0.60136,-0.55979,1,0
1,GO REGULATION OF KIDNEY DEVELOPMENT,9.6689e-06,-0.60169,-0.59793,1,0
1,GO PROSTATIC BUD FORMATION,5.2428e-05,-0.60195,-0.58845,1,0
1,GO CELL PROJECTION ORGANIZATION,5.337e-06,-0.60196,-0.59017,1,0
1,GO CARDIAC MUSCLE CONTRACTION,6.6813e-06,-0.60198,-0.56555,1,0
1,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,4.9495e-06,-0.60216,-0.60772,1,0
1,GO SMOOTH MUSCLE CELL DIFFERENTIATION,5.7533e-06,-0.60227,-0.62282,1,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00060992,-0.60237,-0.65652,1,0
1,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,4.9495e-06,-0.60246,-0.59516,1,0
1,GO REGULATION OF DENDRITE MORPHOGENESIS,4.9495e-06,-0.60247,-0.63492,1,0
1,GO MEIOTIC SPINDLE ORGANIZATION,2.2907e-05,-0.60277,-0.63923,1,0
1,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,8.3461e-06,-0.60282,-0.60391,1,0
1,GO LIPOPROTEIN LOCALIZATION,9.6689e-06,-0.60304,-0.62574,1,0
1,GO RECEPTOR INTERNALIZATION,4.5891e-06,-0.60311,-0.59856,1,0
1,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,2.1347e-05,-0.60324,-0.59079,1,0
1,GO INNERVATION,0.00024771,-0.60331,-0.71012,1,0
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,3.9422e-06,-0.60337,-0.59629,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,7.8298e-05,-0.60353,-0.57851,1,0
1,GO PHAGOCYTOSIS,8.9843e-06,-0.60354,-0.67088,1,0
1,GO PLATELET DEGRANULATION,1.4947e-05,-0.60354,-0.64131,1,0
1,GO SERTOLI CELL DEVELOPMENT,7.7514e-06,-0.60362,-0.63226,1,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00072571,-0.60367,-0.58264,1,0
1,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,4.9495e-06,-0.60369,-0.62073,1,0
1,GO ODONTOGENESIS,6.2007e-06,-0.6037,-0.61158,1,0
1,GO REGULATION OF TUBE SIZE,7.7514e-06,-0.60372,-0.53695,1,0
1,GO VOCALIZATION BEHAVIOR,0.00029789,-0.60376,-0.52274,1,0
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,1.0403e-05,-0.60384,-0.64495,1,0
1,GO NOTCH SIGNALING PATHWAY,7.7514e-06,-0.60392,-0.60278,1,0
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.011063,-0.60397,-0.57249,1,0
1,GO RESPONSE TO CARBOHYDRATE,5.337e-06,-0.60407,-0.56102,1,0
1,GO RESPONSE TO INTERLEUKIN 15,0.00019306,-0.6041,-0.76376,1,0
1,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.00010866,-0.60413,-0.56808,1,0
1,GO REGULATION OF PROTEIN POLYMERIZATION,4.5891e-06,-0.60439,-0.61396,1,0
1,GO DENDRITIC SPINE DEVELOPMENT,5.337e-06,-0.60442,-0.63123,1,0
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,5.7533e-06,-0.60443,-0.60945,1,0
1,GO REGULATION OF METANEPHROS DEVELOPMENT,1.8524e-05,-0.60465,-0.66367,1,0
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,8.9327e-05,-0.60487,-0.57569,1,0
1,GO T CELL EXTRAVASATION,0.00035748,-0.60495,-0.65435,1,0
1,GO GAMMA DELTA T CELL ACTIVATION,5.6086e-05,-0.60509,-0.67546,1,0
1,GO RESPONSE TO PEPTIDE,4.5891e-06,-0.60516,-0.59193,1,0
1,GO MUSCLE STRUCTURE DEVELOPMENT,4.5891e-06,-0.60586,-0.58148,1,0
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,7.7514e-06,-0.60606,-0.63505,1,0
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,4.5891e-06,-0.60633,-0.65306,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.00040321,-0.60678,-0.5192,1,0
1,GO ORGAN GROWTH,4.5891e-06,-0.60688,-0.58004,1,0
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,4.9495e-06,-0.60693,-0.6075,1,0
1,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,8.9843e-06,-0.607,-0.61608,1,0
1,GO NEGATIVE REGULATION OF GROWTH,4.9495e-06,-0.60706,-0.58543,1,0
1,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,4.2539e-06,-0.60727,-0.68889,1,0
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,8.9843e-06,-0.6073,-0.64902,1,0
1,GO REGULATION OF CELL PROJECTION ASSEMBLY,4.5891e-06,-0.60748,-0.58601,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,4.5891e-06,-0.60755,-0.58217,1,0
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.00051151,-0.60755,-0.70599,1,0
1,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,1.2939e-05,-0.60759,-0.5771,1,0
1,GO CELLULAR RESPONSE TO PH,1.3909e-05,-0.6076,-0.57099,1,0
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,4.5891e-06,-0.60764,-0.59865,1,0
1,GO HYALURONAN CATABOLIC PROCESS,1.0403e-05,-0.60779,-0.61714,1,0
1,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,9.6689e-06,-0.60783,-0.71846,1,0
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,2.2907e-05,-0.60814,-0.66468,1,0
1,GO CARDIAC CELL DEVELOPMENT,4.9495e-06,-0.6082,-0.55577,1,0
1,GO CANONICAL WNT SIGNALING PATHWAY,4.9495e-06,-0.60831,-0.57443,1,0
1,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,7.1973e-06,-0.60846,-0.61361,1,0
1,GO SMOOTH MUSCLE CELL PROLIFERATION,5.337e-06,-0.60849,-0.63641,1,0
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,4.5891e-06,-0.60855,-0.59036,1,0
1,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,3.4805e-05,-0.60871,-0.64219,1,0
1,GO RESPONSE TO PEPTIDE HORMONE,4.5891e-06,-0.60873,-0.57605,1,0
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,7.3279e-05,-0.60875,-0.6694,1,0
1,GO REGULATION OF PROTEIN DEACETYLATION,7.7514e-06,-0.6088,-0.59229,1,0
1,GO REGULATION OF ENDOCYTOSIS,4.5891e-06,-0.60895,-0.63688,1,0
1,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.00029789,-0.60914,-0.56825,1,0
1,GO RESPONSE TO INSULIN,4.9495e-06,-0.60922,-0.56815,1,0
1,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,1.0403e-05,-0.60934,-0.5861,1,0
1,GO EXCRETION,1.7249e-05,-0.60947,-0.51793,1,0
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,4.8997e-05,-0.60947,-0.57684,1,0
1,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,4.2539e-06,-0.60952,-0.58083,1,0
1,GO PROTEIN KINASE B SIGNALING,4.9495e-06,-0.61004,-0.59506,1,0
1,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,6.6813e-06,-0.61005,-0.5575,1,0
1,GO CELLULAR COMPONENT MORPHOGENESIS,4.2539e-06,-0.61007,-0.63348,1,0
1,GO EMBRYONIC DIGIT MORPHOGENESIS,5.7533e-06,-0.61008,-0.5862,1,0
1,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,7.8298e-05,-0.61016,-0.54351,1,0
1,GO RADIAL GLIAL CELL DIFFERENTIATION,9.6689e-06,-0.61017,-0.61284,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,6.2007e-06,-0.61018,-0.62872,1,0
1,GO BRANCHED CHAIN AMINO ACID TRANSPORT,1.4947e-05,-0.61023,-0.7072,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,3.0304e-05,-0.61026,-0.66042,1,0
1,GO TISSUE MORPHOGENESIS,4.2539e-06,-0.61027,-0.59577,1,0
1,GO NEGATIVE REGULATION OF CELL GROWTH,4.9495e-06,-0.61048,-0.60783,1,0
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0013481,-0.61057,-0.68858,1,0
1,GO BONE RESORPTION,6.2007e-06,-0.61071,-0.67873,1,0
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,4.9495e-06,-0.61072,-0.64696,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,6.2007e-06,-0.61101,-0.55218,1,0
1,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,4.5891e-06,-0.61152,-0.58565,1,0
1,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,4.5891e-06,-0.61155,-0.61378,1,0
1,GO ENDOCARDIAL CUSHION MORPHOGENESIS,3.9422e-06,-0.61163,-0.69641,1,0
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,4.9495e-06,-0.61165,-0.67033,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00028019,-0.61172,-0.52774,1,0
1,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,2.8267e-05,-0.61182,-0.621,1,0
1,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00010181,-0.61214,-0.54575,1,0
1,GO DEMETHYLATION,5.337e-06,-0.61221,-0.59618,1,0
1,GO REGULATION OF DENDRITE DEVELOPMENT,5.7533e-06,-0.61224,-0.62244,1,0
1,GO DEVELOPMENTAL CELL GROWTH,4.5891e-06,-0.61227,-0.64258,1,0
1,GO COAGULATION,4.9495e-06,-0.61227,-0.63625,1,0
1,GO OVULATION,9.6689e-06,-0.61237,-0.60016,1,0
1,GO FIBRINOLYSIS,4.8997e-05,-0.61239,-0.64291,1,0
1,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,5.337e-06,-0.61242,-0.6221,1,0
1,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.00033648,-0.61255,-0.56725,1,0
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,7.7514e-06,-0.61259,-0.57402,1,0
1,GO AMINOGLYCAN CATABOLIC PROCESS,1.0403e-05,-0.6127,-0.63506,1,0
1,GO CELL MOTILITY,4.5891e-06,-0.61295,-0.61796,1,0
1,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00015974,-0.6131,-0.64121,1,0
1,GO MITOCHONDRIAL DNA METABOLIC PROCESS,1.9888e-05,-0.61315,-0.59267,1,0
1,GO MULTI ORGANISM CELLULAR PROCESS,1.2939e-05,-0.61318,-0.69807,1,0
1,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,1.0403e-05,-0.61332,-0.63708,1,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,4.9495e-06,-0.61341,-0.61767,1,0
1,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.0036751,-0.61386,-0.67207,1,0
1,GO ENDOSOMAL TRANSPORT,4.5891e-06,-0.61405,-0.58921,1,0
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00042807,-0.61412,-0.73901,1,0
1,GO HEPATOCYTE APOPTOTIC PROCESS,3.0304e-05,-0.61412,-0.61566,1,0
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,1.2939e-05,-0.61421,-0.67839,1,0
1,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,5.7533e-06,-0.61421,-0.63445,1,0
1,GO RESPONSE TO GROWTH HORMONE,7.1973e-06,-0.61422,-0.57751,1,0
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,9.6689e-06,-0.61425,-0.68061,1,0
1,GO REGULATION OF DEVELOPMENTAL GROWTH,4.5891e-06,-0.61454,-0.59761,1,0
1,GO LEFT RIGHT PATTERN FORMATION,9.6689e-06,-0.6146,-0.5626,1,0
1,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,5.9985e-05,-0.61482,-0.53786,1,0
1,GO REGULATION OF VESICLE MEDIATED TRANSPORT,4.9495e-06,-0.61497,-0.61293,1,0
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,1.2939e-05,-0.61526,-0.67987,1,0
1,GO CELLULAR EXTRAVASATION,2.8267e-05,-0.61538,-0.68248,1,0
1,GO CRANIAL NERVE MORPHOGENESIS,1.2035e-05,-0.61548,-0.6398,1,0
1,GO NEUROTROPHIN SIGNALING PATHWAY,6.2007e-06,-0.61552,-0.58767,1,0
1,GO GLYCOGEN BIOSYNTHETIC PROCESS,1.1191e-05,-0.61556,-0.53991,1,0
1,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,4.5891e-06,-0.6156,-0.63983,1,0
1,GO HISTONE H3 DEACETYLATION,1.2939e-05,-0.61569,-0.54939,1,0
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00015974,-0.61569,-0.745,1,0
1,GO I KAPPAB PHOSPHORYLATION,1.2035e-05,-0.61572,-0.68802,1,0
1,GO REGULATION OF INCLUSION BODY ASSEMBLY,4.8997e-05,-0.6158,-0.621,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,2.1347e-05,-0.61582,-0.67889,1,0
1,GO LYMPH NODE DEVELOPMENT,8.9843e-06,-0.61585,-0.68362,1,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,1.1191e-05,-0.61611,-0.64459,1,0
1,GO MYOFIBRIL ASSEMBLY,5.337e-06,-0.6162,-0.6182,1,0
1,GO LOCALIZATION WITHIN MEMBRANE,6.6813e-06,-0.61622,-0.63728,1,0
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,4.2539e-06,-0.61624,-0.64112,1,0
1,GO NEURON PROJECTION EXTENSION,4.5891e-06,-0.6165,-0.66291,1,0
1,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,5.7533e-06,-0.61656,-0.62029,1,0
1,GO POSITIVE REGULATION OF LIPID STORAGE,9.6689e-06,-0.61658,-0.69198,1,0
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,7.1973e-06,-0.61659,-0.62264,1,0
1,GO STEM CELL PROLIFERATION,5.337e-06,-0.61704,-0.60153,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.00024771,-0.61721,-0.68976,1,0
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,3.9422e-06,-0.61725,-0.63447,1,0
1,GO CELLULAR RESPONSE TO INSULIN STIMULUS,4.9495e-06,-0.6173,-0.57413,1,0
1,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,7.1973e-06,-0.61735,-0.59698,1,0
1,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,4.9495e-06,-0.61736,-0.65317,1,0
1,GO APICAL PROTEIN LOCALIZATION,3.0304e-05,-0.61744,-0.5704,1,0
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,4.5891e-06,-0.61747,-0.58171,1,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,4.2539e-06,-0.61753,-0.62739,1,0
1,GO REGULATION OF ANION TRANSPORT,8.9843e-06,-0.61754,-0.54191,1,0
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,5.337e-06,-0.61768,-0.62669,1,0
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,7.1973e-06,-0.61791,-0.63099,1,0
1,GO RESPONSE TO ESTROGEN,6.2007e-06,-0.61809,-0.58608,1,0
1,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,8.9843e-06,-0.61811,-0.58131,1,0
1,GO METANEPHROS MORPHOGENESIS,1.6059e-05,-0.61816,-0.61358,1,0
1,GO CELLULAR RESPONSE TO NUTRIENT,9.6689e-06,-0.61826,-0.63052,1,0
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,4.2539e-06,-0.6183,-0.62551,1,0
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,4.9495e-06,-0.61876,-0.66146,1,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,4.5891e-06,-0.61881,-0.63654,1,0
1,GO NEURON PROJECTION REGENERATION,6.6813e-06,-0.61884,-0.63626,1,0
1,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.1191e-05,-0.61921,-0.58224,1,0
1,GO UROGENITAL SYSTEM DEVELOPMENT,5.7533e-06,-0.61927,-0.58976,1,0
1,GO REGULATION OF RECEPTOR CLUSTERING,0.00031664,-0.61934,-0.59637,1,0
1,GO PHOSPHATIDIC ACID METABOLIC PROCESS,6.6813e-06,-0.61952,-0.59306,1,0
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,5.7533e-06,-0.61984,-0.63226,1,0
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,3.0304e-05,-0.62004,-0.583,1,0
1,GO RESPONSE TO INTERFERON ALPHA,0.0023095,-0.62008,-0.66278,1,0
1,GO REGULATION OF ERBB SIGNALING PATHWAY,5.337e-06,-0.62021,-0.62605,1,0
1,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,7.7514e-06,-0.62033,-0.62587,1,0
1,GO EMBRYONIC MORPHOGENESIS,4.9495e-06,-0.62034,-0.60256,1,0
1,GO JNK CASCADE,4.2539e-06,-0.62105,-0.63677,1,0
1,GO CYTOSKELETON ORGANIZATION,4.2539e-06,-0.6211,-0.60488,1,0
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,5.9985e-05,-0.62115,-0.7178,1,0
1,GO REGULATION OF CELL PROJECTION ORGANIZATION,4.2539e-06,-0.6212,-0.63005,1,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,4.5891e-06,-0.62143,-0.61535,1,0
1,GO PEPTIDYL SERINE MODIFICATION,4.2539e-06,-0.62149,-0.63288,1,0
1,GO 3 UTR MEDIATED MRNA STABILIZATION,6.6813e-06,-0.62152,-0.62212,1,0
1,GO REGULATION OF BONE MINERALIZATION,1.0403e-05,-0.62163,-0.63409,1,0
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,4.5891e-06,-0.62169,-0.61992,1,0
1,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,4.5891e-06,-0.62188,-0.62769,1,0
1,GO REGULATION OF PLATELET ACTIVATION,4.5779e-05,-0.62201,-0.68859,1,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,5.9985e-05,-0.62201,-0.57028,1,0
1,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,4.9495e-06,-0.62206,-0.60568,1,0
1,GO RESPONSE TO PROGESTERONE,7.1973e-06,-0.6221,-0.63613,1,0
1,GO REGULATION OF RUFFLE ASSEMBLY,9.6689e-06,-0.62225,-0.59424,1,0
1,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,2.2907e-05,-0.62232,-0.58452,1,0
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,1.9888e-05,-0.62237,-0.74463,1,0
1,GO HEPARIN METABOLIC PROCESS,5.337e-06,-0.62257,-0.7014,1,0
1,GO MUSCLE CELL DIFFERENTIATION,4.5891e-06,-0.62257,-0.58476,1,0
1,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,5.337e-06,-0.62264,-0.67329,1,0
1,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,6.4139e-05,-0.62295,-0.56283,1,0
1,GO LUNG MORPHOGENESIS,1.0403e-05,-0.62304,-0.6353,1,0
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,5.337e-06,-0.62305,-0.63859,1,0
1,GO REGULATION OF GOLGI ORGANIZATION,5.337e-06,-0.62324,-0.66771,1,0
1,GO LAMELLIPODIUM ORGANIZATION,3.9422e-06,-0.62327,-0.61759,1,0
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,6.6813e-06,-0.62332,-0.64735,1,0
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,1.2939e-05,-0.62336,-0.61419,1,0
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,4.2539e-06,-0.6234,-0.62986,1,0
1,GO ENDOCYTOSIS,4.9495e-06,-0.62353,-0.62543,1,0
1,GO STRIATUM DEVELOPMENT,8.9843e-06,-0.62354,-0.59583,1,0
1,GO CELLULAR RESPONSE TO PEPTIDE,4.2539e-06,-0.62365,-0.59979,1,0
1,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.00010866,-0.62372,-0.52289,1,0
1,GO NEGATIVE REGULATION OF HEART CONTRACTION,4.2539e-06,-0.62376,-0.6183,1,0
1,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.00086166,-0.62415,-0.57121,1,0
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,5.337e-06,-0.62417,-0.67359,1,0
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,5.7533e-06,-0.62419,-0.64082,1,0
1,GO REGULATION OF ISOTYPE SWITCHING,7.1973e-06,-0.62441,-0.65147,1,0
1,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,8.3641e-05,-0.62459,-0.5711,1,0
1,GO VESICLE CYTOSKELETAL TRAFFICKING,4.9495e-06,-0.62486,-0.66777,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00013188,-0.62488,-0.70663,1,0
1,GO GDP METABOLIC PROCESS,1.3909e-05,-0.62497,-0.52377,1,0
1,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,2.4576e-05,-0.625,-0.57443,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,6.2007e-06,-0.62513,-0.60511,1,0
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,8.3461e-06,-0.62529,-0.62768,1,0
1,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,1.3909e-05,-0.62535,-0.59252,1,0
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,3.4805e-05,-0.62545,-0.60775,1,0
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,4.2539e-06,-0.62546,-0.615,1,0
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,1.7249e-05,-0.62555,-0.61982,1,0
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,7.7514e-06,-0.62561,-0.63864,1,0
1,GO RUFFLE ASSEMBLY,8.3461e-06,-0.62567,-0.60294,1,0
1,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,3.4805e-05,-0.62571,-0.60283,1,0
1,GO NEGATIVE REGULATION OF TOR SIGNALING,4.2539e-06,-0.62605,-0.63396,1,0
1,GO ACTIN FILAMENT BASED MOVEMENT,4.2539e-06,-0.62612,-0.62231,1,0
1,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,1.2035e-05,-0.62665,-0.5938,1,0
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,6.2007e-06,-0.627,-0.68795,1,0
1,GO LEUKOCYTE AGGREGATION,0.00031664,-0.62711,-0.73257,1,0
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,1.9888e-05,-0.62715,-0.70805,1,0
1,GO CARDIAC SEPTUM MORPHOGENESIS,4.5891e-06,-0.62739,-0.65689,1,0
1,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,1.4947e-05,-0.62746,-0.62584,1,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,8.3641e-05,-0.62766,-0.67873,1,0
1,GO PROTEIN LOCALIZATION TO VACUOLE,4.9495e-06,-0.62766,-0.64,1,0
1,GO REGULATION OF ORGANIC ACID TRANSPORT,2.636e-05,-0.62767,-0.51088,1,0
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,1.9888e-05,-0.62773,-0.67151,1,0
1,GO NEURON PROJECTION GUIDANCE,4.9495e-06,-0.62773,-0.67419,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.636e-05,-0.62778,-0.66852,1,0
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,5.7533e-06,-0.62789,-0.66413,1,0
1,GO ASTROCYTE ACTIVATION,1.8524e-05,-0.62796,-0.69302,1,0
1,GO SCHWANN CELL DEVELOPMENT,6.2007e-06,-0.62802,-0.6416,1,0
1,GO OLIGOPEPTIDE TRANSPORT,7.1973e-06,-0.62815,-0.61773,1,0
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,1.7249e-05,-0.62818,-0.71711,1,0
1,GO CELLULAR RESPONSE TO STEROL DEPLETION,1.0403e-05,-0.62829,-0.62216,1,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,4.9495e-06,-0.62832,-0.6608,1,0
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.00010866,-0.62841,-0.5731,1,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,3.9936e-05,-0.62842,-0.66145,1,0
1,GO PEPTIDYL TYROSINE MODIFICATION,4.2539e-06,-0.62843,-0.64983,1,0
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,4.9495e-06,-0.62857,-0.63157,1,0
1,GO CHAPERONE MEDIATED AUTOPHAGY,1.9888e-05,-0.62859,-0.53528,1,0
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,4.9495e-06,-0.62864,-0.60986,1,0
1,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,4.8997e-05,-0.62883,-0.75512,1,0
1,GO REGULATION OF CELL ADHESION,6.2007e-06,-0.62884,-0.65776,1,0
1,GO OLIGOSACCHARIDE METABOLIC PROCESS,6.6813e-06,-0.62888,-0.59282,1,0
1,GO RESPONSE TO INTERLEUKIN 2,0.00011593,-0.62912,-0.69955,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,1.1191e-05,-0.62922,-0.56812,1,0
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,4.2539e-06,-0.62923,-0.59233,1,0
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,4.2539e-06,-0.62925,-0.64301,1,0
1,GO OPTIC NERVE DEVELOPMENT,0.00026348,-0.62936,-0.55656,1,0
1,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0003797,-0.62948,-0.6041,1,0
1,GO TRABECULA FORMATION,9.6689e-06,-0.6295,-0.64095,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,4.2539e-06,-0.62954,-0.61792,1,0
1,GO SCHWANN CELL DIFFERENTIATION,6.2007e-06,-0.62955,-0.62566,1,0
1,GO CARDIOCYTE DIFFERENTIATION,4.2539e-06,-0.6296,-0.60045,1,0
1,GO TAXIS,5.7533e-06,-0.63,-0.60552,1,0
1,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,4.5891e-06,-0.6301,-0.61996,1,0
1,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,4.2539e-06,-0.63015,-0.63654,1,0
1,GO AMINO ACID IMPORT,9.6689e-06,-0.63019,-0.56199,1,0
1,GO VENTRICULAR SYSTEM DEVELOPMENT,4.9495e-06,-0.63029,-0.6263,1,0
1,GO PROSTAGLANDIN TRANSPORT,1.8524e-05,-0.63051,-0.59383,1,0
1,GO MEMBRANE RAFT ORGANIZATION,4.2763e-05,-0.63074,-0.66948,1,0
1,GO POSITIVE REGULATION OF NEURON DEATH,4.5891e-06,-0.63097,-0.60785,1,0
1,GO MESENCHYME MORPHOGENESIS,5.7533e-06,-0.63112,-0.67015,1,0
1,GO BIOLOGICAL ADHESION,4.9495e-06,-0.63127,-0.63731,1,0
1,GO INTRACELLULAR LIPID TRANSPORT,4.2539e-06,-0.63178,-0.62157,1,0
1,GO RESPONSE TO MANGANESE ION,6.2007e-06,-0.63185,-0.60825,1,0
1,GO CARDIAC MUSCLE CELL DIFFERENTIATION,4.2539e-06,-0.63203,-0.58768,1,0
1,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,1.2035e-05,-0.63207,-0.60406,1,0
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,4.9495e-06,-0.63246,-0.6253,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,3.9422e-06,-0.63264,-0.6038,1,0
1,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,2.2907e-05,-0.63284,-0.60318,1,0
1,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.00010181,-0.63288,-0.73756,1,0
1,GO POSITIVE REGULATION OF BLOOD CIRCULATION,6.2007e-06,-0.63302,-0.55954,1,0
1,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,4.5891e-06,-0.63311,-0.58533,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,5.337e-06,-0.63348,-0.66723,1,0
1,GO ERBB SIGNALING PATHWAY,3.9422e-06,-0.63355,-0.61315,1,0
1,GO SPHINGOMYELIN METABOLIC PROCESS,4.5779e-05,-0.63367,-0.55391,1,0
1,GO MUSCLE ADAPTATION,4.5891e-06,-0.63373,-0.64224,1,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,6.6813e-06,-0.63376,-0.61556,1,0
1,GO REGULATION OF FATTY ACID OXIDATION,1.2939e-05,-0.63415,-0.5701,1,0
1,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,7.7514e-06,-0.63416,-0.60024,1,0
1,GO RESPONSE TO ANGIOTENSIN,5.337e-06,-0.63431,-0.67086,1,0
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,7.7514e-06,-0.63432,-0.64599,1,0
1,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,9.6689e-06,-0.63433,-0.55613,1,0
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,2.1347e-05,-0.63438,-0.68785,1,0
1,GO INOSITOL LIPID MEDIATED SIGNALING,3.9422e-06,-0.63441,-0.65359,1,0
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,8.9843e-06,-0.63442,-0.69508,1,0
1,GO NEURON PROJECTION ORGANIZATION,4.9495e-06,-0.63447,-0.65614,1,0
1,GO POSITIVE REGULATION OF VASCULOGENESIS,8.3641e-05,-0.63481,-0.57644,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.00081392,-0.63484,-0.63685,1,0
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,1.8524e-05,-0.63498,-0.6379,1,0
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.011574,-0.635,-0.78934,1,0
1,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,3.7287e-05,-0.63516,-0.59749,1,0
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,5.7533e-06,-0.63524,-0.63739,1,0
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,4.9495e-06,-0.63526,-0.61197,1,0
1,GO RESPONSE TO INACTIVITY,6.2007e-06,-0.63546,-0.64982,1,0
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,4.9495e-06,-0.63558,-0.62768,1,0
1,GO FAT CELL DIFFERENTIATION,6.2007e-06,-0.63576,-0.59292,1,0
1,GO REGULATION OF AXONOGENESIS,4.5891e-06,-0.63579,-0.70263,1,0
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,1.2939e-05,-0.63582,-0.67521,1,0
1,GO POST ANAL TAIL MORPHOGENESIS,4.2539e-06,-0.63583,-0.66487,1,0
1,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,7.1973e-06,-0.63602,-0.63773,1,0
1,GO NEGATIVE REGULATION OF JNK CASCADE,3.9422e-06,-0.63622,-0.64314,1,0
1,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,5.7533e-06,-0.63625,-0.64387,1,0
1,GO STRIATED MUSCLE ADAPTATION,7.7514e-06,-0.63627,-0.62272,1,0
1,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,4.8997e-05,-0.63641,-0.55007,1,0
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.9422e-06,-0.63646,-0.64039,1,0
1,GO MEMBRANE REPOLARIZATION,1.0403e-05,-0.63648,-0.60653,1,0
1,GO CELLULAR COMPONENT MAINTENANCE,4.9495e-06,-0.63654,-0.64784,1,0
1,GO MITRAL VALVE DEVELOPMENT,8.9327e-05,-0.63697,-0.6592,1,0
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,4.2539e-06,-0.63707,-0.64719,1,0
1,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,8.3461e-06,-0.63724,-0.68907,1,0
1,GO OVULATION CYCLE,3.9422e-06,-0.63741,-0.62089,1,0
1,GO HYALURONAN METABOLIC PROCESS,5.337e-06,-0.63748,-0.6498,1,0
1,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,4.2539e-06,-0.63758,-0.68229,1,0
1,GO VITAMIN TRANSMEMBRANE TRANSPORT,3.9936e-05,-0.63764,-0.59289,1,0
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.9888e-05,-0.63774,-0.59618,1,0
1,GO REGULATION OF CELLULAR COMPONENT SIZE,4.2539e-06,-0.63803,-0.63287,1,0
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,2.1347e-05,-0.63808,-0.66245,1,0
1,GO HISTONE DEACETYLATION,5.7533e-06,-0.63812,-0.60452,1,0
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,4.5891e-06,-0.63814,-0.64453,1,0
1,GO NEURAL CREST CELL MIGRATION,5.7533e-06,-0.63818,-0.61972,1,0
1,GO REGULATION OF ACTION POTENTIAL,4.2539e-06,-0.63824,-0.66072,1,0
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,3.9422e-06,-0.6383,-0.61956,1,0
1,GO REGULATION OF PROTEIN SUMOYLATION,6.2007e-06,-0.63836,-0.5996,1,0
1,GO HISTONE DEUBIQUITINATION,4.2539e-06,-0.63856,-0.7027,1,0
1,GO COPII COATED VESICLE CARGO LOADING,4.9495e-06,-0.63903,-0.67179,1,0
1,GO RDNA HETEROCHROMATIN ASSEMBLY,1.8524e-05,-0.63904,-0.67384,1,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,5.337e-06,-0.63962,-0.68207,1,0
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,3.248e-05,-0.63974,-0.60045,1,0
1,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,7.7514e-06,-0.63992,-0.71245,1,0
1,GO RUFFLE ORGANIZATION,6.2007e-06,-0.63994,-0.64227,1,0
1,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,4.9495e-06,-0.64028,-0.64767,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,6.6813e-06,-0.64028,-0.62214,1,0
1,GO LACTATION,3.9422e-06,-0.64031,-0.64569,1,0
1,GO CARDIAC VENTRICLE DEVELOPMENT,4.9495e-06,-0.64053,-0.63396,1,0
1,GO PEPTIDYL LYSINE TRIMETHYLATION,4.5891e-06,-0.64083,-0.67698,1,0
1,GO SIALYLATION,8.9327e-05,-0.64089,-0.5585,1,0
1,GO SMOOTH MUSCLE CONTRACTION,5.337e-06,-0.64098,-0.57724,1,0
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,2.4576e-05,-0.641,-0.5874,1,0
1,GO CARDIAC CHAMBER MORPHOGENESIS,4.9495e-06,-0.64115,-0.64899,1,0
1,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,4.2539e-06,-0.64145,-0.66937,1,0
1,GO PROTEIN LOCALIZATION TO CYTOSKELETON,5.337e-06,-0.64149,-0.66163,1,0
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,5.7533e-06,-0.64159,-0.63418,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,3.248e-05,-0.64161,-0.54954,1,0
1,GO CARDIAC MYOFIBRIL ASSEMBLY,5.337e-06,-0.6421,-0.68079,1,0
1,GO REGULATION OF CELLULAR EXTRAVASATION,5.9985e-05,-0.64218,-0.67924,1,0
1,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,8.3461e-06,-0.64227,-0.62846,1,0
1,GO CELLULAR RESPONSE TO VITAMIN D,7.3279e-05,-0.64245,-0.52207,1,0
1,GO CELL JUNCTION ORGANIZATION,4.9495e-06,-0.64265,-0.64359,1,0
1,GO EXOCRINE SYSTEM DEVELOPMENT,6.2007e-06,-0.64266,-0.67538,1,0
1,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,4.9495e-06,-0.64276,-0.58934,1,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,7.7514e-06,-0.64279,-0.63744,1,0
1,GO REGULATION OF TORC1 SIGNALING,4.5891e-06,-0.64309,-0.66696,1,0
1,GO BRONCHUS DEVELOPMENT,7.8298e-05,-0.64315,-0.62916,1,0
1,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,5.7533e-06,-0.6436,-0.61585,1,0
1,GO ENDOCARDIUM DEVELOPMENT,1.1191e-05,-0.6437,-0.59453,1,0
1,GO COMMISSURAL NEURON AXON GUIDANCE,2.2907e-05,-0.64381,-0.66275,1,0
1,GO NEUROBLAST DIVISION,4.2539e-06,-0.64392,-0.67729,1,0
1,GO KERATINOCYTE PROLIFERATION,8.3461e-06,-0.64397,-0.60535,1,0
1,GO REGULATION OF NEURON PROJECTION REGENERATION,6.2007e-06,-0.64411,-0.66728,1,0
1,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,5.2428e-05,-0.64412,-0.60037,1,0
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,6.6813e-06,-0.64464,-0.6117,1,0
1,GO REGULATION OF MEMBRANE INVAGINATION,0.00014062,-0.64471,-0.71875,1,0
1,GO TRANSCYTOSIS,6.6813e-06,-0.64487,-0.66765,1,0
1,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00010866,-0.64489,-0.70671,1,0
1,GO RECEPTOR CLUSTERING,7.1973e-06,-0.64498,-0.66444,1,0
1,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,1.9888e-05,-0.6451,-0.69288,1,0
1,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,4.2539e-06,-0.64512,-0.60916,1,0
1,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,4.5891e-06,-0.64516,-0.68748,1,0
1,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,4.9495e-06,-0.64519,-0.6421,1,0
1,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,4.2539e-06,-0.64521,-0.67147,1,0
1,GO SPINAL CORD PATTERNING,9.5377e-05,-0.64525,-0.62704,1,0
1,GO METANEPHRIC NEPHRON MORPHOGENESIS,6.2007e-06,-0.64543,-0.65732,1,0
1,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,4.5891e-06,-0.6456,-0.63604,1,0
1,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,6.6813e-06,-0.64563,-0.63848,1,0
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,3.248e-05,-0.64564,-0.62551,1,0
1,GO CHOLESTEROL STORAGE,8.9843e-06,-0.64586,-0.70884,1,0
1,GO CAMP METABOLIC PROCESS,1.3909e-05,-0.64597,-0.65106,1,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,6.2007e-06,-0.64633,-0.66022,1,0
1,GO PROTEIN TARGETING TO VACUOLE,5.7533e-06,-0.64651,-0.66387,1,0
1,GO NEUROEPITHELIAL CELL DIFFERENTIATION,5.6086e-05,-0.64672,-0.58851,1,0
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.9422e-06,-0.64682,-0.64574,1,0
1,GO EPITHELIAL TUBE MORPHOGENESIS,4.9495e-06,-0.64702,-0.60848,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,4.2763e-05,-0.64704,-0.62674,1,0
1,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,3.248e-05,-0.64721,-0.718,1,0
1,GO MESENCHYMAL CELL DIFFERENTIATION,6.2007e-06,-0.64725,-0.62239,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,1.3909e-05,-0.64731,-0.61427,1,0
1,GO POSITIVE REGULATION OF JNK CASCADE,4.9495e-06,-0.64757,-0.67552,1,0
1,GO EMBRYONIC PLACENTA DEVELOPMENT,8.9843e-06,-0.64774,-0.62166,1,0
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,4.2539e-06,-0.6481,-0.65795,1,0
1,GO NEGATIVE REGULATION OF CELL ADHESION,6.2007e-06,-0.64819,-0.66964,1,0
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,7.7514e-06,-0.64822,-0.71124,1,0
1,GO ACTIN CYTOSKELETON REORGANIZATION,3.9422e-06,-0.64826,-0.69179,1,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,5.7533e-06,-0.6483,-0.67549,1,0
1,GO CELL JUNCTION ASSEMBLY,4.9495e-06,-0.6484,-0.64254,1,0
1,GO REGULATION OF EXTENT OF CELL GROWTH,4.5891e-06,-0.64841,-0.68669,1,0
1,GO EYE MORPHOGENESIS,4.5891e-06,-0.64853,-0.60777,1,0
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,8.9843e-06,-0.64861,-0.70809,1,0
1,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,6.6813e-06,-0.64871,-0.57012,1,0
1,GO UV PROTECTION,4.9495e-06,-0.64874,-0.61523,1,0
1,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,4.5891e-06,-0.64877,-0.65605,1,0
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,4.5891e-06,-0.64891,-0.64366,1,0
1,GO PRO B CELL DIFFERENTIATION,1.0403e-05,-0.64901,-0.68067,1,0
1,GO NEGATIVE REGULATION OF AXONOGENESIS,4.9495e-06,-0.64918,-0.69765,1,0
1,GO REGULATION OF MEMBRANE REPOLARIZATION,9.6689e-06,-0.64951,-0.65905,1,0
1,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,8.3461e-06,-0.64965,-0.64319,1,0
1,GO POSITIVE REGULATION OF ERAD PATHWAY,4.2539e-06,-0.64974,-0.67402,1,0
1,GO CELL JUNCTION MAINTENANCE,3.0304e-05,-0.64994,-0.63954,1,0
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,4.9495e-06,-0.64995,-0.63134,1,0
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.00015974,-0.65007,-0.66745,1,0
1,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.1191e-05,-0.65017,-0.68534,1,0
1,GO INSULIN RECEPTOR SIGNALING PATHWAY,4.9495e-06,-0.65023,-0.60502,1,0
1,GO NEGATIVE REGULATION OF ANION TRANSPORT,4.5891e-06,-0.65024,-0.61256,1,0
1,GO MESODERM MORPHOGENESIS,5.337e-06,-0.65025,-0.60471,1,0
1,GO CENTRIOLE CENTRIOLE COHESION,6.6813e-06,-0.65045,-0.7796,1,0
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,4.2539e-06,-0.65053,-0.63685,1,0
1,GO MORPHOGENESIS OF AN ENDOTHELIUM,7.7514e-06,-0.65053,-0.66026,1,0
1,GO ESTROUS CYCLE,1.9888e-05,-0.65054,-0.63126,1,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,4.2539e-06,-0.65064,-0.65179,1,0
1,GO PROTEOGLYCAN METABOLIC PROCESS,4.5891e-06,-0.65143,-0.66374,1,0
1,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,6.2007e-06,-0.65157,-0.62465,1,0
1,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,4.2539e-06,-0.65171,-0.66001,1,0
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,4.5891e-06,-0.65186,-0.65623,1,0
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,1.2939e-05,-0.65196,-0.70501,1,0
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,1.2035e-05,-0.65197,-0.6613,1,0
1,GO PERICARDIUM DEVELOPMENT,9.6689e-06,-0.65198,-0.68968,1,0
1,GO MAMMARY GLAND MORPHOGENESIS,1.3909e-05,-0.65238,-0.67784,1,0
1,GO RESPONSE TO LIPOTEICHOIC ACID,0.00042807,-0.65246,-0.63784,1,0
1,GO RESPONSE TO PROSTAGLANDIN E,2.2907e-05,-0.65264,-0.62028,1,0
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,4.2539e-06,-0.65265,-0.65934,1,0
1,GO HAIR FOLLICLE MATURATION,3.9422e-06,-0.65287,-0.65135,1,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00045436,-0.65299,-0.59459,1,0
1,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,6.4139e-05,-0.65302,-0.56593,1,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,4.9495e-06,-0.65302,-0.62633,1,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,6.2007e-06,-0.65331,-0.61823,1,0
1,GO RNA DECAPPING,5.337e-06,-0.65335,-0.63228,1,0
1,GO REGULATION OF NOTCH SIGNALING PATHWAY,8.3461e-06,-0.6534,-0.664,1,0
1,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,1.7249e-05,-0.65349,-0.63793,1,0
1,GO REGULATION OF HISTONE H3 K9 METHYLATION,5.337e-06,-0.65349,-0.66642,1,0
1,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,8.9843e-06,-0.65356,-0.68012,1,0
1,GO CELL MORPHOGENESIS,4.2539e-06,-0.65357,-0.65505,1,0
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,4.5891e-06,-0.65358,-0.62354,1,0
1,GO SECONDARY PALATE DEVELOPMENT,7.1973e-06,-0.6536,-0.70797,1,0
1,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,4.2539e-06,-0.65363,-0.64262,1,0
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,3.9422e-06,-0.65366,-0.66927,1,0
1,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,6.2007e-06,-0.65377,-0.63725,1,0
1,GO MEMBRANE PROTEIN PROTEOLYSIS,4.9495e-06,-0.65418,-0.70943,1,0
1,GO RENAL SYSTEM PROCESS,6.2007e-06,-0.65438,-0.62167,1,0
1,GO PROTEIN DEMANNOSYLATION,5.7533e-06,-0.65456,-0.70808,1,0
1,GO REGULATION OF MUSCLE ADAPTATION,4.9495e-06,-0.6548,-0.6467,1,0
1,GO SELECTIVE AUTOPHAGY,5.337e-06,-0.65502,-0.61584,1,0
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,4.9495e-06,-0.65508,-0.62845,1,0
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,1.1191e-05,-0.65529,-0.57679,1,0
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,1.0403e-05,-0.65541,-0.60133,1,0
1,GO MUSCLE ORGAN MORPHOGENESIS,4.5891e-06,-0.65571,-0.62207,1,0
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,4.9495e-06,-0.65572,-0.66509,1,0
1,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,1.3909e-05,-0.65572,-0.58756,1,0
1,GO REGULATION OF TISSUE REMODELING,7.1973e-06,-0.65578,-0.70268,1,0
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,7.7514e-06,-0.65602,-0.63532,1,0
1,GO PLATELET AGGREGATION,3.9422e-06,-0.65626,-0.70586,1,0
1,GO RENAL WATER HOMEOSTASIS,1.3909e-05,-0.65632,-0.63161,1,0
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,4.9495e-06,-0.65645,-0.63373,1,0
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,6.8565e-05,-0.65653,-0.75762,1,0
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,2.2907e-05,-0.65654,-0.69019,1,0
1,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,4.2539e-06,-0.6566,-0.67752,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,4.9495e-06,-0.6567,-0.63813,1,0
1,GO MICROTUBULE ANCHORING AT CENTROSOME,7.1973e-06,-0.65678,-0.72086,1,0
1,GO CELLULAR RESPONSE TO ALCOHOL,4.2539e-06,-0.65689,-0.68104,1,0
1,GO CORTICAL CYTOSKELETON ORGANIZATION,4.2539e-06,-0.65708,-0.67059,1,0
1,GO ENTRY OF BACTERIUM INTO HOST CELL,5.337e-06,-0.6571,-0.69277,1,0
1,GO NEGATIVE REGULATION OF MAPK CASCADE,4.5891e-06,-0.6572,-0.64918,1,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,9.6689e-06,-0.65722,-0.63515,1,0
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,4.5891e-06,-0.65727,-0.66541,1,0
1,GO EXPORT ACROSS PLASMA MEMBRANE,6.2007e-06,-0.65771,-0.58243,1,0
1,GO AMEBOIDAL TYPE CELL MIGRATION,4.2539e-06,-0.65774,-0.66378,1,0
1,GO DETECTION OF MECHANICAL STIMULUS,1.0403e-05,-0.65804,-0.5882,1,0
1,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,0.00013188,-0.65826,-0.65765,1,0
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,3.9422e-06,-0.65853,-0.59561,1,0
1,GO HEART DEVELOPMENT,4.2539e-06,-0.65915,-0.62705,1,0
1,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.00021879,-0.65915,-0.54747,1,0
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,3.9422e-06,-0.65944,-0.69063,1,0
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,8.3461e-06,-0.65952,-0.64805,1,0
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,4.5891e-06,-0.65961,-0.62821,1,0
1,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,9.6689e-06,-0.66002,-0.61216,1,0
1,GO CARDIAC MUSCLE CELL CONTRACTION,4.5891e-06,-0.66028,-0.64277,1,0
1,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,3.0304e-05,-0.66036,-0.60791,1,0
1,GO PROTEIN DEPOLYMERIZATION,4.5891e-06,-0.66065,-0.7048,1,0
1,GO ROOF OF MOUTH DEVELOPMENT,4.5891e-06,-0.66101,-0.65997,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,1.6059e-05,-0.66121,-0.62816,1,0
1,GO MATERNAL PLACENTA DEVELOPMENT,5.337e-06,-0.66139,-0.69909,1,0
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,1.0403e-05,-0.66156,-0.64043,1,0
1,GO CELL VOLUME HOMEOSTASIS,8.3461e-06,-0.66204,-0.60392,1,0
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,4.2539e-06,-0.66222,-0.62386,1,0
1,GO RESPONSE TO INTERLEUKIN 6,1.8524e-05,-0.66231,-0.68739,1,0
1,GO GLIAL CELL MIGRATION,5.337e-06,-0.66258,-0.68148,1,0
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,4.5779e-05,-0.66264,-0.68283,1,0
1,GO CIRCULATORY SYSTEM DEVELOPMENT,4.2539e-06,-0.6627,-0.66571,1,0
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,3.9422e-06,-0.66272,-0.65533,1,0
1,GO NEGATIVE REGULATION OF AXON EXTENSION,4.9495e-06,-0.66291,-0.68195,1,0
1,GO MUSCLE HYPERTROPHY,4.5891e-06,-0.66296,-0.62971,1,0
1,GO RESPONSE TO GROWTH FACTOR,4.9495e-06,-0.66318,-0.63577,1,0
1,GO HISTONE H3 K9 METHYLATION,3.9422e-06,-0.66336,-0.68168,1,0
1,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,4.5891e-06,-0.6635,-0.60319,1,0
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,8.9843e-06,-0.66354,-0.71973,1,0
1,GO POST EMBRYONIC DEVELOPMENT,3.9422e-06,-0.66354,-0.65089,1,0
1,GO VENTRICULAR SEPTUM MORPHOGENESIS,6.6813e-06,-0.66406,-0.64445,1,0
1,GO SKELETAL SYSTEM DEVELOPMENT,4.5891e-06,-0.66428,-0.64436,1,0
1,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,1.1191e-05,-0.66439,-0.63448,1,0
1,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,6.6813e-06,-0.66458,-0.65178,1,0
1,GO REGULATION OF PLASMINOGEN ACTIVATION,6.4139e-05,-0.66537,-0.69303,1,0
1,GO PROTEIN LOCALIZATION TO AXON,0.00028019,-0.66543,-0.64846,1,0
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,7.7514e-06,-0.66553,-0.67682,1,0
1,GO PINOCYTOSIS,5.337e-06,-0.66558,-0.71189,1,0
1,GO ENAMEL MINERALIZATION,1.4947e-05,-0.66562,-0.7078,1,0
1,GO PROTEIN K48 LINKED DEUBIQUITINATION,4.5891e-06,-0.66606,-0.71947,1,0
1,GO POSITIVE REGULATION OF ACTIN NUCLEATION,5.337e-06,-0.66627,-0.65321,1,0
1,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00031664,-0.6663,-0.58213,1,0
1,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,8.3461e-06,-0.66632,-0.70319,1,0
1,GO CAMERA TYPE EYE MORPHOGENESIS,8.3461e-06,-0.66693,-0.58298,1,0
1,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,1.4947e-05,-0.66698,-0.60691,1,0
1,GO REGULATION OF CELL MORPHOGENESIS,4.2539e-06,-0.667,-0.67462,1,0
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,3.9422e-06,-0.66708,-0.70235,1,0
1,GO FIBROBLAST ACTIVATION,3.9422e-06,-0.66717,-0.72057,1,0
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,5.7533e-06,-0.6673,-0.74345,1,0
1,GO ATRIAL SEPTUM DEVELOPMENT,5.2428e-05,-0.6674,-0.62229,1,0
1,GO TUBE DEVELOPMENT,4.9495e-06,-0.66757,-0.64929,1,0
1,GO MITOCHONDRION DISTRIBUTION,1.1191e-05,-0.66762,-0.66634,1,0
1,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,3.9422e-06,-0.66773,-0.70808,1,0
1,GO MICROTUBULE ANCHORING,5.337e-06,-0.66794,-0.68232,1,0
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,5.337e-06,-0.66803,-0.65631,1,0
1,GO SPHINGOID METABOLIC PROCESS,7.1973e-06,-0.66843,-0.65798,1,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,5.7533e-06,-0.66851,-0.65318,1,0
1,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,4.2539e-06,-0.66857,-0.67962,1,0
1,GO REGULATION OF PODOSOME ASSEMBLY,4.2539e-06,-0.6688,-0.74889,1,0
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,5.337e-06,-0.66882,-0.75653,1,0
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,1.9888e-05,-0.66889,-0.62715,1,0
1,GO PROTEIN LOCALIZATION TO LYSOSOME,5.7533e-06,-0.66903,-0.66008,1,0
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,4.5891e-06,-0.66904,-0.665,1,0
1,GO NEPHRON DEVELOPMENT,5.7533e-06,-0.66924,-0.64543,1,0
1,GO APOPTOTIC CELL CLEARANCE,3.7287e-05,-0.66925,-0.72612,1,0
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,3.9422e-06,-0.66926,-0.64839,1,0
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,3.9422e-06,-0.66963,-0.68322,1,0
1,GO RETROGRADE AXONAL TRANSPORT,7.7514e-06,-0.66975,-0.73308,1,0
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00064645,-0.66979,-0.63567,1,0
1,GO STEM CELL DIVISION,5.337e-06,-0.66985,-0.67945,1,0
1,GO ENDOTHELIAL CELL MIGRATION,4.2539e-06,-0.66985,-0.6852,1,0
1,GO TORC1 SIGNALING,4.5891e-06,-0.6702,-0.69358,1,0
1,GO INCLUSION BODY ASSEMBLY,3.9936e-05,-0.67076,-0.61529,1,0
1,GO HEART MORPHOGENESIS,3.9422e-06,-0.67079,-0.63509,1,0
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,5.7533e-06,-0.67101,-0.65154,1,0
1,GO HISTONE H3 K9 DEMETHYLATION,7.1973e-06,-0.67121,-0.71571,1,0
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,2.4576e-05,-0.67137,-0.65613,1,0
1,GO ACTIN FILAMENT ORGANIZATION,4.5891e-06,-0.67147,-0.64594,1,0
1,GO GLYCOLIPID CATABOLIC PROCESS,1.2035e-05,-0.6717,-0.71764,1,0
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,5.7533e-06,-0.67181,-0.66117,1,0
1,GO REVERSE CHOLESTEROL TRANSPORT,5.2428e-05,-0.67181,-0.70614,1,0
1,GO PEPTIDYL THREONINE MODIFICATION,4.5891e-06,-0.67187,-0.67393,1,0
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,1.2035e-05,-0.67196,-0.64523,1,0
1,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,6.4139e-05,-0.6722,-0.76661,1,0
1,GO CARDIAC VENTRICLE MORPHOGENESIS,6.6813e-06,-0.6722,-0.62305,1,0
1,GO RESPONSE TO STEROL,3.9422e-06,-0.67224,-0.75918,1,0
1,GO COLLATERAL SPROUTING,7.7514e-06,-0.67249,-0.72939,1,0
1,GO ACTIVATION OF MAPK ACTIVITY,4.9495e-06,-0.67252,-0.62444,1,0
1,GO PLATELET ACTIVATION,3.9422e-06,-0.67288,-0.71408,1,0
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.00024771,-0.67298,-0.71483,1,0
1,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.4947e-05,-0.67312,-0.63926,1,0
1,GO LIPID PHOSPHORYLATION,3.9422e-06,-0.67333,-0.67734,1,0
1,GO REGULATION OF CELL SIZE,3.9422e-06,-0.67364,-0.6763,1,0
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,3.9422e-06,-0.67374,-0.68874,1,0
1,GO XENOBIOTIC TRANSPORT,6.6813e-06,-0.67383,-0.65459,1,0
1,GO BONE MATURATION,6.6813e-06,-0.67384,-0.65263,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.00014062,-0.67387,-0.62966,1,0
1,GO REGULATION OF HISTONE DEACETYLATION,1.4947e-05,-0.6739,-0.58899,1,0
1,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,6.6813e-06,-0.67414,-0.62056,1,0
1,GO MULTICELLULAR ORGANISM GROWTH,4.9495e-06,-0.6749,-0.65681,1,0
1,GO LIPID TRANSLOCATION,7.7514e-06,-0.67501,-0.66081,1,0
1,GO CELLULAR RESPONSE TO ETHANOL,1.8524e-05,-0.67539,-0.73492,1,0
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,4.2539e-06,-0.67549,-0.64644,1,0
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,3.4805e-05,-0.67557,-0.66538,1,0
1,GO REGULATION OF BONE REMODELING,5.7533e-06,-0.6759,-0.70882,1,0
1,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,9.6689e-06,-0.67596,-0.65111,1,0
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,3.9422e-06,-0.67621,-0.63903,1,0
1,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,1.1191e-05,-0.67657,-0.75084,1,0
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,5.7533e-06,-0.6766,-0.63646,1,0
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,1.0403e-05,-0.67666,-0.67011,1,0
1,GO FILOPODIUM ASSEMBLY,4.5891e-06,-0.67677,-0.69245,1,0
1,GO CYTOSOLIC TRANSPORT,4.9495e-06,-0.67719,-0.68737,1,0
1,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,7.1973e-06,-0.67732,-0.61383,1,0
1,GO TISSUE MIGRATION,4.2539e-06,-0.67745,-0.68698,1,0
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,7.3279e-05,-0.67772,-0.62369,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,3.9422e-06,-0.67795,-0.73413,1,0
1,GO DENDRITIC TRANSPORT,3.7287e-05,-0.67807,-0.75851,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,1.2939e-05,-0.6781,-0.68104,1,0
1,GO NEGATIVE REGULATION OF HISTONE METHYLATION,8.9843e-06,-0.67818,-0.67858,1,0
1,GO CARTILAGE DEVELOPMENT,4.9495e-06,-0.6782,-0.66438,1,0
1,GO PEPTIDE CROSS LINKING,0.00015974,-0.67843,-0.6137,1,0
1,GO CELLULAR RESPONSE TO STEROL,4.5891e-06,-0.67861,-0.74026,1,0
1,GO REGULATION OF MUSCLE HYPERTROPHY,4.9495e-06,-0.67867,-0.63328,1,0
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,6.6813e-06,-0.67894,-0.63591,1,0
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,1.6059e-05,-0.67899,-0.62441,1,0
1,GO NEURAL TUBE DEVELOPMENT,5.337e-06,-0.67917,-0.62477,1,0
1,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,8.3461e-06,-0.67942,-0.67396,1,0
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,4.2539e-06,-0.68041,-0.66287,1,0
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,4.9495e-06,-0.68062,-0.67291,1,0
1,GO MYELOID CELL DEVELOPMENT,3.9422e-06,-0.6809,-0.72584,1,0
1,GO ANIMAL ORGAN MATURATION,1.3909e-05,-0.68123,-0.60549,1,0
1,GO CARNITINE SHUTTLE,3.7287e-05,-0.6816,-0.57879,1,0
1,GO AXON EXTENSION,3.9422e-06,-0.68171,-0.70457,1,0
1,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,5.337e-06,-0.68234,-0.69753,1,0
1,GO BEHAVIORAL RESPONSE TO PAIN,7.7514e-06,-0.68241,-0.61761,1,0
1,GO POSITIVE REGULATION OF ENDOCYTOSIS,4.9495e-06,-0.68281,-0.68836,1,0
1,GO RESPIRATORY SYSTEM DEVELOPMENT,4.9495e-06,-0.68357,-0.66081,1,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,4.5891e-06,-0.68365,-0.68792,1,0
1,GO POSITIVE REGULATION OF AXONOGENESIS,4.2539e-06,-0.68378,-0.73746,1,0
1,GO HEMOGLOBIN METABOLIC PROCESS,2.1347e-05,-0.68395,-0.609,1,0
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,1.9888e-05,-0.684,-0.7331,1,0
1,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,6.8565e-05,-0.68409,-0.57506,1,0
1,GO LYSOSOMAL TRANSPORT,4.2539e-06,-0.6841,-0.69135,1,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,4.5891e-06,-0.68411,-0.66719,1,0
1,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,7.1973e-06,-0.68421,-0.6312,1,0
1,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00035748,-0.68426,-0.70795,1,0
1,GO POSITIVE REGULATION OF AUTOPHAGY,4.2539e-06,-0.68441,-0.6553,1,0
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,6.2007e-06,-0.6845,-0.66529,1,0
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.2939e-05,-0.68458,-0.74656,1,0
1,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,1.3909e-05,-0.68474,-0.64857,1,0
1,GO PROTEIN DEGLYCOSYLATION,4.5891e-06,-0.68484,-0.71366,1,0
1,GO RECEPTOR CATABOLIC PROCESS,3.9422e-06,-0.68494,-0.67691,1,0
1,GO REGULATION OF PROTEIN DEPOLYMERIZATION,4.2539e-06,-0.68539,-0.70846,1,0
1,GO REGULATION OF GASTRULATION,4.5891e-06,-0.68596,-0.66792,1,0
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,8.3461e-06,-0.68649,-0.75913,1,0
1,GO REGULATION OF CELL JUNCTION ASSEMBLY,4.9495e-06,-0.68656,-0.6652,1,0
1,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,4.2539e-06,-0.68675,-0.68355,1,0
1,GO VASCULATURE DEVELOPMENT,4.2539e-06,-0.68695,-0.71674,1,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.1973e-06,-0.68702,-0.67607,1,0
1,GO ACTIVATION OF MAPKK ACTIVITY,4.5891e-06,-0.68702,-0.72635,1,0
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,7.1973e-06,-0.68733,-0.64205,1,0
1,GO REGULATION OF BONE DEVELOPMENT,5.7533e-06,-0.68738,-0.73559,1,0
1,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,5.7533e-06,-0.68772,-0.67609,1,0
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,7.7514e-06,-0.68805,-0.713,1,0
1,GO SMAD PROTEIN SIGNAL TRANSDUCTION,6.2007e-06,-0.68813,-0.64209,1,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,4.2539e-06,-0.68824,-0.65923,1,0
1,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,6.6813e-06,-0.68862,-0.66345,1,0
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,7.3279e-05,-0.68875,-0.61373,1,0
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,5.7533e-06,-0.68878,-0.68036,1,0
1,GO GANGLIOSIDE METABOLIC PROCESS,2.4576e-05,-0.68884,-0.62048,1,0
1,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,4.5891e-06,-0.68921,-0.69674,1,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,4.2539e-06,-0.68935,-0.64339,1,0
1,GO MEMBRANE LIPID CATABOLIC PROCESS,8.3461e-06,-0.68939,-0.66945,1,0
1,GO REGULATION OF ENDOCYTIC RECYCLING,8.9843e-06,-0.68982,-0.70125,1,0
1,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,4.9495e-06,-0.68984,-0.72545,1,0
1,GO CARDIAC CHAMBER DEVELOPMENT,4.5891e-06,-0.69028,-0.67294,1,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,8.9843e-06,-0.69029,-0.68617,1,0
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,9.6689e-06,-0.69085,-0.66872,1,0
1,GO RESPONSE TO HYDROXYUREA,1.0403e-05,-0.69092,-0.64036,1,0
1,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00060992,-0.691,-0.56793,1,0
1,GO OSTEOCLAST DEVELOPMENT,6.6813e-06,-0.69119,-0.76316,1,0
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,6.2007e-06,-0.69136,-0.76724,1,0
1,GO T HELPER 2 CELL DIFFERENTIATION,0.00068502,-0.69141,-0.63408,1,0
1,GO EPITHELIAL CELL DEVELOPMENT,5.337e-06,-0.69175,-0.66298,1,0
1,GO MOTOR NEURON AXON GUIDANCE,8.9843e-06,-0.69193,-0.64171,1,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,2.1347e-05,-0.69228,-0.6965,1,0
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,4.9495e-06,-0.69245,-0.64219,1,0
1,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,0.011574,-0.69246,-0.80205,1,0
1,GO REGULATION OF FAT CELL DIFFERENTIATION,8.3461e-06,-0.69248,-0.64359,1,0
1,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,6.6813e-06,-0.69252,-0.74283,1,0
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,6.2007e-06,-0.69266,-0.62499,1,0
1,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,4.5891e-06,-0.69289,-0.70031,1,0
1,GO TRABECULA MORPHOGENESIS,5.7533e-06,-0.69289,-0.74317,1,0
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,2.636e-05,-0.69291,-0.6846,1,0
1,GO REGULATION OF MITOPHAGY,5.337e-06,-0.69324,-0.71889,1,0
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,4.2539e-06,-0.69326,-0.67921,1,0
1,GO REGULATION OF VASCULATURE DEVELOPMENT,5.337e-06,-0.69331,-0.70623,1,0
1,GO ACTIN FILAMENT BASED PROCESS,4.2539e-06,-0.69336,-0.6564,1,0
1,GO CHONDROCYTE PROLIFERATION,4.9495e-06,-0.69435,-0.73312,1,0
1,GO ERYTHROCYTE MATURATION,7.1973e-06,-0.69463,-0.65771,1,0
1,GO HISTONE H3 K4 TRIMETHYLATION,6.2007e-06,-0.69491,-0.76965,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,5.337e-06,-0.69507,-0.67195,1,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,4.2539e-06,-0.6955,-0.69463,1,0
1,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,4.2539e-06,-0.69673,-0.68077,1,0
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,3.9422e-06,-0.69698,-0.71605,1,0
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,7.1973e-06,-0.69707,-0.68358,1,0
1,GO RESPONSE TO PH,1.1191e-05,-0.69742,-0.63715,1,0
1,GO VENTRICULAR SEPTUM DEVELOPMENT,4.5891e-06,-0.69753,-0.66923,1,0
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,8.3641e-05,-0.69762,-0.71601,1,0
1,GO BONE REMODELING,5.337e-06,-0.69797,-0.71338,1,0
1,GO SALIVARY GLAND DEVELOPMENT,4.2539e-06,-0.69834,-0.74065,1,0
1,GO EMBRYONIC BODY MORPHOGENESIS,6.2007e-06,-0.69842,-0.6957,1,0
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,2.1347e-05,-0.69875,-0.70064,1,0
1,GO CONNECTIVE TISSUE DEVELOPMENT,4.9495e-06,-0.69881,-0.66785,1,0
1,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,4.2539e-06,-0.69882,-0.72845,1,0
1,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,3.9422e-06,-0.69915,-0.73456,1,0
1,GO ACTIN FILAMENT NETWORK FORMATION,1.6059e-05,-0.6992,-0.66929,1,0
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,1.9888e-05,-0.69957,-0.67471,1,0
1,GO RESPONSE TO ISCHEMIA,4.5891e-06,-0.69973,-0.70345,1,0
1,GO REGULATION OF CELL SHAPE,3.9422e-06,-0.69974,-0.7065,1,0
1,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,4.2539e-06,-0.7002,-0.68267,1,0
1,GO BARBED END ACTIN FILAMENT CAPPING,3.9422e-06,-0.70038,-0.70986,1,0
1,GO BLOOD VESSEL MORPHOGENESIS,4.5891e-06,-0.70081,-0.71603,1,0
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,4.5891e-06,-0.70086,-0.69827,1,0
1,GO OUTFLOW TRACT MORPHOGENESIS,4.5891e-06,-0.70107,-0.67179,1,0
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,1.2035e-05,-0.70124,-0.68017,1,0
1,GO ENDOCARDIAL CUSHION FORMATION,4.5891e-06,-0.70131,-0.73873,1,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,4.9495e-06,-0.70149,-0.6908,1,0
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,5.7533e-06,-0.70175,-0.75275,1,0
1,GO REGULATION OF PINOCYTOSIS,4.9495e-06,-0.70188,-0.71326,1,0
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,1.0403e-05,-0.70259,-0.69446,1,0
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,4.9495e-06,-0.70264,-0.65719,1,0
1,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,2.1347e-05,-0.70312,-0.62869,1,0
1,GO INTRACELLULAR MRNA LOCALIZATION,4.5891e-06,-0.70367,-0.6408,1,0
1,GO CARDIAC SEPTUM DEVELOPMENT,4.5891e-06,-0.70368,-0.70807,1,0
1,GO PROTEIN KINASE C SIGNALING,1.0403e-05,-0.70386,-0.6808,1,0
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,6.6813e-06,-0.70395,-0.72041,1,0
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,3.248e-05,-0.70401,-0.73997,1,0
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,8.9843e-06,-0.70471,-0.748,1,0
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,4.2539e-06,-0.70487,-0.69416,1,0
1,GO BONE DEVELOPMENT,3.9422e-06,-0.70493,-0.70225,1,0
1,GO CONVERGENT EXTENSION,1.4947e-05,-0.70526,-0.64463,1,0
1,GO PEPTIDE CATABOLIC PROCESS,6.2007e-06,-0.70534,-0.66467,1,0
1,GO TYPE B PANCREATIC CELL DEVELOPMENT,1.2035e-05,-0.70541,-0.65982,1,0
1,GO ENERGY HOMEOSTASIS,1.2939e-05,-0.70562,-0.61554,1,0
1,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,4.9495e-06,-0.70574,-0.64793,1,0
1,GO AROMATIC AMINO ACID TRANSPORT,9.6689e-06,-0.70592,-0.74527,1,0
1,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,6.6813e-06,-0.70597,-0.68265,1,0
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,4.5891e-06,-0.70597,-0.66108,1,0
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,6.6813e-06,-0.70648,-0.74062,1,0
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,4.9495e-06,-0.7071,-0.72732,1,0
1,GO METANEPHRIC NEPHRON DEVELOPMENT,6.2007e-06,-0.70735,-0.73248,1,0
1,GO ADHERENS JUNCTION ORGANIZATION,4.2539e-06,-0.70772,-0.73319,1,0
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,1.0403e-05,-0.70849,-0.67224,1,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,3.9422e-06,-0.7085,-0.70095,1,0
1,GO CELL CELL JUNCTION ORGANIZATION,5.337e-06,-0.70865,-0.64695,1,0
1,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,1.3909e-05,-0.70913,-0.64788,1,0
1,GO HEMATOPOIETIC STEM CELL PROLIFERATION,4.5891e-06,-0.70921,-0.70927,1,0
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,5.7533e-06,-0.70949,-0.66856,1,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,4.2539e-06,-0.70966,-0.68315,1,0
1,GO MAMMARY GLAND DEVELOPMENT,4.5891e-06,-0.71015,-0.66335,1,0
1,GO CELL CELL JUNCTION ASSEMBLY,5.7533e-06,-0.71023,-0.61317,1,0
1,GO TRACHEA MORPHOGENESIS,4.2539e-06,-0.71048,-0.74885,1,0
1,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,5.7533e-06,-0.71057,-0.67462,1,0
1,GO ESTABLISHMENT OF CELL POLARITY,4.2539e-06,-0.7108,-0.69158,1,0
1,GO HISTONE H3 K36 METHYLATION,4.2539e-06,-0.71191,-0.77003,1,0
1,GO NEGATIVE REGULATION OF TISSUE REMODELING,2.1347e-05,-0.71194,-0.80171,1,0
1,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,4.5891e-06,-0.71234,-0.68335,1,0
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,5.337e-06,-0.71251,-0.6805,1,0
1,GO GOLGI TO VACUOLE TRANSPORT,4.2539e-06,-0.71259,-0.75197,1,0
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,2.4576e-05,-0.71269,-0.64887,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,2.1347e-05,-0.71286,-0.63727,1,0
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,8.3461e-06,-0.71306,-0.66464,1,0
1,GO ANATOMICAL STRUCTURE ARRANGEMENT,5.337e-06,-0.71361,-0.73266,1,0
1,GO PROTEIN TARGETING TO LYSOSOME,7.7514e-06,-0.71368,-0.6659,1,0
1,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,5.7533e-06,-0.71392,-0.69159,1,0
1,GO NOREPINEPHRINE METABOLIC PROCESS,0.00010866,-0.71454,-0.61394,1,0
1,GO CELL JUNCTION DISASSEMBLY,5.2428e-05,-0.71469,-0.78748,1,0
1,GO REGULATION OF JUN KINASE ACTIVITY,4.9495e-06,-0.7149,-0.69763,1,0
1,GO ACTIVATION OF JUN KINASE ACTIVITY,5.337e-06,-0.71512,-0.75372,1,0
1,GO CIRCADIAN REGULATION OF GENE EXPRESSION,8.3461e-06,-0.71551,-0.6883,1,0
1,GO TISSUE REMODELING,4.9495e-06,-0.71552,-0.73535,1,0
1,GO PHAGOCYTOSIS RECOGNITION,5.6086e-05,-0.71554,-0.67741,1,0
1,GO EMBRYONIC EYE MORPHOGENESIS,4.2539e-06,-0.71655,-0.73114,1,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,5.337e-06,-0.71686,-0.67147,1,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,3.9422e-06,-0.71775,-0.71278,1,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,4.5891e-06,-0.71836,-0.73663,1,0
1,GO NEGATIVE CHEMOTAXIS,4.9495e-06,-0.71874,-0.72721,1,0
1,GO REGULATION OF HIPPO SIGNALING,1.2035e-05,-0.71893,-0.6813,1,0
1,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,1.3909e-05,-0.7192,-0.76083,1,0
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,4.5891e-06,-0.71923,-0.74274,1,0
1,GO RESPONSE TO BMP,5.7533e-06,-0.71925,-0.66969,1,0
1,GO INACTIVATION OF MAPK ACTIVITY,1.2939e-05,-0.71969,-0.63973,1,0
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,5.337e-06,-0.71996,-0.69079,1,0
1,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,8.9843e-06,-0.7203,-0.6872,1,0
1,GO ERYTHROCYTE DEVELOPMENT,3.9422e-06,-0.72058,-0.70482,1,0
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,4.9495e-06,-0.72101,-0.76021,1,0
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,8.9843e-06,-0.72123,-0.73327,1,0
1,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,6.6813e-06,-0.72229,-0.67466,1,0
1,GO ACTIN CROSSLINK FORMATION,7.1973e-06,-0.72301,-0.69556,1,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE,7.1973e-06,-0.72321,-0.69277,1,0
1,GO REPLACEMENT OSSIFICATION,1.0403e-05,-0.7241,-0.68915,1,0
1,GO LAMELLIPODIUM MORPHOGENESIS,1.2939e-05,-0.72493,-0.63998,1,0
1,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,6.6813e-06,-0.72503,-0.70092,1,0
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,4.5891e-06,-0.7254,-0.76824,1,0
1,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,3.9422e-06,-0.72574,-0.69641,1,0
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,5.7533e-06,-0.72579,-0.70206,1,0
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,4.9495e-06,-0.72585,-0.69458,1,0
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,7.1973e-06,-0.72639,-0.67626,1,0
1,GO ACTIVATION OF JNKK ACTIVITY,4.5891e-06,-0.72669,-0.78564,1,0
1,GO CORPUS CALLOSUM DEVELOPMENT,5.337e-06,-0.72682,-0.72843,1,0
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,5.337e-06,-0.72753,-0.79933,1,0
1,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,2.1347e-05,-0.72768,-0.69073,1,0
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,3.9422e-06,-0.72784,-0.73743,1,0
1,GO PULMONARY VALVE DEVELOPMENT,4.9495e-06,-0.72831,-0.81117,1,0
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,4.5891e-06,-0.7284,-0.75633,1,0
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,4.9495e-06,-0.72851,-0.69724,1,0
1,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,1.2939e-05,-0.72997,-0.6765,1,0
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,6.4139e-05,-0.73011,-0.83712,1,0
1,GO REGULATION OF FIBROBLAST MIGRATION,4.2539e-06,-0.73053,-0.69465,1,0
1,GO REGULATION OF MIRNA METABOLIC PROCESS,4.5891e-06,-0.73098,-0.75594,1,0
1,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,4.5891e-06,-0.73106,-0.77453,1,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,2.2907e-05,-0.73108,-0.67829,1,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,6.2007e-06,-0.7311,-0.67527,1,0
1,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.1191e-05,-0.73118,-0.63519,1,0
1,GO REGULATION OF GTPASE ACTIVITY,4.2539e-06,-0.7313,-0.69224,1,0
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,3.9422e-06,-0.73222,-0.74078,1,0
1,GO GLYCOPROTEIN CATABOLIC PROCESS,5.7533e-06,-0.73233,-0.75363,1,0
1,GO PROTEIN AUTOPHOSPHORYLATION,3.9422e-06,-0.73234,-0.71547,1,0
1,GO KERATAN SULFATE CATABOLIC PROCESS,8.9327e-05,-0.7343,-0.76318,1,0
1,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,3.0304e-05,-0.73437,-0.70911,1,0
1,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,4.2539e-06,-0.73468,-0.73295,1,0
1,GO P38MAPK CASCADE,4.9495e-06,-0.73485,-0.74907,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,4.5891e-06,-0.73491,-0.68639,1,0
1,GO FIBROBLAST MIGRATION,3.9422e-06,-0.73518,-0.69067,1,0
1,GO PLASMA MEMBRANE ORGANIZATION,4.5891e-06,-0.73522,-0.70549,1,0
1,GO REGULATION OF DEACETYLASE ACTIVITY,5.337e-06,-0.73634,-0.73591,1,0
1,GO REGULATION OF BMP SIGNALING PATHWAY,5.337e-06,-0.73675,-0.70292,1,0
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,5.7533e-06,-0.73723,-0.75347,1,0
1,GO BLEB ASSEMBLY,5.2428e-05,-0.73735,-0.72409,1,0
1,GO BONE CELL DEVELOPMENT,3.9422e-06,-0.73761,-0.77537,1,0
1,GO CELL ADHESION MEDIATED BY INTEGRIN,1.7249e-05,-0.73768,-0.80933,1,0
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,1.2035e-05,-0.73783,-0.79502,1,0
1,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,8.3461e-06,-0.73798,-0.70822,1,0
1,GO REGULATION OF FATTY ACID BETA OXIDATION,6.2007e-06,-0.73839,-0.70118,1,0
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,4.2539e-06,-0.73845,-0.6973,1,0
1,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,4.5891e-06,-0.73858,-0.70923,1,0
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,6.6813e-06,-0.73898,-0.7812,1,0
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,7.7514e-06,-0.73941,-0.75537,1,0
1,GO PODOSOME ASSEMBLY,3.9422e-06,-0.74193,-0.81446,1,0
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.9422e-06,-0.74199,-0.72257,1,0
1,GO ALANINE TRANSPORT,1.1191e-05,-0.74201,-0.71663,1,0
1,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.9422e-06,-0.74218,-0.77603,1,0
1,GO INHIBITORY SYNAPSE ASSEMBLY,6.4139e-05,-0.74249,-0.68,1,0
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,2.4576e-05,-0.74315,-0.72301,1,0
1,GO TUBULIN DEACETYLATION,6.6813e-06,-0.74361,-0.73484,1,0
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.4576e-05,-0.74379,-0.79252,1,0
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,4.9495e-06,-0.74426,-0.80644,1,0
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,5.337e-06,-0.74432,-0.66649,1,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,2.4576e-05,-0.74462,-0.75083,1,0
1,GO GASTRULATION WITH MOUTH FORMING SECOND,1.1191e-05,-0.74492,-0.68728,1,0
1,GO CELL MATRIX ADHESION,3.9422e-06,-0.74561,-0.77531,1,0
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,4.2539e-06,-0.7465,-0.72552,1,0
1,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,4.5891e-06,-0.74678,-0.74932,1,0
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,1.2035e-05,-0.7471,-0.74202,1,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,1.4947e-05,-0.74792,-0.6865,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,4.5779e-05,-0.74933,-0.72251,1,0
1,GO RNA DESTABILIZATION,3.9422e-06,-0.74961,-0.75487,1,0
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,4.9495e-06,-0.75086,-0.72335,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,4.9495e-06,-0.75096,-0.67666,1,0
1,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,4.9495e-06,-0.75153,-0.76462,1,0
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,4.5891e-06,-0.75261,-0.71165,1,0
1,GO POSITIVE REGULATION OF AXON EXTENSION,3.9422e-06,-0.75325,-0.75428,1,0
1,GO ACTIN FILAMENT BUNDLE ORGANIZATION,4.5891e-06,-0.75342,-0.70234,1,0
1,GO ANATOMICAL STRUCTURE REGRESSION,7.3279e-05,-0.75409,-0.66002,1,0
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,4.2539e-06,-0.7548,-0.73853,1,0
1,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,5.9985e-05,-0.7548,-0.73556,1,0
1,GO PULMONARY VALVE MORPHOGENESIS,5.7533e-06,-0.75484,-0.79176,1,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,8.3461e-06,-0.75577,-0.70188,1,0
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,8.9843e-06,-0.75627,-0.6749,1,0
1,GO COLLAGEN CATABOLIC PROCESS,3.7287e-05,-0.7565,-0.73854,1,0
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,4.9495e-06,-0.75662,-0.72616,1,0
1,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,3.4805e-05,-0.75677,-0.69586,1,0
1,GO AXO DENDRITIC PROTEIN TRANSPORT,1.2035e-05,-0.75709,-0.78397,1,0
1,GO REGULATION OF CARTILAGE DEVELOPMENT,4.9495e-06,-0.75729,-0.70142,1,0
1,GO KERATINOCYTE MIGRATION,4.2539e-06,-0.75737,-0.72676,1,0
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,1.0403e-05,-0.75778,-0.76665,1,0
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,4.5891e-06,-0.75849,-0.69896,1,0
1,GO REGULATION OF AXON GUIDANCE,4.5891e-06,-0.75852,-0.77073,1,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,4.2539e-06,-0.75903,-0.76345,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,3.9422e-06,-0.75923,-0.72128,1,0
1,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,8.9327e-05,-0.75944,-0.66961,1,0
1,GO HEART VALVE DEVELOPMENT,3.9422e-06,-0.75959,-0.77856,1,0
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,4.5891e-06,-0.75973,-0.69873,1,0
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.00021879,-0.75993,-0.86572,1,0
1,GO PLATELET MORPHOGENESIS,3.9422e-06,-0.76025,-0.74533,1,0
1,GO CELLULAR RESPONSE TO CHOLESTEROL,4.5891e-06,-0.76068,-0.8051,1,0
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,4.9495e-06,-0.76091,-0.76449,1,0
1,GO STRESS FIBER ASSEMBLY,4.2539e-06,-0.76196,-0.70259,1,0
1,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.00096503,-0.76242,-0.59765,1,0
1,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,3.4805e-05,-0.76294,-0.67312,1,0
1,GO REGULATION OF NEURON MIGRATION,6.6813e-06,-0.76295,-0.75124,1,0
1,GO CORONARY VASCULATURE MORPHOGENESIS,5.337e-06,-0.76304,-0.79162,1,0
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,3.9422e-06,-0.76392,-0.75687,1,0
1,GO REGULATION OF STEM CELL DIVISION,1.1191e-05,-0.76428,-0.71993,1,0
1,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,4.5891e-06,-0.76487,-0.72704,1,0
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,4.9495e-06,-0.7657,-0.71647,1,0
1,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,0.00076864,-0.7661,-0.65932,1,0
1,GO CLATHRIN DEPENDENT ENDOCYTOSIS,5.337e-06,-0.76669,-0.73675,1,0
1,GO ACTIVATION OF GTPASE ACTIVITY,4.9495e-06,-0.76729,-0.73438,1,0
1,GO MEGAKARYOCYTE DEVELOPMENT,3.9422e-06,-0.76735,-0.78911,1,0
1,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,1.3909e-05,-0.76766,-0.74578,1,0
1,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,5.6086e-05,-0.76817,-0.65044,1,0
1,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,4.2539e-06,-0.76859,-0.74136,1,0
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.2035e-05,-0.76859,-0.82418,1,0
1,GO EPITHELIAL CELL CELL ADHESION,7.1973e-06,-0.7686,-0.78672,1,0
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,5.337e-06,-0.76861,-0.74735,1,0
1,GO FACIAL NERVE MORPHOGENESIS,2.2907e-05,-0.76879,-0.74192,1,0
1,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,3.9422e-06,-0.76954,-0.82527,1,0
1,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,7.1973e-06,-0.76956,-0.71335,1,0
1,GO RESPONSE TO MUSCLE STRETCH,5.6086e-05,-0.76981,-0.6962,1,0
1,GO CERAMIDE CATABOLIC PROCESS,7.7514e-06,-0.76993,-0.73572,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,2.8267e-05,-0.77038,-0.73152,1,0
1,GO GAP JUNCTION ASSEMBLY,0.00015974,-0.77271,-0.72565,1,0
1,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,9.6689e-06,-0.77297,-0.75301,1,0
1,GO REGULATION OF SPROUTING ANGIOGENESIS,4.5891e-06,-0.77311,-0.74678,1,0
1,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,5.7533e-06,-0.77319,-0.73964,1,0
1,GO GLOMERULUS DEVELOPMENT,4.5891e-06,-0.77377,-0.799,1,0
1,GO ACTIN FILAMENT BASED TRANSPORT,6.6813e-06,-0.7739,-0.76499,1,0
1,GO NEGATIVE REGULATION OF TORC1 SIGNALING,6.2007e-06,-0.77536,-0.75747,1,0
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,4.5891e-06,-0.77548,-0.75954,1,0
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,3.9422e-06,-0.77559,-0.78598,1,0
1,GO MYELIN MAINTENANCE,6.6813e-06,-0.77577,-0.69431,1,0
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,4.2539e-06,-0.77591,-0.75418,1,0
1,GO BASEMENT MEMBRANE ORGANIZATION,5.337e-06,-0.77764,-0.78603,1,0
1,GO REGULATION OF CYTOPLASMIC TRANSPORT,4.9495e-06,-0.77772,-0.71955,1,0
1,GO ENDOCYTIC RECYCLING,4.2539e-06,-0.77876,-0.72033,1,0
1,GO NEGATIVE REGULATION OF BONE REMODELING,3.9936e-05,-0.77945,-0.7818,1,0
1,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,1.3909e-05,-0.78044,-0.7742,1,0
1,GO ENDODERM DEVELOPMENT,5.337e-06,-0.78066,-0.79083,1,0
1,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,5.337e-06,-0.78125,-0.75355,1,0
1,GO RESPONSE TO AMYLOID BETA,4.2539e-06,-0.78154,-0.78515,1,0
1,GO REGULATION OF PROTEIN KINASE C SIGNALING,3.248e-05,-0.7823,-0.74882,1,0
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,6.2007e-06,-0.78237,-0.78062,1,0
1,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,6.8565e-05,-0.78329,-0.64753,1,0
1,GO PROTEIN ACTIVATION CASCADE,7.8298e-05,-0.78342,-0.6725,1,0
1,GO ARTERY MORPHOGENESIS,5.337e-06,-0.78437,-0.75781,1,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,5.7533e-06,-0.78457,-0.7438,1,0
1,GO SYNAPTIC VESICLE CLUSTERING,5.2428e-05,-0.78495,-0.7368,1,0
1,GO ARF PROTEIN SIGNAL TRANSDUCTION,5.337e-06,-0.78531,-0.82528,1,0
1,GO GOLGI RIBBON FORMATION,5.7533e-06,-0.78554,-0.80722,1,0
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,7.1973e-06,-0.78743,-0.84469,1,0
1,GO BODY MORPHOGENESIS,4.5891e-06,-0.78847,-0.77576,1,0
1,GO REGULATION OF NEURON MATURATION,5.2428e-05,-0.78854,-0.5943,1,0
1,GO NEGATIVE REGULATION OF AXON GUIDANCE,4.2539e-06,-0.78873,-0.80726,1,0
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,6.2007e-06,-0.78951,-0.80978,1,0
1,GO LATERAL VENTRICLE DEVELOPMENT,8.3461e-06,-0.7903,-0.79303,1,0
1,GO NEUTROPHIL HOMEOSTASIS,3.9422e-06,-0.79157,-0.85263,1,0
1,GO COLLAGEN METABOLIC PROCESS,7.7514e-06,-0.7916,-0.82487,1,0
1,GO BLOOD VESSEL REMODELING,5.7533e-06,-0.79229,-0.78265,1,0
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,9.5377e-05,-0.79283,-0.71392,1,0
1,GO ASTRAL MICROTUBULE ORGANIZATION,1.2939e-05,-0.79317,-0.73457,1,0
1,GO MACROPHAGE CYTOKINE PRODUCTION,1.1191e-05,-0.79379,-0.80921,1,0
1,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,4.9495e-06,-0.79407,-0.81628,1,0
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,4.5891e-06,-0.79421,-0.81732,1,0
1,GO MONONUCLEAR CELL DIFFERENTIATION,8.9843e-06,-0.79477,-0.77665,1,0
1,GO CELLULAR RESPONSE TO AMYLOID BETA,4.2539e-06,-0.7948,-0.77004,1,0
1,GO SOMATIC STEM CELL DIVISION,0.00020554,-0.79509,-0.66278,1,0
1,GO HEMIDESMOSOME ASSEMBLY,0.0029965,-0.79576,-0.61857,1,0
1,GO SEMI LUNAR VALVE DEVELOPMENT,3.9422e-06,-0.79617,-0.80288,1,0
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,4.2539e-06,-0.79731,-0.79023,1,0
1,GO MICROTUBULE NUCLEATION,7.7514e-06,-0.79751,-0.75232,1,0
1,GO REGULATION OF NEUTROPHIL ACTIVATION,5.2428e-05,-0.7977,-0.83358,1,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,4.5891e-06,-0.79856,-0.77856,1,0
1,GO FOCAL ADHESION ASSEMBLY,4.5891e-06,-0.79983,-0.80414,1,0
1,GO CORONARY VASCULATURE DEVELOPMENT,4.9495e-06,-0.80022,-0.77099,1,0
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,4.9495e-06,-0.80024,-0.75687,1,0
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.2539e-06,-0.80075,-0.81262,1,0
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,4.9495e-06,-0.80165,-0.7599,1,0
1,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,1.2035e-05,-0.80309,-0.72083,1,0
1,GO ACTIVATION OF MAPKKK ACTIVITY,9.6689e-06,-0.80531,-0.74581,1,0
1,GO AORTIC VALVE DEVELOPMENT,3.9422e-06,-0.80779,-0.79801,1,0
1,GO MRNA TRANSCRIPTION,4.9495e-06,-0.81072,-0.76623,1,0
1,GO FACE DEVELOPMENT,3.9422e-06,-0.81235,-0.81281,1,0
1,GO NEURON PROJECTION ARBORIZATION,5.337e-06,-0.81343,-0.80788,1,0
1,GO TOOTH MINERALIZATION,8.9843e-06,-0.81815,-0.78462,1,0
1,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,6.2007e-06,-0.8191,-0.79962,1,0
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,3.9422e-06,-0.81925,-0.80809,1,0
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,4.9495e-06,-0.82102,-0.8462,1,0
1,GO DEFINITIVE HEMOPOIESIS,5.7533e-06,-0.82161,-0.79034,1,0
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,5.337e-06,-0.82381,-0.7953,1,0
1,GO PROTEIN DEMETHYLATION,5.337e-06,-0.82492,-0.77927,1,0
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,5.7533e-06,-0.82521,-0.86157,1,0
1,GO DERMATAN SULFATE METABOLIC PROCESS,1.7249e-05,-0.82609,-0.78288,1,0
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,4.5891e-06,-0.82673,-0.78494,1,0
1,GO ARTERY DEVELOPMENT,4.2539e-06,-0.82761,-0.77903,1,0
1,GO CELL CELL ADHESION MEDIATED BY CADHERIN,1.2939e-05,-0.82837,-0.75117,1,0
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,8.3461e-06,-0.82895,-0.8807,1,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,4.2539e-06,-0.8295,-0.90414,1,0
1,GO AORTA MORPHOGENESIS,4.5891e-06,-0.83074,-0.83012,1,0
1,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,3.0304e-05,-0.83205,-0.81208,1,0
1,GO POSITIVE REGULATION OF MITOPHAGY,4.5891e-06,-0.83661,-0.82286,1,0
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,5.7533e-06,-0.83899,-0.80782,1,0
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,4.9495e-06,-0.84009,-0.77599,1,0
1,GO AORTA DEVELOPMENT,3.9422e-06,-0.8413,-0.84837,1,0
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,4.9495e-06,-0.84219,-0.81273,1,0
1,GO COLLAGEN BIOSYNTHETIC PROCESS,5.337e-06,-0.84308,-0.87921,1,0
1,GO ACTIN FILAMENT SEVERING,7.7514e-06,-0.84336,-0.75795,1,0
1,GO SECRETORY GRANULE LOCALIZATION,9.6689e-06,-0.84367,-0.83168,1,0
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,5.337e-06,-0.84392,-0.83597,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,4.9495e-06,-0.84469,-0.79187,1,0
1,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,8.3461e-06,-0.84571,-0.8092,1,0
1,GO REGULATION OF KERATINOCYTE MIGRATION,3.9422e-06,-0.84584,-0.8404,1,0
1,GO RESPONSE TO FLUID SHEAR STRESS,4.2539e-06,-0.84676,-0.84496,1,0
1,GO PLACENTA BLOOD VESSEL DEVELOPMENT,8.3461e-06,-0.85048,-0.74664,1,0
1,GO LYMPH VESSEL MORPHOGENESIS,7.1973e-06,-0.85123,-0.78633,1,0
1,GO LOCOMOTOR RHYTHM,7.7514e-06,-0.85172,-0.80442,1,0
1,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,4.2539e-06,-0.85229,-0.78868,1,0
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,4.5891e-06,-0.85694,-0.80201,1,0
1,GO ENDODERM FORMATION,6.2007e-06,-0.86165,-0.84597,1,0
1,GO NUCLEAR MIGRATION,4.9495e-06,-0.86204,-0.85039,1,0
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,3.9422e-06,-0.86213,-0.78574,1,0
1,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,4.9495e-06,-0.86471,-0.79302,1,0
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,4.5891e-06,-0.86679,-0.80255,1,0
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,5.7533e-06,-0.86752,-0.8143,1,0
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,3.0304e-05,-0.87039,-0.82941,1,0
1,GO DENSE CORE GRANULE TRANSPORT,7.3279e-05,-0.87745,-0.82685,1,0
1,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,4.9495e-06,-0.88511,-0.83822,1,0
1,GO PLASMA MEMBRANE TUBULATION,3.9422e-06,-0.8861,-0.8318,1,0
1,GO BASEMENT MEMBRANE ASSEMBLY,1.0403e-05,-0.88748,-0.84353,1,0
1,GO NUCLEUS LOCALIZATION,5.337e-06,-0.88833,-0.82596,1,0
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,4.5891e-06,-0.88962,-0.88419,1,0
1,GO MYELIN ASSEMBLY,5.7533e-06,-0.89118,-0.78658,1,0
1,GO CELL MIGRATION IN HINDBRAIN,2.4576e-05,-0.89268,-0.77661,1,0
1,GO COLLAGEN FIBRIL ORGANIZATION,6.6813e-06,-0.89278,-0.96117,1,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,6.2007e-06,-0.89294,-0.82067,1,0
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,1.2035e-05,-0.89721,-0.89054,1,0
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,6.2007e-06,-0.89995,-0.82521,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,3.9422e-06,-0.9042,-0.94446,1,0
1,GO POSITIVE REGULATION OF NEURON MIGRATION,3.9422e-06,-0.91511,-0.92234,1,0
1,GO ENDODERMAL CELL DIFFERENTIATION,5.337e-06,-0.9161,-0.93054,1,0
1,GO LYMPH VESSEL DEVELOPMENT,6.2007e-06,-0.91933,-0.83874,1,0
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00010866,-0.92291,-0.99863,1,0
1,GO BONE TRABECULA MORPHOGENESIS,7.8298e-05,-0.92476,-0.85409,1,0
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,1.7249e-05,-0.92506,-0.95161,1,0
1,GO HYALURONAN BIOSYNTHETIC PROCESS,4.9495e-06,-0.92603,-0.89323,1,0
1,GO ADHERENS JUNCTION ASSEMBLY,5.337e-06,-0.92618,-0.87721,1,0
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,3.9422e-06,-0.92655,-0.92373,1,0
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,7.1973e-06,-0.92879,-0.9716,1,0
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,5.337e-06,-0.93067,-0.87451,1,0
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,8.3641e-05,-0.93355,-0.89202,1,0
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,1.1191e-05,-0.93707,-0.84373,1,0
1,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,4.2539e-06,-0.93762,-0.87361,1,0
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,4.2539e-06,-0.93953,-0.9054,1,0
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,1.1191e-05,-0.94049,-0.97005,1,0
1,GO MACROPHAGE PROLIFERATION,5.2428e-05,-0.94062,-0.88075,1,0
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,5.7533e-06,-0.94297,-0.94619,1,0
1,GO PROTEIN LOCALIZATION TO ENDOSOME,6.2007e-06,-0.95664,-0.85341,1,0
1,GO PROTEIN LOCALIZATION TO PRESYNAPSE,1.4947e-05,-0.95881,-0.84176,1,0
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,6.4139e-05,-0.95924,-0.79733,1,0
1,GO SKIN MORPHOGENESIS,8.9843e-06,-0.96257,-0.91253,1,0
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,4.9495e-06,-0.97458,-0.89019,1,0
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,6.2007e-06,-0.9843,-0.87976,1,0
1,GO REGULATION OF NEURON PROJECTION ARBORIZATION,8.9843e-06,-0.99135,-0.8693,1,0
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,5.337e-06,-1.0646,-0.96008,1,0
1,GO ELASTIC FIBER ASSEMBLY,1.0403e-05,-1.0784,-1.0383,1,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,4.2539e-06,-1.1525,-1.1533,1,0
1,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.091819,0.13768,0.086126,0,1
1,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.10811,0.1185,0.079637,0,1
1,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.054439,0.14442,0.12896,0,0
1,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.18102,0.11873,0.04378,0,0
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.10134,0.09617,0.095433,0,0
1,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.29248,0.088266,0.029721,0,0
1,GO OXYGEN TRANSPORT,0.65188,0.086736,-0.066425,0,0
1,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.27821,0.066894,0.019169,0,0
1,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.50109,0.054832,0.0060933,0,0
1,GO TRANSLATIONAL TERMINATION,0.51122,0.050554,-0.015039,0,0
1,GO REGULATION OF APPETITE,0.62923,0.046798,-0.1192,0,0
1,GO MITOCHONDRIAL TRANSLATION,0.76963,0.032666,-0.065235,0,0
1,GO SEQUESTERING OF ACTIN MONOMERS,0.69814,0.031164,0.067921,0,0
1,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.76963,0.030923,-0.043814,0,0
1,GO OXIDATIVE PHOSPHORYLATION,0.81845,0.029227,-0.020852,0,0
1,GO TRANSLATIONAL INITIATION,0.53179,0.0023127,0.032857,0,0
1,GO PROTEASOME ASSEMBLY,0.33029,-0.0081704,-0.10382,0,0
1,GO MITOCHONDRIAL GENE EXPRESSION,0.32248,-0.012501,-0.10628,0,0
1,GO XENOBIOTIC CATABOLIC PROCESS,0.52145,-0.018781,-0.094319,0,0
1,GO TRANSLATIONAL ELONGATION,0.53179,-0.019058,-0.068676,0,0
1,GO GAS TRANSPORT,0.33821,-0.01985,-0.16505,0,0
1,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.60692,-0.020305,-0.04752,0,0
1,GO PROTEIN NEDDYLATION,0.36271,-0.024538,-0.067986,0,0
1,GO PROTEIN TARGETING TO MEMBRANE,0.89296,-0.025854,-0.007756,0,0
1,GO CYTOPLASMIC TRANSLATION,0.32248,-0.030683,-0.040193,0,0
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.27821,-0.03324,-0.088737,0,0
1,GO GTP BIOSYNTHETIC PROCESS,0.28529,-0.035358,-0.09055,0,0
1,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.24463,-0.04311,-0.10006,0,0
1,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.37111,-0.043679,-0.077005,0,0
1,GO CHROMATIN REMODELING AT CENTROMERE,0.08588,-0.060854,-0.15244,0,0
1,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.1475,-0.061545,-0.1477,0,0
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.70989,-0.063905,-0.058636,0,0
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.17591,-0.067946,-0.14978,0,0
1,GO RIBOSOME ASSEMBLY,0.08881,-0.067994,-0.068351,0,0
1,GO VIRAL GENE EXPRESSION,0.098083,-0.070823,-0.055811,0,0
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.0036751,-0.072602,-0.19366,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.10468,-0.072707,-0.11673,0,0
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.33821,-0.075498,-0.037737,0,0
1,GO PIRNA METABOLIC PROCESS,0.08881,-0.075898,-0.16574,0,0
1,GO UTP METABOLIC PROCESS,0.25111,-0.076824,-0.11159,0,0
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.069906,-0.07806,-0.13178,0,0
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.091819,-0.078448,-0.084043,0,0
1,GO RRNA 3 END PROCESSING,0.11894,-0.079117,-0.12558,0,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0172,-0.086193,-0.13495,0,0
1,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.15655,-0.094099,-0.11505,0,0
1,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.023112,-0.095135,-0.18776,0,0
1,GO ELECTRON TRANSPORT CHAIN,0.054439,-0.10396,-0.11871,0,0
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.022172,-0.10664,-0.16038,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.062884,-0.10974,-0.070651,0,0
1,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.2259,-0.11228,-0.12954,0,0
1,GO ALDEHYDE CATABOLIC PROCESS,0.046961,-0.11548,-0.12635,0,0
1,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.0028457,-0.11549,-0.20324,0,0
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.0063209,-0.11771,-0.2043,0,0
1,GO REGULATION OF RESPONSE TO FOOD,0.12662,-0.11899,-0.19595,0,0
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.024086,-0.12493,-0.16504,0,0
1,GO CYTOCHROME COMPLEX ASSEMBLY,0.0040644,-0.12886,-0.19795,0,0
1,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.013834,-0.12954,-0.21845,0,0
1,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0052065,-0.12958,-0.19436,0,0
1,GO TRNA 5 LEADER REMOVAL,0.056456,-0.1313,-0.14005,0,0
1,GO TRNA 5 END PROCESSING,0.02951,-0.13262,-0.15997,0,0
1,GO HISTONE EXCHANGE,0.010572,-0.13825,-0.20609,0,0
1,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.53179,-0.13838,-0.073621,0,0
1,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.037377,-0.13912,-0.15963,0,0
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.013235,-0.14162,-0.1517,0,0
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.010101,-0.14221,-0.17266,0,0
1,GO ANTIMICROBIAL HUMORAL RESPONSE,0.16602,-0.14226,-0.17803,0,0
1,GO MITOCHONDRIAL TRANSCRIPTION,0.0010209,-0.14806,-0.2397,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0083971,-0.14988,-0.2194,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.0024341,-0.15186,-0.22683,0,0
1,GO DETOXIFICATION OF INORGANIC COMPOUND,0.27126,-0.15478,-0.23521,0,0
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.00072571,-0.15616,-0.20479,0,0
1,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.58498,-0.15709,-0.10483,0,0
1,GO ANTIBACTERIAL HUMORAL RESPONSE,0.17591,-0.15864,-0.22556,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,9.6689e-06,-0.1594,-0.2008,0,0
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0011418,-0.16058,-0.18918,0,0
1,GO REGULATION OF DEOXYRIBONUCLEASE ACTIVITY,0.0042727,-0.16102,-0.22622,0,0
1,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0028457,-0.16139,-0.25039,0,0
1,GO TELENCEPHALON REGIONALIZATION,0.11894,-0.16249,-0.28739,0,0
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00072571,-0.16258,-0.22147,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.022172,-0.16792,-0.20414,0,0
1,GO KILLING OF CELLS OF OTHER ORGANISM,0.072385,-0.16886,-0.18732,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.0042727,-0.17253,-0.24935,0,0
1,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.014457,-0.17265,-0.20427,0,0
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.13885,-0.17875,-0.3562,0,0
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00035748,-0.18511,-0.26795,0,0
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00051151,-0.18692,-0.18381,0,0
1,GO PEPTIDE BIOSYNTHETIC PROCESS,7.7514e-06,-0.18868,-0.24244,0,0
1,GO MIDBODY ABSCISSION,0.00091199,-0.18982,-0.29396,0,0
1,GO DNA LIGATION,0.0034935,-0.19033,-0.25995,0,0
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.00096503,-0.19225,-0.22117,0,0
1,GO PROTEIN DENEDDYLATION,0.01266,-0.19358,-0.21396,0,0
1,GO PENTOSE METABOLIC PROCESS,0.00024771,-0.19616,-0.30071,0,0
1,GO ERROR PRONE TRANSLESION SYNTHESIS,0.0017696,-0.19732,-0.23978,0,0
1,GO REGULATION OF GLUTAMATE SECRETION,0.010101,-0.20061,-0.41694,0,0
1,GO AEROBIC RESPIRATION,0.0031545,-0.20126,-0.20496,0,0
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00020554,-0.20208,-0.28408,0,0
1,GO ESCRT COMPLEX DISASSEMBLY,0.00076864,-0.2038,-0.28012,0,0
1,GO RIBOSOME BIOGENESIS,3.9936e-05,-0.20424,-0.25968,0,0
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.00010181,-0.2046,-0.27378,0,0
1,GO CORNIFICATION,0.10134,-0.20461,-0.18233,0,0
1,GO KERATINIZATION,0.052482,-0.20476,-0.17802,0,0
1,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,7.8298e-05,-0.21036,-0.29814,0,0
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.00086166,-0.21129,-0.28229,0,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.007293,-0.21264,-0.21965,0,0
1,GO TRNA METABOLIC PROCESS,3.9936e-05,-0.21298,-0.31216,0,0
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,1.2939e-05,-0.21528,-0.28707,0,0
1,GO RNA CATABOLIC PROCESS,7.7514e-06,-0.21624,-0.25133,0,0
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,2.2907e-05,-0.21943,-0.28283,0,0
1,GO TRNA PROCESSING,2.636e-05,-0.21964,-0.31231,0,0
1,GO MATURATION OF LSU RRNA,0.0016767,-0.22019,-0.21711,0,0
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.074935,-0.22469,-0.36229,0,0
1,GO REGULATION OF TRANSLATIONAL ELONGATION,3.9936e-05,-0.2255,-0.27582,0,0
1,GO MALE MEIOSIS I,0.015776,-0.22698,-0.33245,0,0
1,GO RRNA METABOLIC PROCESS,1.4947e-05,-0.22735,-0.29878,0,0
1,GO CORTICOSTEROID HORMONE SECRETION,0.034576,-0.22838,-0.24579,0,0
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,1.9888e-05,-0.22944,-0.29168,0,0
1,GO NUCLEOSIDE SALVAGE,0.00018128,-0.23012,-0.27613,0,0
1,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00026348,-0.23077,-0.32044,0,0
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,4.8997e-05,-0.2322,-0.29391,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.00081392,-0.23304,-0.23045,0,0
1,GO NCRNA 3 END PROCESSING,0.00015974,-0.2331,-0.27828,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT,9.5377e-05,-0.23421,-0.30892,0,0
1,GO RRNA MODIFICATION,7.3279e-05,-0.23443,-0.32142,0,0
1,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,1.3909e-05,-0.23482,-0.30569,0,0
1,GO MEIOTIC CHROMOSOME SEGREGATION,0.00026348,-0.23491,-0.36801,0,0
1,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,8.9327e-05,-0.23492,-0.32796,0,0
1,GO HISTONE SERINE PHOSPHORYLATION,0.00020554,-0.2352,-0.34102,0,0
1,GO MITOCHONDRIAL RNA METABOLIC PROCESS,9.5377e-05,-0.23605,-0.35128,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.00010866,-0.23615,-0.33941,0,0
1,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.031957,-0.23778,-0.38142,0,0
1,GO VIRAL BUDDING,9.5377e-05,-0.23837,-0.32007,0,0
1,GO TRNA MODIFICATION,1.8524e-05,-0.23885,-0.33885,0,0
1,GO PSEUDOURIDINE SYNTHESIS,0.0016767,-0.24034,-0.27468,0,0
1,GO RRNA METHYLATION,3.0304e-05,-0.24061,-0.33116,0,0
1,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.019548,-0.24069,-0.2444,0,0
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,7.8298e-05,-0.24149,-0.28764,0,0
1,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.00040321,-0.24211,-0.32222,0,0
1,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.43329,-0.24241,-0.32138,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.0003797,-0.24253,-0.27605,0,0
1,GO PEPTIDYL ASPARAGINE MODIFICATION,3.4805e-05,-0.24262,-0.32857,0,0
1,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.0015041,-0.24268,-0.26386,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0003797,-0.24317,-0.2509,0,0
1,GO TELOMERASE RNA LOCALIZATION,0.00020554,-0.24395,-0.26484,0,0
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,2.2907e-05,-0.24417,-0.30379,0,0
1,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.006955,-0.2444,-0.25233,0,0
1,GO STABILIZATION OF MEMBRANE POTENTIAL,0.041938,-0.24482,-0.35658,0,0
1,GO NCRNA PROCESSING,1.6059e-05,-0.24708,-0.31944,0,0
1,GO PURINE CONTAINING COMPOUND SALVAGE,0.00057531,-0.24834,-0.2363,0,0
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,8.9327e-05,-0.24859,-0.29765,0,0
1,GO PROTEIN INSERTION INTO MEMBRANE,5.9985e-05,-0.2508,-0.30027,0,0
1,GO REGULATION OF CILIUM MOVEMENT,0.0052065,-0.25115,-0.21764,0,0
1,GO VIRAL LATENCY,0.00076864,-0.25243,-0.30094,0,0
1,GO RNA 5 END PROCESSING,0.00014062,-0.25253,-0.28323,0,0
1,GO ERROR FREE TRANSLESION SYNTHESIS,0.00033648,-0.25388,-0.28649,0,0
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.00028019,-0.25494,-0.33762,0,0
1,GO MACROMOLECULE DEPALMITOYLATION,0.0015882,-0.25502,-0.22958,0,0
1,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.00012367,-0.25562,-0.32621,0,0
1,GO SNORNA 3 END PROCESSING,0.00086166,-0.256,-0.29412,0,0
1,GO NCRNA METABOLIC PROCESS,1.0403e-05,-0.25646,-0.33111,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,6.2007e-06,-0.2588,-0.3454,0,0
1,GO VITAMIN CATABOLIC PROCESS,0.0092139,-0.2591,-0.27575,0,0
1,GO SENSORY PERCEPTION OF BITTER TASTE,0.0023095,-0.26166,-0.32101,0,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.10811,-0.26196,-0.4118,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,4.5891e-06,-0.26236,-0.31497,0,0
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,3.7287e-05,-0.2635,-0.34288,0,0
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.080256,-0.264,-0.22286,0,0
1,GO MULTIVESICULAR BODY ORGANIZATION,2.636e-05,-0.26504,-0.34225,0,0
1,GO POLYAMINE BIOSYNTHETIC PROCESS,8.9327e-05,-0.26561,-0.30034,0,0
1,GO VIRION ASSEMBLY,9.6689e-06,-0.26624,-0.3343,0,0
1,GO MITOTIC CYTOKINETIC PROCESS,5.9985e-05,-0.26787,-0.37037,0,0
1,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,1.4947e-05,-0.26813,-0.35289,0,0
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,3.9422e-06,-0.2688,-0.29995,0,0
1,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.00035748,-0.26965,-0.32855,0,0
1,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.00029789,-0.27562,-0.37628,0,0
1,GO POSTREPLICATION REPAIR,2.1347e-05,-0.27671,-0.35523,0,0
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,3.9422e-06,-0.27756,-0.31173,0,0
1,GO KINETOCHORE ASSEMBLY,0.0012071,-0.27923,-0.36164,0,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.197,-0.27946,-0.41949,0,0
1,GO TRNA CATABOLIC PROCESS,0.00076864,-0.27951,-0.40048,0,0
1,GO RETINAL ROD CELL DIFFERENTIATION,0.0014241,-0.27986,-0.30265,0,0
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0049572,-0.281,-0.2014,0,0
1,GO PROTEIN TRANSMEMBRANE TRANSPORT,1.9888e-05,-0.2813,-0.31949,0,0
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.00019306,-0.28324,-0.31,0,0
1,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.0024341,-0.28431,-0.34714,0,0
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,1.7249e-05,-0.28455,-0.32606,0,0
1,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,8.3641e-05,-0.28483,-0.38735,0,0
1,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,3.7287e-05,-0.28674,-0.34082,0,0
1,GO RESPONSE TO FOOD,0.0015882,-0.28767,-0.29393,0,0
1,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,3.7287e-05,-0.28822,-0.3587,0,0
1,GO TETRAHYDROFOLATE INTERCONVERSION,0.00024771,-0.29011,-0.30749,0,0
1,GO PROTEIN NITROSYLATION,0.00015974,-0.29027,-0.36411,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,3.248e-05,-0.29036,-0.34178,0,0
1,GO MALE MEIOTIC NUCLEAR DIVISION,0.0015041,-0.29092,-0.37142,0,0
1,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.00068502,-0.29095,-0.35911,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00076864,-0.29156,-0.27855,0,0
1,GO CYTOLYSIS,0.10134,-0.29287,-0.3397,0,0
1,GO TONGUE DEVELOPMENT,3.0304e-05,-0.29303,-0.39362,0,0
1,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.00014989,-0.29319,-0.36342,0,0
1,GO RETINA HOMEOSTASIS,8.9843e-06,-0.2944,-0.34083,0,0
1,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.00029789,-0.29469,-0.32294,0,0
1,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.0025648,-0.29473,-0.27221,0,0
1,GO RNA MODIFICATION,7.1973e-06,-0.29523,-0.37676,0,0
1,GO TRNA METHYLATION,1.4947e-05,-0.29579,-0.37679,0,0
1,GO SIGNAL PEPTIDE PROCESSING,0.0027019,-0.29683,-0.28949,0,0
1,GO ZINC ION HOMEOSTASIS,0.00081392,-0.29785,-0.35162,0,0
1,GO CELLULAR METABOLIC COMPOUND SALVAGE,6.8565e-05,-0.29787,-0.29879,0,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.011574,-0.29854,-0.23408,0,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,7.1973e-06,-0.29862,-0.32719,0,0
1,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00021879,-0.29919,-0.34206,0,0
1,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,9.5377e-05,-0.29991,-0.33895,0,0
1,GO V D J RECOMBINATION,0.0003797,-0.30029,-0.34628,0,0
1,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00014062,-0.30088,-0.33658,0,0
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,1.6059e-05,-0.30138,-0.32302,0,0
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,4.8997e-05,-0.30144,-0.32076,0,0
1,GO CARDIAC CELL FATE COMMITMENT,0.0025648,-0.30239,-0.31403,0,0
1,GO NUCLEOSOME ASSEMBLY,0.00018128,-0.30362,-0.35081,0,0
1,GO POSITIVE REGULATION OF CELL AGING,0.0010209,-0.30406,-0.26193,0,0
1,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.0034935,-0.30624,-0.2996,0,0
1,GO SNORNA METABOLIC PROCESS,7.8298e-05,-0.30682,-0.34629,0,0
1,GO HOMOLOGOUS RECOMBINATION,9.5377e-05,-0.30762,-0.40534,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00014062,-0.30787,-0.3335,0,0
1,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.0012071,-0.30958,-0.30874,0,0
1,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.012106,-0.3118,-0.49125,0,0
1,GO PEPTIDYL METHIONINE MODIFICATION,0.00060992,-0.31247,-0.38188,0,0
1,GO PEPTIDYL ARGININE MODIFICATION,0.00015974,-0.31272,-0.3012,0,0
1,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.00332,-0.31275,-0.30131,0,0
1,GO DNA REPLICATION INITIATION,0.00010181,-0.3131,-0.35462,0,0
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,1.4947e-05,-0.3133,-0.33654,0,0
1,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0015041,-0.31334,-0.26736,0,0
1,GO MRNA METABOLIC PROCESS,6.6813e-06,-0.31354,-0.34804,0,0
1,GO PURINE NUCLEOBASE METABOLIC PROCESS,6.8565e-05,-0.31412,-0.33839,0,0
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,1.3909e-05,-0.3156,-0.32056,0,0
1,GO SNRNA METABOLIC PROCESS,4.5779e-05,-0.31566,-0.34187,0,0
1,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,1.8524e-05,-0.3157,-0.36675,0,0
1,GO MUSCLE FILAMENT SLIDING,0.00013188,-0.31606,-0.31922,0,0
1,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.00072571,-0.31646,-0.3757,0,0
1,GO RNA METHYLATION,6.6813e-06,-0.31775,-0.4161,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,1.7249e-05,-0.31781,-0.41113,0,0
1,GO INTERMEDIATE FILAMENT ORGANIZATION,0.00010181,-0.31785,-0.40056,0,0
1,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,1.9888e-05,-0.31819,-0.37416,0,0
1,GO POLYAMINE METABOLIC PROCESS,3.7287e-05,-0.3183,-0.34729,0,0
1,GO RESPONSE TO NITROSATIVE STRESS,0.00017019,-0.31918,-0.28342,0,0
1,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,4.5779e-05,-0.31946,-0.36359,0,0
1,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.0015882,-0.32046,-0.28271,0,0
1,GO TONIC SMOOTH MUSCLE CONTRACTION,0.00054254,-0.32057,-0.42012,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.00086166,-0.32063,-0.37379,0,0
1,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,1.2035e-05,-0.32072,-0.39495,0,0
1,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,6.4139e-05,-0.32093,-0.38729,0,0
1,GO RNA INTERFERENCE,8.3641e-05,-0.32127,-0.38621,0,0
1,GO GPI ANCHOR METABOLIC PROCESS,0.0011418,-0.32238,-0.30897,0,0
1,GO REGULATION OF RELAXATION OF MUSCLE,0.0092139,-0.3231,-0.40706,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.0018673,-0.32416,-0.35429,0,0
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,3.0304e-05,-0.32421,-0.28963,0,0
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,1.2035e-05,-0.32486,-0.409,0,0
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,5.9985e-05,-0.32617,-0.36978,0,0
1,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.00019306,-0.32648,-0.39053,0,0
1,GO RESPONSE TO ZINC ION,5.6086e-05,-0.32697,-0.37224,0,0
1,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,3.9936e-05,-0.32756,-0.36743,0,0
1,GO RRNA CATABOLIC PROCESS,4.8997e-05,-0.32763,-0.42742,0,0
1,GO NADPH REGENERATION,2.8267e-05,-0.32784,-0.43045,0,0
1,GO DNA STRAND ELONGATION,0.00014062,-0.32921,-0.37473,0,0
1,GO INTRACILIARY RETROGRADE TRANSPORT,0.00042807,-0.32997,-0.43005,0,0
1,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,3.7287e-05,-0.33149,-0.37171,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE,0.00035748,-0.33166,-0.36309,0,0
1,GO MITOCHONDRIAL DNA REPLICATION,9.6689e-06,-0.33313,-0.41042,0,0
1,GO RETINAL CONE CELL DIFFERENTIATION,0.00048214,-0.33387,-0.30694,0,0
1,GO REGULATION OF HELICASE ACTIVITY,0.00033648,-0.33387,-0.33573,0,0
1,GO MATURATION OF 5 8S RRNA,8.3641e-05,-0.33459,-0.33854,0,0
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,7.1973e-06,-0.33502,-0.42991,0,0
1,GO GLYCINE METABOLIC PROCESS,0.00017019,-0.3361,-0.35775,0,0
1,GO MITOCHONDRIAL TRANSPORT,2.8267e-05,-0.3365,-0.37365,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,5.7533e-06,-0.33714,-0.43582,0,0
1,GO REGULATION OF TRANSLATIONAL FIDELITY,3.7287e-05,-0.33852,-0.35474,0,0
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,1.0403e-05,-0.33944,-0.35294,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,3.248e-05,-0.34,-0.37148,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.00045436,-0.34184,-0.39119,0,0
1,GO SNRNA TRANSCRIPTION,9.6689e-06,-0.3425,-0.42411,0,0
1,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,4.8997e-05,-0.34254,-0.35745,0,0
1,GO METAPHASE PLATE CONGRESSION,5.6086e-05,-0.34306,-0.41526,0,0
1,GO NUCLEAR ENVELOPE REASSEMBLY,6.8565e-05,-0.34367,-0.40364,0,0
1,GO RESPONSE TO UV C,2.636e-05,-0.34412,-0.48307,0,0
1,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,1.3909e-05,-0.34519,-0.39445,0,0
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,1.6059e-05,-0.34583,-0.3541,0,0
1,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,8.3641e-05,-0.34711,-0.3369,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEOLUS,6.4139e-05,-0.34715,-0.3574,0,0
1,GO MATURATION OF SSU RRNA,8.3461e-06,-0.34796,-0.34366,0,0
1,GO VIRAL TRANSLATION,3.7287e-05,-0.34827,-0.36515,0,0
1,GO MULTIVESICULAR BODY SORTING PATHWAY,2.4576e-05,-0.34863,-0.38298,0,0
1,GO LIPID DIGESTION,0.030713,-0.34867,-0.29197,0,0
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.1191e-05,-0.34888,-0.36753,0,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,1.7249e-05,-0.34982,-0.43719,0,0
1,GO DENTATE GYRUS DEVELOPMENT,5.9985e-05,-0.35001,-0.39575,0,0
1,GO APOPTOTIC MITOCHONDRIAL CHANGES,1.1191e-05,-0.35107,-0.38785,0,0
1,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.00332,-0.35344,-0.33007,0,0
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.00042807,-0.35472,-0.46347,0,0
1,GO RNA PROCESSING,7.1973e-06,-0.35576,-0.39569,0,0
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,2.4576e-05,-0.35587,-0.39396,0,0
1,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0034935,-0.35696,-0.39214,0,0
1,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,3.7287e-05,-0.35735,-0.39331,0,0
1,GO AMINE METABOLIC PROCESS,2.1347e-05,-0.3574,-0.34564,0,0
1,GO DNA DOUBLE STRAND BREAK PROCESSING,1.8524e-05,-0.35835,-0.46184,0,0
1,GO CELL CYCLE G2 M PHASE TRANSITION,9.6689e-06,-0.35856,-0.43054,0,0
1,GO REGULATION OF CELL PROJECTION SIZE,0.00021879,-0.35893,-0.41322,0,0
1,GO ZINC ION TRANSPORT,1.2939e-05,-0.35978,-0.38911,0,0
1,GO ONE CARBON METABOLIC PROCESS,1.4947e-05,-0.36028,-0.37221,0,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0038653,-0.36034,-0.33176,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,7.1973e-06,-0.36129,-0.42875,0,0
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,2.8267e-05,-0.36169,-0.4324,0,0
1,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.040368,-0.36261,-0.2253,0,0
1,GO EXIT FROM MITOSIS,4.2763e-05,-0.36282,-0.44203,0,0
1,GO REGULATION OF CELLULAR RESPIRATION,4.8997e-05,-0.36327,-0.39091,0,0
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,4.2763e-05,-0.36332,-0.35725,0,0
1,GO REGULATION OF CELL FATE COMMITMENT,0.00014989,-0.36388,-0.41586,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,7.1973e-06,-0.36438,-0.4328,0,0
1,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,7.7514e-06,-0.36485,-0.39618,0,0
1,GO REGULATION OF CENTROSOME DUPLICATION,1.1191e-05,-0.36508,-0.47509,0,0
1,GO REGULATION OF TRANSLATIONAL INITIATION,4.2539e-06,-0.36665,-0.45195,0,0
1,GO PROTEIN LOCALIZATION TO ORGANELLE,4.5891e-06,-0.36711,-0.41511,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,3.0304e-05,-0.36722,-0.4068,0,0
1,GO REGULATION OF MRNA BINDING,1.2939e-05,-0.36732,-0.40905,0,0
1,GO REGULATION OF NUCLEASE ACTIVITY,0.00076864,-0.36738,-0.37134,0,0
1,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,4.8997e-05,-0.36741,-0.41386,0,0
1,GO CHROMOSOME LOCALIZATION,2.8267e-05,-0.3681,-0.43755,0,0
1,GO CELLULAR RESPONSE TO COPPER ION,0.0047188,-0.36815,-0.37415,0,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,1.7249e-05,-0.36894,-0.53413,0,0
1,GO SPLICEOSOMAL COMPLEX ASSEMBLY,5.2428e-05,-0.36902,-0.40892,0,0
1,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0052065,-0.36923,-0.39092,0,0
1,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,2.8267e-05,-0.36947,-0.39585,0,0
1,GO REGULATION OF RNA BINDING,9.6689e-06,-0.36951,-0.42679,0,0
1,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.013235,-0.36977,-0.45085,0,0
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,5.7533e-06,-0.37024,-0.41055,0,0
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,8.9843e-06,-0.37058,-0.37895,0,0
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,4.5891e-06,-0.37205,-0.45933,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.00020554,-0.37297,-0.40352,0,0
1,GO REGULATION OF EXIT FROM MITOSIS,0.00019306,-0.37305,-0.40004,0,0
1,GO NUCLEOSOME ORGANIZATION,2.4576e-05,-0.37405,-0.415,0,0
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00011593,-0.37421,-0.36519,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,1.7249e-05,-0.37453,-0.41025,0,0
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,6.6813e-06,-0.37498,-0.39109,0,0
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.00017019,-0.3753,-0.38818,0,0
1,GO CHRONIC INFLAMMATORY RESPONSE,0.080256,-0.37564,-0.3887,0,0
1,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,2.1347e-05,-0.37617,-0.40299,0,0
1,GO RESPONSE TO COPPER ION,0.0012758,-0.37642,-0.35765,0,0
1,GO DNA CATABOLIC PROCESS,7.1973e-06,-0.37743,-0.43146,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,3.7287e-05,-0.3776,-0.37713,0,0
1,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.00017019,-0.37939,-0.42218,0,0
1,GO MESODERMAL CELL FATE SPECIFICATION,2.2907e-05,-0.3796,-0.43762,0,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00048214,-0.37996,-0.36543,0,0
1,GO NCRNA TRANSCRIPTION,8.9843e-06,-0.38155,-0.4478,0,0
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,2.636e-05,-0.38293,-0.37951,0,0
1,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,6.6813e-06,-0.38341,-0.42705,0,0
1,GO REGULATION OF WATER LOSS VIA SKIN,0.0015041,-0.38364,-0.31579,0,0
1,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,1.7249e-05,-0.38376,-0.41104,0,0
1,GO MYOBLAST MIGRATION,0.0017696,-0.38431,-0.36448,0,0
1,GO HISTONE PHOSPHORYLATION,7.7514e-06,-0.38519,-0.49104,0,0
1,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,5.9985e-05,-0.38599,-0.39648,0,0
1,GO INTRACILIARY TRANSPORT,0.00010181,-0.38621,-0.39397,0,0
1,GO ALDITOL METABOLIC PROCESS,0.0034935,-0.38648,-0.31646,0,0
1,GO REGULATION OF CENTROSOME CYCLE,1.0403e-05,-0.38695,-0.46528,0,0
1,GO SUBSTANTIA NIGRA DEVELOPMENT,9.6689e-06,-0.38719,-0.43126,0,0
1,GO APOPTOTIC DNA FRAGMENTATION,5.7533e-06,-0.38763,-0.41644,0,0
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,1.8524e-05,-0.38805,-0.47096,0,0
1,GO DENDRITE SELF AVOIDANCE,9.5377e-05,-0.38838,-0.481,0,0
1,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.00014989,-0.38891,-0.44478,0,0
1,GO DNA DEPENDENT DNA REPLICATION,1.7249e-05,-0.38937,-0.44489,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,7.1973e-06,-0.38947,-0.43485,0,0
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,5.2428e-05,-0.38973,-0.39097,0,0
1,GO PEPTIDYL PROLINE MODIFICATION,2.8267e-05,-0.38981,-0.39193,0,0
1,GO NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00014062,-0.39005,-0.34786,0,0
1,GO NEURON FATE COMMITMENT,0.0019699,-0.39051,-0.43838,0,0
1,GO ATP DEPENDENT CHROMATIN REMODELING,2.8267e-05,-0.39066,-0.41721,0,0
1,GO MRNA SPLICE SITE SELECTION,9.5377e-05,-0.39167,-0.49535,0,0
1,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.00012367,-0.39252,-0.41041,0,0
1,GO CELLULAR RESPONSE TO ZINC ION,0.0083971,-0.39272,-0.37609,0,0
1,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.00014989,-0.39396,-0.51955,0,0
1,GO REGULATION OF DNA DAMAGE CHECKPOINT,6.8565e-05,-0.39451,-0.42378,0,0
1,GO GENITALIA MORPHOGENESIS,0.00029789,-0.39488,-0.42234,0,0
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,5.2428e-05,-0.3955,-0.38685,0,0
1,GO MITOTIC CELL CYCLE ARREST,6.8565e-05,-0.3956,-0.43306,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.0052065,-0.39588,-0.35882,0,0
1,GO REGULATION OF DNA BINDING,4.9495e-06,-0.39617,-0.47021,0,0
1,GO CHROMATIN SILENCING,1.3909e-05,-0.39648,-0.46315,0,0
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,9.6689e-06,-0.39812,-0.42924,0,0
1,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.00054254,-0.39924,-0.38376,0,0
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.00035748,-0.3994,-0.3785,0,0
1,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.00029789,-0.39967,-0.33381,0,0
1,GO SPERMATID NUCLEUS DIFFERENTIATION,1.7249e-05,-0.39979,-0.45686,0,0
1,GO COBALAMIN METABOLIC PROCESS,3.0304e-05,-0.40001,-0.44101,0,0
1,GO RESPONSE TO CADMIUM ION,2.4576e-05,-0.40071,-0.43799,0,0
1,GO REGULATION OF MEMBRANE PERMEABILITY,1.9888e-05,-0.40145,-0.4128,0,0
1,GO RESPONSE TO VITAMIN A,7.7514e-06,-0.40287,-0.40551,0,0
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,7.7514e-06,-0.4032,-0.47995,0,0
1,GO HORMONE CATABOLIC PROCESS,0.00048214,-0.40324,-0.36576,0,0
1,GO VITAMIN METABOLIC PROCESS,7.1973e-06,-0.40368,-0.4214,0,0
1,GO NUCLEOBASE METABOLIC PROCESS,6.2007e-06,-0.40396,-0.44128,0,0
1,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.00017019,-0.40435,-0.38655,0,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00020554,-0.40471,-0.43033,0,0
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,6.2007e-06,-0.40537,-0.4585,0,0
1,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.00010866,-0.40545,-0.39289,0,0
1,GO MITOTIC RECOMBINATION,1.3909e-05,-0.40585,-0.48526,0,0
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,7.7514e-06,-0.40623,-0.45555,0,0
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,4.2539e-06,-0.4064,-0.47516,0,0
1,GO PHAGOSOME ACIDIFICATION,2.1347e-05,-0.40674,-0.43621,0,0
1,GO HEART INDUCTION,0.0027019,-0.40699,-0.42013,0,0
1,GO ANDROGEN METABOLIC PROCESS,0.00051151,-0.40729,-0.34003,0,0
1,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,8.3641e-05,-0.40753,-0.424,0,0
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,3.0304e-05,-0.40781,-0.40316,0,0
1,GO REGULATION OF DENDRITE EXTENSION,0.00072571,-0.40929,-0.49668,0,0
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,4.5891e-06,-0.40955,-0.44951,0,0
1,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00015974,-0.40976,-0.49557,0,0
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,5.337e-06,-0.40982,-0.44419,0,0
1,GO DNA RECOMBINATION,6.2007e-06,-0.40992,-0.47372,0,0
1,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,1.2939e-05,-0.41021,-0.47407,0,0
1,GO DNA CONFORMATION CHANGE,1.1191e-05,-0.41072,-0.48005,0,0
1,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.00068502,-0.41081,-0.38692,0,0
1,GO BLASTOCYST DEVELOPMENT,5.337e-06,-0.41082,-0.42042,0,0
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,9.6689e-06,-0.41195,-0.40923,0,0
1,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,2.8267e-05,-0.41276,-0.46598,0,0
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,5.337e-06,-0.41283,-0.44895,0,0
1,GO PROTEIN MONOUBIQUITINATION,8.3461e-06,-0.41287,-0.51087,0,0
1,GO ORGANELLE FISSION,1.1191e-05,-0.41361,-0.46862,0,0
1,GO DNA REPLICATION CHECKPOINT,6.4139e-05,-0.41381,-0.4464,0,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,1.2035e-05,-0.41467,-0.43245,0,0
1,GO CELL CYCLE PHASE TRANSITION,7.7514e-06,-0.41524,-0.45391,0,0
1,GO REGULATION OF MULTI ORGANISM PROCESS,6.6813e-06,-0.4153,-0.42309,0,0
1,GO NEGATIVE REGULATION OF GLIOGENESIS,4.5779e-05,-0.4178,-0.3935,0,0
1,GO ORGAN INDUCTION,4.5779e-05,-0.41868,-0.3956,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,2.8267e-05,-0.419,-0.42829,0,0
1,GO RECOMBINATIONAL REPAIR,1.4947e-05,-0.41986,-0.50844,0,0
1,GO REGULATION OF HISTONE UBIQUITINATION,5.7533e-06,-0.4199,-0.50019,0,0
1,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,2.4576e-05,-0.4207,-0.50153,0,0
1,GO REGULATION OF MRNA METABOLIC PROCESS,6.2007e-06,-0.4231,-0.46143,0,0
1,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,1.3909e-05,-0.42329,-0.46912,0,0
1,GO THALAMUS DEVELOPMENT,0.0016767,-0.42341,-0.42306,0,0
1,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0025648,-0.42368,-0.45728,0,0
1,GO SYNAPTIC VESICLE TRANSPORT,8.3641e-05,-0.42371,-0.53062,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,2.4576e-05,-0.42502,-0.46933,0,0
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.00014989,-0.42504,-0.4235,0,0
1,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.0011418,-0.4256,-0.4789,0,0
1,GO REGULATION OF MICROVILLUS ORGANIZATION,0.00021879,-0.42594,-0.48245,0,0
1,GO TONGUE MORPHOGENESIS,0.00081392,-0.42631,-0.36498,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.0010209,-0.42631,-0.3907,0,0
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,3.248e-05,-0.4266,-0.50898,0,0
1,GO PROTEIN REFOLDING,5.9985e-05,-0.42669,-0.43203,0,0
1,GO MRNA MODIFICATION,3.4805e-05,-0.42698,-0.43874,0,0
1,GO REGULATION OF MRNA CATABOLIC PROCESS,4.5891e-06,-0.42714,-0.44969,0,0
1,GO FRUCTOSE METABOLIC PROCESS,4.5779e-05,-0.4275,-0.50443,0,0
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,4.5891e-06,-0.42803,-0.45234,0,0
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,5.337e-06,-0.4282,-0.44554,0,0
1,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,2.636e-05,-0.4282,-0.44709,0,0
1,GO INDOLALKYLAMINE METABOLIC PROCESS,0.0010209,-0.4284,-0.35826,0,0
1,GO CYTOKINETIC PROCESS,1.4947e-05,-0.42845,-0.47939,0,0
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,1.2939e-05,-0.42889,-0.42155,0,0
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,1.1191e-05,-0.42917,-0.49361,0,0
1,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,3.248e-05,-0.4294,-0.44719,0,0
1,GO REGULATION OF MESODERM DEVELOPMENT,1.4947e-05,-0.43024,-0.41517,0,0
1,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,9.6689e-06,-0.4309,-0.49591,0,0
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,6.6813e-06,-0.43097,-0.45331,0,0
1,GO REGULATION OF EXOSOMAL SECRETION,2.2907e-05,-0.43115,-0.51667,0,0
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,1.2035e-05,-0.43162,-0.48323,0,0
1,GO REGULATION OF GTP BINDING,4.2763e-05,-0.43233,-0.47255,0,0
1,GO DNA METABOLIC PROCESS,7.1973e-06,-0.43277,-0.46482,0,0
1,GO GABAERGIC NEURON DIFFERENTIATION,0.08881,-0.43295,-0.4668,0,0
1,GO SISTER CHROMATID COHESION,1.7249e-05,-0.43299,-0.50473,0,0
1,GO CENTROSOME SEPARATION,4.2763e-05,-0.43312,-0.47212,0,0
1,GO CARDIAC VENTRICLE FORMATION,0.00064645,-0.43312,-0.46119,0,0
1,GO TOXIN METABOLIC PROCESS,0.00026348,-0.43349,-0.39473,0,0
1,GO DNA DEALKYLATION,3.248e-05,-0.43356,-0.42805,0,0
1,GO RNA LOCALIZATION,6.6813e-06,-0.43407,-0.4681,0,0
1,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00013188,-0.43455,-0.46186,0,0
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,1.0403e-05,-0.43504,-0.49689,0,0
1,GO BLASTOCYST GROWTH,4.2539e-06,-0.43527,-0.49948,0,0
1,GO VIRAL RELEASE FROM HOST CELL,1.2035e-05,-0.43586,-0.44779,0,0
1,GO HISTONE UBIQUITINATION,7.7514e-06,-0.43604,-0.51552,0,0
1,GO ECTODERMAL PLACODE DEVELOPMENT,3.248e-05,-0.43706,-0.42415,0,0
1,GO RNA EXPORT FROM NUCLEUS,7.7514e-06,-0.43732,-0.47708,0,0
1,GO PROTEIN OXIDATION,0.00018128,-0.43791,-0.41928,0,0
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,7.1973e-06,-0.43826,-0.48349,0,0
1,GO GMP METABOLIC PROCESS,4.5891e-06,-0.43826,-0.45534,0,0
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,4.2539e-06,-0.43828,-0.45488,0,0
1,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.0017696,-0.43867,-0.44438,0,0
1,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,7.1973e-06,-0.43898,-0.46815,0,0
1,GO PROTEIN N LINKED GLYCOSYLATION,9.6689e-06,-0.43901,-0.43834,0,0
1,GO RESPONSE TO OXYGEN RADICAL,1.6059e-05,-0.43953,-0.43066,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,8.3461e-06,-0.43968,-0.49248,0,0
1,GO NEGATIVE REGULATION OF PROTEIN IMPORT,5.2428e-05,-0.44063,-0.45719,0,0
1,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00010866,-0.44116,-0.45961,0,0
1,GO REGULATION OF TRANSLATIONAL TERMINATION,1.3909e-05,-0.44205,-0.46809,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE,5.337e-06,-0.44235,-0.48927,0,0
1,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.00081392,-0.44316,-0.45648,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,1.9888e-05,-0.44327,-0.46977,0,0
1,GO REGULATION OF PROSTAGLANDIN SECRETION,0.00045436,-0.44344,-0.44714,0,0
1,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,4.2763e-05,-0.44409,-0.48805,0,0
1,GO PEPTIDYL CYSTEINE MODIFICATION,2.2907e-05,-0.4441,-0.454,0,0
1,GO PROTEIN K48 LINKED UBIQUITINATION,4.9495e-06,-0.4442,-0.49448,0,0
1,GO TELOMERE ORGANIZATION,8.3461e-06,-0.44423,-0.46475,0,0
1,GO CELLULAR RESPONSE TO UV,4.9495e-06,-0.44423,-0.47769,0,0
1,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.00024771,-0.44523,-0.40319,0,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,3.9422e-06,-0.44553,-0.48665,0,0
1,GO CENTROSOME DUPLICATION,1.3909e-05,-0.44653,-0.53798,0,0
1,GO PARAXIAL MESODERM MORPHOGENESIS,0.00068502,-0.44666,-0.44057,0,0
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,3.9422e-06,-0.44668,-0.48394,0,0
1,GO REGULATION OF NUCLEAR DIVISION,1.0403e-05,-0.44681,-0.46884,0,0
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,4.8997e-05,-0.44695,-0.43114,0,0
1,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,1.2939e-05,-0.44781,-0.56875,0,0
1,GO MYOBLAST DIFFERENTIATION,1.2035e-05,-0.44806,-0.49596,0,0
1,GO REGULATION OF MITOTIC CELL CYCLE,6.6813e-06,-0.44846,-0.48835,0,0
1,GO G0 TO G1 TRANSITION,1.3909e-05,-0.44847,-0.50798,0,0
1,GO LABYRINTHINE LAYER MORPHOGENESIS,0.0003797,-0.44852,-0.51366,0,0
1,GO CELLULAR RESPONSE TO IRON ION,0.0003797,-0.44885,-0.49143,0,0
1,GO REGULATION OF CELL CYCLE PROCESS,6.6813e-06,-0.44941,-0.48903,0,0
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,4.2539e-06,-0.44949,-0.47042,0,0
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,2.636e-05,-0.45119,-0.49511,0,0
1,GO STEROL BIOSYNTHETIC PROCESS,5.6086e-05,-0.45144,-0.4343,0,0
1,GO POSITIVE REGULATION OF DNA BINDING,8.9843e-06,-0.45202,-0.47256,0,0
1,GO DNA REPLICATION,1.4947e-05,-0.4521,-0.47692,0,0
1,GO DOUBLE STRAND BREAK REPAIR,8.3461e-06,-0.45227,-0.51545,0,0
1,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,8.3461e-06,-0.45272,-0.51496,0,0
1,GO CELL CYCLE PROCESS,7.7514e-06,-0.45289,-0.49337,0,0
1,GO HISTAMINE SECRETION,0.00332,-0.45325,-0.38177,0,0
1,GO MITOTIC CELL CYCLE,7.7514e-06,-0.4534,-0.48966,0,0
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,5.7533e-06,-0.45361,-0.49119,0,0
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,4.8997e-05,-0.45411,-0.41456,0,0
1,GO NUCLEAR PORE ORGANIZATION,2.1347e-05,-0.45451,-0.54279,0,0
1,GO REGULATION OF CELL AGING,7.7514e-06,-0.45534,-0.46509,0,0
1,GO MITOTIC SISTER CHROMATID COHESION,1.9888e-05,-0.45569,-0.49545,0,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,5.2428e-05,-0.45596,-0.46295,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,5.337e-06,-0.45613,-0.48974,0,0
1,GO MULTI ORGANISM LOCALIZATION,4.9495e-06,-0.45638,-0.49819,0,0
1,GO CELLULAR RESPONSE TO CADMIUM ION,0.00010866,-0.4564,-0.50347,0,0
1,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,1.6059e-05,-0.45649,-0.48571,0,0
1,GO TRANSCRIPTION BY RNA POLYMERASE I,5.337e-06,-0.45771,-0.49824,0,0
1,GO REGULATION OF CENTRIOLE REPLICATION,1.4947e-05,-0.458,-0.52417,0,0
1,GO ESTABLISHMENT OF RNA LOCALIZATION,5.7533e-06,-0.45808,-0.49786,0,0
1,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,6.2007e-06,-0.45817,-0.47429,0,0
1,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.00010181,-0.45837,-0.46222,0,0
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.5891e-06,-0.45879,-0.46305,0,0
1,GO RESPONSE TO ETHANOL,1.1191e-05,-0.45883,-0.42428,0,0
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,4.2539e-06,-0.45929,-0.49153,0,0
1,GO IMP METABOLIC PROCESS,0.00015974,-0.46032,-0.43585,0,0
1,GO DNA GEOMETRIC CHANGE,7.7514e-06,-0.46052,-0.50573,0,0
1,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,1.4947e-05,-0.46073,-0.50791,0,0
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,4.2539e-06,-0.4612,-0.49257,0,0
1,GO RESPONSE TO LITHIUM ION,0.00010866,-0.46181,-0.44857,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,3.248e-05,-0.46189,-0.45548,0,0
1,GO REGULATION OF CELL CYCLE ARREST,8.9843e-06,-0.46189,-0.48421,0,0
1,GO MITOTIC NUCLEAR DIVISION,1.2035e-05,-0.46241,-0.49289,0,0
1,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,5.7533e-06,-0.4626,-0.4866,0,0
1,GO HYPOTHALAMUS DEVELOPMENT,9.5377e-05,-0.46332,-0.43516,0,0
1,GO DE NOVO PROTEIN FOLDING,2.4576e-05,-0.46472,-0.46652,0,0
1,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,1.2035e-05,-0.46475,-0.54663,0,0
1,GO COCHLEA MORPHOGENESIS,1.3909e-05,-0.46512,-0.46762,0,0
1,GO INDUCTION OF POSITIVE CHEMOTAXIS,6.4139e-05,-0.46517,-0.48616,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,1.4947e-05,-0.46551,-0.47802,0,0
1,GO CELL CYCLE,6.2007e-06,-0.46569,-0.4974,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,6.2007e-06,-0.4657,-0.50332,0,0
1,GO CELLULAR RESPONSE TO RADIATION,4.2539e-06,-0.4659,-0.46424,0,0
1,GO SKIN DEVELOPMENT,1.9888e-05,-0.46601,-0.47629,0,0
1,GO NCRNA CATABOLIC PROCESS,8.3461e-06,-0.4661,-0.4733,0,0
1,GO RETINAL GANGLION CELL AXON GUIDANCE,7.8298e-05,-0.46637,-0.5657,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,8.3461e-06,-0.46664,-0.49415,0,0
1,GO STEROID CATABOLIC PROCESS,0.00040321,-0.46675,-0.45341,0,0
1,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00014062,-0.46683,-0.3977,0,0
1,GO RESPONSE TO UV,5.337e-06,-0.46716,-0.5002,0,0
1,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,8.3641e-05,-0.46741,-0.42264,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE,7.1973e-06,-0.46746,-0.51318,0,0
1,GO MITOTIC SPINDLE ASSEMBLY,1.4947e-05,-0.46773,-0.508,0,0
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,5.7533e-06,-0.46788,-0.50424,0,0
1,GO GLUTAMINE METABOLIC PROCESS,4.5891e-06,-0.46811,-0.52103,0,0
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.9495e-06,-0.46845,-0.45807,0,0
1,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,1.4947e-05,-0.46864,-0.45265,0,0
1,GO LYSINE METABOLIC PROCESS,0.00010866,-0.46973,-0.41362,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,6.2007e-06,-0.46977,-0.5117,0,0
1,GO MRNA TRANSPORT,6.6813e-06,-0.47004,-0.51206,0,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,6.2007e-06,-0.47043,-0.53902,0,0
1,GO CELL CYCLE CHECKPOINT,9.6689e-06,-0.47062,-0.50935,0,0
1,GO PENILE ERECTION,0.00026348,-0.4708,-0.5345,0,0
1,GO IMPORT INTO NUCLEUS,3.9422e-06,-0.47098,-0.50146,0,0
1,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,5.7533e-06,-0.47101,-0.47931,0,0
1,GO PITUITARY GLAND DEVELOPMENT,0.00332,-0.4713,-0.41789,0,0
1,GO REGULATION OF GLIAL CELL DIFFERENTIATION,9.6689e-06,-0.47161,-0.48872,0,0
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.00060992,-0.47165,-0.41324,0,0
1,GO NUCLEAR TRANSPORT,4.2539e-06,-0.47167,-0.494,0,0
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,8.3641e-05,-0.47258,-0.46995,0,0
1,GO LIPID EXPORT FROM CELL,5.2428e-05,-0.47319,-0.41949,0,0
1,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,8.3461e-06,-0.47346,-0.52516,0,0
1,GO REGULATION OF CELL CYCLE,5.337e-06,-0.47369,-0.5064,0,0
1,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,1.9888e-05,-0.4741,-0.50124,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,6.6813e-06,-0.47436,-0.48992,0,0
1,GO DNA BIOSYNTHETIC PROCESS,4.9495e-06,-0.47438,-0.48231,0,0
1,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,9.6689e-06,-0.47514,-0.5058,0,0
1,GO NAD METABOLIC PROCESS,1.2939e-05,-0.47539,-0.54159,0,0
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,2.4576e-05,-0.47558,-0.501,0,0
1,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,2.2907e-05,-0.47591,-0.49226,0,0
1,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.00012367,-0.47598,-0.56001,0,0
1,GO SYNAPTIC VESICLE BUDDING,0.00023283,-0.47643,-0.52299,0,0
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,5.7533e-06,-0.47671,-0.49004,0,0
1,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.4947e-05,-0.47673,-0.47385,0,0
1,GO NOTOCHORD DEVELOPMENT,0.00029789,-0.47675,-0.49849,0,0
1,GO CARBOHYDRATE DERIVATIVE TRANSPORT,2.4576e-05,-0.47723,-0.46091,0,0
1,GO INNER CELL MASS CELL PROLIFERATION,7.7514e-06,-0.47728,-0.56269,0,0
1,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,8.9843e-06,-0.47745,-0.53933,0,0
1,GO PIGMENT GRANULE ORGANIZATION,2.636e-05,-0.47769,-0.45715,0,0
1,GO APOPTOTIC SIGNALING PATHWAY,4.5891e-06,-0.47771,-0.50819,0,0
1,GO POSITIVE REGULATION OF CYTOKINESIS,2.4576e-05,-0.47774,-0.4861,0,0
1,GO LIPID IMPORT INTO CELL,6.6813e-06,-0.47776,-0.5906,0,0
1,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,8.3461e-06,-0.47898,-0.49305,0,0
1,GO REGULATION OF ANIMAL ORGAN FORMATION,2.2907e-05,-0.47936,-0.46544,0,0
1,GO DOPAMINERGIC NEURON DIFFERENTIATION,1.3909e-05,-0.47951,-0.46769,0,0
1,GO REGULATION OF DNA REPLICATION,1.2035e-05,-0.47955,-0.48944,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,2.1347e-05,-0.47974,-0.46851,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,1.2035e-05,-0.48034,-0.59796,0,0
1,GO PORE COMPLEX ASSEMBLY,4.9495e-06,-0.48084,-0.53597,0,0
1,GO BRANCH ELONGATION OF AN EPITHELIUM,4.2763e-05,-0.4811,-0.45216,0,0
1,GO RESPONSE TO ETHER,6.8565e-05,-0.48161,-0.43807,0,0
1,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,6.2007e-06,-0.48186,-0.50634,0,0
1,GO NUCLEAR EXPORT,5.337e-06,-0.48208,-0.51069,0,0
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,7.7514e-06,-0.48293,-0.50854,0,0
1,GO POSITIVE REGULATION OF CHROMATIN BINDING,6.6813e-06,-0.48392,-0.58269,0,0
1,GO HEART TRABECULA FORMATION,0.00014062,-0.48507,-0.48914,0,0
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.00026348,-0.48531,-0.39481,0,0
1,GO RESPONSE TO MUSCLE ACTIVITY,1.4947e-05,-0.48543,-0.47618,0,0
1,GO DICARBOXYLIC ACID CATABOLIC PROCESS,7.3279e-05,-0.48642,-0.388,0,0
1,GO PURINE NUCLEOTIDE TRANSPORT,6.8565e-05,-0.48664,-0.46516,0,0
1,GO HISTONE H4 DEACETYLATION,3.7287e-05,-0.487,-0.44225,0,0
1,GO CELL CYCLE G1 S PHASE TRANSITION,5.7533e-06,-0.48734,-0.49016,0,0
1,GO SPINDLE MIDZONE ASSEMBLY,2.8267e-05,-0.48755,-0.62583,0,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,4.9495e-06,-0.4876,-0.5013,0,0
1,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,5.7533e-06,-0.48761,-0.49285,0,0
1,GO TRNA TRANSPORT,9.6689e-06,-0.48767,-0.54131,0,0
1,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,7.7514e-06,-0.48795,-0.49406,0,0
1,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,4.5891e-06,-0.48825,-0.54006,0,0
1,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.00031664,-0.48842,-0.54728,0,0
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,1.6059e-05,-0.48857,-0.51762,0,0
1,GO NCRNA EXPORT FROM NUCLEUS,8.9843e-06,-0.48866,-0.56191,0,0
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,6.2007e-06,-0.48875,-0.50039,0,0
1,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,2.1347e-05,-0.48897,-0.53054,0,0
1,GO VASODILATION,2.2907e-05,-0.48999,-0.44444,0,0
1,GO POLYOL TRANSPORT,0.00013188,-0.49169,-0.50158,0,0
1,GO REGULATION OF DNA METABOLIC PROCESS,4.5891e-06,-0.49185,-0.51841,0,0
1,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,4.5779e-05,-0.49207,-0.46624,0,0
1,GO FATTY ACID HOMEOSTASIS,1.7249e-05,-0.49269,-0.5157,0,0
1,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,1.0403e-05,-0.49302,-0.5384,0,0
1,GO ENDOCRINE PROCESS,9.6689e-06,-0.49326,-0.51162,0,0
1,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,1.0403e-05,-0.49362,-0.59726,0,0
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,5.337e-06,-0.49379,-0.53622,0,0
1,GO NUCLEAR ENVELOPE ORGANIZATION,8.3461e-06,-0.49396,-0.54661,0,0
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,4.2539e-06,-0.49403,-0.53532,0,0
1,GO REGULATION OF PROTEIN FOLDING,1.2939e-05,-0.49406,-0.49238,0,0
1,GO HISTAMINE TRANSPORT,0.0003797,-0.49495,-0.45126,0,0
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,8.9843e-06,-0.49547,-0.49843,0,0
1,GO REGULATION OF CELL FATE SPECIFICATION,6.4139e-05,-0.49597,-0.52917,0,0
1,GO CELLULAR SENESCENCE,5.337e-06,-0.49632,-0.4841,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,6.6813e-06,-0.49653,-0.5226,0,0
1,GO FOREBRAIN NEURON FATE COMMITMENT,0.17091,-0.49779,-0.40738,0,0
1,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.00010866,-0.49801,-0.51469,0,0
1,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,1.1191e-05,-0.49831,-0.5293,0,0
1,GO NEGATIVE REGULATION OF DNA REPLICATION,1.4947e-05,-0.4984,-0.49122,0,0
1,GO MITOTIC CELL CYCLE CHECKPOINT,8.9843e-06,-0.49845,-0.51473,0,0
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,7.1973e-06,-0.49864,-0.47947,0,0
1,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.00010181,-0.49937,-0.42288,0,0
1,GO PROSTATE GLAND DEVELOPMENT,1.4947e-05,-0.49981,-0.51916,0,0
1,GO DIENCEPHALON DEVELOPMENT,0.00020554,-0.49984,-0.46553,0,0
1,GO REGULATION OF STEM CELL PROLIFERATION,8.3461e-06,-0.50024,-0.52686,0,0
1,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.1191e-05,-0.50025,-0.50431,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,8.9843e-06,-0.50026,-0.53765,0,0
1,GO O GLYCAN PROCESSING,8.9327e-05,-0.5004,-0.46445,0,0
1,GO REGULATION OF NEUROBLAST PROLIFERATION,3.0304e-05,-0.50059,-0.49134,0,0
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,4.5779e-05,-0.50087,-0.48126,0,0
1,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.00023283,-0.50108,-0.50992,0,0
1,GO PEPTIDYL PROLINE HYDROXYLATION,0.00035748,-0.50128,-0.44541,0,0
1,GO RELAXATION OF MUSCLE,1.3909e-05,-0.50161,-0.52193,0,0
1,GO REGULATION OF GLIOGENESIS,5.7533e-06,-0.5021,-0.50982,0,0
1,GO NUCLEOTIDE TRANSPORT,1.2035e-05,-0.50212,-0.48951,0,0
1,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00031664,-0.5026,-0.46977,0,0
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,4.5891e-06,-0.50279,-0.52776,0,0
1,GO NEPHRIC DUCT MORPHOGENESIS,0.00018128,-0.50295,-0.46065,0,0
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,9.6689e-06,-0.50322,-0.52837,0,0
1,GO AUTOPHAGIC CELL DEATH,2.2907e-05,-0.50332,-0.48212,0,0
1,GO SOMATIC STEM CELL POPULATION MAINTENANCE,1.3909e-05,-0.50344,-0.5093,0,0
1,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.00051151,-0.50374,-0.47857,0,0
1,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,3.9422e-06,-0.50435,-0.56022,0,0
1,GO CYTOKINESIS,8.9843e-06,-0.50481,-0.52804,0,0
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,3.9422e-06,-0.50483,-0.55638,0,0
1,GO CARDIAC CHAMBER FORMATION,0.00012367,-0.50514,-0.5382,0,0
1,GO RESPONSE TO NUTRIENT,6.6813e-06,-0.50527,-0.54198,0,0
1,GO MAST CELL ACTIVATION,1.1191e-05,-0.50548,-0.61095,0,0
1,GO DNA INTEGRITY CHECKPOINT,7.7514e-06,-0.50575,-0.52769,0,0
1,GO RESPONSE TO ACTIVITY,6.2007e-06,-0.50605,-0.47584,0,0
1,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,3.9936e-05,-0.5067,-0.51376,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,5.337e-06,-0.50689,-0.52139,0,0
1,GO MITOTIC G1 S TRANSITION CHECKPOINT,8.3461e-06,-0.50693,-0.50514,0,0
1,GO ERAD PATHWAY,4.5891e-06,-0.50698,-0.57357,0,0
1,GO GONADOTROPIN SECRETION,1.1191e-05,-0.50704,-0.50215,0,0
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,1.0403e-05,-0.50734,-0.47279,0,0
1,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,5.337e-06,-0.50743,-0.54358,0,0
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,4.2539e-06,-0.50793,-0.57562,0,0
1,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,6.2007e-06,-0.50832,-0.52269,0,0
1,GO MACROAUTOPHAGY,4.5891e-06,-0.50836,-0.54379,0,0
1,GO PIGMENT ACCUMULATION,4.2763e-05,-0.50844,-0.60973,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS,6.2007e-06,-0.50863,-0.53125,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.0010798,-0.50934,-0.49753,0,0
1,GO ENGULFMENT OF APOPTOTIC CELL,9.6689e-06,-0.50974,-0.62194,0,0
1,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,3.248e-05,-0.50979,-0.56307,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE ARREST,9.6689e-06,-0.51068,-0.51303,0,0
1,GO FOREBRAIN CELL MIGRATION,4.9495e-06,-0.51073,-0.58926,0,0
1,GO GENE SILENCING,5.7533e-06,-0.51091,-0.52588,0,0
1,GO MULTICELLULAR ORGANISM AGING,1.6059e-05,-0.51118,-0.48249,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,1.4947e-05,-0.51124,-0.50979,0,0
1,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,5.337e-06,-0.512,-0.53755,0,0
1,GO THYMUS DEVELOPMENT,7.7514e-06,-0.51208,-0.5082,0,0
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,2.8267e-05,-0.51255,-0.48119,0,0
1,GO EPITHELIAL CELL MATURATION,8.3641e-05,-0.51289,-0.50943,0,0
1,GO ATP BIOSYNTHETIC PROCESS,4.2763e-05,-0.51394,-0.46768,0,0
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,4.9495e-06,-0.51405,-0.5592,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,4.9495e-06,-0.5144,-0.54455,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,4.5891e-06,-0.51442,-0.53796,0,0
1,GO HISTONE H4 K16 ACETYLATION,2.1347e-05,-0.5145,-0.56622,0,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,5.9985e-05,-0.51454,-0.51737,0,0
1,GO THYROID HORMONE METABOLIC PROCESS,0.00010181,-0.51566,-0.45715,0,0
1,GO REGULATION OF DNA RECOMBINATION,4.2539e-06,-0.51584,-0.5727,0,0
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,3.9422e-06,-0.51669,-0.56436,0,0
1,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,2.1347e-05,-0.51684,-0.53359,0,0
1,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,1.6059e-05,-0.51748,-0.54463,0,0
1,GO EPIDERMIS MORPHOGENESIS,0.00023283,-0.51872,-0.51454,0,0
1,GO CELLULAR RESPONSE TO X RAY,3.248e-05,-0.51888,-0.59049,0,0
1,GO VITAMIN TRANSPORT,2.636e-05,-0.51913,-0.47606,0,0
1,GO GLIAL CELL APOPTOTIC PROCESS,1.2035e-05,-0.51931,-0.59165,0,0
1,GO MALE GENITALIA DEVELOPMENT,8.9327e-05,-0.51996,-0.49064,0,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,3.248e-05,-0.52052,-0.52489,0,0
1,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,7.7514e-06,-0.52059,-0.52409,0,0
1,GO RNA STABILIZATION,4.9495e-06,-0.5206,-0.52129,0,0
1,GO GENITALIA DEVELOPMENT,6.2007e-06,-0.52061,-0.52454,0,0
1,GO REGULATION OF INTRACELLULAR TRANSPORT,4.2539e-06,-0.52159,-0.55504,0,0
1,GO L SERINE METABOLIC PROCESS,3.4805e-05,-0.52171,-0.50078,0,0
1,GO MUSCLE CELL CELLULAR HOMEOSTASIS,4.9495e-06,-0.5218,-0.53884,0,0
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,4.5891e-06,-0.52186,-0.56063,0,0
1,GO CEREBRAL CORTEX CELL MIGRATION,1.3909e-05,-0.52189,-0.61552,0,0
1,GO POSITIVE REGULATION OF EXOCYTOSIS,1.2939e-05,-0.52248,-0.56008,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0024341,-0.52302,-0.51995,0,0
1,GO CEREBRAL CORTEX DEVELOPMENT,6.2007e-06,-0.52362,-0.61873,0,0
1,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,6.2007e-06,-0.52406,-0.5723,0,0
1,GO RESPONSE TO GONADOTROPIN,1.7249e-05,-0.52511,-0.52313,0,0
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,1.1191e-05,-0.52578,-0.54417,0,0
1,GO HIPPOCAMPUS DEVELOPMENT,8.3461e-06,-0.52586,-0.52591,0,0
1,GO GOLGI LOCALIZATION,6.6813e-06,-0.52612,-0.49219,0,0
1,GO REGULATION OF GLIAL CELL PROLIFERATION,5.2428e-05,-0.52655,-0.48984,0,0
1,GO MITOTIC DNA REPLICATION,0.00010181,-0.52678,-0.47971,0,0
1,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,7.7514e-06,-0.5268,-0.49244,0,0
1,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00068502,-0.52697,-0.6752,0,0
1,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,1.0403e-05,-0.52725,-0.5881,0,0
1,GO REGULATION OF VESICLE FUSION,8.3641e-05,-0.52775,-0.6408,0,0
1,GO REGULATION OF PEPTIDE SECRETION,7.7514e-06,-0.52857,-0.53211,0,0
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,6.6813e-06,-0.52862,-0.51659,0,0
1,GO SEX DIFFERENTIATION,4.9495e-06,-0.52868,-0.50667,0,0
1,GO PROTEIN K63 LINKED DEUBIQUITINATION,4.9495e-06,-0.52872,-0.60021,0,0
1,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,2.4576e-05,-0.52887,-0.55372,0,0
1,GO REGULATION OF PHOSPHATASE ACTIVITY,4.5891e-06,-0.52894,-0.57487,0,0
1,GO CGMP MEDIATED SIGNALING,8.3461e-06,-0.52908,-0.56134,0,0
1,GO ENDOCRINE SYSTEM DEVELOPMENT,4.8997e-05,-0.5296,-0.52756,0,0
1,GO POSITIVE REGULATION OF SECRETION,7.1973e-06,-0.52996,-0.51339,0,0
1,GO HEART VALVE FORMATION,7.3279e-05,-0.53011,-0.58373,0,0
1,GO RESPONSE TO OXYGEN LEVELS,4.2539e-06,-0.5305,-0.52274,0,0
1,GO PALLIUM DEVELOPMENT,6.6813e-06,-0.53052,-0.56808,0,0
1,GO REGULATION OF CHROMATIN BINDING,6.2007e-06,-0.53064,-0.6103,0,0
1,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,7.7514e-06,-0.53078,-0.54282,0,0
1,GO SUBPALLIUM DEVELOPMENT,0.00015974,-0.5308,-0.5502,0,0
1,GO REGULATION OF METAL ION TRANSPORT,5.337e-06,-0.53092,-0.52872,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,5.7533e-06,-0.53094,-0.51725,0,0
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,9.6689e-06,-0.53174,-0.56423,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,4.5891e-06,-0.53176,-0.61217,0,0
1,GO REGULATION OF ASTROCYTE DIFFERENTIATION,3.4805e-05,-0.53237,-0.52023,0,0
1,GO REGULATION OF HISTONE PHOSPHORYLATION,9.6689e-06,-0.53278,-0.54847,0,0
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,2.4576e-05,-0.53328,-0.49867,0,0
1,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,5.337e-06,-0.53348,-0.49977,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,1.0403e-05,-0.53368,-0.60669,0,0
1,GO PHAGOSOME MATURATION,6.6813e-06,-0.53389,-0.54373,0,0
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,2.8267e-05,-0.53429,-0.53121,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00064645,-0.53429,-0.45388,0,0
1,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,8.9843e-06,-0.53437,-0.52472,0,0
1,GO POSITIVE REGULATION OF CELL DEATH,4.5891e-06,-0.53452,-0.55716,0,0
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,7.1973e-06,-0.53502,-0.52363,0,0
1,GO TELENCEPHALON DEVELOPMENT,4.9495e-06,-0.53534,-0.57181,0,0
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.00057531,-0.53549,-0.46473,0,0
1,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,1.1191e-05,-0.53556,-0.51881,0,0
1,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,6.2007e-06,-0.53572,-0.5242,0,0
1,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,4.9495e-06,-0.53653,-0.52214,0,0
1,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,2.636e-05,-0.53723,-0.59483,0,0
1,GO LYTIC VACUOLE ORGANIZATION,4.9495e-06,-0.53739,-0.58889,0,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,7.1973e-06,-0.53836,-0.62457,0,0
1,GO EMBRYONIC FORELIMB MORPHOGENESIS,1.6059e-05,-0.53854,-0.50401,0,0
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,1.3909e-05,-0.53897,-0.61187,0,0
1,GO ORGANELLE FUSION,6.2007e-06,-0.53934,-0.58763,0,0
1,GO HISTONE H3 K14 ACETYLATION,8.9843e-06,-0.5394,-0.59782,0,0
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,6.2007e-06,-0.53952,-0.54513,0,0
1,GO REGULATION OF HEAT GENERATION,3.4805e-05,-0.53956,-0.51326,0,0
1,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,1.3909e-05,-0.53965,-0.66958,0,0
1,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,2.1347e-05,-0.54055,-0.58599,0,0
1,GO GLIAL CELL FATE COMMITMENT,0.00033648,-0.5409,-0.50326,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,1.2939e-05,-0.54095,-0.53784,0,0
1,GO RESPONSE TO VITAMIN,5.337e-06,-0.54132,-0.59169,0,0
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,1.4947e-05,-0.54153,-0.536,0,0
1,GO RESPONSE TO EPINEPHRINE,2.4576e-05,-0.54171,-0.52151,0,0
1,GO REGULATION OF ODONTOGENESIS,5.7533e-06,-0.54178,-0.56581,0,0
1,GO CELL AGING,5.337e-06,-0.54179,-0.5011,0,0
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,4.2539e-06,-0.54309,-0.56477,0,0
1,GO FIBROBLAST PROLIFERATION,6.6813e-06,-0.54382,-0.56852,0,0
1,GO MITOTIC DNA INTEGRITY CHECKPOINT,7.7514e-06,-0.54528,-0.5406,0,0
1,GO RESPONSE TO IRON ION,1.2035e-05,-0.54693,-0.53424,0,0
1,GO LIPID GLYCOSYLATION,2.2907e-05,-0.54757,-0.59687,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,6.6813e-06,-0.5479,-0.60305,0,0
1,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.00033648,-0.54794,-0.60397,0,0
1,GO CELL FATE COMMITMENT,7.1973e-06,-0.548,-0.52514,0,0
1,GO SEROTONIN TRANSPORT,1.9888e-05,-0.54811,-0.56292,0,0
1,GO MULTI MULTICELLULAR ORGANISM PROCESS,8.9843e-06,-0.54817,-0.55446,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,4.5891e-06,-0.54822,-0.56981,0,0
1,GO LATERAL MESODERM DEVELOPMENT,3.9936e-05,-0.54851,-0.49493,0,0
1,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.00011593,-0.54942,-0.63045,0,0
1,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.00024771,-0.55016,-0.66046,0,0
1,GO POSITIVE REGULATION OF VESICLE FUSION,2.636e-05,-0.55039,-0.5584,0,0
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,7.1973e-06,-0.55118,-0.53739,0,0
1,GO REGULATION OF TELOMERASE ACTIVITY,8.3461e-06,-0.55136,-0.51429,0,0
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,4.5891e-06,-0.55141,-0.5639,0,0
1,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.00019306,-0.55163,-0.47747,0,0
1,GO REGULATION OF MACROAUTOPHAGY,4.5891e-06,-0.55173,-0.58689,0,0
1,GO ORGANELLE INHERITANCE,7.1973e-06,-0.55174,-0.53651,0,0
1,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,6.6813e-06,-0.55179,-0.52605,0,0
1,GO RENAL VESICLE DEVELOPMENT,1.0403e-05,-0.55209,-0.59411,0,0
1,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,9.6689e-06,-0.55231,-0.5703,0,0
1,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,8.3641e-05,-0.5531,-0.56432,0,0
1,GO CARDIOBLAST DIFFERENTIATION,1.1191e-05,-0.55353,-0.57619,0,0
1,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,8.3461e-06,-0.55431,-0.64427,0,0
1,GO GLUCOSE IMPORT,4.5891e-06,-0.55445,-0.52417,0,0
1,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,1.9888e-05,-0.55478,-0.57127,0,0
1,GO VESICLE ORGANIZATION,4.9495e-06,-0.55478,-0.5655,0,0
1,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,1.4947e-05,-0.55481,-0.56471,0,0
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,4.9495e-06,-0.55499,-0.6434,0,0
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,6.2007e-06,-0.55519,-0.57608,0,0
1,GO REGULATION OF ICOSANOID SECRETION,0.00014062,-0.55526,-0.4311,0,0
1,GO FOREBRAIN DEVELOPMENT,6.2007e-06,-0.55551,-0.56585,0,0
1,GO REGULATION OF DEPHOSPHORYLATION,4.5891e-06,-0.55601,-0.60112,0,0
1,GO ORGANELLE MEMBRANE FUSION,5.7533e-06,-0.55613,-0.61916,0,0
1,GO MALE SEX DIFFERENTIATION,6.2007e-06,-0.55621,-0.54601,0,0
1,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,6.6813e-06,-0.55623,-0.56897,0,0
1,GO SNARE COMPLEX ASSEMBLY,1.2035e-05,-0.5563,-0.58772,0,0
1,GO NEGATIVE REGULATION OF DNA REPAIR,7.7514e-06,-0.55685,-0.54478,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,6.2007e-06,-0.55694,-0.58732,0,0
1,GO NATURAL KILLER CELL CHEMOTAXIS,0.19156,-0.55703,-0.40866,0,0
1,GO CGMP METABOLIC PROCESS,0.00045436,-0.55731,-0.52388,0,0
1,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,4.8997e-05,-0.55758,-0.48964,0,0
1,GO CARTILAGE MORPHOGENESIS,6.2007e-06,-0.55806,-0.66999,0,0
1,GO REGULATION OF POSITIVE CHEMOTAXIS,1.4947e-05,-0.55814,-0.56274,0,0
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,1.8524e-05,-0.55823,-0.61517,0,0
1,GO ER OVERLOAD RESPONSE,2.4576e-05,-0.55888,-0.49278,0,0
1,GO REGULATION OF TELOMERE MAINTENANCE,6.2007e-06,-0.55914,-0.54865,0,0
1,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,7.1973e-06,-0.55927,-0.53677,0,0
1,GO FOREBRAIN GENERATION OF NEURONS,6.8565e-05,-0.56038,-0.52269,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,5.337e-06,-0.56109,-0.60955,0,0
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,5.2428e-05,-0.56119,-0.63739,0,0
1,GO NEGATIVE REGULATION OF CELL DIVISION,1.7249e-05,-0.56175,-0.61542,0,0
1,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0012071,-0.56206,-0.55493,0,0
1,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,1.4947e-05,-0.56219,-0.61551,0,0
1,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,7.1973e-06,-0.56222,-0.53712,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEUS,3.9422e-06,-0.56275,-0.55801,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,4.5891e-06,-0.56285,-0.57244,0,0
1,GO PROTEIN HYDROXYLATION,2.8267e-05,-0.5629,-0.56685,0,0
1,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,5.7533e-06,-0.56296,-0.60132,0,0
1,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,5.337e-06,-0.56319,-0.58007,0,0
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.00029789,-0.56337,-0.53107,0,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,9.6689e-06,-0.56346,-0.54075,0,0
1,GO UTERUS DEVELOPMENT,4.2763e-05,-0.56446,-0.5115,0,0
1,GO ECTODERM DEVELOPMENT,2.1347e-05,-0.5651,-0.46457,0,0
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,4.5891e-06,-0.56513,-0.57793,0,0
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,2.4576e-05,-0.56529,-0.58829,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,6.2007e-06,-0.56559,-0.56272,0,0
1,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,5.337e-06,-0.56576,-0.55807,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,4.9495e-06,-0.56641,-0.61225,0,0
1,GO REGULATION OF GROWTH HORMONE SECRETION,0.0038653,-0.56665,-0.5432,0,0
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,3.9422e-06,-0.56667,-0.60152,0,0
1,GO PROXIMAL DISTAL PATTERN FORMATION,0.00017019,-0.56707,-0.50705,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,3.9936e-05,-0.5671,-0.62713,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,6.6813e-06,-0.56773,-0.55869,0,0
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,1.0403e-05,-0.56862,-0.60938,0,0
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00021879,-0.569,-0.57925,0,0
1,GO POSITIVE REGULATION OF WOUND HEALING,4.9495e-06,-0.56911,-0.60369,0,0
1,GO GLIOGENESIS,6.2007e-06,-0.56922,-0.56468,0,0
1,GO LIMB BUD FORMATION,0.00024771,-0.56936,-0.55866,0,0
1,GO FEMALE SEX DIFFERENTIATION,4.2539e-06,-0.56946,-0.5256,0,0
1,GO INTESTINAL ABSORPTION,0.00012367,-0.57042,-0.53558,0,0
1,GO AUTOPHAGY OF NUCLEUS,4.2539e-06,-0.5707,-0.59588,0,0
1,GO INTESTINAL LIPID ABSORPTION,0.0034935,-0.571,-0.40569,0,0
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,6.6813e-06,-0.57106,-0.57487,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,4.9495e-06,-0.57148,-0.60545,0,0
1,GO REGULATION OF FATTY ACID TRANSPORT,2.1347e-05,-0.57177,-0.51468,0,0
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,4.5891e-06,-0.57222,-0.57396,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO HEAT,5.337e-06,-0.57238,-0.58231,0,0
1,GO REGULATION OF AUTOPHAGY,4.5891e-06,-0.57299,-0.58489,0,0
1,GO OLFACTORY LOBE DEVELOPMENT,4.5779e-05,-0.57307,-0.57392,0,0
1,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,4.5891e-06,-0.57353,-0.56147,0,0
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,1.9888e-05,-0.57401,-0.60644,0,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,7.1973e-06,-0.57419,-0.59091,0,0
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,4.2539e-06,-0.57454,-0.57197,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,4.8997e-05,-0.57478,-0.52608,0,0
1,GO REGULATION OF RESPIRATORY BURST,2.636e-05,-0.57493,-0.53631,0,0
1,GO DISTAL TUBULE DEVELOPMENT,0.00017019,-0.57513,-0.67382,0,0
1,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,1.0403e-05,-0.57542,-0.55315,0,0
1,GO NEUTRAL AMINO ACID TRANSPORT,7.1973e-06,-0.57569,-0.57415,0,0
1,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,1.3909e-05,-0.57593,-0.52811,0,0
1,GO METANEPHROS DEVELOPMENT,8.9843e-06,-0.57604,-0.57995,0,0
1,GO VACUOLE ORGANIZATION,3.9422e-06,-0.57635,-0.59383,0,0
1,GO POSITIVE REGULATION OF CELL MATURATION,3.7287e-05,-0.57662,-0.52183,0,0
1,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,4.8997e-05,-0.57753,-0.56334,0,0
1,GO NEGATIVE REGULATION OF COAGULATION,4.2763e-05,-0.57811,-0.61847,0,0
1,GO EPHRIN RECEPTOR SIGNALING PATHWAY,3.9422e-06,-0.57831,-0.59017,0,0
1,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,1.3909e-05,-0.5785,-0.57358,0,0
1,GO MEMBRANE FUSION,5.7533e-06,-0.57939,-0.57954,0,0
1,GO RESPONSE TO COLD,1.8524e-05,-0.58046,-0.56748,0,0
1,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.00010866,-0.58056,-0.63042,0,0
1,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.00048214,-0.58092,-0.49406,0,0
1,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,4.5779e-05,-0.58133,-0.66903,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.00096503,-0.58207,-0.4586,0,0
1,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00024771,-0.58208,-0.61327,0,0
1,GO REGULATION OF DNA METHYLATION,1.1191e-05,-0.5825,-0.56469,0,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,1.9888e-05,-0.58269,-0.56772,0,0
1,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,8.9327e-05,-0.58273,-0.54253,0,0
1,GO KERATAN SULFATE METABOLIC PROCESS,1.2939e-05,-0.58279,-0.62888,0,0
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,8.9843e-06,-0.58309,-0.59993,0,0
1,GO AUTOPHAGOSOME ORGANIZATION,4.2539e-06,-0.58375,-0.60544,0,0
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,1.4947e-05,-0.58416,-0.64659,0,0
1,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,8.3461e-06,-0.58457,-0.58134,0,0
1,GO LEPTIN MEDIATED SIGNALING PATHWAY,4.2763e-05,-0.58464,-0.51092,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,4.5891e-06,-0.58528,-0.63017,0,0
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,4.2539e-06,-0.58599,-0.54622,0,0
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,1.7249e-05,-0.58709,-0.52415,0,0
1,GO HISTONE H3 K9 MODIFICATION,4.2539e-06,-0.58724,-0.62478,0,0
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,7.1973e-06,-0.58745,-0.58443,0,0
1,GO ENTEROENDOCRINE CELL DIFFERENTIATION,7.1973e-06,-0.58756,-0.60029,0,0
1,GO BONE MINERALIZATION,8.9843e-06,-0.58805,-0.59832,0,0
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,3.9422e-06,-0.58814,-0.60585,0,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.1973e-06,-0.58908,-0.55578,0,0
1,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,1.2035e-05,-0.58991,-0.56721,0,0
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,8.9843e-06,-0.59005,-0.57022,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,4.2539e-06,-0.59074,-0.61795,0,0
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,6.6813e-06,-0.59127,-0.6113,0,0
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,4.2763e-05,-0.5913,-0.60163,0,0
1,GO PARENTAL BEHAVIOR,0.0029965,-0.59153,-0.50789,0,0
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,5.337e-06,-0.59159,-0.60102,0,0
1,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,8.9843e-06,-0.59246,-0.65945,0,0
1,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.00031664,-0.59248,-0.50461,0,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,3.248e-05,-0.59258,-0.56966,0,0
1,GO CELLULAR RESPONSE TO DRUG,4.9495e-06,-0.5932,-0.55415,0,0
1,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,4.5891e-06,-0.59334,-0.62273,0,0
1,GO POSITIVE REGULATION OF TISSUE REMODELING,3.0304e-05,-0.59385,-0.5865,0,0
1,GO FOREBRAIN NEURON DIFFERENTIATION,0.00029789,-0.59409,-0.52689,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,7.7514e-06,-0.59496,-0.55103,0,0
1,GO LYSOSOME LOCALIZATION,4.2539e-06,-0.59499,-0.63557,0,0
1,GO PHOSPHOLIPID DEPHOSPHORYLATION,5.7533e-06,-0.59552,-0.61626,0,0
1,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.00011593,-0.596,-0.5268,0,0
1,GO RESPONSE TO TESTOSTERONE,4.5891e-06,-0.59684,-0.5275,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,7.1973e-06,-0.59761,-0.56189,0,0
1,GO GLAND DEVELOPMENT,5.337e-06,-0.59788,-0.58071,0,0
1,GO RESPONSE TO WOUNDING,4.9495e-06,-0.59797,-0.62815,0,0
1,GO REPLICATIVE SENESCENCE,3.9936e-05,-0.59799,-0.48024,0,0
1,GO CELL PROLIFERATION IN FOREBRAIN,2.8267e-05,-0.59804,-0.61873,0,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,6.6813e-06,-0.59818,-0.62872,0,0
1,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0011418,-0.59838,-0.48658,0,0
1,GO PANCREAS DEVELOPMENT,7.7514e-06,-0.59923,-0.5896,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,5.7533e-06,-0.59941,-0.58763,0,0
1,GO BRANCHING MORPHOGENESIS OF A NERVE,0.00033648,-0.59963,-0.5794,0,0
1,GO GLIAL CELL DEVELOPMENT,6.2007e-06,-0.60032,-0.58412,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,7.1973e-06,-0.6005,-0.63926,0,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,1.9888e-05,-0.60181,-0.57034,0,0
1,GO MAINTENANCE OF CELL NUMBER,4.9495e-06,-0.60181,-0.56622,0,0
1,GO POSITIVE REGULATION OF OSSIFICATION,1.2035e-05,-0.60202,-0.59654,0,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,1.2035e-05,-0.60221,-0.57479,0,0
1,GO OSTEOBLAST DIFFERENTIATION,4.5891e-06,-0.60239,-0.59567,0,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,3.9422e-06,-0.60285,-0.602,0,0
1,GO AXIS ELONGATION,1.4947e-05,-0.6031,-0.54725,0,0
1,GO EPITHELIAL CELL PROLIFERATION,4.9495e-06,-0.60347,-0.60425,0,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,8.9843e-06,-0.60362,-0.61287,0,0
1,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,4.2539e-06,-0.6044,-0.62788,0,0
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.00021879,-0.60504,-0.56791,0,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,2.1347e-05,-0.60523,-0.56998,0,0
1,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0011418,-0.6053,-0.5188,0,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,1.8524e-05,-0.60582,-0.61288,0,0
1,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,8.9843e-06,-0.60584,-0.57477,0,0
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,7.1973e-06,-0.60649,-0.61982,0,0
1,GO REGULATION OF VACUOLE ORGANIZATION,4.5891e-06,-0.60666,-0.61136,0,0
1,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,1.3909e-05,-0.6078,-0.66347,0,0
1,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,1.1191e-05,-0.60788,-0.5976,0,0
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,6.2007e-06,-0.60941,-0.65475,0,0
1,GO GLYCINE TRANSPORT,0.00040321,-0.61061,-0.56627,0,0
1,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,8.9843e-06,-0.61075,-0.59927,0,0
1,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.00021879,-0.61079,-0.57184,0,0
1,GO NEURAL CREST FORMATION,0.0017696,-0.6109,-0.44106,0,0
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,6.6813e-06,-0.61105,-0.66314,0,0
1,GO OSSIFICATION,4.9495e-06,-0.61146,-0.6052,0,0
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,9.6689e-06,-0.61163,-0.64894,0,0
1,GO ERYTHROCYTE HOMEOSTASIS,4.2539e-06,-0.61212,-0.59427,0,0
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.1347e-05,-0.61216,-0.60035,0,0
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,1.1191e-05,-0.61332,-0.61248,0,0
1,GO NEURON REMODELING,5.6086e-05,-0.61375,-0.64364,0,0
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,2.1347e-05,-0.61404,-0.56523,0,0
1,GO VACUOLAR TRANSPORT,4.2539e-06,-0.6144,-0.62984,0,0
1,GO WOUND HEALING,4.5891e-06,-0.6146,-0.65063,0,0
1,GO RESPONSE TO MECHANICAL STIMULUS,8.3461e-06,-0.61464,-0.60813,0,0
1,GO MUSCLE CELL MIGRATION,5.337e-06,-0.61529,-0.67734,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,3.9422e-06,-0.61604,-0.60244,0,0
1,GO SKIN EPIDERMIS DEVELOPMENT,1.1191e-05,-0.61637,-0.56857,0,0
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,6.2007e-06,-0.61685,-0.65913,0,0
1,GO NEPHRIC DUCT DEVELOPMENT,0.00019306,-0.61694,-0.52927,0,0
1,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,1.1191e-05,-0.61703,-0.65007,0,0
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,2.8267e-05,-0.61716,-0.68166,0,0
1,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,5.337e-06,-0.61735,-0.60344,0,0
1,GO MAST CELL MIGRATION,1.9888e-05,-0.61771,-0.64982,0,0
1,GO HOMOTYPIC CELL CELL ADHESION,4.5891e-06,-0.61861,-0.67365,0,0
1,GO TRACHEA DEVELOPMENT,4.2539e-06,-0.61961,-0.68114,0,0
1,GO PROSTATE GLAND MORPHOGENESIS,5.6086e-05,-0.61963,-0.56905,0,0
1,GO LUNG EPITHELIUM DEVELOPMENT,3.248e-05,-0.62016,-0.5578,0,0
1,GO CYTOPLASM ORGANIZATION,1.2939e-05,-0.62118,-0.66168,0,0
1,GO GLAND MORPHOGENESIS,7.1973e-06,-0.62187,-0.66516,0,0
1,GO REGULATION OF OSSIFICATION,8.9843e-06,-0.62279,-0.60917,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,8.3461e-06,-0.62354,-0.61153,0,0
1,GO RESPONSE TO STEROL DEPLETION,8.9843e-06,-0.62447,-0.62917,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,8.9843e-06,-0.62447,-0.57658,0,0
1,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,7.1973e-06,-0.62477,-0.63363,0,0
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,3.9422e-06,-0.62487,-0.68537,0,0
1,GO LUNG CELL DIFFERENTIATION,0.00012367,-0.62549,-0.52191,0,0
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,4.9495e-06,-0.6255,-0.61708,0,0
1,GO LOOP OF HENLE DEVELOPMENT,0.0003797,-0.62567,-0.61046,0,0
1,GO SULFUR COMPOUND TRANSPORT,1.2035e-05,-0.62596,-0.59785,0,0
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,4.5891e-06,-0.62638,-0.62571,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,4.5891e-06,-0.62716,-0.63511,0,0
1,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.7249e-05,-0.62761,-0.7472,0,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.9888e-05,-0.62813,-0.59912,0,0
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,2.8267e-05,-0.6287,-0.66763,0,0
1,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,5.9985e-05,-0.6288,-0.66783,0,0
1,GO MESENCHYMAL CELL PROLIFERATION,1.4947e-05,-0.62904,-0.64377,0,0
1,GO PHOSPHATE ION TRANSPORT,8.3461e-06,-0.63054,-0.61422,0,0
1,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,1.6059e-05,-0.63069,-0.62274,0,0
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,7.1973e-06,-0.63069,-0.59889,0,0
1,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,8.3461e-06,-0.63075,-0.62112,0,0
1,GO TUBE FORMATION,4.2539e-06,-0.63109,-0.58095,0,0
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,4.2539e-06,-0.63129,-0.58908,0,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,4.2539e-06,-0.63233,-0.64396,0,0
1,GO APPENDAGE DEVELOPMENT,4.5891e-06,-0.63331,-0.61719,0,0
1,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,8.9843e-06,-0.63349,-0.61127,0,0
1,GO EPITHELIAL TUBE FORMATION,4.5891e-06,-0.63411,-0.57756,0,0
1,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,4.5891e-06,-0.63417,-0.66111,0,0
1,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,3.9422e-06,-0.63498,-0.63227,0,0
1,GO GALACTOSE METABOLIC PROCESS,3.248e-05,-0.63569,-0.57344,0,0
1,GO NOSE DEVELOPMENT,0.00023283,-0.63668,-0.61958,0,0
1,GO TYPE B PANCREATIC CELL PROLIFERATION,1.0403e-05,-0.63709,-0.64978,0,0
1,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,7.1973e-06,-0.63759,-0.63315,0,0
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,4.2539e-06,-0.63765,-0.63111,0,0
1,GO APPENDAGE MORPHOGENESIS,5.7533e-06,-0.63821,-0.63198,0,0
1,GO RESPONSE TO ACIDIC PH,2.2907e-05,-0.63866,-0.61345,0,0
1,GO LAMELLIPODIUM ASSEMBLY,3.9422e-06,-0.63906,-0.63392,0,0
1,GO ADRENAL GLAND DEVELOPMENT,9.5377e-05,-0.63911,-0.5696,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,1.0403e-05,-0.63926,-0.63687,0,0
1,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,1.7249e-05,-0.63978,-0.56106,0,0
1,GO CHROMATIN DISASSEMBLY,5.9985e-05,-0.63982,-0.59624,0,0
1,GO CARDIAC ATRIUM DEVELOPMENT,9.6689e-06,-0.6399,-0.67568,0,0
1,GO REGULATION OF SULFUR METABOLIC PROCESS,2.8267e-05,-0.6414,-0.64515,0,0
1,GO EPITHELIAL CELL FATE COMMITMENT,2.1347e-05,-0.64183,-0.59925,0,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.3909e-05,-0.64206,-0.56549,0,0
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,4.9495e-06,-0.64357,-0.61315,0,0
1,GO RESPIRATORY SYSTEM PROCESS,4.9495e-06,-0.64391,-0.66907,0,0
1,GO NEGATIVE REGULATION OF OSSIFICATION,7.1973e-06,-0.64434,-0.62762,0,0
1,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,7.8298e-05,-0.64517,-0.64063,0,0
1,GO STRESS GRANULE ASSEMBLY,6.2007e-06,-0.64547,-0.63955,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,1.1191e-05,-0.64641,-0.6763,0,0
1,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,1.9888e-05,-0.64643,-0.63438,0,0
1,GO REGULATION OF VASCULOGENESIS,7.3279e-05,-0.64664,-0.58836,0,0
1,GO REGULATION OF VASOCONSTRICTION,1.1191e-05,-0.6469,-0.63281,0,0
1,GO EMBRYONIC APPENDAGE MORPHOGENESIS,5.7533e-06,-0.64718,-0.6356,0,0
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,4.9495e-06,-0.64755,-0.64496,0,0
1,GO TELENCEPHALON GLIAL CELL MIGRATION,1.0403e-05,-0.64843,-0.66587,0,0
1,GO REGULATION OF FILOPODIUM ASSEMBLY,4.5891e-06,-0.649,-0.68683,0,0
1,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,1.9888e-05,-0.64915,-0.71866,0,0
1,GO REGULATION OF CGMP MEDIATED SIGNALING,6.4139e-05,-0.64924,-0.64919,0,0
1,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00091199,-0.65021,-0.48007,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,6.8565e-05,-0.65142,-0.69664,0,0
1,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,3.4805e-05,-0.65191,-0.55201,0,0
1,GO KERATINOCYTE DEVELOPMENT,5.9985e-05,-0.65246,-0.58559,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,6.2007e-06,-0.65364,-0.66444,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,6.6813e-06,-0.65367,-0.59949,0,0
1,GO AZOLE TRANSMEMBRANE TRANSPORT,2.1347e-05,-0.65386,-0.66217,0,0
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,2.636e-05,-0.65403,-0.66278,0,0
1,GO SKELETAL SYSTEM MORPHOGENESIS,4.5891e-06,-0.65462,-0.64685,0,0
1,GO DISACCHARIDE METABOLIC PROCESS,4.9495e-06,-0.65511,-0.68433,0,0
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,3.9422e-06,-0.65515,-0.70868,0,0
1,GO REGULATION OF MAP KINASE ACTIVITY,4.9495e-06,-0.65542,-0.64689,0,0
1,GO ENDOCRINE PANCREAS DEVELOPMENT,7.1973e-06,-0.65579,-0.59929,0,0
1,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,5.6086e-05,-0.65587,-0.61197,0,0
1,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,4.5779e-05,-0.65599,-0.72647,0,0
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,4.5891e-06,-0.65706,-0.6446,0,0
1,GO TRICARBOXYLIC ACID METABOLIC PROCESS,5.337e-06,-0.6572,-0.61011,0,0
1,GO MODIFICATION OF SYNAPTIC STRUCTURE,6.6813e-06,-0.65726,-0.66985,0,0
1,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,4.5891e-06,-0.65816,-0.61442,0,0
1,GO MICROVILLUS ASSEMBLY,4.5891e-06,-0.65844,-0.63219,0,0
1,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00091199,-0.6586,-0.67252,0,0
1,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,1.8524e-05,-0.65875,-0.71538,0,0
1,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,2.2907e-05,-0.65935,-0.54416,0,0
1,GO REGULATION OF MITOCHONDRIAL FUSION,5.7533e-06,-0.66007,-0.6333,0,0
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,4.5891e-06,-0.66018,-0.64318,0,0
1,GO NEURONAL STEM CELL POPULATION MAINTENANCE,8.3461e-06,-0.66078,-0.65934,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,4.2763e-05,-0.66258,-0.62641,0,0
1,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,1.9888e-05,-0.66295,-0.64635,0,0
1,GO TUBE MORPHOGENESIS,4.5891e-06,-0.66421,-0.6713,0,0
1,GO TRIGEMINAL NERVE DEVELOPMENT,0.00014989,-0.66503,-0.69499,0,0
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.8524e-05,-0.66533,-0.64852,0,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,5.337e-06,-0.66567,-0.64225,0,0
1,GO CARDIAC ATRIUM MORPHOGENESIS,5.7533e-06,-0.66671,-0.71463,0,0
1,GO DENDRITIC SPINE MAINTENANCE,5.7533e-06,-0.66681,-0.69542,0,0
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,2.636e-05,-0.66701,-0.65301,0,0
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,9.6689e-06,-0.66733,-0.64657,0,0
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,8.9843e-06,-0.6699,-0.7321,0,0
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,1.2035e-05,-0.67231,-0.6654,0,0
1,GO RELAXATION OF CARDIAC MUSCLE,2.636e-05,-0.67239,-0.6396,0,0
1,GO MESODERMAL CELL DIFFERENTIATION,4.9495e-06,-0.67242,-0.65128,0,0
1,GO DECIDUALIZATION,8.3461e-06,-0.6726,-0.72041,0,0
1,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,4.5891e-06,-0.67593,-0.68612,0,0
1,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,9.6689e-06,-0.67643,-0.68436,0,0
1,GO CELL CELL JUNCTION MAINTENANCE,1.3909e-05,-0.67651,-0.72939,0,0
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,3.0304e-05,-0.67652,-0.65716,0,0
1,GO TROPHOBLAST CELL MIGRATION,3.9422e-06,-0.67742,-0.68474,0,0
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.00076864,-0.67781,-0.60404,0,0
1,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,4.2539e-06,-0.67896,-0.73316,0,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.00042807,-0.67934,-0.59174,0,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,7.7514e-06,-0.68001,-0.68881,0,0
1,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,1.2939e-05,-0.68014,-0.65312,0,0
1,GO P BODY ASSEMBLY,4.2539e-06,-0.6803,-0.74793,0,0
1,GO REGULATION OF RENAL SYSTEM PROCESS,1.2035e-05,-0.68051,-0.58554,0,0
1,GO CELLULAR RESPONSE TO VITAMIN,1.6059e-05,-0.68075,-0.6261,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,5.7533e-06,-0.68154,-0.68024,0,0
1,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,4.2539e-06,-0.6826,-0.71875,0,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,2.1347e-05,-0.68295,-0.69296,0,0
1,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00013188,-0.68299,-0.661,0,0
1,GO POSITIVE REGULATION OF PROTEIN BINDING,4.5891e-06,-0.68578,-0.64454,0,0
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,4.9495e-06,-0.68605,-0.69976,0,0
1,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,1.7249e-05,-0.6863,-0.71229,0,0
1,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.0027019,-0.68681,-0.50788,0,0
1,GO VASCULOGENESIS,6.6813e-06,-0.68683,-0.70185,0,0
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,9.6689e-06,-0.68782,-0.71871,0,0
1,GO BONE MORPHOGENESIS,4.5891e-06,-0.68793,-0.691,0,0
1,GO PHAGOLYSOSOME ASSEMBLY,6.6813e-06,-0.68794,-0.70668,0,0
1,GO ALDEHYDE BIOSYNTHETIC PROCESS,4.8997e-05,-0.68824,-0.67432,0,0
1,GO HEART TRABECULA MORPHOGENESIS,4.5891e-06,-0.68871,-0.70777,0,0
1,GO GROWTH HORMONE SECRETION,0.00045436,-0.68982,-0.61094,0,0
1,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,1.2035e-05,-0.69325,-0.66816,0,0
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,8.9843e-06,-0.69391,-0.63349,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,8.9843e-06,-0.69409,-0.62534,0,0
1,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,1.0403e-05,-0.69469,-0.64916,0,0
1,GO POSITIVE REGULATION OF BONE RESORPTION,1.6059e-05,-0.69621,-0.66072,0,0
1,GO GASTRULATION,4.9495e-06,-0.69652,-0.68634,0,0
1,GO NEGATIVE REGULATION OF NEURON MIGRATION,5.7533e-06,-0.6971,-0.68972,0,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,8.3461e-06,-0.69807,-0.65541,0,0
1,GO BASIC AMINO ACID TRANSPORT,5.6086e-05,-0.69834,-0.64574,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,9.6689e-06,-0.69869,-0.68174,0,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,5.7533e-06,-0.69874,-0.66805,0,0
1,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,6.6813e-06,-0.69951,-0.68783,0,0
1,GO SMOOTH MUSCLE CELL MIGRATION,5.7533e-06,-0.70045,-0.73991,0,0
1,GO NEURAL TUBE FORMATION,4.5891e-06,-0.7009,-0.63215,0,0
1,GO OSTEOBLAST PROLIFERATION,1.7249e-05,-0.70215,-0.67429,0,0
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,4.5891e-06,-0.70221,-0.71946,0,0
1,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,3.7287e-05,-0.70336,-0.60326,0,0
1,GO RESPONSE TO LEUCINE,6.6813e-06,-0.70353,-0.74156,0,0
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,4.9495e-06,-0.70367,-0.67522,0,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,5.337e-06,-0.706,-0.67007,0,0
1,GO REGULATION OF GLOMERULAR FILTRATION,1.9888e-05,-0.70791,-0.74819,0,0
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,8.9843e-06,-0.7087,-0.67594,0,0
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,4.2539e-06,-0.70872,-0.69171,0,0
1,GO REGULATION OF CELL SUBSTRATE ADHESION,5.7533e-06,-0.70903,-0.74822,0,0
1,GO CELL SUBSTRATE ADHESION,4.5891e-06,-0.70932,-0.75762,0,0
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,1.6059e-05,-0.71008,-0.7016,0,0
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,5.6086e-05,-0.71126,-0.7202,0,0
1,GO EMBRYONIC HEMOPOIESIS,8.3461e-06,-0.71326,-0.70202,0,0
1,GO N GLYCAN PROCESSING,1.3909e-05,-0.71337,-0.68641,0,0
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,3.9422e-06,-0.71352,-0.74029,0,0
1,GO ATRIAL SEPTUM MORPHOGENESIS,5.9985e-05,-0.715,-0.6425,0,0
1,GO FORMATION OF PRIMARY GERM LAYER,4.9495e-06,-0.71524,-0.72217,0,0
1,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,5.7533e-06,-0.71862,-0.74333,0,0
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,7.7514e-06,-0.71973,-0.76268,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,1.6059e-05,-0.71992,-0.71878,0,0
1,GO ENDOTHELIAL CELL CHEMOTAXIS,1.2035e-05,-0.72102,-0.66922,0,0
1,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,4.5891e-06,-0.72129,-0.71531,0,0
1,GO CHONDROCYTE DIFFERENTIATION,4.9495e-06,-0.72163,-0.73198,0,0
1,GO ENDOTHELIAL CELL PROLIFERATION,4.2539e-06,-0.72397,-0.69541,0,0
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,7.7514e-06,-0.7242,-0.7724,0,0
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.7533e-06,-0.72753,-0.78841,0,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,4.2539e-06,-0.72795,-0.69936,0,0
1,GO REGULATION OF THE FORCE OF HEART CONTRACTION,1.0403e-05,-0.72914,-0.61537,0,0
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,2.2907e-05,-0.72949,-0.77046,0,0
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,1.9888e-05,-0.73008,-0.66567,0,0
1,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,7.1973e-06,-0.73049,-0.66148,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,6.2007e-06,-0.73248,-0.77202,0,0
1,GO GOLGI TO ENDOSOME TRANSPORT,5.337e-06,-0.73321,-0.69825,0,0
1,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,1.3909e-05,-0.73358,-0.69209,0,0
1,GO LEYDIG CELL DIFFERENTIATION,0.0010798,-0.7359,-0.55159,0,0
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,7.7514e-06,-0.73603,-0.66475,0,0
1,GO REGULATION OF CELL MATRIX ADHESION,4.2539e-06,-0.73672,-0.76605,0,0
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,7.1973e-06,-0.73693,-0.70195,0,0
1,GO ANOIKIS,8.9843e-06,-0.73805,-0.69679,0,0
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,4.5779e-05,-0.73814,-0.6155,0,0
1,GO MAINTENANCE OF BLOOD BRAIN BARRIER,7.7514e-06,-0.73841,-0.67514,0,0
1,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,1.3909e-05,-0.73889,-0.7183,0,0
1,GO LUTEINIZATION,6.2007e-06,-0.73944,-0.79383,0,0
1,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,1.2035e-05,-0.74054,-0.73017,0,0
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,3.9422e-06,-0.74125,-0.76095,0,0
1,GO APICAL JUNCTION ASSEMBLY,1.4947e-05,-0.74463,-0.57971,0,0
1,GO BONE GROWTH,7.1973e-06,-0.74557,-0.68579,0,0
1,GO EMBRYONIC CAMERA TYPE EYE FORMATION,8.9843e-06,-0.74614,-0.76185,0,0
1,GO NK T CELL DIFFERENTIATION,4.2763e-05,-0.75051,-0.72753,0,0
1,GO REGULATION OF VASCULAR PERMEABILITY,8.3461e-06,-0.75136,-0.66612,0,0
1,GO NEGATIVE REGULATION OF ANOIKIS,3.7287e-05,-0.75152,-0.75199,0,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,4.2539e-06,-0.75203,-0.71148,0,0
1,GO ENDOTHELIUM DEVELOPMENT,4.9495e-06,-0.75273,-0.73264,0,0
1,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,6.2007e-06,-0.75361,-0.76914,0,0
1,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,1.2035e-05,-0.75435,-0.69529,0,0
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,4.9495e-06,-0.75485,-0.75035,0,0
1,GO SPROUTING ANGIOGENESIS,4.2539e-06,-0.75733,-0.7491,0,0
1,GO REGULATION OF ANOIKIS,1.3909e-05,-0.76024,-0.71521,0,0
1,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,8.3461e-06,-0.76062,-0.78489,0,0
1,GO CHONDROCYTE DEVELOPMENT,6.6813e-06,-0.76081,-0.77722,0,0
1,GO EPITHELIAL CELL MORPHOGENESIS,1.2939e-05,-0.76352,-0.73244,0,0
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,4.9495e-06,-0.76365,-0.74048,0,0
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,5.337e-06,-0.76888,-0.79872,0,0
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,5.7533e-06,-0.77066,-0.78881,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,2.1347e-05,-0.77132,-0.73682,0,0
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,9.6689e-06,-0.77739,-0.77762,0,0
1,GO HIPPO SIGNALING,5.337e-06,-0.78114,-0.75705,0,0
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,6.2007e-06,-0.7833,-0.79255,0,0
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,2.2907e-05,-0.78364,-0.80292,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,4.2763e-05,-0.78371,-0.84703,0,0
1,GO LUNG ALVEOLUS DEVELOPMENT,7.7514e-06,-0.78628,-0.78088,0,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,4.9495e-06,-0.78813,-0.76458,0,0
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.9422e-06,-0.78818,-0.77223,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,5.337e-06,-0.78953,-0.77013,0,0
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,4.5891e-06,-0.79048,-0.77108,0,0
1,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,6.6813e-06,-0.79161,-0.77254,0,0
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,4.9495e-06,-0.79277,-0.81876,0,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.9422e-06,-0.79945,-0.79305,0,0
1,GO VASCULAR WOUND HEALING,1.0403e-05,-0.80452,-0.79639,0,0
1,GO ACTIN FILAMENT DEPOLYMERIZATION,4.5891e-06,-0.80482,-0.75971,0,0
1,GO EPIBOLY,3.9422e-06,-0.808,-0.78205,0,0
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,4.5891e-06,-0.80959,-0.7836,0,0
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,3.9422e-06,-0.81139,-0.82052,0,0
1,GO LYMPHANGIOGENESIS,7.1973e-06,-0.81586,-0.75059,0,0
1,GO RENAL FILTRATION,8.3461e-06,-0.82191,-0.87135,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,5.337e-06,-0.83214,-0.78747,0,0
1,GO RESPONSE TO MAGNESIUM ION,2.636e-05,-0.83254,-0.71762,0,0
1,GO HEAD MORPHOGENESIS,4.5891e-06,-0.83643,-0.83265,0,0
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,4.2539e-06,-0.84085,-0.84279,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,1.8524e-05,-0.85296,-0.77231,0,0
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,1.1191e-05,-0.85518,-0.8511,0,0
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,8.3461e-06,-0.85741,-0.74545,0,0
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.2539e-06,-0.859,-0.83283,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,7.7514e-06,-0.86345,-0.75923,0,0
1,GO ENDOTHELIAL CELL DEVELOPMENT,4.5891e-06,-0.87074,-0.8192,0,0
1,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,3.9422e-06,-0.87519,-0.8207,0,0
1,GO EXTRACELLULAR MATRIX ASSEMBLY,6.2007e-06,-0.87593,-0.90861,0,0
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,8.9843e-06,-0.88187,-0.84717,0,0
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,5.337e-06,-0.89113,-0.82292,0,0
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,8.3461e-06,-0.90669,-0.9124,0,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,5.7533e-06,-0.91214,-0.86549,0,0
1,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,6.6813e-06,-0.94111,-0.86766,0,0
1,GO DORSAL AORTA DEVELOPMENT,7.1973e-06,-0.94338,-0.84503,0,0
1,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.4805e-05,-0.94764,-0.82382,0,0
1,GO ENDOTHELIAL CELL MORPHOGENESIS,5.7533e-06,-0.97533,-0.96018,0,0
1,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,5.337e-06,-1.0288,-1.0412,0,0
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,4.5891e-06,-1.0297,-0.91087,0,0
1,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,5.337e-06,-1.0302,-1.0591,0,0
1,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,7.7514e-06,-1.0345,-0.93999,0,0
2,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,4.5779e-05,1.3473,1.2283,1,1
2,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,2.8267e-05,1.3162,1.2983,1,1
2,GO NATURAL KILLER CELL CHEMOTAXIS,0.00010181,1.2871,1.1126,1,1
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,2.8267e-05,1.2695,1.2171,1,1
2,GO DENDRITIC CELL APOPTOTIC PROCESS,4.5779e-05,1.2502,1.1888,1,1
2,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,1.6059e-05,1.1976,1.1257,1,1
2,GO CHRONIC INFLAMMATORY RESPONSE,1.2035e-05,1.166,1.0039,1,1
2,GO TOLERANCE INDUCTION,8.3641e-05,1.0921,0.9378,1,1
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.1191e-05,1.0774,1.0385,1,1
2,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,5.6086e-05,1.0762,0.93325,1,1
2,GO HYPERSENSITIVITY,3.248e-05,1.075,1.0001,1,1
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,9.6689e-06,1.0566,1.023,1,1
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,1.4947e-05,1.0462,1.0267,1,1
2,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.00015974,1.0434,1.0145,1,1
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,7.3279e-05,1.0397,0.9764,1,1
2,GO T CELL TOLERANCE INDUCTION,0.00012367,1.0309,0.94207,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,8.9843e-06,1.0303,1.0168,1,1
2,GO REGULATION OF TOLERANCE INDUCTION,0.00020554,1.0295,0.86245,1,1
2,GO T HELPER 17 CELL LINEAGE COMMITMENT,6.8565e-05,1.0293,0.91249,1,1
2,GO NEGATIVE T CELL SELECTION,4.5779e-05,1.0182,0.97037,1,1
2,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,1.9888e-05,0.99862,0.94811,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,4.8997e-05,0.99143,0.95855,1,1
2,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.00017019,0.99107,0.77769,1,1
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,5.7533e-06,0.98813,0.99596,1,1
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,1.1191e-05,0.98527,0.95856,1,1
2,GO DENDRITIC CELL MIGRATION,3.4805e-05,0.97983,0.86374,1,1
2,GO DENDRITIC CELL CHEMOTAXIS,3.7287e-05,0.97669,0.89033,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,4.5779e-05,0.9764,0.89471,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,3.0304e-05,0.9754,0.94601,1,1
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,1.2939e-05,0.96391,0.87601,1,1
2,GO LYMPHOCYTE CHEMOTAXIS,1.0403e-05,0.94512,0.87876,1,1
2,GO SYNAPSE PRUNING,3.4805e-05,0.94434,1.0171,1,1
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,1.8524e-05,0.93451,0.90261,1,1
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,2.2907e-05,0.9336,0.80445,1,1
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,4.8997e-05,0.93239,0.84768,1,1
2,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,3.0304e-05,0.93037,0.89165,1,1
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,3.9936e-05,0.92589,0.81245,1,1
2,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,1.6059e-05,0.92497,0.85597,1,1
2,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.00013188,0.92431,0.967,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,3.7287e-05,0.92033,0.84674,1,1
2,GO T CELL CHEMOTAXIS,3.0304e-05,0.91746,0.82836,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,2.4576e-05,0.91309,0.81386,1,1
2,GO RESPONSE TO PROTOZOAN,2.2907e-05,0.91174,0.80392,1,1
2,GO T HELPER 1 CELL DIFFERENTIATION,1.3909e-05,0.91136,0.85793,1,1
2,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,4.8997e-05,0.9095,0.86753,1,1
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,2.8267e-05,0.90882,0.85178,1,1
2,GO DENDRITIC CELL DIFFERENTIATION,3.7287e-05,0.90857,0.81405,1,1
2,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,3.7287e-05,0.90013,0.83762,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,8.9327e-05,0.89968,0.83641,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,1.2939e-05,0.89764,0.80491,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,2.636e-05,0.89692,0.83488,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,1.1191e-05,0.88948,0.88765,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,3.9936e-05,0.8884,0.89315,1,1
2,GO DETECTION OF OTHER ORGANISM,2.2907e-05,0.88355,0.81017,1,1
2,GO INTERLEUKIN 10 PRODUCTION,1.6059e-05,0.88275,0.76367,1,1
2,GO POSITIVE T CELL SELECTION,5.9985e-05,0.88118,0.77332,1,1
2,GO T HELPER CELL LINEAGE COMMITMENT,4.5779e-05,0.87903,0.79836,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,1.2939e-05,0.87738,0.80534,1,1
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,2.1347e-05,0.87504,0.81521,1,1
2,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,2.4576e-05,0.87226,0.84793,1,1
2,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,3.7287e-05,0.87117,0.76319,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,1.9888e-05,0.86576,0.81785,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.1347e-05,0.8647,0.81937,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,4.8997e-05,0.8626,0.7323,1,1
2,GO B CELL RECEPTOR SIGNALING PATHWAY,4.8997e-05,0.86101,0.80064,1,1
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,2.1347e-05,0.8599,0.82795,1,1
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,1.2939e-05,0.85721,0.83104,1,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,4.2763e-05,0.85506,0.78494,1,1
2,GO POSITIVE THYMIC T CELL SELECTION,0.00010866,0.85384,0.8319,1,1
2,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,2.636e-05,0.85309,0.84855,1,1
2,GO LEUKOCYTE AGGREGATION,3.248e-05,0.8515,0.88935,1,1
2,GO RESPONSE TO PEPTIDOGLYCAN,6.6813e-06,0.84808,0.84406,1,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,6.8565e-05,0.84441,0.82511,1,1
2,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,5.2428e-05,0.84301,0.73001,1,1
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,3.248e-05,0.84084,0.71004,1,1
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,1.2939e-05,0.83957,0.78879,1,1
2,GO CYTOLYSIS,3.7287e-05,0.83877,0.87952,1,1
2,GO T CELL MEDIATED CYTOTOXICITY,1.2939e-05,0.83775,0.81036,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,2.4576e-05,0.83633,0.73997,1,1
2,GO T HELPER 2 CELL DIFFERENTIATION,1.2035e-05,0.83629,0.82087,1,1
2,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.0010209,0.83371,0.71117,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,1.7249e-05,0.83206,0.72692,1,1
2,GO RESPONSE TO CHEMOKINE,7.7514e-06,0.83105,0.80893,1,1
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.2907e-05,0.8309,0.74977,1,1
2,GO NEGATIVE REGULATION OF CELL KILLING,5.6086e-05,0.83075,0.8456,1,1
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,3.9936e-05,0.82915,0.75125,1,1
2,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,2.8267e-05,0.82835,0.81143,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,2.636e-05,0.8282,0.86888,1,1
2,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,1.8524e-05,0.82699,0.80281,1,1
2,GO POSITIVE REGULATION OF T CELL MIGRATION,3.0304e-05,0.82687,0.73068,1,1
2,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,4.5779e-05,0.8252,0.83529,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,1.7249e-05,0.82352,0.76222,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,1.8524e-05,0.82258,0.80996,1,1
2,GO MONOCYTE CHEMOTAXIS,8.3461e-06,0.82228,0.85929,1,1
2,GO ADAPTIVE IMMUNE RESPONSE,3.248e-05,0.82211,0.73301,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,2.8267e-05,0.82057,0.76082,1,1
2,GO CYCLOOXYGENASE PATHWAY,1.3909e-05,0.81668,0.85515,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,1.2939e-05,0.81658,0.82124,1,1
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE,3.248e-05,0.81415,0.83447,1,1
2,GO CELLULAR DEFENSE RESPONSE,3.248e-05,0.81281,0.77619,1,1
2,GO REGULATION OF GLIAL CELL MIGRATION,2.4576e-05,0.81242,0.70661,1,1
2,GO B CELL PROLIFERATION,4.2763e-05,0.81081,0.74896,1,1
2,GO T CELL SELECTION,6.8565e-05,0.81056,0.72635,1,1
2,GO EOSINOPHIL MIGRATION,0.00014989,0.81034,0.84504,1,1
2,GO TYPE 2 IMMUNE RESPONSE,1.1191e-05,0.80958,0.77421,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,3.9936e-05,0.80914,0.72671,1,1
2,GO DETECTION OF BIOTIC STIMULUS,1.6059e-05,0.80884,0.71302,1,1
2,GO LYMPHOCYTE MIGRATION,3.248e-05,0.80883,0.74924,1,1
2,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,2.8267e-05,0.80765,0.80169,1,1
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,2.636e-05,0.80703,0.72476,1,1
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.2939e-05,0.80686,0.7535,1,1
2,GO T CELL MIGRATION,3.248e-05,0.80663,0.76849,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,4.5779e-05,0.80654,0.72615,1,1
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.4947e-05,0.80527,0.77117,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,3.9936e-05,0.80454,0.79313,1,1
2,GO COMPLEMENT ACTIVATION,2.4576e-05,0.80439,0.83768,1,1
2,GO MYELOID DENDRITIC CELL ACTIVATION,4.8997e-05,0.80309,0.7659,1,1
2,GO INFLAMMATORY RESPONSE TO WOUNDING,1.1191e-05,0.80302,0.75255,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,8.9327e-05,0.80283,0.79908,1,1
2,GO INTERLEUKIN 2 PRODUCTION,1.0403e-05,0.80167,0.7572,1,1
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.636e-05,0.80104,0.72416,1,1
2,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.4576e-05,0.79816,0.79601,1,1
2,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00010181,0.79672,0.68776,1,1
2,GO REGULATION OF NEUTROPHIL ACTIVATION,0.00015974,0.79581,0.71695,1,1
2,GO T CELL EXTRAVASATION,1.6059e-05,0.79425,0.71614,1,1
2,GO THYMIC T CELL SELECTION,8.3641e-05,0.79367,0.7488,1,1
2,GO INTERLEUKIN 4 PRODUCTION,2.2907e-05,0.79312,0.75416,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,1.3909e-05,0.79266,0.81239,1,1
2,GO RESPONSE TO INTERLEUKIN 18,7.8298e-05,0.79218,0.70904,1,1
2,GO REGULATION OF T CELL CYTOKINE PRODUCTION,2.4576e-05,0.79089,0.757,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.8267e-05,0.79083,0.73372,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,1.9888e-05,0.78892,0.74893,1,1
2,GO NEUTROPHIL MIGRATION,1.6059e-05,0.78851,0.71299,1,1
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,2.636e-05,0.78812,0.7516,1,1
2,GO REGULATION OF T CELL CHEMOTAXIS,3.7287e-05,0.78783,0.71936,1,1
2,GO NEUTROPHIL CHEMOTAXIS,2.636e-05,0.78756,0.74537,1,1
2,GO INTERLEUKIN 1 BETA PRODUCTION,1.3909e-05,0.78715,0.72733,1,1
2,GO IMMUNOGLOBULIN SECRETION,3.248e-05,0.78338,0.65095,1,1
2,GO INTERLEUKIN 13 PRODUCTION,1.1191e-05,0.77998,0.80081,1,1
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,2.2907e-05,0.77742,0.6935,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,3.9936e-05,0.77586,0.72395,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,4.8997e-05,0.77577,0.71094,1,1
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,3.248e-05,0.77505,0.68889,1,1
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00013188,0.77393,0.71105,1,1
2,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00011593,0.77306,0.70804,1,1
2,GO GLIAL CELL ACTIVATION,2.636e-05,0.77237,0.75713,1,1
2,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,3.9936e-05,0.77101,0.80299,1,1
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,8.3461e-06,0.77099,0.77697,1,1
2,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,1.9888e-05,0.76966,0.73984,1,1
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,3.7287e-05,0.76926,0.75334,1,1
2,GO CHEMOKINE SECRETION,2.1347e-05,0.76716,0.81212,1,1
2,GO EOSINOPHIL CHEMOTAXIS,0.00010866,0.76681,0.81943,1,1
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,1.8524e-05,0.76553,0.72215,1,1
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,3.248e-05,0.76467,0.75596,1,1
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,3.7287e-05,0.76426,0.71544,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,1.8524e-05,0.76364,0.76986,1,1
2,GO T CELL CYTOKINE PRODUCTION,1.9888e-05,0.76265,0.70028,1,1
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,1.7249e-05,0.76081,0.69732,1,1
2,GO RESPONSE TO INTERLEUKIN 15,1.6059e-05,0.75858,0.78503,1,1
2,GO AMINO SUGAR CATABOLIC PROCESS,1.6059e-05,0.75836,0.75628,1,1
2,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,3.4805e-05,0.75796,0.79923,1,1
2,GO OPSONIZATION,0.00045436,0.75704,0.64349,1,1
2,GO INTERLEUKIN 12 PRODUCTION,7.8298e-05,0.75702,0.70856,1,1
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,5.2428e-05,0.75689,0.76227,1,1
2,GO VITAMIN D BIOSYNTHETIC PROCESS,0.00010866,0.75646,0.65538,1,1
2,GO REGULATION OF B CELL PROLIFERATION,3.7287e-05,0.75617,0.71515,1,1
2,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.00031664,0.75557,0.65015,1,1
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,1.0403e-05,0.75529,0.71717,1,1
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,2.636e-05,0.75471,0.80441,1,1
2,GO T CELL MEDIATED IMMUNITY,1.8524e-05,0.75431,0.67381,1,1
2,GO MYELOID DENDRITIC CELL DIFFERENTIATION,5.9985e-05,0.75408,0.68168,1,1
2,GO MONONUCLEAR CELL MIGRATION,6.2007e-06,0.75404,0.77834,1,1
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,3.7287e-05,0.75377,0.65896,1,1
2,GO REGULATION OF OSTEOCLAST DEVELOPMENT,8.3641e-05,0.75364,0.70354,1,1
2,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00010866,0.75347,0.66921,1,1
2,GO ALPHA BETA T CELL PROLIFERATION,0.00010866,0.75338,0.67269,1,1
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,9.5377e-05,0.74968,0.6358,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,4.8997e-05,0.74944,0.66551,1,1
2,GO LYMPHOCYTE COSTIMULATION,0.00012367,0.74888,0.63003,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.1347e-05,0.74778,0.68556,1,1
2,GO REGULATION OF CELL KILLING,2.636e-05,0.74758,0.6975,1,1
2,GO GRANULOCYTE MIGRATION,1.6059e-05,0.74623,0.67435,1,1
2,GO REGULATORY T CELL DIFFERENTIATION,0.00033648,0.7449,0.59968,1,1
2,GO RESPONSE TO INTERFERON GAMMA,1.9888e-05,0.74021,0.69987,1,1
2,GO POSITIVE REGULATION OF CELL KILLING,3.7287e-05,0.73976,0.69275,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.2763e-05,0.73953,0.7064,1,1
2,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.8267e-05,0.73918,0.65364,1,1
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,2.2907e-05,0.73834,0.70131,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,3.0304e-05,0.7376,0.66721,1,1
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,3.7287e-05,0.73717,0.84769,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,1.2939e-05,0.73693,0.75417,1,1
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,5.337e-06,0.73651,0.71558,1,1
2,GO INTERFERON GAMMA PRODUCTION,3.248e-05,0.7357,0.71789,1,1
2,GO INTERLEUKIN 1 PRODUCTION,9.6689e-06,0.73515,0.71667,1,1
2,GO MATURE B CELL DIFFERENTIATION,2.4576e-05,0.73315,0.7216,1,1
2,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,5.2428e-05,0.73235,0.70215,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,8.3641e-05,0.73203,0.71705,1,1
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,1.7249e-05,0.73193,0.68311,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,3.7287e-05,0.73075,0.63989,1,1
2,GO GRANULOCYTE CHEMOTAXIS,1.8524e-05,0.73075,0.6961,1,1
2,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,1.3909e-05,0.73064,0.67259,1,1
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,2.2907e-05,0.73027,0.64984,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,3.248e-05,0.72959,0.68593,1,1
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,9.5377e-05,0.72753,0.64353,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,2.8267e-05,0.72707,0.66325,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00011593,0.72702,0.68119,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,3.9936e-05,0.72583,0.64883,1,1
2,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00013188,0.72461,0.69886,1,1
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,3.0304e-05,0.72417,0.67494,1,1
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,2.2907e-05,0.72409,0.66144,1,1
2,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,3.248e-05,0.72384,0.68501,1,1
2,GO LEUKOCYTE TETHERING OR ROLLING,0.00011593,0.72341,0.63273,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,3.9422e-06,0.72219,0.83473,1,1
2,GO ALPHA BETA T CELL ACTIVATION,4.2763e-05,0.722,0.6646,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,8.3641e-05,0.72172,0.64935,1,1
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,3.0304e-05,0.71912,0.67409,1,1
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,9.6689e-06,0.71875,0.73589,1,1
2,GO GERMINAL CENTER FORMATION,9.5377e-05,0.71872,0.76418,1,1
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,7.3279e-05,0.71844,0.75009,1,1
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,1.1191e-05,0.7175,0.75615,1,1
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,1.0403e-05,0.71699,0.75208,1,1
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,3.0304e-05,0.71633,0.68165,1,1
2,GO NEUROINFLAMMATORY RESPONSE,4.5779e-05,0.71617,0.68949,1,1
2,GO ETHANOL OXIDATION,1.4947e-05,0.71519,0.88788,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,4.5779e-05,0.71507,0.71252,1,1
2,GO NEGATIVE REGULATION OF BONE REMODELING,9.5377e-05,0.71436,0.67209,1,1
2,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,4.5779e-05,0.71199,0.63512,1,1
2,GO ALPHA BETA T CELL DIFFERENTIATION,4.5779e-05,0.71159,0.6646,1,1
2,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.00020554,0.71148,0.62274,1,1
2,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00024771,0.71118,0.616,1,1
2,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,4.2763e-05,0.70961,0.63487,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,1.7249e-05,0.70949,0.67183,1,1
2,GO INTERLEUKIN 17 PRODUCTION,2.2907e-05,0.7081,0.69287,1,1
2,GO B CELL MEDIATED IMMUNITY,2.4576e-05,0.70792,0.68193,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,3.0304e-05,0.70764,0.66184,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,3.0304e-05,0.70764,0.63855,1,1
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,2.8267e-05,0.70648,0.69172,1,1
2,GO INTERLEUKIN 8 PRODUCTION,7.7514e-06,0.70617,0.66196,1,1
2,GO LYMPHOCYTE MEDIATED IMMUNITY,3.0304e-05,0.70563,0.64369,1,1
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.1347e-05,0.70397,0.65827,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,2.1347e-05,0.7031,0.68256,1,1
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,2.8267e-05,0.70186,0.62624,1,1
2,GO REGULATION OF LYMPHOCYTE MIGRATION,4.2763e-05,0.70117,0.63466,1,1
2,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,2.4576e-05,0.70092,0.68583,1,1
2,GO REGULATION OF MYOBLAST FUSION,9.5377e-05,0.69786,0.67848,1,1
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,5.2428e-05,0.69762,0.69722,1,1
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,4.2763e-05,0.69066,0.63472,1,1
2,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,9.5377e-05,0.68752,0.70044,1,1
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.0304e-05,0.68695,0.61404,1,1
2,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,3.248e-05,0.68497,0.64268,1,1
2,GO REGULATION OF B CELL DIFFERENTIATION,6.4139e-05,0.68431,0.64906,1,1
2,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.00014989,0.68287,0.70225,1,1
2,GO REGULATION OF NEUTROPHIL MIGRATION,7.3279e-05,0.68248,0.64424,1,1
2,GO RESPONSE TO INTERFERON BETA,7.8298e-05,0.68045,0.59917,1,1
2,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,5.6086e-05,0.68044,0.59768,1,1
2,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,5.6086e-05,0.67956,0.65142,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,3.9936e-05,0.6788,0.6033,1,1
2,GO LEUKOCYTE CELL CELL ADHESION,3.7287e-05,0.67761,0.61084,1,1
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,8.3641e-05,0.6765,0.60404,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,3.248e-05,0.67622,0.62949,1,1
2,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,3.4805e-05,0.67518,0.61479,1,1
2,GO GAMMA DELTA T CELL ACTIVATION,0.00018128,0.67389,0.62311,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,7.1973e-06,0.67352,0.69965,1,1
2,GO ADHESION OF SYMBIONT TO HOST,0.0017696,0.6724,0.56066,1,1
2,GO MACROPHAGE MIGRATION,1.0403e-05,0.67221,0.65438,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00010866,0.67177,0.66531,1,1
2,GO REGULATION OF T CELL MIGRATION,5.2428e-05,0.67168,0.62863,1,1
2,GO CELLULAR EXTRAVASATION,4.5779e-05,0.67092,0.62752,1,1
2,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.3279e-05,0.66864,0.73163,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,3.9936e-05,0.66683,0.60472,1,1
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00042807,0.66612,0.64876,1,1
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,6.8565e-05,0.66463,0.73663,1,1
2,GO REGULATION OF PHAGOCYTOSIS,2.4576e-05,0.66416,0.63299,1,1
2,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,2.636e-05,0.66366,0.63577,1,1
2,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,1.3909e-05,0.66318,0.66096,1,1
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,2.1347e-05,0.66198,0.60946,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,3.9936e-05,0.66066,0.57802,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,4.2763e-05,0.66043,0.59934,1,1
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,3.7287e-05,0.66021,0.60971,1,1
2,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,9.5377e-05,0.65941,0.63805,1,1
2,GO INTERLEUKIN 5 PRODUCTION,0.00024771,0.65937,0.62274,1,1
2,GO CELLULAR RESPONSE TO ETHANOL,0.00012367,0.6588,0.56426,1,1
2,GO NATURAL KILLER CELL MEDIATED IMMUNITY,7.3279e-05,0.6587,0.61988,1,1
2,GO ANTIBACTERIAL HUMORAL RESPONSE,0.00045436,0.65848,0.58212,1,1
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,2.8267e-05,0.65759,0.64415,1,1
2,GO REGULATION OF T CELL DIFFERENTIATION,5.9985e-05,0.65699,0.57445,1,1
2,GO MACROPHAGE PROLIFERATION,0.00010181,0.65682,0.7491,1,1
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,2.4576e-05,0.65652,0.58519,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,3.0304e-05,0.65573,0.70362,1,1
2,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00013188,0.65519,0.55971,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,4.8997e-05,0.65423,0.60948,1,1
2,GO APOPTOTIC CELL CLEARANCE,4.5779e-05,0.65404,0.62467,1,1
2,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.4576e-05,0.65264,0.59716,1,1
2,GO CYTOKINE METABOLIC PROCESS,1.0403e-05,0.65137,0.64236,1,1
2,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010866,0.6512,0.6616,1,1
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,5.9985e-05,0.64989,0.56002,1,1
2,GO REGULATION OF MACROPHAGE MIGRATION,1.2035e-05,0.64975,0.63884,1,1
2,GO RESPONSE TO LIPOTEICHOIC ACID,1.4947e-05,0.64947,0.70589,1,1
2,GO LEUKOCYTE PROLIFERATION,4.8997e-05,0.64868,0.6048,1,1
2,GO REGULATION OF MACROPHAGE ACTIVATION,1.7249e-05,0.64742,0.66419,1,1
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,6.4139e-05,0.64733,0.65464,1,1
2,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.00076864,0.64651,0.54466,1,1
2,GO REGULATION OF B CELL ACTIVATION,6.4139e-05,0.64634,0.61517,1,1
2,GO MYELOID LEUKOCYTE MIGRATION,2.2907e-05,0.64531,0.59818,1,1
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,4.2763e-05,0.64514,0.61362,1,1
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,1.4947e-05,0.64507,0.62117,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,2.4576e-05,0.64507,0.64636,1,1
2,GO POSITIVE REGULATION OF B CELL PROLIFERATION,4.8997e-05,0.64424,0.59552,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,3.248e-05,0.64337,0.57819,1,1
2,GO CELL KILLING,2.4576e-05,0.64267,0.59131,1,1
2,GO POSITIVE REGULATION OF CELL ACTIVATION,3.7287e-05,0.64237,0.60292,1,1
2,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.4576e-05,0.64236,0.59116,1,1
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,3.0304e-05,0.64214,0.57907,1,1
2,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00019306,0.64131,0.58758,1,1
2,GO LEUKOCYTE APOPTOTIC PROCESS,3.248e-05,0.64066,0.58617,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,2.636e-05,0.64033,0.60829,1,1
2,GO RESPONSE TO INTERFERON ALPHA,0.00014989,0.63892,0.64357,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,3.7287e-05,0.63831,0.59545,1,1
2,GO T CELL DIFFERENTIATION,7.3279e-05,0.63685,0.55968,1,1
2,GO FIBRINOLYSIS,3.248e-05,0.63618,0.65434,1,1
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.00021879,0.63616,0.59402,1,1
2,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,2.8267e-05,0.63443,0.69973,1,1
2,GO INTEGRIN ACTIVATION,5.6086e-05,0.63386,0.64811,1,1
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,3.4805e-05,0.63376,0.59177,1,1
2,GO PHAGOCYTOSIS RECOGNITION,2.4576e-05,0.63362,0.65388,1,1
2,GO ASTROCYTE ACTIVATION,2.4576e-05,0.6335,0.58124,1,1
2,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,3.0304e-05,0.63333,0.66519,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,2.2907e-05,0.63321,0.58376,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,2.2907e-05,0.63239,0.57729,1,1
2,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.00019306,0.63232,0.62451,1,1
2,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00014989,0.63208,0.52656,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,2.2907e-05,0.63149,0.59317,1,1
2,GO NEUTROPHIL EXTRAVASATION,8.9327e-05,0.63109,0.62741,1,1
2,GO RESPONSE TO TYPE I INTERFERON,0.00015974,0.63089,0.57172,1,1
2,GO REGULATION OF T CELL ACTIVATION,5.9985e-05,0.63023,0.58345,1,1
2,GO HUMORAL IMMUNE RESPONSE,2.8267e-05,0.63002,0.64573,1,1
2,GO LEUKOCYTE CHEMOTAXIS,2.4576e-05,0.62995,0.61602,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00024771,0.62969,0.54539,1,1
2,GO T CELL PROLIFERATION,3.9936e-05,0.62849,0.6119,1,1
2,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.1347e-05,0.62826,0.58326,1,1
2,GO MACROPHAGE ACTIVATION,2.4576e-05,0.62825,0.66339,1,1
2,GO REGULATION OF PLATELET ACTIVATION,0.00020554,0.62786,0.58465,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,1.6059e-05,0.62769,0.58924,1,1
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,4.2763e-05,0.62699,0.58142,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,2.1347e-05,0.62692,0.59663,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,4.8997e-05,0.62679,0.57455,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,4.8997e-05,0.62652,0.5948,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.636e-05,0.62558,0.6036,1,1
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,6.4139e-05,0.6253,0.58564,1,1
2,GO REGULATION OF CELLULAR EXTRAVASATION,1.8524e-05,0.62503,0.67913,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,8.3461e-06,0.62417,0.67401,1,1
2,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,2.1347e-05,0.62331,0.66909,1,1
2,GO REGULATION OF BONE DEVELOPMENT,4.8997e-05,0.6231,0.60402,1,1
2,GO NATURAL KILLER CELL ACTIVATION,6.8565e-05,0.62307,0.55228,1,1
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,6.4139e-05,0.62301,0.55609,1,1
2,GO CD40 SIGNALING PATHWAY,3.4805e-05,0.62102,0.562,1,1
2,GO T HELPER 17 TYPE IMMUNE RESPONSE,4.2763e-05,0.62092,0.62074,1,1
2,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,7.8298e-05,0.61927,0.68209,1,1
2,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.00012367,0.61864,0.59619,1,1
2,GO T CELL APOPTOTIC PROCESS,2.8267e-05,0.61848,0.58317,1,1
2,GO PLASMINOGEN ACTIVATION,0.00011593,0.61677,0.57251,1,1
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00031664,0.61619,0.56108,1,1
2,GO MACROPHAGE CHEMOTAXIS,1.2035e-05,0.61536,0.61972,1,1
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,5.2428e-05,0.61532,0.55551,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.9888e-05,0.61334,0.58018,1,1
2,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.9985e-05,0.61318,0.56982,1,1
2,GO REGULATION OF MEMBRANE INVAGINATION,0.00011593,0.61282,0.66037,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,3.7287e-05,0.61266,0.61071,1,1
2,GO REGULATION OF PLASMINOGEN ACTIVATION,0.00033648,0.61219,0.56887,1,1
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,4.8997e-05,0.611,0.54737,1,1
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,5.9985e-05,0.61076,0.55634,1,1
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00015974,0.60961,0.55391,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,5.2428e-05,0.6096,0.54213,1,1
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00011593,0.60959,0.60708,1,1
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,2.8267e-05,0.60948,0.63809,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,5.337e-06,0.60911,0.67395,1,1
2,GO PROTEIN ACTIVATION CASCADE,6.4139e-05,0.6089,0.64773,1,1
2,GO MHC CLASS II BIOSYNTHETIC PROCESS,6.8565e-05,0.60883,0.56265,1,1
2,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,5.6086e-05,0.60871,0.53802,1,1
2,GO ETHANOL METABOLIC PROCESS,3.7287e-05,0.6083,0.67563,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00011593,0.60829,0.57189,1,1
2,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,2.1347e-05,0.60823,0.63377,1,1
2,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,0.00029789,0.60811,0.53622,1,1
2,GO AMYLOID BETA CLEARANCE,5.9985e-05,0.608,0.57513,1,1
2,GO T CELL ACTIVATION,5.2428e-05,0.60757,0.56083,1,1
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,5.9985e-05,0.60722,0.62094,1,1
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.6059e-05,0.60645,0.59759,1,1
2,GO REGULATION OF MACROPHAGE CHEMOTAXIS,2.1347e-05,0.60638,0.57897,1,1
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,3.4805e-05,0.60589,0.58218,1,1
2,GO INTERLEUKIN 6 PRODUCTION,3.4805e-05,0.60544,0.55368,1,1
2,GO I KAPPAB PHOSPHORYLATION,3.248e-05,0.60299,0.57211,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00020554,0.60298,0.56876,1,1
2,GO REGULATION OF CELL ACTIVATION,4.8997e-05,0.60224,0.54448,1,1
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,2.636e-05,0.60138,0.60424,1,1
2,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.0054671,0.60137,0.48391,1,1
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0003797,0.59959,0.5357,1,1
2,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,3.9936e-05,0.59809,0.62867,1,1
2,GO CYTOKINE SECRETION,2.8267e-05,0.59783,0.54156,1,1
2,GO ACUTE PHASE RESPONSE,1.9888e-05,0.59743,0.56648,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,1.9888e-05,0.597,0.58972,1,1
2,GO NEUTROPHIL HOMEOSTASIS,1.3909e-05,0.59535,0.60654,1,1
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,3.7287e-05,0.59507,0.52201,1,1
2,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,1.8524e-05,0.59481,0.57773,1,1
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00010866,0.59479,0.55538,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,3.0304e-05,0.59439,0.6054,1,1
2,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,1.9888e-05,0.59437,0.65703,1,1
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,3.9936e-05,0.59165,0.63099,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,6.4139e-05,0.59157,0.54716,1,1
2,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.9888e-05,0.59156,0.58749,1,1
2,GO LYMPHOCYTE APOPTOTIC PROCESS,3.0304e-05,0.59059,0.53944,1,1
2,GO ACUTE INFLAMMATORY RESPONSE,1.7249e-05,0.58896,0.54794,1,1
2,GO LYMPHOCYTE DIFFERENTIATION,6.8565e-05,0.58857,0.53294,1,1
2,GO IMMUNE RESPONSE TO TUMOR CELL,1.8524e-05,0.58815,0.58737,1,1
2,GO REGULATION OF LEUKOCYTE MIGRATION,1.8524e-05,0.58618,0.59086,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,5.2428e-05,0.58501,0.55198,1,1
2,GO T CELL LINEAGE COMMITMENT,0.00013188,0.58392,0.53572,1,1
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,4.5779e-05,0.58386,0.53937,1,1
2,GO CELL ADHESION MEDIATED BY INTEGRIN,0.00019306,0.58336,0.58057,1,1
2,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.00029789,0.58276,0.55044,1,1
2,GO BLEB ASSEMBLY,0.00045436,0.58221,0.56816,1,1
2,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,7.8298e-05,0.58098,0.56617,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.6086e-05,0.58077,0.60076,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,2.2907e-05,0.57871,0.59244,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,4.5779e-05,0.57643,0.53995,1,1
2,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,3.248e-05,0.57587,0.58797,1,1
2,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,6.4139e-05,0.57557,0.5097,1,1
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.4576e-05,0.57441,0.56233,1,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,1.2939e-05,0.57399,0.63602,1,1
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,4.8997e-05,0.57364,0.50677,1,1
2,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.00010866,0.57351,0.5385,1,1
2,GO PROSTANOID BIOSYNTHETIC PROCESS,8.9843e-06,0.57303,0.61535,1,1
2,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.00024771,0.57242,0.53645,1,1
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,3.248e-05,0.57206,0.6513,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,8.9327e-05,0.57144,0.51595,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00010866,0.571,0.6585,1,1
2,GO MACROPHAGE DIFFERENTIATION,4.2763e-05,0.57069,0.55584,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,2.8267e-05,0.57045,0.61298,1,1
2,GO RESPONSE TO MURAMYL DIPEPTIDE,4.8997e-05,0.57023,0.547,1,1
2,GO RESPONSE TO INTERLEUKIN 2,0.00072571,0.56997,0.54797,1,1
2,GO OSTEOCLAST DEVELOPMENT,8.3641e-05,0.56948,0.60491,1,1
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,5.2428e-05,0.56937,0.58923,1,1
2,GO INTERFERON ALPHA PRODUCTION,9.5377e-05,0.56887,0.50604,1,1
2,GO DEFENSE RESPONSE TO BACTERIUM,2.2907e-05,0.56619,0.53571,1,1
2,GO RESPIRATORY BURST,0.00010866,0.56573,0.56145,1,1
2,GO REGULATION OF IMMUNE RESPONSE,3.7287e-05,0.56336,0.50675,1,1
2,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00045436,0.56285,0.5528,1,1
2,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.00018128,0.56218,0.50159,1,1
2,GO POSITIVE REGULATION OF CYTOKINE SECRETION,5.6086e-05,0.5604,0.52112,1,1
2,GO LYMPHOCYTE ACTIVATION,6.4139e-05,0.56029,0.51623,1,1
2,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00012367,0.55914,0.55253,1,1
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,1.1191e-05,0.55708,0.63956,1,1
2,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00024771,0.55706,0.57975,1,1
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,2.1347e-05,0.55698,0.54351,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,5.6086e-05,0.55611,0.50812,1,1
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,3.7287e-05,0.55541,0.5329,1,1
2,GO REGULATION OF B CELL MEDIATED IMMUNITY,6.4139e-05,0.55486,0.53859,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00035748,0.55466,0.48041,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00033648,0.55465,0.47865,1,1
2,GO PHAGOCYTOSIS,3.248e-05,0.55287,0.53318,1,1
2,GO POSITIVE REGULATION OF B CELL ACTIVATION,5.2428e-05,0.55263,0.55701,1,1
2,GO BONE TRABECULA MORPHOGENESIS,0.0063209,0.55227,0.44507,1,1
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.00014989,0.55176,0.51257,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,3.7287e-05,0.5511,0.52551,1,1
2,GO CELL JUNCTION DISASSEMBLY,0.00010866,0.55089,0.65717,1,1
2,GO LEUKOCYTE HOMEOSTASIS,8.9327e-05,0.55036,0.49484,1,1
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,1.9888e-05,0.5499,0.6582,1,1
2,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,8.3641e-05,0.54956,0.50555,1,1
2,GO LYMPH NODE DEVELOPMENT,0.00033648,0.54951,0.53371,1,1
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.0304e-05,0.54816,0.51436,1,1
2,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,2.8267e-05,0.54793,0.53692,1,1
2,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,1.9888e-05,0.54791,0.53644,1,1
2,GO ZYMOGEN INHIBITION,3.248e-05,0.54752,0.5746,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,4.5779e-05,0.54516,0.50092,1,1
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.8524e-05,0.54511,0.54365,1,1
2,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00014989,0.54401,0.53361,1,1
2,GO NAD BIOSYNTHETIC PROCESS,1.4947e-05,0.54313,0.51579,1,1
2,GO REGULATION OF AMYLOID BETA CLEARANCE,6.4139e-05,0.54272,0.54439,1,1
2,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,9.5377e-05,0.5424,0.4713,1,1
2,GO CHEMOKINE PRODUCTION,1.1191e-05,0.54219,0.56471,1,1
2,GO B CELL HOMEOSTASIS,0.00026348,0.542,0.47315,1,1
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,9.6689e-06,0.54156,0.57814,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,2.1347e-05,0.5415,0.52839,1,1
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,3.248e-05,0.54133,0.52863,1,1
2,GO CYTIDINE TO URIDINE EDITING,7.8298e-05,0.54114,0.57808,1,1
2,GO CELL CHEMOTAXIS,3.7287e-05,0.54109,0.54591,1,1
2,GO MACROPHAGE CYTOKINE PRODUCTION,0.00024771,0.54108,0.58595,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,5.6086e-05,0.5397,0.49699,1,1
2,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.2907e-05,0.53873,0.54753,1,1
2,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,1.6059e-05,0.53743,0.61079,1,1
2,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,3.7287e-05,0.53583,0.65821,1,1
2,GO REGULATION OF CELL CELL ADHESION,5.6086e-05,0.53525,0.50452,1,1
2,GO LEUKOCYTE DIFFERENTIATION,4.8997e-05,0.53514,0.50324,1,1
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,7.3279e-05,0.53478,0.45948,1,1
2,GO LYMPHOCYTE HOMEOSTASIS,0.00013188,0.53394,0.47185,1,1
2,GO INFLAMMATORY RESPONSE,3.0304e-05,0.53273,0.51498,1,1
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.00010866,0.53193,0.49252,1,1
2,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00013188,0.5319,0.45725,1,1
2,GO B CELL ACTIVATION,7.3279e-05,0.53161,0.52375,1,1
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,2.8267e-05,0.5309,0.60446,1,1
2,GO ACTIVATION OF IMMUNE RESPONSE,3.9936e-05,0.53061,0.48792,1,1
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,3.7287e-05,0.5306,0.46415,1,1
2,GO INNATE IMMUNE RESPONSE,2.4576e-05,0.53059,0.50048,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,3.4805e-05,0.5291,0.4897,1,1
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.7287e-05,0.52857,0.48186,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,5.6086e-05,0.52857,0.50973,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,7.8298e-05,0.52843,0.57684,1,1
2,GO LEUKOCYTE MIGRATION,4.5779e-05,0.52827,0.52824,1,1
2,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,8.3641e-05,0.52814,0.52969,1,1
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,3.7287e-05,0.52669,0.49015,1,1
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,1.6059e-05,0.5265,0.54687,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.0304e-05,0.52575,0.49656,1,1
2,GO MYELOID LEUKOCYTE DIFFERENTIATION,3.0304e-05,0.52428,0.47679,1,1
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00020554,0.5236,0.5211,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010181,0.52291,0.49847,1,1
2,GO IMMUNOGLOBULIN PRODUCTION,4.2763e-05,0.52276,0.51178,1,1
2,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,3.248e-05,0.52195,0.53712,1,1
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,1.9888e-05,0.52151,0.59126,1,1
2,GO MEMBRANE RAFT ORGANIZATION,0.00013188,0.52139,0.54146,1,1
2,GO ICOSANOID BIOSYNTHETIC PROCESS,1.6059e-05,0.52046,0.55191,1,1
2,GO VITAMIN D METABOLIC PROCESS,0.00010866,0.52021,0.49008,1,1
2,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,6.8565e-05,0.51935,0.50516,1,1
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,2.8267e-05,0.51909,0.47829,1,1
2,GO HEMIDESMOSOME ASSEMBLY,0.025096,0.51853,0.4636,1,1
2,GO REGULATION OF MAST CELL ACTIVATION,0.00020554,0.51803,0.48462,1,1
2,GO RESPONSE TO HYDROPEROXIDE,0.00023283,0.51676,0.50702,1,1
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,3.248e-05,0.5157,0.46958,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,3.0304e-05,0.51569,0.47744,1,1
2,GO REGULATION OF INTEGRIN ACTIVATION,0.00023283,0.51522,0.49913,1,1
2,GO RESPONSE TO BACTERIUM,3.0304e-05,0.51498,0.51207,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,9.5377e-05,0.51457,0.60263,1,1
2,GO PEPTIDE CROSS LINKING,0.00017019,0.51417,0.52923,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,5.9985e-05,0.51303,0.47798,1,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.0403e-05,0.51163,0.53197,1,1
2,GO POSITIVE REGULATION OF CELL ADHESION,4.5779e-05,0.5114,0.51216,1,1
2,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.0011418,0.51129,0.49503,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,2.4576e-05,0.5088,0.50547,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,5.6086e-05,0.50873,0.51732,1,1
2,GO REGULATION OF RESPONSE TO TUMOR CELL,0.00010181,0.50872,0.49725,1,1
2,GO SUPEROXIDE ANION GENERATION,8.3641e-05,0.50857,0.48325,1,1
2,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00029789,0.50816,0.48153,1,1
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.00010181,0.50758,0.47548,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00035748,0.50604,0.4735,1,1
2,GO LEUKOCYTE MEDIATED IMMUNITY,2.636e-05,0.50514,0.47225,1,1
2,GO T HELPER 2 CELL CYTOKINE PRODUCTION,4.2763e-05,0.5049,0.58574,1,1
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00015974,0.50483,0.52554,1,1
2,GO GAMMA DELTA T CELL DIFFERENTIATION,0.00045436,0.50288,0.50441,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE,3.0304e-05,0.50145,0.49056,1,1
2,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.9985e-05,0.50118,0.49589,1,1
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,3.4805e-05,0.50056,0.52049,1,1
2,GO CYTOKINE PRODUCTION,3.4805e-05,0.49999,0.47201,1,1
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00014989,0.49906,0.49225,1,1
2,GO REGULATION OF FIBRINOLYSIS,3.7287e-05,0.49864,0.60673,1,1
2,GO MYOBLAST FUSION,9.5377e-05,0.49827,0.4944,1,1
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,3.0304e-05,0.49686,0.49937,1,1
2,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,8.3641e-05,0.49643,0.45298,1,1
2,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0063209,0.49638,0.38045,1,1
2,GO RESPONSE TO TUMOR CELL,9.5377e-05,0.4963,0.48504,1,1
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.7287e-05,0.49596,0.4867,1,1
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,4.5779e-05,0.49569,0.44616,1,1
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00018128,0.4952,0.45723,1,1
2,GO T CELL DIFFERENTIATION IN THYMUS,0.00014062,0.49444,0.47779,1,1
2,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.0017696,0.49403,0.47776,1,1
2,GO IMMUNE EFFECTOR PROCESS,3.248e-05,0.4922,0.46035,1,1
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.8267e-05,0.49112,0.46195,1,1
2,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.00014989,0.49108,0.56386,1,1
2,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.248e-05,0.49008,0.48596,1,1
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,7.8298e-05,0.48953,0.42857,1,1
2,GO MULTI ORGANISM CELLULAR PROCESS,6.4139e-05,0.48904,0.55183,1,1
2,GO REGULATION OF MACROPHAGE DIFFERENTIATION,3.248e-05,0.48838,0.50366,1,1
2,GO IMMUNOLOGICAL MEMORY PROCESS,0.00054254,0.48837,0.51522,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.0012071,0.48831,0.42745,1,1
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00040321,0.48773,0.47555,1,1
2,GO MAST CELL MEDIATED IMMUNITY,0.00081392,0.48616,0.4243,1,1
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.00014989,0.48582,0.49622,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00040321,0.48529,0.46756,1,1
2,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.00010866,0.48488,0.49952,1,1
2,GO TUMOR NECROSIS FACTOR SECRETION,2.636e-05,0.48379,0.48654,1,1
2,GO REGULATION OF STEM CELL DIVISION,0.00081392,0.48368,0.48866,1,1
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,3.9936e-05,0.48285,0.57414,1,1
2,GO OSTEOCLAST DIFFERENTIATION,7.8298e-05,0.48228,0.44798,1,1
2,GO MACROPHAGE APOPTOTIC PROCESS,0.00096503,0.48226,0.44079,1,1
2,GO POSITIVE REGULATION OF CHEMOTAXIS,0.00010181,0.48193,0.47228,1,1
2,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.00013188,0.4819,0.47982,1,1
2,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.00014989,0.48174,0.53699,1,1
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,2.1347e-05,0.48164,0.53693,1,1
2,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,2.2907e-05,0.48154,0.48605,1,1
2,GO SEROTONIN SECRETION,0.00096503,0.48105,0.43873,1,1
2,GO MYELOID LEUKOCYTE ACTIVATION,3.4805e-05,0.48047,0.4638,1,1
2,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,1.7249e-05,0.48021,0.56977,1,1
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,6.4139e-05,0.48006,0.7158,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00021879,0.47943,0.51382,1,1
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.00086166,0.47888,0.43904,1,1
2,GO DEFENSE RESPONSE TO VIRUS,0.00014989,0.4774,0.43259,1,1
2,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.00024771,0.47696,0.51866,1,1
2,GO T CELL RECEPTOR SIGNALING PATHWAY,6.4139e-05,0.47679,0.43046,1,1
2,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.0013481,0.47659,0.47204,1,1
2,GO FLUID TRANSPORT,0.00048214,0.47543,0.46087,1,1
2,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.00057531,0.47522,0.41342,1,1
2,GO NEGATIVE REGULATION OF VIRAL PROCESS,7.3279e-05,0.47516,0.46404,1,1
2,GO DEFENSE RESPONSE,3.4805e-05,0.47446,0.44326,1,1
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.00017019,0.47442,0.47669,1,1
2,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.00081392,0.47409,0.40082,1,1
2,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00060992,0.47366,0.50421,1,1
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,3.7287e-05,0.47361,0.47335,1,1
2,GO IRON ION TRANSMEMBRANE TRANSPORT,8.3641e-05,0.47238,0.43887,1,1
2,GO RESPONSE TO PROSTAGLANDIN,0.00035748,0.47232,0.42937,1,1
2,GO OLIGOSACCHARIDE CATABOLIC PROCESS,3.7287e-05,0.47196,0.50241,1,1
2,GO REVERSE CHOLESTEROL TRANSPORT,0.00057531,0.47156,0.47113,1,1
2,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00013188,0.47097,0.5539,1,1
2,GO RESPONSE TO BIOTIC STIMULUS,3.0304e-05,0.47083,0.4372,1,1
2,GO ELASTIC FIBER ASSEMBLY,0.0011418,0.47059,0.71244,1,1
2,GO MONONUCLEAR CELL DIFFERENTIATION,2.4576e-05,0.47043,0.56401,1,1
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.7249e-05,0.4703,0.53471,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,6.8565e-05,0.47019,0.58748,1,1
2,GO ASTROCYTE DEVELOPMENT,0.00010181,0.46927,0.46586,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,4.8997e-05,0.46849,0.53012,1,1
2,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00026348,0.46792,0.49154,1,1
2,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.00031664,0.46747,0.42678,1,1
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.00042807,0.46713,0.40861,1,1
2,GO POSITIVE REGULATION OF HEMOPOIESIS,2.8267e-05,0.46645,0.47636,1,1
2,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.00012367,0.4662,0.65655,1,1
2,GO FOAM CELL DIFFERENTIATION,8.9327e-05,0.46611,0.47587,1,1
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,3.0304e-05,0.46413,0.53923,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.00048214,0.46401,0.47551,1,1
2,GO BONE RESORPTION,0.00017019,0.46383,0.45217,1,1
2,GO RESPONSE TO VIRUS,9.5377e-05,0.46369,0.41607,1,1
2,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.00024771,0.46333,0.4547,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00015974,0.46224,0.47291,1,1
2,GO ACTIVATED T CELL PROLIFERATION,0.00048214,0.46164,0.40864,1,1
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,4.2763e-05,0.46155,0.45582,1,1
2,GO T CELL HOMEOSTASIS,0.00031664,0.46128,0.37867,1,1
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,4.8997e-05,0.46098,0.57882,1,1
2,GO B CELL DIFFERENTIATION,8.9327e-05,0.46088,0.5043,1,1
2,GO CELL ACTIVATION,5.2428e-05,0.4602,0.43512,1,1
2,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.00020554,0.46011,0.45794,1,1
2,GO MEMBRANE INVAGINATION,0.00012367,0.45862,0.47625,1,1
2,GO RESPONSE TO PROSTAGLANDIN E,0.0016767,0.45683,0.39525,1,1
2,GO SYNCYTIUM FORMATION,5.6086e-05,0.45674,0.47059,1,1
2,GO MYELOID CELL APOPTOTIC PROCESS,1.2939e-05,0.45658,0.46506,1,1
2,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,7.3279e-05,0.45608,0.41132,1,1
2,GO LEUKOTRIENE METABOLIC PROCESS,4.8997e-05,0.45583,0.50689,1,1
2,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,9.5377e-05,0.45579,0.47011,1,1
2,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.00021879,0.45535,0.47787,1,1
2,GO ANTIMICROBIAL HUMORAL RESPONSE,0.00023283,0.45503,0.47201,1,1
2,GO PROTEIN CONTAINING COMPLEX REMODELING,9.5377e-05,0.45342,0.44711,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,4.2763e-05,0.4519,0.50232,1,1
2,GO FEVER GENERATION,4.8997e-05,0.45184,0.46227,1,1
2,GO WATER TRANSPORT,0.00086166,0.45183,0.49776,1,1
2,GO MITRAL VALVE DEVELOPMENT,0.0042727,0.45166,0.36565,1,1
2,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00023283,0.45042,0.50416,1,1
2,GO STORE OPERATED CALCIUM ENTRY,0.00020554,0.44999,0.40098,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00014989,0.44938,0.53801,1,1
2,GO LIPOPROTEIN LOCALIZATION,0.0003797,0.44937,0.39995,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,5.9985e-05,0.44839,0.48746,1,1
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,3.7287e-05,0.44791,0.423,1,1
2,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,1.3909e-05,0.4476,0.44721,1,1
2,GO HETEROTYPIC CELL CELL ADHESION,3.9936e-05,0.44626,0.4721,1,1
2,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.00028019,0.44595,0.40846,1,1
2,GO AMINE CATABOLIC PROCESS,0.00010866,0.44578,0.40322,1,1
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.00013188,0.44559,0.42335,1,1
2,GO ZYMOGEN ACTIVATION,5.9985e-05,0.44555,0.46886,1,1
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,1.8524e-05,0.44524,0.48846,1,1
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,8.9327e-05,0.44521,0.42849,1,1
2,GO RESPONSE TO FUNGUS,0.00054254,0.44512,0.43821,1,1
2,GO GAS TRANSPORT,0.0047188,0.44507,0.40175,1,1
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00020554,0.44451,0.37176,1,1
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.7287e-05,0.44395,0.4765,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0015041,0.44346,0.39612,1,1
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,7.3279e-05,0.44232,0.42028,1,1
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.1347e-05,0.44166,0.45446,1,1
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.00054254,0.44103,0.44536,1,1
2,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.00042807,0.4406,0.44712,1,1
2,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.00026348,0.4404,0.44212,1,1
2,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00012367,0.43965,0.44685,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,3.4805e-05,0.43948,0.45918,1,1
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.00011593,0.43751,0.48274,1,1
2,GO GRANULOCYTE DIFFERENTIATION,2.2907e-05,0.43724,0.50416,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,3.0304e-05,0.43409,0.40023,1,1
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00014989,0.43392,0.43094,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,3.248e-05,0.43337,0.48752,1,1
2,GO THYMOCYTE APOPTOTIC PROCESS,0.00018128,0.43284,0.42296,1,1
2,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.00031664,0.43275,0.60902,1,1
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.00060992,0.43254,0.43959,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00024771,0.43174,0.41076,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00026348,0.43156,0.42036,1,1
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,8.9327e-05,0.43077,0.52889,1,1
2,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.00033648,0.43045,0.52092,1,1
2,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,2.4576e-05,0.43021,0.52029,1,1
2,GO PYROPTOSIS,0.00054254,0.42978,0.4244,1,1
2,GO COLLAGEN CATABOLIC PROCESS,0.00012367,0.42972,0.50646,1,1
2,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.00010181,0.42909,0.45752,1,1
2,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,1.6059e-05,0.42901,0.47218,1,1
2,GO ACTIN FILAMENT SEVERING,0.00012367,0.42772,0.48839,1,1
2,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.0018673,0.42767,0.40958,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,3.7287e-05,0.42732,0.41532,1,1
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00035748,0.42695,0.42284,1,1
2,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,8.9327e-05,0.42692,0.46679,1,1
2,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.00012367,0.42641,0.4579,1,1
2,GO CHOLESTEROL STORAGE,0.00014062,0.42593,0.47662,1,1
2,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.00057531,0.4254,0.41427,1,1
2,GO POSITIVE REGULATION OF COAGULATION,2.8267e-05,0.42487,0.49125,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.1347e-05,0.42395,0.41974,1,1
2,GO REGULATION OF DEFENSE RESPONSE,3.9936e-05,0.42366,0.40207,1,1
2,GO BONE CELL DEVELOPMENT,0.00019306,0.4236,0.4434,1,1
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.1191e-05,0.42302,0.44379,1,1
2,GO ENTRY INTO HOST,5.2428e-05,0.42232,0.43798,1,1
2,GO PROSTANOID METABOLIC PROCESS,1.8524e-05,0.42193,0.45561,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00023283,0.42137,0.43142,1,1
2,GO RESPONSE TO INTERLEUKIN 1,1.4947e-05,0.42127,0.39844,1,1
2,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.00026348,0.42085,0.40546,1,1
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00018128,0.42084,0.40535,1,1
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00013188,0.42061,0.37633,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,3.7287e-05,0.41893,0.40863,1,1
2,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.3909e-05,0.41869,0.46964,1,1
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0021907,0.41803,0.37609,1,1
2,GO PSEUDOPODIUM ORGANIZATION,0.00096503,0.41793,0.36681,1,1
2,GO REGULATION OF CHEMOTAXIS,7.3279e-05,0.41756,0.42905,1,1
2,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00019306,0.41745,0.46832,1,1
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00014989,0.41714,0.44372,1,1
2,GO RESPONSE TO INTERLEUKIN 4,5.6086e-05,0.41708,0.43033,1,1
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,4.8997e-05,0.41704,0.39548,1,1
2,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.00021879,0.41633,0.46514,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00018128,0.41585,0.37368,1,1
2,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0012071,0.41579,0.36245,1,1
2,GO SOMATIC STEM CELL DIVISION,0.0049572,0.41521,0.40119,1,1
2,GO ERK1 AND ERK2 CASCADE,3.9936e-05,0.41451,0.42944,1,1
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,5.2428e-05,0.4145,0.40318,1,1
2,GO DNA DEAMINATION,0.00068502,0.4142,0.3932,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.00035748,0.41369,0.35744,1,1
2,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00091199,0.41347,0.40178,1,1
2,GO CELL ADHESION MOLECULE PRODUCTION,0.00020554,0.41347,0.49609,1,1
2,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,4.5779e-05,0.41089,0.44497,1,1
2,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00018128,0.41079,0.47231,1,1
2,GO RESPONSE TO INTERLEUKIN 6,0.0003797,0.41071,0.41745,1,1
2,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.00013188,0.41066,0.4412,1,1
2,GO RETINOL METABOLIC PROCESS,2.2907e-05,0.41023,0.40895,1,1
2,GO PROGRAMMED NECROTIC CELL DEATH,6.8565e-05,0.40941,0.40826,1,1
2,GO HYALURONAN CATABOLIC PROCESS,4.8997e-05,0.40868,0.49562,1,1
2,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,3.4805e-05,0.40768,0.37936,1,1
2,GO RESPONSE TO CYTOKINE,4.2763e-05,0.40741,0.39594,1,1
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,3.0304e-05,0.40689,0.42028,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00019306,0.40656,0.41033,1,1
2,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00064645,0.40645,0.42883,1,1
2,GO MUCUS SECRETION,5.2428e-05,0.40541,0.46475,1,1
2,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00057531,0.40496,0.36708,1,1
2,GO OXYGEN TRANSPORT,0.058535,0.40474,0.26083,1,1
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,2.636e-05,0.4045,0.39682,1,1
2,GO TRANSCYTOSIS,0.0021907,0.40449,0.40308,1,1
2,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00096503,0.40385,0.42519,1,1
2,GO PINOCYTOSIS,0.00031664,0.40306,0.40551,1,1
2,GO LIPOXYGENASE PATHWAY,0.0023095,0.40304,0.42043,1,1
2,GO GLYCOLIPID CATABOLIC PROCESS,0.00031664,0.403,0.45278,1,1
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,1.7249e-05,0.40294,0.45891,1,1
2,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00014989,0.40281,0.42228,1,1
2,GO KERATAN SULFATE CATABOLIC PROCESS,0.00064645,0.40257,0.56703,1,1
2,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00013188,0.40165,0.46604,1,1
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00086166,0.40078,0.46263,1,1
2,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00042807,0.39956,0.43074,1,1
2,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00029789,0.39937,0.44721,1,1
2,GO GAP JUNCTION ASSEMBLY,0.0010209,0.39927,0.49937,1,1
2,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00021879,0.39882,0.44881,1,1
2,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00024771,0.39776,0.40649,1,1
2,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.00057531,0.39768,0.4487,1,1
2,GO SKIN MORPHOGENESIS,0.006955,0.39753,0.37316,1,1
2,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,4.5779e-05,0.39741,0.453,1,1
2,GO NATURAL KILLER CELL DIFFERENTIATION,0.00068502,0.39521,0.39044,1,1
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.00023283,0.39477,0.40549,1,1
2,GO DIET INDUCED THERMOGENESIS,0.0018673,0.39475,0.34895,1,1
2,GO EXTRACELLULAR MATRIX DISASSEMBLY,4.5779e-05,0.39417,0.50116,1,1
2,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,7.3279e-05,0.39414,0.3911,1,1
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,7.3279e-05,0.39357,0.38018,1,1
2,GO CELLULAR RESPONSE TO LITHIUM ION,0.00014989,0.39323,0.32253,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00012367,0.39281,0.37871,1,1
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,8.3641e-05,0.39258,0.41383,1,1
2,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00060992,0.3921,0.40072,1,1
2,GO PROTEIN TRIMERIZATION,0.00011593,0.3914,0.47523,1,1
2,GO REGULATION OF STEROL TRANSPORT,0.00010866,0.38989,0.39555,1,1
2,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00012367,0.38985,0.54124,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,2.4576e-05,0.3891,0.41073,1,1
2,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,5.9985e-05,0.38845,0.45302,1,1
2,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00076864,0.38827,0.3759,1,1
2,GO AMYLOID FIBRIL FORMATION,0.00026348,0.38768,0.39591,1,1
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,7.7514e-06,0.38766,0.48411,1,1
2,GO LIVER MORPHOGENESIS,8.9327e-05,0.3875,0.39812,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00042807,0.38709,0.39981,1,1
2,GO ETHANOL CATABOLIC PROCESS,0.00017019,0.3862,0.41468,1,1
2,GO REGULATION OF BONE REMODELING,0.0010798,0.38608,0.36484,1,1
2,GO PODOSOME ASSEMBLY,0.00045436,0.38602,0.43875,1,1
2,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0013481,0.38574,0.39104,1,1
2,GO REGULATION OF LIPASE ACTIVITY,1.4947e-05,0.38556,0.41645,1,1
2,GO REGULATION OF HEMOPOIESIS,6.4139e-05,0.38543,0.38529,1,1
2,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.00017019,0.38528,0.46334,1,1
2,GO CHONDROCYTE PROLIFERATION,0.0038653,0.38509,0.35434,1,1
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,3.7287e-05,0.38484,0.42966,1,1
2,GO REGULATION OF PODOSOME ASSEMBLY,0.00054254,0.38455,0.42192,1,1
2,GO REGULATION OF COAGULATION,0.00021879,0.38438,0.4502,1,1
2,GO COLLAGEN BIOSYNTHETIC PROCESS,0.00035748,0.3838,0.46897,1,1
2,GO PLATELET DEGRANULATION,0.00020554,0.38373,0.45276,1,1
2,GO COLLAGEN METABOLIC PROCESS,0.00026348,0.38316,0.45905,1,1
2,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.00010866,0.38218,0.4444,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00026348,0.382,0.32691,1,1
2,GO ENDODERMAL CELL DIFFERENTIATION,0.0021907,0.38177,0.4319,1,1
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,2.4576e-05,0.3815,0.4431,1,1
2,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0014241,0.38074,0.35616,1,1
2,GO STEROL HOMEOSTASIS,3.248e-05,0.3805,0.3983,1,1
2,GO REGULATION OF PLATELET AGGREGATION,0.0025648,0.38023,0.38472,1,1
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00040321,0.38002,0.3017,1,1
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0034935,0.37938,0.31014,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.0003797,0.3792,0.34681,1,1
2,GO OSTEOBLAST DEVELOPMENT,0.0029965,0.379,0.30779,1,1
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.9936e-05,0.37863,0.42332,1,1
2,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.0010209,0.37853,0.40023,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00040321,0.37805,0.41589,1,1
2,GO RESPONSE TO INTERLEUKIN 7,0.00019306,0.37791,0.38616,1,1
2,GO PLATELET AGGREGATION,0.0012071,0.37778,0.38801,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00040321,0.37766,0.46013,1,1
2,GO INTERFERON BETA PRODUCTION,0.00033648,0.37732,0.38043,1,1
2,GO CELLULAR RESPONSE TO VIRUS,0.0003797,0.37719,0.3729,1,1
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,2.8267e-05,0.37636,0.41638,1,1
2,GO NIK NF KAPPAB SIGNALING,3.4805e-05,0.37614,0.35308,1,1
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.3909e-05,0.37545,0.44605,1,1
2,GO REGULATION OF TISSUE REMODELING,0.00081392,0.37476,0.36558,1,1
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,2.636e-05,0.3747,0.48167,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,6.8565e-05,0.37463,0.43234,1,1
2,GO PLATELET ACTIVATION,0.0015882,0.37396,0.35793,1,1
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.00026348,0.37369,0.40196,1,1
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.008797,0.37361,0.37169,1,1
2,GO TRABECULA FORMATION,0.0038653,0.37335,0.3447,1,1
2,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.00060992,0.37319,0.4425,1,1
2,GO POSITIVE REGULATION OF LIPID STORAGE,0.0010209,0.37271,0.38821,1,1
2,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,4.8997e-05,0.37237,0.40201,1,1
2,GO FATTY ACID DERIVATIVE TRANSPORT,8.9327e-05,0.37203,0.35954,1,1
2,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,7.8298e-05,0.37148,0.35641,1,1
2,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00010181,0.37099,0.38734,1,1
2,GO REGULATION OF RECEPTOR BINDING,0.00054254,0.37078,0.37673,1,1
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,3.7287e-05,0.37077,0.38062,1,1
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.00033648,0.37067,0.36992,1,1
2,GO VAGINA DEVELOPMENT,0.0019699,0.36992,0.36644,1,1
2,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.0029965,0.3699,0.41923,1,1
2,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.00033648,0.36964,0.39603,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00048214,0.36953,0.43107,1,1
2,GO REGULATION OF CELL ADHESION,0.00014062,0.36924,0.41025,1,1
2,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.00014062,0.36922,0.35307,1,1
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.00024771,0.36833,0.46724,1,1
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,1.4947e-05,0.36804,0.43513,1,1
2,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,3.4805e-05,0.36738,0.36099,1,1
2,GO SERTOLI CELL DEVELOPMENT,0.00060992,0.36718,0.34437,1,1
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00010181,0.36706,0.4874,1,1
2,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00054254,0.36687,0.39156,1,1
2,GO RENAL ABSORPTION,5.2428e-05,0.3662,0.51471,1,1
2,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00031664,0.36611,0.43466,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,9.6689e-06,0.36601,0.42174,1,1
2,GO RESPONSE TO FLUID SHEAR STRESS,0.00011593,0.3659,0.46504,1,1
2,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,3.7287e-05,0.36557,0.43218,1,1
2,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00040321,0.3651,0.3626,1,1
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,8.9327e-05,0.36477,0.38567,1,1
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0016767,0.36452,0.35764,1,1
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,3.9936e-05,0.3645,0.37139,1,1
2,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0027019,0.36407,0.33605,1,1
2,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00018128,0.36288,0.38427,1,1
2,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00035748,0.36271,0.38478,1,1
2,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.00064645,0.3613,0.38347,1,1
2,GO I KAPPAB KINASE NF KAPPAB SIGNALING,5.6086e-05,0.36074,0.38299,1,1
2,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,8.3641e-05,0.36059,0.40507,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.00051151,0.36017,0.43928,1,1
2,GO MOVEMENT IN HOST ENVIRONMENT,6.4139e-05,0.35982,0.37444,1,1
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.2907e-05,0.35971,0.43984,1,1
2,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.0052065,0.3594,0.40967,1,1
2,GO P38MAPK CASCADE,2.8267e-05,0.3592,0.41471,1,1
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00023283,0.35918,0.43261,1,1
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00019306,0.35886,0.38149,1,1
2,GO AMINOGLYCAN CATABOLIC PROCESS,0.00024771,0.35868,0.40215,1,1
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.00021879,0.35814,0.36487,1,1
2,GO RESPONSE TO MINERALOCORTICOID,0.0003797,0.35798,0.32801,1,1
2,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00024771,0.35782,0.40323,1,1
2,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.00081392,0.35656,0.39377,1,1
2,GO SEQUESTERING OF METAL ION,0.00091199,0.35591,0.35187,1,1
2,GO INTERACTION WITH SYMBIONT,1.9888e-05,0.35537,0.36391,1,1
2,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0024341,0.35509,0.39363,1,1
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0076456,0.35429,0.36359,1,1
2,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00023283,0.35396,0.42023,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00035748,0.35368,0.33222,1,1
2,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00012367,0.35338,0.41413,1,1
2,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00035748,0.35338,0.40861,1,1
2,GO RESPONSE TO MANGANESE ION,5.6086e-05,0.35314,0.36867,1,1
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00021879,0.35231,0.3692,1,1
2,GO SUPEROXIDE METABOLIC PROCESS,0.00010866,0.35225,0.3632,1,1
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,4.5779e-05,0.35187,0.39557,1,1
2,GO COPPER ION TRANSPORT,0.00064645,0.35173,0.32378,1,1
2,GO ARACHIDONIC ACID METABOLIC PROCESS,7.3279e-05,0.3516,0.37977,1,1
2,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0042727,0.35098,0.33182,1,1
2,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.0027019,0.35014,0.49176,1,1
2,GO CALCIUM MEDIATED SIGNALING,0.00028019,0.35008,0.34381,1,1
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.00017019,0.34978,0.36298,1,1
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,7.3279e-05,0.34959,0.43512,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,6.4139e-05,0.34954,0.39305,1,1
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00013188,0.34953,0.48344,1,1
2,GO RESPONSE TO ANGIOTENSIN,0.00011593,0.34947,0.35725,1,1
2,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.0016767,0.34831,0.38237,1,1
2,GO DEFENSE RESPONSE TO FUNGUS,0.00332,0.34831,0.36288,1,1
2,GO ETHER BIOSYNTHETIC PROCESS,0.00048214,0.34829,0.35318,1,1
2,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.00015974,0.34822,0.34632,1,1
2,GO COLLAGEN FIBRIL ORGANIZATION,0.0049572,0.3481,0.46554,1,1
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.00010181,0.34804,0.40706,1,1
2,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,3.9936e-05,0.34769,0.36839,1,1
2,GO SALIVA SECRETION,0.0040644,0.34744,0.3199,1,1
2,GO TYPE I INTERFERON PRODUCTION,0.00035748,0.34742,0.33843,1,1
2,GO RESPONSE TO THYROID HORMONE,0.0014241,0.3469,0.30554,1,1
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00021879,0.34653,0.36244,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,6.4139e-05,0.34641,0.39855,1,1
2,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00012367,0.34616,0.43436,1,1
2,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00026348,0.34557,0.35427,1,1
2,GO BONE REMODELING,0.00042807,0.34539,0.38279,1,1
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.0010798,0.34534,0.33918,1,1
2,GO PHOSPHOLIPID HOMEOSTASIS,6.8565e-05,0.34487,0.3815,1,1
2,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.00048214,0.3447,0.341,1,1
2,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.0010209,0.34457,0.37838,1,1
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0096484,0.34455,0.29828,1,1
2,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.0028457,0.34434,0.32957,1,1
2,GO TRANSEPITHELIAL TRANSPORT,0.0023095,0.34434,0.32668,1,1
2,GO SKELETAL MUSCLE TISSUE REGENERATION,0.00012367,0.34423,0.34914,1,1
2,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,7.3279e-05,0.34277,0.38336,1,1
2,GO MYELOID CELL DEVELOPMENT,0.00014989,0.34276,0.38404,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00021879,0.34255,0.35329,1,1
2,GO LIPOPROTEIN CATABOLIC PROCESS,6.8565e-05,0.34224,0.35108,1,1
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00081392,0.34216,0.39525,1,1
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00014989,0.34178,0.29604,1,1
2,GO RESPONSE TO VITAMIN D,0.0028457,0.34165,0.31425,1,1
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00068502,0.34095,0.34551,1,1
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0014241,0.34017,0.39846,1,1
2,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.011063,0.33962,0.34777,1,1
2,GO RETINAL METABOLIC PROCESS,0.00015974,0.33901,0.45358,1,1
2,GO SMOOTH MUSCLE CELL PROLIFERATION,8.9327e-05,0.33764,0.39082,1,1
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00051151,0.33693,0.38143,1,1
2,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0057394,0.33587,0.31458,1,1
2,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,3.7287e-05,0.33482,0.39076,1,1
2,GO TISSUE REMODELING,0.0003797,0.33472,0.39661,1,1
2,GO BARBED END ACTIN FILAMENT CAPPING,0.00029789,0.33446,0.32731,1,1
2,GO TRIGLYCERIDE METABOLIC PROCESS,2.4576e-05,0.33321,0.31905,1,1
2,GO REGULATION OF LYSOSOMAL LUMEN PH,8.3641e-05,0.33285,0.36073,1,1
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.00031664,0.33274,0.43134,1,1
2,GO ENDODERM FORMATION,0.00072571,0.33248,0.4231,1,1
2,GO NEGATIVE REGULATION OF CELL ADHESION,0.00015974,0.33224,0.3847,1,1
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00015974,0.33212,0.41229,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0023095,0.33201,0.35066,1,1
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,7.3279e-05,0.3311,0.35411,1,1
2,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.0027019,0.33097,0.33335,1,1
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00033648,0.33083,0.38633,1,1
2,GO STEROID ESTERIFICATION,0.00014989,0.33046,0.33691,1,1
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.00054254,0.32904,0.30583,1,1
2,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00081392,0.32774,0.40142,1,1
2,GO IMMUNE SYSTEM DEVELOPMENT,0.00018128,0.32681,0.34202,1,1
2,GO MODULATION BY HOST OF VIRAL PROCESS,8.9327e-05,0.32642,0.33927,1,1
2,GO KILLING OF CELLS OF OTHER ORGANISM,0.00023283,0.32589,0.37416,1,1
2,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,8.9327e-05,0.32585,0.34736,1,1
2,GO REGULATION OF VIRAL LIFE CYCLE,0.00026348,0.32567,0.34592,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00020554,0.32481,0.33204,1,1
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.0012758,0.32455,0.32618,1,1
2,GO PULMONARY VALVE DEVELOPMENT,0.0027019,0.32452,0.3879,1,1
2,GO PHOSPHOLIPID CATABOLIC PROCESS,5.2428e-05,0.32376,0.36363,1,1
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.00054254,0.32331,0.3214,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00057531,0.3232,0.30106,1,1
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00040321,0.32278,0.31314,1,1
2,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0063209,0.32244,0.36253,1,1
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,6.4139e-05,0.32227,0.34609,1,1
2,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00068502,0.32225,0.30215,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00045436,0.32199,0.33569,1,1
2,GO RETINOIC ACID METABOLIC PROCESS,0.00026348,0.32191,0.35998,1,1
2,GO REGULATION OF KERATINOCYTE MIGRATION,0.0038653,0.32181,0.33426,1,1
2,GO REGULATION OF LIPID STORAGE,0.00045436,0.32139,0.33468,1,1
2,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.0060238,0.32138,0.28644,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.0034935,0.32107,0.28569,1,1
2,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.0028457,0.32,0.42461,1,1
2,GO BILE ACID AND BILE SALT TRANSPORT,0.00024771,0.31984,0.32507,1,1
2,GO PROSTAGLANDIN TRANSPORT,0.00051151,0.3198,0.38018,1,1
2,GO CHOLESTEROL EFFLUX,0.00086166,0.31977,0.31795,1,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,9.5377e-05,0.31973,0.41545,1,1
2,GO NEGATIVE REGULATION OF WOUND HEALING,0.00042807,0.31933,0.39416,1,1
2,GO RESPONSE TO DEXAMETHASONE,0.00019306,0.31923,0.27978,1,1
2,GO REGULATION OF CALCIUM ION IMPORT,0.00033648,0.31882,0.36333,1,1
2,GO RESPONSE TO CORTICOSTERONE,0.0080134,0.31828,0.29046,1,1
2,GO ENTRY OF BACTERIUM INTO HOST CELL,0.015776,0.3181,0.26165,1,1
2,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.013834,0.31775,0.26777,1,1
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00028019,0.3177,0.38497,1,1
2,GO CELLULAR RESPONSE TO DSRNA,0.0013481,0.31751,0.3412,1,1
2,GO MEMBRANE PROTEIN PROTEOLYSIS,8.3641e-05,0.31742,0.39717,1,1
2,GO NECROTIC CELL DEATH,0.00010181,0.31713,0.33335,1,1
2,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.00076864,0.31712,0.32963,1,1
2,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.00029789,0.31707,0.37237,1,1
2,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00029789,0.31699,0.36615,1,1
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00068502,0.3168,0.37181,1,1
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.00019306,0.3168,0.3138,1,1
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0044907,0.31661,0.31755,1,1
2,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00014989,0.31633,0.29927,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0010209,0.31631,0.36959,1,1
2,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.0014241,0.3157,0.42055,1,1
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.00054254,0.31562,0.35688,1,1
2,GO RESPONSE TO NITRIC OXIDE,0.0024341,0.31519,0.26118,1,1
2,GO EPOXYGENASE P450 PATHWAY,0.0010209,0.31515,0.30715,1,1
2,GO REGULATION OF ISOTYPE SWITCHING,0.00060992,0.31514,0.3622,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.00060992,0.31505,0.37721,1,1
2,GO GLIAL CELL PROLIFERATION,0.00057531,0.31398,0.34606,1,1
2,GO B CELL APOPTOTIC PROCESS,0.00035748,0.31392,0.33664,1,1
2,GO SEQUESTERING OF CALCIUM ION,0.00057531,0.31391,0.33313,1,1
2,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.013235,0.3135,0.25459,1,1
2,GO REGULATION OF METANEPHROS DEVELOPMENT,0.00072571,0.31261,0.41799,1,1
2,GO REGULATION OF WOUND HEALING,0.0003797,0.31244,0.37007,1,1
2,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00010866,0.31215,0.36017,1,1
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.0012071,0.31113,0.35355,1,1
2,GO RESPONSE TO DSRNA,0.00048214,0.31096,0.30062,1,1
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00028019,0.31092,0.35146,1,1
2,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0013481,0.30952,0.34087,1,1
2,GO RESPONSE TO AMYLOID BETA,0.0012758,0.30943,0.34479,1,1
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,3.4805e-05,0.30933,0.36089,1,1
2,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0018673,0.30881,0.38997,1,1
2,GO REGULATION OF PROTEIN MATURATION,6.8565e-05,0.30872,0.35365,1,1
2,GO BLOOD VESSEL REMODELING,0.0028457,0.3081,0.39557,1,1
2,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.00096503,0.3078,0.29354,1,1
2,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00086166,0.30754,0.37264,1,1
2,GO HYALURONAN METABOLIC PROCESS,0.0012758,0.3075,0.36196,1,1
2,GO SEMI LUNAR VALVE DEVELOPMENT,0.0029965,0.30734,0.38477,1,1
2,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00013188,0.30718,0.33875,1,1
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.8298e-05,0.3063,0.32992,1,1
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,6.4139e-05,0.30629,0.34347,1,1
2,GO CELLULAR RESPONSE TO AMYLOID BETA,0.0027019,0.30559,0.33705,1,1
2,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.0019699,0.30546,0.34373,1,1
2,GO SKELETAL MUSCLE CELL PROLIFERATION,0.0028457,0.30531,0.31674,1,1
2,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.0027019,0.30523,0.30543,1,1
2,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00033648,0.30504,0.33556,1,1
2,GO REGULATION OF VIRAL GENOME REPLICATION,0.0011418,0.30436,0.31717,1,1
2,GO CELL CELL RECOGNITION,9.5377e-05,0.30341,0.2954,1,1
2,GO POSITIVE CHEMOTAXIS,0.00064645,0.30327,0.36632,1,1
2,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0040644,0.30306,0.25819,1,1
2,GO DETERMINATION OF ADULT LIFESPAN,0.060677,0.30252,0.17882,1,1
2,GO OVULATION,0.00015974,0.30218,0.39424,1,1
2,GO ARACHIDONIC ACID SECRETION,0.00045436,0.302,0.29135,1,1
2,GO CERAMIDE TRANSPORT,0.0023095,0.30195,0.29471,1,1
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,5.2428e-05,0.30188,0.33367,1,1
2,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0003797,0.30154,0.40975,1,1
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00017019,0.30145,0.42172,1,1
2,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.013834,0.30115,0.27261,1,1
2,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.0020776,0.30041,0.36147,1,1
2,GO TRABECULA MORPHOGENESIS,0.01266,0.30016,0.28333,1,1
2,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.0029965,0.29987,0.32616,1,1
2,GO REGULATION OF SYMBIOTIC PROCESS,0.00031664,0.29982,0.30423,1,1
2,GO LYMPH VESSEL DEVELOPMENT,0.0044907,0.29967,0.38999,1,1
2,GO GLYCEROLIPID CATABOLIC PROCESS,0.00072571,0.29965,0.26446,1,1
2,GO POSITIVE REGULATION OF JNK CASCADE,0.00064645,0.29887,0.32513,1,1
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.0076456,0.29885,0.28434,1,1
2,GO REGULATION OF BONE MINERALIZATION,0.0016767,0.29827,0.33865,1,1
2,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00020554,0.29815,0.3846,1,1
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0036751,0.29812,0.34367,1,1
2,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.00054254,0.29802,0.36199,1,1
2,GO NUCLEOSIDE CATABOLIC PROCESS,9.5377e-05,0.29787,0.31804,1,1
2,GO RESPONSE TO PROGESTERONE,0.0016767,0.29776,0.31174,1,1
2,GO REGULATION OF PINOCYTOSIS,0.008797,0.29755,0.26637,1,1
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0015041,0.2972,0.36669,1,1
2,GO REGULATION OF LIPID CATABOLIC PROCESS,0.00033648,0.29702,0.32378,1,1
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0017696,0.29701,0.24231,1,1
2,GO MATERNAL PLACENTA DEVELOPMENT,0.0010209,0.29673,0.31552,1,1
2,GO ARGININE METABOLIC PROCESS,0.00011593,0.29657,0.32805,1,1
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00060992,0.29618,0.36109,1,1
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.01266,0.29612,0.25752,1,1
2,GO CELL REDOX HOMEOSTASIS,0.00020554,0.2961,0.29673,1,1
2,GO PROSTATE GLAND GROWTH,0.0017696,0.29567,0.3016,1,1
2,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00015974,0.29551,0.36797,1,1
2,GO ICOSANOID METABOLIC PROCESS,9.5377e-05,0.2951,0.35286,1,1
2,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.0023095,0.29506,0.37215,1,1
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00031664,0.29484,0.30447,1,1
2,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00072571,0.29469,0.27864,1,1
2,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.0010798,0.29425,0.31584,1,1
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0076456,0.29421,0.35001,1,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00054254,0.29418,0.2656,1,1
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00042807,0.29405,0.26231,1,1
2,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.0020776,0.29389,0.29381,1,1
2,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0015882,0.29363,0.30682,1,1
2,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0027019,0.29354,0.33521,1,1
2,GO HYPOTONIC RESPONSE,0.0036751,0.29323,0.32765,1,1
2,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00028019,0.29316,0.34527,1,1
2,GO INTERACTION WITH HOST,0.00013188,0.29302,0.2985,1,1
2,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.00091199,0.29267,0.36507,1,1
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.0027019,0.2926,0.2205,1,1
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00068502,0.29253,0.28056,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00029789,0.29243,0.31916,1,1
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.0010798,0.29196,0.32967,1,1
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0015041,0.29186,0.31242,1,1
2,GO REGULATION OF BIOMINERALIZATION,0.0034935,0.29179,0.30098,1,1
2,GO PROTEIN DEGLYCOSYLATION,0.0019699,0.29177,0.3135,1,1
2,GO HEPATOCYTE APOPTOTIC PROCESS,0.00096503,0.29136,0.30937,1,1
2,GO PEPTIDE CATABOLIC PROCESS,0.0003797,0.2913,0.36344,1,1
2,GO RESPONSE TO INACTIVITY,0.010572,0.29121,0.24556,1,1
2,GO MYELOID CELL DIFFERENTIATION,0.00014062,0.29081,0.33417,1,1
2,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.0016767,0.29046,0.28704,1,1
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0015041,0.29045,0.2841,1,1
2,GO RESPONSE TO INTERLEUKIN 12,0.00068502,0.28949,0.27185,1,1
2,GO POSITIVE REGULATION OF GLIOGENESIS,0.0010798,0.28932,0.28379,1,1
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00051151,0.28919,0.29501,1,1
2,GO COAGULATION,0.00086166,0.28837,0.32334,1,1
2,GO HOMOCYSTEINE METABOLIC PROCESS,0.007293,0.28826,0.20911,1,1
2,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.0054671,0.28816,0.28421,1,1
2,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.00051151,0.288,0.29387,1,1
2,GO FC RECEPTOR SIGNALING PATHWAY,0.00042807,0.28735,0.28503,1,1
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00060992,0.28721,0.34023,1,1
2,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.00033648,0.28682,0.31574,1,1
2,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.0040644,0.28673,0.29977,1,1
2,GO CELLULAR RESPONSE TO SALT STRESS,0.00026348,0.2867,0.34834,1,1
2,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.013834,0.28642,0.30702,1,1
2,GO HYALURONAN BIOSYNTHETIC PROCESS,0.026142,0.28608,0.30199,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.024086,0.28586,0.27878,1,1
2,GO KERATINOCYTE MIGRATION,0.0047188,0.28576,0.28854,1,1
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.00040321,0.28568,0.34036,1,1
2,GO POSITIVE REGULATION OF MYELINATION,0.0054671,0.28548,0.29481,1,1
2,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.065157,0.2854,0.19406,1,1
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.0052065,0.28481,0.26053,1,1
2,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00023283,0.28475,0.34862,1,1
2,GO STEM CELL DIVISION,0.014457,0.28467,0.25853,1,1
2,GO HEAT GENERATION,0.0010209,0.28408,0.30233,1,1
2,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0042727,0.28408,0.34455,1,1
2,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.0060238,0.28364,0.2585,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.0092139,0.28362,0.27846,1,1
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00017019,0.28285,0.2971,1,1
2,GO SERTOLI CELL DIFFERENTIATION,0.0024341,0.28283,0.29935,1,1
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,5.9985e-05,0.28266,0.36275,1,1
2,GO BLOOD VESSEL MORPHOGENESIS,0.00086166,0.28248,0.35326,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.00024771,0.28205,0.30091,1,1
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0021907,0.28202,0.28139,1,1
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0010798,0.28191,0.33978,1,1
2,GO PROSTAGLANDIN SECRETION,0.0023095,0.28151,0.34211,1,1
2,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00081392,0.28116,0.36849,1,1
2,GO RUFFLE ORGANIZATION,0.00031664,0.28096,0.32532,1,1
2,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.0036751,0.28072,0.26844,1,1
2,GO REGULATION OF RESPONSE TO WOUNDING,0.00033648,0.28057,0.32876,1,1
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,8.9327e-05,0.28031,0.33727,1,1
2,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.012106,0.28001,0.24676,1,1
2,GO TISSUE MIGRATION,0.00072571,0.27993,0.32108,1,1
2,GO VASCULATURE DEVELOPMENT,0.00068502,0.27969,0.34106,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00060992,0.27968,0.32624,1,1
2,GO RESPONSE TO STEROL,0.0013481,0.27939,0.29642,1,1
2,GO TRIGLYCERIDE CATABOLIC PROCESS,0.0027019,0.27912,0.25019,1,1
2,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.00048214,0.27891,0.34403,1,1
2,GO ENDOTHELIAL CELL MIGRATION,0.00054254,0.27885,0.34672,1,1
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0016767,0.2788,0.29792,1,1
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.00076864,0.27832,0.33066,1,1
2,GO METANEPHRIC NEPHRON DEVELOPMENT,0.00332,0.27822,0.3152,1,1
2,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.010572,0.27822,0.24227,1,1
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00028019,0.27797,0.37756,1,1
2,GO KERATINOCYTE PROLIFERATION,0.0040644,0.2778,0.28537,1,1
2,GO HEPATOCYTE DIFFERENTIATION,0.031957,0.27739,0.2071,1,1
2,GO POSITIVE REGULATION OF HAIR CYCLE,0.018736,0.27738,0.24685,1,1
2,GO PULMONARY VALVE MORPHOGENESIS,0.010572,0.27738,0.34932,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00054254,0.27732,0.29589,1,1
2,GO TERPENOID METABOLIC PROCESS,0.00011593,0.27719,0.27369,1,1
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00010866,0.27712,0.31903,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00029789,0.27674,0.30919,1,1
2,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,6.8565e-05,0.27664,0.32019,1,1
2,GO ENAMEL MINERALIZATION,0.00026348,0.27637,0.4056,1,1
2,GO ASTROCYTE DIFFERENTIATION,0.0018673,0.27634,0.28602,1,1
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.019548,0.27599,0.24552,1,1
2,GO RESPONSE TO ATP,0.00011593,0.27584,0.32838,1,1
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0021907,0.27582,0.3417,1,1
2,GO REGULATION OF AMYLOID BETA FORMATION,0.00068502,0.27488,0.30409,1,1
2,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.00081392,0.27479,0.2841,1,1
2,GO POSITIVE REGULATION OF URINE VOLUME,0.0076456,0.27474,0.3211,1,1
2,GO MUSCLE CELL PROLIFERATION,0.00026348,0.27419,0.33218,1,1
2,GO GLOMERULUS DEVELOPMENT,0.0063209,0.27405,0.34345,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0028457,0.27358,0.28097,1,1
2,GO GLIAL CELL MIGRATION,0.0057394,0.27273,0.2767,1,1
2,GO LAMELLIPODIUM MORPHOGENESIS,0.0021907,0.27273,0.30296,1,1
2,GO INTRACELLULAR STEROL TRANSPORT,0.0014241,0.2726,0.27157,1,1
2,GO CELL MATRIX ADHESION,0.0044907,0.2725,0.31866,1,1
2,GO MUSCLE CELL FATE COMMITMENT,0.00096503,0.27236,0.31329,1,1
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,3.4805e-05,0.27207,0.31596,1,1
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00040321,0.27191,0.30775,1,1
2,GO IRON ION HOMEOSTASIS,0.00045436,0.27188,0.2749,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0018673,0.27176,0.3232,1,1
2,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.012106,0.27162,0.25334,1,1
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.00064645,0.27137,0.31394,1,1
2,GO ENDODERM DEVELOPMENT,0.0060238,0.27126,0.29955,1,1
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.00076864,0.27085,0.27065,1,1
2,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00076864,0.27077,0.39679,1,1
2,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00010866,0.26983,0.37194,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00072571,0.26945,0.30701,1,1
2,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.031957,0.26914,0.21025,1,1
2,GO POSITIVE REGULATION OF MAPK CASCADE,0.00033648,0.26831,0.31276,1,1
2,GO CELLULAR RESPONSE TO LIPID,0.00023283,0.2677,0.2848,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.0036751,0.26751,0.28679,1,1
2,GO VIRAL GENOME REPLICATION,0.0014241,0.26695,0.28298,1,1
2,GO AORTIC VALVE DEVELOPMENT,0.0054671,0.26689,0.37204,1,1
2,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.0019699,0.26647,0.31382,1,1
2,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.0042727,0.26629,0.23556,1,1
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.00010181,0.26623,0.32688,1,1
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00021879,0.26599,0.29834,1,1
2,GO RIG I SIGNALING PATHWAY,0.00081392,0.26592,0.27596,1,1
2,GO PROTEIN KINASE B SIGNALING,0.00024771,0.26587,0.31727,1,1
2,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0020776,0.26564,0.25186,1,1
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00031664,0.2654,0.26777,1,1
2,GO RESPONSE TO CORTICOSTEROID,0.00051151,0.26532,0.28705,1,1
2,GO SULFATION,0.0083971,0.26492,0.27034,1,1
2,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.00076864,0.26492,0.34475,1,1
2,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.006955,0.26487,0.25314,1,1
2,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0044907,0.2645,0.36226,1,1
2,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.0020776,0.26429,0.26623,1,1
2,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.0019699,0.26395,0.30473,1,1
2,GO MEMBRANE LIPID CATABOLIC PROCESS,0.0031545,0.26394,0.30151,1,1
2,GO PROSTATIC BUD FORMATION,0.0080134,0.26385,0.34914,1,1
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00013188,0.2637,0.27899,1,1
2,GO RESPONSE TO LIPID,0.00031664,0.26366,0.27459,1,1
2,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00042807,0.26351,0.30267,1,1
2,GO AMINO SUGAR METABOLIC PROCESS,4.8997e-05,0.26333,0.36175,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.00064645,0.26286,0.2926,1,1
2,GO REGULATION OF CELL SHAPE,0.00048214,0.26202,0.31994,1,1
2,GO PEPTIDYL TYROSINE MODIFICATION,0.00033648,0.26173,0.31778,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.00091199,0.26173,0.32914,1,1
2,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0028457,0.26169,0.26986,1,1
2,GO MYOTUBE DIFFERENTIATION,0.0014241,0.26136,0.27377,1,1
2,GO SEQUESTERING OF TRIGLYCERIDE,0.0047188,0.26126,0.2779,1,1
2,GO WHITE FAT CELL DIFFERENTIATION,0.0015882,0.2612,0.30415,1,1
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.00081392,0.26106,0.30253,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00045436,0.26083,0.28699,1,1
2,GO MAMMARY GLAND MORPHOGENESIS,0.0021907,0.26034,0.34044,1,1
2,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.0052065,0.26005,0.27928,1,1
2,GO PANCREATIC JUICE SECRETION,0.014457,0.25993,0.25762,1,1
2,GO CELLULAR OXIDANT DETOXIFICATION,3.248e-05,0.25935,0.29131,1,1
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00015974,0.25903,0.28359,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0012758,0.25883,0.27953,1,1
2,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.00011593,0.25843,0.29421,1,1
2,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0023095,0.25792,0.24145,1,1
2,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.0057394,0.25787,0.37326,1,1
2,GO EXOCYTOSIS,0.00072571,0.25751,0.26235,1,1
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.00051151,0.2574,0.27905,1,1
2,GO CELLULAR RESPONSE TO NUTRIENT,0.035953,0.25694,0.21534,1,1
2,GO REGULATION OF TRANSPOSITION,0.025096,0.25693,0.19572,1,1
2,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.052482,0.25661,0.29346,1,1
2,GO REGULATION OF CHOLESTEROL EFFLUX,0.0054671,0.25631,0.30059,1,1
2,GO REGULATION OF LIPID LOCALIZATION,0.00086166,0.25619,0.26158,1,1
2,GO CERAMIDE CATABOLIC PROCESS,0.0023095,0.25617,0.32139,1,1
2,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0025648,0.25603,0.24003,1,1
2,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.021265,0.25551,0.29315,1,1
2,GO VIRAL LIFE CYCLE,0.00031664,0.25543,0.28042,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.011063,0.25534,0.24548,1,1
2,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.016475,0.25519,0.23622,1,1
2,GO PROTEIN DEMANNOSYLATION,0.0083971,0.25485,0.26944,1,1
2,GO CELLULAR IRON ION HOMEOSTASIS,0.0012758,0.25477,0.2318,1,1
2,GO BONE MATURATION,0.0096484,0.25452,0.2696,1,1
2,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0034935,0.25422,0.2984,1,1
2,GO ARTERY MORPHOGENESIS,0.0021907,0.25402,0.32724,1,1
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0014241,0.2539,0.26475,1,1
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00033648,0.25326,0.3063,1,1
2,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.0031545,0.25296,0.27001,1,1
2,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.0023095,0.25265,0.30934,1,1
2,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.0034935,0.2523,0.27527,1,1
2,GO BEHAVIORAL RESPONSE TO PAIN,0.0044907,0.25223,0.2903,1,1
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0012758,0.25222,0.32372,1,1
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.046961,0.2522,0.23999,1,1
2,GO NEGATIVE REGULATION OF GENE SILENCING,0.00081392,0.25191,0.27472,1,1
2,GO ACYLGLYCEROL HOMEOSTASIS,0.0003797,0.2519,0.30685,1,1
2,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.00091199,0.2515,0.23036,1,1
2,GO SALIVARY GLAND DEVELOPMENT,0.010101,0.25148,0.30805,1,1
2,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0010209,0.25109,0.28292,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0042727,0.25078,0.30081,1,1
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.0025648,0.25039,0.22183,1,1
2,GO ARTERY DEVELOPMENT,0.0038653,0.25021,0.3164,1,1
2,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0010209,0.24982,0.29034,1,1
2,GO FATTY ACID BIOSYNTHETIC PROCESS,4.2763e-05,0.24944,0.2729,1,1
2,GO CORNIFICATION,0.060677,0.24928,0.17093,1,1
2,GO BRONCHUS DEVELOPMENT,0.012106,0.24894,0.32423,1,1
2,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.022172,0.24854,0.23918,1,1
2,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0036751,0.24811,0.25941,1,1
2,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,5.6086e-05,0.24809,0.27756,1,1
2,GO EMBRYO IMPLANTATION,0.00081392,0.24809,0.31883,1,1
2,GO ISOPRENOID METABOLIC PROCESS,0.00012367,0.24773,0.2372,1,1
2,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.013235,0.24771,0.24393,1,1
2,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0024341,0.24728,0.27412,1,1
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0028457,0.24694,0.23343,1,1
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.00021879,0.24655,0.25183,1,1
2,GO TISSUE REGENERATION,0.00072571,0.24637,0.24679,1,1
2,GO REPLACEMENT OSSIFICATION,0.0063209,0.24622,0.29878,1,1
2,GO MIDGUT DEVELOPMENT,0.027226,0.24603,0.25065,1,1
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00023283,0.24557,0.28475,1,1
2,GO MANGANESE ION TRANSPORT,0.0057394,0.24556,0.2283,1,1
2,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.026142,0.24549,0.27679,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00051151,0.24522,0.26557,1,1
2,GO POSITIVE REGULATION OF HEAT GENERATION,0.008797,0.2451,0.2664,1,1
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0034935,0.24477,0.27445,1,1
2,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.018736,0.24438,0.261,1,1
2,GO HEART VALVE DEVELOPMENT,0.0066311,0.24433,0.31772,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00045436,0.24422,0.28756,1,1
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00020554,0.24399,0.25631,1,1
2,GO TRANSITION METAL ION HOMEOSTASIS,0.00024771,0.24381,0.24815,1,1
2,GO RESPONSE TO HYPEROXIA,0.00081392,0.24298,0.30201,1,1
2,GO REGULATION OF GASTRULATION,0.0012758,0.24288,0.28876,1,1
2,GO FIBROBLAST ACTIVATION,0.0054671,0.24284,0.27957,1,1
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.0080134,0.24283,0.26913,1,1
2,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00072571,0.24264,0.25588,1,1
2,GO SECRETION BY TISSUE,0.00091199,0.24205,0.251,1,1
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0012071,0.24203,0.24003,1,1
2,GO RESPONSE TO GROWTH HORMONE,0.00048214,0.24182,0.26862,1,1
2,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.00042807,0.24116,0.24613,1,1
2,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.013834,0.24109,0.2148,1,1
2,GO LUNG MORPHOGENESIS,0.0057394,0.24104,0.28881,1,1
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.0020776,0.24102,0.2567,1,1
2,GO RESPONSE TO RETINOIC ACID,0.0016767,0.24101,0.26534,1,1
2,GO BIOMINERALIZATION,0.0038653,0.24098,0.25479,1,1
2,GO TAXIS,0.0017696,0.24081,0.26859,1,1
2,GO BONE DEVELOPMENT,0.0016767,0.24072,0.2848,1,1
2,GO RESPONSE TO FATTY ACID,0.00060992,0.23988,0.25358,1,1
2,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0066311,0.23937,0.33092,1,1
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.013235,0.23917,0.29556,1,1
2,GO REGULATION OF RUFFLE ASSEMBLY,0.0028457,0.23823,0.2478,1,1
2,GO FEMALE GENITALIA DEVELOPMENT,0.0076456,0.23781,0.20977,1,1
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.007293,0.23778,0.28126,1,1
2,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.043559,0.23655,0.26193,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00042807,0.23649,0.27202,1,1
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0044907,0.23634,0.24985,1,1
2,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0040644,0.23614,0.28814,1,1
2,GO PLASMA MEMBRANE FUSION,0.0042727,0.23613,0.28137,1,1
2,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00054254,0.23608,0.25555,1,1
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00060992,0.23565,0.25155,1,1
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00019306,0.23564,0.27268,1,1
2,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.0080134,0.23507,0.26233,1,1
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.026142,0.23459,0.21304,1,1
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.0063209,0.23447,0.22055,1,1
2,GO TRANSPOSITION,0.034576,0.23429,0.17236,1,1
2,GO REGULATION OF BODY FLUID LEVELS,0.0028457,0.23404,0.25775,1,1
2,GO REGULATION OF PEPTIDASE ACTIVITY,0.00031664,0.23398,0.26658,1,1
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00023283,0.23383,0.25636,1,1
2,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0021907,0.23378,0.24619,1,1
2,GO RESPONSE TO ESTROGEN,0.0015041,0.23364,0.2643,1,1
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.00023283,0.23362,0.25156,1,1
2,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.006955,0.23292,0.26901,1,1
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.0019699,0.23281,0.28428,1,1
2,GO CELL CELL ADHESION,0.00096503,0.23278,0.2875,1,1
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0014241,0.23258,0.30319,1,1
2,GO MEGAKARYOCYTE DEVELOPMENT,0.0060238,0.23252,0.26171,1,1
2,GO ODONTOGENESIS,0.0031545,0.2325,0.25694,1,1
2,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0018673,0.23236,0.2586,1,1
2,GO DRUG METABOLIC PROCESS,0.0020776,0.2323,0.27827,1,1
2,GO COPPER ION HOMEOSTASIS,0.0010209,0.23166,0.232,1,1
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.040368,0.23123,0.20467,1,1
2,GO DETOXIFICATION,0.00011593,0.23119,0.24179,1,1
2,GO ENDODERMAL CELL FATE COMMITMENT,0.046961,0.23105,0.18464,1,1
2,GO STEROL TRANSPORT,0.00054254,0.23077,0.28312,1,1
2,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0027019,0.23063,0.25974,1,1
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.00072571,0.23053,0.24965,1,1
2,GO AMEBOIDAL TYPE CELL MIGRATION,0.0047188,0.22942,0.26175,1,1
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.0038653,0.2292,0.2408,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.01266,0.2292,0.2996,1,1
2,GO AMYLOID BETA FORMATION,0.0013481,0.22913,0.25967,1,1
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.0057394,0.22843,0.26093,1,1
2,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0010209,0.22834,0.28426,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.018736,0.22804,0.19545,1,1
2,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.016475,0.22791,0.24218,1,1
2,GO BROWN FAT CELL DIFFERENTIATION,0.0027019,0.22759,0.23499,1,1
2,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00081392,0.2271,0.2601,1,1
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.007293,0.22698,0.2419,1,1
2,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.0020776,0.22687,0.23905,1,1
2,GO REGULATION OF RECEPTOR RECYCLING,0.0014241,0.22666,0.24661,1,1
2,GO ENDOCARDIAL CUSHION FORMATION,0.040368,0.22666,0.27338,1,1
2,GO ACTIN CYTOSKELETON REORGANIZATION,0.00081392,0.22608,0.28529,1,1
2,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0021907,0.22607,0.20785,1,1
2,GO FACE DEVELOPMENT,0.035953,0.22561,0.23418,1,1
2,GO RESPONSE TO ANTIBIOTIC,0.00045436,0.22498,0.241,1,1
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,3.4805e-05,0.22478,0.25642,1,1
2,GO MRNA TRANSCRIPTION,0.011063,0.22473,0.26167,1,1
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.01266,0.22455,0.29252,1,1
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.031957,0.22451,0.22314,1,1
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.00045436,0.22431,0.25306,1,1
2,GO LIPID STORAGE,0.00076864,0.22378,0.27083,1,1
2,GO TERPENOID BIOSYNTHETIC PROCESS,0.00019306,0.22362,0.25813,1,1
2,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.00072571,0.22361,0.26314,1,1
2,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.0027019,0.22348,0.23706,1,1
2,GO FATTY ACID TRANSPORT,0.00017019,0.22311,0.27545,1,1
2,GO LIPID HOMEOSTASIS,0.00031664,0.22219,0.25917,1,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00045436,0.22209,0.24362,1,1
2,GO SENSORY PERCEPTION OF TASTE,0.040368,0.22153,0.28033,1,1
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00014062,0.2215,0.25658,1,1
2,GO BIOLOGICAL ADHESION,0.0015882,0.22108,0.28469,1,1
2,GO RESPONSE TO GAMMA RADIATION,0.0017696,0.22101,0.24034,1,1
2,GO REGULATION OF LIPID TRANSPORT,0.0012071,0.22071,0.24299,1,1
2,GO AMELOGENESIS,0.00096503,0.22042,0.31601,1,1
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0019699,0.22027,0.23875,1,1
2,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0011418,0.2195,0.21929,1,1
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00064645,0.2195,0.24704,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00096503,0.21872,0.29102,1,1
2,GO DRUG CATABOLIC PROCESS,0.015104,0.21863,0.20754,1,1
2,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.0063209,0.21845,0.28551,1,1
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0013481,0.21781,0.25332,1,1
2,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00048214,0.21762,0.29284,1,1
2,GO RESPONSE TO OSMOTIC STRESS,0.0021907,0.21725,0.21504,1,1
2,GO SULFUR COMPOUND CATABOLIC PROCESS,0.0024341,0.21681,0.27776,1,1
2,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0036751,0.21652,0.2601,1,1
2,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0012758,0.21622,0.26454,1,1
2,GO TRACHEA MORPHOGENESIS,0.033245,0.2161,0.30768,1,1
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.0049572,0.21599,0.23402,1,1
2,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.020391,0.21581,0.23793,1,1
2,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.0016767,0.2158,0.25501,1,1
2,GO REGULATION OF MAPK CASCADE,0.00086166,0.21569,0.26657,1,1
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.016475,0.21537,0.29124,1,1
2,GO RESPONSE TO ORGANOPHOSPHORUS,0.0003797,0.21534,0.2784,1,1
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.00096503,0.21526,0.2711,1,1
2,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0018673,0.21499,0.29173,1,1
2,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.011574,0.21447,0.3093,1,1
2,GO NEPHRON TUBULE FORMATION,0.0083971,0.21384,0.24798,1,1
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.0017696,0.21365,0.2049,1,1
2,GO BILE ACID METABOLIC PROCESS,0.00086166,0.21358,0.21879,1,1
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.00031664,0.21354,0.2406,1,1
2,GO AORTA DEVELOPMENT,0.0047188,0.21344,0.2957,1,1
2,GO HEPARIN METABOLIC PROCESS,0.015776,0.21292,0.26666,1,1
2,GO ANIMAL ORGAN REGENERATION,0.00029789,0.21203,0.24756,1,1
2,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0172,0.21199,0.23122,1,1
2,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0031545,0.21197,0.24184,1,1
2,GO PROTEIN AUTOPROCESSING,0.015104,0.21191,0.19025,1,1
2,GO BICARBONATE TRANSPORT,0.037377,0.21173,0.18123,1,1
2,GO POSITIVE REGULATION OF ERAD PATHWAY,0.0024341,0.21164,0.23053,1,1
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0027019,0.21138,0.22482,1,1
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0054671,0.21131,0.24625,1,1
2,GO ACTIVATION OF MAPK ACTIVITY,0.0025648,0.21109,0.22604,1,1
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.0010798,0.21108,0.25699,1,1
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.008797,0.21065,0.20894,1,1
2,GO PRIMARY MIRNA PROCESSING,0.01266,0.21029,0.26462,1,1
2,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.017954,0.21011,0.25261,1,1
2,GO TISSUE HOMEOSTASIS,0.00054254,0.21011,0.25297,1,1
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.025096,0.21002,0.20394,1,1
2,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.0172,0.2098,0.1899,1,1
2,GO METAL ION HOMEOSTASIS,0.0031545,0.20977,0.22939,1,1
2,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.0016767,0.20971,0.24646,1,1
2,GO ESTROUS CYCLE,0.031957,0.20934,0.24928,1,1
2,GO RESPONSE TO SALT STRESS,0.030713,0.20906,0.20227,1,1
2,GO CELLULAR RESPONSE TO ALCOHOL,0.0024341,0.20878,0.24626,1,1
2,GO ERBB SIGNALING PATHWAY,0.0017696,0.20877,0.23921,1,1
2,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0020776,0.2085,0.24588,1,1
2,GO ETHER METABOLIC PROCESS,0.0014241,0.20833,0.22429,1,1
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0080134,0.20832,0.29422,1,1
2,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0083971,0.20828,0.20336,1,1
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.00014989,0.20827,0.26128,1,1
2,GO MYELOID CELL HOMEOSTASIS,0.00060992,0.20803,0.24909,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.018736,0.20801,0.22195,1,1
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0066311,0.20789,0.21745,1,1
2,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0036751,0.20766,0.23843,1,1
2,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.008797,0.20693,0.23526,1,1
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.007293,0.20684,0.25432,1,1
2,GO INTRACELLULAR LIPID TRANSPORT,0.0054671,0.20675,0.20745,1,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.011063,0.20668,0.20603,1,1
2,GO FAT CELL DIFFERENTIATION,0.00332,0.20651,0.23882,1,1
2,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0010798,0.20635,0.20929,1,1
2,GO REGULATION OF RESPONSE TO STRESS,0.00060992,0.20622,0.23695,1,1
2,GO REGULATION OF NECROTIC CELL DEATH,0.0015041,0.20584,0.24966,1,1
2,GO PLATELET MORPHOGENESIS,0.0034935,0.20573,0.28931,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0016767,0.20541,0.24312,1,1
2,GO POLYSACCHARIDE CATABOLIC PROCESS,0.0016767,0.2053,0.22311,1,1
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.00057531,0.2051,0.34747,1,1
2,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0049572,0.20501,0.26142,1,1
2,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.0063209,0.20479,0.28398,1,1
2,GO CELLULAR RESPONSE TO CAMP,0.00081392,0.20464,0.24316,1,1
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.041938,0.20462,0.23663,1,1
2,GO INTERMEMBRANE LIPID TRANSFER,0.00096503,0.20456,0.27517,1,1
2,GO CELL MOTILITY,0.0028457,0.20445,0.2398,1,1
2,GO LONG CHAIN FATTY ACID TRANSPORT,0.00081392,0.20438,0.22801,1,1
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.011063,0.2043,0.32159,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0016767,0.20424,0.22119,1,1
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.0021907,0.20414,0.24185,1,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0047188,0.20337,0.2078,1,1
2,GO MAINTENANCE OF LOCATION IN CELL,0.0012071,0.20272,0.23877,1,1
2,GO CELLULAR RESPONSE TO ATP,0.0025648,0.20268,0.26105,1,1
2,GO KERATINOCYTE DIFFERENTIATION,0.012106,0.20232,0.19129,1,1
2,GO CELLULAR ION HOMEOSTASIS,0.0038653,0.20197,0.21215,1,1
2,GO HEMOGLOBIN METABOLIC PROCESS,0.0012758,0.20173,0.25992,1,1
2,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.00024771,0.20171,0.25072,1,1
2,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.008797,0.20168,0.24574,1,1
2,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0025648,0.20161,0.23664,1,1
2,GO FOREGUT MORPHOGENESIS,0.024086,0.2016,0.24546,1,1
2,GO ERYTHROCYTE DEVELOPMENT,0.0038653,0.20103,0.2348,1,1
2,GO RESPONSE TO CAMP,0.0016767,0.20059,0.26263,1,1
2,GO FIBROBLAST APOPTOTIC PROCESS,0.006955,0.20022,0.23724,1,1
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0010209,0.19912,0.24119,1,1
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.0044907,0.19902,0.19242,1,1
2,GO CELLULAR RESPONSE TO STEROL,0.038848,0.19897,0.19983,1,1
2,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0015882,0.19894,0.23299,1,1
2,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0018673,0.19883,0.23778,1,1
2,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0038653,0.19871,0.22247,1,1
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0096484,0.19829,0.22705,1,1
2,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.045233,0.19799,0.18601,1,1
2,GO ACTIN FILAMENT BASED TRANSPORT,0.037377,0.19785,0.24066,1,1
2,GO PROTEIN PROCESSING,0.00060992,0.19772,0.26149,1,1
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0060238,0.19755,0.2318,1,1
2,GO XENOBIOTIC TRANSPORT,0.060677,0.19673,0.18217,1,1
2,GO LIPID CATABOLIC PROCESS,0.00057531,0.19667,0.21502,1,1
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0063209,0.19656,0.22864,1,1
2,GO REGULATION OF CELL POPULATION PROLIFERATION,0.00086166,0.19651,0.23304,1,1
2,GO PERICARDIUM DEVELOPMENT,0.0038653,0.19624,0.29346,1,1
2,GO PROTEIN ADP RIBOSYLATION,0.007293,0.19612,0.22203,1,1
2,GO RESPONSE TO KETONE,0.0016767,0.19608,0.2255,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.015776,0.19599,0.22469,1,1
2,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.00091199,0.19597,0.25638,1,1
2,GO ANIMAL ORGAN MATURATION,0.0172,0.19596,0.23317,1,1
2,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.006955,0.19527,0.20637,1,1
2,GO RNA DECAPPING,0.0096484,0.19462,0.21173,1,1
2,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.0054671,0.19449,0.21279,1,1
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0011418,0.19386,0.34689,1,1
2,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0012758,0.19378,0.24599,1,1
2,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.021265,0.19361,0.19107,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00096503,0.19321,0.24951,1,1
2,GO REGULATION OF PROTEOLYSIS,0.00064645,0.19294,0.21982,1,1
2,GO NUCLEOTIDE SALVAGE,0.0057394,0.19288,0.20091,1,1
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0027019,0.19232,0.23127,1,1
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0003797,0.19187,0.23161,1,1
2,GO MYOBLAST PROLIFERATION,0.0060238,0.19163,0.2893,1,1
2,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0024341,0.1916,0.22109,1,1
2,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.031957,0.19141,0.20434,1,1
2,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0092139,0.19112,0.2287,1,1
2,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0029965,0.19094,0.2038,1,1
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.0031545,0.1906,0.18304,1,1
2,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0054671,0.19032,0.24166,1,1
2,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.0044907,0.19011,0.25678,1,1
2,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.02951,0.18994,0.19157,1,1
2,GO MAINTENANCE OF LOCATION,0.0016767,0.18982,0.22096,1,1
2,GO ERBB2 SIGNALING PATHWAY,0.0040644,0.18982,0.22377,1,1
2,GO CELLULAR RESPONSE TO FATTY ACID,0.0076456,0.18963,0.20069,1,1
2,GO NEGATIVE REGULATION OF AUTOPHAGY,0.013235,0.18946,0.18978,1,1
2,GO FATTY ACID METABOLIC PROCESS,0.00096503,0.18941,0.19204,1,1
2,GO GLUTATHIONE METABOLIC PROCESS,0.0031545,0.18936,0.17994,1,1
2,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.015104,0.18902,0.25425,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0010209,0.18892,0.23973,1,1
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00064645,0.18889,0.23644,1,1
2,GO RESPONSE TO OXIDATIVE STRESS,0.00028019,0.18841,0.2215,1,1
2,GO ION HOMEOSTASIS,0.0031545,0.18809,0.20936,1,1
2,GO GLYCOSIDE METABOLIC PROCESS,0.0003797,0.18799,0.21216,1,1
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.0010798,0.18781,0.18158,1,1
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0014241,0.18773,0.2144,1,1
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0010798,0.18741,0.21572,1,1
2,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.015104,0.18716,0.21094,1,1
2,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0020776,0.18639,0.22357,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0096484,0.18584,0.20779,1,1
2,GO KIDNEY MESENCHYME DEVELOPMENT,0.0096484,0.18542,0.25215,1,1
2,GO ER NUCLEUS SIGNALING PATHWAY,0.017954,0.18541,0.17372,1,1
2,GO PROTEIN HOMOTETRAMERIZATION,0.0036751,0.18496,0.21822,1,1
2,GO LAMELLIPODIUM ORGANIZATION,0.0025648,0.18492,0.22817,1,1
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.016475,0.18484,0.24898,1,1
2,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.011063,0.18482,0.20856,1,1
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0015882,0.18473,0.26509,1,1
2,GO REGULATION OF ENDOCYTIC RECYCLING,0.015104,0.18456,0.24497,1,1
2,GO NEGATIVE REGULATION OF CELL DEATH,0.00064645,0.18433,0.20811,1,1
2,GO GLYCEROLIPID METABOLIC PROCESS,0.0044907,0.18402,0.18167,1,1
2,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0040644,0.18367,0.23551,1,1
2,GO JNK CASCADE,0.0036751,0.18319,0.2265,1,1
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.018736,0.18305,0.14488,1,1
2,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0029965,0.18304,0.18583,1,1
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.021265,0.18296,0.18923,1,1
2,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.017954,0.18262,0.17684,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.018736,0.18261,0.20523,1,1
2,GO AUTOPHAGOSOME MATURATION,0.0057394,0.18165,0.17464,1,1
2,GO SECRETION,0.0044907,0.18136,0.20594,1,1
2,GO IMP BIOSYNTHETIC PROCESS,0.062884,0.18124,0.10971,1,1
2,GO DIGESTION,0.013235,0.18122,0.18015,1,1
2,GO LINOLEIC ACID METABOLIC PROCESS,0.011574,0.18116,0.21221,1,1
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0057394,0.18115,0.20203,1,1
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.00040321,0.18112,0.20204,1,1
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.00014062,0.18085,0.23544,1,1
2,GO BILE ACID BIOSYNTHETIC PROCESS,0.00076864,0.18046,0.23429,1,1
2,GO PLACENTA DEVELOPMENT,0.0083971,0.18006,0.19899,1,1
2,GO EMBRYONIC PLACENTA DEVELOPMENT,0.013235,0.17987,0.19886,1,1
2,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.013834,0.17966,0.23375,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0021907,0.17952,0.20955,1,1
2,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0015882,0.17927,0.21445,1,1
2,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0025648,0.1792,0.22742,1,1
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00091199,0.17894,0.20947,1,1
2,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0092139,0.17866,0.1662,1,1
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.00045436,0.17863,0.23766,1,1
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0017696,0.1784,0.27442,1,1
2,GO RESPONSE TO UV B,0.0063209,0.17801,0.21168,1,1
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0063209,0.17746,0.19929,1,1
2,GO ENDOCYTOSIS,0.0052065,0.17716,0.22264,1,1
2,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0016767,0.17706,0.22756,1,1
2,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0076456,0.1769,0.23565,1,1
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.034576,0.17682,0.24013,1,1
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0031545,0.17675,0.23227,1,1
2,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.021265,0.17669,0.21212,1,1
2,GO SECOND MESSENGER MEDIATED SIGNALING,0.023112,0.17646,0.17721,1,1
2,GO CELLULAR RESPONSE TO KETONE,0.0076456,0.17644,0.18478,1,1
2,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.0020776,0.17616,0.21891,1,1
2,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.037377,0.17607,0.20762,1,1
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00068502,0.17576,0.21269,1,1
2,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.060677,0.17574,0.16397,1,1
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0003797,0.17561,0.22352,1,1
2,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.017954,0.17553,0.21043,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.031957,0.17525,0.10757,1,1
2,GO CELLULAR LIPID METABOLIC PROCESS,0.0012071,0.17524,0.1877,1,1
2,GO DIGESTIVE SYSTEM PROCESS,0.0096484,0.1749,0.18754,1,1
2,GO STEROL METABOLIC PROCESS,0.0016767,0.17451,0.20963,1,1
2,GO LIPID OXIDATION,0.013834,0.17438,0.14819,1,1
2,GO ACTIVATION OF JUN KINASE ACTIVITY,0.010101,0.17435,0.24586,1,1
2,GO REGULATION OF PROTEIN IMPORT,0.0021907,0.17428,0.20652,1,1
2,GO RESPONSE TO ALCOHOL,0.00332,0.17424,0.20627,1,1
2,GO HEME METABOLIC PROCESS,0.00045436,0.17395,0.20355,1,1
2,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0057394,0.17349,0.19002,1,1
2,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.031957,0.17202,0.17598,1,1
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0036751,0.17164,0.19676,1,1
2,GO GLYCEROL ETHER METABOLIC PROCESS,0.015104,0.17071,0.17909,1,1
2,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.040368,0.17043,0.20496,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0083971,0.1697,0.21419,1,1
2,GO STEROID METABOLIC PROCESS,0.0012758,0.16949,0.18661,1,1
2,GO CELLULAR RESPONSE TO MANGANESE ION,0.006955,0.16915,0.18632,1,1
2,GO POSITIVE REGULATION OF SIGNALING,0.0076456,0.16819,0.18121,1,1
2,GO AMYLOID BETA METABOLIC PROCESS,0.0080134,0.16815,0.2104,1,1
2,GO RESPONSE TO MUSCLE STRETCH,0.052482,0.16813,0.22936,1,1
2,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.069906,0.16793,0.15082,1,1
2,GO INACTIVATION OF MAPK ACTIVITY,0.011574,0.16758,0.23073,1,1
2,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.0066311,0.16706,0.21318,1,1
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0034935,0.16703,0.19826,1,1
2,GO RUFFLE ASSEMBLY,0.0054671,0.16699,0.21498,1,1
2,GO CELL RECOGNITION,0.008797,0.16668,0.19679,1,1
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0025648,0.16601,0.22942,1,1
2,GO LIVER REGENERATION,0.00096503,0.16595,0.23025,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.030713,0.16526,0.21402,1,1
2,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.0066311,0.16523,0.20186,1,1
2,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.026142,0.16463,0.17692,1,1
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.016475,0.16432,0.18718,1,1
2,GO MONOCARBOXYLIC ACID TRANSPORT,0.00096503,0.1642,0.23737,1,1
2,GO REGENERATION,0.0029965,0.1639,0.20035,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.034576,0.16348,0.20927,1,1
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.028348,0.16338,0.14458,1,1
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.016475,0.16333,0.16257,1,1
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.026142,0.1631,0.15925,1,1
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0017696,0.1631,0.21741,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.011063,0.16307,0.17935,1,1
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.041938,0.16299,0.20889,1,1
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.0042727,0.16258,0.18342,1,1
2,GO RESPONSE TO IONIZING RADIATION,0.031957,0.16246,0.1594,1,1
2,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.060677,0.1623,0.14595,1,1
2,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.043559,0.1623,0.19603,1,1
2,GO SYMBIOTIC PROCESS,0.0015882,0.16208,0.17607,1,1
2,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.021265,0.16177,0.21864,1,1
2,GO CARTILAGE DEVELOPMENT,0.011574,0.16156,0.23392,1,1
2,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.0052065,0.16148,0.28217,1,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.008797,0.16115,0.24584,1,1
2,GO ALCOHOL METABOLIC PROCESS,0.0010798,0.16111,0.20169,1,1
2,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.01266,0.16099,0.23758,1,1
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0016767,0.1609,0.21662,1,1
2,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.013235,0.16068,0.16896,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.011574,0.16026,0.19314,1,1
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0016767,0.16015,0.19598,1,1
2,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0047188,0.15987,0.18884,1,1
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0012071,0.15952,0.19792,1,1
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0040644,0.15903,0.21218,1,1
2,GO REGULATION OF CELL DEATH,0.0012071,0.15894,0.19895,1,1
2,GO GDP METABOLIC PROCESS,0.021265,0.15878,0.21218,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.01266,0.15822,0.17297,1,1
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.0023095,0.15788,0.23289,1,1
2,GO VACUOLAR ACIDIFICATION,0.0031545,0.15787,0.20136,1,1
2,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.008797,0.15768,0.18313,1,1
2,GO RESPONSE TO SALT,0.065157,0.15766,0.12642,1,1
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00068502,0.15766,0.22667,1,1
2,GO RNA DESTABILIZATION,0.058535,0.15739,0.19834,1,1
2,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.010101,0.15736,0.17654,1,1
2,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.058535,0.15695,0.1368,1,1
2,GO PROTEIN MATURATION,0.0015041,0.1566,0.20201,1,1
2,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0049572,0.15651,0.22523,1,1
2,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.046961,0.1563,0.16238,1,1
2,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0049572,0.15598,0.19441,1,1
2,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0038653,0.15576,0.19572,1,1
2,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.043559,0.15548,0.16026,1,1
2,GO BLASTODERM SEGMENTATION,0.0028457,0.15502,0.23719,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.010101,0.15474,0.1696,1,1
2,GO PROTEIN AUTOPHOSPHORYLATION,0.01266,0.15434,0.20851,1,1
2,GO REGULATION OF CELLULAR PH,0.041938,0.1543,0.13649,1,1
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00018128,0.15395,0.20271,1,1
2,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.010572,0.15373,0.17563,1,1
2,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0076456,0.15367,0.15757,1,1
2,GO ESTROGEN METABOLIC PROCESS,0.0060238,0.15367,0.16515,1,1
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0047188,0.15322,0.17004,1,1
2,GO REGULATION OF DNA CATABOLIC PROCESS,0.012106,0.15272,0.15655,1,1
2,GO ACTIN FILAMENT ORGANIZATION,0.0083971,0.15171,0.19989,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0021907,0.15168,0.16611,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0014241,0.15131,0.22407,1,1
2,GO RESPONSE TO X RAY,0.037377,0.15125,0.19309,1,1
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.011574,0.1509,0.16571,1,1
2,GO LIPID METABOLIC PROCESS,0.0024341,0.15051,0.17737,1,1
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.00064645,0.15021,0.20972,1,1
2,GO EPIDERMIS DEVELOPMENT,0.045233,0.14989,0.14595,1,1
2,GO DNA DEMETHYLATION,0.060677,0.14983,0.15102,1,1
2,GO CARDIOLIPIN METABOLIC PROCESS,0.013834,0.14959,0.14929,1,1
2,GO BODY FLUID SECRETION,0.030713,0.14922,0.14711,1,1
2,GO REGULATION OF ACTIN NUCLEATION,0.041938,0.14908,0.1515,1,1
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.022172,0.14832,0.18155,1,1
2,GO IRON ION TRANSPORT,0.0076456,0.14832,0.17846,1,1
2,GO FOLIC ACID METABOLIC PROCESS,0.0092139,0.1483,0.16137,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.027226,0.14788,0.18316,1,1
2,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.037377,0.14773,0.14525,1,1
2,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.027226,0.14747,0.19142,1,1
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.011063,0.14704,0.22153,1,1
2,GO MESODERMAL CELL FATE COMMITMENT,0.026142,0.14643,0.13692,1,1
2,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0040644,0.14635,0.25823,1,1
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0049572,0.14627,0.20597,1,1
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0049572,0.14583,0.16445,1,1
2,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0096484,0.14536,0.14494,1,1
2,GO DIVALENT INORGANIC CATION TRANSPORT,0.0049572,0.1452,0.19107,1,1
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0013481,0.14496,0.17461,1,1
2,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.010572,0.14476,0.19869,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.067497,0.14381,0.13391,1,1
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.007293,0.14358,0.16298,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.010101,0.1435,0.17784,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.024086,0.14325,0.18631,1,1
2,GO VESICLE BUDDING FROM MEMBRANE,0.025096,0.14299,0.13627,1,1
2,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.034576,0.14292,0.1737,1,1
2,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0023095,0.14255,0.19243,1,1
2,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.0027019,0.14205,0.155,1,1
2,GO MITOCHONDRIAL DEPOLARIZATION,0.016475,0.14197,0.21947,1,1
2,GO REGULATION OF VIRAL TRANSCRIPTION,0.0060238,0.14173,0.18287,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.0014241,0.14164,0.23145,1,1
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0012758,0.14161,0.15522,1,1
2,GO POSITIVE REGULATION OF NEURON DEATH,0.0092139,0.14155,0.19801,1,1
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0012758,0.14146,0.16547,1,1
2,GO REGULATION OF RIBOSOME BIOGENESIS,0.040368,0.14135,0.14975,1,1
2,GO SLEEP,0.013235,0.14078,0.16598,1,1
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0019699,0.14019,0.1924,1,1
2,GO NADP METABOLIC PROCESS,0.019548,0.13978,0.15327,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.024086,0.13919,0.19457,1,1
2,GO POSITIVE REGULATION OF TRANSPORT,0.015776,0.13915,0.16352,1,1
2,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.016475,0.13883,0.19253,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.007293,0.13877,0.16864,1,1
2,GO GASTRIC ACID SECRETION,0.069906,0.13875,0.1331,1,1
2,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.023112,0.13862,0.16599,1,1
2,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.007293,0.13846,0.18417,1,1
2,GO CELLULAR KETONE METABOLIC PROCESS,0.0023095,0.13703,0.14863,1,1
2,GO NEUTRAL LIPID CATABOLIC PROCESS,0.040368,0.13667,0.16503,1,1
2,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.030713,0.13584,0.20174,1,1
2,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.033245,0.13532,0.193,1,1
2,GO TRANSITION METAL ION TRANSPORT,0.0076456,0.1353,0.16074,1,1
2,GO REGULATION OF HYDROLASE ACTIVITY,0.0036751,0.13528,0.1921,1,1
2,GO CELLULAR HOMEOSTASIS,0.0066311,0.1351,0.16891,1,1
2,GO VESICLE CARGO LOADING,0.038848,0.13506,0.14853,1,1
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0096484,0.13399,0.17121,1,1
2,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0076456,0.13296,0.23313,1,1
2,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0034935,0.13286,0.17054,1,1
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.037377,0.13278,0.1346,1,1
2,GO RESPONSE TO TOXIC SUBSTANCE,0.0036751,0.1327,0.16046,1,1
2,GO SULFUR COMPOUND METABOLIC PROCESS,0.0047188,0.13239,0.15648,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.050584,0.13202,0.14119,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0028457,0.13177,0.19269,1,1
2,GO BLASTOCYST FORMATION,0.0049572,0.13167,0.15671,1,1
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0044907,0.13154,0.17804,1,1
2,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.043559,0.13052,0.20324,1,1
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0036751,0.1304,0.15694,1,1
2,GO GTP METABOLIC PROCESS,0.0049572,0.13002,0.16085,1,1
2,GO HOMEOSTATIC PROCESS,0.0076456,0.12997,0.16994,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.067497,0.12992,0.14629,1,1
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.037377,0.12905,0.16029,1,1
2,GO LIPID BIOSYNTHETIC PROCESS,0.007293,0.12892,0.15402,1,1
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.048745,0.12871,0.15236,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.013834,0.12851,0.15296,1,1
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.020391,0.1285,0.16382,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.024086,0.1284,0.15907,1,1
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.040368,0.12683,0.1292,1,1
2,GO URONIC ACID METABOLIC PROCESS,0.0049572,0.1267,0.13856,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0031545,0.12649,0.15778,1,1
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.045233,0.1263,0.12161,1,1
2,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.02951,0.12613,0.18184,1,1
2,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.045233,0.12517,0.14448,1,1
2,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.018736,0.12494,0.14215,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.048745,0.12459,0.11576,1,1
2,GO MICROVILLUS ORGANIZATION,0.067497,0.12332,0.13847,1,1
2,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.040368,0.12317,0.14028,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0047188,0.12312,0.17789,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.015104,0.12289,0.1716,1,1
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.019548,0.12261,0.14918,1,1
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.023112,0.12215,0.15931,1,1
2,GO RESPONSE TO PEPTIDE,0.016475,0.12209,0.1642,1,1
2,GO EXTRACELLULAR VESICLE BIOGENESIS,0.019548,0.12203,0.14226,1,1
2,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0023095,0.12036,0.17556,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.013834,0.12006,0.15902,1,1
2,GO PROTEIN TETRAMERIZATION,0.014457,0.11985,0.16726,1,1
2,GO TETRAPYRROLE METABOLIC PROCESS,0.0066311,0.11793,0.16155,1,1
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.008797,0.11773,0.16526,1,1
2,GO REGULATION OF PH,0.056456,0.11634,0.12065,1,1
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.037377,0.11633,0.14174,1,1
2,GO ACTIN NUCLEATION,0.008797,0.11631,0.1665,1,1
2,GO CELLULAR RESPONSE TO PEPTIDE,0.041938,0.11622,0.15417,1,1
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.0096484,0.1156,0.16357,1,1
2,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.016475,0.11427,0.1532,1,1
2,GO AMP METABOLIC PROCESS,0.031957,0.11323,0.14036,1,1
2,GO COPII COATED VESICLE BUDDING,0.045233,0.11321,0.13396,1,1
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.0063209,0.11263,0.16026,1,1
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.054439,0.11249,0.1393,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0076456,0.11137,0.14967,1,1
2,GO STEROID BIOSYNTHETIC PROCESS,0.0052065,0.11121,0.1398,1,1
2,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.065157,0.11119,0.13035,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.020391,0.11108,0.13341,1,1
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.006955,0.10961,0.16748,1,1
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.0023095,0.1091,0.16023,1,1
2,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.052482,0.10817,0.12793,1,1
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.026142,0.10802,0.15833,1,1
2,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.060677,0.108,0.14003,1,1
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.011063,0.10715,0.18851,1,1
2,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.052482,0.10205,0.11893,1,1
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.052482,0.10157,0.12552,1,1
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.069906,0.10148,0.10944,1,1
2,GO GOLGI VESICLE BUDDING,0.045233,0.10131,0.13343,1,1
2,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0036751,0.10059,0.13939,1,1
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.028348,0.098073,0.16519,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.045233,0.097961,0.10889,1,1
2,GO ORGANIC ACID METABOLIC PROCESS,0.0096484,0.097728,0.14244,1,1
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.069906,0.097302,0.1251,1,1
2,GO REGULATION OF LIGASE ACTIVITY,0.038848,0.097268,0.12944,1,1
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.065157,0.096585,0.11586,1,1
2,GO NUCLEOSIDE METABOLIC PROCESS,0.010101,0.096158,0.1299,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.030713,0.095326,0.11028,1,1
2,GO MUSCLE CELL APOPTOTIC PROCESS,0.02951,0.094703,0.16224,1,1
2,GO PROTEIN DESTABILIZATION,0.022172,0.094451,0.15496,1,1
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.050584,0.092188,0.18168,1,1
2,GO THIOESTER METABOLIC PROCESS,0.038848,0.090659,0.13636,1,1
2,GO REGULATION OF ERAD PATHWAY,0.048745,0.089587,0.15544,1,1
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.010101,0.089322,0.13575,1,1
2,GO POSITIVE REGULATION OF TRANSLATION,0.034576,0.089208,0.12162,1,1
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0092139,0.087023,0.13624,1,1
2,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.065157,0.086843,0.12299,1,1
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.067497,0.08391,0.14237,1,1
2,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.069906,0.082938,0.13855,1,1
2,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.050584,0.082346,0.1422,1,1
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.023112,0.079362,0.13129,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.050584,0.076029,0.13864,1,1
2,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.038848,0.072567,0.13438,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.0027019,0.37571,0.45207,1,0
2,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0013481,0.29145,0.32777,1,0
2,GO URETER DEVELOPMENT,0.033245,0.28225,0.20758,1,0
2,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.030713,0.28175,0.30802,1,0
2,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.058535,0.24778,0.27072,1,0
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.0080134,0.2475,0.24194,1,0
2,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.023112,0.2405,0.22032,1,0
2,GO RESPONSE TO ISCHEMIA,0.0012758,0.23601,0.29126,1,0
2,GO AMINOGLYCAN METABOLIC PROCESS,0.0029965,0.2349,0.27362,1,0
2,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.022172,0.23105,0.27442,1,0
2,GO LYMPH VESSEL MORPHOGENESIS,0.011574,0.23063,0.34537,1,0
2,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0036751,0.22816,0.25999,1,0
2,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.0083971,0.22468,0.28929,1,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.020391,0.21737,0.27162,1,0
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.0012758,0.21595,0.3085,1,0
2,GO LABYRINTHINE LAYER DEVELOPMENT,0.031957,0.21512,0.17801,1,0
2,GO TOOTH MINERALIZATION,0.010101,0.21091,0.29473,1,0
2,GO PROGESTERONE METABOLIC PROCESS,0.013834,0.20664,0.28608,1,0
2,GO RECEPTOR RECYCLING,0.019548,0.20065,0.18013,1,0
2,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.034576,0.19582,0.19878,1,0
2,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.019548,0.19552,0.22697,1,0
2,GO PHOSPHOLIPID TRANSPORT,0.013235,0.19493,0.20896,1,0
2,GO BASEMENT MEMBRANE ORGANIZATION,0.018736,0.19413,0.29066,1,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0060238,0.19387,0.25014,1,0
2,GO MIDDLE EAR MORPHOGENESIS,0.027226,0.19363,0.14794,1,0
2,GO AORTA MORPHOGENESIS,0.019548,0.1926,0.26768,1,0
2,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.035953,0.19104,0.24248,1,0
2,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.0066311,0.19053,0.23354,1,0
2,GO MESENCHYMAL CELL DIFFERENTIATION,0.058535,0.19,0.18907,1,0
2,GO REGULATION OF MYELINATION,0.015776,0.18969,0.21228,1,0
2,GO CIRCULATORY SYSTEM DEVELOPMENT,0.007293,0.18954,0.24445,1,0
2,GO LIPID LOCALIZATION,0.0028457,0.18709,0.2239,1,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.046961,0.18705,0.19167,1,0
2,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.041938,0.18613,0.23635,1,0
2,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.030713,0.1836,0.16699,1,0
2,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.028348,0.17798,0.15328,1,0
2,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.043559,0.17499,0.26865,1,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.023112,0.17434,0.20579,1,0
2,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.034576,0.17408,0.18315,1,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.035953,0.17353,0.2206,1,0
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.0010798,0.17347,0.20514,1,0
2,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.021265,0.17237,0.26927,1,0
2,GO TUBE DEVELOPMENT,0.010572,0.1721,0.2213,1,0
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.017954,0.17139,0.21222,1,0
2,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.056456,0.17105,0.23406,1,0
2,GO REGULATION OF JUN KINASE ACTIVITY,0.016475,0.16949,0.21129,1,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.034576,0.16878,0.22973,1,0
2,GO NEGATIVE REGULATION OF MAPK CASCADE,0.0049572,0.16757,0.21672,1,0
2,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.021265,0.16446,0.18228,1,0
2,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0038653,0.16363,0.19517,1,0
2,GO RESPONSE TO STEROID HORMONE,0.007293,0.16319,0.1949,1,0
2,GO ACTIVATION OF MAPKK ACTIVITY,0.060677,0.16299,0.1737,1,0
2,GO CELL VOLUME HOMEOSTASIS,0.0038653,0.16231,0.26424,1,0
2,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.065157,0.15951,0.15945,1,0
2,GO EPIDERMAL CELL DIFFERENTIATION,0.046961,0.158,0.14271,1,0
2,GO POSITIVE REGULATION OF AUTOPHAGY,0.018736,0.15795,0.18417,1,0
2,GO REGULATION OF URINE VOLUME,0.043559,0.15687,0.22988,1,0
2,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.062884,0.15625,0.22486,1,0
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.015104,0.15622,0.21695,1,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.058535,0.15575,0.13825,1,0
2,GO STRIATED MUSCLE CELL PROLIFERATION,0.021265,0.15447,0.19549,1,0
2,GO CARDIAC SEPTUM DEVELOPMENT,0.056456,0.15428,0.1944,1,0
2,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.013834,0.15383,0.18359,1,0
2,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0028457,0.15288,0.2018,1,0
2,GO MESENCHYME MORPHOGENESIS,0.041938,0.15259,0.241,1,0
2,GO OLIGOPEPTIDE TRANSPORT,0.026142,0.15069,0.21124,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.006955,0.15034,0.19027,1,0
2,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.048745,0.15001,0.14445,1,0
2,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0042727,0.14933,0.19037,1,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.010572,0.14919,0.19488,1,0
2,GO ANION HOMEOSTASIS,0.0049572,0.14835,0.21925,1,0
2,GO CELL AGGREGATION,0.065157,0.14715,0.19035,1,0
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0172,0.147,0.20246,1,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.056456,0.14688,0.18917,1,0
2,GO REGULATION OF MUSCLE HYPERTROPHY,0.048745,0.14622,0.16526,1,0
2,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.02951,0.14568,0.18394,1,0
2,GO NEGATIVE REGULATION OF SECRETION,0.0057394,0.14559,0.19636,1,0
2,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.023112,0.14503,0.17643,1,0
2,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.011574,0.14498,0.18337,1,0
2,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.024086,0.14479,0.19141,1,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.020391,0.14342,0.25735,1,0
2,GO RECEPTOR CATABOLIC PROCESS,0.026142,0.14295,0.20421,1,0
2,GO CHEMICAL HOMEOSTASIS,0.010572,0.14273,0.17977,1,0
2,GO RESPONSE TO HORMONE,0.011574,0.14272,0.17318,1,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0057394,0.14218,0.2802,1,0
2,GO PIGMENT GRANULE LOCALIZATION,0.037377,0.14201,0.15222,1,0
2,GO REGULATION OF GTPASE ACTIVITY,0.019548,0.14182,0.19328,1,0
2,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.025096,0.14085,0.15806,1,0
2,GO ERYTHROCYTE MATURATION,0.045233,0.13943,0.21843,1,0
2,GO MUSCLE ADAPTATION,0.021265,0.13932,0.18609,1,0
2,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.013834,0.13889,0.17017,1,0
2,GO REGULATION OF FATTY ACID OXIDATION,0.031957,0.13885,0.18325,1,0
2,GO ANIMAL ORGAN FORMATION,0.054439,0.13877,0.18493,1,0
2,GO REGULATION OF PHOSPHORYLATION,0.010101,0.13853,0.16999,1,0
2,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.035953,0.13813,0.18761,1,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.045233,0.13775,0.17842,1,0
2,GO PROTEOGLYCAN METABOLIC PROCESS,0.052482,0.13761,0.17771,1,0
2,GO APOPTOTIC PROCESS,0.0029965,0.13709,0.17587,1,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.023112,0.13679,0.16692,1,0
2,GO ADAPTIVE THERMOGENESIS,0.050584,0.13641,0.14585,1,0
2,GO NEGATIVE REGULATION OF TRANSPORT,0.0092139,0.13572,0.17151,1,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.043559,0.13535,0.16353,1,0
2,GO RADIAL GLIAL CELL DIFFERENTIATION,0.040368,0.13472,0.18986,1,0
2,GO CORONARY VASCULATURE DEVELOPMENT,0.037377,0.13469,0.24967,1,0
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.014457,0.134,0.20231,1,0
2,GO TEMPERATURE HOMEOSTASIS,0.024086,0.1338,0.16178,1,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.037377,0.13203,0.14797,1,0
2,GO CONNECTIVE TISSUE DEVELOPMENT,0.020391,0.13168,0.20961,1,0
2,GO ACTIN FILAMENT BASED PROCESS,0.033245,0.13122,0.17589,1,0
2,GO RENAL SYSTEM PROCESS,0.050584,0.13101,0.19774,1,0
2,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.056456,0.12971,0.15235,1,0
2,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.027226,0.12902,0.16251,1,0
2,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.069906,0.12902,0.1556,1,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.030713,0.129,0.17922,1,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.010572,0.1269,0.16845,1,0
2,GO REGULATION OF ENDOCYTOSIS,0.041938,0.12681,0.15975,1,0
2,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.043559,0.12678,0.19022,1,0
2,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.046961,0.12564,0.16808,1,0
2,GO POSITIVE REGULATION OF HEART GROWTH,0.022172,0.12541,0.1995,1,0
2,GO FOCAL ADHESION ASSEMBLY,0.050584,0.12504,0.23285,1,0
2,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.046961,0.12476,0.15389,1,0
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.020391,0.12443,0.17422,1,0
2,GO STEM CELL DIFFERENTIATION,0.024086,0.12388,0.14752,1,0
2,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.020391,0.12355,0.15415,1,0
2,GO REGULATION OF PROTEIN BINDING,0.069906,0.12188,0.14895,1,0
2,GO HORMONE METABOLIC PROCESS,0.013834,0.12123,0.16434,1,0
2,GO NEGATIVE REGULATION OF SIGNALING,0.030713,0.12,0.15028,1,0
2,GO SELECTIVE AUTOPHAGY,0.054439,0.11952,0.14229,1,0
2,GO REGULATION OF MUSCLE ADAPTATION,0.046961,0.11848,0.16358,1,0
2,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.016475,0.11772,0.15845,1,0
2,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.024086,0.11699,0.15576,1,0
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.054439,0.11694,0.15209,1,0
2,GO RESPIRATORY SYSTEM DEVELOPMENT,0.040368,0.11679,0.19309,1,0
2,GO RESPONSE TO ESTRADIOL,0.024086,0.1167,0.17086,1,0
2,GO LIPID MODIFICATION,0.050584,0.11549,0.13415,1,0
2,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.025096,0.11498,0.15848,1,0
2,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.033245,0.11459,0.18028,1,0
2,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.062884,0.11453,0.17073,1,0
2,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.012106,0.11441,0.17008,1,0
2,GO ACTIN FILAMENT BASED MOVEMENT,0.043559,0.11382,0.16907,1,0
2,GO SKELETAL SYSTEM DEVELOPMENT,0.02951,0.1124,0.19034,1,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.010572,0.11145,0.18523,1,0
2,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.065157,0.11123,0.12075,1,0
2,GO RESPONSE TO INORGANIC SUBSTANCE,0.040368,0.11118,0.13985,1,0
2,GO ALCOHOL CATABOLIC PROCESS,0.038848,0.11001,0.13811,1,0
2,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.027226,0.10984,0.15056,1,0
2,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.021265,0.10961,0.15616,1,0
2,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.028348,0.10957,0.18622,1,0
2,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.020391,0.10868,0.15832,1,0
2,GO REGULATION OF ORGAN GROWTH,0.016475,0.10855,0.19057,1,0
2,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.033245,0.10832,0.15388,1,0
2,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.041938,0.1082,0.14964,1,0
2,GO REGULATION OF HEART GROWTH,0.028348,0.10778,0.17036,1,0
2,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.025096,0.10768,0.14239,1,0
2,GO CELLULAR PIGMENTATION,0.025096,0.10755,0.15675,1,0
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.046961,0.10748,0.14394,1,0
2,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.045233,0.10745,0.15314,1,0
2,GO MUSCLE STRUCTURE DEVELOPMENT,0.045233,0.10704,0.15733,1,0
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.0096484,0.10677,0.14299,1,0
2,GO POSITIVE REGULATION OF ION TRANSPORT,0.065157,0.10667,0.14404,1,0
2,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.023112,0.10661,0.16078,1,0
2,GO LIPID PHOSPHORYLATION,0.067497,0.10643,0.16034,1,0
2,GO RECEPTOR METABOLIC PROCESS,0.034576,0.10613,0.14984,1,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.017954,0.10576,0.13956,1,0
2,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.058535,0.10518,0.16526,1,0
2,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.015776,0.10512,0.15628,1,0
2,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.048745,0.10417,0.15712,1,0
2,GO RESPONSE TO ENDOGENOUS STIMULUS,0.043559,0.10409,0.14708,1,0
2,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.017954,0.10406,0.15425,1,0
2,GO AGING,0.013235,0.10326,0.16689,1,0
2,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.023112,0.10287,0.18076,1,0
2,GO GLYCOPROTEIN METABOLIC PROCESS,0.031957,0.10268,0.15378,1,0
2,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.056456,0.10242,0.18265,1,0
2,GO ORGANIC ACID CATABOLIC PROCESS,0.031957,0.10203,0.12599,1,0
2,GO RESPONSE TO DRUG,0.021265,0.10196,0.15452,1,0
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.046961,0.10075,0.11615,1,0
2,GO PROTEOLYSIS,0.017954,0.099867,0.14489,1,0
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.02951,0.099651,0.15568,1,0
2,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.040368,0.099397,0.21546,1,0
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.030713,0.096838,0.16911,1,0
2,GO CALCINEURIN MEDIATED SIGNALING,0.056456,0.096663,0.16178,1,0
2,GO REGULATION OF BLOOD PRESSURE,0.023112,0.096326,0.18133,1,0
2,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.027226,0.096266,0.1481,1,0
2,GO MODIFIED AMINO ACID TRANSPORT,0.056456,0.095201,0.1572,1,0
2,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.046961,0.094746,0.16896,1,0
2,GO REGULATION OF TRANSFERASE ACTIVITY,0.069906,0.094323,0.13466,1,0
2,GO FIBROBLAST MIGRATION,0.056456,0.093812,0.18951,1,0
2,GO MUSCLE CELL DIFFERENTIATION,0.067497,0.093617,0.14167,1,0
2,GO REGULATION OF CELL DIFFERENTIATION,0.069906,0.093329,0.13903,1,0
2,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.069906,0.093178,0.15234,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.02951,0.092984,0.19222,1,0
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.026142,0.092702,0.13864,1,0
2,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.065157,0.092602,0.14306,1,0
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.037377,0.091185,0.12504,1,0
2,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.022172,0.090526,0.15532,1,0
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.045233,0.090256,0.19343,1,0
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.054439,0.089787,0.11758,1,0
2,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.056456,0.089673,0.13851,1,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.034576,0.08882,0.14199,1,0
2,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.035953,0.08771,0.12959,1,0
2,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.018736,0.085333,0.13742,1,0
2,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.067497,0.084637,0.15338,1,0
2,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.058535,0.083149,0.16188,1,0
2,GO NEGATIVE REGULATION OF ION TRANSPORT,0.050584,0.081995,0.13628,1,0
2,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.065157,0.081928,0.10899,1,0
2,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.062884,0.081342,0.13808,1,0
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.058535,0.081062,0.11521,1,0
2,GO RESPONSE TO NITROGEN COMPOUND,0.054439,0.080045,0.13147,1,0
2,GO KETONE BIOSYNTHETIC PROCESS,0.048745,0.07895,0.13464,1,0
2,GO OXIDATION REDUCTION PROCESS,0.025096,0.078367,0.10793,1,0
2,GO MEGAKARYOCYTE DIFFERENTIATION,0.050584,0.077561,0.16008,1,0
2,GO HORMONE BIOSYNTHETIC PROCESS,0.024086,0.076028,0.14059,1,0
2,GO RESPONSE TO ACID CHEMICAL,0.052482,0.075897,0.12982,1,0
2,GO POLYOL BIOSYNTHETIC PROCESS,0.041938,0.075346,0.13635,1,0
2,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.067497,0.075261,0.13256,1,0
2,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.038848,0.074964,0.13851,1,0
2,GO PEROXISOMAL TRANSPORT,0.038848,0.072743,0.10222,1,0
2,GO PEROXISOME ORGANIZATION,0.025096,0.070894,0.10291,1,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.052482,0.067619,0.13719,1,0
2,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.050584,0.049264,0.1146,1,0
2,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.062884,-0.070943,-0.17917,1,0
2,GO REGULATION OF CHROMOSOME SEPARATION,0.060677,-0.077592,-0.21596,1,0
2,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.052482,-0.080884,-0.25731,1,0
2,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.034576,-0.085031,-0.058161,1,0
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.01266,-0.088829,-0.11853,1,0
2,GO REGULATION OF CHROMOSOME SEGREGATION,0.065157,-0.096854,-0.21808,1,0
2,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.045233,-0.096951,-0.068372,1,0
2,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.050584,-0.098028,-0.10914,1,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.0044907,-0.10769,-0.13778,1,0
2,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.069906,-0.10885,-0.19187,1,0
2,GO COENZYME A BIOSYNTHETIC PROCESS,0.045233,-0.1097,-0.10123,1,0
2,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.019548,-0.10999,-0.15955,1,0
2,GO RESPONSE TO DOPAMINE,0.037377,-0.11115,-0.09942,1,0
2,GO MEIOTIC CELL CYCLE,0.030713,-0.11127,-0.18773,1,0
2,GO NUCLEOTIDE EXCISION REPAIR,0.067497,-0.11445,-0.095025,1,0
2,GO REGULATION OF CYTOKINESIS,0.048745,-0.11489,-0.15314,1,0
2,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.045233,-0.11589,-0.21056,1,0
2,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.069906,-0.11659,-0.11452,1,0
2,GO CHROMOSOME SEGREGATION,0.060677,-0.11684,-0.195,1,0
2,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.046961,-0.11932,-0.11552,1,0
2,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.038848,-0.11955,-0.12697,1,0
2,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.069906,-0.12327,-0.10761,1,0
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.058535,-0.12506,-0.10719,1,0
2,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.038848,-0.12517,-0.16681,1,0
2,GO TUBULIN DEACETYLATION,0.060677,-0.12651,-0.1255,1,0
2,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.043559,-0.12696,-0.23661,1,0
2,GO SISTER CHROMATID SEGREGATION,0.046961,-0.12922,-0.22082,1,0
2,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.027226,-0.13006,-0.28229,1,0
2,GO NUCLEAR CHROMOSOME SEGREGATION,0.050584,-0.13014,-0.20814,1,0
2,GO MITOCHONDRIAL FUSION,0.069906,-0.13112,-0.078796,1,0
2,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.067497,-0.13137,-0.14722,1,0
2,GO MEMBRANE FISSION,0.046961,-0.13243,-0.10936,1,0
2,GO MICROTUBULE BASED MOVEMENT,0.043559,-0.13299,-0.1566,1,0
2,GO REGULATION OF TUBULIN DEACETYLATION,0.038848,-0.13436,-0.14311,1,0
2,GO REGULATION OF SPINDLE ASSEMBLY,0.065157,-0.13638,-0.16122,1,0
2,GO METENCEPHALON DEVELOPMENT,0.048745,-0.13639,-0.14791,1,0
2,GO MEMBRANE DOCKING,0.018736,-0.13673,-0.14742,1,0
2,GO MITOCHONDRION LOCALIZATION,0.02951,-0.1376,-0.15571,1,0
2,GO PHOTORECEPTOR CELL DEVELOPMENT,0.017954,-0.14106,-0.1463,1,0
2,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.01266,-0.14118,-0.30351,1,0
2,GO REGULATION OF MEIOTIC CELL CYCLE,0.006955,-0.14167,-0.19127,1,0
2,GO REGULATION OF MICROTUBULE BASED PROCESS,0.018736,-0.1417,-0.15934,1,0
2,GO CEREBELLAR CORTEX DEVELOPMENT,0.052482,-0.142,-0.15021,1,0
2,GO REGULATION OF MRNA PROCESSING,0.067497,-0.14276,-0.11194,1,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.048745,-0.14325,-0.10166,1,0
2,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.054439,-0.14417,-0.15097,1,0
2,GO POSITIVE REGULATION OF MRNA PROCESSING,0.013834,-0.14752,-0.16771,1,0
2,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.050584,-0.15017,-0.22911,1,0
2,GO MICROTUBULE BASED PROCESS,0.037377,-0.15069,-0.1529,1,0
2,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.010572,-0.15213,-0.15981,1,0
2,GO HISTONE H2A ACETYLATION,0.054439,-0.15219,-0.16595,1,0
2,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.045233,-0.15232,-0.15085,1,0
2,GO DENDRITE MORPHOGENESIS,0.046961,-0.15417,-0.14909,1,0
2,GO SYNAPSE ORGANIZATION,0.069906,-0.15432,-0.11279,1,0
2,GO SPINDLE ASSEMBLY,0.056456,-0.15476,-0.18681,1,0
2,GO MEIOTIC CELL CYCLE PROCESS,0.0172,-0.15697,-0.22098,1,0
2,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.037377,-0.15765,-0.13383,1,0
2,GO MITOTIC SISTER CHROMATID SEGREGATION,0.035953,-0.15869,-0.22973,1,0
2,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.035953,-0.15992,-0.14565,1,0
2,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.02951,-0.16055,-0.15384,1,0
2,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.023112,-0.16119,-0.25754,1,0
2,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.014457,-0.16223,-0.19202,1,0
2,GO REGULATION OF DENDRITE MORPHOGENESIS,0.048745,-0.16249,-0.13992,1,0
2,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.0052065,-0.16252,-0.19684,1,0
2,GO RRNA 3 END PROCESSING,0.041938,-0.16258,-0.15563,1,0
2,GO INOSITOL METABOLIC PROCESS,0.062884,-0.16286,-0.1538,1,0
2,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.024086,-0.16318,-0.17719,1,0
2,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.038848,-0.1635,-0.13922,1,0
2,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.054439,-0.16531,-0.12757,1,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.023112,-0.16532,-0.1737,1,0
2,GO LOCOMOTORY BEHAVIOR,0.060677,-0.16592,-0.12841,1,0
2,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.058535,-0.1665,-0.14039,1,0
2,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.058535,-0.16765,-0.15476,1,0
2,GO MICROTUBULE BASED TRANSPORT,0.040368,-0.16834,-0.14816,1,0
2,GO NEURON MIGRATION,0.069906,-0.17039,-0.13849,1,0
2,GO DNA PACKAGING,0.048745,-0.17066,-0.19449,1,0
2,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.02951,-0.17176,-0.13093,1,0
2,GO CEREBELLAR CORTEX FORMATION,0.067497,-0.17227,-0.14401,1,0
2,GO DORSAL VENTRAL PATTERN FORMATION,0.014457,-0.17431,-0.18765,1,0
2,GO DICARBOXYLIC ACID TRANSPORT,0.048745,-0.17455,-0.11601,1,0
2,GO TRANSPORT ALONG MICROTUBULE,0.019548,-0.17548,-0.16691,1,0
2,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.065157,-0.17639,-0.16275,1,0
2,GO FEEDING BEHAVIOR,0.01266,-0.17677,-0.16027,1,0
2,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.033245,-0.17793,-0.14984,1,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.062884,-0.17858,-0.175,1,0
2,GO CELL CYCLE DNA REPLICATION,0.058535,-0.17873,-0.22717,1,0
2,GO REGULATION OF SYNAPTIC PLASTICITY,0.065157,-0.17873,-0.12983,1,0
2,GO REGULATION OF SYNAPSE ASSEMBLY,0.045233,-0.1788,-0.16332,1,0
2,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0047188,-0.17977,-0.2025,1,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0172,-0.18019,-0.14825,1,0
2,GO REGULATION OF SYNAPSE MATURATION,0.038848,-0.18048,-0.28514,1,0
2,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.045233,-0.18069,-0.23275,1,0
2,GO CILIUM ORGANIZATION,0.060677,-0.18115,-0.14752,1,0
2,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.048745,-0.18175,-0.17089,1,0
2,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.031957,-0.18178,-0.23494,1,0
2,GO REGULATION OF SISTER CHROMATID COHESION,0.033245,-0.18253,-0.21678,1,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.015104,-0.18264,-0.23176,1,0
2,GO MEIOSIS I CELL CYCLE PROCESS,0.011574,-0.18272,-0.25034,1,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.035953,-0.1846,-0.14207,1,0
2,GO REGULATION OF MEMBRANE POTENTIAL,0.028348,-0.18712,-0.12156,1,0
2,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.011063,-0.18859,-0.20772,1,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.035953,-0.18894,-0.17228,1,0
2,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.037377,-0.18897,-0.24336,1,0
2,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.046961,-0.18955,-0.15056,1,0
2,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.035953,-0.19026,-0.24113,1,0
2,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.052482,-0.19082,-0.1605,1,0
2,GO PEPTIDE HORMONE SECRETION,0.048745,-0.19162,-0.09951,1,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.018736,-0.19202,-0.29492,1,0
2,GO SECRETORY GRANULE LOCALIZATION,0.027226,-0.19383,-0.23387,1,0
2,GO EMBRYONIC BRAIN DEVELOPMENT,0.034576,-0.19452,-0.20163,1,0
2,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.069906,-0.19543,-0.27295,1,0
2,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.0083971,-0.19557,-0.18573,1,0
2,GO SPINDLE ORGANIZATION,0.026142,-0.19559,-0.20983,1,0
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.046961,-0.19584,-0.2909,1,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.041938,-0.19635,-0.18046,1,0
2,GO DETECTION OF TEMPERATURE STIMULUS,0.026142,-0.19661,-0.1614,1,0
2,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.0052065,-0.19811,-0.30073,1,0
2,GO AXO DENDRITIC PROTEIN TRANSPORT,0.016475,-0.19845,-0.22429,1,0
2,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.025096,-0.19893,-0.245,1,0
2,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.027226,-0.19937,-0.18293,1,0
2,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.046961,-0.19961,-0.14623,1,0
2,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.0092139,-0.2,-0.24331,1,0
2,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.022172,-0.20027,-0.21473,1,0
2,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.025096,-0.20053,-0.15559,1,0
2,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.0057394,-0.20104,-0.26612,1,0
2,GO VESICLE DOCKING,0.027226,-0.20121,-0.1197,1,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.023112,-0.20152,-0.17151,1,0
2,GO POSITIVE REGULATION OF DNA REPLICATION,0.050584,-0.20283,-0.15128,1,0
2,GO CENTROMERE COMPLEX ASSEMBLY,0.0092139,-0.20427,-0.33316,1,0
2,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.037377,-0.20486,-0.18677,1,0
2,GO SYNAPTIC SIGNALING,0.023112,-0.20571,-0.16362,1,0
2,GO NEURAL RETINA DEVELOPMENT,0.015776,-0.20599,-0.19725,1,0
2,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.0060238,-0.20797,-0.24285,1,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0080134,-0.20856,-0.27492,1,0
2,GO RETROGRADE AXONAL TRANSPORT,0.054439,-0.20863,-0.20089,1,0
2,GO MICROTUBULE NUCLEATION,0.030713,-0.20927,-0.16758,1,0
2,GO MITOTIC SPINDLE ORGANIZATION,0.0092139,-0.21039,-0.26885,1,0
2,GO MICROTUBULE SEVERING,0.02951,-0.21045,-0.19255,1,0
2,GO PRESYNAPSE ORGANIZATION,0.025096,-0.21181,-0.17803,1,0
2,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.021265,-0.21223,-0.22029,1,0
2,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.030713,-0.21224,-0.17338,1,0
2,GO CELL DIFFERENTIATION IN SPINAL CORD,0.019548,-0.21308,-0.19585,1,0
2,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0083971,-0.21339,-0.22229,1,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.01266,-0.21383,-0.22487,1,0
2,GO NEUROMUSCULAR PROCESS,0.067497,-0.21507,-0.13606,1,0
2,GO MICROTUBULE POLYMERIZATION,0.0040644,-0.21519,-0.22794,1,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.028348,-0.2156,-0.18005,1,0
2,GO SYNAPTIC VESICLE RECYCLING,0.010572,-0.21594,-0.16424,1,0
2,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.033245,-0.21627,-0.16841,1,0
2,GO NEURONAL ACTION POTENTIAL,0.022172,-0.21684,-0.19033,1,0
2,GO CHROMOSOME CONDENSATION,0.010101,-0.21755,-0.32393,1,0
2,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.033245,-0.22064,-0.18786,1,0
2,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.028348,-0.22125,-0.2193,1,0
2,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.021265,-0.22166,-0.19136,1,0
2,GO REGULATION OF AMINO ACID TRANSPORT,0.045233,-0.22262,-0.15164,1,0
2,GO SPINAL CORD DEVELOPMENT,0.030713,-0.22377,-0.1947,1,0
2,GO ANTEROGRADE AXONAL TRANSPORT,0.010572,-0.22415,-0.2146,1,0
2,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.0049572,-0.22459,-0.32292,1,0
2,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.040368,-0.22515,-0.17868,1,0
2,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.0049572,-0.22616,-0.1918,1,0
2,GO REGULATION OF RESPONSE TO FOOD,0.034576,-0.22671,-0.21801,1,0
2,GO FOREBRAIN NEURON DEVELOPMENT,0.058535,-0.22727,-0.15692,1,0
2,GO SUCKLING BEHAVIOR,0.010572,-0.22812,-0.27314,1,0
2,GO REGULATION OF SPINDLE ORGANIZATION,0.007293,-0.22887,-0.23059,1,0
2,GO LAYER FORMATION IN CEREBRAL CORTEX,0.016475,-0.23064,-0.23739,1,0
2,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.015104,-0.23155,-0.23105,1,0
2,GO NEGATIVE REGULATION OF RNA SPLICING,0.016475,-0.23213,-0.19846,1,0
2,GO ACIDIC AMINO ACID TRANSPORT,0.020391,-0.23308,-0.15159,1,0
2,GO CELL JUNCTION MAINTENANCE,0.020391,-0.23326,-0.20822,1,0
2,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0017696,-0.23382,-0.25249,1,0
2,GO MICROTUBULE BUNDLE FORMATION,0.033245,-0.23393,-0.19738,1,0
2,GO AXO DENDRITIC TRANSPORT,0.0076456,-0.23452,-0.21401,1,0
2,GO RESPONSE TO COCAINE,0.013235,-0.23536,-0.20729,1,0
2,GO AXONAL TRANSPORT,0.0054671,-0.23705,-0.2254,1,0
2,GO ADULT LOCOMOTORY BEHAVIOR,0.0063209,-0.23715,-0.20226,1,0
2,GO EXOCYTIC PROCESS,0.030713,-0.24074,-0.14352,1,0
2,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.0060238,-0.24078,-0.22426,1,0
2,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.031957,-0.24087,-0.21087,1,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0012758,-0.24105,-0.26317,1,0
2,GO PRESYNAPTIC ENDOCYTOSIS,0.0092139,-0.24126,-0.17619,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.050584,-0.24188,-0.18481,1,0
2,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.026142,-0.24332,-0.2091,1,0
2,GO AXONAL TRANSPORT OF MITOCHONDRION,0.0057394,-0.24373,-0.25847,1,0
2,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0019699,-0.24381,-0.24657,1,0
2,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.023112,-0.24382,-0.1951,1,0
2,GO DORSAL SPINAL CORD DEVELOPMENT,0.050584,-0.24537,-0.20875,1,0
2,GO VENTRAL SPINAL CORD DEVELOPMENT,0.0057394,-0.24666,-0.21966,1,0
2,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00332,-0.24702,-0.25594,1,0
2,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0036751,-0.24888,-0.26367,1,0
2,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.011063,-0.25018,-0.28779,1,0
2,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.013235,-0.25232,-0.2293,1,0
2,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.016475,-0.25305,-0.21584,1,0
2,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.040368,-0.25334,-0.16426,1,0
2,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.011063,-0.25371,-0.24744,1,0
2,GO GROOMING BEHAVIOR,0.013834,-0.25385,-0.25769,1,0
2,GO SECONDARY HEART FIELD SPECIFICATION,0.031957,-0.25407,-0.25116,1,0
2,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.027226,-0.2544,-0.1936,1,0
2,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.035953,-0.25506,-0.25448,1,0
2,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.0015041,-0.25678,-0.27993,1,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0015041,-0.25768,-0.26481,1,0
2,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.014457,-0.25896,-0.20486,1,0
2,GO PROTEIN PALMITOYLATION,0.016475,-0.25989,-0.21336,1,0
2,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.043559,-0.2615,-0.14488,1,0
2,GO CHROMATIN SILENCING AT TELOMERE,0.012106,-0.26338,-0.26069,1,0
2,GO MICROTUBULE DEPOLYMERIZATION,0.0036751,-0.2643,-0.33191,1,0
2,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0076456,-0.26794,-0.22885,1,0
2,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.050584,-0.26994,-0.27537,1,0
2,GO RETINA LAYER FORMATION,0.0172,-0.27013,-0.28377,1,0
2,GO RESPONSE TO FORSKOLIN,0.067497,-0.27233,-0.18467,1,0
2,GO CHROMATIN REMODELING AT CENTROMERE,0.0023095,-0.27336,-0.39302,1,0
2,GO EATING BEHAVIOR,0.0040644,-0.27518,-0.22463,1,0
2,GO FOREBRAIN REGIONALIZATION,0.058535,-0.27697,-0.19143,1,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.0083971,-0.27717,-0.247,1,0
2,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.027226,-0.27753,-0.29927,1,0
2,GO DETECTION OF CALCIUM ION,0.006955,-0.27884,-0.23087,1,0
2,GO SYNAPSE ASSEMBLY,0.022172,-0.27901,-0.20333,1,0
2,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0018673,-0.28035,-0.28349,1,0
2,GO SYNAPTIC MEMBRANE ADHESION,0.02951,-0.28047,-0.28279,1,0
2,GO KINETOCHORE ORGANIZATION,0.0080134,-0.28145,-0.4304,1,0
2,GO OUTER DYNEIN ARM ASSEMBLY,0.067497,-0.28418,-0.28503,1,0
2,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0080134,-0.28449,-0.26391,1,0
2,GO TRANSMISSION OF NERVE IMPULSE,0.016475,-0.28957,-0.21912,1,0
2,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.016475,-0.29024,-0.20963,1,0
2,GO NEURAL NUCLEUS DEVELOPMENT,0.0015882,-0.29251,-0.26604,1,0
2,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.038848,-0.29338,-0.23531,1,0
2,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.040368,-0.29346,-0.21183,1,0
2,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.040368,-0.29484,-0.19535,1,0
2,GO SYNAPSE MATURATION,0.050584,-0.29632,-0.27936,1,0
2,GO RESPONSE TO ACETYLCHOLINE,0.020391,-0.29736,-0.24499,1,0
2,GO REFLEX,0.043559,-0.30692,-0.2127,1,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.0031545,-0.31033,-0.28078,1,0
2,GO GLUTAMATE SECRETION,0.0054671,-0.31067,-0.25615,1,0
2,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.0019699,-0.31124,-0.27854,1,0
2,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.0012071,-0.31177,-0.29502,1,0
2,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.007293,-0.3121,-0.19066,1,0
2,GO VOCALIZATION BEHAVIOR,0.034576,-0.31403,-0.2586,1,0
2,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.010572,-0.31427,-0.3119,1,0
2,GO MITOTIC CHROMOSOME CONDENSATION,0.018736,-0.31522,-0.36641,1,0
2,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.0080134,-0.31835,-0.26663,1,0
2,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.015104,-0.31986,-0.30309,1,0
2,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.023112,-0.32247,-0.27847,1,0
2,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.017954,-0.32325,-0.26125,1,0
2,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0034935,-0.32333,-0.27649,1,0
2,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.008797,-0.32396,-0.31567,1,0
2,GO RESPONSE TO AUDITORY STIMULUS,0.038848,-0.32474,-0.22023,1,0
2,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.021265,-0.32487,-0.26711,1,0
2,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.046961,-0.33103,-0.22243,1,0
2,GO ADULT BEHAVIOR,0.0036751,-0.33138,-0.24971,1,0
2,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.00081392,-0.33264,-0.28938,1,0
2,GO MONOAMINE TRANSPORT,0.023112,-0.33396,-0.22738,1,0
2,GO GANGLION DEVELOPMENT,0.0096484,-0.3346,-0.33281,1,0
2,GO DOPAMINE BIOSYNTHETIC PROCESS,0.010572,-0.33486,-0.27112,1,0
2,GO SYNAPTIC VESICLE LOCALIZATION,0.0024341,-0.33708,-0.26552,1,0
2,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.054439,-0.34272,-0.26847,1,0
2,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.0057394,-0.34553,-0.23174,1,0
2,GO NEURONAL ION CHANNEL CLUSTERING,0.007293,-0.35024,-0.32264,1,0
2,GO REGULATION OF MICROTUBULE BINDING,0.0019699,-0.35074,-0.30581,1,0
2,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.01266,-0.3511,-0.26507,1,0
2,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0024341,-0.36002,-0.28087,1,0
2,GO NEUROPEPTIDE SIGNALING PATHWAY,0.0038653,-0.36032,-0.25811,1,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.0092139,-0.36062,-0.27025,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0031545,-0.36387,-0.2986,1,0
2,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.021265,-0.36399,-0.25409,1,0
2,GO NEUROTRANSMITTER TRANSPORT,0.0019699,-0.36505,-0.27569,1,0
2,GO SPINAL CORD PATTERNING,0.00332,-0.36758,-0.3523,1,0
2,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.0011418,-0.3706,-0.32967,1,0
2,GO CATECHOLAMINE UPTAKE,0.011063,-0.37271,-0.29133,1,0
2,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0011418,-0.38122,-0.35273,1,0
2,GO DENDRITE EXTENSION,0.0015041,-0.38128,-0.33658,1,0
2,GO AMINE TRANSPORT,0.0036751,-0.38731,-0.27264,1,0
2,GO SYNAPTIC VESICLE EXOCYTOSIS,0.0012071,-0.38802,-0.33579,1,0
2,GO DENDRITIC TRANSPORT,0.0011418,-0.38882,-0.43782,1,0
2,GO PROTEIN POLYGLUTAMYLATION,0.0011418,-0.38907,-0.3423,1,0
2,GO POSTSYNAPSE ASSEMBLY,0.0066311,-0.3899,-0.31458,1,0
2,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.023112,-0.39899,-0.28929,1,0
2,GO PREPULSE INHIBITION,0.010572,-0.40054,-0.35916,1,0
2,GO RESPONSE TO INSECTICIDE,0.00012367,-0.40062,-0.39977,1,0
2,GO MECHANOSENSORY BEHAVIOR,0.016475,-0.40709,-0.32374,1,0
2,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.02951,-0.40842,-0.30659,1,0
2,GO NEUROTRANSMITTER SECRETION,0.0012071,-0.41015,-0.31856,1,0
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0076456,-0.41156,-0.32078,1,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0028457,-0.41372,-0.39733,1,0
2,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.013235,-0.415,-0.40287,1,0
2,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.035953,-0.41604,-0.25678,1,0
2,GO PROTEIN LOCALIZATION TO AXON,0.020391,-0.41669,-0.29462,1,0
2,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.012106,-0.46264,-0.32269,1,0
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0052065,-0.46785,-0.41913,1,0
2,GO STARTLE RESPONSE,0.0060238,-0.46843,-0.34469,1,0
2,GO SYNAPTIC VESICLE PRIMING,0.00064645,-0.4708,-0.39381,1,0
2,GO VESICLE FUSION TO PLASMA MEMBRANE,0.0011418,-0.47871,-0.40866,1,0
2,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.00081392,-0.48073,-0.48695,1,0
2,GO DOPAMINE TRANSPORT,0.00054254,-0.48571,-0.40516,1,0
2,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.00332,-0.49754,-0.36537,1,0
2,GO CATECHOLAMINE SECRETION,0.0015041,-0.49994,-0.35919,1,0
2,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.0023095,-0.50848,-0.36042,1,0
2,GO REGULATION OF DOPAMINE SECRETION,0.0003797,-0.51401,-0.44244,1,0
2,GO INNERVATION,0.0047188,-0.51472,-0.39722,1,0
2,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0018673,-0.51507,-0.45479,1,0
2,GO NEURON CELL CELL ADHESION,0.0017696,-0.51855,-0.43565,1,0
2,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.0019699,-0.52536,-0.44152,1,0
2,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0054671,-0.53109,-0.44011,1,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0012758,-0.53641,-0.45269,1,0
2,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0060238,-0.53878,-0.44326,1,0
2,GO DENSE CORE GRANULE TRANSPORT,0.00040321,-0.55399,-0.56797,1,0
2,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0021907,-0.55628,-0.44008,1,0
2,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00086166,-0.56348,-0.44021,1,0
2,GO NEURON FATE SPECIFICATION,0.0003797,-0.5689,-0.5203,1,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS,0.00096503,-0.57641,-0.42491,1,0
2,GO SYNAPTIC VESICLE MATURATION,0.00023283,-0.58106,-0.53142,1,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00091199,-0.58497,-0.44591,1,0
2,GO SYNAPTIC VESICLE CLUSTERING,0.0010798,-0.61728,-0.49429,1,0
2,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.00332,-0.62938,-0.44517,1,0
2,GO SYNAPTIC VESICLE DOCKING,0.00031664,-0.63695,-0.58735,1,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00023283,-0.68102,-0.65115,1,0
2,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00029789,-0.77525,-0.6715,1,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.00035748,-0.77549,-0.61207,1,0
2,GO PONS DEVELOPMENT,0.0017696,-0.78513,-0.67904,1,0
2,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.0003797,-0.84042,-0.63936,1,0
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.00029789,-0.93279,-0.76532,1,0
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.072385,0.27791,0.22153,0,1
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.11894,0.24403,0.2641,0,1
2,GO HEAD MORPHOGENESIS,0.072385,0.24242,0.21092,0,1
2,GO REGULATION OF GASTRIC ACID SECRETION,0.077559,0.22755,0.22888,0,1
2,GO MYELIN MAINTENANCE,0.10134,0.21104,0.18671,0,1
2,GO NOTOCHORD DEVELOPMENT,0.077559,0.20561,0.18551,0,1
2,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.34626,0.20276,0.068409,0,1
2,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.18624,0.20065,0.17524,0,1
2,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.16123,0.1987,0.13598,0,1
2,GO SENSORY PERCEPTION OF BITTER TASTE,0.17591,0.19538,0.26166,0,1
2,GO REGULATION OF VASCULOGENESIS,0.072385,0.18786,0.25223,0,1
2,GO HIPPO SIGNALING,0.26442,0.18694,0.14401,0,1
2,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.11524,0.185,0.15758,0,1
2,GO CELL CELL JUNCTION MAINTENANCE,0.074935,0.18389,0.20934,0,1
2,GO CELL PROLIFERATION IN HINDBRAIN,0.091819,0.18303,0.15292,0,1
2,GO MYOBLAST MIGRATION,0.08588,0.18183,0.18066,0,1
2,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.080256,0.17938,0.16641,0,1
2,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.1475,0.17888,0.19468,0,1
2,GO REGULATION OF DNA METHYLATION,0.11524,0.16838,0.13695,0,1
2,GO RESPONSE TO UV C,0.077559,0.16634,0.16564,0,1
2,GO PROTEIN AUTO ADP RIBOSYLATION,0.08588,0.1645,0.19032,0,1
2,GO MALE GENITALIA DEVELOPMENT,0.072385,0.16065,0.16197,0,1
2,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.21989,0.15969,0.09192,0,1
2,GO PSEUDOURIDINE SYNTHESIS,0.11524,0.15725,0.083831,0,1
2,GO PROTEIN TARGETING TO LYSOSOME,0.13467,0.14883,0.14008,0,1
2,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.074935,0.1476,0.1351,0,1
2,GO SIGNAL PEPTIDE PROCESSING,0.214,0.14329,0.11632,0,1
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.13467,0.14,0.10414,0,1
2,GO FILOPODIUM ASSEMBLY,0.08588,0.13797,0.15543,0,1
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.10811,0.13611,0.12534,0,1
2,GO PARTURITION,0.1306,0.12917,0.15797,0,1
2,GO MUSCLE FILAMENT SLIDING,0.10468,0.12818,0.1407,0,1
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.13885,0.12423,0.13027,0,1
2,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.11894,0.12064,0.087711,0,1
2,GO VIRAL RNA GENOME REPLICATION,0.18624,0.12053,0.098137,0,1
2,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.11163,0.1187,0.11226,0,1
2,GO V D J RECOMBINATION,0.20822,0.11828,0.1084,0,1
2,GO NEPHRIC DUCT MORPHOGENESIS,0.11163,0.11774,0.1835,0,1
2,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.29248,0.11639,0.091828,0,1
2,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.17591,0.116,0.081078,0,1
2,GO VENTRICULAR SEPTUM DEVELOPMENT,0.098083,0.11596,0.17071,0,1
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.37111,0.11564,0.026186,0,1
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.074935,0.11373,0.21584,0,1
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.15655,0.11311,0.095234,0,1
2,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.098083,0.11279,0.15307,0,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.1306,0.11065,0.069191,0,1
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.42405,0.11016,0.017072,0,1
2,GO PORE COMPLEX ASSEMBLY,0.13467,0.10946,0.12232,0,1
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.1475,0.10921,0.13271,0,1
2,GO TOXIN TRANSPORT,0.18624,0.1092,0.11303,0,1
2,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.12662,0.10914,0.1438,0,1
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.20822,0.10846,0.082397,0,1
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.13467,0.10595,0.12342,0,1
2,GO BASE EXCISION REPAIR AP SITE FORMATION,0.51122,0.10402,0.0083551,0,1
2,GO COPII COATED VESICLE CARGO LOADING,0.10468,0.10377,0.13057,0,1
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.2577,0.10376,0.082758,0,1
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.091819,0.10275,0.12018,0,1
2,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.072385,0.10263,0.18077,0,1
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.42405,0.10181,0.048056,0,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.074935,0.10125,0.14596,0,1
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.24463,0.1008,0.095062,0,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.80618,0.098924,-0.019968,0,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.17091,0.097488,0.14325,0,1
2,GO NEGATIVE REGULATION OF CELL DIVISION,0.42405,0.09486,0.053805,0,1
2,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.12662,0.09463,0.13276,0,1
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.17091,0.092645,0.11007,0,1
2,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.15655,0.092148,0.10011,0,1
2,GO DNA METHYLATION OR DEMETHYLATION,0.27126,0.090269,0.076021,0,1
2,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.36271,0.089981,0.056094,0,1
2,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.08588,0.088578,0.1027,0,1
2,GO MULTIVESICULAR BODY SORTING PATHWAY,0.15197,0.088441,0.081304,0,1
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.10468,0.08804,0.14182,0,1
2,GO VIRAL RELEASE FROM HOST CELL,0.091819,0.086993,0.10692,0,1
2,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.26442,0.084901,0.092556,0,1
2,GO ACETYL COA METABOLIC PROCESS,0.094909,0.082606,0.15471,0,1
2,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.17091,0.081937,0.12058,0,1
2,GO POLYAMINE BIOSYNTHETIC PROCESS,0.14312,0.081218,0.064917,0,1
2,GO PIGMENT ACCUMULATION,0.16602,0.080863,0.22147,0,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.23203,0.080783,0.075337,0,1
2,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.12662,0.080668,0.11524,0,1
2,GO POLYAMINE METABOLIC PROCESS,0.30724,0.079741,0.046656,0,1
2,GO MULTI ORGANISM LOCALIZATION,0.43329,0.079531,0.045705,0,1
2,GO REGULATION OF MRNA CATABOLIC PROCESS,0.2577,0.079077,0.068225,0,1
2,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.074935,0.078987,0.11848,0,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.16123,0.077517,0.081481,0,1
2,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.18102,0.076859,0.098487,0,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.27126,0.076846,0.099387,0,1
2,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.080256,0.075137,0.12769,0,1
2,GO ALDITOL METABOLIC PROCESS,0.34626,0.074442,0.033993,0,1
2,GO IMPORT INTO NUCLEUS,0.50109,0.073794,0.061783,0,1
2,GO THYMUS DEVELOPMENT,0.23827,0.073459,0.095848,0,1
2,GO REGULATION OF CATABOLIC PROCESS,0.12273,0.071864,0.10578,0,1
2,GO RESPONSE TO NITROSATIVE STRESS,0.18624,0.070299,0.07841,0,1
2,GO PENTOSE METABOLIC PROCESS,0.10134,0.06741,0.13546,0,1
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.074935,0.063417,0.1385,0,1
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.214,0.062877,0.070151,0,1
2,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.098083,0.061714,0.13777,0,1
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.40594,0.05593,0.047433,0,1
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.18102,0.054124,0.088626,0,1
2,GO RETINA HOMEOSTASIS,0.15197,0.052876,0.078372,0,1
2,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.23203,0.052617,0.088491,0,1
2,GO VIRAL GENE EXPRESSION,0.38829,0.049592,0.030258,0,1
2,GO TRNA 5 LEADER REMOVAL,0.69814,0.047721,0.0033016,0,1
2,GO RNA 5 END PROCESSING,0.62923,0.041999,0.018864,0,1
2,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.00042807,0.55437,0.53658,0,0
2,GO NK T CELL DIFFERENTIATION,0.0017696,0.49942,0.4964,0,0
2,GO MAST CELL ACTIVATION,0.00076864,0.4898,0.43703,0,0
2,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00096503,0.45989,0.57964,0,0
2,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.00060992,0.41928,0.38858,0,0
2,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.00332,0.38604,0.42696,0,0
2,GO NEGATIVE REGULATION OF COAGULATION,0.00029789,0.38286,0.47658,0,0
2,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.0025648,0.37621,0.35582,0,0
2,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.0024341,0.37604,0.53149,0,0
2,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0042727,0.37427,0.35736,0,0
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0031545,0.37219,0.34995,0,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0018673,0.35143,0.29114,0,0
2,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0010798,0.35131,0.39909,0,0
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0025648,0.34766,0.33798,0,0
2,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0025648,0.34152,0.4363,0,0
2,GO TONIC SMOOTH MUSCLE CONTRACTION,0.00086166,0.34151,0.3433,0,0
2,GO VASCULAR WOUND HEALING,0.0010209,0.34141,0.42804,0,0
2,GO DECIDUALIZATION,0.00076864,0.33415,0.38602,0,0
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.012106,0.33079,0.30795,0,0
2,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.00068502,0.32525,0.34974,0,0
2,GO LABYRINTHINE LAYER MORPHOGENESIS,0.007293,0.32214,0.30677,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00019306,0.31718,0.41492,0,0
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00096503,0.31208,0.37191,0,0
2,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.062884,0.30942,0.25797,0,0
2,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0172,0.30612,0.30887,0,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0044907,0.30459,0.38612,0,0
2,GO CELLULAR RESPONSE TO VITAMIN,0.034576,0.30349,0.24444,0,0
2,GO REGULATION OF GLOMERULAR FILTRATION,0.0028457,0.30329,0.42366,0,0
2,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0010798,0.30156,0.33054,0,0
2,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.00091199,0.30116,0.41697,0,0
2,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.019548,0.29846,0.35795,0,0
2,GO HOMOTYPIC CELL CELL ADHESION,0.0024341,0.29716,0.32162,0,0
2,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.0012071,0.29535,0.3934,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0021907,0.29459,0.36386,0,0
2,GO LYMPHANGIOGENESIS,0.0025648,0.29308,0.4061,0,0
2,GO POSITIVE REGULATION OF WOUND HEALING,0.00045436,0.29261,0.35874,0,0
2,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0042727,0.29251,0.33367,0,0
2,GO THYROID HORMONE METABOLIC PROCESS,0.0042727,0.29124,0.26869,0,0
2,GO STEROID CATABOLIC PROCESS,0.0054671,0.29052,0.26218,0,0
2,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.015104,0.28896,0.27592,0,0
2,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0172,0.28764,0.37537,0,0
2,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.031957,0.28366,0.21692,0,0
2,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.015104,0.28091,0.31071,0,0
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0040644,0.27981,0.26246,0,0
2,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.007293,0.27946,0.30294,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0003797,0.27808,0.39107,0,0
2,GO CELL SUBSTRATE ADHESION,0.0038653,0.27672,0.32786,0,0
2,GO REGULATION OF RESPIRATORY BURST,0.015776,0.27585,0.23672,0,0
2,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.025096,0.27503,0.24112,0,0
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.0028457,0.27329,0.39053,0,0
2,GO REGULATION OF CELL SUBSTRATE ADHESION,0.0021907,0.27259,0.32682,0,0
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.019548,0.272,0.3245,0,0
2,GO HISTAMINE SECRETION,0.098083,0.27014,0.21162,0,0
2,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0057394,0.26975,0.26847,0,0
2,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.011574,0.26826,0.25817,0,0
2,GO WOUND HEALING,0.0011418,0.26682,0.31405,0,0
2,GO POLYOL TRANSPORT,0.052482,0.26509,0.20764,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00021879,0.26384,0.33597,0,0
2,GO GLAND MORPHOGENESIS,0.0038653,0.26234,0.30928,0,0
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.0057394,0.26228,0.25409,0,0
2,GO PROTEIN NITROSYLATION,0.00064645,0.26065,0.31931,0,0
2,GO POSITIVE REGULATION OF OSSIFICATION,0.011574,0.25995,0.26094,0,0
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.010101,0.25985,0.24846,0,0
2,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.00332,0.25938,0.3645,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.008797,0.25912,0.30616,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.013834,0.25592,0.22714,0,0
2,GO LYSOSOME LOCALIZATION,0.012106,0.25536,0.23941,0,0
2,GO SPROUTING ANGIOGENESIS,0.00091199,0.25425,0.34489,0,0
2,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.018736,0.25399,0.31195,0,0
2,GO CELLULAR RESPONSE TO X RAY,0.015776,0.25094,0.26763,0,0
2,GO PHAGOLYSOSOME ASSEMBLY,0.026142,0.25041,0.235,0,0
2,GO REGULATION OF CELL FATE COMMITMENT,0.0080134,0.25031,0.25817,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00057531,0.25028,0.32456,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.0013481,0.25027,0.32033,0,0
2,GO VASCULOGENESIS,0.006955,0.25015,0.31251,0,0
2,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0025648,0.24954,0.40485,0,0
2,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00060992,0.24658,0.30235,0,0
2,GO RESPONSE TO VITAMIN,0.0044907,0.24452,0.23186,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.013834,0.2432,0.23755,0,0
2,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0020776,0.24191,0.28484,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.0076456,0.24168,0.31178,0,0
2,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.016475,0.24148,0.23259,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.025096,0.24079,0.2713,0,0
2,GO PROSTATE GLAND DEVELOPMENT,0.0076456,0.24026,0.27216,0,0
2,GO RESPONSE TO PARATHYROID HORMONE,0.080256,0.23942,0.16448,0,0
2,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.035953,0.23931,0.39079,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.067497,0.23786,0.29326,0,0
2,GO RENAL VESICLE DEVELOPMENT,0.017954,0.23781,0.23748,0,0
2,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0018673,0.23719,0.25357,0,0
2,GO RESPONSE TO WOUNDING,0.0018673,0.23688,0.28097,0,0
2,GO ENGULFMENT OF APOPTOTIC CELL,0.013235,0.23582,0.25388,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.027226,0.23535,0.30662,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0044907,0.23513,0.24334,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.014457,0.23343,0.2944,0,0
2,GO CELLULAR RESPONSE TO CADMIUM ION,0.0076456,0.23276,0.25795,0,0
2,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00064645,0.23251,0.25609,0,0
2,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.050584,0.23231,0.18445,0,0
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.016475,0.23168,0.23567,0,0
2,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0057394,0.23056,0.26782,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.072385,0.23051,0.20156,0,0
2,GO REGULATION OF POSITIVE CHEMOTAXIS,0.018736,0.22845,0.29499,0,0
2,GO MYOBLAST DIFFERENTIATION,0.0012071,0.22815,0.27492,0,0
2,GO BIOLOGICAL PHASE,0.094909,0.2279,0.19224,0,0
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.0044907,0.22654,0.24697,0,0
2,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.0013481,0.22583,0.3094,0,0
2,GO TRACHEA DEVELOPMENT,0.0028457,0.22406,0.33474,0,0
2,GO EPIBOLY,0.0028457,0.22383,0.29942,0,0
2,GO EPIDERMIS MORPHOGENESIS,0.013834,0.22347,0.27676,0,0
2,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0063209,0.22336,0.32088,0,0
2,GO REGULATION OF OSSIFICATION,0.006955,0.22332,0.25383,0,0
2,GO BONE MINERALIZATION,0.008797,0.22224,0.2653,0,0
2,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0012758,0.22168,0.25462,0,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0018673,0.22113,0.33376,0,0
2,GO TROPHOBLAST CELL MIGRATION,0.00332,0.21996,0.26482,0,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0076456,0.21988,0.23615,0,0
2,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.024086,0.21976,0.22969,0,0
2,GO TUBE MORPHOGENESIS,0.0031545,0.21913,0.26634,0,0
2,GO KERATAN SULFATE METABOLIC PROCESS,0.0015882,0.21822,0.33123,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.08588,0.21821,0.15597,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.022172,0.21814,0.22855,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0092139,0.21789,0.24245,0,0
2,GO REGULATION OF ODONTOGENESIS,0.006955,0.21776,0.31564,0,0
2,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.00081392,0.21716,0.33714,0,0
2,GO FIBROBLAST PROLIFERATION,0.00064645,0.21692,0.27209,0,0
2,GO MUSCLE CELL MIGRATION,0.0044907,0.21656,0.27042,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0057394,0.21585,0.29124,0,0
2,GO INTESTINAL ABSORPTION,0.0172,0.21531,0.26531,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0023095,0.21517,0.28311,0,0
2,GO DETOXIFICATION OF INORGANIC COMPOUND,0.5959,0.21506,0.076694,0,0
2,GO RELAXATION OF CARDIAC MUSCLE,0.15655,0.21433,0.15079,0,0
2,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0034935,0.21403,0.31541,0,0
2,GO REGULATION OF CELL MATRIX ADHESION,0.008797,0.21382,0.27888,0,0
2,GO O GLYCAN PROCESSING,0.037377,0.21331,0.19383,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0012071,0.21292,0.27104,0,0
2,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.050584,0.2123,0.22272,0,0
2,GO RESPONSE TO NUTRIENT,0.0019699,0.2105,0.22512,0,0
2,GO CELLULAR RESPONSE TO VITAMIN D,0.23827,0.2103,0.13907,0,0
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.0019699,0.2091,0.31626,0,0
2,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.019548,0.20897,0.21466,0,0
2,GO RENAL FILTRATION,0.045233,0.20869,0.29603,0,0
2,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.080256,0.20771,0.23431,0,0
2,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0060238,0.20594,0.25819,0,0
2,GO SMOOTH MUSCLE CELL MIGRATION,0.0063209,0.20538,0.28837,0,0
2,GO CARDIOBLAST DIFFERENTIATION,0.050584,0.2048,0.21266,0,0
2,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0057394,0.20478,0.23846,0,0
2,GO REGULATION OF PROSTAGLANDIN SECRETION,0.019548,0.20409,0.28598,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.014457,0.20314,0.30063,0,0
2,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0031545,0.20276,0.27973,0,0
2,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0020776,0.20258,0.27722,0,0
2,GO PEPTIDYL PROLINE HYDROXYLATION,0.091819,0.2019,0.13584,0,0
2,GO MESODERMAL CELL DIFFERENTIATION,0.0052065,0.20185,0.27357,0,0
2,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.028348,0.20184,0.21065,0,0
2,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.056456,0.20067,0.2466,0,0
2,GO PHOSPHATE ION TRANSPORT,0.0044907,0.1988,0.28249,0,0
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.011063,0.19864,0.27372,0,0
2,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.067497,0.19847,0.19916,0,0
2,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.0057394,0.19688,0.22109,0,0
2,GO OSTEOBLAST PROLIFERATION,0.028348,0.19497,0.23738,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.013235,0.19367,0.29845,0,0
2,GO FORMATION OF PRIMARY GERM LAYER,0.0054671,0.1935,0.28151,0,0
2,GO EPITHELIAL CELL PROLIFERATION,0.011063,0.19321,0.21832,0,0
2,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0011418,0.19209,0.2308,0,0
2,GO REGULATION OF MAP KINASE ACTIVITY,0.0060238,0.19179,0.21348,0,0
2,GO RESPONSE TO MECHANICAL STIMULUS,0.016475,0.19129,0.20382,0,0
2,GO OSSIFICATION,0.015776,0.19095,0.21163,0,0
2,GO ENDOTHELIUM DEVELOPMENT,0.025096,0.19065,0.25862,0,0
2,GO ZINC ION HOMEOSTASIS,0.019548,0.18956,0.21552,0,0
2,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.016475,0.1888,0.26547,0,0
2,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.016475,0.18838,0.20741,0,0
2,GO CORONARY VASCULATURE MORPHOGENESIS,0.10134,0.18733,0.21591,0,0
2,GO INTESTINAL LIPID ABSORPTION,0.072385,0.18693,0.19868,0,0
2,GO POSITIVE REGULATION OF BONE RESORPTION,0.048745,0.18681,0.21198,0,0
2,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0044907,0.18623,0.23682,0,0
2,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0025648,0.18607,0.22625,0,0
2,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.27126,0.18562,0.19406,0,0
2,GO REGULATION OF HEAT GENERATION,0.0096484,0.18536,0.25061,0,0
2,GO GENITALIA DEVELOPMENT,0.035953,0.18316,0.18489,0,0
2,GO REGULATION OF CELL FATE SPECIFICATION,0.08588,0.18267,0.22965,0,0
2,GO OSTEOBLAST DIFFERENTIATION,0.010101,0.18252,0.20793,0,0
2,GO ENDOTHELIAL CELL PROLIFERATION,0.0052065,0.18191,0.28048,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.08881,0.18145,0.19637,0,0
2,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.074935,0.18139,0.19067,0,0
2,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.050584,0.18137,0.18234,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.014457,0.18124,0.30679,0,0
2,GO ERYTHROCYTE HOMEOSTASIS,0.0014241,0.18055,0.21658,0,0
2,GO CHONDROCYTE DIFFERENTIATION,0.045233,0.18033,0.22426,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0066311,0.17929,0.27593,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.020391,0.17908,0.24736,0,0
2,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.098083,0.17812,0.18112,0,0
2,GO NEGATIVE REGULATION OF ANOIKIS,0.10468,0.17763,0.21615,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.034576,0.17725,0.1815,0,0
2,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.0040644,0.17694,0.26611,0,0
2,GO CELLULAR RESPONSE TO COPPER ION,0.27821,0.17678,0.12372,0,0
2,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.022172,0.17513,0.2624,0,0
2,GO NEURON REMODELING,0.031957,0.17484,0.26148,0,0
2,GO ENDOCRINE PROCESS,0.0076456,0.17423,0.23571,0,0
2,GO REGULATION OF NUCLEASE ACTIVITY,0.043559,0.17363,0.15795,0,0
2,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.08881,0.17337,0.21153,0,0
2,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.20256,0.17321,0.12699,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.094909,0.17307,0.17774,0,0
2,GO GENITALIA MORPHOGENESIS,0.043559,0.17151,0.23448,0,0
2,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.077559,0.1713,0.23821,0,0
2,GO BONE MORPHOGENESIS,0.011574,0.17115,0.25669,0,0
2,GO VITAMIN METABOLIC PROCESS,0.00029789,0.17055,0.20616,0,0
2,GO CHONDROCYTE DEVELOPMENT,0.048745,0.16988,0.24805,0,0
2,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.030713,0.16985,0.25386,0,0
2,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.11524,0.16934,0.22751,0,0
2,GO CARDIAC CHAMBER MORPHOGENESIS,0.077559,0.16896,0.18145,0,0
2,GO SKIN DEVELOPMENT,0.035953,0.16855,0.15132,0,0
2,GO CELLULAR RESPONSE TO IRON ION,0.15655,0.16824,0.18396,0,0
2,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.013235,0.168,0.18096,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.013834,0.16654,0.19114,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.048745,0.16609,0.29201,0,0
2,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.043559,0.16556,0.22803,0,0
2,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.080256,0.16535,0.19081,0,0
2,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.023112,0.16524,0.2608,0,0
2,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.045233,0.16519,0.18314,0,0
2,GO POSITIVE REGULATION OF CELL AGING,0.1306,0.16422,0.097578,0,0
2,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.13467,0.16415,0.17355,0,0
2,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.067497,0.16388,0.22451,0,0
2,GO HISTAMINE TRANSPORT,0.17591,0.16375,0.17054,0,0
2,GO REGULATION OF ANOIKIS,0.054439,0.16321,0.21106,0,0
2,GO LIPID EXPORT FROM CELL,0.015104,0.16298,0.20696,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0096484,0.16293,0.27389,0,0
2,GO RELAXATION OF MUSCLE,0.15197,0.1627,0.12553,0,0
2,GO REGULATION OF WATER LOSS VIA SKIN,0.2259,0.16236,0.079091,0,0
2,GO EMBRYONIC HEMOPOIESIS,0.013235,0.16206,0.24727,0,0
2,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.077559,0.16164,0.21973,0,0
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.025096,0.16154,0.22142,0,0
2,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.08303,0.16147,0.24486,0,0
2,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.016475,0.16126,0.17905,0,0
2,GO LATERAL VENTRICLE DEVELOPMENT,0.20822,0.16101,0.18209,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.031957,0.16096,0.24704,0,0
2,GO NEGATIVE REGULATION OF OSSIFICATION,0.014457,0.16073,0.22556,0,0
2,GO CELLULAR RESPONSE TO ZINC ION,0.40594,0.16011,0.084135,0,0
2,GO POSITIVE REGULATION OF CELL DEATH,0.0014241,0.15997,0.21235,0,0
2,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.10468,0.15984,0.15122,0,0
2,GO CARDIAC SEPTUM MORPHOGENESIS,0.11163,0.15955,0.18322,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.0063209,0.15936,0.18928,0,0
2,GO REGULATION OF FATTY ACID TRANSPORT,0.013834,0.15916,0.2295,0,0
2,GO COCHLEA MORPHOGENESIS,0.074935,0.15867,0.15745,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.062884,0.15822,0.15613,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.2259,0.15757,0.18296,0,0
2,GO CHLORIDE ION HOMEOSTASIS,0.10811,0.15743,0.16127,0,0
2,GO DORSAL AORTA DEVELOPMENT,0.058535,0.15737,0.24405,0,0
2,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.033245,0.15672,0.1971,0,0
2,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.13885,0.15664,0.21268,0,0
2,GO LIPID IMPORT INTO CELL,0.045233,0.15632,0.17001,0,0
2,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.10134,0.15621,0.17895,0,0
2,GO LAMELLIPODIUM ASSEMBLY,0.013834,0.15515,0.19399,0,0
2,GO LYTIC VACUOLE ORGANIZATION,0.033245,0.15459,0.1645,0,0
2,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.10134,0.154,0.12387,0,0
2,GO LIPID DIGESTION,0.15197,0.15353,0.15901,0,0
2,GO METANEPHROS DEVELOPMENT,0.022172,0.1532,0.21627,0,0
2,GO BODY MORPHOGENESIS,0.1475,0.15315,0.15426,0,0
2,GO RESPONSE TO CADMIUM ION,0.013834,0.15226,0.1879,0,0
2,GO ECTODERM DEVELOPMENT,0.33821,0.15223,0.066064,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.02951,0.15221,0.22781,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.074935,0.15194,0.17867,0,0
2,GO PARAXIAL MESODERM MORPHOGENESIS,0.15655,0.15187,0.14369,0,0
2,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0096484,0.15119,0.2032,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.022172,0.15034,0.24119,0,0
2,GO EPITHELIAL CELL CELL ADHESION,0.19156,0.14979,0.1753,0,0
2,GO VITAMIN TRANSPORT,0.0092139,0.14924,0.19893,0,0
2,GO GLIAL CELL APOPTOTIC PROCESS,0.022172,0.14906,0.19846,0,0
2,GO APOPTOTIC SIGNALING PATHWAY,0.0018673,0.14848,0.18686,0,0
2,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.08588,0.14781,0.12782,0,0
2,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.197,0.1477,0.09242,0,0
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.17091,0.1467,0.16044,0,0
2,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.1306,0.1462,0.1929,0,0
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.010101,0.14611,0.29829,0,0
2,GO DISACCHARIDE METABOLIC PROCESS,0.017954,0.14607,0.24247,0,0
2,GO PROTEIN O LINKED GLYCOSYLATION,0.11894,0.14556,0.12118,0,0
2,GO REGULATION OF HIPPO SIGNALING,0.51122,0.14543,0.089217,0,0
2,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.18102,0.14539,0.14423,0,0
2,GO AZOLE TRANSMEMBRANE TRANSPORT,0.49108,0.14503,0.099263,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.27821,0.1449,0.091773,0,0
2,GO CYSTEINE METABOLIC PROCESS,0.098083,0.14476,0.15272,0,0
2,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.062884,0.14457,0.18205,0,0
2,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.47137,0.14445,0.058117,0,0
2,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.11894,0.14436,0.15572,0,0
2,GO L GLUTAMATE IMPORT,0.15655,0.14406,0.12519,0,0
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.072385,0.14399,0.21217,0,0
2,GO REGULATION OF CELL PROJECTION SIZE,0.68646,0.14393,0.021458,0,0
2,GO REGULATION OF GLIAL CELL PROLIFERATION,0.038848,0.14388,0.2062,0,0
2,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.11163,0.14367,0.25598,0,0
2,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.023112,0.14339,0.23281,0,0
2,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.17091,0.14337,0.18527,0,0
2,GO REGULATION OF PEPTIDE SECRETION,0.038848,0.14324,0.15808,0,0
2,GO ACTIN FILAMENT DEPOLYMERIZATION,0.027226,0.14289,0.20394,0,0
2,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.012106,0.14263,0.1864,0,0
2,GO RESPONSE TO ZINC ION,0.028348,0.14262,0.15028,0,0
2,GO TONGUE DEVELOPMENT,0.072385,0.14244,0.15575,0,0
2,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0080134,0.14233,0.18604,0,0
2,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.045233,0.14226,0.1769,0,0
2,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.64051,0.14187,0.062809,0,0
2,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.074935,0.14176,0.13786,0,0
2,GO GASTRULATION,0.011063,0.14084,0.21996,0,0
2,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.10134,0.13978,0.26299,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.052482,0.13894,0.2535,0,0
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.27821,0.13865,0.11152,0,0
2,GO CARDIAC ATRIUM MORPHOGENESIS,0.23203,0.13862,0.14059,0,0
2,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.1475,0.13859,0.13009,0,0
2,GO MAST CELL MIGRATION,0.16602,0.13853,0.17866,0,0
2,GO AUTOPHAGIC CELL DEATH,0.0096484,0.13837,0.18336,0,0
2,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.18624,0.13833,0.1584,0,0
2,GO RESPONSE TO OXYGEN RADICAL,0.019548,0.13803,0.15023,0,0
2,GO OUTFLOW TRACT MORPHOGENESIS,0.091819,0.13791,0.21068,0,0
2,GO AMINO ACID IMPORT,0.077559,0.13786,0.16461,0,0
2,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.037377,0.13774,0.19835,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.048745,0.13766,0.22409,0,0
2,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.015776,0.13648,0.16491,0,0
2,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.23827,0.13631,0.11436,0,0
2,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.013235,0.13623,0.21478,0,0
2,GO REGULATION OF METAL ION TRANSPORT,0.007293,0.136,0.18578,0,0
2,GO HEART TRABECULA MORPHOGENESIS,0.1306,0.13521,0.1947,0,0
2,GO OVULATION CYCLE PROCESS,0.11524,0.13515,0.14885,0,0
2,GO RESPONSE TO COPPER ION,0.15197,0.13513,0.1241,0,0
2,GO DERMATAN SULFATE METABOLIC PROCESS,0.13885,0.13468,0.23055,0,0
2,GO ACTIVATION OF MAPKKK ACTIVITY,0.08588,0.13413,0.17828,0,0
2,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.072385,0.13378,0.21991,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.015104,0.13358,0.19023,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.10134,0.13339,0.16479,0,0
2,GO REGULATION OF HAIR CYCLE,0.080256,0.13306,0.17213,0,0
2,GO MESENCHYME DEVELOPMENT,0.091819,0.13264,0.16118,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.067497,0.13261,0.22302,0,0
2,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.08881,0.13249,0.21167,0,0
2,GO REGULATION OF RENAL SYSTEM PROCESS,0.052482,0.13238,0.22119,0,0
2,GO WATER HOMEOSTASIS,0.16602,0.13192,0.12117,0,0
2,GO REGULATION OF AXON GUIDANCE,0.2577,0.13185,0.13361,0,0
2,GO L SERINE METABOLIC PROCESS,0.69814,0.13102,-0.0052295,0,0
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.0029965,0.13052,0.20732,0,0
2,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.13885,0.13015,0.15176,0,0
2,GO MITOTIC CELL CYCLE ARREST,0.046961,0.13005,0.17687,0,0
2,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.197,0.12959,0.1505,0,0
2,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.11894,0.12919,0.17092,0,0
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.39705,0.12918,0.074203,0,0
2,GO PROTEIN KINASE A SIGNALING,0.10811,0.1291,0.12961,0,0
2,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0066311,0.12888,0.21114,0,0
2,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.052482,0.12873,0.22879,0,0
2,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.065157,0.12843,0.23178,0,0
2,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.094909,0.12832,0.13009,0,0
2,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.080256,0.12823,0.24273,0,0
2,GO POSITIVE REGULATION OF SECRETION,0.11524,0.12806,0.12213,0,0
2,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.17091,0.12776,0.18387,0,0
2,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.046961,0.12757,0.26835,0,0
2,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.10811,0.12736,0.14475,0,0
2,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.21989,0.1273,0.1298,0,0
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.067497,0.12677,0.11694,0,0
2,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.17091,0.1265,0.17367,0,0
2,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.24463,0.1264,0.1087,0,0
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.026142,0.12629,0.16317,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.052482,0.12601,0.2185,0,0
2,GO INTERMEDIATE FILAMENT ORGANIZATION,0.054439,0.12589,0.15581,0,0
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.62923,0.12586,0.026337,0,0
2,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0038653,0.12581,0.19369,0,0
2,GO RESPONSE TO EPINEPHRINE,0.10468,0.12578,0.18124,0,0
2,GO GLYCINE TRANSPORT,0.2577,0.12533,0.12817,0,0
2,GO GALACTOSE METABOLIC PROCESS,0.058535,0.12525,0.17716,0,0
2,GO BASEMENT MEMBRANE ASSEMBLY,0.15197,0.12512,0.22855,0,0
2,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.197,0.12494,0.11927,0,0
2,GO NADPH REGENERATION,0.15655,0.12466,0.1023,0,0
2,GO GLIAL CELL DEVELOPMENT,0.16123,0.12448,0.12575,0,0
2,GO ENDOTHELIAL CELL CHEMOTAXIS,0.019548,0.12413,0.27723,0,0
2,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.12662,0.12399,0.21017,0,0
2,GO NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.14312,0.12327,0.11972,0,0
2,GO LUNG ALVEOLUS DEVELOPMENT,0.1475,0.12292,0.18971,0,0
2,GO REGULATION OF VASOCONSTRICTION,0.022172,0.12276,0.26501,0,0
2,GO OVULATION CYCLE,0.072385,0.12261,0.17593,0,0
2,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.17091,0.12229,0.15575,0,0
2,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.14312,0.12212,0.11276,0,0
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.00054254,0.12189,0.18677,0,0
2,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00332,0.12187,0.13905,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.29248,0.12183,0.1222,0,0
2,GO MOTOR NEURON AXON GUIDANCE,0.4521,0.12157,0.10638,0,0
2,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.050584,0.12156,0.14745,0,0
2,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.10468,0.12153,0.18229,0,0
2,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.054439,0.12066,0.13346,0,0
2,GO REGULATION OF CILIUM MOVEMENT,0.90549,0.12055,-0.0047188,0,0
2,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.091819,0.1202,0.19448,0,0
2,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.060677,0.12012,0.19922,0,0
2,GO ENDOTHELIAL CELL DEVELOPMENT,0.054439,0.11988,0.24067,0,0
2,GO GLYCINE METABOLIC PROCESS,0.29248,0.11976,0.08351,0,0
2,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.12662,0.11966,0.22752,0,0
2,GO EPITHELIAL STRUCTURE MAINTENANCE,0.19156,0.11947,0.11915,0,0
2,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.074935,0.11945,0.20105,0,0
2,GO IMP METABOLIC PROCESS,0.098083,0.11934,0.10042,0,0
2,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.12662,0.11912,0.1744,0,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.11894,0.11873,0.15882,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.08588,0.1187,0.14539,0,0
2,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.16602,0.11849,0.11609,0,0
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.08303,0.11793,0.10427,0,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.065157,0.1178,0.1783,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.031957,0.11735,0.17222,0,0
2,GO PEPTIDYL ASPARAGINE MODIFICATION,0.040368,0.11691,0.14727,0,0
2,GO NEURAL CREST CELL DIFFERENTIATION,0.15655,0.11684,0.14178,0,0
2,GO RESPONSE TO VITAMIN A,0.080256,0.11661,0.15645,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.16602,0.11656,0.18704,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.10134,0.11631,0.15467,0,0
2,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.027226,0.11597,0.21322,0,0
2,GO DEFINITIVE HEMOPOIESIS,0.10468,0.11591,0.20692,0,0
2,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.040368,0.1158,0.1903,0,0
2,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.50109,0.11554,0.081247,0,0
2,GO PROTEIN OXIDATION,0.094909,0.11546,0.12606,0,0
2,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.11163,0.1153,0.19031,0,0
2,GO ACTIVATION OF JNKK ACTIVITY,0.08881,0.11504,0.17595,0,0
2,GO PHAGOSOME MATURATION,0.060677,0.11502,0.16322,0,0
2,GO DNA DEALKYLATION,0.067497,0.11482,0.13824,0,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.15655,0.11402,0.08142,0,0
2,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.072385,0.11398,0.19588,0,0
2,GO SKELETAL SYSTEM MORPHOGENESIS,0.12662,0.11382,0.15541,0,0
2,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.08588,0.11343,0.12706,0,0
2,GO BASIC AMINO ACID TRANSPORT,0.62923,0.11333,0.074705,0,0
2,GO CALCIUM ION IMPORT INTO CYTOSOL,0.46168,0.11327,0.099405,0,0
2,GO REPLICATIVE SENESCENCE,0.28529,0.11303,0.091193,0,0
2,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.074935,0.1127,0.14631,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.197,0.11219,0.17969,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.25111,0.11216,0.096995,0,0
2,GO NEPHRON DEVELOPMENT,0.08588,0.11203,0.17668,0,0
2,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.197,0.11195,0.13885,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.18624,0.11143,0.12491,0,0
2,GO MUSCLE HYPERTROPHY,0.17591,0.11141,0.13186,0,0
2,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.13885,0.1114,0.15426,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.36271,0.11136,0.13428,0,0
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.13467,0.11074,0.083109,0,0
2,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.067497,0.11019,0.24009,0,0
2,GO CARDIAC CHAMBER DEVELOPMENT,0.077559,0.10973,0.16991,0,0
2,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.1306,0.10906,0.14924,0,0
2,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.062884,0.109,0.19815,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.10134,0.10873,0.11743,0,0
2,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.091819,0.10869,0.12961,0,0
2,GO REGULATION OF ICOSANOID SECRETION,0.035953,0.10863,0.19189,0,0
2,GO REGULATION OF EXOSOMAL SECRETION,0.27126,0.10845,0.088447,0,0
2,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.38829,0.10839,0.063068,0,0
2,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.091819,0.10839,0.12594,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.058535,0.10827,0.16389,0,0
2,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.11163,0.10809,0.14231,0,0
2,GO IRON COORDINATION ENTITY TRANSPORT,0.2577,0.10807,0.11951,0,0
2,GO HEART MORPHOGENESIS,0.091819,0.10755,0.16495,0,0
2,GO HORMONE CATABOLIC PROCESS,0.15197,0.10732,0.12636,0,0
2,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.072385,0.10652,0.1361,0,0
2,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.12273,0.10648,0.12199,0,0
2,GO PROSTATE GLAND MORPHOGENESIS,0.27126,0.10627,0.14939,0,0
2,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.098083,0.10625,0.23199,0,0
2,GO KERATINIZATION,0.2259,0.10584,0.085643,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.030713,0.1058,0.11251,0,0
2,GO POSITIVE REGULATION OF PROTEIN BINDING,0.034576,0.10577,0.1595,0,0
2,GO REGULATION OF MIRNA METABOLIC PROCESS,0.13467,0.10564,0.16734,0,0
2,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.47137,0.10537,0.084318,0,0
2,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.1306,0.10531,0.15621,0,0
2,GO CELLULAR RESPONSE TO DRUG,0.0042727,0.10528,0.17317,0,0
2,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.27126,0.10523,0.11611,0,0
2,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.072385,0.10502,0.16894,0,0
2,GO UV PROTECTION,0.098083,0.10491,0.16811,0,0
2,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.077559,0.10486,0.13712,0,0
2,GO RESPONSE TO IRON ION,0.47137,0.1048,0.087897,0,0
2,GO REGULATION OF CARTILAGE DEVELOPMENT,0.1475,0.1047,0.15622,0,0
2,GO CARDIAC MUSCLE CELL CONTRACTION,0.14312,0.10449,0.12134,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION,0.098083,0.10429,0.12359,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.24463,0.10346,0.12499,0,0
2,GO RESPONSE TO OXYGEN LEVELS,0.0092139,0.10337,0.14854,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.29248,0.1033,0.13285,0,0
2,GO NEGATIVE REGULATION OF GROWTH,0.08303,0.10327,0.14352,0,0
2,GO MICROVILLUS ASSEMBLY,0.26442,0.103,0.10151,0,0
2,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.069906,0.10268,0.14303,0,0
2,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.32248,0.10248,0.1008,0,0
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0044907,0.10245,0.16865,0,0
2,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.18102,0.10224,0.099402,0,0
2,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.49108,0.10184,0.090241,0,0
2,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.098083,0.10183,0.11949,0,0
2,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.14312,0.10139,0.11301,0,0
2,GO SEROTONIN TRANSPORT,0.15197,0.10119,0.18214,0,0
2,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.10134,0.10117,0.2358,0,0
2,GO ENDOCYTIC RECYCLING,0.15655,0.101,0.14692,0,0
2,GO REGULATION OF ANION TRANSPORT,0.11163,0.1009,0.13788,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.33821,0.10088,0.094396,0,0
2,GO AXIS ELONGATION,0.12662,0.10063,0.15911,0,0
2,GO REGULATION OF NEURON PROJECTION REGENERATION,0.214,0.1002,0.14279,0,0
2,GO REGULATION OF FILOPODIUM ASSEMBLY,0.28529,0.099709,0.11971,0,0
2,GO ANDROGEN METABOLIC PROCESS,0.033245,0.09963,0.12366,0,0
2,GO REGULATION OF HISTONE DEACETYLATION,0.18624,0.099539,0.12481,0,0
2,GO DENDRITE SELF AVOIDANCE,0.27821,0.099214,0.11478,0,0
2,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.23203,0.098872,0.095485,0,0
2,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.197,0.098865,0.16329,0,0
2,GO INDOLALKYLAMINE METABOLIC PROCESS,0.25111,0.098651,0.12393,0,0
2,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.17091,0.098559,0.14188,0,0
2,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.16602,0.098003,0.17514,0,0
2,GO MUSCLE ORGAN DEVELOPMENT,0.080256,0.097909,0.13907,0,0
2,GO CARDIAC MUSCLE CELL PROLIFERATION,0.11163,0.097643,0.16701,0,0
2,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.15197,0.09746,0.12558,0,0
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.20256,0.096875,0.10823,0,0
2,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.098083,0.096761,0.12416,0,0
2,GO ACTIN MEDIATED CELL CONTRACTION,0.098083,0.096711,0.13756,0,0
2,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.10134,0.096711,0.1388,0,0
2,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.64051,0.096706,0.0758,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.10468,0.096562,0.18706,0,0
2,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.094909,0.096517,0.11607,0,0
2,GO MESENCHYMAL CELL PROLIFERATION,0.21989,0.096376,0.15795,0,0
2,GO CARDIAC VENTRICLE DEVELOPMENT,0.25111,0.095982,0.10932,0,0
2,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.25111,0.095751,0.085576,0,0
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.11894,0.095744,0.11082,0,0
2,GO UROGENITAL SYSTEM DEVELOPMENT,0.08588,0.095659,0.16294,0,0
2,GO RESPONSE TO GROWTH FACTOR,0.11524,0.095552,0.14872,0,0
2,GO MUSCLE TISSUE DEVELOPMENT,0.098083,0.095504,0.13226,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.1306,0.095474,0.11214,0,0
2,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.1306,0.09547,0.17125,0,0
2,GO RESPONSE TO WATER,0.17591,0.095237,0.14599,0,0
2,GO MAMMARY GLAND DEVELOPMENT,0.13467,0.095127,0.15645,0,0
2,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.23827,0.095018,0.13725,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.57414,0.095007,0.02349,0,0
2,GO RESPONSE TO ETHANOL,0.043559,0.094994,0.12681,0,0
2,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.7336,0.094718,0.045445,0,0
2,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,0.08303,0.094571,0.23155,0,0
2,GO NEGATIVE CHEMOTAXIS,0.29248,0.094563,0.14121,0,0
2,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.20822,0.09429,0.12112,0,0
2,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.89296,0.094288,0.014182,0,0
2,GO REGULATION OF PEPTIDE TRANSPORT,0.098083,0.094108,0.12143,0,0
2,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.23827,0.094055,0.11986,0,0
2,GO CARBOHYDRATE TRANSPORT,0.12662,0.093841,0.12406,0,0
2,GO CARDIOCYTE DIFFERENTIATION,0.072385,0.093731,0.14503,0,0
2,GO STRESS FIBER ASSEMBLY,0.094909,0.093678,0.18347,0,0
2,GO DENDRITIC SPINE MAINTENANCE,0.16123,0.093374,0.16522,0,0
2,GO DENTATE GYRUS DEVELOPMENT,0.75756,0.093366,-0.0084595,0,0
2,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,0.24463,0.093014,0.090317,0,0
2,GO PH REDUCTION,0.27126,0.09295,0.071002,0,0
2,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.29248,0.092784,0.11338,0,0
2,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.15197,0.092622,0.15729,0,0
2,GO CARDIAC VENTRICLE MORPHOGENESIS,0.7336,0.092563,0.062972,0,0
2,GO HAIR FOLLICLE MATURATION,0.2998,0.092557,0.11187,0,0
2,GO FACIAL NERVE MORPHOGENESIS,0.39705,0.092329,0.12926,0,0
2,GO NEURAL CREST CELL MIGRATION,0.20256,0.092157,0.11765,0,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.23203,0.09208,0.13217,0,0
2,GO PROTEIN IMPORT,0.37111,0.092046,0.079864,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.14312,0.091967,0.14961,0,0
2,GO ENSHEATHMENT OF NEURONS,0.2998,0.091644,0.10837,0,0
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.36271,0.091527,0.11132,0,0
2,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.08588,0.091501,0.12561,0,0
2,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.12273,0.091487,0.11181,0,0
2,GO PIGMENT CELL DIFFERENTIATION,0.2577,0.091312,0.10917,0,0
2,GO RESPONSE TO GONADOTROPIN,0.18624,0.090849,0.12446,0,0
2,GO HEART TRABECULA FORMATION,0.25111,0.090698,0.14687,0,0
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.015776,0.090298,0.15858,0,0
2,GO MUSCLE ORGAN MORPHOGENESIS,0.214,0.090276,0.11362,0,0
2,GO NEGATIVE REGULATION OF JNK CASCADE,0.11894,0.090103,0.12551,0,0
2,GO MELANOCYTE DIFFERENTIATION,0.46168,0.090103,0.061385,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.072385,0.090051,0.16076,0,0
2,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.27821,0.089941,0.16356,0,0
2,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.33029,0.089725,0.078469,0,0
2,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.12662,0.089714,0.12717,0,0
2,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.069906,0.089526,0.13352,0,0
2,GO REGULATION OF MULTI ORGANISM PROCESS,0.013834,0.089033,0.14057,0,0
2,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.36271,0.088985,0.10756,0,0
2,GO EXOCRINE SYSTEM DEVELOPMENT,0.13467,0.08842,0.18128,0,0
2,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.08881,0.088274,0.14174,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.15197,0.088263,0.11879,0,0
2,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.30724,0.088159,0.11299,0,0
2,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.15655,0.08805,0.21983,0,0
2,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.15655,0.088014,0.17107,0,0
2,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.094909,0.087941,0.11147,0,0
2,GO FATTY ACID BETA OXIDATION,0.27126,0.087835,0.089231,0,0
2,GO ALANINE TRANSPORT,0.56341,0.087598,0.10088,0,0
2,GO HINDLIMB MORPHOGENESIS,0.62923,0.087548,0.077815,0,0
2,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.08881,0.087498,0.15276,0,0
2,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.10811,0.087323,0.13273,0,0
2,GO LENS FIBER CELL DEVELOPMENT,0.54223,0.087194,0.074421,0,0
2,GO VASODILATION,0.12662,0.086814,0.13473,0,0
2,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.33029,0.086718,0.090882,0,0
2,GO SEGMENTATION,0.28529,0.086613,0.1096,0,0
2,GO REGULATION OF TUBE SIZE,0.11524,0.086531,0.16206,0,0
2,GO MORPHOGENESIS OF AN EPITHELIUM,0.098083,0.086432,0.14106,0,0
2,GO ASYMMETRIC CELL DIVISION,0.23203,0.086359,0.10282,0,0
2,GO RESPONSE TO ACTIVITY,0.11163,0.086259,0.12149,0,0
2,GO NEGATIVE REGULATION OF BINDING,0.2259,0.086135,0.096854,0,0
2,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.1306,0.086114,0.12258,0,0
2,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.2577,0.085906,0.15065,0,0
2,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.19156,0.085709,0.1669,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.12273,0.085693,0.12502,0,0
2,GO SPLEEN DEVELOPMENT,0.091819,0.085646,0.12716,0,0
2,GO COBALAMIN METABOLIC PROCESS,0.062884,0.08553,0.16419,0,0
2,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.10811,0.08547,0.12376,0,0
2,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.41494,0.085373,0.09897,0,0
2,GO AUTOPHAGOSOME ORGANIZATION,0.10811,0.085333,0.12225,0,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.12273,0.085212,0.12174,0,0
2,GO PIRNA METABOLIC PROCESS,0.56341,0.085194,0.043168,0,0
2,GO LONG TERM MEMORY,0.85555,0.084816,0.038935,0,0
2,GO PIGMENT GRANULE ORGANIZATION,0.027226,0.084525,0.21217,0,0
2,GO PLASMA MEMBRANE ORGANIZATION,0.18102,0.084367,0.14196,0,0
2,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.17591,0.083928,0.12526,0,0
2,GO NEUROBLAST DIVISION,0.14312,0.083661,0.14889,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.17591,0.083628,0.12229,0,0
2,GO KIDNEY EPITHELIUM DEVELOPMENT,0.33029,0.083558,0.11945,0,0
2,GO STEROID HORMONE SECRETION,0.35442,0.083419,0.11152,0,0
2,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.050584,0.083242,0.17092,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.27126,0.083201,0.07477,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.098083,0.082984,0.19063,0,0
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.39705,0.082947,0.066068,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.28529,0.082914,0.091349,0,0
2,GO HEART GROWTH,0.12662,0.082584,0.13938,0,0
2,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.57414,0.082561,0.065527,0,0
2,GO EPITHELIAL TUBE MORPHOGENESIS,0.11894,0.082393,0.14528,0,0
2,GO APICAL JUNCTION ASSEMBLY,0.32248,0.082339,0.10389,0,0
2,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.12273,0.082323,0.14511,0,0
2,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.33821,0.082287,0.085942,0,0
2,GO REGULATION OF MESODERM DEVELOPMENT,0.66333,0.082129,0.047069,0,0
2,GO MAGNESIUM ION HOMEOSTASIS,0.67486,0.081957,0.032301,0,0
2,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.10134,0.081922,0.1062,0,0
2,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.32248,0.081777,0.11611,0,0
2,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.080256,0.081673,0.12957,0,0
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.026142,0.081596,0.16617,0,0
2,GO REGULATION OF GLIOGENESIS,0.031957,0.081396,0.16359,0,0
2,GO REGULATION OF HISTONE H4 ACETYLATION,0.29248,0.081394,0.087184,0,0
2,GO REGULATION OF SENSORY PERCEPTION,0.197,0.081253,0.096387,0,0
2,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.57414,0.081221,0.074154,0,0
2,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.48117,0.081141,0.0917,0,0
2,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.2259,0.081001,0.13005,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.12662,0.080957,0.14238,0,0
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.2259,0.080955,0.12169,0,0
2,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.12273,0.080719,0.2114,0,0
2,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.56341,0.080673,0.067176,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.1475,0.080545,0.11355,0,0
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.091819,0.080447,0.099848,0,0
2,GO RESPONSE TO TESTOSTERONE,0.33821,0.080357,0.077683,0,0
2,GO RECEPTOR INTERNALIZATION,0.25111,0.0802,0.11789,0,0
2,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.23827,0.080174,0.1096,0,0
2,GO XENOBIOTIC CATABOLIC PROCESS,0.24463,0.080054,0.11889,0,0
2,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.20256,0.080034,0.12886,0,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.60692,0.079985,0.11891,0,0
2,GO RENAL WATER HOMEOSTASIS,0.20256,0.079807,0.15374,0,0
2,GO GLIOGENESIS,0.197,0.079537,0.11548,0,0
2,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.50109,0.079434,0.074967,0,0
2,GO FUCOSE METABOLIC PROCESS,0.29248,0.079376,0.083798,0,0
2,GO MESODERM MORPHOGENESIS,0.08588,0.079117,0.16384,0,0
2,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.15197,0.078983,0.16102,0,0
2,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.1306,0.078891,0.12113,0,0
2,GO CIRCULATORY SYSTEM PROCESS,0.08881,0.078816,0.14933,0,0
2,GO PRO B CELL DIFFERENTIATION,0.62923,0.078778,0.066437,0,0
2,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.85555,0.078754,0.018408,0,0
2,GO CALCIUM ION IMPORT,0.18102,0.078257,0.10697,0,0
2,GO MYOFIBRIL ASSEMBLY,0.14312,0.078216,0.15689,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.11524,0.078116,0.11286,0,0
2,GO REGULATION OF FIBROBLAST MIGRATION,0.11894,0.077986,0.17047,0,0
2,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.23203,0.077844,0.095526,0,0
2,GO SKELETAL MUSCLE CONTRACTION,0.33821,0.077716,0.074252,0,0
2,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.072385,0.077696,0.13836,0,0
2,GO GOLGI RIBBON FORMATION,0.30724,0.077692,0.11784,0,0
2,GO ORGANIC ANION TRANSPORT,0.12662,0.077586,0.11695,0,0
2,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.25111,0.077571,0.10921,0,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.08881,0.077394,0.14402,0,0
2,GO NEGATIVE REGULATION OF NEURON DEATH,0.39705,0.07739,0.081271,0,0
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.14312,0.077381,0.18046,0,0
2,GO VACUOLE ORGANIZATION,0.058535,0.077297,0.12723,0,0
2,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.20822,0.077172,0.1246,0,0
2,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.14312,0.077133,0.17291,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.23827,0.076917,0.098552,0,0
2,GO DIGESTIVE TRACT MORPHOGENESIS,0.36271,0.076767,0.1058,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.197,0.076664,0.14323,0,0
2,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.11524,0.076568,0.11915,0,0
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.4521,0.076554,0.11565,0,0
2,GO CELL CELL JUNCTION ASSEMBLY,0.37964,0.076553,0.10347,0,0
2,GO PEPTIDE SECRETION,0.12273,0.076332,0.12904,0,0
2,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.098083,0.076318,0.16792,0,0
2,GO MOLTING CYCLE,0.36271,0.076301,0.089554,0,0
2,GO ACTIVATION OF GTPASE ACTIVITY,0.091819,0.076202,0.16952,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.1475,0.076133,0.16851,0,0
2,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.37964,0.076105,0.076178,0,0
2,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.30724,0.076077,0.096815,0,0
2,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.17591,0.076044,0.11717,0,0
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.098083,0.076035,0.13453,0,0
2,GO L ASCORBIC ACID METABOLIC PROCESS,0.098083,0.07591,0.16674,0,0
2,GO RNA STABILIZATION,0.4521,0.075739,0.052514,0,0
2,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.11163,0.075706,0.12149,0,0
2,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.41494,0.075503,0.099312,0,0
2,GO DNA MODIFICATION,0.28529,0.075491,0.069071,0,0
2,GO CELLULAR RESPONSE TO UV,0.16602,0.075407,0.10244,0,0
2,GO EXPLORATION BEHAVIOR,0.53179,0.07534,0.074499,0,0
2,GO TISSUE MORPHOGENESIS,0.11894,0.075152,0.13456,0,0
2,GO RESPONSE TO PEPTIDE HORMONE,0.077559,0.074924,0.1327,0,0
2,GO NEURON DEATH,0.26442,0.074876,0.10012,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.23203,0.074823,0.0992,0,0
2,GO ALPHA AMINO ACID METABOLIC PROCESS,0.10468,0.074762,0.088444,0,0
2,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.094909,0.074732,0.10472,0,0
2,GO RESPONSE TO CALCIUM ION,0.1475,0.074625,0.11253,0,0
2,GO RESPONSE TO PH,0.20256,0.074598,0.13626,0,0
2,GO SIALYLATION,0.39705,0.074427,0.1055,0,0
2,GO NEPHRON MORPHOGENESIS,0.11894,0.074254,0.1365,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.42405,0.074239,0.055903,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.24463,0.074158,0.052388,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.35442,0.074094,0.049159,0,0
2,GO BONE GROWTH,0.091819,0.074046,0.20611,0,0
2,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.3148,0.073878,0.096648,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.13467,0.073407,0.16564,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.1475,0.073292,0.097934,0,0
2,GO MESODERM DEVELOPMENT,0.197,0.073157,0.10727,0,0
2,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.56341,0.073092,0.054456,0,0
2,GO REGULATION OF TRANSPORT,0.24463,0.072975,0.10247,0,0
2,GO REGULATION OF BINDING,0.3148,0.07277,0.095649,0,0
2,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.11524,0.072672,0.13108,0,0
2,GO NUCLEOBASE METABOLIC PROCESS,0.12662,0.072555,0.089171,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.5959,0.072542,0.035705,0,0
2,GO ROOF OF MOUTH DEVELOPMENT,0.40594,0.072402,0.088732,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.36271,0.072306,0.15549,0,0
2,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.33029,0.071764,0.10288,0,0
2,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.20256,0.071128,0.14789,0,0
2,GO POSITIVE REGULATION OF BINDING,0.68646,0.071016,0.070242,0,0
2,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.64051,0.070508,0.076239,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION,0.23827,0.070412,0.10722,0,0
2,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.24463,0.070242,0.12174,0,0
2,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.79394,0.070187,0.030776,0,0
2,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.52145,0.070123,0.069001,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.18102,0.070089,0.15257,0,0
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.10134,0.070081,0.12666,0,0
2,GO GLUTAMINE METABOLIC PROCESS,0.35442,0.070044,0.067157,0,0
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.80618,0.069789,-0.00021991,0,0
2,GO REGULATION OF FATTY ACID BETA OXIDATION,0.35442,0.069402,0.12014,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.091819,0.069288,0.11953,0,0
2,GO SARCOMERE ORGANIZATION,0.12273,0.069219,0.12521,0,0
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.4521,0.069021,0.047036,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.27821,0.06893,0.078051,0,0
2,GO QUINONE METABOLIC PROCESS,0.27821,0.068911,0.049175,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.34626,0.068883,0.078673,0,0
2,GO FATTY ACID CATABOLIC PROCESS,0.44264,0.068847,0.072398,0,0
2,GO REGULATION OF VACUOLE ORGANIZATION,0.077559,0.068845,0.12558,0,0
2,GO LIPID TRANSLOCATION,0.54223,0.06878,0.092903,0,0
2,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.27821,0.068693,0.12197,0,0
2,GO VESICLE TARGETING,0.20256,0.068451,0.096794,0,0
2,GO RESPONSE TO METAL ION,0.18102,0.068438,0.10649,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.077559,0.06823,0.091091,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.50109,0.068079,0.1175,0,0
2,GO EPITHELIUM DEVELOPMENT,0.16123,0.068049,0.10867,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.18102,0.06797,0.11157,0,0
2,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.34626,0.067894,0.081707,0,0
2,GO NEUROTROPHIN SIGNALING PATHWAY,0.26442,0.067703,0.10105,0,0
2,GO GMP METABOLIC PROCESS,0.17591,0.067671,0.099192,0,0
2,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.50109,0.067436,0.076793,0,0
2,GO ANION TRANSPORT,0.15655,0.067436,0.10432,0,0
2,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.49108,0.067402,0.095596,0,0
2,GO MUSCLE SYSTEM PROCESS,0.16602,0.067252,0.12588,0,0
2,GO LIPOSACCHARIDE METABOLIC PROCESS,0.28529,0.067029,0.084763,0,0
2,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.17091,0.066936,0.094736,0,0
2,GO REGULATION OF HEART MORPHOGENESIS,0.214,0.066908,0.14342,0,0
2,GO NCRNA CATABOLIC PROCESS,0.49108,0.066895,0.048197,0,0
2,GO LENS FIBER CELL DIFFERENTIATION,0.51122,0.066878,0.078724,0,0
2,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.2577,0.066723,0.092706,0,0
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.08881,0.066518,0.16374,0,0
2,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.23203,0.066302,0.093643,0,0
2,GO REGULATION OF ENDOCRINE PROCESS,0.26442,0.06602,0.12774,0,0
2,GO ORGAN GROWTH,0.072385,0.065873,0.16502,0,0
2,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.197,0.065833,0.11179,0,0
2,GO CANONICAL WNT SIGNALING PATHWAY,0.39705,0.065826,0.099381,0,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.56341,0.06582,0.055047,0,0
2,GO REGULATION OF HISTONE PHOSPHORYLATION,0.74555,0.065787,0.063746,0,0
2,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.17591,0.065604,0.11459,0,0
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.27126,0.06554,0.11218,0,0
2,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.23203,0.065409,0.10905,0,0
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.24463,0.065151,0.1302,0,0
2,GO ERAD PATHWAY,0.13885,0.064849,0.1142,0,0
2,GO BLASTOCYST GROWTH,0.85555,0.064754,0.020998,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.3148,0.06466,0.083121,0,0
2,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.33029,0.064589,0.096888,0,0
2,GO CELL CELL JUNCTION ORGANIZATION,0.51122,0.064467,0.10364,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.96843,0.064406,-0.037396,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.52145,0.064357,0.067206,0,0
2,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.34626,0.064191,0.095676,0,0
2,GO LOCOMOTOR RHYTHM,0.34626,0.063777,0.11003,0,0
2,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.17591,0.063737,0.10811,0,0
2,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.3148,0.06369,0.072732,0,0
2,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.57414,0.063532,0.074417,0,0
2,GO PROTEIN HYDROXYLATION,0.23827,0.063486,0.10549,0,0
2,GO NEURON PROJECTION ARBORIZATION,1,0.06346,0.064929,0,0
2,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.25111,0.063453,0.24643,0,0
2,GO SPINDLE MIDZONE ASSEMBLY,0.83078,0.063263,-0.068326,0,0
2,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.41494,0.063231,0.10908,0,0
2,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.70989,0.06279,0.054853,0,0
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.29248,0.062662,0.090612,0,0
2,GO EPITHELIAL CELL DEVELOPMENT,0.214,0.062475,0.13298,0,0
2,GO PROTEIN N LINKED GLYCOSYLATION,0.062884,0.062229,0.13878,0,0
2,GO PHAGOSOME ACIDIFICATION,0.30724,0.062132,0.080319,0,0
2,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.16123,0.062004,0.10297,0,0
2,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.53179,0.061972,0.090568,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.21989,0.061837,0.081972,0,0
2,GO SKIN EPIDERMIS DEVELOPMENT,0.41494,0.06182,0.087116,0,0
2,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.38829,0.061673,0.085931,0,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.4521,0.061544,0.096783,0,0
2,GO INTRACELLULAR MRNA LOCALIZATION,0.197,0.06153,0.12647,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.1475,0.061424,0.12275,0,0
2,GO SULFUR AMINO ACID METABOLIC PROCESS,0.29248,0.061177,0.065221,0,0
2,GO ACTIN FILAMENT NETWORK FORMATION,0.49108,0.061147,0.092695,0,0
2,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.16602,0.061066,0.10109,0,0
2,GO SPHINGOLIPID METABOLIC PROCESS,0.29248,0.060917,0.097843,0,0
2,GO SNORNA METABOLIC PROCESS,0.84314,0.060841,-0.022194,0,0
2,GO RESPONSE TO ABIOTIC STIMULUS,0.15655,0.060717,0.098236,0,0
2,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.12273,0.06056,0.12081,0,0
2,GO REGULATION OF DNA RECOMBINATION,0.47137,0.060526,0.062581,0,0
2,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.60692,0.06051,0.052962,0,0
2,GO MEMBRANE ORGANIZATION,0.25111,0.060328,0.092494,0,0
2,GO REGULATION OF MUSCLE CONTRACTION,0.2577,0.060312,0.10231,0,0
2,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.50109,0.060295,0.094077,0,0
2,GO ANIMAL ORGAN MORPHOGENESIS,0.27126,0.060245,0.11451,0,0
2,GO MITOCHONDRIAL RNA PROCESSING,0.89296,0.06004,0.013774,0,0
2,GO SPHINGOID METABOLIC PROCESS,0.40594,0.060017,0.10795,0,0
2,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.1475,0.059821,0.11035,0,0
2,GO RESPONSE TO MUSCLE ACTIVITY,0.20822,0.059749,0.087741,0,0
2,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.2577,0.059644,0.12127,0,0
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.074935,0.059409,0.12701,0,0
2,GO TUBE FORMATION,0.53179,0.059116,0.069412,0,0
2,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.50109,0.058932,0.093609,0,0
2,GO RESPONSE TO COLD,0.35442,0.05892,0.079962,0,0
2,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.30724,0.058774,0.10535,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.99368,0.058747,-0.0024146,0,0
2,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.46168,0.05869,0.076216,0,0
2,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.094909,0.058605,0.10164,0,0
2,GO RESPONSE TO BMP,0.34626,0.058542,0.1279,0,0
2,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.50109,0.058366,0.077718,0,0
2,GO PLASMA MEMBRANE TUBULATION,0.37111,0.058247,0.12833,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.58498,0.05821,0.051015,0,0
2,GO ENDOCRINE HORMONE SECRETION,0.23203,0.058144,0.11343,0,0
2,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.81845,0.057857,0.07332,0,0
2,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.33029,0.05774,0.09146,0,0
2,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.2577,0.057667,0.098992,0,0
2,GO MESONEPHROS DEVELOPMENT,0.33821,0.057602,0.099257,0,0
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.18102,0.057578,0.12702,0,0
2,GO REGULATION OF FERTILIZATION,0.2577,0.057546,0.06165,0,0
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.13885,0.057502,0.097939,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.60692,0.057499,0.073722,0,0
2,GO REGULATION OF CELLULAR LOCALIZATION,0.41494,0.057474,0.082568,0,0
2,GO RRNA MODIFICATION,0.23827,0.056916,0.054129,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.098083,0.056828,0.11252,0,0
2,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.3148,0.056563,0.088734,0,0
2,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.5959,0.056397,0.067355,0,0
2,GO ER OVERLOAD RESPONSE,0.36271,0.056277,0.086468,0,0
2,GO INORGANIC ANION TRANSPORT,0.37111,0.056259,0.07902,0,0
2,GO LEFT RIGHT AXIS SPECIFICATION,0.57414,0.05624,0.079076,0,0
2,GO PEROXISOMAL MEMBRANE TRANSPORT,0.35442,0.056225,0.065675,0,0
2,GO SNORNA 3 END PROCESSING,0.90549,0.056161,-0.051339,0,0
2,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.26442,0.056124,0.13882,0,0
2,GO EPITHELIAL TUBE FORMATION,0.65188,0.056043,0.058933,0,0
2,GO NEGATIVE REGULATION OF CELL GROWTH,0.40594,0.055958,0.09437,0,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.52145,0.055925,0.084807,0,0
2,GO NEURON APOPTOTIC PROCESS,0.69814,0.055781,0.054334,0,0
2,GO PIGMENTATION,0.38829,0.055731,0.067828,0,0
2,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.27821,0.055587,0.12527,0,0
2,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.10134,0.055579,0.11424,0,0
2,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.72171,0.055537,0.036421,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.84314,0.055455,0.040598,0,0
2,GO PROTEIN LOCALIZATION TO ENDOSOME,0.42405,0.055351,0.13247,0,0
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.30724,0.055323,0.119,0,0
2,GO REGULATION OF SODIUM ION TRANSPORT,0.5959,0.055262,0.060396,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.37964,0.05513,0.085145,0,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.15197,0.055098,0.15736,0,0
2,GO DNA METHYLATION,0.57414,0.055095,0.039852,0,0
2,GO LYSOSOMAL TRANSPORT,0.40594,0.055041,0.088795,0,0
2,GO SMOOTH MUSCLE CONTRACTION,0.1475,0.054882,0.14536,0,0
2,GO CARDIAC ATRIUM DEVELOPMENT,0.78176,0.054682,0.063364,0,0
2,GO RESPONSE TO INSULIN,0.1475,0.054596,0.11949,0,0
2,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.16123,0.054503,0.097552,0,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.23827,0.05448,0.13838,0,0
2,GO REGULATION OF REPRODUCTIVE PROCESS,0.29248,0.054421,0.079109,0,0
2,GO INSEMINATION,0.35442,0.054379,0.13033,0,0
2,GO SPERM EGG RECOGNITION,0.197,0.054285,0.081553,0,0
2,GO REGULATION OF PROTEIN SUMOYLATION,0.27821,0.054285,0.10475,0,0
2,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.47137,0.054214,0.072917,0,0
2,GO HEART DEVELOPMENT,0.1475,0.054159,0.13755,0,0
2,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.23827,0.054021,0.15567,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY,0.42405,0.053997,0.089976,0,0
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.25111,0.053778,0.11497,0,0
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.79394,0.05372,0.017594,0,0
2,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.3148,0.053662,0.175,0,0
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.11894,0.0536,0.10364,0,0
2,GO MACROMOLECULE CATABOLIC PROCESS,0.30724,0.053596,0.077518,0,0
2,GO NEPHRON EPITHELIUM DEVELOPMENT,0.26442,0.053512,0.12785,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.98106,0.053338,0.011252,0,0
2,GO LACTATE METABOLIC PROCESS,0.67486,0.053302,0.04443,0,0
2,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.91805,0.053276,0.018658,0,0
2,GO AUTOPHAGY OF NUCLEUS,0.24463,0.053247,0.10387,0,0
2,GO KIDNEY MORPHOGENESIS,0.2259,0.053201,0.11824,0,0
2,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.32248,0.053048,0.089984,0,0
2,GO MALE SEX DIFFERENTIATION,0.21989,0.052898,0.10985,0,0
2,GO CELLULAR GLUCAN METABOLIC PROCESS,0.83078,0.052874,0.0090043,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.1475,0.052866,0.078793,0,0
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.57414,0.052688,0.048578,0,0
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.85555,0.052611,0.020624,0,0
2,GO REGULATION OF BEHAVIOR,0.51122,0.052448,0.046493,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.27126,0.052106,0.096376,0,0
2,GO NEGATIVE REGULATION OF AXON EXTENSION,0.91805,0.051964,0.036979,0,0
2,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.33821,0.051944,0.043256,0,0
2,GO CERAMIDE METABOLIC PROCESS,0.17091,0.051851,0.11456,0,0
2,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.33029,0.051787,0.099985,0,0
2,GO CELLULAR RESPONSE TO RADIATION,0.214,0.051753,0.094911,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.44264,0.051741,0.041177,0,0
2,GO PROTEIN K48 LINKED UBIQUITINATION,0.74555,0.051715,0.048408,0,0
2,GO GOLGI TO ENDOSOME TRANSPORT,0.197,0.051643,0.1253,0,0
2,GO RESPONSE TO ETHER,0.197,0.051603,0.12154,0,0
2,GO MATURATION OF SSU RRNA,0.64051,0.051444,0.010572,0,0
2,GO ORGANIC ACID TRANSPORT,0.32248,0.051326,0.094149,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.96843,0.051264,-0.006674,0,0
2,GO HEART VALVE FORMATION,0.52145,0.051136,0.091165,0,0
2,GO ORGAN INDUCTION,0.42405,0.051062,0.10483,0,0
2,GO REGULATION OF SECRETION,0.37964,0.051007,0.086203,0,0
2,GO ANOIKIS,0.24463,0.050804,0.13373,0,0
2,GO NAD METABOLIC PROCESS,0.33029,0.050788,0.095611,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.36271,0.050693,0.10462,0,0
2,GO POSITIVE REGULATION OF FERTILIZATION,0.56341,0.050637,0.04734,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.60692,0.05062,0.036857,0,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.13467,0.050566,0.18361,0,0
2,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.23203,0.050551,0.08732,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.44264,0.050534,0.065436,0,0
2,GO REGULATION OF PROTEIN DEACETYLATION,0.53179,0.050476,0.067016,0,0
2,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.70989,0.050386,0.061281,0,0
2,GO RESPONSE TO ACIDIC PH,0.42405,0.050254,0.096027,0,0
2,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.33821,0.050188,0.10454,0,0
2,GO REGULATION OF TELOMERASE ACTIVITY,0.4521,0.050064,0.046264,0,0
2,GO LIPOPROTEIN METABOLIC PROCESS,0.3148,0.049887,0.080409,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS,0.21989,0.049887,0.10754,0,0
2,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.28529,0.049542,0.1403,0,0
2,GO HISTONE H3 ACETYLATION,0.47137,0.04953,0.070147,0,0
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.25111,0.049526,0.083935,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.29248,0.049445,0.095647,0,0
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.27821,0.049312,0.090133,0,0
2,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.60692,0.049091,0.070504,0,0
2,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.37111,0.048997,0.09105,0,0
2,GO DEVELOPMENTAL PIGMENTATION,0.37964,0.048957,0.088501,0,0
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.21989,0.04874,0.11705,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.16123,0.048669,0.086698,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY,0.197,0.048627,0.087104,0,0
2,GO RHYTHMIC BEHAVIOR,0.57414,0.04859,0.06175,0,0
2,GO FRUCTOSE METABOLIC PROCESS,0.214,0.048584,0.12097,0,0
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.61803,0.048558,0.01079,0,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.28529,0.048475,0.10257,0,0
2,GO AMINE METABOLIC PROCESS,0.1475,0.048441,0.083391,0,0
2,GO MEMBRANE LIPID METABOLIC PROCESS,0.26442,0.04843,0.089956,0,0
2,GO REGULATION OF LYASE ACTIVITY,0.43329,0.048387,0.046365,0,0
2,GO DIGESTIVE SYSTEM DEVELOPMENT,0.81845,0.047882,0.056661,0,0
2,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.16602,0.047842,0.098916,0,0
2,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.24463,0.047837,0.1149,0,0
2,GO SEGMENT SPECIFICATION,0.42405,0.047836,0.096366,0,0
2,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.13885,0.047814,0.060703,0,0
2,GO ION TRANSPORT,0.35442,0.047638,0.082955,0,0
2,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.69814,0.047631,0.085521,0,0
2,GO GOLGI LOCALIZATION,0.30724,0.047189,0.065708,0,0
2,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.11524,0.047064,0.095652,0,0
2,GO GLIAL CELL DIFFERENTIATION,0.7336,0.046991,0.072346,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.197,0.046948,0.1087,0,0
2,GO CARNITINE SHUTTLE,0.66333,0.046906,0.035513,0,0
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.23827,0.046886,0.074116,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.53179,0.046833,0.047548,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.60692,0.046803,0.070372,0,0
2,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.49108,0.046712,0.084949,0,0
2,GO POLYOL METABOLIC PROCESS,0.38829,0.046278,0.082657,0,0
2,GO REGULATION OF DEACETYLASE ACTIVITY,0.7336,0.046274,0.086118,0,0
2,GO REGULATION OF AUTOPHAGY,0.2259,0.046272,0.097324,0,0
2,GO REGULATION OF CELLULAR COMPONENT SIZE,0.2998,0.046258,0.11526,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.33821,0.046235,0.11627,0,0
2,GO VIRION ASSEMBLY,0.11524,0.046176,0.073587,0,0
2,GO RESPONSE TO UV,0.69814,0.046149,0.052499,0,0
2,GO POSITIVE REGULATION OF DNA BINDING,0.52145,0.046142,0.04747,0,0
2,GO POSITIVE REGULATION OF CELL DIVISION,0.54223,0.046035,0.073436,0,0
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.41494,0.045795,0.044527,0,0
2,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.20256,0.045793,0.11901,0,0
2,GO LATERAL MESODERM DEVELOPMENT,0.37964,0.045726,0.11422,0,0
2,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.47137,0.045701,0.12898,0,0
2,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.70989,0.045635,0.019995,0,0
2,GO CARDIAC MUSCLE CONTRACTION,0.30724,0.045564,0.081095,0,0
2,GO REGULATION OF ANIMAL ORGAN FORMATION,0.29248,0.045529,0.10719,0,0
2,GO POLYSACCHARIDE METABOLIC PROCESS,1,0.045448,0.041542,0,0
2,GO INNER CELL MASS CELL PROLIFERATION,0.79394,0.045437,-0.060741,0,0
2,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.38829,0.045289,0.091005,0,0
2,GO REGULATION OF CELL MORPHOGENESIS,0.83078,0.045271,0.072348,0,0
2,GO ATP BIOSYNTHETIC PROCESS,0.20822,0.045139,0.10311,0,0
2,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.52145,0.044751,-0.033509,0,0
2,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.4521,0.044716,0.065647,0,0
2,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.54223,0.044436,0.061347,0,0
2,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.66333,0.044379,0.061318,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.62923,0.044348,0.014466,0,0
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.85555,0.044288,-0.0020265,0,0
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.74555,0.044207,0.017208,0,0
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.78176,0.044031,0.00047052,0,0
2,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.28529,0.043937,0.088638,0,0
2,GO VITAMIN CATABOLIC PROCESS,0.69814,0.043895,0.045245,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.94321,0.043839,0.06073,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.21989,0.043666,0.06433,0,0
2,GO HISTONE H3 K9 ACETYLATION,0.5959,0.043538,0.059994,0,0
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.065157,0.043468,0.1066,0,0
2,GO GOLGI TO VACUOLE TRANSPORT,0.49108,0.043434,0.10552,0,0
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.42405,0.043425,0.080326,0,0
2,GO REGULATION OF BMP SIGNALING PATHWAY,0.24463,0.043131,0.16407,0,0
2,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.93062,0.042927,0.021565,0,0
2,GO NOTCH SIGNALING PATHWAY,0.79394,0.04291,0.048917,0,0
2,GO REGULATION OF ION TRANSPORT,0.33029,0.042905,0.083624,0,0
2,GO MAINTENANCE OF CELL NUMBER,0.60692,0.042857,0.082449,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.41494,0.042845,0.085391,0,0
2,GO PROTEIN LOCALIZATION TO VACUOLE,0.62923,0.042799,0.074636,0,0
2,GO RESPONSE TO AXON INJURY,0.84314,0.042684,0.052909,0,0
2,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.3148,0.042681,0.090458,0,0
2,GO GLUCOSE IMPORT,0.57414,0.042634,0.060972,0,0
2,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.52145,0.042634,0.074032,0,0
2,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.34626,0.042412,0.084916,0,0
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.32248,0.042403,0.055457,0,0
2,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.42405,0.04237,0.086106,0,0
2,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.57414,0.04231,0.048453,0,0
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.41494,0.042226,0.0577,0,0
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.44264,0.042142,0.075724,0,0
2,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.33029,0.042122,0.02442,0,0
2,GO GOLGI VESICLE TRANSPORT,0.47137,0.042103,0.063498,0,0
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.56341,0.042074,0.070031,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.23827,0.042064,0.11143,0,0
2,GO IMPORT ACROSS PLASMA MEMBRANE,0.40594,0.042017,0.080316,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.54223,0.041892,0.040652,0,0
2,GO REGULATION OF PROTEIN STABILITY,0.29248,0.041819,0.079472,0,0
2,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.91805,0.041625,0.027579,0,0
2,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.90549,0.041541,0.025738,0,0
2,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.28529,0.041474,0.084288,0,0
2,GO ATRIAL SEPTUM MORPHOGENESIS,0.99368,0.041412,0.0095503,0,0
2,GO STEROL BIOSYNTHETIC PROCESS,0.51122,0.041411,0.073054,0,0
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.2259,0.041394,0.10131,0,0
2,GO ONE CARBON METABOLIC PROCESS,0.49108,0.041362,0.03563,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.33821,0.041279,0.087593,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.44264,0.040995,0.10866,0,0
2,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.37111,0.040953,0.072507,0,0
2,GO REGULATION OF EXCRETION,0.2577,0.040948,0.13606,0,0
2,GO DISTAL TUBULE DEVELOPMENT,0.89296,0.040942,0.0014682,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION,0.34626,0.040749,0.084299,0,0
2,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.90549,0.040638,0.030802,0,0
2,GO PROTEIN COMPLEX OLIGOMERIZATION,0.26442,0.040597,0.08142,0,0
2,GO MULTICELLULAR ORGANISM AGING,0.81845,0.040434,0.044738,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.57414,0.040199,0.052093,0,0
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.23827,0.040123,0.084078,0,0
2,GO PROTEIN K63 LINKED UBIQUITINATION,0.39705,0.040108,0.07409,0,0
2,GO RENAL TUBULE DEVELOPMENT,0.3148,0.039858,0.11306,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.17591,0.039842,0.10195,0,0
2,GO PROTEIN POLYUBIQUITINATION,0.68646,0.039839,0.04741,0,0
2,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.094909,0.039806,0.067784,0,0
2,GO DETECTION OF STIMULUS,0.4521,0.039792,0.058554,0,0
2,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.39705,0.039726,0.11679,0,0
2,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.58498,0.039683,0.063785,0,0
2,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.14312,0.039581,0.12972,0,0
2,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.61803,0.039507,0.058689,0,0
2,GO ENDOSOME TO LYSOSOME TRANSPORT,0.49108,0.039282,0.055666,0,0
2,GO METAL ION TRANSPORT,0.23203,0.039192,0.095418,0,0
2,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.64051,0.039164,0.065139,0,0
2,GO NUCLEOSIDE SALVAGE,0.37964,0.039048,0.044726,0,0
2,GO ADAPTATION OF SIGNALING PATHWAY,0.51122,0.038857,0.056225,0,0
2,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.55277,0.038787,0.06688,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.64051,0.038765,0.05398,0,0
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.81845,0.038527,0.043146,0,0
2,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.93062,0.038467,0.012412,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.30724,0.038438,0.079925,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.29248,0.038308,0.10465,0,0
2,GO RRNA METHYLATION,0.39705,0.038269,0.055377,0,0
2,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.23203,0.038184,0.10113,0,0
2,GO TRANSMEMBRANE TRANSPORT,0.43329,0.038178,0.068158,0,0
2,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.32248,0.038177,0.087465,0,0
2,GO CYTOPLASM ORGANIZATION,0.37964,0.038058,0.14502,0,0
2,GO HISTONE H2B UBIQUITINATION,0.67486,0.038049,0.038047,0,0
2,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.60692,0.038029,0.056693,0,0
2,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.95582,0.037946,-0.012856,0,0
2,GO POST ANAL TAIL MORPHOGENESIS,0.93062,0.037891,0.030612,0,0
2,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.67486,0.037559,0.041826,0,0
2,GO PARAXIAL MESODERM DEVELOPMENT,0.58498,0.037268,0.057334,0,0
2,GO PROTEIN CATABOLIC PROCESS,0.44264,0.037253,0.073676,0,0
2,GO REGULATION OF ACROSOME REACTION,0.94321,0.036961,0.0098928,0,0
2,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.54223,0.036926,0.035733,0,0
2,GO CARBOHYDRATE METABOLIC PROCESS,0.18102,0.036923,0.10125,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.49108,0.036745,0.084035,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.75756,0.036733,-0.016416,0,0
2,GO GLYCOSYLATION,0.49108,0.036666,0.072937,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.38829,0.036584,0.076629,0,0
2,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.80618,0.036551,-0.0098665,0,0
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.54223,0.03638,0.039512,0,0
2,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.56341,0.036364,0.068735,0,0
2,GO PURINE CONTAINING COMPOUND SALVAGE,0.3148,0.03633,0.074873,0,0
2,GO CONVERGENT EXTENSION,0.72171,0.03622,0.07368,0,0
2,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.94321,0.036043,-0.084605,0,0
2,GO SENSORY PERCEPTION,0.80618,0.035859,0.036805,0,0
2,GO REGULATION OF DNA BINDING,0.79394,0.035796,0.023872,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.25111,0.035751,0.059799,0,0
2,GO CELLULAR SENESCENCE,0.46168,0.035729,0.062483,0,0
2,GO METANEPHROS MORPHOGENESIS,0.70989,0.035712,0.081473,0,0
2,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.44264,0.035709,0.074925,0,0
2,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.42405,0.035601,0.1148,0,0
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.29248,0.035509,0.087327,0,0
2,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.4521,0.035482,0.095031,0,0
2,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.66333,0.035476,0.060898,0,0
2,GO STRIATED MUSCLE CONTRACTION,0.54223,0.035449,0.056779,0,0
2,GO TRNA 5 END PROCESSING,0.90549,0.035423,-0.018224,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.20256,0.035114,0.11452,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.33821,0.035029,0.10008,0,0
2,GO REGULATION OF RELAXATION OF MUSCLE,0.83078,0.034939,-0.041422,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.96843,0.034705,-0.0049786,0,0
2,GO NUCLEAR PORE ORGANIZATION,0.91805,0.034672,-0.031196,0,0
2,GO CELL CELL SIGNALING BY WNT,0.69814,0.034572,0.074319,0,0
2,GO VACUOLAR TRANSPORT,0.40594,0.034525,0.080234,0,0
2,GO RESPONSE TO TEMPERATURE STIMULUS,0.60692,0.034421,0.058284,0,0
2,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.61803,0.034074,0.074441,0,0
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.89296,0.033922,0.016584,0,0
2,GO GTP BIOSYNTHETIC PROCESS,0.42405,0.033731,0.055137,0,0
2,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.23203,0.03349,0.10473,0,0
2,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.79394,0.033365,0.057145,0,0
2,GO CERAMIDE BIOSYNTHETIC PROCESS,0.3148,0.033352,0.09272,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.50109,0.033319,0.038319,0,0
2,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.47137,0.033291,0.050728,0,0
2,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.56341,0.033154,0.074325,0,0
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.15655,0.033016,0.10689,0,0
2,GO MESODERMAL CELL FATE SPECIFICATION,0.99368,0.033001,-0.0069169,0,0
2,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.46168,0.032863,0.08124,0,0
2,GO RESPONSE TO STEROL DEPLETION,0.11894,0.032849,0.16199,0,0
2,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.61803,0.032812,0.054724,0,0
2,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.67486,0.032502,0.058081,0,0
2,GO PROTEIN POLYMERIZATION,0.55277,0.032485,0.075421,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.83078,0.03236,0.074452,0,0
2,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.78176,0.032287,0.032728,0,0
2,GO MACROMOLECULE DEPALMITOYLATION,0.43329,0.032284,0.041932,0,0
2,GO IN UTERO EMBRYONIC DEVELOPMENT,0.2998,0.032253,0.097648,0,0
2,GO CELLULAR RESPONSE TO HEAT,0.72171,0.032202,0.043892,0,0
2,GO ANATOMICAL STRUCTURE MATURATION,0.35442,0.032114,0.080712,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.38829,0.032008,0.064095,0,0
2,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.94321,0.031972,0.059166,0,0
2,GO SULFUR COMPOUND TRANSPORT,0.43329,0.031847,0.076416,0,0
2,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.96843,0.031747,0.048848,0,0
2,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.40594,0.031685,0.080894,0,0
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.68646,0.031635,-0.04507,0,0
2,GO EMBRYONIC MORPHOGENESIS,0.52145,0.031402,0.089753,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.56341,0.031293,0.070128,0,0
2,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.35442,0.030959,0.083921,0,0
2,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.50109,0.030869,0.052405,0,0
2,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.55277,0.030856,0.055982,0,0
2,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.79394,0.030819,0.050456,0,0
2,GO RESPONSE TO MAGNESIUM ION,0.5959,0.030583,0.091408,0,0
2,GO LACTATION,0.96843,0.030486,0.045834,0,0
2,GO PEPTIDYL AMINO ACID MODIFICATION,0.39705,0.030111,0.088014,0,0
2,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.93062,0.030083,0.00022097,0,0
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.094909,0.029777,0.11057,0,0
2,GO ANION TRANSMEMBRANE TRANSPORT,0.67486,0.029745,0.060866,0,0
2,GO PIGMENT METABOLIC PROCESS,0.29248,0.029356,0.076979,0,0
2,GO EMBRYONIC ORGAN DEVELOPMENT,0.48117,0.029272,0.086659,0,0
2,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.80618,0.028998,0.035632,0,0
2,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.50109,0.028954,0.021166,0,0
2,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.52145,0.028917,0.09399,0,0
2,GO ENDOCARDIUM DEVELOPMENT,0.58498,0.02888,0.092236,0,0
2,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.3148,0.028726,0.13897,0,0
2,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.57414,0.028601,0.084847,0,0
2,GO CELLULAR RESPONSE TO PH,0.89296,0.028582,0.031401,0,0
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.91805,0.028556,0.019978,0,0
2,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.98106,0.028359,-0.020814,0,0
2,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.81845,0.028351,0.043236,0,0
2,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.57414,0.028043,0.067826,0,0
2,GO REGULATION OF MITOCHONDRIAL FISSION,0.83078,0.028007,0.044902,0,0
2,GO REGULATION OF PROTON TRANSPORT,0.48117,0.027955,0.059285,0,0
2,GO RNA INTERFERENCE,0.81845,0.027937,-0.016197,0,0
2,GO REGULATION OF VASCULAR PERMEABILITY,0.33029,0.027655,0.15588,0,0
2,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.44264,0.027612,0.087469,0,0
2,GO REGULATION OF GENE SILENCING,0.5959,0.027521,0.054783,0,0
2,GO CELLULAR RESPONSE TO STARVATION,0.61803,0.027135,0.059453,0,0
2,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.53179,0.027024,0.082071,0,0
2,GO DNA RECOMBINATION,0.83078,0.026852,-0.037922,0,0
2,GO CELLULAR RESPONSE TO CALCIUM ION,0.90549,0.026847,0.037845,0,0
2,GO SENSORY PERCEPTION OF SMELL,0.64051,0.026833,-0.033693,0,0
2,GO ENERGY RESERVE METABOLIC PROCESS,0.85555,0.026799,0.0063028,0,0
2,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.33821,0.026611,0.14041,0,0
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.95582,0.026606,-0.011622,0,0
2,GO NUCLEAR TRANSPORT,0.94321,0.026366,0.017023,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.37111,0.026293,0.078367,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.54223,0.026266,0.059296,0,0
2,GO GROWTH,0.75756,0.026184,0.074037,0,0
2,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.76963,0.026132,0.056258,0,0
2,GO ENDOSOMAL TRANSPORT,0.50109,0.026114,0.069916,0,0
2,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.78176,0.026021,-0.033049,0,0
2,GO RNA MODIFICATION,0.25111,0.025947,0.072813,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.93062,0.025921,0.036282,0,0
2,GO RNA SURVEILLANCE,0.84314,0.025854,-0.031052,0,0
2,GO ELECTRON TRANSPORT CHAIN,0.42405,0.025801,0.034766,0,0
2,GO FUCOSYLATION,0.91805,0.025789,0.015404,0,0
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.29248,0.025778,0.078831,0,0
2,GO PROTEIN HOMOOLIGOMERIZATION,0.38829,0.025738,0.069907,0,0
2,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.19156,0.025734,0.12396,0,0
2,GO POST EMBRYONIC DEVELOPMENT,0.46168,0.025709,0.092408,0,0
2,GO MEMBRANE FUSION,0.79394,0.025692,0.048972,0,0
2,GO REGULATION OF ATP METABOLIC PROCESS,0.74555,0.0255,0.041815,0,0
2,GO RESPONSE TO HEAT,0.46168,0.025196,0.066286,0,0
2,GO SYNAPTIC VESICLE BUDDING,0.55277,0.025182,0.078835,0,0
2,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.5959,0.025151,0.039815,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.49108,0.024899,0.083173,0,0
2,GO HISTONE H3 K4 TRIMETHYLATION,0.65188,0.024893,0.084506,0,0
2,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.58498,0.024839,0.088841,0,0
2,GO RESPONSE TO LEPTIN,0.89296,0.024802,0.065093,0,0
2,GO ENDOSOME ORGANIZATION,0.29248,0.024786,0.079172,0,0
2,GO MULTIVESICULAR BODY ORGANIZATION,0.70989,0.024735,0.030318,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.95582,0.02473,0.020243,0,0
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.69814,0.024677,0.029034,0,0
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.51122,0.024592,0.045038,0,0
2,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.79394,0.024402,0.049414,0,0
2,GO POSITIVE REGULATION OF AXON EXTENSION,0.79394,0.024363,0.044816,0,0
2,GO KETONE BODY METABOLIC PROCESS,0.43329,0.024149,0.047016,0,0
2,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.62923,0.023923,0.025436,0,0
2,GO ADIPOSE TISSUE DEVELOPMENT,0.85555,0.023828,0.020867,0,0
2,GO VESICLE ORGANIZATION,0.52145,0.02375,0.06762,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.99368,0.023742,0.019195,0,0
2,GO MRNA MODIFICATION,0.70989,0.023685,0.051767,0,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.42405,0.023642,0.071382,0,0
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.26442,0.023536,0.095537,0,0
2,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.96843,0.023484,-0.01502,0,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION,0.89296,0.023447,0.021321,0,0
2,GO SPHINGOMYELIN METABOLIC PROCESS,0.90549,0.023433,0.03163,0,0
2,GO EXCRETION,0.52145,0.023422,0.071945,0,0
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.64051,0.023331,0.058453,0,0
2,GO MUSCLE CONTRACTION,0.3148,0.023233,0.10318,0,0
2,GO DEPHOSPHORYLATION,0.50109,0.022889,0.068294,0,0
2,GO 3 UTR MEDIATED MRNA STABILIZATION,0.61803,0.022868,0.082728,0,0
2,GO PENILE ERECTION,0.83078,0.022776,-0.0022164,0,0
2,GO REGULATION OF GLUCOSE IMPORT,0.64051,0.022719,0.049327,0,0
2,GO REPRODUCTION,0.96843,0.022585,0.028894,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.42405,0.022539,0.094459,0,0
2,GO REGULATION OF GROWTH,0.57414,0.022398,0.082728,0,0
2,GO SODIUM ION HOMEOSTASIS,0.44264,0.022366,0.087028,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.83078,0.022274,0.0507,0,0
2,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.41494,0.022113,0.095816,0,0
2,GO RENAL SODIUM EXCRETION,0.30724,0.022112,0.12367,0,0
2,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.72171,0.022026,0.056735,0,0
2,GO INTERMEDIATE FILAMENT BASED PROCESS,0.57414,0.021864,0.054736,0,0
2,GO REGULATION OF RECEPTOR CLUSTERING,0.88046,0.021779,0.012996,0,0
2,GO SEX DIFFERENTIATION,0.67486,0.021695,0.063724,0,0
2,GO GOLGI ORGANIZATION,0.5959,0.021568,0.068648,0,0
2,GO REGULATION OF PROTEIN TARGETING,0.40594,0.021536,0.076689,0,0
2,GO MITOTIC CYTOKINETIC PROCESS,0.89296,0.021407,-0.0091137,0,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.89296,0.021351,0.033168,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE,0.95582,0.021343,0.0087483,0,0
2,GO CELL JUNCTION ASSEMBLY,0.75756,0.021291,0.030172,0,0
2,GO REGULATION OF PROTEIN POLYMERIZATION,0.69814,0.021081,0.068794,0,0
2,GO VIRAL TRANSLATION,0.43329,0.021057,0.052323,0,0
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.49108,0.020966,0.078121,0,0
2,GO RETINAL ROD CELL DIFFERENTIATION,0.98106,0.02091,-0.013017,0,0
2,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.74555,0.020881,0.055741,0,0
2,GO POSITIVE REGULATION OF CELL GROWTH,0.80618,0.020879,0.058493,0,0
2,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.84314,0.020797,0.048225,0,0
2,GO REGULATION OF PHOSPHATASE ACTIVITY,0.68646,0.020722,0.068654,0,0
2,GO PEPTIDYL PROLINE MODIFICATION,0.44264,0.020708,0.055776,0,0
2,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.86799,0.020612,0.024285,0,0
2,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.99368,0.020424,0.017478,0,0
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.67486,0.020308,0.027882,0,0
2,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.84314,0.020275,0.015379,0,0
2,GO CELL AGING,0.2998,0.020222,0.08833,0,0
2,GO REGULATION OF TELOMERE MAINTENANCE,0.93062,0.020051,-0.0065372,0,0
2,GO REGULATION OF CELL DIVISION,0.86799,0.019966,0.02441,0,0
2,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.79394,0.019876,0.036975,0,0
2,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.26442,0.019873,0.12339,0,0
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.75756,0.019779,0.033063,0,0
2,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.27821,0.019779,0.06565,0,0
2,GO SECONDARY METABOLIC PROCESS,0.96843,0.01973,0.021612,0,0
2,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.65188,0.019675,0.066586,0,0
2,GO EMBRYONIC DIGIT MORPHOGENESIS,0.86799,0.019638,0.045517,0,0
2,GO REGULATION OF CELL AGING,0.74555,0.019516,0.016818,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.56341,0.019475,0.067758,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.67486,0.01945,-0.086751,0,0
2,GO RNA CATABOLIC PROCESS,0.46168,0.019383,0.030286,0,0
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.49108,0.019029,0.061242,0,0
2,GO STRIATED MUSCLE ADAPTATION,0.7336,0.019012,0.056646,0,0
2,GO CRANIAL NERVE MORPHOGENESIS,0.70989,0.018769,0.073634,0,0
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.56341,0.018678,0.019452,0,0
2,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.86799,0.018497,0.014402,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.84314,0.018398,-0.010237,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,1,0.018362,0.0057322,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.88046,0.018351,0.026526,0,0
2,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.95582,0.018249,0.032478,0,0
2,GO EAR MORPHOGENESIS,0.94321,0.018198,0.016815,0,0
2,GO SOMITOGENESIS,0.7336,0.018096,0.048468,0,0
2,GO ACTIN CROSSLINK FORMATION,0.98106,0.017948,0.039873,0,0
2,GO UTERUS DEVELOPMENT,0.64051,0.017622,0.039914,0,0
2,GO RESPONSE TO LITHIUM ION,0.79394,0.017593,0.054614,0,0
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.65188,0.017589,0.058831,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.89296,0.017346,0.04179,0,0
2,GO EAR DEVELOPMENT,0.98106,0.017301,0.025504,0,0
2,GO REGULATION OF MACROAUTOPHAGY,0.64051,0.017102,0.057548,0,0
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.39705,0.016963,0.045225,0,0
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.80618,0.016918,-0.020481,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.93062,0.016725,0.028035,0,0
2,GO METHYLATION,0.99368,0.016685,0.0092117,0,0
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.46168,0.016669,0.14177,0,0
2,GO SECRETORY GRANULE ORGANIZATION,0.64051,0.016603,-0.022321,0,0
2,GO PROTEIN STABILIZATION,0.64051,0.016562,0.058347,0,0
2,GO CARTILAGE MORPHOGENESIS,0.54223,0.016525,0.10217,0,0
2,GO CATION TRANSPORT,0.48117,0.016437,0.06914,0,0
2,GO STEM CELL PROLIFERATION,0.84314,0.016376,0.026788,0,0
2,GO SENSORY ORGAN MORPHOGENESIS,0.95582,0.016202,0.030789,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.43329,0.016163,0.078532,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.44264,0.016119,0.088521,0,0
2,GO NEURAL TUBE FORMATION,0.68646,0.016105,0.059084,0,0
2,GO NON CANONICAL WNT SIGNALING PATHWAY,0.64051,0.015942,0.054407,0,0
2,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.99368,0.015937,0.024769,0,0
2,GO HISTONE H4 DEACETYLATION,0.84314,0.015935,-0.010604,0,0
2,GO REGULATION OF STEM CELL PROLIFERATION,0.90549,0.01588,0.0090961,0,0
2,GO REGULATION OF FEEDING BEHAVIOR,0.65188,0.015732,0.012451,0,0
2,GO RESPONSE TO RADIATION,0.65188,0.015655,0.057012,0,0
2,GO MEMBRANE DISASSEMBLY,0.56341,0.015509,-0.071563,0,0
2,GO AUTOPHAGY OF MITOCHONDRION,0.81845,0.015352,0.044854,0,0
2,GO POSITIVE REGULATION OF GROWTH,0.79394,0.015265,0.072832,0,0
2,GO FEMALE GAMETE GENERATION,0.67486,0.015072,-0.02217,0,0
2,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.74555,0.014845,0.0046358,0,0
2,GO INNER EAR MORPHOGENESIS,0.94321,0.014791,0.0025337,0,0
2,GO LUNG EPITHELIUM DEVELOPMENT,0.64051,0.014771,0.048584,0,0
2,GO NEURON CELLULAR HOMEOSTASIS,0.84314,0.014476,-0.022966,0,0
2,GO PROXIMAL DISTAL PATTERN FORMATION,0.94321,0.014471,0.030166,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.65188,0.014421,0.0068804,0,0
2,GO REGULATION OF DEPHOSPHORYLATION,0.65188,0.014394,0.071835,0,0
2,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.66333,0.0142,0.051534,0,0
2,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.56341,0.014179,-0.030484,0,0
2,GO CARBOHYDRATE PHOSPHORYLATION,0.75756,0.014173,0.064136,0,0
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.83078,0.014038,0.037971,0,0
2,GO MODULATION BY VIRUS OF HOST PROCESS,0.72171,0.013704,0.065332,0,0
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.93062,0.013657,0.014678,0,0
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.52145,0.013629,0.039699,0,0
2,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.93062,0.013406,0.023695,0,0
2,GO CELLULAR AMIDE METABOLIC PROCESS,0.197,0.013375,0.064597,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.84314,0.013366,0.067488,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.65188,0.013329,0.067058,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.96843,0.013314,0.023851,0,0
2,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.46168,0.013312,0.09033,0,0
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.39705,0.01322,0.046078,0,0
2,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.95582,0.013045,0.0082259,0,0
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.91805,0.013017,-0.012214,0,0
2,GO ORGANIC CATION TRANSPORT,0.44264,0.012972,0.095883,0,0
2,GO MACROAUTOPHAGY,0.48117,0.012876,0.058985,0,0
2,GO CYTOKINETIC PROCESS,0.83078,0.012842,-0.035635,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.94321,0.012813,-0.011126,0,0
2,GO PROTON TRANSMEMBRANE TRANSPORT,0.80618,0.012737,0.0061097,0,0
2,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.81845,0.012723,0.051385,0,0
2,GO MANNOSYLATION,1,0.012638,0.0036713,0,0
2,GO DEVELOPMENTAL INDUCTION,0.96843,0.012629,0.0051289,0,0
2,GO PEPTIDYL SERINE MODIFICATION,0.90549,0.012619,0.056466,0,0
2,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.89296,0.012562,0.0043244,0,0
2,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.93062,0.012446,0.029796,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.33821,0.012401,0.079957,0,0
2,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.62923,0.012342,-0.0058674,0,0
2,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.99368,0.012242,0.019553,0,0
2,GO HISTONE PHOSPHORYLATION,0.76963,0.012232,-0.023933,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE,1,0.012152,0.0058156,0,0
2,GO CAMP METABOLIC PROCESS,0.65188,0.012086,0.079974,0,0
2,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.42405,0.01207,0.06504,0,0
2,GO HISTONE DEACETYLATION,0.81845,0.011987,0.035794,0,0
2,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.98106,0.011873,0.03579,0,0
2,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.94321,0.011785,0.0064616,0,0
2,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.58498,0.011717,0.084843,0,0
2,GO NEURON PROJECTION REGENERATION,0.80618,0.011583,0.055824,0,0
2,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.70989,0.011475,0.073121,0,0
2,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.64051,0.011354,0.020932,0,0
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.81845,0.011345,0.029309,0,0
2,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.48117,0.011128,0.091483,0,0
2,GO APOPTOTIC MITOCHONDRIAL CHANGES,1,0.010983,0.01438,0,0
2,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.60692,0.010917,0.067156,0,0
2,GO TETRAHYDROFOLATE INTERCONVERSION,1,0.010878,-0.069262,0,0
2,GO KERATINOCYTE DEVELOPMENT,0.38829,0.010773,0.15548,0,0
2,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.60692,0.010727,-0.0019213,0,0
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.84314,0.010576,0.048667,0,0
2,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.33029,0.010561,0.11793,0,0
2,GO MATURATION OF 5 8S RRNA,0.93062,0.010478,-0.018329,0,0
2,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.57414,0.010427,0.055429,0,0
2,GO EXECUTION PHASE OF APOPTOSIS,0.88046,0.010416,0.039998,0,0
2,GO DEMETHYLATION,0.78176,0.01021,0.042568,0,0
2,GO POSITIVE REGULATION OF HEART RATE,0.4521,0.010207,0.070668,0,0
2,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.68646,0.010143,0.008808,0,0
2,GO FATTY ACID HOMEOSTASIS,0.38829,0.010094,0.081386,0,0
2,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.70989,0.010093,0.071796,0,0
2,GO FEMALE SEX DIFFERENTIATION,0.54223,0.009885,0.074026,0,0
2,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.62923,0.0096574,0.07176,0,0
2,GO EMBRYONIC EYE MORPHOGENESIS,0.79394,0.0095054,0.089264,0,0
2,GO ESTABLISHMENT OF TISSUE POLARITY,0.85555,0.0094541,0.028754,0,0
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.96843,0.0092669,0.014179,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.83078,0.0092113,0.029457,0,0
2,GO MULTI ORGANISM PROCESS,0.80618,0.0091667,0.012768,0,0
2,GO HISTONE H3 K14 ACETYLATION,0.85555,0.0090835,0.036074,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.98106,0.0088686,0.0021365,0,0
2,GO GLAND DEVELOPMENT,0.46168,0.0087407,0.10232,0,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.88046,0.0087198,0.036953,0,0
2,GO EMBRYONIC PATTERN SPECIFICATION,0.99368,0.0085595,0.021693,0,0
2,GO REGULATION OF DNA METABOLIC PROCESS,0.96843,0.0085367,0.023206,0,0
2,GO CELL MATURATION,0.83078,0.008351,0.053039,0,0
2,GO ESTABLISHMENT OF CELL POLARITY,0.50109,0.0083121,0.090719,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.93062,0.0081283,0.040641,0,0
2,GO PROTEIN DEPHOSPHORYLATION,0.67486,0.0080522,0.059959,0,0
2,GO DETECTION OF MECHANICAL STIMULUS,0.94321,0.0079856,0.057276,0,0
2,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.61803,0.0079655,0.049812,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.91805,0.0078901,0.031022,0,0
2,GO RESPONSE TO CARBOHYDRATE,0.78176,0.0077944,0.057705,0,0
2,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.67486,0.0076379,0.063611,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.69814,0.0075962,0.064032,0,0
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.86799,0.0075846,-0.002056,0,0
2,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.53179,0.0074109,0.067433,0,0
2,GO ZINC ION TRANSPORT,0.60692,0.0071117,0.05679,0,0
2,GO REGULATION OF CYCLASE ACTIVITY,0.78176,0.0070167,0.026046,0,0
2,GO NODAL SIGNALING PATHWAY,0.84314,0.0068925,0.011277,0,0
2,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.85555,0.0067772,0.05932,0,0
2,GO HYPEROSMOTIC RESPONSE,0.76963,0.0067053,0.06351,0,0
2,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.81845,0.0066853,0.054275,0,0
2,GO LUTEINIZATION,0.50109,0.0066776,0.094642,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.99368,0.0066554,0.00089418,0,0
2,GO REGULATION OF DEOXYRIBONUCLEASE ACTIVITY,0.7336,0.0065283,0.036238,0,0
2,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.90549,0.0064778,0.022306,0,0
2,GO NCRNA EXPORT FROM NUCLEUS,0.80618,0.0064553,-0.04234,0,0
2,GO RESPIRATORY SYSTEM PROCESS,0.57414,0.0063429,0.081634,0,0
2,GO REGULATION OF MICROVILLUS ORGANIZATION,0.34626,0.0063393,0.11138,0,0
2,GO BLASTOCYST DEVELOPMENT,0.70989,0.0063307,-0.010363,0,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.89296,0.0062806,-0.0095952,0,0
2,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.54223,0.0062052,0.068752,0,0
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.67486,0.0061887,0.071237,0,0
2,GO ECTODERMAL PLACODE DEVELOPMENT,0.80618,0.0058965,0.017369,0,0
2,GO RESPONSE TO CAFFEINE,0.95582,0.0058097,0.014742,0,0
2,GO COLLECTING DUCT DEVELOPMENT,0.90549,0.0057676,-0.01508,0,0
2,GO REGULATION OF GLUCONEOGENESIS,0.65188,0.0057498,0.061065,0,0
2,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.86799,0.0057447,0.014619,0,0
2,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.57414,0.0056449,-0.062517,0,0
2,GO REGULATION OF TRANSPORTER ACTIVITY,0.58498,0.0053723,0.060596,0,0
2,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.68646,0.0053312,0.058482,0,0
2,GO COPULATION,0.48117,0.0052742,0.096051,0,0
2,GO VIRAL BUDDING,0.78176,0.0052723,-0.00091562,0,0
2,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.70989,0.0052519,-0.0025144,0,0
2,GO CELL FATE COMMITMENT,0.88046,0.0051194,0.051646,0,0
2,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.95582,0.0051047,0.053903,0,0
2,GO MUSCLE CELL DEVELOPMENT,0.72171,0.0050627,0.07158,0,0
2,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.64051,0.0049661,0.061058,0,0
2,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.41494,0.0044424,-0.03633,0,0
2,GO PROTEIN TARGETING TO VACUOLE,0.62923,0.0042612,0.081162,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.65188,0.0041508,0.0020671,0,0
2,GO PYRUVATE METABOLIC PROCESS,0.99368,0.0041037,0.027047,0,0
2,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.96843,0.0040417,-0.0025231,0,0
2,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.83078,0.0039871,0.054719,0,0
2,GO MATURATION OF LSU RRNA,0.96843,0.0038883,-0.0075197,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.81845,0.0037592,0.098744,0,0
2,GO NEUTRAL AMINO ACID TRANSPORT,0.39705,0.0036781,0.10227,0,0
2,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.94321,0.0036348,0.042011,0,0
2,GO ADHERENS JUNCTION ASSEMBLY,0.7336,0.0035209,0.018639,0,0
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.74555,0.0034562,0.02536,0,0
2,GO GENE SILENCING,0.89296,0.0033911,0.017141,0,0
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.75756,0.0033125,0.047135,0,0
2,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.7336,0.0032772,0.02358,0,0
2,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.84314,0.0031724,0.035696,0,0
2,GO TRANSLATIONAL INITIATION,0.91805,0.0031652,0.0013434,0,0
2,GO REGULATION OF GONAD DEVELOPMENT,0.44264,0.0031065,0.069448,0,0
2,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.7336,0.0030196,0.070405,0,0
2,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.99368,0.0028506,0.027706,0,0
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.84314,0.0028439,0.043038,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.99368,0.0028079,0.025328,0,0
2,GO VESICLE LOCALIZATION,0.80618,0.0027754,0.023064,0,0
2,GO RHYTHMIC PROCESS,0.99368,0.0027038,0.036643,0,0
2,GO CELL JUNCTION ORGANIZATION,0.60692,0.0025335,0.0090153,0,0
2,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.52145,0.0024948,-0.040814,0,0
2,GO REGULATION OF HORMONE LEVELS,1,0.0022174,0.034376,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.66333,0.0021931,0.073776,0,0
2,GO CELL GROWTH,0.99368,0.002118,0.053657,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.57414,0.0018515,0.00059654,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.79394,0.0016753,0.069519,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.93062,0.0015356,0.036043,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.75756,0.0015133,0.047034,0,0
2,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.54223,0.0014539,0.058906,0,0
2,GO POSITIVE REGULATION OF HEART CONTRACTION,0.66333,0.0014021,-0.020504,0,0
2,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.83078,0.0013982,0.0033219,0,0
2,GO L AMINO ACID TRANSPORT,0.57414,0.0013743,0.067696,0,0
2,GO MIRNA METABOLIC PROCESS,0.74555,0.0010347,0.059932,0,0
2,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.78176,0.00083036,0.0098031,0,0
2,GO POSITIVE REGULATION OF MITOPHAGY,0.99368,0.00068971,0.040238,0,0
2,GO RNA METHYLATION,0.70989,0.00063353,0.035923,0,0
2,GO PEPTIDYL METHIONINE MODIFICATION,0.83078,0.00062056,-0.0011876,0,0
2,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.74555,0.00059501,0.031104,0,0
2,GO REGULATION OF CATION CHANNEL ACTIVITY,0.98106,0.00057977,0.024365,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.53179,0.0005632,0.069304,0,0
2,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.5959,0.00048886,0.071648,0,0
2,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.88046,0.00040796,0.013903,0,0
2,GO CARBOHYDRATE HOMEOSTASIS,0.84314,0.00036583,0.026261,0,0
2,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.55277,0.00018991,0.089176,0,0
2,GO POSITIVE REGULATION OF NEURON MIGRATION,0.94321,0.00010713,0.045539,0,0
2,GO RIBOSOME ASSEMBLY,0.70989,-3.4812e-06,-0.017305,0,0
2,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.90549,-9.9081e-05,0.0034136,0,0
2,GO TRNA PROCESSING,0.79394,-0.00010649,0.021736,0,0
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.90549,-0.00011692,-0.010912,0,0
2,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.91805,-0.00030647,-0.054194,0,0
2,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.69814,-0.00051843,-0.0039036,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.93062,-0.00053085,0.011624,0,0
2,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.54223,-0.00060188,0.043864,0,0
2,GO REGULATION OF CELL SIZE,0.99368,-0.00098979,0.059159,0,0
2,GO IMPORT INTO CELL,0.75756,-0.001017,0.050971,0,0
2,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.84314,-0.0010862,0.0052988,0,0
2,GO DEVELOPMENTAL GROWTH,0.88046,-0.0012455,0.043027,0,0
2,GO TRNA MODIFICATION,0.66333,-0.0013283,0.031809,0,0
2,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.84314,-0.0013553,-0.00043825,0,0
2,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.60692,-0.0016128,0.072349,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.96843,-0.0016451,-0.019985,0,0
2,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.61803,-0.0016797,0.061381,0,0
2,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.76963,-0.002007,0.053745,0,0
2,GO MITOCHONDRIAL TRANSLATION,0.50109,-0.0020882,-0.049057,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.83078,-0.0021948,0.015586,0,0
2,GO ION TRANSMEMBRANE TRANSPORT,0.75756,-0.0022085,0.048754,0,0
2,GO RESPONSE TO AMINO ACID STARVATION,0.48117,-0.002256,-0.009588,0,0
2,GO TRNA TRANSPORT,0.78176,-0.0027113,-0.049808,0,0
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.86799,-0.0027966,0.026855,0,0
2,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.85555,-0.0028925,-0.0040708,0,0
2,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.96843,-0.002943,0.036477,0,0
2,GO OVARIAN FOLLICLE DEVELOPMENT,0.65188,-0.0029634,-0.015471,0,0
2,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.70989,-0.0029674,-0.044662,0,0
2,GO MIDBODY ABSCISSION,0.58498,-0.0029748,-0.039679,0,0
2,GO RESPONSE TO STARVATION,0.94321,-0.0030046,0.03759,0,0
2,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.80618,-0.0030051,0.053245,0,0
2,GO CARDIAC MYOFIBRIL ASSEMBLY,0.72171,-0.0030848,-0.029379,0,0
2,GO EPITHELIAL CELL MORPHOGENESIS,0.95582,-0.0030931,0.044708,0,0
2,GO GLUCOSE METABOLIC PROCESS,0.94321,-0.0032218,0.043904,0,0
2,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.99368,-0.0032744,0.011609,0,0
2,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.88046,-0.0035098,0.042975,0,0
2,GO RRNA METABOLIC PROCESS,0.86799,-0.0035118,0.0021025,0,0
2,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.78176,-0.0036913,0.0039353,0,0
2,GO HORMONE MEDIATED SIGNALING PATHWAY,0.99368,-0.0038227,0.039758,0,0
2,GO NCRNA METABOLIC PROCESS,0.83078,-0.0039225,0.012712,0,0
2,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.80618,-0.0039544,0.011942,0,0
2,GO HEXOSE CATABOLIC PROCESS,1,-0.0040233,0.037904,0,0
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.61803,-0.0041687,-0.020469,0,0
2,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.51122,-0.0042059,0.059191,0,0
2,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.72171,-0.0042139,0.0089809,0,0
2,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.79394,-0.0042234,0.023245,0,0
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.84314,-0.0042743,-0.01708,0,0
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.89296,-0.0042955,0.019805,0,0
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.90549,-0.0043777,0.011015,0,0
2,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.86799,-0.0043922,0.050894,0,0
2,GO NUCLEAR ENVELOPE ORGANIZATION,0.64051,-0.0044851,-0.016823,0,0
2,GO SPERM CAPACITATION,0.95582,-0.0045132,0.022089,0,0
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.66333,-0.0046111,-0.037028,0,0
2,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.74555,-0.004673,-0.031471,0,0
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.60692,-0.0048711,-0.034041,0,0
2,GO RIBOSOME BIOGENESIS,0.74555,-0.0050709,0.0050221,0,0
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.61803,-0.0051035,0.057122,0,0
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.90549,-0.0051046,0.017874,0,0
2,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.51122,-0.0051211,-0.0063163,0,0
2,GO EMBRYO DEVELOPMENT,0.76963,-0.0051955,0.067422,0,0
2,GO TRNA WOBBLE URIDINE MODIFICATION,0.89296,-0.0054896,0.0067753,0,0
2,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.96843,-0.0056622,0.031312,0,0
2,GO CATION TRANSMEMBRANE TRANSPORT,0.79394,-0.005905,0.050419,0,0
2,GO MULTICELLULAR ORGANISM REPRODUCTION,0.70989,-0.006064,0.0020909,0,0
2,GO POSITIVE REGULATION OF ANION TRANSPORT,0.56341,-0.006126,0.07072,0,0
2,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.53179,-0.0061322,0.062347,0,0
2,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.86799,-0.0062058,0.050384,0,0
2,GO P BODY ASSEMBLY,0.88046,-0.0065269,0.028668,0,0
2,GO AMIDE BIOSYNTHETIC PROCESS,0.70989,-0.0065682,0.02624,0,0
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.91805,-0.0068221,-0.012558,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.98106,-0.0068811,0.030744,0,0
2,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.86799,-0.0069332,0.040963,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.95582,-0.0070219,0.024306,0,0
2,GO NCRNA PROCESSING,0.66333,-0.0071141,0.02026,0,0
2,GO MITOCHONDRIAL GENE EXPRESSION,0.54223,-0.0072054,-0.044052,0,0
2,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.46168,-0.0072316,-0.018162,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.93062,-0.0073024,0.03768,0,0
2,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.98106,-0.0073369,-1.2579e-05,0,0
2,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.85555,-0.0074026,0.032388,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.99368,-0.0074847,0.019692,0,0
2,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.55277,-0.0076492,0.069968,0,0
2,GO PROTEIN SUMOYLATION,0.90549,-0.0077179,0.018267,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.84314,-0.0078929,0.020866,0,0
2,GO CORTICOSTEROID HORMONE SECRETION,1,-0.0078938,-0.00035706,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.80618,-0.0079011,0.029986,0,0
2,GO REGULATION OF RECEPTOR INTERNALIZATION,0.75756,-0.0079317,0.035398,0,0
2,GO REGULATION OF DEVELOPMENTAL GROWTH,0.78176,-0.0079416,0.029748,0,0
2,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.98106,-0.0079633,-0.048984,0,0
2,GO PROTEIN LOCALIZATION TO LYSOSOME,0.93062,-0.008131,0.032561,0,0
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.80618,-0.0082411,-0.020666,0,0
2,GO COGNITION,0.78176,-0.0082962,-0.0017928,0,0
2,GO CYTOSKELETON ORGANIZATION,0.88046,-0.008301,0.039064,0,0
2,GO NEURAL TUBE DEVELOPMENT,0.84314,-0.0083531,0.046891,0,0
2,GO REGULATION OF PROTEIN ACETYLATION,0.98106,-0.0083976,0.034778,0,0
2,GO TRANSCRIPTION BY RNA POLYMERASE I,0.86799,-0.0084422,-0.0023569,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.95582,-0.0088511,0.039904,0,0
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.75756,-0.0090078,0.019481,0,0
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.27821,-0.0090776,-0.11715,0,0
2,GO REGULATION OF HEART RATE,0.80618,-0.0091438,0.025829,0,0
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.76963,-0.0093924,-0.007431,0,0
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.89296,-0.009604,0.020104,0,0
2,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.93062,-0.0099216,0.019632,0,0
2,GO CARDIAC CELL DEVELOPMENT,0.65188,-0.010056,0.063469,0,0
2,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.90549,-0.010256,0.025317,0,0
2,GO AEROBIC RESPIRATION,0.16602,-0.01042,-0.046341,0,0
2,GO FORELIMB MORPHOGENESIS,0.60692,-0.010443,-0.027459,0,0
2,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.78176,-0.01054,0.028798,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.74555,-0.010864,0.015482,0,0
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.67486,-0.01097,0.0095525,0,0
2,GO UTP METABOLIC PROCESS,0.88046,-0.011026,-0.0013785,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.84314,-0.011205,0.00012257,0,0
2,GO LUNG CELL DIFFERENTIATION,0.84314,-0.011248,-0.040406,0,0
2,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.93062,-0.011251,-0.0042385,0,0
2,GO C4 DICARBOXYLATE TRANSPORT,0.85555,-0.011507,0.029674,0,0
2,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.69814,-0.011516,0.048449,0,0
2,GO SPECIFICATION OF SYMMETRY,0.89296,-0.011634,0.033862,0,0
2,GO CELL CYCLE ARREST,0.89296,-0.011802,0.0099434,0,0
2,GO LONG TERM SYNAPTIC POTENTIATION,0.58498,-0.011906,-0.021269,0,0
2,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.2998,-0.011931,-0.080938,0,0
2,GO HISTONE H3 K4 METHYLATION,0.62923,-0.012034,-0.052751,0,0
2,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.72171,-0.012089,0.028115,0,0
2,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.37111,-0.012281,-0.054948,0,0
2,GO SHORT TERM MEMORY,0.95582,-0.012307,0.025245,0,0
2,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.56341,-0.012348,0.065585,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.55277,-0.012619,0.012339,0,0
2,GO TOXIN METABOLIC PROCESS,0.79394,-0.012691,0.015265,0,0
2,GO TOR SIGNALING,0.94321,-0.012729,0.040618,0,0
2,GO ACID SECRETION,1,-0.012854,0.013857,0,0
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.7336,-0.012916,-0.0077142,0,0
2,GO CYTOPLASMIC TRANSLATION,0.46168,-0.013085,-0.031363,0,0
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.49108,-0.013144,-0.025447,0,0
2,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.70989,-0.013192,0.024054,0,0
2,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.62923,-0.013452,-0.039173,0,0
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.61803,-0.013523,-0.026344,0,0
2,GO LIPID DROPLET ORGANIZATION,0.90549,-0.013775,0.0089563,0,0
2,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.91805,-0.01379,0.032924,0,0
2,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.7336,-0.013795,0.058396,0,0
2,GO RESPONSE TO DIETARY EXCESS,0.98106,-0.013811,0.012494,0,0
2,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.83078,-0.013882,0.013209,0,0
2,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.88046,-0.013883,0.029942,0,0
2,GO HISTONE SERINE PHOSPHORYLATION,0.67486,-0.014024,-0.08518,0,0
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.60692,-0.01409,0.037555,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.85555,-0.014123,0.0098713,0,0
2,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.86799,-0.014123,0.045598,0,0
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.61803,-0.014138,-0.03751,0,0
2,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.93062,-0.014187,0.038678,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.89296,-0.014296,0.018654,0,0
2,GO REGULATION OF TORC1 SIGNALING,0.62923,-0.014366,-0.011116,0,0
2,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.4521,-0.014472,-0.030794,0,0
2,GO PEPTIDE METABOLIC PROCESS,0.40594,-0.014498,0.04478,0,0
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.68646,-0.014742,0.047847,0,0
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.83078,-0.0148,0.005394,0,0
2,GO RNA LOCALIZATION,0.65188,-0.014843,-0.022649,0,0
2,GO PIGMENT BIOSYNTHETIC PROCESS,0.69814,-0.014852,0.043583,0,0
2,GO CELLULAR MACROMOLECULE LOCALIZATION,0.75756,-0.014889,0.019453,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.76963,-0.014919,-0.014189,0,0
2,GO CELL MORPHOGENESIS,0.69814,-0.015182,0.030728,0,0
2,GO REGULATION OF BLOOD CIRCULATION,0.66333,-0.01522,0.060159,0,0
2,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.72171,-0.015266,0.01238,0,0
2,GO RESPONSE TO AMPHETAMINE,0.86799,-0.015426,-0.0044132,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.94321,-0.015794,0.016727,0,0
2,GO MEMBRANE REPOLARIZATION,0.99368,-0.015885,0.03834,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.33821,-0.015957,-0.049925,0,0
2,GO PROTEIN AUTOUBIQUITINATION,0.80618,-0.016052,-0.00058078,0,0
2,GO DNA CATABOLIC PROCESS,0.88046,-0.016109,0.021585,0,0
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.98106,-0.016195,0.020881,0,0
2,GO UV DAMAGE EXCISION REPAIR,0.91805,-0.01623,0.0072051,0,0
2,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.76963,-0.016383,-0.004291,0,0
2,GO PHOTOTRANSDUCTION,0.96843,-0.016397,0.0014553,0,0
2,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.98106,-0.01646,0.037467,0,0
2,GO APPENDAGE MORPHOGENESIS,0.95582,-0.016529,0.0445,0,0
2,GO REGULATION OF CELLULAR RESPIRATION,0.64051,-0.016547,0.0042648,0,0
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.44264,-0.016571,-0.026026,0,0
2,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.96843,-0.016741,0.013498,0,0
2,GO MALE MEIOTIC NUCLEAR DIVISION,0.33029,-0.016948,-0.1135,0,0
2,GO NEGATIVE REGULATION OF AXONOGENESIS,0.76963,-0.017108,-0.0043441,0,0
2,GO APPENDAGE DEVELOPMENT,0.86799,-0.017202,0.041585,0,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.47137,-0.017597,0.0021093,0,0
2,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.57414,-0.017625,0.009496,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.52145,-0.017773,-0.034693,0,0
2,GO REGULATION OF CELL DEVELOPMENT,0.69814,-0.017997,0.025737,0,0
2,GO REGULATION OF TRANSLATIONAL ELONGATION,0.33821,-0.018077,-0.043932,0,0
2,GO PROTEASOME ASSEMBLY,0.81845,-0.018088,-0.024295,0,0
2,GO HISTONE H3 K9 MODIFICATION,0.79394,-0.018125,-0.013812,0,0
2,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.78176,-0.01813,-0.0075292,0,0
2,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.76963,-0.018212,0.014541,0,0
2,GO REGULATION OF NEUROBLAST PROLIFERATION,0.70989,-0.018302,-0.026389,0,0
2,GO REGULATION OF MITOTIC CELL CYCLE,0.43329,-0.018344,-0.041988,0,0
2,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.93062,-0.018377,-0.0081621,0,0
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.66333,-0.018401,-0.012834,0,0
2,GO OXIDATIVE DEMETHYLATION,0.51122,-0.018528,-0.042692,0,0
2,GO REGULATION OF ORGANELLE ORGANIZATION,0.7336,-0.018649,0.020178,0,0
2,GO TRNA WOBBLE BASE MODIFICATION,0.80618,-0.018676,-0.0012073,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.89296,-0.018697,0.0052753,0,0
2,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.83078,-0.018731,0.05248,0,0
2,GO LIPID GLYCOSYLATION,0.49108,-0.018738,-0.031903,0,0
2,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.64051,-0.018789,-0.01469,0,0
2,GO MUSCLE FIBER DEVELOPMENT,0.61803,-0.018879,-0.013845,0,0
2,GO MAGNESIUM ION TRANSPORT,0.81845,-0.018889,-0.024442,0,0
2,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.72171,-0.018897,0.014866,0,0
2,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.94321,-0.018906,0.028428,0,0
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.58498,-0.018909,-0.025083,0,0
2,GO DNA BIOSYNTHETIC PROCESS,0.78176,-0.018985,0.0078251,0,0
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.33029,-0.019059,0.12524,0,0
2,GO CELLULAR SODIUM ION HOMEOSTASIS,0.86799,-0.019201,0.028029,0,0
2,GO REGULATION OF CELL CYCLE,0.4521,-0.019246,-0.029662,0,0
2,GO RESPONSE TO MONOSACCHARIDE,0.80618,-0.019271,0.028885,0,0
2,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.56341,-0.019528,0.12935,0,0
2,GO MACROMOLECULE DEACYLATION,0.89296,-0.019547,0.031372,0,0
2,GO NEGATIVE REGULATION OF DNA BINDING,0.68646,-0.01961,-0.035777,0,0
2,GO SENSORY ORGAN DEVELOPMENT,0.84314,-0.019735,0.032193,0,0
2,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.62923,-0.019875,-0.042099,0,0
2,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.69814,-0.020072,0.0042553,0,0
2,GO MITOPHAGY,0.94321,-0.020184,0.028012,0,0
2,GO REGULATION OF CHROMATIN ASSEMBLY,0.99368,-0.020208,0.020168,0,0
2,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.62923,-0.02024,0.048717,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.7336,-0.020358,0.055773,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.67486,-0.020455,-0.017071,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.94321,-0.020465,0.032584,0,0
2,GO REGULATION OF HISTONE MODIFICATION,0.85555,-0.02077,0.014065,0,0
2,GO NEPHRIC DUCT DEVELOPMENT,0.95582,-0.020897,0.033336,0,0
2,GO ESCRT COMPLEX DISASSEMBLY,0.75756,-0.020955,-0.024254,0,0
2,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.64051,-0.021011,0.033515,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.3148,-0.021106,-0.1339,0,0
2,GO THYROID GLAND DEVELOPMENT,0.54223,-0.021138,-0.0094445,0,0
2,GO ATRIAL SEPTUM DEVELOPMENT,0.47137,-0.02118,-0.040351,0,0
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.54223,-0.021298,-0.042886,0,0
2,GO CELL CELL SIGNALING,0.79394,-0.021396,0.026454,0,0
2,GO MITOCHONDRION ORGANIZATION,0.72171,-0.021435,0.011117,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.29248,-0.02161,-0.09655,0,0
2,GO SODIUM ION TRANSPORT,0.72171,-0.021768,-0.0020917,0,0
2,GO POSITIVE REGULATION OF ACROSOME REACTION,0.83078,-0.021794,-0.021907,0,0
2,GO REGULATION OF TOR SIGNALING,0.88046,-0.021877,0.030634,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.80618,-0.021889,0.036177,0,0
2,GO GANGLIOSIDE METABOLIC PROCESS,0.46168,-0.021978,0.11451,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.69814,-0.021981,-0.028549,0,0
2,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.84314,-0.022196,0.045109,0,0
2,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.72171,-0.022249,-0.051501,0,0
2,GO REGULATION OF CHROMATIN ORGANIZATION,0.79394,-0.022286,0.0093588,0,0
2,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.7336,-0.022385,0.020682,0,0
2,GO GONADOTROPIN SECRETION,0.7336,-0.022401,0.01347,0,0
2,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.57414,-0.022665,-0.017742,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.94321,-0.022716,0.0013209,0,0
2,GO POSITIVE REGULATION OF HORMONE SECRETION,0.4521,-0.022746,-0.023624,0,0
2,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.53179,-0.022913,-0.049248,0,0
2,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.4521,-0.022983,-0.016248,0,0
2,GO DE NOVO PROTEIN FOLDING,0.53179,-0.02335,-0.013542,0,0
2,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.86799,-0.023505,0.056737,0,0
2,GO TRNA METABOLIC PROCESS,0.96843,-0.023562,-0.00076865,0,0
2,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.27126,-0.023642,-0.060149,0,0
2,GO TRANSLATIONAL TERMINATION,0.40594,-0.023679,-0.048214,0,0
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.5959,-0.023683,-0.048354,0,0
2,GO PROTEIN LOCALIZATION TO ORGANELLE,0.64051,-0.023915,0.0076259,0,0
2,GO SPERM MOTILITY,0.54223,-0.024,-0.047704,0,0
2,GO CELL PROLIFERATION IN FOREBRAIN,0.70989,-0.024141,-0.030735,0,0
2,GO PEPTIDYL THREONINE MODIFICATION,0.81845,-0.024384,0.029854,0,0
2,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.58498,-0.02443,0.015157,0,0
2,GO MEMORY,0.64051,-0.024593,-0.010227,0,0
2,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,1,-0.024603,0.08511,0,0
2,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.99368,-0.024708,0.027503,0,0
2,GO INTRACELLULAR TRANSPORT,0.84314,-0.024727,0.023214,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.52145,-0.024758,-0.026605,0,0
2,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.83078,-0.024871,0.0071723,0,0
2,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.65188,-0.024998,0.019513,0,0
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.79394,-0.024999,-0.0088151,0,0
2,GO PHOTOPERIODISM,0.98106,-0.025236,0.013261,0,0
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.96843,-0.025294,-0.012002,0,0
2,GO HEART PROCESS,0.75756,-0.0253,0.042192,0,0
2,GO MRNA TRANSPORT,0.58498,-0.025453,-0.034256,0,0
2,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.89296,-0.026301,0.037178,0,0
2,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.62923,-0.026312,-0.0057328,0,0
2,GO MYELIN ASSEMBLY,0.66333,-0.026417,0.02732,0,0
2,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.74555,-0.026578,-0.00071964,0,0
2,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.55277,-0.026591,-0.038148,0,0
2,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.66333,-0.026884,0.080246,0,0
2,GO NUCLEAR EXPORT,0.67486,-0.0269,-0.018641,0,0
2,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.89296,-0.027014,0.0084923,0,0
2,GO REGULATION OF ORGANELLE ASSEMBLY,0.51122,-0.02704,-0.012269,0,0
2,GO RESPONSE TO AMINE,0.80618,-0.027224,-0.0062582,0,0
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.80618,-0.0273,0.037971,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.7336,-0.027499,0.028132,0,0
2,GO NUCLEOTIDE PHOSPHORYLATION,0.79394,-0.027544,0.012531,0,0
2,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.90549,-0.027645,0.014192,0,0
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.40594,-0.027723,-0.087612,0,0
2,GO CGMP MEDIATED SIGNALING,0.99368,-0.027857,0.020022,0,0
2,GO PROTEIN LOCALIZATION TO MEMBRANE,0.58498,-0.027905,0.013765,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.56341,-0.027966,-0.023324,0,0
2,GO REGULATION OF CELL CYCLE PROCESS,0.33821,-0.027983,-0.053843,0,0
2,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.65188,-0.028031,0.013262,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.65188,-0.028125,0.022469,0,0
2,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.98106,-0.028273,-0.0031806,0,0
2,GO TRANSFERRIN TRANSPORT,0.72171,-0.028357,0.0057658,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.99368,-0.028361,0.044406,0,0
2,GO TORC1 SIGNALING,0.83078,-0.028482,0.016915,0,0
2,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.68646,-0.028709,0.044226,0,0
2,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.98106,-0.028718,0.02756,0,0
2,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.90549,-0.028752,0.027912,0,0
2,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.75756,-0.02902,-0.037997,0,0
2,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.86799,-0.029176,0.0013645,0,0
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.52145,-0.029257,-0.037032,0,0
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.50109,-0.029324,-0.045642,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.62923,-0.029373,-0.022524,0,0
2,GO CELL CYCLE PHASE TRANSITION,0.50109,-0.029473,-0.050226,0,0
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.81845,-0.029479,0.033787,0,0
2,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.72171,-0.029678,-0.022626,0,0
2,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.88046,-0.029889,0.00069233,0,0
2,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.47137,-0.029923,-0.038124,0,0
2,GO INTRACELLULAR PROTEIN TRANSPORT,0.7336,-0.029954,0.015219,0,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.81845,-0.030145,0.0039778,0,0
2,GO CHLORIDE TRANSPORT,0.95582,-0.03023,0.027348,0,0
2,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.42405,-0.030354,0.0035524,0,0
2,GO APOPTOTIC DNA FRAGMENTATION,0.58498,-0.03037,-0.006636,0,0
2,GO PROTEIN TARGETING,0.56341,-0.03039,0.0049379,0,0
2,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.37964,-0.030406,-0.040571,0,0
2,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.64051,-0.030594,0.0021363,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.84314,-0.030608,0.042054,0,0
2,GO CELLULAR RESPONSE TO ALKALOID,0.74555,-0.030609,0.0030831,0,0
2,GO TRICARBOXYLIC ACID CYCLE,0.57414,-0.030638,-0.011771,0,0
2,GO SENSORY SYSTEM DEVELOPMENT,0.7336,-0.030641,0.029431,0,0
2,GO DNA METABOLIC PROCESS,0.52145,-0.030794,-0.039891,0,0
2,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.62923,-0.031028,-0.0023576,0,0
2,GO CELLULAR RESPIRATION,0.12273,-0.031145,-0.045951,0,0
2,GO TELOMERE ORGANIZATION,0.54223,-0.031211,-0.061185,0,0
2,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.70989,-0.031284,-0.033425,0,0
2,GO REGULATION OF MEMBRANE PERMEABILITY,0.33821,-0.031319,-0.038619,0,0
2,GO MITOCHONDRIAL FISSION,0.85555,-0.031465,0.040058,0,0
2,GO EMBRYONIC ORGAN MORPHOGENESIS,0.99368,-0.031606,0.035724,0,0
2,GO REGULATION OF GTP BINDING,0.94321,-0.031673,0.019991,0,0
2,GO CELLULAR GLUCOSE HOMEOSTASIS,0.42405,-0.031906,-0.0037929,0,0
2,GO PROTEIN MONOUBIQUITINATION,0.39705,-0.031971,-0.056379,0,0
2,GO FATTY ACYL COA METABOLIC PROCESS,0.98106,-0.03201,0.044256,0,0
2,GO MITOCHONDRIAL TRANSPORT,0.50109,-0.032026,-0.012679,0,0
2,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.72171,-0.03224,0.070304,0,0
2,GO REGULATION OF TELOMERE CAPPING,0.55277,-0.032662,-0.040047,0,0
2,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.58498,-0.032879,-0.030338,0,0
2,GO MRNA METHYLATION,0.65188,-0.032922,-0.018887,0,0
2,GO NCRNA 3 END PROCESSING,0.44264,-0.033095,-0.054398,0,0
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.39705,-0.033173,-0.078936,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.43329,-0.033257,-0.00897,0,0
2,GO TONGUE MORPHOGENESIS,0.83078,-0.033399,-0.028199,0,0
2,GO REGULATION OF SYSTEM PROCESS,0.88046,-0.033419,0.043579,0,0
2,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.76963,-0.033739,0.055336,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.96843,-0.033895,0.021631,0,0
2,GO REGULATION OF SULFUR METABOLIC PROCESS,0.99368,-0.033971,0.035435,0,0
2,GO MITOCHONDRION MORPHOGENESIS,0.42405,-0.033988,-0.023959,0,0
2,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.95582,-0.034245,0.054807,0,0
2,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.81845,-0.034289,0.012406,0,0
2,GO HEART FORMATION,0.84314,-0.034303,0.016969,0,0
2,GO RRNA CATABOLIC PROCESS,0.53179,-0.034424,-0.046094,0,0
2,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.46168,-0.034457,-0.063802,0,0
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.65188,-0.034497,0.045694,0,0
2,GO CYTOSOLIC TRANSPORT,0.99368,-0.034589,0.030667,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.5959,-0.034616,-0.028482,0,0
2,GO SNRNA PROCESSING,0.88046,-0.0347,-0.012778,0,0
2,GO ORGANELLE DISASSEMBLY,0.93062,-0.034856,0.02068,0,0
2,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.58498,-0.03488,0.011469,0,0
2,GO NUCLEAR ENVELOPE REASSEMBLY,0.62923,-0.034887,-0.014605,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.49108,-0.035286,-0.055767,0,0
2,GO REGULATION OF APPETITE,0.5959,-0.035366,-0.048706,0,0
2,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.78176,-0.03567,-0.0030065,0,0
2,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.44264,-0.03586,-0.02949,0,0
2,GO GPI ANCHOR METABOLIC PROCESS,0.69814,-0.035906,-0.013458,0,0
2,GO POSITIVE REGULATION OF AXONOGENESIS,0.42405,-0.035924,-0.00762,0,0
2,GO NEGATIVE REGULATION OF CELL AGING,0.5959,-0.035943,-0.033857,0,0
2,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.90549,-0.036035,0.013633,0,0
2,GO CYTOCHROME COMPLEX ASSEMBLY,0.80618,-0.036056,0.02579,0,0
2,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.90549,-0.036075,0.017693,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.33821,-0.036076,-0.030761,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.49108,-0.036084,-0.011966,0,0
2,GO CLATHRIN COAT ASSEMBLY,0.36271,-0.036149,-0.015788,0,0
2,GO MYOTUBE CELL DEVELOPMENT,0.96843,-0.036162,0.0089606,0,0
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.51122,-0.03618,-0.093453,0,0
2,GO TRNA METHYLATION,0.69814,-0.036181,0.033052,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.42405,-0.036186,-0.03185,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.20822,-0.036374,-0.13213,0,0
2,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.48117,-0.036463,0.0025687,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.38829,-0.036543,-0.01056,0,0
2,GO DIOL METABOLIC PROCESS,0.66333,-0.036605,-0.010323,0,0
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.61803,-0.036748,-0.029321,0,0
2,GO CARDIAC CELL FATE COMMITMENT,0.54223,-0.03677,-0.066328,0,0
2,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.5959,-0.036819,-0.036551,0,0
2,GO MALE GAMETE GENERATION,0.30724,-0.036976,-0.056672,0,0
2,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.55277,-0.037017,0.073362,0,0
2,GO REGULATION OF ORGANIC ACID TRANSPORT,0.78176,-0.03703,0.036966,0,0
2,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.74555,-0.03724,0.02251,0,0
2,GO MITOTIC CELL CYCLE CHECKPOINT,0.36271,-0.037379,-0.089989,0,0
2,GO REGULATION OF CELL CYCLE ARREST,0.32248,-0.037415,-0.053733,0,0
2,GO TRANSLATIONAL ELONGATION,0.10468,-0.037426,-0.068281,0,0
2,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.90549,-0.037536,0.063504,0,0
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.57414,-0.03765,-0.045819,0,0
2,GO NEGATIVE REGULATION OF DNA REPLICATION,0.46168,-0.037711,-0.070059,0,0
2,GO EYE MORPHOGENESIS,0.88046,-0.038004,0.041948,0,0
2,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.99368,-0.038119,0.035011,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.08303,-0.038284,-0.14161,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.65188,-0.038327,0.048436,0,0
2,GO TYPE B PANCREATIC CELL PROLIFERATION,0.78176,-0.038398,0.015527,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.26442,-0.038456,-0.16524,0,0
2,GO APICAL PROTEIN LOCALIZATION,0.51122,-0.03849,-0.037396,0,0
2,GO REGULATION OF ACTION POTENTIAL,0.95582,-0.038622,0.02185,0,0
2,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.48117,-0.039,-0.0059001,0,0
2,GO PEPTIDYL LYSINE TRIMETHYLATION,0.81845,-0.03933,-0.0031282,0,0
2,GO SECONDARY PALATE DEVELOPMENT,0.91805,-0.039386,-0.0049459,0,0
2,GO NEURAL TUBE PATTERNING,0.88046,-0.039567,-0.0087919,0,0
2,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.96843,-0.039607,0.029732,0,0
2,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.50109,-0.039702,-0.046723,0,0
2,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.37964,-0.040009,-0.024985,0,0
2,GO MITOCHONDRIAL DNA REPLICATION,0.88046,-0.040092,-0.026722,0,0
2,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.56341,-0.040176,-0.035705,0,0
2,GO MULTICELLULAR ORGANISM GROWTH,0.36271,-0.040196,-0.00068931,0,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.52145,-0.040321,-0.002617,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.95582,-0.040327,0.094121,0,0
2,GO HISTONE MRNA METABOLIC PROCESS,0.62923,-0.040597,-0.048896,0,0
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.37964,-0.040683,-0.052731,0,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.88046,-0.040695,0.00038264,0,0
2,GO SOMITE DEVELOPMENT,0.72171,-0.040834,0.0053196,0,0
2,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.72171,-0.040944,0.02255,0,0
2,GO THIOESTER BIOSYNTHETIC PROCESS,0.75756,-0.041011,0.058866,0,0
2,GO RESPONSE TO LIGHT STIMULUS,0.74555,-0.041057,0.0072857,0,0
2,GO HISTONE DEUBIQUITINATION,0.91805,-0.041078,0.012159,0,0
2,GO MRNA CLEAVAGE,0.90549,-0.041225,0.020898,0,0
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.61803,-0.041343,-0.026041,0,0
2,GO SEXUAL REPRODUCTION,0.28529,-0.041428,-0.043225,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.51122,-0.04161,-0.036052,0,0
2,GO PROTEIN TARGETING TO MEMBRANE,0.15197,-0.041666,-0.039281,0,0
2,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.30724,-0.04175,-0.051296,0,0
2,GO CAMERA TYPE EYE DEVELOPMENT,0.66333,-0.041796,0.021758,0,0
2,GO CIRCADIAN RHYTHM,0.49108,-0.04203,-0.0031005,0,0
2,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.51122,-0.042376,-0.014008,0,0
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.28529,-0.04242,-0.0652,0,0
2,GO ALDEHYDE CATABOLIC PROCESS,0.41494,-0.042453,-0.045516,0,0
2,GO GAMETE GENERATION,0.28529,-0.042612,-0.048714,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.84314,-0.042671,0.056999,0,0
2,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.54223,-0.042699,0.0070881,0,0
2,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.53179,-0.043063,-0.0069017,0,0
2,GO ORGANELLE MEMBRANE FUSION,0.36271,-0.043078,-0.0076313,0,0
2,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.40594,-0.043103,-0.010167,0,0
2,GO REGULATION OF CENTROSOME DUPLICATION,0.20256,-0.043459,-0.11238,0,0
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.11163,-0.043558,-0.12161,0,0
2,GO RESPONSE TO HYDROXYUREA,0.18102,-0.043643,-0.11905,0,0
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.56341,-0.043684,-0.040788,0,0
2,GO POSITIVE REGULATION OF TOR SIGNALING,0.54223,-0.043988,-0.014085,0,0
2,GO NUCLEUS ORGANIZATION,0.40594,-0.043993,-0.045685,0,0
2,GO AMINO ACID BETAINE METABOLIC PROCESS,0.54223,-0.044024,-0.026902,0,0
2,GO VESICLE CYTOSKELETAL TRAFFICKING,0.214,-0.044252,-0.046315,0,0
2,GO GENETIC IMPRINTING,0.51122,-0.044452,-0.036666,0,0
2,GO DETECTION OF LIGHT STIMULUS,0.35442,-0.044459,-0.046008,0,0
2,GO REGULATION OF EXTENT OF CELL GROWTH,0.52145,-0.044466,-0.026524,0,0
2,GO REGULATION OF NEURON MATURATION,0.46168,-0.044636,0.0071825,0,0
2,GO NOREPINEPHRINE METABOLIC PROCESS,0.50109,-0.044774,-0.040326,0,0
2,GO REGULATION OF GOLGI ORGANIZATION,0.86799,-0.044802,0.032599,0,0
2,GO AXON EXTENSION,0.4521,-0.044972,-0.012269,0,0
2,GO NEGATIVE REGULATION OF TOR SIGNALING,0.80618,-0.044972,0.02307,0,0
2,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.65188,-0.045088,-0.0013812,0,0
2,GO CELL CYCLE,0.32248,-0.045145,-0.048403,0,0
2,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.4521,-0.045325,-0.032558,0,0
2,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.81845,-0.045545,0.023177,0,0
2,GO TELOMERASE RNA LOCALIZATION,0.23827,-0.045754,-0.1097,0,0
2,GO RNA PROCESSING,0.49108,-0.045781,-0.027474,0,0
2,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.23203,-0.046095,-0.066569,0,0
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.90549,-0.046103,-0.0039825,0,0
2,GO NEGATIVE REGULATION OF BEHAVIOR,0.58498,-0.046128,-0.041887,0,0
2,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.62923,-0.046271,0.015201,0,0
2,GO G2 DNA DAMAGE CHECKPOINT,0.32248,-0.046325,-0.11168,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.43329,-0.046405,-0.0095557,0,0
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.70989,-0.046479,-0.020927,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.28529,-0.046631,-0.078807,0,0
2,GO LOCALIZATION WITHIN MEMBRANE,0.75756,-0.046645,0.012749,0,0
2,GO ENDOTHELIAL CELL MORPHOGENESIS,0.85555,-0.046692,0.049405,0,0
2,GO PROTEIN TARGETING TO MITOCHONDRION,0.197,-0.047596,-0.019948,0,0
2,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.54223,-0.047852,-0.025886,0,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.62923,-0.047906,-0.033171,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.79394,-0.048146,0.030853,0,0
2,GO DNA INTEGRITY CHECKPOINT,0.46168,-0.048426,-0.069408,0,0
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.37111,-0.048474,-0.053201,0,0
2,GO CELL FATE DETERMINATION,0.90549,-0.048478,0.0041193,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.35442,-0.048711,-0.082965,0,0
2,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.52145,-0.048734,-0.091624,0,0
2,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.28529,-0.048793,-0.045136,0,0
2,GO RRNA TRANSCRIPTION,0.68646,-0.048974,-0.025189,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE,0.214,-0.048988,-0.054473,0,0
2,GO REGULATION OF HISTONE METHYLATION,0.39705,-0.048994,-0.044336,0,0
2,GO OOGENESIS,0.17091,-0.049119,-0.097207,0,0
2,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.18102,-0.049163,-0.025505,0,0
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.37964,-0.049347,-0.070166,0,0
2,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.69814,-0.049396,-0.027379,0,0
2,GO PEPTIDYL LYSINE MODIFICATION,0.51122,-0.049406,-0.021584,0,0
2,GO LONG TERM SYNAPTIC DEPRESSION,0.65188,-0.049409,-0.03098,0,0
2,GO REGULATION OF CELL MATURATION,0.70989,-0.049617,-0.012072,0,0
2,GO MATING,0.81845,-0.049809,0.007725,0,0
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.33029,-0.049994,-0.071618,0,0
2,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.86799,-0.050023,-0.028422,0,0
2,GO CELL CYCLE PROCESS,0.214,-0.050066,-0.067728,0,0
2,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.28529,-0.050177,-0.10004,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.79394,-0.050198,0.03287,0,0
2,GO AXONAL FASCICULATION,0.49108,-0.050238,-0.07392,0,0
2,GO DETECTION OF ABIOTIC STIMULUS,0.08303,-0.050399,-0.058423,0,0
2,GO EMBRYONIC BODY MORPHOGENESIS,0.96843,-0.050494,0.011796,0,0
2,GO RNA EXPORT FROM NUCLEUS,0.39705,-0.05051,-0.058202,0,0
2,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.2259,-0.050597,-0.1118,0,0
2,GO CELL CYCLE CHECKPOINT,0.34626,-0.051091,-0.09622,0,0
2,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.2998,-0.051235,-0.053161,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.11163,-0.051295,-0.02929,0,0
2,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.30724,-0.051324,-0.022366,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.89296,-0.051746,0.035929,0,0
2,GO DIVALENT METAL ION EXPORT,0.54223,-0.051804,-0.054022,0,0
2,GO EPITHELIAL CELL FATE COMMITMENT,0.64051,-0.052267,-0.0020553,0,0
2,GO HISTONE H3 K9 METHYLATION,0.4521,-0.052335,-0.055066,0,0
2,GO ORGANELLE LOCALIZATION,0.17091,-0.052866,-0.056057,0,0
2,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.4521,-0.052905,-0.0061447,0,0
2,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.40594,-0.053003,-0.036478,0,0
2,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.47137,-0.05302,-0.041345,0,0
2,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.49108,-0.053111,-0.057111,0,0
2,GO SPERMATID DIFFERENTIATION,0.37111,-0.053324,-0.062177,0,0
2,GO DIOL BIOSYNTHETIC PROCESS,0.47137,-0.053368,-0.018773,0,0
2,GO FOREBRAIN CELL MIGRATION,0.33821,-0.053529,-0.054722,0,0
2,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.43329,-0.053537,-0.082448,0,0
2,GO ADHERENS JUNCTION ORGANIZATION,0.67486,-0.053693,0.026478,0,0
2,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.68646,-0.053752,-0.0028645,0,0
2,GO GERM CELL DEVELOPMENT,0.18624,-0.053767,-0.076388,0,0
2,GO PROTEIN DEMETHYLATION,0.37964,-0.053846,-0.045442,0,0
2,GO HETEROCHROMATIN ORGANIZATION,0.52145,-0.053876,-0.040069,0,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.17091,-0.053958,-0.17171,0,0
2,GO CILIUM MOVEMENT,0.4521,-0.054051,-0.073108,0,0
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.60692,-0.054187,-0.1187,0,0
2,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.61803,-0.054266,-0.014575,0,0
2,GO AROMATIC AMINO ACID TRANSPORT,0.61803,-0.054506,-0.0093452,0,0
2,GO AMINO ACID ACTIVATION,0.66333,-0.054547,-0.030571,0,0
2,GO PROTEIN HETEROOLIGOMERIZATION,0.20822,-0.054576,-0.054934,0,0
2,GO SCHWANN CELL DIFFERENTIATION,0.88046,-0.05465,0.045854,0,0
2,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.55277,-0.054661,0.0063279,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.2998,-0.054669,-0.13156,0,0
2,GO TRNA CATABOLIC PROCESS,0.85555,-0.054814,-0.019574,0,0
2,GO REGULATION OF CHROMATIN BINDING,0.46168,-0.055083,-0.047654,0,0
2,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.25111,-0.055084,-0.10595,0,0
2,GO FERTILIZATION,0.2259,-0.055449,-0.049552,0,0
2,GO ATP METABOLIC PROCESS,0.2577,-0.055474,-0.028792,0,0
2,GO MRNA METABOLIC PROCESS,0.4521,-0.055572,-0.030804,0,0
2,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.94321,-0.055577,0.014417,0,0
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.54223,-0.055687,0.095514,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.32248,-0.055715,-0.06741,0,0
2,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.37111,-0.056223,-0.019258,0,0
2,GO EXTRACELLULAR TRANSPORT,0.95582,-0.056329,-0.016346,0,0
2,GO MEMBRANE BIOGENESIS,0.57414,-0.056516,-0.011236,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.37964,-0.056557,-0.094711,0,0
2,GO PATTERN SPECIFICATION PROCESS,0.36271,-0.056615,-0.02004,0,0
2,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.20822,-0.056734,-0.11434,0,0
2,GO RESPONSE TO IMMOBILIZATION STRESS,0.69814,-0.056968,-0.016372,0,0
2,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.90549,-0.057146,0.025219,0,0
2,GO PROTEIN METHYLATION,0.3148,-0.057517,-0.072979,0,0
2,GO MIDBRAIN DEVELOPMENT,0.33029,-0.057567,-0.0099913,0,0
2,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.51122,-0.057707,-0.034258,0,0
2,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.7336,-0.057718,-0.019556,0,0
2,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.91805,-0.057861,0.026789,0,0
2,GO REGULATION OF MITOCHONDRIAL FUSION,0.46168,-0.057903,-0.016524,0,0
2,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.43329,-0.057904,-0.04846,0,0
2,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.34626,-0.057971,-0.059464,0,0
2,GO CORPUS CALLOSUM DEVELOPMENT,1,-0.058095,0.054108,0,0
2,GO NERVOUS SYSTEM PROCESS,0.52145,-0.058165,-0.004095,0,0
2,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.70989,-0.058425,-0.0043812,0,0
2,GO MITOTIC CELL CYCLE,0.20822,-0.058481,-0.074462,0,0
2,GO LEFT RIGHT PATTERN FORMATION,0.61803,-0.058563,-0.024388,0,0
2,GO SIGNAL RELEASE,0.56341,-0.058714,0.0016328,0,0
2,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.42405,-0.058839,-0.013751,0,0
2,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.88046,-0.058968,0.013299,0,0
2,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.18102,-0.05908,-0.070002,0,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.34626,-0.059198,-0.052563,0,0
2,GO REGULATION OF MEMBRANE REPOLARIZATION,0.66333,-0.059306,-0.00079871,0,0
2,GO ORGANELLE FUSION,0.13467,-0.059335,-0.031818,0,0
2,GO MITOTIC CYTOKINESIS,0.12662,-0.059452,-0.11168,0,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.40594,-0.059467,-0.027517,0,0
2,GO NEURON PROJECTION GUIDANCE,0.37111,-0.059776,-0.02347,0,0
2,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.80618,-0.059839,0.00094729,0,0
2,GO ENERGY HOMEOSTASIS,0.50109,-0.060092,-0.0081625,0,0
2,GO ASSOCIATIVE LEARNING,0.20822,-0.060158,-0.064496,0,0
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.91805,-0.06017,0.013706,0,0
2,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.65188,-0.060173,-0.015727,0,0
2,GO RESPONSE TO LEAD ION,0.60692,-0.060572,0.00012847,0,0
2,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.93062,-0.060653,0.042065,0,0
2,GO METHIONINE METABOLIC PROCESS,0.74555,-0.060763,-0.010388,0,0
2,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.72171,-0.060881,0.0030541,0,0
2,GO MEMBRANE DEPOLARIZATION,0.50109,-0.060884,-0.02791,0,0
2,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.41494,-0.060887,-0.014696,0,0
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.067497,-0.061051,-0.11059,0,0
2,GO PROTEIN INSERTION INTO MEMBRANE,0.23827,-0.061113,-0.029401,0,0
2,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.69814,-0.06129,-0.041469,0,0
2,GO RESPONSE TO ELECTRICAL STIMULUS,0.81845,-0.061302,-0.010093,0,0
2,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.17591,-0.061345,-0.11963,0,0
2,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.29248,-0.06137,-0.037327,0,0
2,GO REGULATION OF CENTROSOME CYCLE,0.1475,-0.06139,-0.13879,0,0
2,GO REGULATION OF SPINDLE CHECKPOINT,0.13885,-0.061476,-0.19455,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.54223,-0.061512,0.004097,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.3148,-0.061636,-0.038137,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.2259,-0.061727,-0.053456,0,0
2,GO OTIC VESICLE DEVELOPMENT,0.79394,-0.061806,0.02433,0,0
2,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.13885,-0.061889,-0.066034,0,0
2,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.61803,-0.062001,-0.0078238,0,0
2,GO REGULATION OF MITOPHAGY,0.55277,-0.06212,-0.012666,0,0
2,GO REGULATION OF PROTEIN FOLDING,0.094909,-0.062312,-0.058688,0,0
2,GO HISTONE MONOUBIQUITINATION,0.57414,-0.062755,-0.048169,0,0
2,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.26442,-0.062818,-0.070745,0,0
2,GO POTASSIUM ION HOMEOSTASIS,0.52145,-0.062833,-0.02971,0,0
2,GO FAT CELL PROLIFERATION,0.23827,-0.062958,-0.07995,0,0
2,GO PROTEIN FOLDING,0.13885,-0.063161,-0.028778,0,0
2,GO POSITIVE REGULATION OF CELL MATURATION,0.75756,-0.063501,0.0049811,0,0
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.15655,-0.063616,-0.074152,0,0
2,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.51122,-0.063921,0.0018864,0,0
2,GO PEPTIDYL LYSINE METHYLATION,0.34626,-0.06403,-0.070435,0,0
2,GO RESPONSE TO LEUCINE,0.18624,-0.064084,-0.12695,0,0
2,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.3148,-0.064373,-0.084679,0,0
2,GO HISTONE H2A UBIQUITINATION,0.42405,-0.064562,-0.057406,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.52145,-0.064722,-0.067636,0,0
2,GO OOCYTE DIFFERENTIATION,0.08588,-0.064792,-0.10876,0,0
2,GO CELL DIVISION,0.1306,-0.064937,-0.098611,0,0
2,GO TELOMERE CAPPING,0.4521,-0.065137,-0.045944,0,0
2,GO CELL CYCLE G2 M PHASE TRANSITION,0.11163,-0.065257,-0.10997,0,0
2,GO PROTEIN REFOLDING,0.33821,-0.065303,-0.060242,0,0
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.47137,-0.0654,-0.05039,0,0
2,GO NEUROGENESIS,0.27126,-0.065469,-0.02375,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.49108,-0.065697,-0.034833,0,0
2,GO METHIONINE BIOSYNTHETIC PROCESS,0.83078,-0.065722,0.011617,0,0
2,GO POSITIVE REGULATION OF EXOCYTOSIS,0.44264,-0.065753,-0.022105,0,0
2,GO TELENCEPHALON DEVELOPMENT,0.214,-0.065892,-0.057265,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.10468,-0.065989,-0.15881,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.74555,-0.066078,0.072221,0,0
2,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.54223,-0.066101,-0.017082,0,0
2,GO REGULATION OF ATPASE ACTIVITY,0.17091,-0.066385,-0.023273,0,0
2,GO RESPONSE TO ALKALOID,0.214,-0.066518,-0.037843,0,0
2,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.66333,-0.066573,-0.011342,0,0
2,GO IRON SULFUR CLUSTER ASSEMBLY,0.47137,-0.066722,-0.01878,0,0
2,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.85555,-0.066784,0.010871,0,0
2,GO VIRAL LATENCY,0.49108,-0.066847,-0.071243,0,0
2,GO REGIONALIZATION,0.34626,-0.067018,-0.021164,0,0
2,GO CARNITINE METABOLIC PROCESS,0.69814,-0.067154,0.0076838,0,0
2,GO COVALENT CHROMATIN MODIFICATION,0.46168,-0.0674,-0.036824,0,0
2,GO NEUROBLAST PROLIFERATION,0.197,-0.06744,-0.094011,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.2998,-0.067458,-0.047387,0,0
2,GO CELL PROJECTION ASSEMBLY,0.56341,-0.067551,-0.0039306,0,0
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.17091,-0.067651,-0.078422,0,0
2,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.33821,-0.067706,-0.088574,0,0
2,GO MRNA EXPORT FROM NUCLEUS,0.33821,-0.068436,-0.06669,0,0
2,GO RESPONSE TO MISFOLDED PROTEIN,0.34626,-0.068592,0.0011479,0,0
2,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.33029,-0.068639,-0.097804,0,0
2,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.86799,-0.068747,0.017664,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.85555,-0.068774,0.013341,0,0
2,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.36271,-0.068809,-0.032042,0,0
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.98106,-0.068964,0.016372,0,0
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.80618,-0.068971,-0.0083622,0,0
2,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.20822,-0.069194,-0.081462,0,0
2,GO ORGANELLE INHERITANCE,0.7336,-0.069261,-0.0077462,0,0
2,GO CARDIAC CHAMBER FORMATION,0.55277,-0.069308,-0.066444,0,0
2,GO NCRNA TRANSCRIPTION,0.37964,-0.069343,-0.046447,0,0
2,GO ACTION POTENTIAL,0.27126,-0.069527,-0.039556,0,0
2,GO DNA LIGATION,0.16602,-0.069532,-0.12506,0,0
2,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.10134,-0.069566,-0.042241,0,0
2,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.54223,-0.069922,-0.092414,0,0
2,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.32248,-0.069937,-0.082004,0,0
2,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.43329,-0.070238,-0.084834,0,0
2,GO SENSORY PERCEPTION OF PAIN,0.99368,-0.070257,0.03794,0,0
2,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.36271,-0.070511,-0.13265,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.29248,-0.070531,-0.070742,0,0
2,GO G0 TO G1 TRANSITION,0.35442,-0.070536,-0.10492,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.58498,-0.070576,-0.030808,0,0
2,GO REGULATION OF NEURON MIGRATION,0.29248,-0.070876,-0.090253,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.33029,-0.071065,-0.056903,0,0
2,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.15655,-0.071065,-0.05497,0,0
2,GO ATP TRANSPORT,0.25111,-0.071092,-0.032033,0,0
2,GO AXON DEVELOPMENT,0.2577,-0.071118,-0.047241,0,0
2,GO PURINE NUCLEOTIDE TRANSPORT,0.17591,-0.071189,-0.035634,0,0
2,GO REPLICATION FORK PROCESSING,0.39705,-0.071227,-0.11867,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.50109,-0.071243,-0.013523,0,0
2,GO SKELETAL MUSCLE ADAPTATION,0.62923,-0.071463,-0.015097,0,0
2,GO SINGLE FERTILIZATION,0.10811,-0.071476,-0.062437,0,0
2,GO DEVELOPMENTAL MATURATION,0.57414,-0.071618,-0.0051961,0,0
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.93062,-0.071637,0.046673,0,0
2,GO SCHWANN CELL DEVELOPMENT,0.66333,-0.07167,-0.011783,0,0
2,GO HISTONE METHYLATION,0.29248,-0.071697,-0.075237,0,0
2,GO BRAIN MORPHOGENESIS,0.39705,-0.071802,-0.062851,0,0
2,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,1,-0.071948,0.024425,0,0
2,GO HISTONE UBIQUITINATION,0.34626,-0.071955,-0.071411,0,0
2,GO MITOCHONDRIAL TRANSCRIPTION,0.41494,-0.072296,-0.057545,0,0
2,GO NEUROTRANSMITTER REUPTAKE,0.36271,-0.072402,-0.062196,0,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.49108,-0.072706,-0.070848,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.56341,-0.072908,-0.0096926,0,0
2,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.41494,-0.07303,0.010009,0,0
2,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.2259,-0.073038,-0.10718,0,0
2,GO CHROMOSOME ORGANIZATION,0.18624,-0.073118,-0.092648,0,0
2,GO DOSAGE COMPENSATION,0.30724,-0.073153,-0.078346,0,0
2,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.39705,-0.073402,-0.020998,0,0
2,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.42405,-0.073462,-0.045562,0,0
2,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.72171,-0.073736,0.011868,0,0
2,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.2998,-0.073907,-0.056203,0,0
2,GO DETECTION OF VISIBLE LIGHT,0.1306,-0.074212,-0.076249,0,0
2,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.43329,-0.074222,-0.010171,0,0
2,GO REGULATION OF MRNA 3 END PROCESSING,0.27126,-0.074587,-0.059992,0,0
2,GO SNRNA TRANSCRIPTION,0.52145,-0.074623,-0.031723,0,0
2,GO COENZYME A METABOLIC PROCESS,0.17091,-0.074697,-0.05632,0,0
2,GO RECOMBINATIONAL REPAIR,0.19156,-0.074699,-0.13086,0,0
2,GO HISTONE H3 DEACETYLATION,0.51122,-0.074849,-0.027595,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.15655,-0.074938,-0.07344,0,0
2,GO REGULATION OF NEURON DIFFERENTIATION,0.19156,-0.075196,-0.051029,0,0
2,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.37111,-0.075234,-0.07869,0,0
2,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.18102,-0.075279,-0.059997,0,0
2,GO POSITIVE REGULATION OF VESICLE FUSION,0.35442,-0.075469,-0.045351,0,0
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.18624,-0.07624,-0.14406,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.50109,-0.076275,-0.015349,0,0
2,GO POSITIVE REGULATION OF CYTOKINESIS,0.18102,-0.076393,-0.13629,0,0
2,GO PROTEIN ACETYLATION,0.30724,-0.076533,-0.045229,0,0
2,GO POSITIVE REGULATION OF BEHAVIOR,0.60692,-0.076533,-0.030006,0,0
2,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.80618,-0.076645,0.038274,0,0
2,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.15655,-0.076782,-0.12759,0,0
2,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.28529,-0.076849,-0.093976,0,0
2,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.5959,-0.076875,-0.068052,0,0
2,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.33029,-0.076878,-0.031468,0,0
2,GO PROTEIN HETEROTETRAMERIZATION,0.32248,-0.077133,-0.0576,0,0
2,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.08303,-0.077585,-0.21078,0,0
2,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.83078,-0.077642,-0.020811,0,0
2,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.11894,-0.077752,-0.12289,0,0
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.4521,-0.077907,-0.053029,0,0
2,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.30724,-0.078212,-0.0088546,0,0
2,GO HEART INDUCTION,0.62923,-0.078506,0.0016105,0,0
2,GO NON RECOMBINATIONAL REPAIR,0.3148,-0.078724,-0.060132,0,0
2,GO OXIDATIVE PHOSPHORYLATION,0.021265,-0.078811,-0.092112,0,0
2,GO EMBRYONIC AXIS SPECIFICATION,0.21989,-0.078929,-0.078659,0,0
2,GO CHROMATIN ORGANIZATION,0.27126,-0.078988,-0.066834,0,0
2,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.10468,-0.07903,-0.15963,0,0
2,GO RESPONSE TO PAIN,0.60692,-0.079402,-0.024772,0,0
2,GO NADH METABOLIC PROCESS,0.26442,-0.079459,-0.050643,0,0
2,GO RECEPTOR CLUSTERING,0.58498,-0.07963,-0.013497,0,0
2,GO VENTRICULAR SYSTEM DEVELOPMENT,0.21989,-0.079679,-0.056763,0,0
2,GO NUCLEOTIDE TRANSPORT,0.43329,-0.079849,-0.008359,0,0
2,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.17091,-0.080608,-0.053774,0,0
2,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.43329,-0.08063,-0.039637,0,0
2,GO INTRA S DNA DAMAGE CHECKPOINT,0.23203,-0.080968,-0.10254,0,0
2,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.23203,-0.080969,-0.087919,0,0
2,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.25111,-0.081133,-0.051432,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.2577,-0.081223,-0.10859,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.20822,-0.081256,-0.06412,0,0
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.41494,-0.081317,-0.035627,0,0
2,GO MONOVALENT INORGANIC CATION TRANSPORT,0.32248,-0.081324,-0.032132,0,0
2,GO NEURAL PRECURSOR CELL PROLIFERATION,0.2259,-0.081703,-0.055431,0,0
2,GO EXPORT ACROSS PLASMA MEMBRANE,0.50109,-0.081754,-0.012133,0,0
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.38829,-0.081793,-0.076203,0,0
2,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.49108,-0.081818,0.00052364,0,0
2,GO LIMBIC SYSTEM DEVELOPMENT,0.13885,-0.081995,-0.06994,0,0
2,GO SULFATE TRANSPORT,0.17091,-0.082011,-0.096933,0,0
2,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.33821,-0.082033,-0.053692,0,0
2,GO REGULATION OF HISTONE UBIQUITINATION,0.24463,-0.082178,-0.067656,0,0
2,GO CRISTAE FORMATION,0.26442,-0.082244,-0.050591,0,0
2,GO PEPTIDYL ARGININE MODIFICATION,0.86799,-0.082261,0.012464,0,0
2,GO DOUBLE STRAND BREAK REPAIR,0.23203,-0.082427,-0.11174,0,0
2,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.86799,-0.082493,0.026442,0,0
2,GO RNA 3 END PROCESSING,0.34626,-0.082663,-0.068474,0,0
2,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.17591,-0.083252,-0.12051,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.072385,-0.083297,-0.081546,0,0
2,GO RNA POLYADENYLATION,0.43329,-0.083909,-0.036023,0,0
2,GO PEPTIDYL LYSINE ACETYLATION,0.3148,-0.083929,-0.043562,0,0
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.015776,-0.083975,-0.093313,0,0
2,GO CHROMATIN REMODELING,0.214,-0.084006,-0.10845,0,0
2,GO LEYDIG CELL DIFFERENTIATION,0.85555,-0.084168,-0.0050893,0,0
2,GO DENDRITIC SPINE DEVELOPMENT,0.24463,-0.084218,-0.076117,0,0
2,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.32248,-0.084898,-0.044184,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.3148,-0.08508,-0.034502,0,0
2,GO RESPONSE TO REDOX STATE,0.39705,-0.085405,-0.04594,0,0
2,GO MRNA 3 END PROCESSING,0.28529,-0.085507,-0.076361,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.16123,-0.085582,-0.11623,0,0
2,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.25111,-0.08584,-0.085339,0,0
2,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.2577,-0.085947,-0.05251,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.14312,-0.086104,-0.073117,0,0
2,GO PROTEIN ACYLATION,0.20822,-0.086128,-0.067168,0,0
2,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.26442,-0.086227,-0.10551,0,0
2,GO STRIATUM DEVELOPMENT,0.93062,-0.086244,0.029692,0,0
2,GO CELL PROJECTION ORGANIZATION,0.3148,-0.086556,-0.023734,0,0
2,GO PROTEIN NEDDYLATION,0.11163,-0.086572,-0.071404,0,0
2,GO CEREBRAL CORTEX CELL MIGRATION,0.17091,-0.086785,-0.11246,0,0
2,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.39705,-0.08684,-0.046695,0,0
2,GO ANATOMICAL STRUCTURE REGRESSION,0.68646,-0.087072,-0.012547,0,0
2,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.091819,-0.087102,-0.064726,0,0
2,GO NUCLEUS LOCALIZATION,0.43329,-0.087229,-0.046195,0,0
2,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.41494,-0.087417,-0.020624,0,0
2,GO PROTEIN O LINKED MANNOSYLATION,0.57414,-0.087938,-0.049365,0,0
2,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.072385,-0.08796,-0.20996,0,0
2,GO DNA DEPENDENT DNA REPLICATION,0.14312,-0.088024,-0.16993,0,0
2,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.4521,-0.088114,-0.037092,0,0
2,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.43329,-0.088251,-0.062723,0,0
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.18624,-0.08826,-0.06311,0,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.20256,-0.088263,-0.09595,0,0
2,GO N GLYCAN PROCESSING,0.85555,-0.088426,0.058484,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.28529,-0.0885,-0.092194,0,0
2,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.33029,-0.088512,-0.046358,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.34626,-0.088558,-0.059693,0,0
2,GO SNARE COMPLEX ASSEMBLY,0.17591,-0.0889,-0.059702,0,0
2,GO CELL PART MORPHOGENESIS,0.1306,-0.089253,-0.073354,0,0
2,GO RESPONSE TO NERVE GROWTH FACTOR,0.091819,-0.089259,-0.088676,0,0
2,GO DNA GEOMETRIC CHANGE,0.17091,-0.089374,-0.1313,0,0
2,GO HINDBRAIN MORPHOGENESIS,0.197,-0.089395,-0.066899,0,0
2,GO CAMERA TYPE EYE MORPHOGENESIS,0.65188,-0.089433,0.0090486,0,0
2,GO REGULATION OF TRANSLATIONAL FIDELITY,0.34626,-0.089526,-0.077238,0,0
2,GO HIPPOCAMPUS DEVELOPMENT,0.18624,-0.089708,-0.077688,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.022172,-0.089799,-0.066644,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.15197,-0.089828,-0.066277,0,0
2,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,0.3148,-0.090024,-0.064778,0,0
2,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.43329,-0.09031,-0.039346,0,0
2,GO RESPONSE TO GLUCAGON,0.30724,-0.090342,-0.064221,0,0
2,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.14312,-0.090371,-0.059608,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.11163,-0.090453,-0.14675,0,0
2,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.197,-0.090988,-0.053114,0,0
2,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.21989,-0.091113,-0.046377,0,0
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.84314,-0.091124,0.0056592,0,0
2,GO REGULATION OF AXONOGENESIS,0.30724,-0.091236,-0.052754,0,0
2,GO CRANIAL NERVE DEVELOPMENT,0.42405,-0.091292,-0.073958,0,0
2,GO BEHAVIOR,0.214,-0.091459,-0.056653,0,0
2,GO MECHANORECEPTOR DIFFERENTIATION,0.17091,-0.091526,-0.059277,0,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.32248,-0.0917,-0.04783,0,0
2,GO REGULATION OF POTASSIUM ION TRANSPORT,0.20256,-0.09177,-0.050627,0,0
2,GO NUCLEAR MIGRATION,0.37111,-0.091818,-0.04942,0,0
2,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.17091,-0.091835,-0.15678,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.2259,-0.091945,-0.07624,0,0
2,GO GLUCOSE CATABOLIC PROCESS,0.35442,-0.092131,-0.044824,0,0
2,GO CELLULAR COMPONENT MORPHOGENESIS,0.18102,-0.092422,-0.056136,0,0
2,GO CHROMATIN SILENCING,0.11524,-0.092557,-0.12826,0,0
2,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.24463,-0.092562,-0.0629,0,0
2,GO REGULATION OF MRNA BINDING,0.12662,-0.092711,-0.076232,0,0
2,GO CHROMOSOME SEPARATION,0.074935,-0.092725,-0.21307,0,0
2,GO NEURON DIFFERENTIATION,0.18102,-0.092728,-0.053598,0,0
2,GO LEARNING,0.1475,-0.092859,-0.10885,0,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.1475,-0.093045,-0.10542,0,0
2,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.2577,-0.09323,-0.04303,0,0
2,GO UBIQUINONE METABOLIC PROCESS,0.38829,-0.093251,-0.043426,0,0
2,GO CENTROSOME DUPLICATION,0.074935,-0.093336,-0.1659,0,0
2,GO DNA REPLICATION,0.1475,-0.093404,-0.13482,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.3148,-0.093419,-0.07853,0,0
2,GO MALE SEX DETERMINATION,0.2259,-0.09347,-0.14686,0,0
2,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.2577,-0.093655,-0.085756,0,0
2,GO SMOOTHENED SIGNALING PATHWAY,0.35442,-0.093716,-0.036659,0,0
2,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.42405,-0.093996,-0.039008,0,0
2,GO OLIGODENDROCYTE DIFFERENTIATION,0.33821,-0.094007,-0.039192,0,0
2,GO POLYOL CATABOLIC PROCESS,0.10468,-0.094301,-0.09741,0,0
2,GO POSTREPLICATION REPAIR,0.12662,-0.094359,-0.095323,0,0
2,GO DNA REPAIR,0.18102,-0.094585,-0.10468,0,0
2,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.40594,-0.094596,-0.0044785,0,0
2,GO HEAD DEVELOPMENT,0.13885,-0.094942,-0.065426,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.25111,-0.095494,-0.105,0,0
2,GO SEX DETERMINATION,0.36271,-0.095732,-0.080591,0,0
2,GO RESPONSE TO CATECHOLAMINE,0.08303,-0.096317,-0.074183,0,0
2,GO NUCLEAR BODY ORGANIZATION,0.080256,-0.096352,-0.096045,0,0
2,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.27126,-0.096434,-0.1228,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.66333,-0.096627,-0.007192,0,0
2,GO PROTEIN K11 LINKED UBIQUITINATION,0.10134,-0.096876,-0.09051,0,0
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.93062,-0.096911,-0.00093234,0,0
2,GO REGULATION OF CARDIAC CONDUCTION,0.68646,-0.097131,0.0032482,0,0
2,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.10134,-0.097432,-0.11273,0,0
2,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.33029,-0.097959,-0.045114,0,0
2,GO WALKING BEHAVIOR,0.074935,-0.098016,-0.12641,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.08303,-0.098112,-0.17979,0,0
2,GO MOTILE CILIUM ASSEMBLY,0.18102,-0.098141,-0.16428,0,0
2,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.23203,-0.098268,-0.068191,0,0
2,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.42405,-0.098341,-0.069285,0,0
2,GO POSITIVE REGULATION OF DNA REPAIR,0.11163,-0.098367,-0.097389,0,0
2,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.08303,-0.098499,-0.11457,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.15655,-0.098601,-0.048128,0,0
2,GO EXIT FROM MITOSIS,0.065157,-0.098947,-0.16532,0,0
2,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.15197,-0.099142,-0.22071,0,0
2,GO SUBSTANTIA NIGRA DEVELOPMENT,0.056456,-0.099206,-0.092329,0,0
2,GO STRESS GRANULE ASSEMBLY,0.25111,-0.099451,-0.058703,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.21989,-0.099588,-0.097103,0,0
2,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.038848,-0.099637,-0.088062,0,0
2,GO HISTONE H4 K16 ACETYLATION,0.2259,-0.099643,-0.10488,0,0
2,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.3148,-0.099806,-0.084239,0,0
2,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.15197,-0.099818,-0.098043,0,0
2,GO SNRNA METABOLIC PROCESS,0.52145,-0.099903,-0.037266,0,0
2,GO NEURON DEVELOPMENT,0.14312,-0.099943,-0.059639,0,0
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.52145,-0.10014,-0.058933,0,0
2,GO REGULATION OF DNA REPLICATION,0.1475,-0.10059,-0.11389,0,0
2,GO HISTONE H3 K9 TRIMETHYLATION,0.35442,-0.10073,-0.071588,0,0
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.30724,-0.10099,-0.04994,0,0
2,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.24463,-0.101,-0.029641,0,0
2,GO CYTOKINESIS,0.048745,-0.10105,-0.13154,0,0
2,GO POSTSYNAPSE ORGANIZATION,0.080256,-0.10107,-0.10794,0,0
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.040368,-0.10145,-0.090707,0,0
2,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.1306,-0.10183,-0.12414,0,0
2,GO REGULATION OF NUCLEAR DIVISION,0.040368,-0.10209,-0.12638,0,0
2,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0057394,-0.10216,-0.13169,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.197,-0.10237,-0.070632,0,0
2,GO NEURON PROJECTION ORGANIZATION,0.16602,-0.10257,-0.070004,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.21989,-0.10269,-0.1562,0,0
2,GO ACROSOME REACTION,0.14312,-0.10348,-0.07893,0,0
2,GO SPINDLE LOCALIZATION,0.077559,-0.10363,-0.14571,0,0
2,GO ENDOCRINE PANCREAS DEVELOPMENT,0.1475,-0.10381,-0.069325,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.19156,-0.10397,-0.062789,0,0
2,GO NEUROTRANSMITTER UPTAKE,0.35442,-0.10409,-0.043411,0,0
2,GO REGULATION OF EXOCYTOSIS,0.34626,-0.10416,-0.031001,0,0
2,GO BRANCHING MORPHOGENESIS OF A NERVE,0.34626,-0.10437,-0.080781,0,0
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.025096,-0.10518,-0.10657,0,0
2,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.1306,-0.1053,-0.12331,0,0
2,GO CARDIAC CONDUCTION,0.3148,-0.10534,-0.046311,0,0
2,GO RESPONSE TO FOOD,0.10468,-0.10545,-0.13115,0,0
2,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.48117,-0.10551,-0.03685,0,0
2,GO PROTEIN DEPOLYMERIZATION,0.074935,-0.10552,-0.063085,0,0
2,GO CELL DIFFERENTIATION IN HINDBRAIN,0.23203,-0.10572,-0.093801,0,0
2,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.24463,-0.10601,-0.058909,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.12273,-0.10613,-0.093616,0,0
2,GO CHAPERONE MEDIATED AUTOPHAGY,0.70989,-0.10623,-0.0043994,0,0
2,GO REGULATION OF HORMONE SECRETION,0.24463,-0.1064,-0.040541,0,0
2,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.11894,-0.10644,-0.11207,0,0
2,GO OOCYTE MATURATION,0.13467,-0.10647,-0.13465,0,0
2,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.021265,-0.10675,-0.12962,0,0
2,GO MALE MEIOSIS I,0.10134,-0.10698,-0.14901,0,0
2,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.20822,-0.10736,-0.04974,0,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.18624,-0.10744,-0.066924,0,0
2,GO FOREBRAIN DEVELOPMENT,0.11894,-0.10815,-0.083288,0,0
2,GO MITOTIC RECOMBINATION,0.43329,-0.1083,-0.057615,0,0
2,GO PEPTIDYL CYSTEINE MODIFICATION,0.16123,-0.10833,-0.073885,0,0
2,GO AXIS SPECIFICATION,0.14312,-0.10873,-0.08007,0,0
2,GO FEAR RESPONSE,0.1306,-0.10876,-0.10564,0,0
2,GO REGULATION OF MRNA POLYADENYLATION,0.17091,-0.10887,-0.075609,0,0
2,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.24463,-0.10918,-0.10401,0,0
2,GO REGULATION OF RNA BINDING,0.17091,-0.10942,-0.091046,0,0
2,GO HISTONE H3 K36 METHYLATION,0.16602,-0.10963,-0.13028,0,0
2,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.12662,-0.1097,-0.12117,0,0
2,GO LOOP OF HENLE DEVELOPMENT,0.61803,-0.1097,-0.073048,0,0
2,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.18624,-0.10971,-0.05478,0,0
2,GO REGULATION OF DNA REPAIR,0.13467,-0.10988,-0.097752,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.045233,-0.10996,-0.1842,0,0
2,GO PALLIUM DEVELOPMENT,0.091819,-0.11029,-0.10766,0,0
2,GO PROTEIN KINASE C SIGNALING,0.81845,-0.11034,0.079503,0,0
2,GO HORMONE TRANSPORT,0.19156,-0.11059,-0.047424,0,0
2,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.32248,-0.11064,-0.08197,0,0
2,GO ORGANELLE ASSEMBLY,0.18102,-0.11064,-0.057659,0,0
2,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.1475,-0.11073,-0.098533,0,0
2,GO DNA CONFORMATION CHANGE,0.10468,-0.1111,-0.15041,0,0
2,GO CENTRIOLE ASSEMBLY,0.12273,-0.11198,-0.15059,0,0
2,GO REGULATION OF CENTRIOLE REPLICATION,0.1475,-0.1121,-0.14937,0,0
2,GO REGULATION OF CIRCADIAN RHYTHM,0.17091,-0.11246,-0.074625,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.18624,-0.1127,-0.075544,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.080256,-0.11298,-0.087552,0,0
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.62923,-0.11326,-0.027536,0,0
2,GO RNA CAPPING,0.14312,-0.11333,-0.079698,0,0
2,GO MITOCHONDRION DISTRIBUTION,0.23203,-0.11343,-0.061412,0,0
2,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.50109,-0.11379,-0.024662,0,0
2,GO DENDRITE DEVELOPMENT,0.098083,-0.11381,-0.10722,0,0
2,GO PROTEIN LOCALIZATION TO CHROMATIN,0.16123,-0.11388,-0.15632,0,0
2,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.65188,-0.1139,-0.021628,0,0
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.37111,-0.114,-0.027283,0,0
2,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.14312,-0.11407,-0.08711,0,0
2,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.17091,-0.11411,-0.074736,0,0
2,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.55277,-0.11423,-0.027091,0,0
2,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.11894,-0.1149,-0.11951,0,0
2,GO CHROMATIN DISASSEMBLY,0.81845,-0.11492,-0.0070947,0,0
2,GO HISTONE H4 ACETYLATION,0.18102,-0.11534,-0.078367,0,0
2,GO COCHLEA DEVELOPMENT,0.23827,-0.11541,-0.071511,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.14312,-0.11618,-0.14221,0,0
2,GO MITOTIC METAPHASE PLATE CONGRESSION,0.016475,-0.1162,-0.21651,0,0
2,GO ORGANELLE FISSION,0.052482,-0.11642,-0.15097,0,0
2,GO ACROSOME ASSEMBLY,0.24463,-0.11698,-0.12773,0,0
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.28529,-0.11722,-0.072477,0,0
2,GO SINGLE STRAND BREAK REPAIR,0.11894,-0.11729,-0.10873,0,0
2,GO HISTONE H2A MONOUBIQUITINATION,0.197,-0.11754,-0.10504,0,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.16602,-0.11769,-0.083392,0,0
2,GO MRNA PROCESSING,0.17591,-0.11773,-0.08299,0,0
2,GO LYSINE METABOLIC PROCESS,0.50109,-0.11782,-0.064316,0,0
2,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.16602,-0.11808,-0.052574,0,0
2,GO SYNAPTIC TRANSMISSION GABAERGIC,0.08588,-0.11824,-0.10916,0,0
2,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.4521,-0.11845,-0.066716,0,0
2,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.48117,-0.11856,-0.076653,0,0
2,GO RESPONSE TO NICOTINE,0.33029,-0.11883,-0.074036,0,0
2,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.3148,-0.11936,-0.05152,0,0
2,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.10468,-0.11946,-0.1081,0,0
2,GO EPITHELIAL CELL MATURATION,0.10811,-0.11948,-0.1769,0,0
2,GO NEURAL CREST FORMATION,0.99368,-0.11974,0.033356,0,0
2,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.11163,-0.11998,-0.1026,0,0
2,GO COMMISSURAL NEURON AXON GUIDANCE,0.26442,-0.12003,-0.12728,0,0
2,GO NEUROTRANSMITTER METABOLIC PROCESS,0.55277,-0.12039,-0.042898,0,0
2,GO DEVELOPMENTAL CELL GROWTH,0.23203,-0.12044,-0.053739,0,0
2,GO VISUAL BEHAVIOR,0.12662,-0.12052,-0.080586,0,0
2,GO MAINTENANCE OF ORGANELLE LOCATION,0.3148,-0.12055,-0.09407,0,0
2,GO BASE EXCISION REPAIR,0.16123,-0.12066,-0.1274,0,0
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.14312,-0.12072,-0.10742,0,0
2,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.20822,-0.12082,-0.11896,0,0
2,GO CELLULAR COMPONENT MAINTENANCE,0.18102,-0.121,-0.071064,0,0
2,GO CHROMOSOME LOCALIZATION,0.034576,-0.12142,-0.18888,0,0
2,GO TRANSLESION SYNTHESIS,0.1475,-0.12184,-0.091626,0,0
2,GO CENTROSOME SEPARATION,0.13885,-0.12192,-0.20075,0,0
2,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.27126,-0.12194,-0.092641,0,0
2,GO REGULATION OF DENDRITE DEVELOPMENT,0.08303,-0.12195,-0.10519,0,0
2,GO CATECHOLAMINE METABOLIC PROCESS,0.27821,-0.12195,-0.055597,0,0
2,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.20256,-0.12205,-0.069989,0,0
2,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.15197,-0.12269,-0.13337,0,0
2,GO EXCITATORY SYNAPSE ASSEMBLY,0.13467,-0.12278,-0.15716,0,0
2,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.13467,-0.12296,-0.099773,0,0
2,GO CELL FATE SPECIFICATION,0.094909,-0.12386,-0.12611,0,0
2,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.4521,-0.12423,-0.013382,0,0
2,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.43329,-0.1245,-0.046785,0,0
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.13885,-0.12462,-0.10096,0,0
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.19156,-0.12495,-0.098704,0,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.02951,-0.12515,-0.14773,0,0
2,GO SPERM AXONEME ASSEMBLY,0.29248,-0.12521,-0.08969,0,0
2,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.050584,-0.12525,-0.15773,0,0
2,GO CEREBRAL CORTEX DEVELOPMENT,0.069906,-0.12549,-0.1354,0,0
2,GO RNA SPLICING,0.16123,-0.12563,-0.08485,0,0
2,GO REGULATION OF EXIT FROM MITOSIS,0.045233,-0.12583,-0.21939,0,0
2,GO REGULATION OF INSULIN SECRETION,0.1475,-0.12592,-0.052638,0,0
2,GO SUBPALLIUM DEVELOPMENT,0.18624,-0.12609,-0.11695,0,0
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.033245,-0.12623,-0.13834,0,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.014457,-0.12626,-0.13794,0,0
2,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.20256,-0.12697,-0.13912,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.214,-0.12814,-0.067482,0,0
2,GO REGULATION OF PROTEIN GLYCOSYLATION,0.23827,-0.12837,-0.098507,0,0
2,GO OLFACTORY LOBE DEVELOPMENT,0.75756,-0.1284,-0.0015728,0,0
2,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.18624,-0.12881,-0.062292,0,0
2,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.37111,-0.12912,-0.066071,0,0
2,GO TELENCEPHALON GLIAL CELL MIGRATION,0.094909,-0.1299,-0.14008,0,0
2,GO RESPONSE TO L GLUTAMATE,0.26442,-0.13035,-0.091748,0,0
2,GO OPTIC NERVE DEVELOPMENT,0.17091,-0.13043,-0.2077,0,0
2,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.08303,-0.13075,-0.15229,0,0
2,GO HISTONE H3 K9 DEMETHYLATION,0.23827,-0.1311,-0.098963,0,0
2,GO PROTEIN MANNOSYLATION,0.28529,-0.13181,-0.081887,0,0
2,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.17091,-0.13181,-0.084603,0,0
2,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.2259,-0.13269,-0.081123,0,0
2,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0172,-0.13286,-0.18909,0,0
2,GO BEHAVIORAL RESPONSE TO COCAINE,0.17091,-0.13289,-0.15655,0,0
2,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.12273,-0.13307,-0.097965,0,0
2,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.48117,-0.13348,-0.052059,0,0
2,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.12662,-0.13368,-0.10357,0,0
2,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.14312,-0.13388,-0.16744,0,0
2,GO CHEMOSENSORY BEHAVIOR,0.35442,-0.13412,-0.082507,0,0
2,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.069906,-0.13414,-0.15506,0,0
2,GO CARDIAC VENTRICLE FORMATION,0.30724,-0.13425,-0.13443,0,0
2,GO MITOTIC NUCLEAR DIVISION,0.048745,-0.13428,-0.17405,0,0
2,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.1306,-0.13447,-0.10976,0,0
2,GO MISMATCH REPAIR,0.10811,-0.13533,-0.12761,0,0
2,GO POSITIVE REGULATION OF RNA SPLICING,0.077559,-0.13553,-0.11672,0,0
2,GO HAIR CELL DIFFERENTIATION,0.2577,-0.13589,-0.050942,0,0
2,GO METAPHASE PLATE CONGRESSION,0.033245,-0.13592,-0.21055,0,0
2,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.25111,-0.13603,-0.072345,0,0
2,GO CENTRIOLE CENTRIOLE COHESION,0.11524,-0.13615,-0.19746,0,0
2,GO NEURON PROJECTION EXTENSION,0.18102,-0.13616,-0.068864,0,0
2,GO ENDOCRINE SYSTEM DEVELOPMENT,0.058535,-0.13658,-0.10737,0,0
2,GO REGULATION OF RNA SPLICING,0.15197,-0.13688,-0.078902,0,0
2,GO HISTONE H3 K27 METHYLATION,0.2577,-0.13725,-0.1279,0,0
2,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.11894,-0.13774,-0.11988,0,0
2,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.091819,-0.13797,-0.13043,0,0
2,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.094909,-0.1383,-0.11534,0,0
2,GO NEURON RECOGNITION,0.214,-0.13909,-0.10217,0,0
2,GO HINDBRAIN DEVELOPMENT,0.15655,-0.1393,-0.080659,0,0
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.13885,-0.13936,-0.09615,0,0
2,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.02951,-0.13976,-0.15919,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0042727,-0.14007,-0.20139,0,0
2,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.15655,-0.14035,-0.098279,0,0
2,GO DENDRITIC SPINE MORPHOGENESIS,0.10134,-0.14052,-0.13639,0,0
2,GO GASTRULATION WITH MOUTH FORMING SECOND,0.39705,-0.14052,-0.051678,0,0
2,GO CEREBELLAR CORTEX MORPHOGENESIS,0.10134,-0.14055,-0.12852,0,0
2,GO MULTICELLULAR ORGANISMAL SIGNALING,0.1306,-0.14123,-0.080151,0,0
2,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.13885,-0.14152,-0.076855,0,0
2,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.15655,-0.14251,-0.13958,0,0
2,GO REGULATION OF CELL CYCLE CHECKPOINT,0.27821,-0.1426,-0.13528,0,0
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.10811,-0.14268,-0.10742,0,0
2,GO PROTEIN DENEDDYLATION,0.0172,-0.14279,-0.11086,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.13885,-0.143,-0.16204,0,0
2,GO AMINE BIOSYNTHETIC PROCESS,0.46168,-0.14329,-0.035612,0,0
2,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.074935,-0.14336,-0.1699,0,0
2,GO REGULATION OF CAMP MEDIATED SIGNALING,0.19156,-0.1438,-0.071983,0,0
2,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.18624,-0.14404,-0.12795,0,0
2,GO INCLUSION BODY ASSEMBLY,0.074935,-0.1444,-0.04478,0,0
2,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.20822,-0.1459,-0.13393,0,0
2,GO INTERSTRAND CROSS LINK REPAIR,0.13885,-0.14633,-0.16833,0,0
2,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.062884,-0.14667,-0.098503,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.10134,-0.14672,-0.11759,0,0
2,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.18102,-0.14729,-0.12307,0,0
2,GO REGULATION OF HELICASE ACTIVITY,0.15197,-0.14764,-0.12549,0,0
2,GO PANCREAS DEVELOPMENT,0.10811,-0.14845,-0.085958,0,0
2,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.10811,-0.1501,-0.22699,0,0
2,GO REGULATION OF CILIUM ASSEMBLY,0.11524,-0.1502,-0.12922,0,0
2,GO AMINO ACID TRANSPORT,0.17091,-0.15034,-0.055506,0,0
2,GO MICROTUBULE ANCHORING AT CENTROSOME,0.19156,-0.15068,-0.13822,0,0
2,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.10134,-0.15137,-0.10873,0,0
2,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.027226,-0.15237,-0.16719,0,0
2,GO MITOCHONDRIAL GENOME MAINTENANCE,0.25111,-0.15243,-0.070048,0,0
2,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.17091,-0.15317,-0.063374,0,0
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.08303,-0.15327,-0.10674,0,0
2,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.014457,-0.15425,-0.17862,0,0
2,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.25111,-0.15426,-0.13335,0,0
2,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.39705,-0.15435,-0.044613,0,0
2,GO PEPTIDYL ARGININE METHYLATION,0.098083,-0.1549,-0.11386,0,0
2,GO OLIGODENDROCYTE DEVELOPMENT,0.08303,-0.15525,-0.10537,0,0
2,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.13467,-0.15606,-0.13644,0,0
2,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.067497,-0.15632,-0.13286,0,0
2,GO NEGATIVE REGULATION OF GLIOGENESIS,0.24463,-0.15702,-0.071632,0,0
2,GO RESPONSE TO POTASSIUM ION,0.077559,-0.15705,-0.22523,0,0
2,GO MEIOTIC CHROMOSOME SEGREGATION,0.018736,-0.15819,-0.27934,0,0
2,GO INNER DYNEIN ARM ASSEMBLY,0.197,-0.15855,-0.2036,0,0
2,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.41494,-0.15888,-0.0883,0,0
2,GO POTASSIUM ION TRANSPORT,0.1306,-0.15954,-0.081639,0,0
2,GO REGULATION OF COLLATERAL SPROUTING,0.15655,-0.15968,-0.14165,0,0
2,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.15197,-0.1611,-0.085974,0,0
2,GO MICROTUBULE ANCHORING,0.1475,-0.16164,-0.114,0,0
2,GO REGULATION OF OOGENESIS,0.080256,-0.16207,-0.10627,0,0
2,GO GLUTAMATE METABOLIC PROCESS,0.13467,-0.16219,-0.075995,0,0
2,GO PHOTORECEPTOR CELL MAINTENANCE,0.11524,-0.16418,-0.12676,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.68646,-0.16455,0.034537,0,0
2,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.11894,-0.16461,-0.10639,0,0
2,GO DORSAL VENTRAL AXIS SPECIFICATION,0.3148,-0.16463,-0.07786,0,0
2,GO HYPOTHALAMUS DEVELOPMENT,0.12273,-0.16553,-0.11154,0,0
2,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.214,-0.16609,-0.061768,0,0
2,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.18102,-0.16781,-0.073374,0,0
2,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.077559,-0.16865,-0.1278,0,0
2,GO SEQUESTERING OF ACTIN MONOMERS,0.023112,-0.16979,-0.18707,0,0
2,GO MAINTENANCE OF CELL POLARITY,0.08881,-0.16991,-0.12465,0,0
2,GO ERROR FREE TRANSLESION SYNTHESIS,0.015104,-0.17028,-0.17483,0,0
2,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.15655,-0.17047,-0.16512,0,0
2,GO SPERMATID NUCLEUS DIFFERENTIATION,0.026142,-0.17109,-0.21163,0,0
2,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.19156,-0.17175,-0.12273,0,0
2,GO MITOTIC SPINDLE ASSEMBLY,0.011063,-0.17264,-0.25235,0,0
2,GO NOTCH RECEPTOR PROCESSING,0.11163,-0.17307,-0.13411,0,0
2,GO HEART FIELD SPECIFICATION,0.33821,-0.17319,-0.11514,0,0
2,GO NON MOTILE CILIUM ASSEMBLY,0.098083,-0.17324,-0.13983,0,0
2,GO NUCLEOSOME ORGANIZATION,0.056456,-0.1741,-0.1761,0,0
2,GO MEMBRANE HYPERPOLARIZATION,0.20256,-0.17426,-0.10811,0,0
2,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.2577,-0.17459,-0.11824,0,0
2,GO RETINAL CONE CELL DIFFERENTIATION,0.38829,-0.17465,-0.073241,0,0
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.28529,-0.1747,-0.11411,0,0
2,GO KINETOCHORE ASSEMBLY,0.028348,-0.17534,-0.34519,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.44264,-0.17538,-0.071341,0,0
2,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.08881,-0.17546,-0.085261,0,0
2,GO AXONEME ASSEMBLY,0.091819,-0.17621,-0.19723,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.072385,-0.17651,-0.1296,0,0
2,GO NERVE DEVELOPMENT,0.094909,-0.17661,-0.14512,0,0
2,GO FOREBRAIN GENERATION OF NEURONS,0.13467,-0.17693,-0.09652,0,0
2,GO ASTRAL MICROTUBULE ORGANIZATION,0.20822,-0.17725,-0.13465,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.080256,-0.17899,-0.18678,0,0
2,GO ATP DEPENDENT CHROMATIN REMODELING,0.017954,-0.17919,-0.24173,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.27821,-0.18113,-0.11544,0,0
2,GO MATING BEHAVIOR,0.21989,-0.18123,-0.11484,0,0
2,GO NEURON MATURATION,0.08881,-0.18166,-0.11449,0,0
2,GO HOMOLOGOUS RECOMBINATION,0.02951,-0.18181,-0.22299,0,0
2,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.2577,-0.18279,-0.098432,0,0
2,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.060677,-0.18348,-0.28963,0,0
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.08303,-0.18381,-0.19479,0,0
2,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.013235,-0.18462,-0.21377,0,0
2,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.010101,-0.1853,-0.36763,0,0
2,GO RDNA HETEROCHROMATIN ASSEMBLY,0.12662,-0.18565,-0.14559,0,0
2,GO PROTEIN LOCALIZATION TO CILIUM,0.08588,-0.18582,-0.14057,0,0
2,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.074935,-0.18603,-0.16606,0,0
2,GO INSULIN SECRETION,0.074935,-0.18661,-0.083976,0,0
2,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.077559,-0.18762,-0.24182,0,0
2,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.10811,-0.18838,-0.13415,0,0
2,GO MITOTIC SISTER CHROMATID COHESION,0.050584,-0.18863,-0.21343,0,0
2,GO SISTER CHROMATID COHESION,0.056456,-0.18941,-0.21886,0,0
2,GO COLLATERAL SPROUTING,0.15655,-0.18955,-0.11581,0,0
2,GO DOPAMINE METABOLIC PROCESS,0.1306,-0.19022,-0.096095,0,0
2,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.36271,-0.19093,-0.03555,0,0
2,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.12662,-0.1912,-0.18122,0,0
2,GO HISTONE H4 K5 ACETYLATION,0.11894,-0.19351,-0.13569,0,0
2,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.098083,-0.19515,-0.18317,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.12662,-0.19725,-0.17536,0,0
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.11894,-0.20096,-0.1036,0,0
2,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.10134,-0.20179,-0.18743,0,0
2,GO AMMONIUM ION METABOLIC PROCESS,0.094909,-0.20317,-0.15228,0,0
2,GO NOREPINEPHRINE SECRETION,0.36271,-0.2034,-0.091259,0,0
2,GO DNA REPLICATION CHECKPOINT,0.056456,-0.20371,-0.26454,0,0
2,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.10468,-0.20507,-0.15072,0,0
2,GO NUCLEOSOME ASSEMBLY,0.018736,-0.20633,-0.23611,0,0
2,GO ERROR PRONE TRANSLESION SYNTHESIS,0.0031545,-0.2093,-0.23481,0,0
2,GO MITOTIC DNA REPLICATION,0.067497,-0.20977,-0.25058,0,0
2,GO DNA REPLICATION INITIATION,0.031957,-0.2108,-0.2637,0,0
2,GO LIMB BUD FORMATION,0.86799,-0.21197,0.015914,0,0
2,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.013235,-0.21264,-0.19162,0,0
2,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.11163,-0.21481,-0.13949,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.0057394,-0.21983,-0.29715,0,0
2,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.021265,-0.22101,-0.20223,0,0
2,GO ADRENAL GLAND DEVELOPMENT,0.17091,-0.22184,-0.11159,0,0
2,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.12273,-0.22614,-0.14569,0,0
2,GO MEIOTIC SPINDLE ORGANIZATION,0.08881,-0.22747,-0.23345,0,0
2,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.37964,-0.22839,-0.058369,0,0
2,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.10134,-0.22846,-0.12474,0,0
2,GO TRIGEMINAL NERVE DEVELOPMENT,0.098083,-0.22889,-0.25603,0,0
2,GO REPRODUCTIVE BEHAVIOR,0.08303,-0.22903,-0.15374,0,0
2,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.13885,-0.22926,-0.15415,0,0
2,GO HISTONE EXCHANGE,0.006955,-0.22999,-0.29414,0,0
2,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.067497,-0.23146,-0.14978,0,0
2,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.14312,-0.23317,-0.16288,0,0
2,GO CELL MIGRATION IN HINDBRAIN,0.12273,-0.23527,-0.10213,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.072385,-0.23534,-0.16367,0,0
2,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.031957,-0.23557,-0.25265,0,0
2,GO DNA STRAND ELONGATION,0.022172,-0.23605,-0.30252,0,0
2,GO SYNAPTIC VESICLE TRANSPORT,0.0080134,-0.23751,-0.19378,0,0
2,GO MEIOTIC CHROMOSOME SEPARATION,0.074935,-0.24104,-0.28721,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.11894,-0.24172,-0.14687,0,0
2,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.091819,-0.24247,-0.15382,0,0
2,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.11524,-0.25369,-0.12386,0,0
2,GO FOREBRAIN NEURON DIFFERENTIATION,0.067497,-0.26263,-0.14573,0,0
2,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.056456,-0.27056,-0.25841,0,0
2,GO INTRACILIARY TRANSPORT,0.018736,-0.27097,-0.23421,0,0
2,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.037377,-0.27327,-0.22715,0,0
2,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.012106,-0.27435,-0.21503,0,0
2,GO NOREPINEPHRINE TRANSPORT,0.24463,-0.28147,-0.12403,0,0
2,GO MRNA SPLICE SITE SELECTION,0.023112,-0.28899,-0.24141,0,0
2,GO INHIBITORY SYNAPSE ASSEMBLY,0.1306,-0.29026,-0.17294,0,0
2,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.024086,-0.29113,-0.37628,0,0
2,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.015776,-0.29241,-0.24707,0,0
2,GO DIENCEPHALON DEVELOPMENT,0.021265,-0.29314,-0.19597,0,0
2,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.021265,-0.29823,-0.38822,0,0
2,GO INTRACILIARY RETROGRADE TRANSPORT,0.016475,-0.2998,-0.26939,0,0
2,GO PARENTAL BEHAVIOR,0.060677,-0.30092,-0.26541,0,0
2,GO THALAMUS DEVELOPMENT,0.006955,-0.30399,-0.2996,0,0
2,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.028348,-0.30677,-0.25282,0,0
2,GO TELENCEPHALON REGIONALIZATION,0.033245,-0.31226,-0.24327,0,0
2,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.17591,-0.31267,-0.15065,0,0
2,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.0096484,-0.33364,-0.33715,0,0
2,GO CGMP METABOLIC PROCESS,0.016475,-0.33616,-0.25672,0,0
2,GO REGULATION OF VESICLE FUSION,0.0027019,-0.33653,-0.27841,0,0
2,GO RETINAL GANGLION CELL AXON GUIDANCE,0.0052065,-0.33726,-0.30528,0,0
2,GO PITUITARY GLAND DEVELOPMENT,0.013834,-0.33837,-0.26627,0,0
2,GO REGULATION OF CGMP MEDIATED SIGNALING,0.016475,-0.34167,-0.25319,0,0
2,GO STABILIZATION OF MEMBRANE POTENTIAL,0.10468,-0.34222,-0.24731,0,0
2,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.13885,-0.347,-0.19917,0,0
2,GO NEURON FATE COMMITMENT,0.0038653,-0.35368,-0.30273,0,0
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0020776,-0.3562,-0.32553,0,0
2,GO REGULATION OF GLUTAMATE SECRETION,0.011574,-0.35652,-0.32535,0,0
2,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.006955,-0.36242,-0.39279,0,0
2,GO NOSE DEVELOPMENT,0.060677,-0.36441,-0.34345,0,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.0014241,-0.37062,-0.35652,0,0
2,GO GLIAL CELL FATE COMMITMENT,0.0092139,-0.40471,-0.37256,0,0
2,GO GROWTH HORMONE SECRETION,0.010101,-0.41456,-0.3205,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.007293,-0.41814,-0.41789,0,0
2,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.017954,-0.42036,-0.35394,0,0
2,GO REGULATION OF DENDRITE EXTENSION,0.0019699,-0.45263,-0.36828,0,0
2,GO FOREBRAIN NEURON FATE COMMITMENT,0.041938,-0.48615,-0.38402,0,0
2,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.0015882,-0.49053,-0.40909,0,0
2,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0047188,-0.50335,-0.36594,0,0
2,GO REGULATION OF GROWTH HORMONE SECRETION,0.0080134,-0.53324,-0.45822,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00031664,-0.59279,-0.55943,0,0
2,GO GABAERGIC NEURON DIFFERENTIATION,0.0028457,-0.66296,-0.4833,0,0
2,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.0014241,-0.85385,-0.68228,0,0
3,GO OUTER DYNEIN ARM ASSEMBLY,0.0016767,0.78155,0.67742,1,1
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00010181,0.74171,0.66715,1,1
3,GO RESPONSE TO POTASSIUM ION,6.6813e-06,0.7205,0.69981,1,1
3,GO NEURON CELL CELL ADHESION,1.2939e-05,0.70031,0.74462,1,1
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,4.5779e-05,0.69195,0.73166,1,1
3,GO INNER DYNEIN ARM ASSEMBLY,0.006955,0.68756,0.56731,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00017019,0.68474,0.65109,1,1
3,GO SYNAPTIC VESICLE DOCKING,1.6059e-05,0.68102,0.8091,1,1
3,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.00091199,0.67389,0.5943,1,1
3,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,5.9985e-05,0.67104,0.65759,1,1
3,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00035748,0.64875,0.55325,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00014989,0.63281,0.6673,1,1
3,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.00035748,0.63225,0.51743,1,1
3,GO INHIBITORY POSTSYNAPTIC POTENTIAL,2.636e-05,0.63112,0.79534,1,1
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,1.6059e-05,0.62761,0.61144,1,1
3,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.00014062,0.62293,0.57303,1,1
3,GO SYNAPTIC MEMBRANE ADHESION,5.9985e-05,0.61574,0.5937,1,1
3,GO PREPULSE INHIBITION,8.3641e-05,0.6121,0.61698,1,1
3,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,9.5377e-05,0.60263,0.71021,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,8.9327e-05,0.59323,0.55681,1,1
3,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00057531,0.59188,0.57425,1,1
3,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0024341,0.58344,0.4637,1,1
3,GO STARTLE RESPONSE,2.8267e-05,0.58154,0.54016,1,1
3,GO INHIBITORY SYNAPSE ASSEMBLY,1.9888e-05,0.57614,0.69064,1,1
3,GO MAINTENANCE OF SYNAPSE STRUCTURE,2.2907e-05,0.57595,0.62262,1,1
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00045436,0.5733,0.63774,1,1
3,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.00035748,0.56669,0.54256,1,1
3,GO DIVALENT METAL ION EXPORT,0.0012071,0.56391,0.46343,1,1
3,GO COLLECTING DUCT DEVELOPMENT,0.00029789,0.56307,0.57986,1,1
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.00011593,0.56267,0.53114,1,1
3,GO VOCALIZATION BEHAVIOR,0.00017019,0.55873,0.49441,1,1
3,GO SYNAPSE MATURATION,0.00042807,0.54698,0.50601,1,1
3,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,6.8565e-05,0.54598,0.54216,1,1
3,GO REGULATION OF SYNAPSE MATURATION,0.0011418,0.54349,0.47787,1,1
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.0029965,0.5253,0.62178,1,1
3,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,6.8565e-05,0.52508,0.68847,1,1
3,GO RETINA LAYER FORMATION,3.7287e-05,0.52494,0.57013,1,1
3,GO CENTRIOLE CENTRIOLE COHESION,0.00014989,0.52339,0.51042,1,1
3,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,6.4139e-05,0.52195,0.47729,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00026348,0.51991,0.46993,1,1
3,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00035748,0.51961,0.53681,1,1
3,GO POSTSYNAPSE ASSEMBLY,5.9985e-05,0.51926,0.60209,1,1
3,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,8.3641e-05,0.51636,0.51174,1,1
3,GO MICROTUBULE DEPOLYMERIZATION,0.00010181,0.51538,0.49197,1,1
3,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.00018128,0.51225,0.4692,1,1
3,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,5.2428e-05,0.51178,0.51389,1,1
3,GO AXONEME ASSEMBLY,0.00040321,0.50903,0.50995,1,1
3,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,5.6086e-05,0.5088,0.53256,1,1
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.00031664,0.50304,0.3917,1,1
3,GO ASTRAL MICROTUBULE ORGANIZATION,8.9327e-05,0.50274,0.51084,1,1
3,GO MALE SEX DETERMINATION,0.0023095,0.49922,0.38265,1,1
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00035748,0.49906,0.52017,1,1
3,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,3.4805e-05,0.49819,0.49482,1,1
3,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,7.8298e-05,0.49712,0.44955,1,1
3,GO MICROTUBULE BUNDLE FORMATION,7.3279e-05,0.49615,0.4786,1,1
3,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.00017019,0.49549,0.48081,1,1
3,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,5.6086e-05,0.49528,0.49996,1,1
3,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,4.5779e-05,0.48991,0.50688,1,1
3,GO REGULATION OF NEURON MIGRATION,5.6086e-05,0.48691,0.53576,1,1
3,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00010866,0.48674,0.51693,1,1
3,GO NEURONAL ION CHANNEL CLUSTERING,1.1191e-05,0.48651,0.54951,1,1
3,GO CALCIUM ION IMPORT INTO CYTOSOL,0.00064645,0.48618,0.44571,1,1
3,GO BEHAVIORAL RESPONSE TO COCAINE,3.0304e-05,0.48604,0.50607,1,1
3,GO REGULATION OF COLLATERAL SPROUTING,0.00033648,0.48527,0.48743,1,1
3,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.00015974,0.48468,0.48964,1,1
3,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.00010866,0.48247,0.4758,1,1
3,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0011418,0.48133,0.52274,1,1
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.7249e-05,0.47908,0.52812,1,1
3,GO LONG TERM SYNAPTIC DEPRESSION,4.2763e-05,0.47901,0.45721,1,1
3,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0031545,0.47881,0.56375,1,1
3,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.00054254,0.47837,0.44645,1,1
3,GO OPTIC NERVE DEVELOPMENT,0.0020776,0.4781,0.45654,1,1
3,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0031545,0.47801,0.42445,1,1
3,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,3.9936e-05,0.47714,0.52998,1,1
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.00029789,0.47502,0.4231,1,1
3,GO MICROTUBULE ANCHORING AT CENTROSOME,4.2763e-05,0.47461,0.54825,1,1
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0010798,0.4733,0.42415,1,1
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.00035748,0.47046,0.43115,1,1
3,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,5.9985e-05,0.47038,0.48961,1,1
3,GO PONS DEVELOPMENT,0.0010798,0.46986,0.55285,1,1
3,GO DENDRITIC TRANSPORT,0.00068502,0.46932,0.47272,1,1
3,GO HISTONE H3 K36 METHYLATION,4.2763e-05,0.4686,0.50339,1,1
3,GO FACIAL NERVE MORPHOGENESIS,0.00042807,0.4682,0.49292,1,1
3,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.00048214,0.46747,0.55724,1,1
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00068502,0.4668,0.52225,1,1
3,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.00010181,0.4663,0.44518,1,1
3,GO MAGNESIUM ION HOMEOSTASIS,0.00060992,0.46509,0.44527,1,1
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.00028019,0.46504,0.51861,1,1
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00019306,0.46429,0.51985,1,1
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00020554,0.46313,0.46908,1,1
3,GO ANATOMICAL STRUCTURE REGRESSION,0.00026348,0.46234,0.47271,1,1
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00020554,0.46205,0.54093,1,1
3,GO NUCLEAR MIGRATION,3.0304e-05,0.46198,0.52161,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,9.5377e-05,0.46065,0.37502,1,1
3,GO MOTILE CILIUM ASSEMBLY,0.0010798,0.45956,0.42188,1,1
3,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,5.2428e-05,0.45878,0.47005,1,1
3,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,3.9936e-05,0.45878,0.51507,1,1
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.00035748,0.4581,0.54685,1,1
3,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,7.8298e-05,0.45657,0.43647,1,1
3,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.00013188,0.45636,0.48119,1,1
3,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00042807,0.45544,0.49648,1,1
3,GO COLLATERAL SPROUTING,0.00015974,0.45451,0.47882,1,1
3,GO NUCLEUS LOCALIZATION,2.636e-05,0.45281,0.52298,1,1
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,1.3909e-05,0.45002,0.45471,1,1
3,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.00014062,0.44751,0.42395,1,1
3,GO INNERVATION,0.00033648,0.4463,0.52358,1,1
3,GO EXPLORATION BEHAVIOR,0.00045436,0.44604,0.41636,1,1
3,GO REGULATION OF SYNAPSE ASSEMBLY,5.6086e-05,0.44505,0.44645,1,1
3,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.0017696,0.44461,0.44096,1,1
3,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00054254,0.44291,0.45334,1,1
3,GO CELL JUNCTION MAINTENANCE,2.2907e-05,0.4429,0.46494,1,1
3,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.0020776,0.44272,0.58784,1,1
3,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0013481,0.44198,0.42099,1,1
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00029789,0.4403,0.48876,1,1
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0013481,0.43911,0.38846,1,1
3,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.00024771,0.43905,0.50162,1,1
3,GO SYNAPTIC VESICLE MATURATION,0.00023283,0.43888,0.55357,1,1
3,GO PRESYNAPSE ORGANIZATION,7.8298e-05,0.43838,0.46314,1,1
3,GO SYNAPTIC VESICLE CLUSTERING,0.00017019,0.43836,0.60433,1,1
3,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0016767,0.43705,0.43243,1,1
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,7.3279e-05,0.43668,0.51441,1,1
3,GO SYNAPSE ASSEMBLY,1.8524e-05,0.43577,0.5047,1,1
3,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.00031664,0.43482,0.40198,1,1
3,GO RESPONSE TO AUDITORY STIMULUS,0.00012367,0.43389,0.46851,1,1
3,GO SECONDARY PALATE DEVELOPMENT,0.0020776,0.4337,0.41096,1,1
3,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.0020776,0.43356,0.40831,1,1
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,7.8298e-05,0.43333,0.45169,1,1
3,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,7.3279e-05,0.43322,0.42979,1,1
3,GO SYNAPTIC TRANSMISSION GABAERGIC,2.636e-05,0.43162,0.46687,1,1
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,8.3641e-05,0.43162,0.43966,1,1
3,GO HISTONE H3 K9 DEMETHYLATION,1.1191e-05,0.43149,0.46992,1,1
3,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,2.4576e-05,0.43078,0.48729,1,1
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,4.5779e-05,0.43019,0.78608,1,1
3,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00019306,0.42945,0.53669,1,1
3,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.0023095,0.42873,0.40691,1,1
3,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,7.3279e-05,0.4287,0.44027,1,1
3,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,6.4139e-05,0.42814,0.42319,1,1
3,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.00010866,0.42779,0.38739,1,1
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00042807,0.4267,0.4408,1,1
3,GO EXTRACELLULAR TRANSPORT,0.00076864,0.42622,0.42616,1,1
3,GO CILIUM MOVEMENT,0.00014062,0.42595,0.42803,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,4.5779e-05,0.42542,0.48703,1,1
3,GO MEIOTIC CHROMOSOME SEPARATION,0.0012071,0.42494,0.37772,1,1
3,GO SUCKLING BEHAVIOR,9.5377e-05,0.4242,0.4223,1,1
3,GO FOREBRAIN REGIONALIZATION,0.024086,0.42316,0.29618,1,1
3,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,6.8565e-05,0.42228,0.55161,1,1
3,GO REGULATION OF CILIUM ASSEMBLY,1.7249e-05,0.42169,0.42695,1,1
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.00040321,0.42145,0.49447,1,1
3,GO CRANIAL NERVE MORPHOGENESIS,0.0003797,0.42115,0.39677,1,1
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00023283,0.42104,0.38431,1,1
3,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.00042807,0.42047,0.40258,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.0403e-05,0.41909,0.47596,1,1
3,GO HISTONE H3 K27 METHYLATION,2.8267e-05,0.41875,0.50506,1,1
3,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,2.8267e-05,0.41861,0.42613,1,1
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0010209,0.41824,0.42629,1,1
3,GO TUBULIN DEACETYLATION,4.2763e-05,0.41712,0.45218,1,1
3,GO RESPONSE TO COCAINE,1.1191e-05,0.41449,0.43624,1,1
3,GO MATING BEHAVIOR,7.3279e-05,0.41376,0.42348,1,1
3,GO GLUTAMATE SECRETION,0.00042807,0.41113,0.39869,1,1
3,GO DENSE CORE GRANULE TRANSPORT,0.0020776,0.41078,0.52086,1,1
3,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,8.3641e-05,0.41054,0.43942,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0003797,0.41022,0.39835,1,1
3,GO PROTEIN LOCALIZATION TO AXON,0.0044907,0.4092,0.39991,1,1
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,3.0304e-05,0.40817,0.5038,1,1
3,GO NEURAL TUBE PATTERNING,0.00010866,0.40693,0.36944,1,1
3,GO PEPTIDYL LYSINE TRIMETHYLATION,3.248e-05,0.40688,0.42072,1,1
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0012071,0.40598,0.55113,1,1
3,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.0036751,0.40541,0.49311,1,1
3,GO REPRODUCTIVE BEHAVIOR,3.7287e-05,0.40482,0.44473,1,1
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.00017019,0.40449,0.56173,1,1
3,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.00060992,0.40436,0.32762,1,1
3,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,7.3279e-05,0.40369,0.488,1,1
3,GO EXCITATORY SYNAPSE ASSEMBLY,0.00021879,0.40321,0.53935,1,1
3,GO AXONAL FASCICULATION,0.00051151,0.40217,0.44264,1,1
3,GO HISTONE H3 K4 TRIMETHYLATION,0.00014062,0.40208,0.47379,1,1
3,GO COMMISSURAL NEURON AXON GUIDANCE,0.01266,0.40184,0.34309,1,1
3,GO EMBRYONIC BODY MORPHOGENESIS,0.00013188,0.4013,0.42291,1,1
3,GO BRAIN MORPHOGENESIS,5.6086e-05,0.40115,0.40149,1,1
3,GO CEREBELLAR CORTEX MORPHOGENESIS,0.00018128,0.40038,0.3937,1,1
3,GO AXO DENDRITIC PROTEIN TRANSPORT,0.00012367,0.39909,0.52864,1,1
3,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00096503,0.39897,0.39536,1,1
3,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,9.5377e-05,0.39889,0.41304,1,1
3,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00076864,0.39867,0.4313,1,1
3,GO RECEPTOR CLUSTERING,0.00014062,0.39858,0.40648,1,1
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00057531,0.39848,0.55106,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,5.2428e-05,0.39822,0.43509,1,1
3,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.00048214,0.397,0.39211,1,1
3,GO ACROSOME ASSEMBLY,0.00021879,0.3966,0.3766,1,1
3,GO ADULT BEHAVIOR,4.9495e-06,0.39654,0.45319,1,1
3,GO SCHWANN CELL DEVELOPMENT,0.00015974,0.39597,0.39491,1,1
3,GO HAIR CELL DIFFERENTIATION,0.00012367,0.39576,0.4168,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,2.4576e-05,0.39551,0.51287,1,1
3,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.00015974,0.39547,0.39037,1,1
3,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.9888e-05,0.39524,0.43471,1,1
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.00010181,0.39523,0.47981,1,1
3,GO INOSITOL METABOLIC PROCESS,4.5779e-05,0.39505,0.44186,1,1
3,GO REGULATION OF MICROTUBULE BINDING,0.00010866,0.39406,0.43981,1,1
3,GO MECHANORECEPTOR DIFFERENTIATION,2.2907e-05,0.39334,0.41044,1,1
3,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.00012367,0.39251,0.41231,1,1
3,GO SPINAL CORD PATTERNING,0.0015882,0.39199,0.41169,1,1
3,GO PROTEIN POLYGLUTAMYLATION,0.00031664,0.39168,0.40101,1,1
3,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.0038653,0.39134,0.31465,1,1
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,6.4139e-05,0.39125,0.43242,1,1
3,GO PROTEIN LOCALIZATION TO SYNAPSE,0.00018128,0.3912,0.45481,1,1
3,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,8.3641e-05,0.39089,0.34416,1,1
3,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00031664,0.39008,0.42253,1,1
3,GO NERVE DEVELOPMENT,0.00029789,0.3898,0.39777,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,6.4139e-05,0.38881,0.39503,1,1
3,GO FORELIMB MORPHOGENESIS,0.0012071,0.38865,0.34459,1,1
3,GO SEX DETERMINATION,8.3641e-05,0.38779,0.37334,1,1
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.00017019,0.38769,0.42178,1,1
3,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,1.2035e-05,0.38705,0.45563,1,1
3,GO PROTEIN LOCALIZATION TO CELL JUNCTION,9.5377e-05,0.38669,0.4208,1,1
3,GO NEURON CELLULAR HOMEOSTASIS,0.00068502,0.38642,0.40664,1,1
3,GO NEGATIVE REGULATION OF AXONOGENESIS,3.248e-05,0.38618,0.45863,1,1
3,GO RESPONSE TO FORSKOLIN,0.0019699,0.386,0.40237,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00023283,0.38576,0.42528,1,1
3,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.00013188,0.38575,0.39302,1,1
3,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.0060238,0.3857,0.37443,1,1
3,GO HISTONE H3 K9 TRIMETHYLATION,1.8524e-05,0.3855,0.41957,1,1
3,GO DENDRITE MORPHOGENESIS,2.8267e-05,0.38507,0.43392,1,1
3,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.007293,0.38487,0.38618,1,1
3,GO CELL PROLIFERATION IN HINDBRAIN,0.017954,0.38475,0.29579,1,1
3,GO HISTONE H3 K9 METHYLATION,4.8997e-05,0.38473,0.42317,1,1
3,GO CALCIUM ION REGULATED EXOCYTOSIS,0.00031664,0.38455,0.53665,1,1
3,GO MEMBRANE HYPERPOLARIZATION,0.0025648,0.38401,0.40072,1,1
3,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00096503,0.38337,0.38496,1,1
3,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,5.9985e-05,0.38271,0.41791,1,1
3,GO NEGATIVE REGULATION OF AXON EXTENSION,4.5779e-05,0.38262,0.4466,1,1
3,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.01266,0.38228,0.37578,1,1
3,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.00028019,0.38198,0.4228,1,1
3,GO CHROMATIN SILENCING AT TELOMERE,7.3279e-05,0.3818,0.36459,1,1
3,GO CORONARY VASCULATURE MORPHOGENESIS,0.00081392,0.38152,0.42573,1,1
3,GO NOREPINEPHRINE SECRETION,0.0016767,0.38137,0.42322,1,1
3,GO NOREPINEPHRINE TRANSPORT,0.0023095,0.38061,0.4247,1,1
3,GO FEAR RESPONSE,2.8267e-05,0.38038,0.38831,1,1
3,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0027019,0.3802,0.40982,1,1
3,GO CARDIAC MYOFIBRIL ASSEMBLY,5.2428e-05,0.38013,0.42726,1,1
3,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.0012758,0.38008,0.35462,1,1
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.00048214,0.37997,0.38006,1,1
3,GO DOPAMINE TRANSPORT,0.00028019,0.37982,0.45435,1,1
3,GO MECHANOSENSORY BEHAVIOR,0.00057531,0.37966,0.45855,1,1
3,GO PROTEIN LOCALIZATION TO CILIUM,7.8298e-05,0.37932,0.39432,1,1
3,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0016767,0.37905,0.38857,1,1
3,GO DORSAL SPINAL CORD DEVELOPMENT,0.0016767,0.37897,0.3793,1,1
3,GO MICROTUBULE ANCHORING,1.8524e-05,0.37892,0.4641,1,1
3,GO CENTRIOLE ASSEMBLY,0.00035748,0.37885,0.35154,1,1
3,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.00040321,0.3788,0.47412,1,1
3,GO RETROGRADE AXONAL TRANSPORT,0.00033648,0.37858,0.45563,1,1
3,GO CHEMOSENSORY BEHAVIOR,5.9985e-05,0.37847,0.42474,1,1
3,GO LATERAL VENTRICLE DEVELOPMENT,0.00010181,0.37838,0.4293,1,1
3,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.0003797,0.37813,0.41534,1,1
3,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,3.4805e-05,0.37807,0.43354,1,1
3,GO DRUG CATABOLIC PROCESS,0.025096,0.37715,0.27031,1,1
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,3.9936e-05,0.37708,0.41369,1,1
3,GO CEREBELLAR CORTEX FORMATION,0.00012367,0.37683,0.40862,1,1
3,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0012071,0.37682,0.32007,1,1
3,GO MICROTUBULE SEVERING,0.00015974,0.37667,0.37033,1,1
3,GO DOSAGE COMPENSATION,0.00020554,0.37619,0.37732,1,1
3,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00081392,0.37592,0.41762,1,1
3,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.0047188,0.37359,0.42067,1,1
3,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00029789,0.37264,0.39461,1,1
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.00013188,0.37222,0.41409,1,1
3,GO MICROTUBULE NUCLEATION,2.4576e-05,0.37191,0.40851,1,1
3,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.00048214,0.37151,0.40088,1,1
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.0076456,0.37103,0.35951,1,1
3,GO REGULATION OF MICROTUBULE POLYMERIZATION,7.3279e-05,0.37069,0.43388,1,1
3,GO SYNAPTIC VESICLE PRIMING,0.00010866,0.37032,0.57552,1,1
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.00011593,0.3703,0.41452,1,1
3,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.0015882,0.37025,0.37576,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.024086,0.36994,0.56498,1,1
3,GO REGULATION OF AMINO ACID TRANSPORT,0.00048214,0.36984,0.35107,1,1
3,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,8.9327e-05,0.36937,0.49171,1,1
3,GO REGULATION OF CHROMATIN ASSEMBLY,4.5779e-05,0.36906,0.40404,1,1
3,GO UV DAMAGE EXCISION REPAIR,7.3279e-05,0.36901,0.35924,1,1
3,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.0018673,0.36901,0.40134,1,1
3,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.00021879,0.36868,0.36918,1,1
3,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.0018673,0.36853,0.38048,1,1
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.00018128,0.3681,0.43538,1,1
3,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,3.0304e-05,0.3681,0.43835,1,1
3,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.00017019,0.36809,0.39951,1,1
3,GO RESPONSE TO INSECTICIDE,0.0017696,0.36781,0.33977,1,1
3,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,3.9936e-05,0.36755,0.40185,1,1
3,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,2.636e-05,0.36749,0.44455,1,1
3,GO LEARNING,1.2939e-05,0.36733,0.43832,1,1
3,GO PROTEIN LOCALIZATION TO MICROTUBULE,2.1347e-05,0.36723,0.41591,1,1
3,GO INNER EAR RECEPTOR CELL DEVELOPMENT,1.8524e-05,0.36711,0.41578,1,1
3,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.00010181,0.36697,0.40257,1,1
3,GO POSITIVE REGULATION OF TORC1 SIGNALING,2.8267e-05,0.36691,0.40698,1,1
3,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0040644,0.36627,0.46618,1,1
3,GO CILIUM ORGANIZATION,1.7249e-05,0.36618,0.38799,1,1
3,GO REGULATION OF AXON GUIDANCE,0.00051151,0.36587,0.39398,1,1
3,GO NEURON MATURATION,2.4576e-05,0.36583,0.40544,1,1
3,GO ACTIN CROSSLINK FORMATION,7.8298e-05,0.36583,0.41123,1,1
3,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0034935,0.36571,0.41452,1,1
3,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,8.9327e-05,0.3648,0.49842,1,1
3,GO SECRETORY GRANULE LOCALIZATION,0.0027019,0.36421,0.39448,1,1
3,GO POSTSYNAPSE ORGANIZATION,3.248e-05,0.36421,0.41165,1,1
3,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.00028019,0.36409,0.39125,1,1
3,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00015974,0.36391,0.42843,1,1
3,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,8.3641e-05,0.36386,0.35868,1,1
3,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.0054671,0.36353,0.37821,1,1
3,GO MUSCLE FIBER DEVELOPMENT,7.8298e-05,0.36352,0.34842,1,1
3,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.011063,0.36332,0.35458,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.00072571,0.36285,0.37432,1,1
3,GO AMMONIUM ION METABOLIC PROCESS,0.00015974,0.36193,0.40304,1,1
3,GO RESPONSE TO GLUCAGON,6.8565e-05,0.36096,0.39041,1,1
3,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00031664,0.36064,0.46273,1,1
3,GO SYNAPTIC VESICLE EXOCYTOSIS,4.8997e-05,0.35991,0.50045,1,1
3,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.00026348,0.35987,0.39161,1,1
3,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00011593,0.35955,0.40646,1,1
3,GO REGULATION OF TUBULIN DEACETYLATION,6.8565e-05,0.35941,0.44409,1,1
3,GO METENCEPHALON DEVELOPMENT,1.7249e-05,0.35915,0.37575,1,1
3,GO NEUROTRANSMITTER REUPTAKE,9.5377e-05,0.3588,0.38345,1,1
3,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.00086166,0.35868,0.43872,1,1
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00010866,0.35855,0.39238,1,1
3,GO SHORT TERM MEMORY,0.00054254,0.3585,0.41825,1,1
3,GO CATECHOLAMINE SECRETION,3.248e-05,0.35781,0.45823,1,1
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,9.5377e-05,0.35755,0.36906,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,3.7287e-05,0.35748,0.39429,1,1
3,GO PEPTIDYL LYSINE DIMETHYLATION,1.8524e-05,0.35736,0.40767,1,1
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,4.5779e-05,0.35668,0.50376,1,1
3,GO REGULATION OF ACTION POTENTIAL,4.2763e-05,0.35632,0.42389,1,1
3,GO NEUROTRANSMITTER TRANSPORT,2.2907e-05,0.35509,0.45284,1,1
3,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.00045436,0.35431,0.39286,1,1
3,GO FOREBRAIN NEURON DEVELOPMENT,0.00096503,0.3543,0.34395,1,1
3,GO ENTRAINMENT OF CIRCADIAN CLOCK,8.3461e-06,0.35411,0.38577,1,1
3,GO ASSOCIATIVE LEARNING,1.7249e-05,0.35374,0.40971,1,1
3,GO REPLICATION FORK PROCESSING,0.0025648,0.35373,0.34525,1,1
3,GO AMINE TRANSPORT,3.4805e-05,0.35328,0.38988,1,1
3,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.00031664,0.35314,0.33645,1,1
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,2.1347e-05,0.35311,0.39663,1,1
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.013235,0.35293,0.29887,1,1
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00019306,0.35289,0.36184,1,1
3,GO REGULATION OF RECEPTOR CLUSTERING,0.00060992,0.35225,0.43615,1,1
3,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.00035748,0.35212,0.40576,1,1
3,GO SCHWANN CELL DIFFERENTIATION,0.00021879,0.35204,0.33905,1,1
3,GO LONG TERM MEMORY,0.00033648,0.35202,0.38427,1,1
3,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.00029789,0.3518,0.36348,1,1
3,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,7.8298e-05,0.35086,0.3879,1,1
3,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.0010209,0.35068,0.43232,1,1
3,GO REGULATION OF SYNAPTIC VESICLE CYCLE,8.9327e-05,0.35053,0.4902,1,1
3,GO HISTONE METHYLATION,1.9888e-05,0.35021,0.38177,1,1
3,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.0012758,0.34953,0.38626,1,1
3,GO CATECHOLAMINE UPTAKE,0.00035748,0.34947,0.43762,1,1
3,GO OTIC VESICLE DEVELOPMENT,0.0040644,0.34914,0.29658,1,1
3,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00010181,0.34872,0.45628,1,1
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,3.248e-05,0.34837,0.3925,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.00013188,0.34829,0.3933,1,1
3,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.00035748,0.34823,0.3297,1,1
3,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.00010866,0.34799,0.40385,1,1
3,GO NEUROTRANSMITTER SECRETION,2.636e-05,0.34798,0.48606,1,1
3,GO MICROTUBULE BASED MOVEMENT,2.2907e-05,0.34788,0.37637,1,1
3,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,3.0304e-05,0.34776,0.4645,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.00014062,0.34726,0.37299,1,1
3,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.00033648,0.34716,0.3558,1,1
3,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.6059e-05,0.347,0.4099,1,1
3,GO GOLGI RIBBON FORMATION,0.00018128,0.34677,0.40329,1,1
3,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00057531,0.34628,0.35293,1,1
3,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00010181,0.34601,0.38197,1,1
3,GO FUCOSYLATION,4.2763e-05,0.34589,0.37729,1,1
3,GO AMINO ACID BETAINE METABOLIC PROCESS,0.00018128,0.34586,0.39463,1,1
3,GO REGULATION OF EXTENT OF CELL GROWTH,3.7287e-05,0.34557,0.42219,1,1
3,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,2.2907e-05,0.34542,0.35908,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.00081392,0.345,0.33858,1,1
3,GO DENDRITE DEVELOPMENT,2.8267e-05,0.34497,0.39884,1,1
3,GO SYNAPSE ORGANIZATION,1.9888e-05,0.34488,0.43315,1,1
3,GO NEURAL CREST CELL MIGRATION,0.00072571,0.34465,0.32503,1,1
3,GO RESPONSE TO ACETYLCHOLINE,0.00013188,0.34438,0.43806,1,1
3,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,1.7249e-05,0.344,0.38912,1,1
3,GO OOCYTE MATURATION,0.00029789,0.34387,0.32698,1,1
3,GO MICROTUBULE BASED TRANSPORT,5.9985e-05,0.34355,0.33851,1,1
3,GO CELL JUNCTION ASSEMBLY,8.9327e-05,0.34324,0.35776,1,1
3,GO MICROTUBULE POLYMERIZATION,2.4576e-05,0.34244,0.41478,1,1
3,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,2.1347e-05,0.34244,0.36635,1,1
3,GO PROTEIN DEMETHYLATION,3.248e-05,0.34198,0.43869,1,1
3,GO REGULATION OF TRANS SYNAPTIC SIGNALING,1.8524e-05,0.34193,0.44404,1,1
3,GO GASTRULATION WITH MOUTH FORMING SECOND,0.00054254,0.34185,0.39924,1,1
3,GO CRANIAL NERVE DEVELOPMENT,0.00064645,0.34181,0.36078,1,1
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,5.2428e-05,0.34161,0.4122,1,1
3,GO CELLULAR RESPONSE TO VITAMIN D,0.027226,0.34153,0.23661,1,1
3,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,9.5377e-05,0.34138,0.34591,1,1
3,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,6.8565e-05,0.34092,0.35985,1,1
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.0012071,0.34091,0.3438,1,1
3,GO FEEDING BEHAVIOR,2.8267e-05,0.34057,0.3579,1,1
3,GO MONOAMINE TRANSPORT,4.8997e-05,0.34056,0.40023,1,1
3,GO REGULATION OF DENDRITE DEVELOPMENT,1.8524e-05,0.34037,0.39978,1,1
3,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.0013481,0.34024,0.29661,1,1
3,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.031957,0.33999,0.2654,1,1
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00014062,0.33975,0.39924,1,1
3,GO NEUROMUSCULAR PROCESS,3.4805e-05,0.3396,0.40025,1,1
3,GO REGULATION OF NEUROTRANSMITTER LEVELS,2.2907e-05,0.33919,0.44053,1,1
3,GO POSITIVE REGULATION OF AXONOGENESIS,6.8565e-05,0.33902,0.41085,1,1
3,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00023283,0.33882,0.38742,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.00026348,0.33874,0.43915,1,1
3,GO GENETIC IMPRINTING,0.00076864,0.33847,0.33796,1,1
3,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,4.5779e-05,0.33834,0.37465,1,1
3,GO SYNAPTIC VESICLE RECYCLING,0.00010181,0.33806,0.42313,1,1
3,GO REGULATION OF DENDRITE MORPHOGENESIS,1.6059e-05,0.33792,0.42401,1,1
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.0080134,0.3377,0.34328,1,1
3,GO LOCOMOTORY BEHAVIOR,8.3461e-06,0.3377,0.42212,1,1
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,5.2428e-05,0.33733,0.41338,1,1
3,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,7.3279e-05,0.33731,0.3654,1,1
3,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,6.8565e-05,0.3373,0.3837,1,1
3,GO NON MOTILE CILIUM ASSEMBLY,2.4576e-05,0.33701,0.3605,1,1
3,GO ACIDIC AMINO ACID TRANSPORT,4.2763e-05,0.33691,0.38151,1,1
3,GO REGULATION OF AXONOGENESIS,4.2763e-05,0.3368,0.41893,1,1
3,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.0029965,0.33635,0.3093,1,1
3,GO HYPEROSMOTIC RESPONSE,0.0003797,0.33632,0.37813,1,1
3,GO CAMP METABOLIC PROCESS,0.0015041,0.3363,0.35411,1,1
3,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.00332,0.33581,0.30769,1,1
3,GO SPERM MOTILITY,0.00011593,0.33574,0.36767,1,1
3,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,4.5779e-05,0.33473,0.45516,1,1
3,GO CEREBELLAR CORTEX DEVELOPMENT,0.00011593,0.33471,0.34935,1,1
3,GO DERMATAN SULFATE METABOLIC PROCESS,0.038848,0.33439,0.30178,1,1
3,GO POSITIVE REGULATION OF BEHAVIOR,0.0034935,0.33419,0.26687,1,1
3,GO ADHERENS JUNCTION ASSEMBLY,8.3641e-05,0.33371,0.39812,1,1
3,GO NEGATIVE CHEMOTAXIS,0.00054254,0.33342,0.39724,1,1
3,GO NEUROTRANSMITTER UPTAKE,7.8298e-05,0.3333,0.32003,1,1
3,GO ANTEROGRADE AXONAL TRANSPORT,0.00010866,0.33308,0.38749,1,1
3,GO VESICLE FUSION TO PLASMA MEMBRANE,0.0029965,0.333,0.44826,1,1
3,GO PROTEIN PALMITOYLATION,3.7287e-05,0.33279,0.39595,1,1
3,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.0060238,0.33256,0.51718,1,1
3,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,5.9985e-05,0.33181,0.33592,1,1
3,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,4.2763e-05,0.33181,0.40439,1,1
3,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,6.8565e-05,0.33176,0.3308,1,1
3,GO EPITHELIAL CELL CELL ADHESION,0.0042727,0.33158,0.3137,1,1
3,GO NEUROPEPTIDE SIGNALING PATHWAY,3.248e-05,0.33139,0.38372,1,1
3,GO NEURON RECOGNITION,0.0015041,0.33037,0.3593,1,1
3,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0027019,0.33029,0.34526,1,1
3,GO HINDLIMB MORPHOGENESIS,5.9985e-05,0.33027,0.35655,1,1
3,GO ATRIAL SEPTUM DEVELOPMENT,0.00057531,0.33006,0.38619,1,1
3,GO STEM CELL DIVISION,0.0016767,0.32985,0.30172,1,1
3,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.00010181,0.32966,0.39853,1,1
3,GO NOREPINEPHRINE METABOLIC PROCESS,0.015776,0.3296,0.29476,1,1
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.0010209,0.32908,0.35916,1,1
3,GO DENDRITIC SPINE DEVELOPMENT,4.2763e-05,0.32899,0.41243,1,1
3,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,1.8524e-05,0.32869,0.36024,1,1
3,GO CELLULAR POTASSIUM ION HOMEOSTASIS,6.8565e-05,0.32841,0.368,1,1
3,GO INSEMINATION,0.0034935,0.32829,0.35282,1,1
3,GO NEURAL RETINA DEVELOPMENT,8.9327e-05,0.32802,0.37192,1,1
3,GO REGULATION OF RESPONSE TO FOOD,0.00064645,0.32783,0.37218,1,1
3,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.00029789,0.32747,0.36556,1,1
3,GO CARDIAC CONDUCTION,7.3279e-05,0.32726,0.40203,1,1
3,GO URETER DEVELOPMENT,0.050584,0.32686,0.27733,1,1
3,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.0020776,0.32679,0.31839,1,1
3,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.00076864,0.32674,0.3841,1,1
3,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,3.0304e-05,0.32672,0.38194,1,1
3,GO REGULATION OF CARDIAC CONDUCTION,0.00021879,0.32574,0.37775,1,1
3,GO ADHERENS JUNCTION ORGANIZATION,4.5779e-05,0.32548,0.38381,1,1
3,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.00031664,0.32533,0.33743,1,1
3,GO NEURON PROJECTION GUIDANCE,0.00010181,0.32524,0.37752,1,1
3,GO REGULATION OF DOPAMINE SECRETION,0.0015882,0.3252,0.44175,1,1
3,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.00057531,0.32513,0.29728,1,1
3,GO MEMBRANE DISASSEMBLY,0.00024771,0.32506,0.35263,1,1
3,GO METHIONINE BIOSYNTHETIC PROCESS,0.00060992,0.3246,0.31217,1,1
3,GO SODIUM ION HOMEOSTASIS,0.00081392,0.32459,0.33933,1,1
3,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.0031545,0.32454,0.35723,1,1
3,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.00031664,0.32449,0.33668,1,1
3,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.0010209,0.32432,0.35783,1,1
3,GO VENTRICULAR SYSTEM DEVELOPMENT,4.5779e-05,0.32398,0.3884,1,1
3,GO FAT CELL PROLIFERATION,0.0034935,0.32231,0.34569,1,1
3,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,5.6086e-05,0.32184,0.37878,1,1
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,3.248e-05,0.32178,0.4363,1,1
3,GO RDNA HETEROCHROMATIN ASSEMBLY,2.2907e-05,0.32157,0.44051,1,1
3,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,7.8298e-05,0.32142,0.39557,1,1
3,GO RESPONSE TO L GLUTAMATE,0.0021907,0.32097,0.2718,1,1
3,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,6.4139e-05,0.32069,0.37018,1,1
3,GO PEPTIDYL LYSINE METHYLATION,2.2907e-05,0.32063,0.39081,1,1
3,GO LIPID TRANSLOCATION,0.00051151,0.3206,0.34961,1,1
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00064645,0.32053,0.37624,1,1
3,GO EATING BEHAVIOR,0.0012071,0.32044,0.30601,1,1
3,GO HISTONE H3 K4 METHYLATION,0.00010181,0.32044,0.3451,1,1
3,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,2.1347e-05,0.31969,0.33286,1,1
3,GO EMBRYONIC BRAIN DEVELOPMENT,0.010572,0.31957,0.26383,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,3.7287e-05,0.31945,0.40305,1,1
3,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.038848,0.31837,0.25614,1,1
3,GO MATING,0.00010181,0.31814,0.33425,1,1
3,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.00017019,0.31806,0.33944,1,1
3,GO REGULATION OF SPINDLE CHECKPOINT,0.01266,0.31794,0.25083,1,1
3,GO HINDBRAIN DEVELOPMENT,1.3909e-05,0.31765,0.33872,1,1
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.00014062,0.31763,0.37421,1,1
3,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.00033648,0.3173,0.32221,1,1
3,GO LEFT RIGHT PATTERN FORMATION,0.0010209,0.31726,0.30212,1,1
3,GO SEGMENT SPECIFICATION,0.0036751,0.3172,0.33289,1,1
3,GO SYNAPTIC VESICLE LOCALIZATION,0.00019306,0.31697,0.41444,1,1
3,GO CYSTEINE METABOLIC PROCESS,0.023112,0.31677,0.24459,1,1
3,GO COCHLEA DEVELOPMENT,0.00033648,0.31672,0.33463,1,1
3,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,4.5779e-05,0.3166,0.3966,1,1
3,GO PHOTOPERIODISM,1.1191e-05,0.31651,0.34716,1,1
3,GO REGULATION OF MICROTUBULE BASED PROCESS,1.8524e-05,0.31638,0.33753,1,1
3,GO PHOTORECEPTOR CELL DEVELOPMENT,8.3641e-05,0.31624,0.34639,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,4.5779e-05,0.316,0.33821,1,1
3,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.00014062,0.31556,0.37425,1,1
3,GO VENTRAL SPINAL CORD DEVELOPMENT,0.00064645,0.31554,0.30571,1,1
3,GO NEUROTRANSMITTER METABOLIC PROCESS,0.0015882,0.31533,0.35673,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.00051151,0.31514,0.42961,1,1
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION,1.9888e-05,0.31509,0.34309,1,1
3,GO CARNITINE SHUTTLE,0.00013188,0.31508,0.36549,1,1
3,GO SPINAL CORD DEVELOPMENT,0.00017019,0.31506,0.3741,1,1
3,GO REGULATION OF POSTSYNAPSE ORGANIZATION,4.8997e-05,0.31491,0.39425,1,1
3,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,8.3641e-05,0.31486,0.37099,1,1
3,GO POSITIVE REGULATION OF AXON EXTENSION,7.8298e-05,0.31485,0.39424,1,1
3,GO REGULATION OF BLOOD CIRCULATION,0.00023283,0.31478,0.31632,1,1
3,GO DEFINITIVE HEMOPOIESIS,0.00081392,0.31469,0.38059,1,1
3,GO TORC1 SIGNALING,4.2763e-05,0.31435,0.38192,1,1
3,GO SOMATIC STEM CELL DIVISION,0.0096484,0.31414,0.34428,1,1
3,GO BEHAVIOR,1.1191e-05,0.31414,0.37061,1,1
3,GO REGULATION OF MRNA PROCESSING,1.8524e-05,0.314,0.33496,1,1
3,GO BASEMENT MEMBRANE ASSEMBLY,0.0092139,0.31396,0.3932,1,1
3,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.0172,0.31381,0.26605,1,1
3,GO CELL DIFFERENTIATION IN SPINAL CORD,0.00057531,0.3137,0.32038,1,1
3,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,7.3279e-05,0.3134,0.38123,1,1
3,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.034576,0.31305,0.27388,1,1
3,GO MYELIN ASSEMBLY,0.00010866,0.31305,0.38965,1,1
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00072571,0.3129,0.41404,1,1
3,GO PRESYNAPTIC ENDOCYTOSIS,0.00012367,0.31244,0.41105,1,1
3,GO SODIUM ION TRANSPORT,8.3641e-05,0.3123,0.37,1,1
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00013188,0.31161,0.33366,1,1
3,GO CELL PART MORPHOGENESIS,2.8267e-05,0.31146,0.36767,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,5.9985e-05,0.31037,0.41519,1,1
3,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.0024341,0.31031,0.37795,1,1
3,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.00012367,0.31029,0.34833,1,1
3,GO POTASSIUM ION HOMEOSTASIS,8.9327e-05,0.31028,0.36371,1,1
3,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.0010798,0.31006,0.38101,1,1
3,GO AXON EXTENSION,2.636e-05,0.3089,0.41765,1,1
3,GO AXO DENDRITIC TRANSPORT,0.00024771,0.30862,0.36164,1,1
3,GO CELLULAR COMPONENT MAINTENANCE,1.8524e-05,0.30845,0.3784,1,1
3,GO PROTEIN METHYLATION,2.2907e-05,0.30824,0.35285,1,1
3,GO OSTEOBLAST DEVELOPMENT,0.017954,0.30821,0.23707,1,1
3,GO HINDBRAIN MORPHOGENESIS,0.00010181,0.30753,0.34402,1,1
3,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.0057394,0.30752,0.28907,1,1
3,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0014241,0.30741,0.34023,1,1
3,GO MULTICELLULAR ORGANISMAL SIGNALING,3.248e-05,0.3074,0.40778,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.00011593,0.30727,0.36109,1,1
3,GO DENDRITIC SPINE MORPHOGENESIS,0.00014062,0.30705,0.44152,1,1
3,GO NEGATIVE REGULATION OF HORMONE SECRETION,2.8267e-05,0.30705,0.3365,1,1
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.00040321,0.30686,0.38941,1,1
3,GO ADULT LOCOMOTORY BEHAVIOR,5.6086e-05,0.3067,0.34502,1,1
3,GO MYOTUBE CELL DEVELOPMENT,0.00011593,0.30668,0.29883,1,1
3,GO SYNAPTIC SIGNALING,1.2939e-05,0.30636,0.43286,1,1
3,GO CELLULAR COMPONENT MORPHOGENESIS,3.0304e-05,0.30632,0.3598,1,1
3,GO EMBRYONIC PATTERN SPECIFICATION,2.4576e-05,0.30628,0.33134,1,1
3,GO REGULATION OF MEMBRANE REPOLARIZATION,0.0015882,0.30618,0.36789,1,1
3,GO ACID SECRETION,0.00029789,0.30601,0.30233,1,1
3,GO NEURON MIGRATION,0.00014989,0.30569,0.38241,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,4.2763e-05,0.30549,0.37404,1,1
3,GO NEURON PROJECTION ARBORIZATION,0.00031664,0.30541,0.38454,1,1
3,GO MAINTENANCE OF ORGANELLE LOCATION,0.00040321,0.305,0.32716,1,1
3,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,2.4576e-05,0.30494,0.39294,1,1
3,GO TRANSPORT ALONG MICROTUBULE,6.4139e-05,0.30492,0.32232,1,1
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,7.3279e-05,0.3048,0.3991,1,1
3,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.0010798,0.30465,0.28776,1,1
3,GO OOGENESIS,2.636e-05,0.30439,0.3036,1,1
3,GO REGULATION OF APPETITE,0.0096484,0.30438,0.31804,1,1
3,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,4.2763e-05,0.30425,0.34598,1,1
3,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,3.7287e-05,0.30425,0.36583,1,1
3,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00013188,0.30413,0.29881,1,1
3,GO POTASSIUM ION TRANSPORT,5.9985e-05,0.30411,0.37783,1,1
3,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.0010209,0.30408,0.29809,1,1
3,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.0016767,0.30394,0.31673,1,1
3,GO AXON DEVELOPMENT,4.2763e-05,0.30392,0.36627,1,1
3,GO VISUAL BEHAVIOR,3.9936e-05,0.30387,0.35314,1,1
3,GO NEURON PROJECTION EXTENSION,3.0304e-05,0.30349,0.40288,1,1
3,GO AXONAL TRANSPORT,0.00021879,0.30288,0.36457,1,1
3,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,1.6059e-05,0.30243,0.37761,1,1
3,GO HISTONE H4 K5 ACETYLATION,4.5779e-05,0.30233,0.35057,1,1
3,GO CELL MIGRATION IN HINDBRAIN,0.0036751,0.3023,0.38045,1,1
3,GO REGULATION OF PROTEIN SUMOYLATION,0.00057531,0.30212,0.30894,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.00057531,0.30203,0.37844,1,1
3,GO CHLORIDE ION HOMEOSTASIS,0.0020776,0.3013,0.30143,1,1
3,GO MISMATCH REPAIR,0.00018128,0.30093,0.30549,1,1
3,GO MEMBRANE DEPOLARIZATION,0.0015882,0.30092,0.35716,1,1
3,GO MICROTUBULE BASED PROCESS,1.3909e-05,0.30089,0.33928,1,1
3,GO REGULATION OF TORC1 SIGNALING,4.2763e-05,0.30054,0.36683,1,1
3,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.00014989,0.30031,0.3924,1,1
3,GO RESPONSE TO INACTIVITY,0.0019699,0.30029,0.3082,1,1
3,GO KINETOCHORE ORGANIZATION,0.019548,0.30021,0.26969,1,1
3,GO REGULATION OF CAMP MEDIATED SIGNALING,0.00012367,0.30019,0.3725,1,1
3,GO CELL JUNCTION ORGANIZATION,4.2763e-05,0.29991,0.36226,1,1
3,GO CAMERA TYPE EYE MORPHOGENESIS,0.00012367,0.29972,0.3182,1,1
3,GO REGULATION OF GONAD DEVELOPMENT,0.00081392,0.29961,0.28897,1,1
3,GO MEMBRANE DOCKING,1.9888e-05,0.29952,0.31952,1,1
3,GO LONG TERM SYNAPTIC POTENTIATION,0.00029789,0.29935,0.38523,1,1
3,GO PRO B CELL DIFFERENTIATION,0.007293,0.29923,0.33425,1,1
3,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00010181,0.29916,0.35095,1,1
3,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.00048214,0.29887,0.331,1,1
3,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.0025648,0.2984,0.31482,1,1
3,GO G2 DNA DAMAGE CHECKPOINT,0.00033648,0.29823,0.32299,1,1
3,GO ASYMMETRIC CELL DIVISION,0.00018128,0.29794,0.32653,1,1
3,GO REGULATION OF HIPPO SIGNALING,0.0016767,0.29767,0.31782,1,1
3,GO CIRCADIAN REGULATION OF GENE EXPRESSION,2.636e-05,0.29758,0.35064,1,1
3,GO REGULATION OF TELOMERE CAPPING,0.00014062,0.29743,0.32557,1,1
3,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.015776,0.29732,0.20864,1,1
3,GO FUCOSE METABOLIC PROCESS,0.00010181,0.29729,0.30211,1,1
3,GO ACROSOME REACTION,0.0003797,0.29677,0.30653,1,1
3,GO DIACYLGLYCEROL METABOLIC PROCESS,8.9327e-05,0.29677,0.39298,1,1
3,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.00076864,0.29652,0.32224,1,1
3,GO MAINTENANCE OF CELL POLARITY,0.0015882,0.29636,0.32899,1,1
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0036751,0.29634,0.29413,1,1
3,GO NEURON PROJECTION ORGANIZATION,0.00011593,0.29623,0.39096,1,1
3,GO MEIOTIC SPINDLE ORGANIZATION,0.00081392,0.2962,0.36927,1,1
3,GO RENAL WATER HOMEOSTASIS,0.0016767,0.29589,0.35668,1,1
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.00072571,0.29526,0.30924,1,1
3,GO MEIOSIS I CELL CYCLE PROCESS,0.00086166,0.29488,0.28335,1,1
3,GO REGULATION OF RNA SPLICING,1.6059e-05,0.2948,0.32131,1,1
3,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.030713,0.29475,0.23615,1,1
3,GO REGULATION OF FATTY ACID BETA OXIDATION,0.00014989,0.29459,0.3722,1,1
3,GO THYROID GLAND DEVELOPMENT,0.0003797,0.29457,0.35225,1,1
3,GO EMBRYONIC AXIS SPECIFICATION,2.8267e-05,0.29454,0.32922,1,1
3,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.00045436,0.29452,0.32197,1,1
3,GO RENAL SODIUM EXCRETION,0.011063,0.29452,0.30703,1,1
3,GO APICAL PROTEIN LOCALIZATION,0.0017696,0.29415,0.31939,1,1
3,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,1.3909e-05,0.29391,0.42912,1,1
3,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00048214,0.29369,0.3379,1,1
3,GO REGULATION OF CHOLESTEROL EFFLUX,0.0076456,0.2936,0.281,1,1
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.020391,0.29302,0.24115,1,1
3,GO PROTEIN KINASE C SIGNALING,0.0066311,0.29291,0.3149,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00015974,0.29244,0.39878,1,1
3,GO EXPORT ACROSS PLASMA MEMBRANE,0.00021879,0.2924,0.3473,1,1
3,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.0024341,0.29218,0.39262,1,1
3,GO DETECTION OF TEMPERATURE STIMULUS,0.0027019,0.29208,0.35397,1,1
3,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.018736,0.29205,0.29059,1,1
3,GO REGULATION OF MRNA POLYADENYLATION,1.6059e-05,0.29189,0.38679,1,1
3,GO NOTCH RECEPTOR PROCESSING,0.035953,0.29181,0.27687,1,1
3,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.0018673,0.29174,0.31646,1,1
3,GO NEUROBLAST PROLIFERATION,0.0018673,0.29137,0.28536,1,1
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.041938,0.29106,0.23443,1,1
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.00023283,0.29099,0.29169,1,1
3,GO RESPONSE TO ELECTRICAL STIMULUS,0.0010209,0.29067,0.2891,1,1
3,GO NEURAL CREST CELL DIFFERENTIATION,0.00076864,0.29061,0.28881,1,1
3,GO RESPONSE TO ALKALOID,5.9985e-05,0.29049,0.29068,1,1
3,GO REGULATION OF CYCLASE ACTIVITY,3.7287e-05,0.29037,0.36089,1,1
3,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0025648,0.2898,0.34528,1,1
3,GO LOCALIZATION WITHIN MEMBRANE,0.00029789,0.28963,0.33904,1,1
3,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,6.8565e-05,0.28942,0.33812,1,1
3,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.0021907,0.28938,0.27,1,1
3,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,4.8997e-05,0.28904,0.3386,1,1
3,GO REGULATION OF SYNAPTIC PLASTICITY,5.2428e-05,0.28889,0.42573,1,1
3,GO ACTION POTENTIAL,0.00010866,0.28882,0.38163,1,1
3,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.00014062,0.28835,0.45,1,1
3,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0060238,0.28824,0.296,1,1
3,GO STRIATUM DEVELOPMENT,0.0024341,0.28822,0.31959,1,1
3,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,5.2428e-05,0.28813,0.38248,1,1
3,GO SPERM CAPACITATION,0.0042727,0.28793,0.25152,1,1
3,GO POST ANAL TAIL MORPHOGENESIS,0.0015882,0.28784,0.31632,1,1
3,GO DETECTION OF VISIBLE LIGHT,5.2428e-05,0.28783,0.25393,1,1
3,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.00064645,0.28781,0.32062,1,1
3,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.021265,0.2876,0.2185,1,1
3,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,4.5779e-05,0.28749,0.36808,1,1
3,GO CELL FATE SPECIFICATION,0.0021907,0.28746,0.27157,1,1
3,GO DEVELOPMENTAL CELL GROWTH,6.8565e-05,0.28745,0.36955,1,1
3,GO GERM CELL DEVELOPMENT,1.2939e-05,0.28744,0.31056,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0060238,0.28732,0.33675,1,1
3,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00012367,0.28717,0.3341,1,1
3,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0015882,0.28669,0.31596,1,1
3,GO METANEPHROS MORPHOGENESIS,0.00026348,0.28668,0.32777,1,1
3,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.0003797,0.28627,0.30014,1,1
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0060238,0.28624,0.3006,1,1
3,GO ORGANIC CATION TRANSPORT,6.8565e-05,0.28587,0.3434,1,1
3,GO POSITIVE REGULATION OF TOR SIGNALING,7.3279e-05,0.28557,0.30083,1,1
3,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.0063209,0.28547,0.26641,1,1
3,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.00020554,0.28546,0.31145,1,1
3,GO TRANSMISSION OF NERVE IMPULSE,1.8524e-05,0.28521,0.45302,1,1
3,GO ACTIVATION OF JNKK ACTIVITY,0.00091199,0.28516,0.32417,1,1
3,GO CELL PROJECTION ORGANIZATION,2.2907e-05,0.28509,0.32749,1,1
3,GO HISTONE H2A MONOUBIQUITINATION,0.00011593,0.28504,0.36287,1,1
3,GO HEART PROCESS,0.00012367,0.28453,0.31228,1,1
3,GO ADAPTATION OF SIGNALING PATHWAY,0.0015041,0.28418,0.3409,1,1
3,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,5.6086e-05,0.28417,0.33667,1,1
3,GO SMOOTHENED SIGNALING PATHWAY,3.7287e-05,0.28398,0.32392,1,1
3,GO RESPONSE TO NICOTINE,0.00021879,0.28375,0.35571,1,1
3,GO NEURON FATE SPECIFICATION,0.016475,0.28373,0.3134,1,1
3,GO SECONDARY METABOLIC PROCESS,0.00033648,0.28351,0.27967,1,1
3,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.00013188,0.28315,0.32427,1,1
3,GO AXONAL TRANSPORT OF MITOCHONDRION,0.010572,0.28279,0.26528,1,1
3,GO AROMATIC AMINO ACID TRANSPORT,0.030713,0.28251,0.24117,1,1
3,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,2.8267e-05,0.28236,0.40629,1,1
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,3.7287e-05,0.28231,0.33256,1,1
3,GO RESPONSE TO HYDROXYUREA,0.00029789,0.28222,0.30173,1,1
3,GO HISTONE H3 DEACETYLATION,1.7249e-05,0.28213,0.37881,1,1
3,GO HISTONE DEUBIQUITINATION,0.00019306,0.28211,0.35635,1,1
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0014241,0.28207,0.34813,1,1
3,GO RESPONSE TO NERVE GROWTH FACTOR,0.00014989,0.28183,0.32868,1,1
3,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.00024771,0.28137,0.33206,1,1
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0017696,0.2809,0.32556,1,1
3,GO LENS FIBER CELL DIFFERENTIATION,0.0003797,0.28079,0.30367,1,1
3,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.015104,0.28079,0.24433,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,6.4139e-05,0.28074,0.36027,1,1
3,GO MESONEPHROS DEVELOPMENT,0.0063209,0.28071,0.2288,1,1
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0172,0.28068,0.26565,1,1
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.00064645,0.28033,0.32491,1,1
3,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0029965,0.28014,0.3188,1,1
3,GO REGULATION OF GLUCONEOGENESIS,2.8267e-05,0.28002,0.36511,1,1
3,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,2.8267e-05,0.28002,0.30628,1,1
3,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0003797,0.27993,0.37681,1,1
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,3.248e-05,0.27982,0.33653,1,1
3,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.0029965,0.27968,0.34358,1,1
3,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,8.9327e-05,0.27941,0.30291,1,1
3,GO COVALENT CHROMATIN MODIFICATION,2.4576e-05,0.27908,0.33544,1,1
3,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.016475,0.27889,0.27278,1,1
3,GO CORPUS CALLOSUM DEVELOPMENT,0.0021907,0.27873,0.34012,1,1
3,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.00010181,0.27871,0.33003,1,1
3,GO REGULATION OF CIRCADIAN RHYTHM,1.6059e-05,0.27854,0.32835,1,1
3,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.015104,0.27839,0.31779,1,1
3,GO REGULATION OF SISTER CHROMATID COHESION,0.0015041,0.27838,0.29959,1,1
3,GO FOREGUT MORPHOGENESIS,0.0076456,0.27823,0.27073,1,1
3,GO SPERM AXONEME ASSEMBLY,0.00096503,0.2781,0.28805,1,1
3,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.0018673,0.27735,0.2309,1,1
3,GO POST EMBRYONIC DEVELOPMENT,0.00012367,0.27709,0.30619,1,1
3,GO MITOTIC CHROMOSOME CONDENSATION,0.030713,0.27707,0.30097,1,1
3,GO NEURON DEVELOPMENT,2.4576e-05,0.27702,0.35383,1,1
3,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00023283,0.27698,0.33393,1,1
3,GO CHROMOSOME CONDENSATION,0.0076456,0.27675,0.2741,1,1
3,GO MONOVALENT INORGANIC CATION TRANSPORT,0.00014062,0.27666,0.31884,1,1
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.00064645,0.27663,0.31482,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00018128,0.27655,0.32478,1,1
3,GO RESPONSE TO PAIN,0.0042727,0.27625,0.31767,1,1
3,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0021907,0.27603,0.32856,1,1
3,GO REGULATION OF EXCRETION,0.020391,0.27592,0.25245,1,1
3,GO IMPORT INTO CELL,0.00029789,0.27585,0.29627,1,1
3,GO OOCYTE DIFFERENTIATION,0.00011593,0.27582,0.28934,1,1
3,GO OVARIAN FOLLICLE DEVELOPMENT,0.00010181,0.27581,0.31587,1,1
3,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,3.7287e-05,0.27555,0.32362,1,1
3,GO REGULATION OF MEIOTIC CELL CYCLE,0.00011593,0.2752,0.28021,1,1
3,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.00014062,0.27513,0.27122,1,1
3,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.027226,0.27506,0.26608,1,1
3,GO INOSITOL PHOSPHATE METABOLIC PROCESS,2.8267e-05,0.27502,0.34839,1,1
3,GO REGULATION OF SPINDLE ORGANIZATION,0.00045436,0.27447,0.28094,1,1
3,GO MEMORY,0.00014062,0.27446,0.34652,1,1
3,GO HISTONE DEACETYLATION,2.4576e-05,0.27441,0.33173,1,1
3,GO CELL PROJECTION ASSEMBLY,3.9936e-05,0.27394,0.3029,1,1
3,GO PROTEIN LOCALIZATION TO LYSOSOME,0.00048214,0.27391,0.31134,1,1
3,GO ACTIVATION OF MAPKKK ACTIVITY,0.0047188,0.2739,0.3028,1,1
3,GO REGULATION OF HISTONE METHYLATION,2.8267e-05,0.27379,0.35655,1,1
3,GO PEPTIDE HORMONE SECRETION,1.6059e-05,0.2737,0.33382,1,1
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.00096503,0.27363,0.30425,1,1
3,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.0023095,0.27362,0.32036,1,1
3,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00012367,0.27353,0.35949,1,1
3,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0012071,0.2734,0.32046,1,1
3,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.0018673,0.27328,0.28951,1,1
3,GO CARDIAC MUSCLE CELL CONTRACTION,0.00096503,0.27324,0.34188,1,1
3,GO DORSAL VENTRAL PATTERN FORMATION,0.00020554,0.27273,0.30917,1,1
3,GO POSITIVE REGULATION OF DNA REPAIR,3.248e-05,0.2727,0.31445,1,1
3,GO SPECIFICATION OF SYMMETRY,5.2428e-05,0.27256,0.32037,1,1
3,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,3.9936e-05,0.27249,0.32572,1,1
3,GO REGULATION OF LYASE ACTIVITY,5.6086e-05,0.27246,0.32751,1,1
3,GO CHAPERONE MEDIATED AUTOPHAGY,0.013235,0.27229,0.22869,1,1
3,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.0010209,0.27226,0.33088,1,1
3,GO HISTONE H4 ACETYLATION,2.636e-05,0.2722,0.32672,1,1
3,GO MYELIN MAINTENANCE,0.015104,0.27207,0.26969,1,1
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.00014989,0.27187,0.32153,1,1
3,GO REGULATION OF HEART RATE,0.00051151,0.2717,0.32344,1,1
3,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.00012367,0.27169,0.28916,1,1
3,GO SPINDLE ORGANIZATION,0.0010798,0.27158,0.28154,1,1
3,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.00028019,0.27127,0.29758,1,1
3,GO REGULATION OF FEEDING BEHAVIOR,0.0016767,0.27117,0.25163,1,1
3,GO RESPONSE TO CATECHOLAMINE,0.00021879,0.27116,0.30014,1,1
3,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,3.7287e-05,0.27106,0.3653,1,1
3,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.045233,0.27091,0.23353,1,1
3,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.00017019,0.27059,0.30938,1,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.0025648,0.2705,0.35118,1,1
3,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.00057531,0.27046,0.28288,1,1
3,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,7.8298e-05,0.27014,0.33982,1,1
3,GO LEFT RIGHT AXIS SPECIFICATION,0.0025648,0.27009,0.28492,1,1
3,GO REGULATION OF ORGANIC ACID TRANSPORT,0.0023095,0.27008,0.24837,1,1
3,GO DOPAMINE METABOLIC PROCESS,0.0054671,0.27008,0.28453,1,1
3,GO SECONDARY HEART FIELD SPECIFICATION,0.0047188,0.27001,0.38326,1,1
3,GO WATER HOMEOSTASIS,0.00332,0.26964,0.282,1,1
3,GO UV PROTECTION,8.3641e-05,0.2696,0.33632,1,1
3,GO CATECHOLAMINE METABOLIC PROCESS,0.0027019,0.26942,0.2852,1,1
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0019699,0.26921,0.29129,1,1
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.00013188,0.26912,0.35449,1,1
3,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0044907,0.26906,0.25833,1,1
3,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.0023095,0.26902,0.28193,1,1
3,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,4.8997e-05,0.26891,0.36747,1,1
3,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.00018128,0.26819,0.29084,1,1
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.00035748,0.26806,0.38561,1,1
3,GO REGULATION OF NEURON DIFFERENTIATION,5.6086e-05,0.26806,0.33781,1,1
3,GO EXCRETION,0.00012367,0.26791,0.33603,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.0019699,0.26789,0.2795,1,1
3,GO VESICLE TRANSPORT ALONG MICROTUBULE,3.7287e-05,0.26775,0.34934,1,1
3,GO DIOL METABOLIC PROCESS,0.0021907,0.26765,0.26243,1,1
3,GO CHROMOSOME SEPARATION,0.0052065,0.26756,0.2407,1,1
3,GO GROOMING BEHAVIOR,0.0027019,0.26756,0.36012,1,1
3,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0023095,0.26754,0.36368,1,1
3,GO SEGMENTATION,0.00013188,0.26719,0.28268,1,1
3,GO REGULATION OF CELL SIZE,4.5779e-05,0.26717,0.352,1,1
3,GO NEURON DIFFERENTIATION,2.1347e-05,0.26714,0.33547,1,1
3,GO TOOTH MINERALIZATION,0.0054671,0.2669,0.36764,1,1
3,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.052482,0.26678,0.28985,1,1
3,GO CELLULAR RESPONSE TO PH,0.00026348,0.26678,0.28955,1,1
3,GO ALANINE TRANSPORT,0.026142,0.26673,0.25883,1,1
3,GO CIRCADIAN RHYTHM,2.4576e-05,0.26664,0.28489,1,1
3,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.045233,0.26659,0.20513,1,1
3,GO INNER EAR MORPHOGENESIS,0.00014989,0.26655,0.30011,1,1
3,GO SOMITE DEVELOPMENT,6.8565e-05,0.26639,0.30725,1,1
3,GO CARBOHYDRATE PHOSPHORYLATION,0.0013481,0.26629,0.26492,1,1
3,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.0027019,0.26621,0.31924,1,1
3,GO CHROMATIN ORGANIZATION,4.2763e-05,0.26621,0.3226,1,1
3,GO POSITIVE REGULATION OF RNA SPLICING,1.8524e-05,0.26614,0.30137,1,1
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.00042807,0.26587,0.28248,1,1
3,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.0040644,0.26568,0.30234,1,1
3,GO PROTEIN O LINKED MANNOSYLATION,0.00023283,0.26562,0.29037,1,1
3,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,7.3279e-05,0.26552,0.34489,1,1
3,GO HISTONE H2A UBIQUITINATION,0.00017019,0.2655,0.31325,1,1
3,GO ESTROUS CYCLE,0.011063,0.26535,0.2718,1,1
3,GO DOPAMINE BIOSYNTHETIC PROCESS,0.019548,0.26475,0.2745,1,1
3,GO PEPTIDYL LYSINE MODIFICATION,3.7287e-05,0.2645,0.29915,1,1
3,GO PEPTIDYL THREONINE MODIFICATION,3.7287e-05,0.26434,0.3265,1,1
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.0049572,0.26429,0.33729,1,1
3,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.00018128,0.26423,0.30074,1,1
3,GO NEGATIVE REGULATION OF TOR SIGNALING,3.9936e-05,0.26417,0.31642,1,1
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00019306,0.26413,0.33374,1,1
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,4.5779e-05,0.26412,0.3171,1,1
3,GO GLUTAMATE METABOLIC PROCESS,3.248e-05,0.26411,0.3092,1,1
3,GO ACTIN FILAMENT NETWORK FORMATION,0.0083971,0.2639,0.26579,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0031545,0.26356,0.33359,1,1
3,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0036751,0.26335,0.28282,1,1
3,GO CAMERA TYPE EYE DEVELOPMENT,3.4805e-05,0.26335,0.3079,1,1
3,GO OLIGODENDROCYTE DEVELOPMENT,2.4576e-05,0.2633,0.32709,1,1
3,GO PROTEIN HETEROTETRAMERIZATION,0.00096503,0.26325,0.25863,1,1
3,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.00033648,0.26323,0.2951,1,1
3,GO CARNITINE METABOLIC PROCESS,0.00029789,0.26267,0.30003,1,1
3,GO EYE MORPHOGENESIS,0.00021879,0.26253,0.29694,1,1
3,GO PROTEIN MANNOSYLATION,2.8267e-05,0.26232,0.33227,1,1
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.0010209,0.26217,0.30123,1,1
3,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.00029789,0.26216,0.29573,1,1
3,GO PIGMENT GRANULE LOCALIZATION,0.0031545,0.26216,0.26715,1,1
3,GO CHROMATIN REMODELING,5.9985e-05,0.26194,0.30736,1,1
3,GO INSULIN SECRETION,1.9888e-05,0.26189,0.33596,1,1
3,GO RNA POLYADENYLATION,8.3641e-05,0.2614,0.3148,1,1
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,9.5377e-05,0.26118,0.31464,1,1
3,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.0028457,0.26117,0.28984,1,1
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.00048214,0.26082,0.34418,1,1
3,GO PROTEIN AUTO ADP RIBOSYLATION,0.0028457,0.26079,0.28864,1,1
3,GO METANEPHRIC NEPHRON DEVELOPMENT,0.024086,0.26064,0.25386,1,1
3,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.00014062,0.26042,0.33376,1,1
3,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0003797,0.26014,0.34217,1,1
3,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.031957,0.26013,0.20825,1,1
3,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0016767,0.26007,0.29522,1,1
3,GO MITOCHONDRION LOCALIZATION,0.00021879,0.26005,0.32225,1,1
3,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.00014062,0.25999,0.32178,1,1
3,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.00332,0.25975,0.28172,1,1
3,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.00021879,0.25968,0.286,1,1
3,GO SENSORY ORGAN MORPHOGENESIS,0.00015974,0.25966,0.27378,1,1
3,GO PEPTIDYL ARGININE METHYLATION,0.0054671,0.25963,0.24981,1,1
3,GO SOMITOGENESIS,0.00010866,0.25913,0.30469,1,1
3,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0016767,0.25874,0.26819,1,1
3,GO CALCINEURIN MEDIATED SIGNALING,0.00057531,0.25872,0.27434,1,1
3,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.019548,0.25865,0.26235,1,1
3,GO PARAXIAL MESODERM DEVELOPMENT,0.038848,0.25836,0.18542,1,1
3,GO PROTEIN ACYLATION,2.4576e-05,0.25823,0.30892,1,1
3,GO HETEROCHROMATIN ORGANIZATION,0.00010866,0.25817,0.32597,1,1
3,GO STRIATED MUSCLE CONTRACTION,0.00045436,0.25802,0.31089,1,1
3,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0029965,0.25798,0.2597,1,1
3,GO DICARBOXYLIC ACID TRANSPORT,0.00019306,0.25797,0.32199,1,1
3,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,1.6059e-05,0.25796,0.2891,1,1
3,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.00017019,0.25786,0.34861,1,1
3,GO HISTONE H3 K9 ACETYLATION,0.0018673,0.25764,0.24671,1,1
3,GO REGULATION OF ORGANELLE ASSEMBLY,2.8267e-05,0.25731,0.29841,1,1
3,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,4.8997e-05,0.25727,0.35027,1,1
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.065157,0.25708,0.18334,1,1
3,GO SIALYLATION,0.0057394,0.25682,0.30727,1,1
3,GO REGULATION OF SPINDLE ASSEMBLY,0.0060238,0.25673,0.22464,1,1
3,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.00017019,0.25658,0.32627,1,1
3,GO NEURONAL ACTION POTENTIAL,0.0020776,0.25644,0.37012,1,1
3,GO SPINDLE ASSEMBLY,0.0017696,0.25644,0.26037,1,1
3,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.0010798,0.25615,0.3918,1,1
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00018128,0.25614,0.2905,1,1
3,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.013834,0.25603,0.29227,1,1
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00015974,0.25591,0.32748,1,1
3,GO RESPONSE TO IMMOBILIZATION STRESS,0.0011418,0.25581,0.29514,1,1
3,GO REGULATION OF HORMONE SECRETION,4.8997e-05,0.25577,0.29035,1,1
3,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.040368,0.25567,0.20274,1,1
3,GO NADH METABOLIC PROCESS,0.0012071,0.25551,0.23866,1,1
3,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,7.8298e-05,0.25541,0.32617,1,1
3,GO REGULATION OF CHROMATIN ORGANIZATION,3.4805e-05,0.25531,0.29647,1,1
3,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.024086,0.25516,0.21046,1,1
3,GO SPINDLE LOCALIZATION,0.00014062,0.25493,0.29687,1,1
3,GO MEMBRANE BIOGENESIS,0.00072571,0.25489,0.35263,1,1
3,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,6.4139e-05,0.25482,0.3124,1,1
3,GO PEPTIDYL LYSINE ACETYLATION,3.4805e-05,0.25464,0.30785,1,1
3,GO REGULATION OF POTASSIUM ION TRANSPORT,8.9327e-05,0.25458,0.34316,1,1
3,GO SENSORY SYSTEM DEVELOPMENT,5.2428e-05,0.25448,0.29872,1,1
3,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.0040644,0.25427,0.23345,1,1
3,GO SPERMATID DIFFERENTIATION,2.2907e-05,0.25406,0.29206,1,1
3,GO MIDGUT DEVELOPMENT,0.0066311,0.25403,0.32441,1,1
3,GO TELOMERE CAPPING,0.00015974,0.25399,0.29469,1,1
3,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,6.8565e-05,0.2539,0.41564,1,1
3,GO MITOTIC SPINDLE ORGANIZATION,0.0063209,0.25373,0.24387,1,1
3,GO OVULATION CYCLE,0.00045436,0.25373,0.3166,1,1
3,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.011574,0.25366,0.26006,1,1
3,GO DEVELOPMENTAL MATURATION,6.8565e-05,0.25354,0.29907,1,1
3,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0012071,0.25343,0.4224,1,1
3,GO NEURAL TUBE DEVELOPMENT,0.00096503,0.25332,0.27592,1,1
3,GO CELLULAR GLUCOSE HOMEOSTASIS,5.9985e-05,0.25322,0.27834,1,1
3,GO REFLEX,0.025096,0.25316,0.29806,1,1
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00042807,0.25309,0.28516,1,1
3,GO NEUROGENESIS,2.8267e-05,0.25308,0.31541,1,1
3,GO PHOTORECEPTOR CELL MAINTENANCE,8.9327e-05,0.25308,0.33593,1,1
3,GO POSITIVE REGULATION OF ACROSOME REACTION,0.0014241,0.253,0.27344,1,1
3,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0044907,0.25294,0.22469,1,1
3,GO METHYLATION,3.248e-05,0.2528,0.26657,1,1
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.00051151,0.25277,0.33202,1,1
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.0040644,0.25272,0.26894,1,1
3,GO REGULATION OF FATTY ACID OXIDATION,0.00060992,0.2527,0.28875,1,1
3,GO HEAD DEVELOPMENT,2.2907e-05,0.25269,0.30392,1,1
3,GO RENAL SYSTEM PROCESS,0.0021907,0.25228,0.26988,1,1
3,GO CHLORIDE TRANSPORT,0.00033648,0.25225,0.3161,1,1
3,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.00017019,0.25225,0.44479,1,1
3,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.027226,0.25217,0.19321,1,1
3,GO CELLULAR SODIUM ION HOMEOSTASIS,0.0038653,0.25208,0.26916,1,1
3,GO PROTEIN ACETYLATION,4.2763e-05,0.25197,0.29525,1,1
3,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.00096503,0.25195,0.27891,1,1
3,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,2.636e-05,0.25183,0.29251,1,1
3,GO REGULATION OF CHROMOSOME SEPARATION,0.011063,0.25157,0.19972,1,1
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.0049572,0.25149,0.23816,1,1
3,GO SEXUAL REPRODUCTION,8.9843e-06,0.25142,0.28089,1,1
3,GO RESPONSE TO DOPAMINE,6.8565e-05,0.25122,0.30289,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.00042807,0.25121,0.27329,1,1
3,GO BIOLOGICAL PHASE,0.033245,0.25085,0.25083,1,1
3,GO PROTEIN DEPOLYMERIZATION,6.4139e-05,0.25065,0.35099,1,1
3,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,3.0304e-05,0.25051,0.30217,1,1
3,GO REGULATION OF HISTONE MODIFICATION,2.4576e-05,0.25045,0.29374,1,1
3,GO CELL CELL JUNCTION ORGANIZATION,0.00048214,0.25045,0.27643,1,1
3,GO CARDIAC MUSCLE CONTRACTION,0.00054254,0.25032,0.30366,1,1
3,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.0047188,0.25004,0.23126,1,1
3,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,9.5377e-05,0.24972,0.4003,1,1
3,GO MEIOTIC CELL CYCLE,0.00019306,0.24952,0.28452,1,1
3,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.0036751,0.24932,0.3042,1,1
3,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.00020554,0.24873,0.30442,1,1
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.0034935,0.24865,0.30726,1,1
3,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.037377,0.24842,0.18645,1,1
3,GO NUCLEAR CHROMOSOME SEGREGATION,0.0036751,0.24824,0.22882,1,1
3,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.0011418,0.2481,0.26099,1,1
3,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00024771,0.24806,0.28798,1,1
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0066311,0.248,0.25717,1,1
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00072571,0.24782,0.28132,1,1
3,GO PATTERN SPECIFICATION PROCESS,3.248e-05,0.24781,0.28936,1,1
3,GO METHIONINE METABOLIC PROCESS,0.00031664,0.24776,0.29575,1,1
3,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,8.3641e-05,0.24773,0.28401,1,1
3,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0034935,0.24768,0.24752,1,1
3,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.01266,0.24742,0.27276,1,1
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.00014989,0.24736,0.26902,1,1
3,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0018673,0.24716,0.30945,1,1
3,GO DETECTION OF CALCIUM ION,0.010572,0.24707,0.33554,1,1
3,GO PANCREATIC JUICE SECRETION,0.058535,0.24706,0.21362,1,1
3,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.01266,0.2466,0.24603,1,1
3,GO SINGLE STRAND BREAK REPAIR,5.2428e-05,0.24652,0.34944,1,1
3,GO MELANOCYTE DIFFERENTIATION,0.00072571,0.24647,0.29617,1,1
3,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.0025648,0.24646,0.28924,1,1
3,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.022172,0.24628,0.23063,1,1
3,GO PARTURITION,0.0031545,0.24609,0.25982,1,1
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,2.4576e-05,0.2459,0.29739,1,1
3,GO REGULATION OF INSULIN SECRETION,1.8524e-05,0.24589,0.33268,1,1
3,GO AMINO ACID TRANSPORT,7.8298e-05,0.24583,0.29159,1,1
3,GO REGULATION OF MITOPHAGY,0.00010181,0.24529,0.37987,1,1
3,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.021265,0.24522,0.24007,1,1
3,GO MITOCHONDRION DISTRIBUTION,0.00014989,0.24503,0.34061,1,1
3,GO ACTIVATION OF MAPKK ACTIVITY,0.00048214,0.24499,0.32639,1,1
3,GO RHYTHMIC PROCESS,1.8524e-05,0.24466,0.28704,1,1
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,3.0304e-05,0.24457,0.32489,1,1
3,GO REGULATION OF PEPTIDE HORMONE SECRETION,1.8524e-05,0.24456,0.33761,1,1
3,GO MRNA METHYLATION,0.00057531,0.24438,0.29083,1,1
3,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.00060992,0.24434,0.31542,1,1
3,GO INTRA S DNA DAMAGE CHECKPOINT,0.00031664,0.24427,0.3371,1,1
3,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0031545,0.24421,0.30356,1,1
3,GO EMBRYONIC DIGIT MORPHOGENESIS,0.00045436,0.24409,0.27842,1,1
3,GO MULTICELLULAR ORGANISM GROWTH,5.9985e-05,0.24396,0.30856,1,1
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.011574,0.24391,0.19117,1,1
3,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.00026348,0.24382,0.28448,1,1
3,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.0047188,0.24379,0.33838,1,1
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.037377,0.24367,0.29238,1,1
3,GO POLYOL CATABOLIC PROCESS,5.9985e-05,0.24363,0.33492,1,1
3,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.008797,0.2436,0.26329,1,1
3,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.031957,0.24344,0.33494,1,1
3,GO LOCOMOTOR RHYTHM,0.0010209,0.24341,0.4189,1,1
3,GO REGULATION OF DNA REPAIR,5.2428e-05,0.24338,0.29275,1,1
3,GO COGNITION,1.8524e-05,0.24313,0.33521,1,1
3,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.0029965,0.24307,0.31003,1,1
3,GO BODY MORPHOGENESIS,0.016475,0.24304,0.25413,1,1
3,GO DIGESTIVE SYSTEM DEVELOPMENT,0.0014241,0.243,0.25013,1,1
3,GO CELL CELL JUNCTION ASSEMBLY,0.00086166,0.24269,0.26699,1,1
3,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0010798,0.24267,0.30759,1,1
3,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.011574,0.24266,0.19732,1,1
3,GO REGULATION OF CYTOKINESIS,0.00019306,0.2423,0.28969,1,1
3,GO REGULATION OF GOLGI ORGANIZATION,0.0047188,0.24212,0.32039,1,1
3,GO REGULATION OF CHROMOSOME SEGREGATION,0.007293,0.24211,0.21814,1,1
3,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.00020554,0.24205,0.33341,1,1
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00054254,0.24204,0.24833,1,1
3,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.062884,0.2419,0.23552,1,1
3,GO MAGNESIUM ION TRANSPORT,0.00057531,0.24186,0.32672,1,1
3,GO OVULATION CYCLE PROCESS,0.00020554,0.24179,0.3297,1,1
3,GO REGIONALIZATION,0.00018128,0.24174,0.26268,1,1
3,GO EPITHELIAL STRUCTURE MAINTENANCE,0.0013481,0.2414,0.27557,1,1
3,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.00018128,0.24134,0.28629,1,1
3,GO MEMBRANE REPOLARIZATION,0.0031545,0.24132,0.33338,1,1
3,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.012106,0.24118,0.28544,1,1
3,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.00060992,0.24116,0.27751,1,1
3,GO MESENCHYMAL CELL DIFFERENTIATION,0.011574,0.24097,0.2308,1,1
3,GO RESPONSE TO MISFOLDED PROTEIN,7.8298e-05,0.24077,0.31572,1,1
3,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,5.6086e-05,0.24074,0.30547,1,1
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.0063209,0.24071,0.18476,1,1
3,GO PROTEIN HETEROOLIGOMERIZATION,0.007293,0.24066,0.23612,1,1
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.00060992,0.24065,0.24263,1,1
3,GO REGULATION OF MEMBRANE POTENTIAL,2.8267e-05,0.2406,0.36945,1,1
3,GO HEART FORMATION,0.0027019,0.24058,0.26706,1,1
3,GO ENAMEL MINERALIZATION,0.0023095,0.24045,0.37843,1,1
3,GO RESPONSE TO LIGHT STIMULUS,1.9888e-05,0.24037,0.26991,1,1
3,GO DEMETHYLATION,7.3279e-05,0.24031,0.31096,1,1
3,GO SENSORY ORGAN DEVELOPMENT,8.3641e-05,0.24015,0.28042,1,1
3,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.017954,0.24011,0.22179,1,1
3,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.037377,0.2401,0.25614,1,1
3,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,7.8298e-05,0.23979,0.33726,1,1
3,GO DETECTION OF LIGHT STIMULUS,5.2428e-05,0.23974,0.24745,1,1
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.0076456,0.23971,0.23392,1,1
3,GO HISTONE H3 ACETYLATION,0.00028019,0.23956,0.25814,1,1
3,GO MACROMOLECULE DEACYLATION,2.636e-05,0.23954,0.31272,1,1
3,GO MOTOR NEURON AXON GUIDANCE,0.0054671,0.23941,0.27714,1,1
3,GO INTERMEDIATE FILAMENT BASED PROCESS,0.0083971,0.23922,0.21625,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.00021879,0.2392,0.33757,1,1
3,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.0036751,0.23894,0.25782,1,1
3,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.0029965,0.23893,0.31211,1,1
3,GO CHROMOSOME SEGREGATION,0.0042727,0.23851,0.22556,1,1
3,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.00014989,0.23835,0.3098,1,1
3,GO ENERGY HOMEOSTASIS,0.00012367,0.2383,0.32511,1,1
3,GO REGULATION OF HISTONE DEACETYLATION,0.00091199,0.2383,0.28255,1,1
3,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.00010866,0.23827,0.32385,1,1
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0042727,0.23821,0.28223,1,1
3,GO KIDNEY EPITHELIUM DEVELOPMENT,0.0034935,0.2382,0.23604,1,1
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00029789,0.23811,0.36878,1,1
3,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0010209,0.23805,0.29038,1,1
3,GO NON RECOMBINATIONAL REPAIR,0.00010181,0.23794,0.27156,1,1
3,GO RECEPTOR RECYCLING,0.0025648,0.23777,0.23955,1,1
3,GO GAMETE GENERATION,1.2939e-05,0.2375,0.28301,1,1
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.00040321,0.2374,0.29855,1,1
3,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.00060992,0.23726,0.28665,1,1
3,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.00091199,0.23705,0.25463,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.00096503,0.2368,0.26591,1,1
3,GO MITOPHAGY,0.00010181,0.2367,0.32011,1,1
3,GO POSITIVE REGULATION OF DNA REPLICATION,0.00020554,0.23663,0.27301,1,1
3,GO POSITIVE REGULATION OF INSULIN SECRETION,0.00064645,0.23661,0.28418,1,1
3,GO ENTRY OF BACTERIUM INTO HOST CELL,0.067497,0.2362,0.20361,1,1
3,GO MULTICELLULAR ORGANISM REPRODUCTION,1.8524e-05,0.2361,0.27064,1,1
3,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0038653,0.23576,0.28146,1,1
3,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.065157,0.23558,0.27323,1,1
3,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0044907,0.2354,0.25626,1,1
3,GO REGULATION OF OOGENESIS,0.0010209,0.23529,0.24378,1,1
3,GO ENDOCARDIUM DEVELOPMENT,0.0096484,0.23519,0.24712,1,1
3,GO DIOL BIOSYNTHETIC PROCESS,0.0015041,0.23508,0.24616,1,1
3,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00014989,0.23482,0.31809,1,1
3,GO REGULATION OF SYSTEM PROCESS,3.7287e-05,0.23481,0.29926,1,1
3,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.0021907,0.23441,0.28447,1,1
3,GO REGULATION OF RECEPTOR RECYCLING,0.011063,0.23438,0.22395,1,1
3,GO DENDRITE EXTENSION,0.0028457,0.23438,0.38879,1,1
3,GO MEIOTIC CELL CYCLE PROCESS,0.00057531,0.23434,0.27276,1,1
3,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.00060992,0.23415,0.25618,1,1
3,GO AORTA MORPHOGENESIS,0.0172,0.23412,0.28152,1,1
3,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.00020554,0.234,0.33051,1,1
3,GO CELL VOLUME HOMEOSTASIS,0.0038653,0.23359,0.26615,1,1
3,GO HORMONE TRANSPORT,4.2763e-05,0.23354,0.28272,1,1
3,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.014457,0.23327,0.28776,1,1
3,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00054254,0.23323,0.36882,1,1
3,GO REGULATION OF BEHAVIOR,0.00081392,0.23319,0.23604,1,1
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0017696,0.23313,0.22434,1,1
3,GO COPULATION,0.030713,0.23296,0.30416,1,1
3,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.031957,0.23286,0.211,1,1
3,GO AXIS SPECIFICATION,0.00011593,0.23285,0.25038,1,1
3,GO POSITIVE REGULATION OF FERTILIZATION,0.00086166,0.23267,0.25761,1,1
3,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.0025648,0.23246,0.25645,1,1
3,GO ALCOHOL CATABOLIC PROCESS,0.0012071,0.23237,0.23152,1,1
3,GO ANIMAL ORGAN FORMATION,0.013235,0.23235,0.19361,1,1
3,GO PROTEIN AUTOUBIQUITINATION,2.2907e-05,0.23231,0.28705,1,1
3,GO ENDOSOME TO LYSOSOME TRANSPORT,6.4139e-05,0.23225,0.33177,1,1
3,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.00040321,0.232,0.27444,1,1
3,GO 2 OXOGLUTARATE METABOLIC PROCESS,6.8565e-05,0.23169,0.29109,1,1
3,GO CENTROMERE COMPLEX ASSEMBLY,0.023112,0.2313,0.21885,1,1
3,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.00029789,0.23117,0.28736,1,1
3,GO LIPOPROTEIN LOCALIZATION,0.00332,0.23111,0.3138,1,1
3,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0027019,0.23092,0.28138,1,1
3,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.00029789,0.23088,0.26704,1,1
3,GO FOCAL ADHESION ASSEMBLY,0.0029965,0.23063,0.3005,1,1
3,GO RESPONSE TO AMINE,0.00018128,0.2306,0.26507,1,1
3,GO VESICLE CYTOSKELETAL TRAFFICKING,9.5377e-05,0.2305,0.33118,1,1
3,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00028019,0.23037,0.2671,1,1
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.018736,0.23035,0.28811,1,1
3,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0010209,0.23019,0.32477,1,1
3,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,7.3279e-05,0.23019,0.28263,1,1
3,GO LACTATION,0.00068502,0.23005,0.26207,1,1
3,GO HORMONE MEDIATED SIGNALING PATHWAY,1.8524e-05,0.23004,0.29117,1,1
3,GO DNA PACKAGING,0.00068502,0.22994,0.28543,1,1
3,GO EAR DEVELOPMENT,0.00029789,0.22989,0.26325,1,1
3,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.00040321,0.22975,0.28347,1,1
3,GO PROTEIN KINASE A SIGNALING,0.0010209,0.22967,0.28475,1,1
3,GO HAIR FOLLICLE MATURATION,0.0016767,0.22944,0.28786,1,1
3,GO DIGESTIVE TRACT MORPHOGENESIS,0.0080134,0.22943,0.26414,1,1
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.00017019,0.2294,0.26068,1,1
3,GO SENSORY PERCEPTION OF SMELL,0.00015974,0.22935,0.24491,1,1
3,GO RESPONSE TO AMPHETAMINE,0.00096503,0.22927,0.26794,1,1
3,GO MRNA 3 END PROCESSING,0.00019306,0.2291,0.26178,1,1
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.00010181,0.22886,0.3527,1,1
3,GO NODAL SIGNALING PATHWAY,0.013834,0.22879,0.27087,1,1
3,GO POSITIVE REGULATION OF MITOPHAGY,0.00064645,0.22877,0.37178,1,1
3,GO MANGANESE ION TRANSPORT,0.007293,0.22871,0.21809,1,1
3,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.00076864,0.22861,0.32011,1,1
3,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00042807,0.22859,0.27737,1,1
3,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.00048214,0.22842,0.3214,1,1
3,GO REGULATION OF TOR SIGNALING,4.5779e-05,0.22835,0.28335,1,1
3,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00081392,0.22817,0.42429,1,1
3,GO MRNA PROCESSING,5.9985e-05,0.22815,0.26241,1,1
3,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.013834,0.22801,0.2254,1,1
3,GO EAR MORPHOGENESIS,0.00031664,0.22783,0.27278,1,1
3,GO FERTILIZATION,1.4947e-05,0.22776,0.24951,1,1
3,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.00064645,0.2277,0.28832,1,1
3,GO STEROID HORMONE SECRETION,0.056456,0.22764,0.17372,1,1
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,7.3279e-05,0.22746,0.29078,1,1
3,GO PROTEIN O LINKED GLYCOSYLATION,0.014457,0.22735,0.22936,1,1
3,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.010101,0.22718,0.20455,1,1
3,GO ACTIN MEDIATED CELL CONTRACTION,0.0020776,0.22714,0.26271,1,1
3,GO RESPONSE TO PARATHYROID HORMONE,0.0080134,0.22674,0.24268,1,1
3,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.00072571,0.2267,0.26331,1,1
3,GO MUSCLE CONTRACTION,0.00086166,0.22666,0.26575,1,1
3,GO CELLULAR RESPONSE TO STEROL,0.0029965,0.22663,0.31475,1,1
3,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,5.2428e-05,0.22658,0.32885,1,1
3,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00020554,0.22649,0.27927,1,1
3,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,4.8997e-05,0.22644,0.26305,1,1
3,GO CELL DIVISION,0.00051151,0.22641,0.23757,1,1
3,GO SENSORY PERCEPTION OF LIGHT STIMULUS,5.6086e-05,0.22612,0.26175,1,1
3,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0012071,0.22592,0.24791,1,1
3,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.00042807,0.22573,0.2761,1,1
3,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.030713,0.22563,0.23161,1,1
3,GO REGULATION OF GASTRIC ACID SECRETION,0.046961,0.22556,0.2291,1,1
3,GO SISTER CHROMATID SEGREGATION,0.0066311,0.22554,0.21242,1,1
3,GO REGULATION OF TUBE SIZE,0.0076456,0.22554,0.21099,1,1
3,GO CHROMATIN REMODELING AT CENTROMERE,0.065157,0.22534,0.15558,1,1
3,GO DNA METHYLATION,0.00081392,0.22519,0.241,1,1
3,GO C4 DICARBOXYLATE TRANSPORT,0.0011418,0.22518,0.2444,1,1
3,GO GLUCOSE CATABOLIC PROCESS,0.010101,0.22514,0.21879,1,1
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.010572,0.22512,0.21232,1,1
3,GO ERYTHROCYTE MATURATION,0.0003797,0.22505,0.36413,1,1
3,GO ORGANELLE ASSEMBLY,1.1191e-05,0.22504,0.28068,1,1
3,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.00091199,0.22502,0.28999,1,1
3,GO DEVELOPMENTAL GROWTH,7.3279e-05,0.22499,0.28588,1,1
3,GO WALKING BEHAVIOR,0.0172,0.22495,0.24927,1,1
3,GO CONVERGENT EXTENSION,0.028348,0.22494,0.24398,1,1
3,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.0054671,0.22486,0.26684,1,1
3,GO CLATHRIN COAT ASSEMBLY,5.2428e-05,0.22485,0.36819,1,1
3,GO RESPONSE TO LEAD ION,0.00060992,0.22475,0.28497,1,1
3,GO RNA DESTABILIZATION,0.00096503,0.22465,0.29797,1,1
3,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0011418,0.22464,0.26737,1,1
3,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,7.3279e-05,0.22462,0.30565,1,1
3,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.065157,0.22449,0.21275,1,1
3,GO NERVOUS SYSTEM PROCESS,2.1347e-05,0.22439,0.29893,1,1
3,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.00042807,0.22433,0.32131,1,1
3,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.0023095,0.22419,0.34419,1,1
3,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,6.4139e-05,0.22407,0.27381,1,1
3,GO ANION TRANSMEMBRANE TRANSPORT,8.9327e-05,0.22407,0.26626,1,1
3,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00064645,0.22399,0.32154,1,1
3,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0025648,0.22396,0.23859,1,1
3,GO REGULATION OF EXOCYTOSIS,0.00028019,0.2238,0.3134,1,1
3,GO RNA SPLICING,8.9327e-05,0.22366,0.24919,1,1
3,GO MALE GAMETE GENERATION,1.6059e-05,0.22359,0.27163,1,1
3,GO CARDIAC SEPTUM MORPHOGENESIS,0.019548,0.22349,0.22493,1,1
3,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.00031664,0.22348,0.25718,1,1
3,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.018736,0.22337,0.21124,1,1
3,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.011063,0.22315,0.28225,1,1
3,GO IRON COORDINATION ENTITY TRANSPORT,0.0040644,0.22287,0.39515,1,1
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0021907,0.22275,0.18792,1,1
3,GO MITOTIC SISTER CHROMATID SEGREGATION,0.010572,0.22273,0.20125,1,1
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.0018673,0.22254,0.32296,1,1
3,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0172,0.2225,0.21203,1,1
3,GO HEART FIELD SPECIFICATION,0.015104,0.22244,0.26489,1,1
3,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.025096,0.22232,0.1882,1,1
3,GO FEMALE GAMETE GENERATION,0.00010866,0.2223,0.26069,1,1
3,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0063209,0.22226,0.24191,1,1
3,GO GOLGI TO VACUOLE TRANSPORT,0.0020776,0.22225,0.33102,1,1
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.010101,0.22197,0.30632,1,1
3,GO CHROMOSOME ORGANIZATION,8.9327e-05,0.22194,0.27886,1,1
3,GO KIDNEY MORPHOGENESIS,0.0036751,0.22183,0.2513,1,1
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.00051151,0.22182,0.26316,1,1
3,GO REGULATION OF CELL MATURATION,0.00017019,0.22174,0.23608,1,1
3,GO SKELETAL MUSCLE ADAPTATION,0.0092139,0.22154,0.29031,1,1
3,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.00012367,0.22149,0.2975,1,1
3,GO REGULATION OF SODIUM ION TRANSPORT,0.00013188,0.22139,0.32933,1,1
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0080134,0.22134,0.25075,1,1
3,GO CARBOHYDRATE HOMEOSTASIS,0.00017019,0.22102,0.22822,1,1
3,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00026348,0.22087,0.2816,1,1
3,GO CELL MORPHOGENESIS,9.5377e-05,0.22072,0.31513,1,1
3,GO REGULATION OF MRNA 3 END PROCESSING,7.3279e-05,0.22054,0.2947,1,1
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00010181,0.22037,0.29792,1,1
3,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.008797,0.22026,0.25251,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0024341,0.22017,0.32489,1,1
3,GO NEURAL NUCLEUS DEVELOPMENT,0.00035748,0.22015,0.31716,1,1
3,GO HISTONE MONOUBIQUITINATION,0.00042807,0.22005,0.29464,1,1
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.01266,0.21997,0.20798,1,1
3,GO ORGANELLE LOCALIZATION,2.636e-05,0.21977,0.2737,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.011063,0.21961,0.25495,1,1
3,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.00332,0.21949,0.28291,1,1
3,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0042727,0.21913,0.26155,1,1
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,6.8565e-05,0.21909,0.28695,1,1
3,GO POLYOL METABOLIC PROCESS,3.0304e-05,0.21909,0.27858,1,1
3,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.01266,0.21905,0.27925,1,1
3,GO REGULATION OF GLUCOSE IMPORT,0.00033648,0.21898,0.25704,1,1
3,GO ATP TRANSPORT,0.00048214,0.21897,0.23432,1,1
3,GO REGULATION OF DEVELOPMENTAL GROWTH,6.8565e-05,0.21894,0.30458,1,1
3,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,5.9985e-05,0.21893,0.27883,1,1
3,GO FATTY ACID BETA OXIDATION,0.00010181,0.21873,0.2606,1,1
3,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.00023283,0.2187,0.30338,1,1
3,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.0038653,0.21866,0.27786,1,1
3,GO CORONARY VASCULATURE DEVELOPMENT,0.006955,0.21865,0.27773,1,1
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.00017019,0.2183,0.22091,1,1
3,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,5.9985e-05,0.21813,0.32307,1,1
3,GO OLIGOPEPTIDE TRANSPORT,0.034576,0.21782,0.21663,1,1
3,GO CELL MATURATION,0.00031664,0.21778,0.25043,1,1
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.00045436,0.21769,0.29677,1,1
3,GO CELLULAR RESPONSE TO ALKALOID,0.00017019,0.21743,0.26025,1,1
3,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.0054671,0.21722,0.24433,1,1
3,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.00026348,0.2171,0.30112,1,1
3,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0025648,0.21696,0.34396,1,1
3,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0076456,0.21696,0.21419,1,1
3,GO LIPID OXIDATION,0.00028019,0.21682,0.23507,1,1
3,GO REGULATION OF NEURON MATURATION,0.0014241,0.21679,0.30447,1,1
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.00013188,0.21666,0.24608,1,1
3,GO REGULATION OF HISTONE H4 ACETYLATION,0.0034935,0.21664,0.20809,1,1
3,GO PROTEIN LOCALIZATION TO VACUOLE,0.00072571,0.2165,0.25359,1,1
3,GO MANNOSYLATION,0.00033648,0.21617,0.23631,1,1
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.00021879,0.21609,0.21993,1,1
3,GO NEUROBLAST DIVISION,0.00332,0.21609,0.27524,1,1
3,GO OUTFLOW TRACT MORPHOGENESIS,0.024086,0.216,0.206,1,1
3,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00017019,0.21573,0.28481,1,1
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0028457,0.21552,0.26829,1,1
3,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.0096484,0.21544,0.19941,1,1
3,GO DETECTION OF ABIOTIC STIMULUS,3.4805e-05,0.21538,0.25771,1,1
3,GO NEPHRON EPITHELIUM DEVELOPMENT,0.0012758,0.21533,0.25878,1,1
3,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0057394,0.2153,0.28057,1,1
3,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,4.5779e-05,0.21525,0.2823,1,1
3,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.00029789,0.21505,0.29986,1,1
3,GO MESENCHYME DEVELOPMENT,0.0063209,0.21504,0.2252,1,1
3,GO CARDIAC CELL DEVELOPMENT,0.0010798,0.21498,0.24761,1,1
3,GO NEPHRON MORPHOGENESIS,0.008797,0.21484,0.22844,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.027226,0.2147,0.20218,1,1
3,GO GANGLION DEVELOPMENT,0.022172,0.21466,0.25449,1,1
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.00023283,0.21455,0.25501,1,1
3,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.022172,0.21438,0.26794,1,1
3,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.00064645,0.21437,0.30295,1,1
3,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.00012367,0.21427,0.25948,1,1
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.065157,0.21422,0.16443,1,1
3,GO REGULATION OF CELL PROJECTION ORGANIZATION,5.9985e-05,0.21417,0.32264,1,1
3,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0010209,0.21405,0.24131,1,1
3,GO MRNA TRANSCRIPTION,0.052482,0.21398,0.2038,1,1
3,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0018673,0.21374,0.23267,1,1
3,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.0060238,0.2137,0.23837,1,1
3,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.0044907,0.21367,0.24166,1,1
3,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.00013188,0.21316,0.25247,1,1
3,GO CYTOSKELETON ORGANIZATION,5.9985e-05,0.21315,0.27524,1,1
3,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00012367,0.21311,0.29531,1,1
3,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0038653,0.21285,0.25765,1,1
3,GO LIPID DROPLET ORGANIZATION,0.00060992,0.21265,0.22889,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,9.5377e-05,0.2126,0.26195,1,1
3,GO POSITIVE REGULATION OF MRNA PROCESSING,0.00019306,0.21209,0.24464,1,1
3,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0015041,0.21204,0.26154,1,1
3,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.00014062,0.21198,0.30174,1,1
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.00060992,0.2118,0.21226,1,1
3,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.056456,0.21173,0.17594,1,1
3,GO OLIGODENDROCYTE DIFFERENTIATION,0.00026348,0.21161,0.24891,1,1
3,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.026142,0.21159,0.22362,1,1
3,GO REGULATION OF HAIR CYCLE,0.0010798,0.21137,0.28118,1,1
3,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.025096,0.21118,0.23962,1,1
3,GO VESICLE DOCKING,0.00015974,0.21111,0.3301,1,1
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,2.2907e-05,0.21075,0.28126,1,1
3,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0012758,0.21073,0.28204,1,1
3,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.00026348,0.21072,0.2685,1,1
3,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.00028019,0.21064,0.24327,1,1
3,GO COPII COATED VESICLE CARGO LOADING,0.0034935,0.21051,0.27061,1,1
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.00014989,0.21044,0.26361,1,1
3,GO SECRETORY GRANULE ORGANIZATION,0.0019699,0.21032,0.27157,1,1
3,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.00023283,0.21012,0.32094,1,1
3,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.0018673,0.21004,0.35081,1,1
3,GO HISTONE H2A ACETYLATION,0.00028019,0.21,0.28506,1,1
3,GO LYMPH VESSEL MORPHOGENESIS,0.023112,0.2099,0.2718,1,1
3,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.0034935,0.20967,0.23577,1,1
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,7.3279e-05,0.20954,0.23302,1,1
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.00332,0.20934,0.29304,1,1
3,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.014457,0.20928,0.22067,1,1
3,GO REGULATION OF CELL DIVISION,0.00015974,0.20922,0.23873,1,1
3,GO CARDIAC VENTRICLE MORPHOGENESIS,0.0047188,0.20908,0.22583,1,1
3,GO PIGMENTATION,0.00028019,0.20889,0.27121,1,1
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,5.6086e-05,0.20878,0.22624,1,1
3,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.0012758,0.20842,0.23403,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.00045436,0.20835,0.31086,1,1
3,GO DEVELOPMENTAL PIGMENTATION,0.00072571,0.20832,0.26012,1,1
3,GO STRIATED MUSCLE ADAPTATION,0.00076864,0.20796,0.32938,1,1
3,GO PROTEIN LOCALIZATION TO CHROMATIN,0.0023095,0.20796,0.27521,1,1
3,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.0020776,0.20781,0.26893,1,1
3,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.00019306,0.2078,0.2234,1,1
3,GO REGULATION OF PROTEIN DEACETYLATION,0.00010866,0.2072,0.31464,1,1
3,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.016475,0.20716,0.28466,1,1
3,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.0047188,0.20708,0.27832,1,1
3,GO MIDDLE EAR MORPHOGENESIS,0.023112,0.20707,0.16534,1,1
3,GO REGULATION OF GENE EXPRESSION EPIGENETIC,8.9327e-05,0.20706,0.27687,1,1
3,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.041938,0.20704,0.23581,1,1
3,GO NOTCH SIGNALING PATHWAY,0.00045436,0.20689,0.26529,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE III,5.6086e-05,0.20679,0.23792,1,1
3,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.010101,0.20669,0.1917,1,1
3,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.00019306,0.20654,0.21959,1,1
3,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00010181,0.20636,0.33292,1,1
3,GO CELLULAR GLUCAN METABOLIC PROCESS,0.00011593,0.20636,0.26678,1,1
3,GO INTERSTRAND CROSS LINK REPAIR,0.0063209,0.20635,0.24071,1,1
3,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,3.7287e-05,0.20611,0.22526,1,1
3,GO REGULATION OF CHROMOSOME ORGANIZATION,9.5377e-05,0.20604,0.25959,1,1
3,GO EMBRYONIC ORGAN MORPHOGENESIS,0.00045436,0.20598,0.27366,1,1
3,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,4.8997e-05,0.20593,0.31851,1,1
3,GO CALCIUM ION IMPORT,0.0012758,0.20585,0.30521,1,1
3,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.0021907,0.20579,0.26828,1,1
3,GO CARDIAC SEPTUM DEVELOPMENT,0.01266,0.20578,0.24705,1,1
3,GO INORGANIC ANION TRANSPORT,0.0025648,0.20573,0.24507,1,1
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0020776,0.20572,0.22602,1,1
3,GO GASTRIC ACID SECRETION,0.0092139,0.20567,0.2249,1,1
3,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.040368,0.20567,0.15126,1,1
3,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.00054254,0.20566,0.25878,1,1
3,GO SENSORY PERCEPTION,5.6086e-05,0.20563,0.24762,1,1
3,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0042727,0.20561,0.21612,1,1
3,GO CIRCULATORY SYSTEM PROCESS,0.0017696,0.20541,0.24401,1,1
3,GO NEURAL PRECURSOR CELL PROLIFERATION,0.00086166,0.2053,0.26099,1,1
3,GO ANATOMICAL STRUCTURE MATURATION,0.0003797,0.2052,0.25035,1,1
3,GO PROTEIN SUMOYLATION,0.00010866,0.20511,0.25936,1,1
3,GO NEGATIVE REGULATION OF CELL AGING,0.0025648,0.20509,0.22791,1,1
3,GO REGULATION OF ACROSOME REACTION,0.017954,0.20507,0.19085,1,1
3,GO LYSOSOMAL TRANSPORT,7.3279e-05,0.20495,0.31549,1,1
3,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.00068502,0.20489,0.24618,1,1
3,GO HISTONE H2B UBIQUITINATION,0.0042727,0.20485,0.19861,1,1
3,GO PHOTOTRANSDUCTION VISIBLE LIGHT,3.9936e-05,0.20438,0.23167,1,1
3,GO REGULATION OF CELL DEVELOPMENT,9.5377e-05,0.20433,0.27958,1,1
3,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.00018128,0.2043,0.25434,1,1
3,GO CATION TRANSMEMBRANE TRANSPORT,0.00012367,0.2042,0.28279,1,1
3,GO TRANSFERRIN TRANSPORT,0.0044907,0.20416,0.22767,1,1
3,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.00021879,0.20403,0.28421,1,1
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.00031664,0.20379,0.2517,1,1
3,GO MEMBRANE FISSION,0.011063,0.20367,0.26307,1,1
3,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.054439,0.20335,0.22087,1,1
3,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,3.0304e-05,0.20319,0.28911,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0076456,0.20312,0.22502,1,1
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.00057531,0.20297,0.2542,1,1
3,GO EMBRYONIC ORGAN DEVELOPMENT,0.00076864,0.20287,0.24741,1,1
3,GO CELL CYCLE DNA REPLICATION,0.052482,0.20282,0.17801,1,1
3,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00064645,0.20267,0.22742,1,1
3,GO CARDIAC MUSCLE CELL PROLIFERATION,0.008797,0.20254,0.20482,1,1
3,GO LENS FIBER CELL DEVELOPMENT,0.01266,0.20245,0.22773,1,1
3,GO ROOF OF MOUTH DEVELOPMENT,0.0028457,0.20212,0.2536,1,1
3,GO MITOCHONDRIAL RNA PROCESSING,0.041938,0.20202,0.16529,1,1
3,GO SULFUR AMINO ACID METABOLIC PROCESS,0.00042807,0.20191,0.22791,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00029789,0.20176,0.31689,1,1
3,GO RNA 3 END PROCESSING,0.00029789,0.20164,0.22204,1,1
3,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,5.9985e-05,0.20157,0.23288,1,1
3,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0012071,0.20138,0.24513,1,1
3,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.034576,0.20131,0.26537,1,1
3,GO NEPHRON DEVELOPMENT,0.0044907,0.20116,0.2486,1,1
3,GO ION TRANSMEMBRANE TRANSPORT,0.00010866,0.20106,0.27984,1,1
3,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0015882,0.20103,0.21912,1,1
3,GO REGULATION OF MUSCLE CONTRACTION,0.00081392,0.20089,0.24454,1,1
3,GO MIRNA METABOLIC PROCESS,0.00051151,0.20082,0.27383,1,1
3,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,4.2763e-05,0.2008,0.26207,1,1
3,GO MULTI ORGANISM PROCESS,1.7249e-05,0.20078,0.24196,1,1
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0083971,0.20069,0.2648,1,1
3,GO REGULATION OF HORMONE LEVELS,7.8298e-05,0.20069,0.25367,1,1
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.007293,0.20043,0.21001,1,1
3,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.023112,0.20036,0.17404,1,1
3,GO TOR SIGNALING,5.6086e-05,0.20025,0.26332,1,1
3,GO PEPTIDYL SERINE MODIFICATION,5.6086e-05,0.20015,0.28109,1,1
3,GO GLUCOSE METABOLIC PROCESS,0.00012367,0.20006,0.23571,1,1
3,GO RESPONSE TO MONOSACCHARIDE,0.00021879,0.20002,0.24112,1,1
3,GO BILE ACID METABOLIC PROCESS,0.00332,0.19993,0.20628,1,1
3,GO PHOTOTRANSDUCTION,7.3279e-05,0.19977,0.20668,1,1
3,GO ACTIN FILAMENT BASED MOVEMENT,0.0010798,0.19971,0.27668,1,1
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0096484,0.1997,0.22385,1,1
3,GO REGULATION OF CATION CHANNEL ACTIVITY,9.5377e-05,0.1991,0.35226,1,1
3,GO EPITHELIAL TUBE MORPHOGENESIS,0.0024341,0.1988,0.23896,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.007293,0.19865,0.20629,1,1
3,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00033648,0.19857,0.25239,1,1
3,GO 3 UTR MEDIATED MRNA STABILIZATION,0.0066311,0.1984,0.24522,1,1
3,GO GLUCOCORTICOID METABOLIC PROCESS,0.040368,0.19838,0.20454,1,1
3,GO RENAL TUBULE DEVELOPMENT,0.0066311,0.19835,0.224,1,1
3,GO MRNA CLEAVAGE,0.00045436,0.19811,0.25039,1,1
3,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0080134,0.19802,0.28849,1,1
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0063209,0.19793,0.24676,1,1
3,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.069906,0.19782,0.14178,1,1
3,GO REGULATION OF RECEPTOR INTERNALIZATION,8.9327e-05,0.19774,0.29217,1,1
3,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.00014989,0.19766,0.24944,1,1
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.033245,0.19744,0.27733,1,1
3,GO EMBRYO DEVELOPMENT,0.00018128,0.19717,0.24687,1,1
3,GO MRNA EXPORT FROM NUCLEUS,0.00023283,0.19697,0.25995,1,1
3,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0040644,0.19694,0.21337,1,1
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00013188,0.19676,0.37512,1,1
3,GO PIGMENT CELL DIFFERENTIATION,0.0012071,0.19674,0.26151,1,1
3,GO AORTA DEVELOPMENT,0.024086,0.19645,0.24484,1,1
3,GO CELLULAR PIGMENTATION,0.0049572,0.19627,0.21255,1,1
3,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00018128,0.19618,0.27464,1,1
3,GO SPHINGOID METABOLIC PROCESS,0.0076456,0.19616,0.26003,1,1
3,GO ADIPOSE TISSUE DEVELOPMENT,0.0003797,0.19613,0.27802,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0015041,0.19595,0.25575,1,1
3,GO DEVELOPMENTAL INDUCTION,0.00332,0.19573,0.22181,1,1
3,GO RESPONSE TO CALCIUM ION,0.0017696,0.19564,0.26921,1,1
3,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,2.8267e-05,0.19555,0.24156,1,1
3,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0012071,0.19539,0.25028,1,1
3,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.008797,0.19475,0.22224,1,1
3,GO EPITHELIAL CELL DIFFERENTIATION,0.0057394,0.19473,0.18864,1,1
3,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0025648,0.19437,0.28436,1,1
3,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.00081392,0.19437,0.30513,1,1
3,GO DNA MODIFICATION,0.00042807,0.19434,0.20951,1,1
3,GO DNA TEMPLATED TRANSCRIPTION INITIATION,7.3279e-05,0.19424,0.21695,1,1
3,GO NUCLEAR BODY ORGANIZATION,0.00064645,0.19407,0.26229,1,1
3,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.00026348,0.19405,0.26142,1,1
3,GO PROTEIN TARGETING TO VACUOLE,0.00024771,0.19404,0.27557,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,5.9985e-05,0.19393,0.21837,1,1
3,GO MUSCLE SYSTEM PROCESS,0.0012071,0.19392,0.24593,1,1
3,GO RESPONSE TO CAFFEINE,0.00048214,0.19377,0.28198,1,1
3,GO EPIDERMAL CELL DIFFERENTIATION,0.045233,0.19352,0.14094,1,1
3,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00332,0.19344,0.23901,1,1
3,GO REPRODUCTION,3.7287e-05,0.19338,0.23997,1,1
3,GO GLOMERULUS DEVELOPMENT,0.060677,0.19329,0.2404,1,1
3,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.00081392,0.19323,0.26482,1,1
3,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.00018128,0.1932,0.24721,1,1
3,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0076456,0.19302,0.22048,1,1
3,GO STEM CELL PROLIFERATION,0.0011418,0.19301,0.25865,1,1
3,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0028457,0.193,0.25306,1,1
3,GO GANGLIOSIDE METABOLIC PROCESS,0.01266,0.19294,0.21104,1,1
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00013188,0.19291,0.22124,1,1
3,GO CELLULAR RESPONSE TO CALCIUM ION,0.00072571,0.19279,0.29013,1,1
3,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.018736,0.19265,0.21862,1,1
3,GO RESPONSE TO CARBOHYDRATE,0.00033648,0.19263,0.23053,1,1
3,GO SINGLE FERTILIZATION,1.8524e-05,0.19252,0.24081,1,1
3,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.00010181,0.19244,0.30035,1,1
3,GO HEART MORPHOGENESIS,0.0025648,0.19233,0.23932,1,1
3,GO PROTEIN POLYUBIQUITINATION,0.00014062,0.19231,0.22022,1,1
3,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.00013188,0.1923,0.28296,1,1
3,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.00013188,0.19222,0.23099,1,1
3,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.010572,0.1921,0.24037,1,1
3,GO RESPONSE TO AMINO ACID STARVATION,0.00012367,0.19207,0.25161,1,1
3,GO ARTERY DEVELOPMENT,0.025096,0.19194,0.21526,1,1
3,GO NEGATIVE REGULATION OF NEURON DEATH,0.00029789,0.19185,0.23447,1,1
3,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.00057531,0.19176,0.23415,1,1
3,GO ARTERY MORPHOGENESIS,0.037377,0.19175,0.21301,1,1
3,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.043559,0.19168,0.25933,1,1
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.0054671,0.19114,0.34052,1,1
3,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,7.8298e-05,0.19107,0.23091,1,1
3,GO FATTY ACID CATABOLIC PROCESS,6.8565e-05,0.19107,0.25332,1,1
3,GO OXIDATIVE DEMETHYLATION,0.00072571,0.19099,0.34322,1,1
3,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.0080134,0.19098,0.25213,1,1
3,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.0040644,0.19081,0.20785,1,1
3,GO DNA REPAIR,0.00020554,0.19075,0.24868,1,1
3,GO HORMONE METABOLIC PROCESS,0.0017696,0.19072,0.20396,1,1
3,GO RESPONSE TO REDOX STATE,0.007293,0.1907,0.27979,1,1
3,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.018736,0.19067,0.27064,1,1
3,GO REGULATION OF PROTEIN ACETYLATION,0.00023283,0.19053,0.24665,1,1
3,GO ANION TRANSPORT,0.00068502,0.19027,0.23187,1,1
3,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.046961,0.19013,0.22247,1,1
3,GO BASE EXCISION REPAIR AP SITE FORMATION,0.010572,0.19006,0.20204,1,1
3,GO CELL GROWTH,0.00021879,0.19005,0.26142,1,1
3,GO REGULATION OF ANION TRANSPORT,0.0076456,0.18976,0.20081,1,1
3,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.0172,0.18968,0.18407,1,1
3,GO EMBRYONIC MORPHOGENESIS,0.00096503,0.18958,0.2391,1,1
3,GO LIMBIC SYSTEM DEVELOPMENT,0.00029789,0.18931,0.25749,1,1
3,GO CELL FATE DETERMINATION,0.018736,0.18929,0.19467,1,1
3,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00011593,0.18919,0.28125,1,1
3,GO NUCLEOTIDE PHOSPHORYLATION,0.00023283,0.18898,0.21895,1,1
3,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.00042807,0.18885,0.213,1,1
3,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.0060238,0.18883,0.26537,1,1
3,GO PLASMA MEMBRANE ORGANIZATION,0.0028457,0.18878,0.27809,1,1
3,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.010101,0.18874,0.27906,1,1
3,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0063209,0.1887,0.20884,1,1
3,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.025096,0.18854,0.23758,1,1
3,GO EXOCYTIC PROCESS,0.00096503,0.1884,0.30874,1,1
3,GO POSITIVE REGULATION OF GROWTH,0.00081392,0.1884,0.2596,1,1
3,GO GROWTH,0.00020554,0.18824,0.23711,1,1
3,GO REGULATION OF TRANSPORTER ACTIVITY,0.00010181,0.18823,0.32687,1,1
3,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.00040321,0.18764,0.21048,1,1
3,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.00072571,0.18743,0.23018,1,1
3,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.069906,0.1873,0.18275,1,1
3,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.00051151,0.18716,0.27821,1,1
3,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,3.7287e-05,0.18709,0.24782,1,1
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.011063,0.18705,0.18594,1,1
3,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.0019699,0.18697,0.24113,1,1
3,GO ENDOCYTIC RECYCLING,0.00048214,0.18684,0.30785,1,1
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00014062,0.18672,0.26283,1,1
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0012758,0.18664,0.20091,1,1
3,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.033245,0.18649,0.15898,1,1
3,GO ESTABLISHMENT OF CELL POLARITY,0.00029789,0.18648,0.27158,1,1
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.038848,0.18641,0.20797,1,1
3,GO RADIAL GLIAL CELL DIFFERENTIATION,0.0063209,0.18637,0.27423,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.00026348,0.18593,0.23086,1,1
3,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00011593,0.18589,0.22749,1,1
3,GO NUCLEUS ORGANIZATION,5.2428e-05,0.18575,0.23983,1,1
3,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00045436,0.18562,0.27879,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00057531,0.18561,0.20775,1,1
3,GO HEXOSE CATABOLIC PROCESS,0.0028457,0.18557,0.20183,1,1
3,GO NEUROTROPHIN SIGNALING PATHWAY,0.00054254,0.18555,0.27104,1,1
3,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.00035748,0.18545,0.2383,1,1
3,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00019306,0.1852,0.21816,1,1
3,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.013834,0.18516,0.24951,1,1
3,GO RESPONSE TO RADIATION,7.3279e-05,0.18513,0.21787,1,1
3,GO NEUTRAL LIPID CATABOLIC PROCESS,0.023112,0.18513,0.17718,1,1
3,GO AMINE BIOSYNTHETIC PROCESS,0.027226,0.18512,0.19093,1,1
3,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.00064645,0.18489,0.21454,1,1
3,GO ENDOCARDIAL CUSHION FORMATION,0.060677,0.18476,0.17921,1,1
3,GO VESICLE LOCALIZATION,9.5377e-05,0.18455,0.28514,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.010572,0.18455,0.23461,1,1
3,GO PHOSPHOLIPID TRANSPORT,0.015104,0.18449,0.20916,1,1
3,GO REGULATION OF DEACETYLASE ACTIVITY,0.0047188,0.18449,0.27417,1,1
3,GO HEART VALVE DEVELOPMENT,0.054439,0.18449,0.22525,1,1
3,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00017019,0.18447,0.29797,1,1
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.00076864,0.18417,0.21352,1,1
3,GO TOXIN TRANSPORT,0.0019699,0.18416,0.23854,1,1
3,GO PROTEIN AUTOPHOSPHORYLATION,0.0027019,0.18386,0.25254,1,1
3,GO REGULATION OF CELL MORPHOGENESIS,0.00014989,0.18379,0.29526,1,1
3,GO SMOOTH MUSCLE CONTRACTION,0.0012758,0.18365,0.22413,1,1
3,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.0052065,0.18364,0.20642,1,1
3,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.007293,0.18358,0.21425,1,1
3,GO POSITIVE REGULATION OF CELL GROWTH,0.00096503,0.18356,0.25536,1,1
3,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.00020554,0.18354,0.23848,1,1
3,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.0025648,0.18341,0.24647,1,1
3,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.020391,0.18341,0.21556,1,1
3,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.010572,0.18323,0.18483,1,1
3,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.010101,0.18307,0.33142,1,1
3,GO METAL ION TRANSPORT,0.00051151,0.18284,0.25678,1,1
3,GO RRNA 3 END PROCESSING,0.010101,0.18278,0.15902,1,1
3,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.0024341,0.18249,0.24581,1,1
3,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.00048214,0.18235,0.23359,1,1
3,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.00017019,0.18224,0.22958,1,1
3,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.0013481,0.18223,0.19013,1,1
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0027019,0.1822,0.20379,1,1
3,GO MODULATION BY VIRUS OF HOST PROCESS,0.00011593,0.1822,0.23842,1,1
3,GO POSITIVE REGULATION OF ANION TRANSPORT,0.015104,0.1822,0.20762,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.00033648,0.18215,0.22575,1,1
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.015104,0.18215,0.25,1,1
3,GO CARBOHYDRATE CATABOLIC PROCESS,0.00045436,0.18197,0.20636,1,1
3,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0063209,0.18176,0.2504,1,1
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,8.3641e-05,0.18174,0.225,1,1
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,5.9985e-05,0.18167,0.27127,1,1
3,GO STRESS FIBER ASSEMBLY,0.008797,0.18131,0.24661,1,1
3,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.00096503,0.18127,0.22346,1,1
3,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.00086166,0.18123,0.2303,1,1
3,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.038848,0.18109,0.26567,1,1
3,GO ION TRANSPORT,0.00048214,0.18107,0.24539,1,1
3,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,5.6086e-05,0.18099,0.23117,1,1
3,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0029965,0.18099,0.24565,1,1
3,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.00011593,0.18092,0.22557,1,1
3,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.0012758,0.18084,0.23841,1,1
3,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.0076456,0.18067,0.22217,1,1
3,GO POSITIVE REGULATION OF AUTOPHAGY,0.0042727,0.18043,0.23035,1,1
3,GO CELL CELL SIGNALING BY WNT,0.00019306,0.18029,0.23911,1,1
3,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0060238,0.18022,0.22471,1,1
3,GO PROTEIN ADP RIBOSYLATION,0.013834,0.18021,0.18087,1,1
3,GO PLATELET MORPHOGENESIS,0.028348,0.18009,0.21934,1,1
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00012367,0.17969,0.20797,1,1
3,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.012106,0.17957,0.20937,1,1
3,GO CYTOSOLIC TRANSPORT,5.6086e-05,0.17955,0.30551,1,1
3,GO TRANSMEMBRANE TRANSPORT,0.00024771,0.1795,0.24031,1,1
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.0172,0.1794,0.2938,1,1
3,GO BASE EXCISION REPAIR,0.00072571,0.17938,0.22413,1,1
3,GO SIGNAL RELEASE,0.00017019,0.17931,0.26727,1,1
3,GO STEROL TRANSPORT,0.0083971,0.17913,0.22608,1,1
3,GO CARDIAC CHAMBER MORPHOGENESIS,0.030713,0.17908,0.20523,1,1
3,GO ERBB SIGNALING PATHWAY,0.015104,0.17907,0.20558,1,1
3,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00076864,0.17904,0.28925,1,1
3,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,5.9985e-05,0.179,0.29975,1,1
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,7.3279e-05,0.17894,0.25706,1,1
3,GO CELL CELL SIGNALING,7.3279e-05,0.17875,0.27308,1,1
3,GO AMINO ACID IMPORT,0.018736,0.1783,0.18861,1,1
3,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0024341,0.17827,0.16534,1,1
3,GO MITOTIC CYTOKINESIS,0.0024341,0.17822,0.20945,1,1
3,GO NEGATIVE REGULATION OF CELL GROWTH,0.0011418,0.17821,0.23399,1,1
3,GO VIRAL RNA GENOME REPLICATION,0.0080134,0.17792,0.2071,1,1
3,GO AMINOGLYCAN METABOLIC PROCESS,0.037377,0.17787,0.20943,1,1
3,GO PLASMA MEMBRANE TUBULATION,0.0096484,0.17782,0.24738,1,1
3,GO MESENCHYME MORPHOGENESIS,0.067497,0.17773,0.18638,1,1
3,GO PYRUVATE METABOLIC PROCESS,0.00042807,0.17769,0.20522,1,1
3,GO LACTATE METABOLIC PROCESS,0.0023095,0.17726,0.19306,1,1
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.027226,0.17718,0.27428,1,1
3,GO SULFATE TRANSPORT,0.0063209,0.17712,0.22731,1,1
3,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.0031545,0.17711,0.27693,1,1
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,9.5377e-05,0.17701,0.23906,1,1
3,GO VENTRICULAR SEPTUM DEVELOPMENT,0.010572,0.17682,0.2281,1,1
3,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.00026348,0.17676,0.2783,1,1
3,GO RESPONSE TO STARVATION,0.00012367,0.17676,0.22166,1,1
3,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.0010798,0.17649,0.22961,1,1
3,GO MEGAKARYOCYTE DIFFERENTIATION,0.00091199,0.17628,0.23774,1,1
3,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0016767,0.17627,0.23305,1,1
3,GO POLYSACCHARIDE METABOLIC PROCESS,0.00051151,0.1762,0.25628,1,1
3,GO RESPONSE TO ISCHEMIA,0.052482,0.17617,0.17814,1,1
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.0028457,0.17607,0.20727,1,1
3,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.0031545,0.17602,0.24172,1,1
3,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.00021879,0.176,0.21238,1,1
3,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0028457,0.17593,0.19829,1,1
3,GO GLYCEROLIPID CATABOLIC PROCESS,0.038848,0.17592,0.16635,1,1
3,GO CRISTAE FORMATION,0.0063209,0.17592,0.1978,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0003797,0.17591,0.28127,1,1
3,GO REGULATION OF PROTEIN BINDING,0.0015041,0.17585,0.22926,1,1
3,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.00091199,0.17584,0.20052,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0044907,0.17582,0.22732,1,1
3,GO MODIFIED AMINO ACID TRANSPORT,0.0096484,0.1758,0.23442,1,1
3,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.0036751,0.17569,0.25649,1,1
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.00014989,0.1755,0.28283,1,1
3,GO REGULATION OF NEURON PROJECTION REGENERATION,0.012106,0.17546,0.27957,1,1
3,GO CARDIAC VENTRICLE DEVELOPMENT,0.0052065,0.17535,0.22448,1,1
3,GO ORGANIC ACID TRANSPORT,0.0012071,0.17518,0.21945,1,1
3,GO CATION TRANSPORT,0.00028019,0.17517,0.25384,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0012758,0.17512,0.25915,1,1
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00021879,0.17506,0.2985,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0044907,0.17505,0.28022,1,1
3,GO GOLGI ORGANIZATION,0.00026348,0.17497,0.28553,1,1
3,GO PROTEIN LOCALIZATION TO ENDOSOME,0.0029965,0.17491,0.29619,1,1
3,GO LIPID PHOSPHORYLATION,0.00076864,0.17471,0.26398,1,1
3,GO CELL CYCLE ARREST,0.00024771,0.1747,0.22244,1,1
3,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.00051151,0.1747,0.18633,1,1
3,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.00091199,0.17461,0.23437,1,1
3,GO REGULATION OF RIBOSOME BIOGENESIS,0.020391,0.17437,0.18701,1,1
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,7.8298e-05,0.17436,0.24933,1,1
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00033648,0.17434,0.22979,1,1
3,GO PROSTATE GLAND GROWTH,0.013834,0.17433,0.19778,1,1
3,GO REGULATION OF ORGANELLE ORGANIZATION,5.2428e-05,0.17422,0.24282,1,1
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.02951,0.17412,0.18157,1,1
3,GO REGULATION OF ENDOCRINE PROCESS,0.015104,0.17403,0.18861,1,1
3,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.00031664,0.174,0.25654,1,1
3,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.00024771,0.17396,0.25903,1,1
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0040644,0.17386,0.21041,1,1
3,GO NEURON PROJECTION REGENERATION,0.0015882,0.17384,0.29423,1,1
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.0063209,0.17383,0.19144,1,1
3,GO ORGANIC ANION TRANSPORT,0.0014241,0.17375,0.21453,1,1
3,GO KETONE BODY METABOLIC PROCESS,0.0038653,0.17371,0.18945,1,1
3,GO RRNA TRANSCRIPTION,0.00026348,0.17369,0.23495,1,1
3,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.0003797,0.17367,0.26352,1,1
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.0029965,0.17358,0.27313,1,1
3,GO POSITIVE REGULATION OF CELL DIVISION,0.0031545,0.17351,0.19278,1,1
3,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0049572,0.17344,0.19709,1,1
3,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00054254,0.17344,0.25661,1,1
3,GO ANIMAL ORGAN MORPHOGENESIS,0.0011418,0.17341,0.23141,1,1
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.023112,0.1734,0.19876,1,1
3,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.0060238,0.1734,0.27288,1,1
3,GO EPITHELIUM DEVELOPMENT,0.0025648,0.17336,0.20215,1,1
3,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.046961,0.17285,0.18569,1,1
3,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0052065,0.17283,0.22721,1,1
3,GO REGULATION OF MYELINATION,0.030713,0.17271,0.20253,1,1
3,GO REGULATION OF CELLULAR PH,0.0172,0.17271,0.17707,1,1
3,GO REGULATION OF ION TRANSPORT,0.00081392,0.17268,0.2591,1,1
3,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,0.0092139,0.17261,0.19663,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0014241,0.17255,0.25292,1,1
3,GO PERICARDIUM DEVELOPMENT,0.027226,0.17249,0.25658,1,1
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.00057531,0.17242,0.18926,1,1
3,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.00086166,0.17232,0.21246,1,1
3,GO ENDOCRINE HORMONE SECRETION,0.010101,0.17229,0.18083,1,1
3,GO ENSHEATHMENT OF NEURONS,0.00086166,0.17223,0.24119,1,1
3,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0034935,0.17217,0.24761,1,1
3,GO REGULATION OF PROTEIN TARGETING,0.00045436,0.17206,0.23353,1,1
3,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.041938,0.17197,0.16166,1,1
3,GO REGULATION OF PH,0.0096484,0.17188,0.17869,1,1
3,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00064645,0.17177,0.16727,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.019548,0.17155,0.24688,1,1
3,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0052065,0.17144,0.19125,1,1
3,GO MUSCLE ORGAN DEVELOPMENT,0.0012758,0.17138,0.23447,1,1
3,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.011574,0.17108,0.26855,1,1
3,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0027019,0.17108,0.24014,1,1
3,GO REGULATION OF PROTON TRANSPORT,0.0049572,0.17103,0.19649,1,1
3,GO L AMINO ACID TRANSPORT,0.0076456,0.17069,0.1918,1,1
3,GO SELECTIVE AUTOPHAGY,0.00060992,0.1706,0.25642,1,1
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00014989,0.1705,0.26299,1,1
3,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.006955,0.17048,0.16388,1,1
3,GO MOLTING CYCLE,0.0017696,0.17045,0.25762,1,1
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.038848,0.17042,0.19098,1,1
3,GO ERYTHROCYTE DEVELOPMENT,0.0025648,0.17041,0.24257,1,1
3,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.018736,0.17034,0.21302,1,1
3,GO NEURON APOPTOTIC PROCESS,0.00026348,0.17028,0.22717,1,1
3,GO PROTEOGLYCAN METABOLIC PROCESS,0.0042727,0.17021,0.24855,1,1
3,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.0012758,0.1701,0.19931,1,1
3,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0017696,0.16964,0.1976,1,1
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0034935,0.16963,0.31875,1,1
3,GO ANIMAL ORGAN MATURATION,0.012106,0.16962,0.25569,1,1
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0038653,0.16955,0.23375,1,1
3,GO REGULATION OF PROTEIN POLYMERIZATION,0.00033648,0.16952,0.25585,1,1
3,GO DNA METHYLATION OR DEMETHYLATION,0.00091199,0.16946,0.21279,1,1
3,GO RESPONSE TO ESTRADIOL,0.0015041,0.16935,0.21851,1,1
3,GO EXECUTION PHASE OF APOPTOSIS,0.00026348,0.16909,0.20498,1,1
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0060238,0.16906,0.23606,1,1
3,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.00045436,0.16898,0.17435,1,1
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.027226,0.16897,0.22482,1,1
3,GO ENDOSOMAL TRANSPORT,0.00010866,0.16884,0.25565,1,1
3,GO EXOCRINE SYSTEM DEVELOPMENT,0.018736,0.16851,0.24406,1,1
3,GO REGULATION OF BLOOD PRESSURE,0.017954,0.16816,0.19043,1,1
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00040321,0.16816,0.27925,1,1
3,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.006955,0.16816,0.1969,1,1
3,GO MYOFIBRIL ASSEMBLY,0.006955,0.16816,0.2341,1,1
3,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.00011593,0.16804,0.24516,1,1
3,GO POSITIVE REGULATION OF HEART GROWTH,0.01266,0.16801,0.18575,1,1
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.0029965,0.16755,0.24184,1,1
3,GO RESPONSE TO BMP,0.0080134,0.16746,0.24359,1,1
3,GO INTRACELLULAR LIPID TRANSPORT,0.0010798,0.16741,0.24846,1,1
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0025648,0.16737,0.22678,1,1
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,6.4139e-05,0.16737,0.25506,1,1
3,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.0010798,0.1672,0.27129,1,1
3,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0028457,0.16712,0.23249,1,1
3,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.011063,0.16702,0.19116,1,1
3,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.037377,0.16696,0.22287,1,1
3,GO SKELETAL MUSCLE CONTRACTION,0.0063209,0.16663,0.30661,1,1
3,GO RESPONSE TO PH,0.0066311,0.16654,0.2317,1,1
3,GO TRNA WOBBLE BASE MODIFICATION,0.0011418,0.16652,0.18875,1,1
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.00019306,0.16642,0.24475,1,1
3,GO MEGAKARYOCYTE DEVELOPMENT,0.013834,0.16631,0.26218,1,1
3,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.0083971,0.16623,0.22553,1,1
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.035953,0.16623,0.19432,1,1
3,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0096484,0.16609,0.19172,1,1
3,GO REGULATION OF BMP SIGNALING PATHWAY,0.02951,0.16603,0.22517,1,1
3,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.037377,0.16596,0.24929,1,1
3,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.028348,0.16595,0.2127,1,1
3,GO C21 STEROID HORMONE METABOLIC PROCESS,0.025096,0.16578,0.18163,1,1
3,GO COENZYME A METABOLIC PROCESS,0.00096503,0.16576,0.19013,1,1
3,GO HEART DEVELOPMENT,0.0012071,0.16575,0.24642,1,1
3,GO PROTEIN TARGETING TO LYSOSOME,0.013235,0.16565,0.23802,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.00014989,0.16559,0.23735,1,1
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.011063,0.16546,0.263,1,1
3,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00051151,0.16541,0.30605,1,1
3,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.00026348,0.16519,0.23025,1,1
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.013834,0.16519,0.21946,1,1
3,GO DETECTION OF MECHANICAL STIMULUS,0.020391,0.16519,0.20683,1,1
3,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.00035748,0.16516,0.20654,1,1
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.006955,0.16514,0.18263,1,1
3,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.013235,0.16506,0.23808,1,1
3,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.010572,0.16494,0.22165,1,1
3,GO AMEBOIDAL TYPE CELL MIGRATION,0.052482,0.16487,0.18807,1,1
3,GO NADP METABOLIC PROCESS,0.0080134,0.16483,0.15527,1,1
3,GO ADAPTIVE THERMOGENESIS,0.013235,0.16477,0.18077,1,1
3,GO NEGATIVE REGULATION OF DNA BINDING,0.028348,0.16477,0.16537,1,1
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.037377,0.16467,0.17484,1,1
3,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0040644,0.16465,0.22506,1,1
3,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.015776,0.16463,0.29289,1,1
3,GO RESPONSE TO GROWTH FACTOR,0.0042727,0.1646,0.21904,1,1
3,GO SPHINGOMYELIN METABOLIC PROCESS,0.037377,0.16458,0.1894,1,1
3,GO L GLUTAMATE IMPORT,0.020391,0.16457,0.20315,1,1
3,GO MAMMARY GLAND DEVELOPMENT,0.0024341,0.16451,0.2518,1,1
3,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.00042807,0.16449,0.18293,1,1
3,GO INTRACELLULAR STEROL TRANSPORT,0.014457,0.16447,0.23997,1,1
3,GO DEPHOSPHORYLATION,5.9985e-05,0.16446,0.25323,1,1
3,GO NUCLEOTIDE EXCISION REPAIR,0.00012367,0.16445,0.19591,1,1
3,GO RNA SURVEILLANCE,0.0018673,0.16403,0.169,1,1
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0063209,0.16385,0.26351,1,1
3,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.0060238,0.16383,0.23508,1,1
3,GO ALCOHOL METABOLIC PROCESS,0.0016767,0.1638,0.20053,1,1
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00057531,0.16345,0.23246,1,1
3,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00031664,0.16332,0.21331,1,1
3,GO REGULATION OF GTPASE ACTIVITY,0.0047188,0.16321,0.24851,1,1
3,GO CELL AGGREGATION,0.043559,0.16309,0.23755,1,1
3,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,6.8565e-05,0.16289,0.19784,1,1
3,GO REGULATION OF URINE VOLUME,0.0172,0.16277,0.24237,1,1
3,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.0027019,0.1626,0.18794,1,1
3,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00064645,0.16245,0.29581,1,1
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00091199,0.16239,0.22918,1,1
3,GO PROTEIN DEPHOSPHORYLATION,5.9985e-05,0.16226,0.24089,1,1
3,GO CANONICAL WNT SIGNALING PATHWAY,0.0003797,0.16223,0.23317,1,1
3,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.045233,0.16198,0.23326,1,1
3,GO UTP METABOLIC PROCESS,0.034576,0.16185,0.17683,1,1
3,GO SECOND MESSENGER MEDIATED SIGNALING,0.0092139,0.16184,0.19434,1,1
3,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.010101,0.16175,0.23756,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.00048214,0.16163,0.19458,1,1
3,GO CELLULAR RESPONSE TO RETINOIC ACID,0.052482,0.16144,0.17072,1,1
3,GO LIPOPROTEIN METABOLIC PROCESS,0.00020554,0.1614,0.20272,1,1
3,GO NEURON DEATH,0.00081392,0.16091,0.21938,1,1
3,GO CELLULAR RESPONSE TO KETONE,0.012106,0.16061,0.17551,1,1
3,GO RESPONSE TO CAMP,0.034576,0.16056,0.165,1,1
3,GO REGULATION OF HEART MORPHOGENESIS,0.031957,0.16051,0.21781,1,1
3,GO ODONTOGENESIS,0.043559,0.16049,0.18911,1,1
3,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.0023095,0.16046,0.31593,1,1
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0076456,0.16039,0.17023,1,1
3,GO ACTIN FILAMENT BASED PROCESS,0.0025648,0.16034,0.24298,1,1
3,GO PROTEIN HOMOOLIGOMERIZATION,0.00033648,0.16028,0.24549,1,1
3,GO PROTON TRANSMEMBRANE TRANSPORT,0.0015882,0.16024,0.18248,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0027019,0.16001,0.19927,1,1
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0060238,0.16001,0.16972,1,1
3,GO SMALL MOLECULE CATABOLIC PROCESS,0.00054254,0.15997,0.18618,1,1
3,GO MONOSACCHARIDE CATABOLIC PROCESS,0.0047188,0.15988,0.19001,1,1
3,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.00086166,0.15983,0.21877,1,1
3,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.0031545,0.15981,0.24708,1,1
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0076456,0.15971,0.24534,1,1
3,GO BASEMENT MEMBRANE ORGANIZATION,0.062884,0.15967,0.26511,1,1
3,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0018673,0.15963,0.18851,1,1
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.00029789,0.15948,0.22581,1,1
3,GO AMELOGENESIS,0.021265,0.15935,0.225,1,1
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0044907,0.15933,0.20537,1,1
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.00010181,0.15919,0.24669,1,1
3,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0076456,0.15917,0.19765,1,1
3,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,2.8267e-05,0.15896,0.19326,1,1
3,GO LIPID MODIFICATION,0.00018128,0.15896,0.2553,1,1
3,GO RESPONSE TO DIETARY EXCESS,0.0096484,0.15893,0.2872,1,1
3,GO CELLULAR MACROMOLECULE LOCALIZATION,2.8267e-05,0.15879,0.21845,1,1
3,GO GOLGI VESICLE TRANSPORT,0.00013188,0.15879,0.24898,1,1
3,GO ENERGY RESERVE METABOLIC PROCESS,0.00028019,0.15878,0.25663,1,1
3,GO CARDIAC CHAMBER DEVELOPMENT,0.0080134,0.15847,0.23012,1,1
3,GO NEGATIVE REGULATION OF RNA SPLICING,0.0052065,0.15846,0.18347,1,1
3,GO BILE ACID BIOSYNTHETIC PROCESS,0.006955,0.15841,0.1927,1,1
3,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.013834,0.15829,0.22369,1,1
3,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.00014062,0.15807,0.19984,1,1
3,GO REGULATION OF GROWTH,0.00054254,0.15782,0.22216,1,1
3,GO TUBE DEVELOPMENT,0.058535,0.15772,0.18363,1,1
3,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.00060992,0.1576,0.16471,1,1
3,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.00035748,0.15759,0.27531,1,1
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.00068502,0.15746,0.18086,1,1
3,GO MUSCLE STRUCTURE DEVELOPMENT,0.0038653,0.15741,0.22324,1,1
3,GO PROTEIN K63 LINKED UBIQUITINATION,0.00091199,0.15738,0.19536,1,1
3,GO SENSORY PERCEPTION OF PAIN,0.0066311,0.15725,0.19278,1,1
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0015882,0.15725,0.17152,1,1
3,GO ACTIVATION OF GTPASE ACTIVITY,0.0044907,0.15714,0.27687,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0010798,0.15693,0.23443,1,1
3,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.0049572,0.15683,0.23466,1,1
3,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0083971,0.15671,0.20148,1,1
3,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,9.5377e-05,0.15662,0.25733,1,1
3,GO REGULATION OF CELLULAR LOCALIZATION,0.00029789,0.15656,0.23741,1,1
3,GO CIRCULATORY SYSTEM DEVELOPMENT,0.038848,0.15649,0.18985,1,1
3,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0003797,0.15618,0.26712,1,1
3,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.011574,0.15618,0.20533,1,1
3,GO ANION HOMEOSTASIS,0.0049572,0.15606,0.22218,1,1
3,GO POLYOL BIOSYNTHETIC PROCESS,0.0015041,0.15606,0.20167,1,1
3,GO RESPONSE TO AXON INJURY,0.0023095,0.15593,0.24504,1,1
3,GO GLYCEROLIPID METABOLIC PROCESS,0.0029965,0.15587,0.21174,1,1
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.00081392,0.15572,0.21962,1,1
3,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.056456,0.1557,0.25384,1,1
3,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.013834,0.15548,0.24953,1,1
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.00072571,0.1553,0.23585,1,1
3,GO MONOSACCHARIDE METABOLIC PROCESS,0.00031664,0.15524,0.20467,1,1
3,GO RESPONSE TO STEROID HORMONE,0.0092139,0.15517,0.19737,1,1
3,GO STRIATED MUSCLE CELL PROLIFERATION,0.015776,0.15515,0.1875,1,1
3,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.00086166,0.15507,0.16769,1,1
3,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.02951,0.15451,0.2046,1,1
3,GO REGULATION OF WNT SIGNALING PATHWAY,0.00051151,0.15451,0.22223,1,1
3,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.00021879,0.15431,0.23873,1,1
3,GO LIPID LOCALIZATION,0.019548,0.15427,0.1814,1,1
3,GO MUSCLE CELL DEVELOPMENT,0.00045436,0.15406,0.2439,1,1
3,GO RHYTHMIC BEHAVIOR,0.0052065,0.15406,0.20944,1,1
3,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.013235,0.15396,0.18308,1,1
3,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0172,0.1538,0.18208,1,1
3,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00017019,0.15378,0.23934,1,1
3,GO MUSCLE ORGAN MORPHOGENESIS,0.0023095,0.15364,0.25445,1,1
3,GO CELLULAR RESPONSE TO STARVATION,6.8565e-05,0.15358,0.23399,1,1
3,GO GLYCOSYLATION,0.0015041,0.15353,0.21376,1,1
3,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0023095,0.15335,0.20496,1,1
3,GO PEPTIDYL AMINO ACID MODIFICATION,0.00017019,0.15335,0.23023,1,1
3,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.021265,0.15332,0.19348,1,1
3,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00015974,0.15326,0.21889,1,1
3,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.007293,0.15306,0.21663,1,1
3,GO FATTY ACID METABOLIC PROCESS,0.0060238,0.15303,0.16892,1,1
3,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0014241,0.15291,0.24323,1,1
3,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0013481,0.15289,0.21921,1,1
3,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.00023283,0.15288,0.21435,1,1
3,GO ACTIVATION OF JUN KINASE ACTIVITY,0.0083971,0.15288,0.28762,1,1
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.00024771,0.1528,0.27539,1,1
3,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0047188,0.15261,0.25341,1,1
3,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.00010181,0.1519,0.18925,1,1
3,GO GLIAL CELL DIFFERENTIATION,0.007293,0.15167,0.20354,1,1
3,GO ORGANIC ACID CATABOLIC PROCESS,0.00024771,0.15147,0.20149,1,1
3,GO REGULATION OF ATP METABOLIC PROCESS,0.00023283,0.15146,0.20708,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.041938,0.15136,0.1684,1,1
3,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.00068502,0.15125,0.19535,1,1
3,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.00020554,0.15111,0.23149,1,1
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.033245,0.15099,0.23,1,1
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.060677,0.15093,0.20798,1,1
3,GO TISSUE MORPHOGENESIS,0.0054671,0.15086,0.20534,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.056456,0.15079,0.15385,1,1
3,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.00081392,0.15069,0.19761,1,1
3,GO MUSCLE HYPERTROPHY,0.008797,0.15044,0.22023,1,1
3,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.023112,0.15043,0.15829,1,1
3,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0052065,0.15036,0.20207,1,1
3,GO NEGATIVE REGULATION OF GROWTH,0.010572,0.15033,0.18241,1,1
3,GO CELLULAR LIPID CATABOLIC PROCESS,0.0052065,0.15029,0.17881,1,1
3,GO REGULATION OF JUN KINASE ACTIVITY,0.0096484,0.1501,0.25547,1,1
3,GO EMBRYONIC EYE MORPHOGENESIS,0.011574,0.15005,0.2521,1,1
3,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.00012367,0.15001,0.22475,1,1
3,GO ERBB2 SIGNALING PATHWAY,0.010101,0.1499,0.23025,1,1
3,GO ACETYL COA METABOLIC PROCESS,0.0063209,0.14985,0.16074,1,1
3,GO REGULATION OF AMYLOID BETA FORMATION,0.027226,0.14977,0.21469,1,1
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.0015041,0.14963,0.20372,1,1
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.011574,0.14959,0.20483,1,1
3,GO REGULATION OF MUSCLE HYPERTROPHY,0.030713,0.14946,0.17805,1,1
3,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0060238,0.14935,0.17874,1,1
3,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0015882,0.14924,0.21639,1,1
3,GO REGULATION OF FERTILIZATION,0.028348,0.14896,0.1495,1,1
3,GO NEGATIVE REGULATION OF SECRETION,0.034576,0.14872,0.15254,1,1
3,GO REGULATION OF HEART GROWTH,0.043559,0.14855,0.15188,1,1
3,GO RECEPTOR CATABOLIC PROCESS,0.018736,0.1485,0.1939,1,1
3,GO RESPONSE TO WATER,0.021265,0.1483,0.18065,1,1
3,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.050584,0.14822,0.18917,1,1
3,GO MESODERM DEVELOPMENT,0.008797,0.14802,0.18271,1,1
3,GO RESPONSE TO PEPTIDE HORMONE,0.00048214,0.14798,0.21332,1,1
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0031545,0.14781,0.215,1,1
3,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0003797,0.14776,0.20022,1,1
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0047188,0.14748,0.16064,1,1
3,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.00021879,0.14746,0.21241,1,1
3,GO PROTEIN POLYMERIZATION,0.00031664,0.14744,0.23937,1,1
3,GO REGULATION OF ACTIN NUCLEATION,0.038848,0.14723,0.17733,1,1
3,GO SNRNA PROCESSING,0.006955,0.14716,0.13357,1,1
3,GO INTRACELLULAR TRANSPORT,3.7287e-05,0.14699,0.20413,1,1
3,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.028348,0.14692,0.1752,1,1
3,GO MORPHOGENESIS OF AN EPITHELIUM,0.0054671,0.14689,0.20425,1,1
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.00086166,0.14676,0.21579,1,1
3,GO RECEPTOR INTERNALIZATION,0.006955,0.14667,0.22882,1,1
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.052482,0.14667,0.14632,1,1
3,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.0066311,0.14663,0.21283,1,1
3,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0044907,0.14643,0.22045,1,1
3,GO RESPONSE TO INSULIN,0.00026348,0.14627,0.21997,1,1
3,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.0172,0.1457,0.18074,1,1
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0028457,0.1457,0.21895,1,1
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.012106,0.14556,0.1801,1,1
3,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.048745,0.14541,0.20135,1,1
3,GO PHOSPHOLIPID METABOLIC PROCESS,0.0057394,0.14535,0.19676,1,1
3,GO MUSCLE CELL DIFFERENTIATION,0.0019699,0.1453,0.23077,1,1
3,GO MUSCLE TISSUE DEVELOPMENT,0.0024341,0.14516,0.2213,1,1
3,GO CELLULAR RESPONSE TO ALCOHOL,0.018736,0.14465,0.21742,1,1
3,GO MITOCHONDRIAL GENOME MAINTENANCE,0.054439,0.14463,0.16886,1,1
3,GO REGULATION OF REPRODUCTIVE PROCESS,0.007293,0.14437,0.16454,1,1
3,GO REGULATION OF CELL DIFFERENTIATION,0.0025648,0.14435,0.21155,1,1
3,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.0080134,0.14425,0.2514,1,1
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.00068502,0.14406,0.20177,1,1
3,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.054439,0.14403,0.19836,1,1
3,GO REGULATION OF CELLULAR COMPONENT SIZE,0.00015974,0.14399,0.27222,1,1
3,GO ESTABLISHMENT OF TISSUE POLARITY,0.0057394,0.14385,0.16154,1,1
3,GO REGULATION OF GENE SILENCING,0.0023095,0.14385,0.19032,1,1
3,GO REGULATION OF CATABOLIC PROCESS,0.00064645,0.14372,0.19135,1,1
3,GO MIDBRAIN DEVELOPMENT,0.0010209,0.14356,0.19994,1,1
3,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.006955,0.14305,0.24456,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.0013481,0.14291,0.18626,1,1
3,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0092139,0.1429,0.16988,1,1
3,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0027019,0.14255,0.19522,1,1
3,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.060677,0.14247,0.15359,1,1
3,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.010101,0.14217,0.20127,1,1
3,GO NON CANONICAL WNT SIGNALING PATHWAY,0.0023095,0.14209,0.19336,1,1
3,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.00332,0.14181,0.22714,1,1
3,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.00076864,0.14175,0.22325,1,1
3,GO VESICLE CARGO LOADING,0.023112,0.14174,0.21995,1,1
3,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0019699,0.14143,0.22925,1,1
3,GO IN UTERO EMBRYONIC DEVELOPMENT,0.00054254,0.14139,0.21982,1,1
3,GO STEM CELL DIFFERENTIATION,0.011574,0.14126,0.17501,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0042727,0.14124,0.15373,1,1
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.040368,0.14107,0.14726,1,1
3,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.00081392,0.14106,0.22361,1,1
3,GO REGULATION OF FAT CELL DIFFERENTIATION,0.022172,0.14093,0.20142,1,1
3,GO RESPONSE TO HORMONE,0.0063209,0.14083,0.1938,1,1
3,GO KETONE BIOSYNTHETIC PROCESS,0.011574,0.14061,0.19953,1,1
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0024341,0.14059,0.19084,1,1
3,GO ISOPRENOID METABOLIC PROCESS,0.050584,0.14037,0.1216,1,1
3,GO INCLUSION BODY ASSEMBLY,0.026142,0.14025,0.22173,1,1
3,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.00017019,0.1402,0.17529,1,1
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.011574,0.14003,0.19594,1,1
3,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.0044907,0.13992,0.22537,1,1
3,GO REGULATION OF TRANSPORT,0.0013481,0.13974,0.2244,1,1
3,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.013235,0.13974,0.24407,1,1
3,GO DIGESTION,0.031957,0.13966,0.15094,1,1
3,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.016475,0.13961,0.2155,1,1
3,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0060238,0.13947,0.23172,1,1
3,GO REGULATION OF MUSCLE ADAPTATION,0.015104,0.13943,0.19288,1,1
3,GO RESPONSE TO DRUG,0.012106,0.13921,0.16552,1,1
3,GO REGULATION OF ORGAN GROWTH,0.011574,0.13903,0.18809,1,1
3,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.0021907,0.13891,0.1874,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.00332,0.13883,0.1502,1,1
3,GO CARBOHYDRATE TRANSPORT,0.021265,0.13878,0.1749,1,1
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0025648,0.1387,0.2679,1,1
3,GO REGULATION OF CARTILAGE DEVELOPMENT,0.038848,0.13867,0.20037,1,1
3,GO PROTEIN IMPORT,0.0015882,0.13866,0.17196,1,1
3,GO FIBROBLAST MIGRATION,0.02951,0.13843,0.194,1,1
3,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.00072571,0.13836,0.22453,1,1
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0044907,0.13821,0.18223,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.026142,0.13812,0.202,1,1
3,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.010572,0.13811,0.2046,1,1
3,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.030713,0.13807,0.20211,1,1
3,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.017954,0.13804,0.18355,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.0012758,0.13801,0.14792,1,1
3,GO ACTIN CYTOSKELETON REORGANIZATION,0.052482,0.13801,0.18815,1,1
3,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0016767,0.13788,0.21446,1,1
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.034576,0.13782,0.25109,1,1
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0083971,0.13773,0.14736,1,1
3,GO POSITIVE REGULATION OF HEART RATE,0.062884,0.13772,0.16876,1,1
3,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.0014241,0.13771,0.26312,1,1
3,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.0057394,0.13767,0.19121,1,1
3,GO TRANSLESION SYNTHESIS,0.020391,0.13746,0.13331,1,1
3,GO FILOPODIUM ASSEMBLY,0.045233,0.13736,0.19398,1,1
3,GO HEART GROWTH,0.011574,0.137,0.19189,1,1
3,GO RESPONSE TO OSMOTIC STRESS,0.0080134,0.13691,0.20799,1,1
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0049572,0.13688,0.26439,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.022172,0.13643,0.26875,1,1
3,GO ORGANELLE DISASSEMBLY,0.0003797,0.13639,0.22165,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0010209,0.13624,0.20216,1,1
3,GO GLYCOPROTEIN METABOLIC PROCESS,0.0092139,0.13621,0.19513,1,1
3,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.0047188,0.136,0.22067,1,1
3,GO EPITHELIAL CELL DEVELOPMENT,0.0024341,0.13599,0.23956,1,1
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0080134,0.13599,0.15662,1,1
3,GO CELLULAR LIPID METABOLIC PROCESS,0.0083971,0.13579,0.17631,1,1
3,GO PROTEIN COMPLEX OLIGOMERIZATION,0.00033648,0.13579,0.23125,1,1
3,GO RESPONSE TO METAL ION,0.0092139,0.13562,0.1742,1,1
3,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.069906,0.13558,0.21861,1,1
3,GO PROTEIN CATABOLIC PROCESS,0.00020554,0.1355,0.19673,1,1
3,GO NEGATIVE REGULATION OF BINDING,0.0024341,0.13517,0.19672,1,1
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.015776,0.13507,0.21256,1,1
3,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0024341,0.13486,0.19667,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0042727,0.13477,0.17191,1,1
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.00096503,0.13441,0.18437,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE,0.0010209,0.13437,0.2145,1,1
3,GO RESPONSE TO PEPTIDE,0.0042727,0.13435,0.19558,1,1
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0021907,0.13434,0.18668,1,1
3,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.056456,0.13413,0.14055,1,1
3,GO REGULATION OF SECRETION,0.0021907,0.13401,0.22059,1,1
3,GO CHEMICAL HOMEOSTASIS,0.016475,0.13389,0.17585,1,1
3,GO REGULATION OF SENSORY PERCEPTION,0.023112,0.13383,0.1974,1,1
3,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.0092139,0.13381,0.21956,1,1
3,GO CARBOHYDRATE METABOLIC PROCESS,0.00021879,0.13373,0.20625,1,1
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0080134,0.13372,0.21593,1,1
3,GO REGULATION OF PROTEIN STABILITY,0.00020554,0.13358,0.18351,1,1
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00051151,0.13351,0.21885,1,1
3,GO POSITIVE REGULATION OF ION TRANSPORT,0.0080134,0.13347,0.19423,1,1
3,GO PEPTIDE SECRETION,0.0066311,0.13345,0.1966,1,1
3,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0172,0.13336,0.1741,1,1
3,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0013481,0.13334,0.15474,1,1
3,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.026142,0.13326,0.19683,1,1
3,GO UROGENITAL SYSTEM DEVELOPMENT,0.010101,0.13312,0.21226,1,1
3,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.00051151,0.13311,0.17701,1,1
3,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.0040644,0.13309,0.17476,1,1
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.035953,0.13291,0.16443,1,1
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0076456,0.13284,0.1465,1,1
3,GO REGULATION OF ATPASE ACTIVITY,0.00048214,0.13278,0.168,1,1
3,GO AUTOPHAGY OF MITOCHONDRION,0.0015041,0.13269,0.22312,1,1
3,GO QUINONE METABOLIC PROCESS,0.0040644,0.13251,0.18705,1,1
3,GO REGULATION OF BINDING,0.0015882,0.1323,0.19465,1,1
3,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.0060238,0.13228,0.17554,1,1
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0040644,0.13224,0.23194,1,1
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.00017019,0.13216,0.24325,1,1
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00035748,0.13205,0.21051,1,1
3,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0027019,0.13203,0.1824,1,1
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.034576,0.13202,0.18128,1,1
3,GO RECEPTOR METABOLIC PROCESS,0.0080134,0.13188,0.20348,1,1
3,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0031545,0.13181,0.19342,1,1
3,GO PROTEIN TETRAMERIZATION,0.0019699,0.13167,0.18957,1,1
3,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0096484,0.13161,0.22728,1,1
3,GO REGULATION OF FIBROBLAST MIGRATION,0.023112,0.13133,0.20428,1,1
3,GO LIPID CATABOLIC PROCESS,0.021265,0.13133,0.15894,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.021265,0.13126,0.19531,1,1
3,GO PROTEIN STABILIZATION,0.00015974,0.13073,0.18232,1,1
3,GO REGULATION OF ENDOCYTOSIS,0.020391,0.1306,0.21479,1,1
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.0044907,0.13054,0.1852,1,1
3,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.00014062,0.13045,0.23236,1,1
3,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.00060992,0.13013,0.17801,1,1
3,GO VESICLE TARGETING,0.00096503,0.1299,0.2263,1,1
3,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,4.8997e-05,0.12984,0.19074,1,1
3,GO ORGANIC ACID METABOLIC PROCESS,0.0020776,0.12975,0.16141,1,1
3,GO INTRACELLULAR PROTEIN TRANSPORT,4.8997e-05,0.12964,0.18216,1,1
3,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.00072571,0.12958,0.19548,1,1
3,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00076864,0.12958,0.18761,1,1
3,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.025096,0.12945,0.19611,1,1
3,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0010209,0.12945,0.18444,1,1
3,GO SARCOMERE ORGANIZATION,0.014457,0.12895,0.169,1,1
3,GO MUSCLE ADAPTATION,0.034576,0.12892,0.18219,1,1
3,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.00060992,0.12859,0.20446,1,1
3,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.00064645,0.12855,0.17883,1,1
3,GO REGULATION OF HORMONE METABOLIC PROCESS,0.034576,0.12848,0.20279,1,1
3,GO PROTEIN LOCALIZATION TO MEMBRANE,5.9985e-05,0.12843,0.17839,1,1
3,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.013235,0.12833,0.21323,1,1
3,GO FAT CELL DIFFERENTIATION,0.028348,0.1283,0.18256,1,1
3,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.0015041,0.12825,0.17578,1,1
3,GO UBIQUINONE METABOLIC PROCESS,0.0018673,0.12821,0.15499,1,1
3,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.058535,0.12801,0.18617,1,1
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.024086,0.12791,0.17665,1,1
3,GO REGULATION OF DNA CATABOLIC PROCESS,0.026142,0.12775,0.13661,1,1
3,GO PROTEIN K11 LINKED UBIQUITINATION,0.043559,0.12771,0.11553,1,1
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.0080134,0.12763,0.12429,1,1
3,GO RESPONSE TO ABIOTIC STIMULUS,0.0015882,0.12735,0.16583,1,1
3,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.00010866,0.12723,0.19319,1,1
3,GO RESPONSE TO TEMPERATURE STIMULUS,0.00031664,0.12723,0.18271,1,1
3,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.01266,0.12712,0.19039,1,1
3,GO INTERMEMBRANE LIPID TRANSFER,0.013834,0.12694,0.20991,1,1
3,GO TRNA WOBBLE URIDINE MODIFICATION,0.0028457,0.12675,0.15441,1,1
3,GO AMYLOID BETA FORMATION,0.017954,0.12658,0.20824,1,1
3,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0044907,0.12625,0.18814,1,1
3,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.014457,0.12603,0.1926,1,1
3,GO INTRACELLULAR MRNA LOCALIZATION,0.011574,0.12594,0.19487,1,1
3,GO LABYRINTHINE LAYER DEVELOPMENT,0.060677,0.12547,0.16539,1,1
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.007293,0.12532,0.14926,1,1
3,GO LIPID METABOLIC PROCESS,0.0060238,0.12526,0.17689,1,1
3,GO RESPONSE TO LEPTIN,0.045233,0.12513,0.20906,1,1
3,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.00029789,0.12506,0.24042,1,1
3,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.0014241,0.12495,0.1508,1,1
3,GO MEMBRANE ORGANIZATION,0.0012071,0.12486,0.20861,1,1
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0057394,0.12475,0.1843,1,1
3,GO HOMEOSTATIC PROCESS,0.010101,0.12469,0.16795,1,1
3,GO BLASTODERM SEGMENTATION,0.038848,0.12469,0.1884,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.00068502,0.12459,0.15951,1,1
3,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.043559,0.12434,0.14573,1,1
3,GO POSITIVE REGULATION OF HEART CONTRACTION,0.043559,0.12426,0.24938,1,1
3,GO MESODERM MORPHOGENESIS,0.034576,0.12423,0.17242,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0060238,0.12409,0.15884,1,1
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.048745,0.12405,0.18895,1,1
3,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.01266,0.12398,0.20589,1,1
3,GO REGULATION OF PROTEIN IMPORT,0.020391,0.12391,0.1608,1,1
3,GO PROGESTERONE METABOLIC PROCESS,0.062884,0.12374,0.23366,1,1
3,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0028457,0.12371,0.21541,1,1
3,GO NEGATIVE REGULATION OF SIGNALING,0.0023095,0.12361,0.20889,1,1
3,GO AMYLOID BETA METABOLIC PROCESS,0.013235,0.12359,0.22409,1,1
3,GO POSITIVE REGULATION OF BINDING,0.0049572,0.12358,0.16766,1,1
3,GO DETECTION OF STIMULUS,0.0016767,0.12329,0.16777,1,1
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.00011593,0.12292,0.17131,1,1
3,GO RNA CAPPING,0.0021907,0.12291,0.14122,1,1
3,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.02951,0.1229,0.13848,1,1
3,GO PIGMENT BIOSYNTHETIC PROCESS,0.00332,0.1229,0.14127,1,1
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.026142,0.12278,0.20712,1,1
3,GO COENZYME A BIOSYNTHETIC PROCESS,0.020391,0.1227,0.154,1,1
3,GO CERAMIDE BIOSYNTHETIC PROCESS,0.0083971,0.12266,0.20091,1,1
3,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.007293,0.12242,0.22725,1,1
3,GO FATTY ACYL COA METABOLIC PROCESS,0.0015882,0.1222,0.18153,1,1
3,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.013834,0.12217,0.21295,1,1
3,GO MACROMOLECULE CATABOLIC PROCESS,0.00076864,0.12216,0.15808,1,1
3,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0014241,0.12211,0.12772,1,1
3,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.015776,0.12198,0.18882,1,1
3,GO SKELETAL SYSTEM DEVELOPMENT,0.019548,0.12173,0.19121,1,1
3,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.023112,0.12164,0.14757,1,1
3,GO ION HOMEOSTASIS,0.040368,0.12159,0.16058,1,1
3,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0019699,0.12149,0.20479,1,1
3,GO NEGATIVE REGULATION OF ION TRANSPORT,0.0052065,0.12141,0.19922,1,1
3,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.016475,0.12136,0.1832,1,1
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.006955,0.1213,0.14946,1,1
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0042727,0.12119,0.19552,1,1
3,GO THIOESTER METABOLIC PROCESS,0.0021907,0.12086,0.15202,1,1
3,GO ACTIN FILAMENT ORGANIZATION,0.013834,0.12083,0.20771,1,1
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.02951,0.12081,0.19851,1,1
3,GO SPLEEN DEVELOPMENT,0.0080134,0.12033,0.21923,1,1
3,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.043559,0.12022,0.19232,1,1
3,GO MITOCHONDRIAL FUSION,0.00332,0.12002,0.18442,1,1
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.0040644,0.11982,0.14611,1,1
3,GO EMBRYONIC PLACENTA DEVELOPMENT,0.052482,0.1198,0.17547,1,1
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.00033648,0.11973,0.13717,1,1
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.062884,0.1196,0.1246,1,1
3,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.031957,0.11904,0.15143,1,1
3,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.012106,0.11898,0.20672,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION,0.00042807,0.11898,0.20679,1,1
3,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.015104,0.11886,0.17266,1,1
3,GO RESPONSE TO NITROGEN COMPOUND,0.0020776,0.11884,0.19816,1,1
3,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0049572,0.1188,0.20117,1,1
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.017954,0.11871,0.16676,1,1
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014457,0.11848,0.2952,1,1
3,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.046961,0.11845,0.17797,1,1
3,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0034935,0.1184,0.19052,1,1
3,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.050584,0.11805,0.15898,1,1
3,GO SPHINGOLIPID METABOLIC PROCESS,0.0063209,0.11761,0.19153,1,1
3,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.050584,0.1173,0.18561,1,1
3,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0027019,0.11717,0.17102,1,1
3,GO TEMPERATURE HOMEOSTASIS,0.018736,0.11704,0.16933,1,1
3,GO REGULATION OF ERAD PATHWAY,0.015776,0.11678,0.1614,1,1
3,GO RESPONSE TO INORGANIC SUBSTANCE,0.018736,0.11675,0.15547,1,1
3,GO LAMELLIPODIUM ORGANIZATION,0.035953,0.1166,0.18439,1,1
3,GO REGULATION OF MITOCHONDRIAL FISSION,0.01266,0.11631,0.19693,1,1
3,GO PEROXISOMAL MEMBRANE TRANSPORT,0.048745,0.11629,0.17545,1,1
3,GO CELLULAR COMPONENT DISASSEMBLY,0.0020776,0.11628,0.16555,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.021265,0.11606,0.22979,1,1
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.0031545,0.11553,0.17296,1,1
3,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.060677,0.11547,0.14541,1,1
3,GO CELLULAR HOMEOSTASIS,0.025096,0.11546,0.15382,1,1
3,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.0047188,0.11535,0.20066,1,1
3,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.006955,0.11489,0.18879,1,1
3,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.012106,0.11486,0.17241,1,1
3,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0052065,0.11483,0.20812,1,1
3,GO REGULATION OF PHOSPHORYLATION,0.017954,0.11477,0.18309,1,1
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0016767,0.11473,0.16176,1,1
3,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,3.9936e-05,0.11462,0.18805,1,1
3,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.0076456,0.11445,0.16017,1,1
3,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.0029965,0.11429,0.17168,1,1
3,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.024086,0.11426,0.23287,1,1
3,GO REGULATION OF TRANSFERASE ACTIVITY,0.0038653,0.11407,0.18879,1,1
3,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.011574,0.11378,0.17443,1,1
3,GO ESTROGEN METABOLIC PROCESS,0.030713,0.11378,0.20155,1,1
3,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.011063,0.11373,0.1609,1,1
3,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.019548,0.1137,0.12775,1,1
3,GO NEGATIVE REGULATION OF JNK CASCADE,0.012106,0.11348,0.21199,1,1
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.062884,0.11337,0.1896,1,1
3,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.030713,0.1133,0.15399,1,1
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.034576,0.11315,0.16869,1,1
3,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.014457,0.11303,0.17633,1,1
3,GO ORGAN GROWTH,0.011574,0.11297,0.20346,1,1
3,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.007293,0.11291,0.1831,1,1
3,GO PROTEIN TARGETING TO MITOCHONDRION,0.00021879,0.11283,0.13662,1,1
3,GO NEGATIVE REGULATION OF TRANSPORT,0.020391,0.11267,0.15818,1,1
3,GO RESPONSE TO ORGANOPHOSPHORUS,0.045233,0.11258,0.15246,1,1
3,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0038653,0.11251,0.19642,1,1
3,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0080134,0.11238,0.18998,1,1
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.015104,0.11195,0.16892,1,1
3,GO VESICLE BUDDING FROM MEMBRANE,0.021265,0.11184,0.17866,1,1
3,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.025096,0.11178,0.20006,1,1
3,GO STEROID METABOLIC PROCESS,0.012106,0.11101,0.16088,1,1
3,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.0042727,0.111,0.16351,1,1
3,GO CONNECTIVE TISSUE DEVELOPMENT,0.045233,0.11084,0.17454,1,1
3,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.016475,0.1105,0.2028,1,1
3,GO PH REDUCTION,0.062884,0.11049,0.13233,1,1
3,GO THIOESTER BIOSYNTHETIC PROCESS,0.0057394,0.11044,0.16739,1,1
3,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.0031545,0.11034,0.16987,1,1
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0172,0.11012,0.18502,1,1
3,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.027226,0.11005,0.1832,1,1
3,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.013235,0.11001,0.16091,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.060677,0.10952,0.10557,1,1
3,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.018736,0.10944,0.15295,1,1
3,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.015104,0.10944,0.18992,1,1
3,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.020391,0.10929,0.15484,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.016475,0.10913,0.14918,1,1
3,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.010572,0.10895,0.1953,1,1
3,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.00068502,0.1089,0.17743,1,1
3,GO DIVALENT INORGANIC CATION TRANSPORT,0.010101,0.10868,0.20624,1,1
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.023112,0.10864,0.15425,1,1
3,GO IRON SULFUR CLUSTER ASSEMBLY,0.0040644,0.10838,0.14614,1,1
3,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.020391,0.10816,0.15818,1,1
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00086166,0.10799,0.18026,1,1
3,GO COPII COATED VESICLE BUDDING,0.0024341,0.10769,0.21064,1,1
3,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.046961,0.10751,0.11955,1,1
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.025096,0.10732,0.19197,1,1
3,GO ENDOSOME ORGANIZATION,0.0012071,0.10715,0.18174,1,1
3,GO GOLGI VESICLE BUDDING,0.0021907,0.10657,0.21237,1,1
3,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.015104,0.10629,0.29493,1,1
3,GO LIPID BIOSYNTHETIC PROCESS,0.0042727,0.10623,0.17217,1,1
3,GO PEROXISOME ORGANIZATION,0.0018673,0.10586,0.17071,1,1
3,GO REGULATION OF HYDROLASE ACTIVITY,0.045233,0.10579,0.1669,1,1
3,GO PIGMENT METABOLIC PROCESS,0.0060238,0.10543,0.13618,1,1
3,GO ALCOHOL BIOSYNTHETIC PROCESS,0.010572,0.10535,0.15279,1,1
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.00057531,0.10534,0.12638,1,1
3,GO OXIDATION REDUCTION PROCESS,0.0017696,0.10504,0.14654,1,1
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.069906,0.10502,0.1601,1,1
3,GO PROTEOLYSIS,0.0172,0.10492,0.16267,1,1
3,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.011574,0.1049,0.19515,1,1
3,GO ATP METABOLIC PROCESS,0.00068502,0.10483,0.12391,1,1
3,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.0080134,0.10475,0.14419,1,1
3,GO RESPONSE TO HEAT,0.0066311,0.10474,0.14638,1,1
3,GO CARDIOCYTE DIFFERENTIATION,0.010572,0.1045,0.20857,1,1
3,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.065157,0.10401,0.18542,1,1
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.058535,0.10397,0.13577,1,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.058535,0.10384,0.12922,1,1
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.015776,0.10383,0.14778,1,1
3,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0027019,0.10379,0.12417,1,1
3,GO REGULATION OF PEPTIDE TRANSPORT,0.0042727,0.10373,0.19005,1,1
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.025096,0.10325,0.17068,1,1
3,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0034935,0.10324,0.13429,1,1
3,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0025648,0.10319,0.15964,1,1
3,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.011063,0.103,0.16319,1,1
3,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0023095,0.10279,0.20299,1,1
3,GO ALPHA AMINO ACID METABOLIC PROCESS,0.00096503,0.10276,0.15381,1,1
3,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0038653,0.10271,0.19769,1,1
3,GO MONOCARBOXYLIC ACID TRANSPORT,0.027226,0.10242,0.17017,1,1
3,GO HISTONE MRNA METABOLIC PROCESS,0.067497,0.10228,0.074527,1,1
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.031957,0.10221,0.15502,1,1
3,GO LIPOSACCHARIDE METABOLIC PROCESS,0.015776,0.10185,0.15808,1,1
3,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.011063,0.10156,0.17918,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.069906,0.10154,0.087614,1,1
3,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.015776,0.10095,0.1784,1,1
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.02951,0.1003,0.16206,1,1
3,GO PROTEIN DESTABILIZATION,0.0047188,0.10016,0.17491,1,1
3,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.013235,0.10007,0.14459,1,1
3,GO SULFUR COMPOUND METABOLIC PROCESS,0.0049572,0.099852,0.16156,1,1
3,GO MAINTENANCE OF PROTEIN LOCATION,0.0054671,0.099642,0.15908,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0080134,0.099606,0.20205,1,1
3,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.056456,0.099418,0.22255,1,1
3,GO MITOCHONDRION ORGANIZATION,0.00026348,0.099157,0.13836,1,1
3,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.043559,0.098943,0.1579,1,1
3,GO AMINO ACID ACTIVATION,0.038848,0.09838,0.10455,1,1
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.043559,0.097356,0.11088,1,1
3,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.024086,0.096583,0.14341,1,1
3,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0038653,0.096411,0.21292,1,1
3,GO RESPIRATORY SYSTEM DEVELOPMENT,0.019548,0.096115,0.20631,1,1
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0049572,0.095549,0.14858,1,1
3,GO REGENERATION,0.069906,0.095199,0.14755,1,1
3,GO PEROXISOMAL TRANSPORT,0.0027019,0.095132,0.15122,1,1
3,GO PROTEIN HOMOTETRAMERIZATION,0.016475,0.095073,0.16446,1,1
3,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.013834,0.094603,0.21062,1,1
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.043559,0.094585,0.15227,1,1
3,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0013481,0.094578,0.12636,1,1
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.018736,0.094469,0.17231,1,1
3,GO MEMBRANE LIPID METABOLIC PROCESS,0.011063,0.094445,0.1745,1,1
3,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.0028457,0.093578,0.15934,1,1
3,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.00076864,0.092994,0.18585,1,1
3,GO SPERM EGG RECOGNITION,0.065157,0.092903,0.091793,1,1
3,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.0054671,0.09186,0.16901,1,1
3,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.054439,0.091482,0.091917,1,1
3,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0014241,0.091126,0.13059,1,1
3,GO PROTEIN FOLDING,0.00072571,0.090911,0.14447,1,1
3,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.019548,0.090764,0.11484,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.020391,0.090707,0.18171,1,1
3,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.033245,0.089879,0.12142,1,1
3,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.018736,0.089842,0.12823,1,1
3,GO HORMONE BIOSYNTHETIC PROCESS,0.0034935,0.089721,0.18104,1,1
3,GO MITOCHONDRIAL FISSION,0.0080134,0.08941,0.17718,1,1
3,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.0040644,0.086836,0.12886,1,1
3,GO MITOCHONDRION MORPHOGENESIS,0.0063209,0.085508,0.16289,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.040368,0.085123,0.13576,1,1
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0047188,0.08456,0.13165,1,1
3,GO CELLULAR RESPONSE TO HEAT,0.017954,0.084342,0.13586,1,1
3,GO RESPONSE TO ACID CHEMICAL,0.0057394,0.083954,0.18647,1,1
3,GO AGING,0.034576,0.082502,0.15235,1,1
3,GO CERAMIDE METABOLIC PROCESS,0.01266,0.081594,0.18997,1,1
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.037377,0.081393,0.13735,1,1
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.048745,0.076335,0.12843,1,1
3,GO APOPTOTIC PROCESS,0.058535,0.076048,0.13879,1,1
3,GO AMIDE BIOSYNTHETIC PROCESS,0.018736,0.075168,0.077623,1,1
3,GO REGULATION OF STEROID METABOLIC PROCESS,0.050584,0.072972,0.13757,1,1
3,GO CELLULAR KETONE METABOLIC PROCESS,0.035953,0.071534,0.10167,1,1
3,GO TRANSITION METAL ION TRANSPORT,0.043559,0.069825,0.13532,1,1
3,GO PEPTIDE METABOLIC PROCESS,0.013834,0.065857,0.075588,1,1
3,GO TRICARBOXYLIC ACID CYCLE,0.028348,0.064478,0.11921,1,1
3,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.043559,0.064184,0.096495,1,1
3,GO CELLULAR AMIDE METABOLIC PROCESS,0.0029965,0.063668,0.096571,1,1
3,GO CELLULAR RESPIRATION,0.034576,0.058135,0.061746,1,1
3,GO PROTEIN TARGETING,0.0040644,0.058049,0.075475,1,1
3,GO REVERSE CHOLESTEROL TRANSPORT,0.025096,0.3141,0.30536,1,0
3,GO SULFATION,0.0083971,0.2654,0.26301,1,0
3,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.040368,0.2369,0.23486,1,0
3,GO LYMPH VESSEL DEVELOPMENT,0.034576,0.23642,0.30204,1,0
3,GO ACTIN FILAMENT BASED TRANSPORT,0.0025648,0.23639,0.31248,1,0
3,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.021265,0.22951,0.25662,1,0
3,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.041938,0.22702,0.25367,1,0
3,GO SENSORY PERCEPTION OF TASTE,0.033245,0.21377,0.18301,1,0
3,GO BONE MATURATION,0.025096,0.20475,0.24105,1,0
3,GO DETERMINATION OF ADULT LIFESPAN,0.034576,0.20441,0.21381,1,0
3,GO XENOBIOTIC TRANSPORT,0.01266,0.19036,0.25525,1,0
3,GO RETINOL METABOLIC PROCESS,0.043559,0.18997,0.14939,1,0
3,GO MYOTUBE DIFFERENTIATION,0.030713,0.18662,0.19566,1,0
3,GO REGULATION OF PINOCYTOSIS,0.056456,0.18529,0.23568,1,0
3,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.0052065,0.18238,0.2805,1,0
3,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.062884,0.17662,0.34257,1,0
3,GO RESPONSE TO PROGESTERONE,0.062884,0.174,0.19534,1,0
3,GO WHITE FAT CELL DIFFERENTIATION,0.056456,0.17293,0.17035,1,0
3,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.018736,0.17068,0.22294,1,0
3,GO GDP METABOLIC PROCESS,0.050584,0.16947,0.18778,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.031957,0.16812,0.17385,1,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0092139,0.16211,0.2248,1,0
3,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.011574,0.16163,0.22669,1,0
3,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.041938,0.16089,0.19686,1,0
3,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.031957,0.16031,0.17069,1,0
3,GO BODY FLUID SECRETION,0.006955,0.16028,0.18687,1,0
3,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.028348,0.15775,0.19144,1,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.065157,0.15632,0.19201,1,0
3,GO EPIDERMIS DEVELOPMENT,0.027226,0.1527,0.16414,1,0
3,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.030713,0.15242,0.21928,1,0
3,GO INOSITOL LIPID MEDIATED SIGNALING,0.056456,0.1514,0.18931,1,0
3,GO CHOLESTEROL EFFLUX,0.038848,0.15088,0.19016,1,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.034576,0.15072,0.16697,1,0
3,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.037377,0.15037,0.23008,1,0
3,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.065157,0.14968,0.17313,1,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.034576,0.14809,0.20999,1,0
3,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.050584,0.14643,0.16162,1,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.056456,0.14615,0.17565,1,0
3,GO PROTEIN DEMANNOSYLATION,0.052482,0.13896,0.19942,1,0
3,GO CELLULAR HORMONE METABOLIC PROCESS,0.021265,0.13553,0.14845,1,0
3,GO TRANSPOSITION,0.045233,0.13519,0.15418,1,0
3,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.038848,0.13424,0.2054,1,0
3,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.017954,0.13287,0.18697,1,0
3,GO LIPID HOMEOSTASIS,0.0172,0.13227,0.17608,1,0
3,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.019548,0.13204,0.2077,1,0
3,GO BROWN FAT CELL DIFFERENTIATION,0.067497,0.13089,0.15369,1,0
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0010798,0.12881,0.22077,1,0
3,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0016767,0.12802,0.18755,1,0
3,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.050584,0.12799,0.15158,1,0
3,GO STEROL METABOLIC PROCESS,0.021265,0.12627,0.16246,1,0
3,GO CELLULAR RESPONSE TO ATP,0.038848,0.12577,0.17898,1,0
3,GO PROTEIN DEGLYCOSYLATION,0.056456,0.12498,0.18237,1,0
3,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.033245,0.12385,0.25314,1,0
3,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.008797,0.12374,0.16821,1,0
3,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.067497,0.12127,0.2092,1,0
3,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.067497,0.12106,0.20292,1,0
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.030713,0.11972,0.19322,1,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.046961,0.11752,0.19902,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.023112,0.11649,0.15052,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.060677,0.11455,0.1762,1,0
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0018673,0.11347,0.19407,1,0
3,GO NEGATIVE REGULATION OF AUTOPHAGY,0.046961,0.11338,0.18099,1,0
3,GO AUTOPHAGOSOME MATURATION,0.010101,0.11298,0.23056,1,0
3,GO ACTIVATION OF MAPK ACTIVITY,0.054439,0.11185,0.20173,1,0
3,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0044907,0.11169,0.18151,1,0
3,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.065157,0.11125,0.18214,1,0
3,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.018736,0.11003,0.2165,1,0
3,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.065157,0.10901,0.1741,1,0
3,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.011063,0.10865,0.15853,1,0
3,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.056456,0.10826,0.17267,1,0
3,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.065157,0.10659,0.17225,1,0
3,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.011063,0.10619,0.19878,1,0
3,GO RNA DECAPPING,0.021265,0.10534,0.19612,1,0
3,GO TETRAPYRROLE METABOLIC PROCESS,0.027226,0.10534,0.12186,1,0
3,GO REGULATION OF ACTIN FILAMENT LENGTH,0.022172,0.10233,0.18845,1,0
3,GO ENDOCYTOSIS,0.056456,0.1016,0.18629,1,0
3,GO MUSCLE CELL APOPTOTIC PROCESS,0.022172,0.10143,0.17915,1,0
3,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.048745,0.10123,0.17241,1,0
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.00096503,0.10117,0.23743,1,0
3,GO RESPONSE TO ALCOHOL,0.040368,0.10093,0.16474,1,0
3,GO RESPONSE TO STEROL,0.031957,0.10086,0.23386,1,0
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.048745,0.099704,0.17827,1,0
3,GO DNA DEMETHYLATION,0.046961,0.099693,0.15986,1,0
3,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.035953,0.098667,0.14802,1,0
3,GO REGULATION OF LIPID METABOLIC PROCESS,0.069906,0.098037,0.1451,1,0
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.048745,0.09494,0.16427,1,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.045233,0.094935,0.17638,1,0
3,GO POSITIVE REGULATION OF SIGNALING,0.037377,0.094905,0.16244,1,0
3,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.046961,0.094433,0.14577,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0047188,0.094419,0.21961,1,0
3,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.056456,0.090253,0.19706,1,0
3,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.027226,0.089892,0.18201,1,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.046961,0.089851,0.1713,1,0
3,GO JNK CASCADE,0.033245,0.088616,0.18776,1,0
3,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0172,0.087883,0.23308,1,0
3,GO POSITIVE REGULATION OF TRANSPORT,0.025096,0.086922,0.17158,1,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.046961,0.084409,0.14209,1,0
3,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.058535,0.082794,0.17256,1,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.054439,0.080986,0.14644,1,0
3,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.069906,0.077574,0.17756,1,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.052482,0.073033,0.13993,1,0
3,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.02951,0.069102,0.16026,1,0
3,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.037377,0.068223,0.20467,1,0
3,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.021265,0.066175,0.11966,1,0
3,GO PRIMARY MIRNA PROCESSING,0.020391,0.06532,0.19353,1,0
3,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.067497,0.064803,0.14752,1,0
3,GO STEROID BIOSYNTHETIC PROCESS,0.043559,0.059914,0.12213,1,0
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.020391,-0.15874,-0.16818,1,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.028348,-0.17684,-0.18562,1,0
3,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.060677,-0.18191,-0.18968,1,0
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0049572,-0.18695,-0.16996,1,0
3,GO DEFENSE RESPONSE TO FUNGUS,0.067497,-0.21986,-0.20923,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.060677,-0.22066,-0.15144,1,0
3,GO LEUKOCYTE AGGREGATION,0.060677,-0.22881,-0.31651,1,0
3,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.025096,-0.23279,-0.2133,1,0
3,GO MONONUCLEAR CELL MIGRATION,0.040368,-0.25376,-0.30723,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0027019,-0.25947,-0.26498,1,0
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0034935,-0.27923,-0.31479,1,0
3,GO INTERLEUKIN 17 PRODUCTION,0.031957,-0.28047,-0.30727,1,0
3,GO REGULATION OF T CELL CHEMOTAXIS,0.035953,-0.28674,-0.32194,1,0
3,GO RESPONSE TO PEPTIDOGLYCAN,0.050584,-0.29282,-0.32446,1,0
3,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.038848,-0.34259,-0.41437,1,0
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.067497,-0.35101,-0.39302,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.048745,-0.37505,-0.30698,1,0
3,GO MONOCYTE CHEMOTAXIS,0.013834,-0.37674,-0.41352,1,0
3,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.048745,-0.38433,-0.31625,1,0
3,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.065157,-0.39161,-0.3632,1,0
3,GO DENDRITIC CELL APOPTOTIC PROCESS,0.067497,-0.39939,-0.47069,1,0
3,GO T CELL CHEMOTAXIS,0.050584,-0.41762,-0.36076,1,0
3,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.034576,-0.41852,-0.33474,1,0
3,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.043559,-0.4262,-0.28701,1,0
3,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.035953,-0.42887,-0.32954,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.0096484,-0.44932,-0.4105,1,0
3,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.043559,-0.45075,-0.38698,1,0
3,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.065157,-0.46323,-0.49589,1,0
3,GO CYTOLYSIS,0.069906,-0.46577,-0.35834,1,0
3,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.014457,-0.50027,-0.53379,1,0
3,GO CHRONIC INFLAMMATORY RESPONSE,0.0092139,-0.52891,-0.53439,1,0
3,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.035953,-0.53061,-0.39249,1,0
3,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,0.040368,-0.58471,-0.56825,1,0
3,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,0.048745,-0.58791,-0.5787,1,0
3,GO EOSINOPHIL MIGRATION,0.0019699,-0.64597,-0.61988,1,0
3,GO EOSINOPHIL CHEMOTAXIS,0.00076864,-0.70251,-0.66434,1,0
3,GO NATURAL KILLER CELL CHEMOTAXIS,0.0172,-0.77692,-0.65432,1,0
3,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.08588,0.38609,0.27957,0,1
3,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.08303,0.36444,0.2686,0,1
3,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.077559,0.34394,0.23132,0,1
3,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.08588,0.33824,0.2398,0,1
3,GO PROSTATE GLAND MORPHOGENESIS,0.08588,0.29946,0.22473,0,1
3,GO PARAXIAL MESODERM MORPHOGENESIS,0.08303,0.2824,0.20621,0,1
3,GO RESPONSE TO CORTICOSTERONE,0.08588,0.27862,0.20531,0,1
3,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.08881,0.27684,0.26756,0,1
3,GO TRANSCYTOSIS,0.23827,0.22806,0.142,0,1
3,GO PROXIMAL DISTAL PATTERN FORMATION,0.23827,0.22376,0.11261,0,1
3,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.10811,0.2228,0.1962,0,1
3,GO POLYOL TRANSPORT,0.13467,0.2223,0.18306,0,1
3,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.13885,0.22207,0.1168,0,1
3,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.10811,0.221,0.16391,0,1
3,GO SPROUTING ANGIOGENESIS,0.08303,0.21997,0.20201,0,1
3,GO TRIGLYCERIDE CATABOLIC PROCESS,0.16123,0.21205,0.1127,0,1
3,GO SPINDLE MIDZONE ASSEMBLY,0.13467,0.21115,0.17422,0,1
3,GO SEMI LUNAR VALVE DEVELOPMENT,0.19156,0.21031,0.16115,0,1
3,GO DENTATE GYRUS DEVELOPMENT,0.074935,0.20679,0.20276,0,1
3,GO PULMONARY VALVE MORPHOGENESIS,0.08303,0.20344,0.21093,0,1
3,GO INTESTINAL LIPID ABSORPTION,0.074935,0.20017,0.24735,0,1
3,GO DRUG METABOLIC PROCESS,0.08588,0.19917,0.18064,0,1
3,GO MALE GENITALIA DEVELOPMENT,0.10468,0.19772,0.14106,0,1
3,GO AORTIC VALVE DEVELOPMENT,0.08881,0.19261,0.19364,0,1
3,GO O GLYCAN PROCESSING,0.094909,0.19183,0.1811,0,1
3,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.072385,0.18984,0.19534,0,1
3,GO LIPID DIGESTION,0.10811,0.18723,0.20733,0,1
3,GO LIPID IMPORT INTO CELL,0.08303,0.18519,0.18178,0,1
3,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.11163,0.18509,0.20838,0,1
3,GO BICARBONATE TRANSPORT,0.074935,0.18432,0.14202,0,1
3,GO PROSTATIC BUD FORMATION,0.16602,0.18159,0.16375,0,1
3,GO PULMONARY VALVE DEVELOPMENT,0.197,0.18036,0.17993,0,1
3,GO ETHANOL CATABOLIC PROCESS,0.08588,0.17979,0.19669,0,1
3,GO HEART INDUCTION,0.32248,0.17494,0.12433,0,1
3,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.15197,0.17263,0.20795,0,1
3,GO CELL CELL JUNCTION MAINTENANCE,0.080256,0.17108,0.21808,0,1
3,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.074935,0.16881,0.17793,0,1
3,GO FIBROBLAST ACTIVATION,0.16602,0.16859,0.14037,0,1
3,GO RESPONSE TO GONADOTROPIN,0.13467,0.1645,0.13467,0,1
3,GO TUBE MORPHOGENESIS,0.091819,0.16228,0.1809,0,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.077559,0.16162,0.18548,0,1
3,GO FACE DEVELOPMENT,0.08881,0.16059,0.19669,0,1
3,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.091819,0.15774,0.16228,0,1
3,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.1306,0.15753,0.079212,0,1
3,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.074935,0.15488,0.16384,0,1
3,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.072385,0.15447,0.2246,0,1
3,GO SALIVARY GLAND DEVELOPMENT,0.10811,0.15413,0.19491,0,1
3,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.17591,0.15347,0.21298,0,1
3,GO VITAMIN TRANSPORT,0.077559,0.15281,0.13615,0,1
3,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.11163,0.15169,0.11633,0,1
3,GO CERAMIDE TRANSPORT,0.08881,0.15039,0.22848,0,1
3,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.072385,0.14646,0.19532,0,1
3,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.077559,0.14623,0.26602,0,1
3,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.074935,0.14537,0.17389,0,1
3,GO DISACCHARIDE METABOLIC PROCESS,0.10134,0.14423,0.24766,0,1
3,GO ARACHIDONIC ACID METABOLIC PROCESS,0.17091,0.14257,0.12697,0,1
3,GO CHONDROCYTE PROLIFERATION,0.15197,0.14108,0.18803,0,1
3,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.10468,0.14107,0.14273,0,1
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.18624,0.13999,0.10741,0,1
3,GO BILE ACID AND BILE SALT TRANSPORT,0.16602,0.13995,0.14127,0,1
3,GO RESPONSE TO EPINEPHRINE,0.14312,0.139,0.22956,0,1
3,GO DIGESTIVE SYSTEM PROCESS,0.080256,0.13707,0.14039,0,1
3,GO TISSUE REGENERATION,0.12662,0.13615,0.14606,0,1
3,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.080256,0.13565,0.12966,0,1
3,GO TERPENOID METABOLIC PROCESS,0.080256,0.13537,0.12535,0,1
3,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.21989,0.13523,0.14262,0,1
3,GO REGULATION OF BODY FLUID LEVELS,0.10468,0.13288,0.15627,0,1
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.08588,0.1325,0.1218,0,1
3,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.1306,0.13233,0.10613,0,1
3,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.11894,0.13183,0.076659,0,1
3,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.08303,0.13125,0.11951,0,1
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.11894,0.12973,0.16062,0,1
3,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.24463,0.12911,0.17209,0,1
3,GO CELL MOTILITY,0.10134,0.12564,0.16383,0,1
3,GO LONG CHAIN FATTY ACID TRANSPORT,0.072385,0.1253,0.13501,0,1
3,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.11894,0.12457,0.12897,0,1
3,GO RESPONSE TO UV B,0.1306,0.12327,0.1352,0,1
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.10468,0.12248,0.11431,0,1
3,GO GOLGI LOCALIZATION,0.21989,0.1218,0.087253,0,1
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.091819,0.11937,0.15855,0,1
3,GO CELLULAR RESPONSE TO SALT STRESS,0.12662,0.11904,0.15351,0,1
3,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.10811,0.11392,0.17777,0,1
3,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.11524,0.11353,0.14741,0,1
3,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.18624,0.11312,0.1433,0,1
3,GO NEGATIVE REGULATION OF OSSIFICATION,0.10811,0.11287,0.17389,0,1
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.11163,0.11237,0.12438,0,1
3,GO RESPONSE TO KETONE,0.08881,0.11198,0.14697,0,1
3,GO PROSTATE GLAND DEVELOPMENT,0.20256,0.11181,0.12768,0,1
3,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.12662,0.11064,0.1574,0,1
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.08881,0.10941,0.1371,0,1
3,GO EPITHELIAL CELL PROLIFERATION,0.11524,0.1094,0.15054,0,1
3,GO RESPONSE TO ETHER,0.10134,0.10919,0.13902,0,1
3,GO PROTEIN AUTOPROCESSING,0.098083,0.10852,0.13931,0,1
3,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.11894,0.10767,0.13291,0,1
3,GO NAD METABOLIC PROCESS,0.077559,0.10656,0.14329,0,1
3,GO RESPONSE TO CORTICOSTEROID,0.14312,0.10594,0.12465,0,1
3,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.11163,0.10554,0.18582,0,1
3,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.10134,0.10498,0.1383,0,1
3,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.13467,0.10459,0.094344,0,1
3,GO REGULATION OF CELL POPULATION PROLIFERATION,0.17091,0.10425,0.13077,0,1
3,GO BONE DEVELOPMENT,0.10468,0.10402,0.16337,0,1
3,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.091819,0.10382,0.11222,0,1
3,GO REGULATION OF ICOSANOID SECRETION,0.17591,0.097929,0.12617,0,1
3,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.08881,0.097695,0.13619,0,1
3,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.074935,0.097614,0.15761,0,1
3,GO POSITIVE REGULATION OF NEURON DEATH,0.098083,0.096673,0.15131,0,1
3,GO ERYTHROCYTE HOMEOSTASIS,0.091819,0.096526,0.13729,0,1
3,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.39705,0.094448,0.054176,0,1
3,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.2259,0.093031,0.21626,0,1
3,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.11163,0.092857,0.13736,0,1
3,GO PENTOSE METABOLIC PROCESS,0.2259,0.088639,0.11336,0,1
3,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.077559,0.087499,0.12918,0,1
3,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.098083,0.087219,0.12648,0,1
3,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.35442,0.08698,0.083379,0,1
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.18102,0.085301,0.11639,0,1
3,GO ACTIN NUCLEATION,0.11163,0.08158,0.13968,0,1
3,GO RESPONSE TO OXIDATIVE STRESS,0.10811,0.079965,0.12646,0,1
3,GO REGULATION OF TRANSLATIONAL ELONGATION,0.2998,0.075902,0.056291,0,1
3,GO RESPONSE TO MUSCLE STRETCH,0.2259,0.073856,0.20649,0,1
3,GO POSITIVE REGULATION OF PROTEOLYSIS,0.1306,0.071986,0.12582,0,1
3,GO REGULATION OF MULTI ORGANISM PROCESS,0.098083,0.070879,0.10866,0,1
3,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.26442,0.070704,0.090299,0,1
3,GO REGULATION OF TRANSLATIONAL TERMINATION,0.17091,0.070232,0.10529,0,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.16123,0.069282,0.065734,0,1
3,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.19156,0.068668,0.10571,0,1
3,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.28529,0.061163,0.081672,0,1
3,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.14312,0.060261,0.08486,0,1
3,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.13467,0.049171,0.066364,0,1
3,GO DISTAL TUBULE DEVELOPMENT,0.0027019,0.57459,0.5251,0,0
3,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0038653,0.4812,0.45699,0,0
3,GO PARENTAL BEHAVIOR,0.0038653,0.4811,0.5886,0,0
3,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.0021907,0.47477,0.38426,0,0
3,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.00023283,0.41036,0.37033,0,0
3,GO MRNA SPLICE SITE SELECTION,0.00010866,0.40647,0.42457,0,0
3,GO TRIGEMINAL NERVE DEVELOPMENT,0.013235,0.39932,0.40957,0,0
3,GO STABILIZATION OF MEMBRANE POTENTIAL,0.0044907,0.37852,0.42684,0,0
3,GO LOOP OF HENLE DEVELOPMENT,0.0029965,0.37182,0.46693,0,0
3,GO REGULATION OF CENTRIOLE REPLICATION,0.00091199,0.36611,0.3354,0,0
3,GO REGULATION OF GLUTAMATE SECRETION,0.0092139,0.36288,0.38514,0,0
3,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.0047188,0.36276,0.32086,0,0
3,GO CARDIAC VENTRICLE FORMATION,0.0031545,0.36013,0.40612,0,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.0096484,0.35762,0.45905,0,0
3,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.046961,0.35719,0.34894,0,0
3,GO LIMB BUD FORMATION,0.02951,0.35484,0.28429,0,0
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0015882,0.3542,0.43016,0,0
3,GO INTRACILIARY RETROGRADE TRANSPORT,0.00060992,0.35361,0.39237,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0063209,0.35005,0.51654,0,0
3,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.08303,0.34896,0.26814,0,0
3,GO INTRACILIARY TRANSPORT,0.00033648,0.34871,0.34543,0,0
3,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0057394,0.3397,0.31747,0,0
3,GO REGULATION OF GROWTH HORMONE SECRETION,0.0042727,0.33801,0.40899,0,0
3,GO CARDIAC CHAMBER FORMATION,0.00332,0.33606,0.40697,0,0
3,GO HISTONE H3 K9 MODIFICATION,5.6086e-05,0.33119,0.38393,0,0
3,GO CEREBRAL CORTEX CELL MIGRATION,0.00081392,0.3273,0.34503,0,0
3,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.0096484,0.32398,0.28468,0,0
3,GO TELENCEPHALON GLIAL CELL MIGRATION,0.0012071,0.32352,0.35643,0,0
3,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.0021907,0.32289,0.33861,0,0
3,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.015104,0.31803,0.23306,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.0047188,0.31709,0.44074,0,0
3,GO CENTROSOME DUPLICATION,0.00081392,0.31436,0.307,0,0
3,GO MITOTIC RECOMBINATION,0.00017019,0.31259,0.34667,0,0
3,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.010572,0.31213,0.36266,0,0
3,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.0028457,0.31181,0.27232,0,0
3,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.00332,0.3112,0.31687,0,0
3,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.00029789,0.30701,0.28777,0,0
3,GO SPERMATID NUCLEUS DIFFERENTIATION,0.00072571,0.30666,0.31276,0,0
3,GO GROWTH HORMONE SECRETION,0.0012758,0.30621,0.39137,0,0
3,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.0018673,0.30575,0.3856,0,0
3,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.008797,0.29532,0.29979,0,0
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0013481,0.29463,0.3377,0,0
3,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.00028019,0.29153,0.37778,0,0
3,GO KINETOCHORE ASSEMBLY,0.0054671,0.28933,0.30785,0,0
3,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.00024771,0.28877,0.32273,0,0
3,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.00029789,0.28867,0.30862,0,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0028457,0.28839,0.32516,0,0
3,GO NOSE DEVELOPMENT,0.040368,0.28788,0.29369,0,0
3,GO NEURAL CREST FORMATION,0.072385,0.28731,0.25709,0,0
3,GO THALAMUS DEVELOPMENT,0.00081392,0.28713,0.3831,0,0
3,GO REGULATION OF CENTROSOME DUPLICATION,0.00020554,0.2854,0.2865,0,0
3,GO BASIC AMINO ACID TRANSPORT,0.030713,0.28391,0.24377,0,0
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.00021879,0.28329,0.37226,0,0
3,GO MEIOTIC CHROMOSOME SEGREGATION,0.0013481,0.28301,0.28726,0,0
3,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00064645,0.28258,0.3321,0,0
3,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0012071,0.28171,0.31773,0,0
3,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.013834,0.28131,0.34552,0,0
3,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.035953,0.27995,0.25549,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.02951,0.27967,0.26761,0,0
3,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.00023283,0.27927,0.30504,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.048745,0.27879,0.23466,0,0
3,GO RETINAL GANGLION CELL AXON GUIDANCE,0.0025648,0.27816,0.34226,0,0
3,GO RESPONSE TO LEUCINE,0.0020776,0.27563,0.35111,0,0
3,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.0038653,0.26978,0.38197,0,0
3,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.00051151,0.26944,0.3267,0,0
3,GO CELL PROLIFERATION IN FOREBRAIN,0.020391,0.26916,0.27911,0,0
3,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.00054254,0.26819,0.2954,0,0
3,GO HISTONE H3 K14 ACETYLATION,0.00026348,0.26678,0.35977,0,0
3,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.0019699,0.26657,0.4214,0,0
3,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.0028457,0.26638,0.30378,0,0
3,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.006955,0.26628,0.26617,0,0
3,GO CARDIAC ATRIUM DEVELOPMENT,0.0042727,0.26531,0.32161,0,0
3,GO REGULATION OF CENTROSOME CYCLE,0.00086166,0.26518,0.25929,0,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.00014062,0.26441,0.32965,0,0
3,GO NEPHRIC DUCT DEVELOPMENT,0.048745,0.26404,0.25693,0,0
3,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0027019,0.26391,0.29159,0,0
3,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.00026348,0.26329,0.32835,0,0
3,GO CORTICOSTEROID HORMONE SECRETION,0.065157,0.26312,0.17672,0,0
3,GO ATP DEPENDENT CHROMATIN REMODELING,0.0021907,0.25908,0.26624,0,0
3,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0012071,0.25898,0.28373,0,0
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0034935,0.25661,0.31958,0,0
3,GO LYMPHANGIOGENESIS,0.072385,0.25625,0.22941,0,0
3,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.0044907,0.25611,0.2981,0,0
3,GO LYSINE METABOLIC PROCESS,0.0052065,0.25609,0.27584,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.022172,0.25426,0.27023,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.0031545,0.25384,0.25787,0,0
3,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0012758,0.25279,0.28921,0,0
3,GO TONGUE DEVELOPMENT,0.0057394,0.25225,0.23605,0,0
3,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.058535,0.25215,0.30576,0,0
3,GO TELENCEPHALON REGIONALIZATION,0.214,0.25191,0.15176,0,0
3,GO HIPPO SIGNALING,0.0034935,0.25155,0.30447,0,0
3,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.0029965,0.25117,0.34465,0,0
3,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.00048214,0.25011,0.36312,0,0
3,GO HOMOLOGOUS RECOMBINATION,0.0016767,0.24909,0.29616,0,0
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.00033648,0.24822,0.29476,0,0
3,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.021265,0.24811,0.23813,0,0
3,GO CEREBRAL CORTEX DEVELOPMENT,0.0011418,0.24805,0.29785,0,0
3,GO CGMP METABOLIC PROCESS,0.0044907,0.24767,0.31667,0,0
3,GO CYTOPLASM ORGANIZATION,0.018736,0.24737,0.26089,0,0
3,GO DNA DOUBLE STRAND BREAK PROCESSING,0.0060238,0.24675,0.26837,0,0
3,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00033648,0.24666,0.29367,0,0
3,GO LEYDIG CELL DIFFERENTIATION,0.040368,0.24659,0.3418,0,0
3,GO HISTONE H4 DEACETYLATION,0.00035748,0.24632,0.26963,0,0
3,GO REGULATION OF CHROMATIN BINDING,0.0024341,0.24594,0.27728,0,0
3,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.0052065,0.24577,0.28907,0,0
3,GO FOREBRAIN CELL MIGRATION,0.00054254,0.24523,0.33404,0,0
3,GO RESPONSE TO FOOD,0.00048214,0.24483,0.2697,0,0
3,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.08303,0.2439,0.23218,0,0
3,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.022172,0.24276,0.25282,0,0
3,GO G0 TO G1 TRANSITION,0.00091199,0.24268,0.30728,0,0
3,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.11894,0.24038,0.17267,0,0
3,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.02951,0.23966,0.20772,0,0
3,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.046961,0.23945,0.4447,0,0
3,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.00072571,0.23893,0.36238,0,0
3,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.062884,0.23835,0.24192,0,0
3,GO SNARE COMPLEX ASSEMBLY,0.0016767,0.23787,0.33163,0,0
3,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.0010209,0.23753,0.28348,0,0
3,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.008797,0.23738,0.29201,0,0
3,GO PENILE ERECTION,0.060677,0.23731,0.35154,0,0
3,GO REGULATION OF VESICLE FUSION,0.011574,0.23698,0.30498,0,0
3,GO RECOMBINATIONAL REPAIR,0.0027019,0.23677,0.26259,0,0
3,GO AZOLE TRANSMEMBRANE TRANSPORT,0.020391,0.23656,0.27258,0,0
3,GO HISTONE H4 K16 ACETYLATION,0.00048214,0.23623,0.31113,0,0
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.0034935,0.23567,0.26136,0,0
3,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.00033648,0.23463,0.35032,0,0
3,GO SYNAPTIC VESICLE TRANSPORT,0.00064645,0.23436,0.33713,0,0
3,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.23203,0.23421,0.14534,0,0
3,GO P BODY ASSEMBLY,0.00051151,0.23402,0.33196,0,0
3,GO TONGUE MORPHOGENESIS,0.0057394,0.23364,0.25293,0,0
3,GO MITOTIC SPINDLE ASSEMBLY,0.022172,0.23343,0.19433,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.0013481,0.23334,0.30441,0,0
3,GO CHROMATIN SILENCING,0.00020554,0.23246,0.29305,0,0
3,GO STRESS GRANULE ASSEMBLY,0.00035748,0.23232,0.29135,0,0
3,GO REGULATION OF CELL PROJECTION SIZE,0.056456,0.23178,0.24525,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00033648,0.23145,0.30236,0,0
3,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0036751,0.23042,0.24724,0,0
3,GO ORGANELLE FISSION,0.00064645,0.22966,0.2355,0,0
3,GO RENAL VESICLE DEVELOPMENT,0.026142,0.22915,0.22872,0,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.023112,0.22854,0.33058,0,0
3,GO RETINAL METABOLIC PROCESS,0.08588,0.22841,0.1784,0,0
3,GO DNA CONFORMATION CHANGE,0.00076864,0.22808,0.27136,0,0
3,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.14312,0.22807,0.15944,0,0
3,GO MESENCHYMAL CELL PROLIFERATION,0.048745,0.22774,0.20846,0,0
3,GO EPITHELIAL TUBE FORMATION,0.00096503,0.22768,0.25098,0,0
3,GO HISTONE EXCHANGE,0.028348,0.22762,0.17984,0,0
3,GO V D J RECOMBINATION,0.091819,0.22749,0.15083,0,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00057531,0.22745,0.30228,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.034576,0.22744,0.23116,0,0
3,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.011574,0.22689,0.22776,0,0
3,GO NEGATIVE REGULATION OF DNA REPAIR,0.00076864,0.22494,0.25232,0,0
3,GO EXIT FROM MITOSIS,0.00048214,0.22472,0.24682,0,0
3,GO PALLIUM DEVELOPMENT,0.0014241,0.22358,0.26053,0,0
3,GO REGULATION OF GTP BINDING,0.0066311,0.22274,0.25281,0,0
3,GO MALE MEIOTIC NUCLEAR DIVISION,0.00332,0.22218,0.27052,0,0
3,GO DENDRITE SELF AVOIDANCE,0.040368,0.22203,0.27066,0,0
3,GO MITOTIC NUCLEAR DIVISION,0.0038653,0.22147,0.22139,0,0
3,GO EXTRACELLULAR MATRIX ASSEMBLY,0.035953,0.22138,0.30003,0,0
3,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00015974,0.22131,0.29992,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.015776,0.22105,0.2394,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.0044907,0.21981,0.32322,0,0
3,GO RETINAL ROD CELL DIFFERENTIATION,0.015104,0.21974,0.26051,0,0
3,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.054439,0.2189,0.19866,0,0
3,GO DOUBLE STRAND BREAK REPAIR,0.00060992,0.21885,0.26424,0,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.00086166,0.21876,0.26258,0,0
3,GO LUTEINIZATION,0.02951,0.2187,0.33354,0,0
3,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.012106,0.21836,0.2316,0,0
3,GO CYTOKINESIS,7.3279e-05,0.21823,0.26341,0,0
3,GO PANCREAS DEVELOPMENT,0.00072571,0.21802,0.30934,0,0
3,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.02951,0.21741,0.27801,0,0
3,GO GLIAL CELL FATE COMMITMENT,0.027226,0.21727,0.25821,0,0
3,GO REGULATION OF NEUROBLAST PROLIFERATION,0.013235,0.21715,0.2537,0,0
3,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.0034935,0.21611,0.25625,0,0
3,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.0076456,0.21493,0.32231,0,0
3,GO SUBPALLIUM DEVELOPMENT,0.019548,0.21448,0.25533,0,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0083971,0.21372,0.23339,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.00076864,0.21359,0.22633,0,0
3,GO ADRENAL GLAND DEVELOPMENT,0.13467,0.21344,0.20099,0,0
3,GO HISTONE UBIQUITINATION,0.00028019,0.21305,0.2907,0,0
3,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.0044907,0.21231,0.33563,0,0
3,GO NEURAL TUBE FORMATION,0.0031545,0.21199,0.24367,0,0
3,GO EPITHELIAL CELL MORPHOGENESIS,0.0080134,0.21178,0.27816,0,0
3,GO CHROMOSOME LOCALIZATION,0.011574,0.21157,0.19301,0,0
3,GO HISTONE PHOSPHORYLATION,0.0042727,0.21038,0.21022,0,0
3,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.048745,0.20972,0.28678,0,0
3,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.0011418,0.20938,0.25069,0,0
3,GO RRNA CATABOLIC PROCESS,0.00332,0.20932,0.20709,0,0
3,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.0023095,0.20916,0.22091,0,0
3,GO MITOTIC SISTER CHROMATID COHESION,0.0044907,0.20916,0.26047,0,0
3,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.027226,0.20901,0.25691,0,0
3,GO METAPHASE PLATE CONGRESSION,0.015776,0.20892,0.18178,0,0
3,GO NUCLEOSOME ORGANIZATION,0.00096503,0.20792,0.25864,0,0
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.016475,0.20792,0.23738,0,0
3,GO TUBE FORMATION,0.0011418,0.2076,0.24806,0,0
3,GO TRACHEA DEVELOPMENT,0.028348,0.20744,0.23032,0,0
3,GO FOREBRAIN DEVELOPMENT,9.5377e-05,0.20642,0.29425,0,0
3,GO SEROTONIN TRANSPORT,0.0096484,0.20598,0.26423,0,0
3,GO NUCLEAR ENVELOPE ORGANIZATION,0.00014989,0.20556,0.23964,0,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0047188,0.20542,0.23372,0,0
3,GO DNA REPLICATION,0.0054671,0.20538,0.23022,0,0
3,GO DNA DEPENDENT DNA REPLICATION,0.034576,0.20512,0.19435,0,0
3,GO RESPONSE TO UV,0.00035748,0.20485,0.23769,0,0
3,GO DNA RECOMBINATION,0.0031545,0.20482,0.21744,0,0
3,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.054439,0.20446,0.2179,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.065157,0.20436,0.35193,0,0
3,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,8.3641e-05,0.20402,0.27704,0,0
3,GO HIPPOCAMPUS DEVELOPMENT,0.0011418,0.20391,0.25761,0,0
3,GO REGULATION OF CILIUM MOVEMENT,0.0040644,0.20368,0.246,0,0
3,GO MITRAL VALVE DEVELOPMENT,0.13467,0.20358,0.19419,0,0
3,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.091819,0.20323,0.21238,0,0
3,GO DNA GEOMETRIC CHANGE,0.0016767,0.20318,0.24921,0,0
3,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00081392,0.20307,0.26931,0,0
3,GO HEART VALVE FORMATION,0.0083971,0.20296,0.34381,0,0
3,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.067497,0.20244,0.15993,0,0
3,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.00076864,0.2012,0.25689,0,0
3,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.040368,0.19989,0.20534,0,0
3,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00091199,0.19962,0.31348,0,0
3,GO REGULATION OF TELOMERE MAINTENANCE,0.00042807,0.19915,0.24549,0,0
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.0003797,0.1991,0.2358,0,0
3,GO MITOTIC DNA REPLICATION,0.18624,0.19879,0.12181,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.048745,0.19836,0.22232,0,0
3,GO POSITIVE REGULATION OF CYTOKINESIS,0.0010798,0.19835,0.24819,0,0
3,GO DNA STRAND ELONGATION,0.067497,0.19805,0.169,0,0
3,GO RESPONSE TO IRON ION,0.016475,0.19672,0.20201,0,0
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00045436,0.19671,0.24466,0,0
3,GO RESPONSE TO PROSTAGLANDIN E,0.62923,0.19651,0.085373,0,0
3,GO NUCLEOSOME ASSEMBLY,0.010572,0.1963,0.23131,0,0
3,GO GENE SILENCING,0.00033648,0.19627,0.23362,0,0
3,GO MITOTIC METAPHASE PLATE CONGRESSION,0.043559,0.19589,0.13416,0,0
3,GO NEURON FATE COMMITMENT,0.019548,0.19586,0.24677,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE,0.00015974,0.19571,0.23148,0,0
3,GO TELENCEPHALON DEVELOPMENT,0.0010209,0.19567,0.26595,0,0
3,GO MULTICELLULAR ORGANISM AGING,0.0066311,0.1949,0.2013,0,0
3,GO MRNA MODIFICATION,0.010101,0.19467,0.17948,0,0
3,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.0066311,0.19454,0.32215,0,0
3,GO COBALAMIN METABOLIC PROCESS,0.0096484,0.19442,0.19969,0,0
3,GO REGULATION OF CELL CYCLE,0.00012367,0.19432,0.23457,0,0
3,GO CHROMATIN DISASSEMBLY,0.022172,0.19366,0.23472,0,0
3,GO DNA CATABOLIC PROCESS,0.00054254,0.19343,0.20258,0,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.094909,0.19309,0.1865,0,0
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.072385,0.193,0.20699,0,0
3,GO RNA EXPORT FROM NUCLEUS,0.0012758,0.19295,0.2235,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.18624,0.19245,0.15335,0,0
3,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.20822,0.19228,0.17447,0,0
3,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.019548,0.1919,0.25443,0,0
3,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0019699,0.19101,0.22912,0,0
3,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.037377,0.19099,0.18786,0,0
3,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.067497,0.19029,0.23634,0,0
3,GO EPIDERMIS MORPHOGENESIS,0.12662,0.19021,0.17401,0,0
3,GO CELL CYCLE,0.00017019,0.1901,0.23567,0,0
3,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.00023283,0.18948,0.22306,0,0
3,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.041938,0.18913,0.19346,0,0
3,GO POSITIVE REGULATION OF CELL MATURATION,0.0060238,0.18904,0.27409,0,0
3,GO ONE CARBON METABOLIC PROCESS,0.0036751,0.18863,0.18265,0,0
3,GO REGULATION OF NUCLEAR DIVISION,0.00091199,0.18834,0.20979,0,0
3,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.028348,0.18833,0.27317,0,0
3,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.00091199,0.18752,0.27116,0,0
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.00096503,0.18727,0.22488,0,0
3,GO PROTEIN MONOUBIQUITINATION,0.00035748,0.18706,0.26696,0,0
3,GO REGULATION OF STEROL TRANSPORT,0.098083,0.18503,0.14788,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.011574,0.18501,0.27972,0,0
3,GO ESCRT COMPLEX DISASSEMBLY,0.0052065,0.1844,0.16041,0,0
3,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.08588,0.18396,0.19779,0,0
3,GO SENSORY PERCEPTION OF BITTER TASTE,0.045233,0.18392,0.1893,0,0
3,GO SISTER CHROMATID COHESION,0.0034935,0.18369,0.2478,0,0
3,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00021879,0.18359,0.23634,0,0
3,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.5959,0.18355,0.11578,0,0
3,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.01266,0.18354,0.19918,0,0
3,GO OXYGEN TRANSPORT,0.23203,0.18353,0.14151,0,0
3,GO REGULATION OF MRNA METABOLIC PROCESS,7.8298e-05,0.18348,0.22433,0,0
3,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.11894,0.18284,0.19136,0,0
3,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.015104,0.18267,0.20289,0,0
3,GO DIENCEPHALON DEVELOPMENT,0.00057531,0.18241,0.28681,0,0
3,GO RNA METHYLATION,0.0013481,0.18199,0.19275,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0020776,0.18188,0.21478,0,0
3,GO ECTODERMAL PLACODE DEVELOPMENT,0.010101,0.18182,0.22741,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0011418,0.18177,0.24455,0,0
3,GO REGULATION OF STEM CELL PROLIFERATION,0.013235,0.18173,0.21815,0,0
3,GO APPENDAGE MORPHOGENESIS,0.0036751,0.18173,0.25801,0,0
3,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.10468,0.18158,0.21709,0,0
3,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.030713,0.18114,0.20254,0,0
3,GO PEPTIDYL CYSTEINE MODIFICATION,0.0029965,0.1811,0.20253,0,0
3,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.00024771,0.18095,0.28868,0,0
3,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.011574,0.18076,0.24401,0,0
3,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.15197,0.18061,0.16889,0,0
3,GO DNA METABOLIC PROCESS,0.00040321,0.18051,0.21159,0,0
3,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.12273,0.18045,0.27703,0,0
3,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.041938,0.18039,0.26525,0,0
3,GO MITOTIC CELL CYCLE CHECKPOINT,0.0029965,0.18033,0.23508,0,0
3,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0027019,0.18019,0.25214,0,0
3,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.0018673,0.1801,0.20628,0,0
3,GO DORSAL AORTA DEVELOPMENT,0.11163,0.17929,0.20114,0,0
3,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.026142,0.1791,0.18737,0,0
3,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.041938,0.17873,0.25963,0,0
3,GO HISTONE SERINE PHOSPHORYLATION,0.041938,0.17863,0.15363,0,0
3,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.091819,0.1785,0.15452,0,0
3,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.00068502,0.17811,0.20771,0,0
3,GO APPENDAGE DEVELOPMENT,0.0015041,0.17804,0.25313,0,0
3,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.0076456,0.17665,0.26151,0,0
3,GO POSITIVE REGULATION OF EXOCYTOSIS,0.0092139,0.17648,0.24267,0,0
3,GO VASCULOGENESIS,0.080256,0.17641,0.19806,0,0
3,GO THYROID HORMONE METABOLIC PROCESS,0.098083,0.17603,0.1891,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00072571,0.1754,0.18286,0,0
3,GO ENDOCRINE SYSTEM DEVELOPMENT,0.0034935,0.17534,0.24653,0,0
3,GO REGULATION OF CELL CYCLE PROCESS,0.00035748,0.17534,0.22429,0,0
3,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.0063209,0.17529,0.26468,0,0
3,GO LIPOXYGENASE PATHWAY,0.56341,0.17526,0.044892,0,0
3,GO RESPONSE TO MINERALOCORTICOID,0.28529,0.17509,0.1161,0,0
3,GO PURINE NUCLEOTIDE TRANSPORT,0.0015041,0.17503,0.20431,0,0
3,GO VACUOLAR TRANSPORT,0.00014989,0.17462,0.27319,0,0
3,GO DNA INTEGRITY CHECKPOINT,0.0018673,0.1746,0.2594,0,0
3,GO MRNA TRANSPORT,0.00086166,0.17403,0.22386,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.00060992,0.17402,0.27651,0,0
3,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.0014241,0.17384,0.24641,0,0
3,GO CELL CYCLE PROCESS,0.00028019,0.17363,0.23565,0,0
3,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.15197,0.17362,0.20091,0,0
3,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.0028457,0.17358,0.2487,0,0
3,GO REGULATION OF DEPHOSPHORYLATION,0.00012367,0.17313,0.2602,0,0
3,GO COCHLEA MORPHOGENESIS,0.038848,0.17312,0.1952,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0036751,0.17304,0.19413,0,0
3,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.00072571,0.17302,0.31003,0,0
3,GO CELLULAR RESPONSE TO UV,0.00064645,0.1722,0.20938,0,0
3,GO ECTODERM DEVELOPMENT,0.010572,0.17216,0.21257,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.10468,0.17204,0.15261,0,0
3,GO SKIN EPIDERMIS DEVELOPMENT,0.0017696,0.17125,0.26046,0,0
3,GO RNA PROCESSING,0.00035748,0.17123,0.19697,0,0
3,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.00040321,0.17122,0.23461,0,0
3,GO INNER CELL MASS CELL PROLIFERATION,0.020391,0.17101,0.18558,0,0
3,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.23203,0.17059,0.12256,0,0
3,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0023095,0.17043,0.19515,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE,0.00081392,0.1703,0.1996,0,0
3,GO N GLYCAN PROCESSING,0.007293,0.17016,0.30144,0,0
3,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.0044907,0.1697,0.24741,0,0
3,GO REGULATION OF PHOSPHATASE ACTIVITY,0.00011593,0.1695,0.26902,0,0
3,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.00096503,0.16947,0.24229,0,0
3,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.020391,0.1692,0.23913,0,0
3,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.08881,0.169,0.17964,0,0
3,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.023112,0.16876,0.2403,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.12662,0.16818,0.17023,0,0
3,GO CELL CYCLE CHECKPOINT,0.0029965,0.16815,0.24487,0,0
3,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.24463,0.16787,0.13581,0,0
3,GO REGULATION OF DNA METABOLIC PROCESS,0.00031664,0.16751,0.21103,0,0
3,GO INTERLEUKIN 5 PRODUCTION,0.4521,0.16739,0.10342,0,0
3,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.026142,0.16735,0.24288,0,0
3,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0012071,0.16727,0.21435,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.12273,0.16705,0.13177,0,0
3,GO SEX DIFFERENTIATION,0.0003797,0.16692,0.22191,0,0
3,GO MALE MEIOSIS I,0.0172,0.16691,0.21988,0,0
3,GO DNA REPLICATION CHECKPOINT,0.052482,0.16688,0.22782,0,0
3,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.21989,0.16638,0.1339,0,0
3,GO NUCLEAR EXPORT,0.00045436,0.16632,0.21773,0,0
3,GO POSITIVE REGULATION OF VESICLE FUSION,0.19156,0.16627,0.17339,0,0
3,GO NCRNA TRANSCRIPTION,0.00020554,0.16576,0.21245,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.048745,0.16575,0.22086,0,0
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.00051151,0.16529,0.21758,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.026142,0.16526,0.24356,0,0
3,GO DORSAL VENTRAL AXIS SPECIFICATION,0.027226,0.16525,0.25979,0,0
3,GO APICAL JUNCTION ASSEMBLY,0.0066311,0.16517,0.22404,0,0
3,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.0076456,0.16514,0.23151,0,0
3,GO DNA LIGATION,0.015104,0.1648,0.15457,0,0
3,GO FEMALE SEX DIFFERENTIATION,0.00019306,0.16455,0.26159,0,0
3,GO AMYLOID FIBRIL FORMATION,0.21989,0.16425,0.14948,0,0
3,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.030713,0.1642,0.25413,0,0
3,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.20822,0.1642,0.12084,0,0
3,GO TYPE B PANCREATIC CELL PROLIFERATION,0.069906,0.16405,0.19548,0,0
3,GO REGULATION OF EXIT FROM MITOSIS,0.014457,0.16373,0.21859,0,0
3,GO BLASTOCYST GROWTH,0.015104,0.16319,0.16714,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0063209,0.16317,0.20324,0,0
3,GO REGULATION OF HISTONE PHOSPHORYLATION,0.013834,0.16308,0.20427,0,0
3,GO TRNA MODIFICATION,0.0047188,0.16266,0.15821,0,0
3,GO MITOTIC CELL CYCLE,0.00064645,0.16258,0.2164,0,0
3,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.060677,0.16218,0.21887,0,0
3,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.023112,0.16213,0.16431,0,0
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0017696,0.16212,0.19393,0,0
3,GO PROTEIN K48 LINKED UBIQUITINATION,0.0063209,0.16211,0.18782,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.019548,0.16204,0.305,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.00064645,0.16192,0.2299,0,0
3,GO REGULATION OF METANEPHROS DEVELOPMENT,0.19156,0.16167,0.17518,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.02951,0.16131,0.15158,0,0
3,GO PEPTIDYL METHIONINE MODIFICATION,0.015104,0.16126,0.17599,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.025096,0.16099,0.20797,0,0
3,GO FOREBRAIN GENERATION OF NEURONS,0.0080134,0.16099,0.2214,0,0
3,GO LIPID GLYCOSYLATION,0.062884,0.16086,0.20414,0,0
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.18624,0.16085,0.13709,0,0
3,GO ENDOCRINE PANCREAS DEVELOPMENT,0.010572,0.16074,0.24268,0,0
3,GO REGULATION OF DNA REPLICATION,0.0024341,0.16034,0.22158,0,0
3,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.08588,0.15977,0.16129,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.060677,0.15923,0.26345,0,0
3,GO REGULATION OF CELL CYCLE ARREST,0.0019699,0.15911,0.20552,0,0
3,GO CELL CYCLE G2 M PHASE TRANSITION,0.00096503,0.15848,0.20537,0,0
3,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.13885,0.15791,0.1434,0,0
3,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.00020554,0.15769,0.22268,0,0
3,GO REGULATION OF CELL AGING,0.0028457,0.15769,0.19157,0,0
3,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00072571,0.15741,0.21617,0,0
3,GO RNA LOCALIZATION,0.0025648,0.15712,0.17937,0,0
3,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.33029,0.1567,0.12536,0,0
3,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.072385,0.15656,0.18861,0,0
3,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.0080134,0.15652,0.18037,0,0
3,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0027019,0.15629,0.19153,0,0
3,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.074935,0.15614,0.18308,0,0
3,GO EPITHELIAL CELL FATE COMMITMENT,0.033245,0.15607,0.21395,0,0
3,GO KERATINIZATION,0.23827,0.15592,0.070519,0,0
3,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.0052065,0.15581,0.17562,0,0
3,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.015776,0.15576,0.29078,0,0
3,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.0038653,0.15533,0.22803,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.023112,0.15506,0.17801,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.062884,0.15485,0.20034,0,0
3,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0052065,0.15408,0.18064,0,0
3,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.026142,0.15396,0.22527,0,0
3,GO MAINTENANCE OF CELL NUMBER,0.0025648,0.15381,0.20268,0,0
3,GO POSITIVE REGULATION OF HAIR CYCLE,0.12662,0.1536,0.22029,0,0
3,GO REGULATION OF RESPIRATORY BURST,0.38829,0.15346,0.111,0,0
3,GO NUCLEOTIDE TRANSPORT,0.0036751,0.15306,0.18238,0,0
3,GO CGMP MEDIATED SIGNALING,0.060677,0.15303,0.23808,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.013834,0.15272,0.24242,0,0
3,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.1475,0.1527,0.12494,0,0
3,GO EPITHELIAL CELL MATURATION,0.040368,0.15248,0.2421,0,0
3,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.014457,0.15236,0.15981,0,0
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.020391,0.15232,0.24193,0,0
3,GO ESTABLISHMENT OF RNA LOCALIZATION,0.0019699,0.15227,0.19636,0,0
3,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.12273,0.15227,0.14647,0,0
3,GO DIET INDUCED THERMOGENESIS,0.08881,0.15196,0.18476,0,0
3,GO REGULATION OF RENAL SYSTEM PROCESS,0.094909,0.15153,0.17666,0,0
3,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.3148,0.15142,0.15676,0,0
3,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.02951,0.15134,0.15654,0,0
3,GO DNA REPLICATION INITIATION,0.15197,0.15088,0.11155,0,0
3,GO MRNA METABOLIC PROCESS,0.00096503,0.15058,0.16499,0,0
3,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.0016767,0.15056,0.18982,0,0
3,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.13885,0.15056,0.15857,0,0
3,GO PIGMENT ACCUMULATION,0.056456,0.15053,0.22777,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0083971,0.15045,0.22812,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.011063,0.1504,0.20707,0,0
3,GO RNA MODIFICATION,0.00081392,0.15037,0.16352,0,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.29248,0.15034,0.12768,0,0
3,GO REGULATION OF MITOTIC CELL CYCLE,0.00060992,0.15029,0.20336,0,0
3,GO SKELETAL SYSTEM MORPHOGENESIS,0.015776,0.15029,0.21268,0,0
3,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.33029,0.15021,0.10712,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.2577,0.14987,0.1557,0,0
3,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.36271,0.14986,0.092735,0,0
3,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.16123,0.14969,0.13366,0,0
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00051151,0.14968,0.2,0,0
3,GO METANEPHROS DEVELOPMENT,0.018736,0.14964,0.2069,0,0
3,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.043559,0.14947,0.19679,0,0
3,GO CELLULAR RESPONSE TO VITAMIN,0.15655,0.14926,0.17424,0,0
3,GO HEART TRABECULA MORPHOGENESIS,0.048745,0.14918,0.19023,0,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.011574,0.14908,0.15745,0,0
3,GO GOLGI TO ENDOSOME TRANSPORT,0.0015041,0.14899,0.31684,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.16602,0.14886,0.12707,0,0
3,GO REGULATION OF DNA RECOMBINATION,0.0021907,0.14883,0.22162,0,0
3,GO GLIAL CELL DEVELOPMENT,0.008797,0.14862,0.20012,0,0
3,GO REGULATION OF HISTONE UBIQUITINATION,0.0027019,0.1483,0.20445,0,0
3,GO TRNA PROCESSING,0.0047188,0.14805,0.13987,0,0
3,GO REGULATION OF WATER LOSS VIA SKIN,0.031957,0.148,0.17977,0,0
3,GO HYPEROSMOTIC SALINITY RESPONSE,0.026142,0.14767,0.34463,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.27821,0.14765,0.13297,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.16123,0.14755,0.144,0,0
3,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.006955,0.14728,0.20976,0,0
3,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00029789,0.14709,0.19113,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.0012071,0.14689,0.19799,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00068502,0.14665,0.18094,0,0
3,GO SKIN DEVELOPMENT,0.030713,0.14658,0.16786,0,0
3,GO HEAD MORPHOGENESIS,0.094909,0.14645,0.21616,0,0
3,GO CELLULAR RESPONSE TO NUTRIENT,0.098083,0.14641,0.18053,0,0
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.00054254,0.14639,0.18483,0,0
3,GO RNA STABILIZATION,0.0052065,0.14608,0.19835,0,0
3,GO REGULATION OF DENDRITE EXTENSION,0.024086,0.1459,0.41667,0,0
3,GO TELOMERE ORGANIZATION,0.0049572,0.14583,0.19125,0,0
3,GO GENITALIA DEVELOPMENT,0.08588,0.1458,0.16531,0,0
3,GO SERTOLI CELL DIFFERENTIATION,0.11524,0.14571,0.17356,0,0
3,GO CELL CYCLE PHASE TRANSITION,0.0016767,0.14562,0.19267,0,0
3,GO NEGATIVE REGULATION OF GLIOGENESIS,0.011574,0.14551,0.19891,0,0
3,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.017954,0.14539,0.27485,0,0
3,GO SUBSTANTIA NIGRA DEVELOPMENT,0.0052065,0.14492,0.20062,0,0
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0057394,0.14483,0.18326,0,0
3,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.010101,0.14481,0.24893,0,0
3,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.013235,0.14455,0.23845,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.0052065,0.14438,0.16183,0,0
3,GO REGULATION OF SPROUTING ANGIOGENESIS,0.15655,0.14428,0.18031,0,0
3,GO ENDOTHELIUM DEVELOPMENT,0.1306,0.14425,0.17576,0,0
3,GO CELL SUBSTRATE ADHESION,0.15655,0.14423,0.19316,0,0
3,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.0096484,0.14413,0.25444,0,0
3,GO CELLULAR RESPONSE TO RADIATION,0.0029965,0.14405,0.16503,0,0
3,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.24463,0.14394,0.14811,0,0
3,GO REGULATION OF FATTY ACID TRANSPORT,0.17091,0.14371,0.12599,0,0
3,GO ERROR PRONE TRANSLESION SYNTHESIS,0.067497,0.14347,0.12119,0,0
3,GO RESPIRATORY SYSTEM PROCESS,0.010101,0.14338,0.29093,0,0
3,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.00091199,0.14329,0.22077,0,0
3,GO LUNG ALVEOLUS DEVELOPMENT,0.034576,0.14313,0.2592,0,0
3,GO PINOCYTOSIS,0.19156,0.14302,0.15264,0,0
3,GO ATRIAL SEPTUM MORPHOGENESIS,0.018736,0.14293,0.27851,0,0
3,GO NEGATIVE REGULATION OF DNA REPLICATION,0.022172,0.14278,0.17593,0,0
3,GO PHOSPHOLIPID CATABOLIC PROCESS,0.098083,0.1427,0.16424,0,0
3,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.19156,0.14254,0.16216,0,0
3,GO RNA INTERFERENCE,0.0034935,0.14224,0.1992,0,0
3,GO NUCLEAR TRANSPORT,0.00076864,0.14203,0.19685,0,0
3,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0040644,0.14198,0.18756,0,0
3,GO RESPONSE TO HYDROPEROXIDE,0.26442,0.14197,0.13508,0,0
3,GO SYNAPTIC VESICLE BUDDING,0.0063209,0.14161,0.26977,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.0024341,0.1415,0.19906,0,0
3,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.20822,0.14142,0.14054,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.062884,0.14133,0.23909,0,0
3,GO TRABECULA MORPHOGENESIS,0.20256,0.14103,0.15064,0,0
3,GO NCRNA CATABOLIC PROCESS,0.0028457,0.14099,0.17844,0,0
3,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.038848,0.14089,0.17644,0,0
3,GO NOTOCHORD DEVELOPMENT,0.13885,0.14073,0.17232,0,0
3,GO SULFUR COMPOUND TRANSPORT,0.0014241,0.14067,0.22534,0,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.10134,0.1405,0.16738,0,0
3,GO ANOIKIS,0.056456,0.14015,0.20583,0,0
3,GO SNRNA TRANSCRIPTION,0.0015041,0.1399,0.18901,0,0
3,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00040321,0.13988,0.19812,0,0
3,GO PIRNA METABOLIC PROCESS,0.013834,0.13933,0.16126,0,0
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.025096,0.13849,0.30494,0,0
3,GO REGULATION OF RUFFLE ASSEMBLY,0.33821,0.13843,0.1099,0,0
3,GO GLUCOSE IMPORT,0.0013481,0.13841,0.22111,0,0
3,GO MITOCHONDRIAL DNA REPLICATION,0.0047188,0.13829,0.1865,0,0
3,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.094909,0.138,0.1431,0,0
3,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.098083,0.13797,0.16234,0,0
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.13885,0.13782,0.15734,0,0
3,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.2998,0.13768,0.10487,0,0
3,GO GLYCINE TRANSPORT,0.23203,0.13754,0.14979,0,0
3,GO CENTROSOME SEPARATION,0.033245,0.13747,0.19183,0,0
3,GO ADHESION OF SYMBIONT TO HOST,0.84314,0.13744,0.049059,0,0
3,GO LAMELLIPODIUM ASSEMBLY,0.013235,0.13743,0.21444,0,0
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0003797,0.1373,0.22896,0,0
3,GO RESPONSE TO PROSTAGLANDIN,0.4521,0.13723,0.091862,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0015041,0.13707,0.18102,0,0
3,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0011418,0.13706,0.20843,0,0
3,GO MACROPHAGE PROLIFERATION,0.75756,0.13665,0.07106,0,0
3,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.021265,0.13654,0.16602,0,0
3,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.1306,0.13631,0.17197,0,0
3,GO REGULATION OF HELICASE ACTIVITY,0.098083,0.13623,0.14591,0,0
3,GO TRNA METHYLATION,0.0063209,0.13623,0.16423,0,0
3,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.10811,0.136,0.17322,0,0
3,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0020776,0.13589,0.16561,0,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.00040321,0.13576,0.20685,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00072571,0.13573,0.21885,0,0
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.018736,0.13573,0.22583,0,0
3,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.12662,0.13571,0.16863,0,0
3,GO DNA DEALKYLATION,0.014457,0.13562,0.17053,0,0
3,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.15655,0.13552,0.19093,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.20822,0.13538,0.11685,0,0
3,GO CELL MATRIX ADHESION,0.14312,0.13522,0.19331,0,0
3,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.3148,0.13517,0.14109,0,0
3,GO REGULATION OF ANIMAL ORGAN FORMATION,0.069906,0.13481,0.14959,0,0
3,GO REGULATION OF VASCULAR PERMEABILITY,0.040368,0.13478,0.20848,0,0
3,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.033245,0.13476,0.14494,0,0
3,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.10811,0.13454,0.16016,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.021265,0.13431,0.19522,0,0
3,GO TRNA METABOLIC PROCESS,0.007293,0.13426,0.13429,0,0
3,GO MAMMARY GLAND MORPHOGENESIS,0.10134,0.13411,0.19799,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.10468,0.13396,0.18465,0,0
3,GO ENDOCRINE PROCESS,0.11163,0.13384,0.13831,0,0
3,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.08881,0.13383,0.13844,0,0
3,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.40594,0.13381,0.12037,0,0
3,GO TRANSEPITHELIAL TRANSPORT,0.12662,0.13354,0.15693,0,0
3,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.39705,0.1335,0.18349,0,0
3,GO SKELETAL MUSCLE CELL PROLIFERATION,0.10468,0.13332,0.14731,0,0
3,GO MYOBLAST MIGRATION,0.32248,0.13331,0.098028,0,0
3,GO TRNA CATABOLIC PROCESS,0.27126,0.13329,0.11312,0,0
3,GO CARDIAC ATRIUM MORPHOGENESIS,0.045233,0.13329,0.2318,0,0
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.034576,0.13329,0.13597,0,0
3,GO CHONDROCYTE DIFFERENTIATION,0.077559,0.13296,0.19331,0,0
3,GO REGULATION OF CELL MATRIX ADHESION,0.17091,0.1327,0.19031,0,0
3,GO REGULATION OF KIDNEY DEVELOPMENT,0.2259,0.13265,0.13385,0,0
3,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,0.20822,0.13234,0.14484,0,0
3,GO GMP METABOLIC PROCESS,0.091819,0.13214,0.12346,0,0
3,GO EPOXYGENASE P450 PATHWAY,0.16123,0.13197,0.17236,0,0
3,GO POSTREPLICATION REPAIR,0.021265,0.13175,0.13134,0,0
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.094909,0.13174,0.14505,0,0
3,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.21989,0.1312,0.10173,0,0
3,GO TISSUE MIGRATION,0.1306,0.13097,0.16573,0,0
3,GO TRIPARTITE REGIONAL SUBDIVISION,0.080256,0.13093,0.16794,0,0
3,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.031957,0.13092,0.26911,0,0
3,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.040368,0.13082,0.23589,0,0
3,GO RESPONSE TO OXYGEN RADICAL,0.038848,0.13079,0.13217,0,0
3,GO RESPONSE TO MURAMYL DIPEPTIDE,0.3148,0.13073,0.12936,0,0
3,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.18102,0.13064,0.1896,0,0
3,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.022172,0.13039,0.20087,0,0
3,GO GENITALIA MORPHOGENESIS,0.08881,0.13035,0.20894,0,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.43329,0.13029,0.12482,0,0
3,GO NEPHRON TUBULE FORMATION,0.13885,0.13026,0.13437,0,0
3,GO GPI ANCHOR METABOLIC PROCESS,0.011063,0.13026,0.16692,0,0
3,GO LATERAL MESODERM DEVELOPMENT,0.067497,0.13026,0.17901,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEUS,0.0020776,0.13013,0.18235,0,0
3,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.21989,0.13013,0.13308,0,0
3,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.024086,0.13008,0.15301,0,0
3,GO SEROTONIN SECRETION,0.37111,0.13004,0.092918,0,0
3,GO AXIS ELONGATION,0.1306,0.13003,0.17291,0,0
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.043559,0.13003,0.1627,0,0
3,GO RESPONSE TO VITAMIN A,0.1475,0.12976,0.1215,0,0
3,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.046961,0.12945,0.22169,0,0
3,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.29248,0.12935,0.22643,0,0
3,GO MACROAUTOPHAGY,0.00033648,0.12928,0.21691,0,0
3,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.11894,0.12921,0.224,0,0
3,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.031957,0.12898,0.23479,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.043559,0.12883,0.26797,0,0
3,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.040368,0.12869,0.20011,0,0
3,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.016475,0.12864,0.18204,0,0
3,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.0076456,0.12853,0.27088,0,0
3,GO GONADOTROPIN SECRETION,0.091819,0.12842,0.15074,0,0
3,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.27821,0.12829,0.15011,0,0
3,GO SALIVA SECRETION,0.50109,0.12821,0.059316,0,0
3,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.0049572,0.12814,0.19041,0,0
3,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.27126,0.1278,0.15453,0,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.037377,0.12771,0.14302,0,0
3,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.17591,0.1277,0.15722,0,0
3,GO SEQUESTERING OF TRIGLYCERIDE,0.08588,0.12762,0.18186,0,0
3,GO REGULATION OF ERBB SIGNALING PATHWAY,0.074935,0.12753,0.16296,0,0
3,GO MALE SEX DIFFERENTIATION,0.0060238,0.12739,0.19824,0,0
3,GO REGULATION OF INTRACELLULAR TRANSPORT,0.00015974,0.12725,0.21209,0,0
3,GO MICROVILLUS ASSEMBLY,0.024086,0.12721,0.18471,0,0
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.21989,0.12717,0.10017,0,0
3,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.0021907,0.12716,0.21847,0,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.1475,0.12693,0.1564,0,0
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.041938,0.12692,0.13396,0,0
3,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.58498,0.12687,0.10379,0,0
3,GO MESODERMAL CELL DIFFERENTIATION,0.15197,0.12686,0.13816,0,0
3,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.074935,0.12678,0.21835,0,0
3,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.12662,0.12674,0.13289,0,0
3,GO REGULATION OF TRANSPOSITION,0.091819,0.12658,0.14195,0,0
3,GO VESICLE ORGANIZATION,0.00086166,0.12636,0.22283,0,0
3,GO REGULATION OF SULFUR METABOLIC PROCESS,0.046961,0.12603,0.22845,0,0
3,GO IMPORT INTO NUCLEUS,0.0018673,0.12579,0.17613,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.11524,0.12573,0.18341,0,0
3,GO REGULATION OF STEM CELL DIVISION,0.37111,0.12573,0.14972,0,0
3,GO REGULATION OF MACROAUTOPHAGY,0.00028019,0.1257,0.2278,0,0
3,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.18102,0.12562,0.14005,0,0
3,GO CELL CYCLE G1 S PHASE TRANSITION,0.0096484,0.12558,0.17098,0,0
3,GO REGULATION OF CELL SUBSTRATE ADHESION,0.30724,0.12552,0.16353,0,0
3,GO STEROL HOMEOSTASIS,0.094909,0.12547,0.12512,0,0
3,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0096484,0.12545,0.1785,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0066311,0.12532,0.24198,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.067497,0.12516,0.1939,0,0
3,GO CELL FATE COMMITMENT,0.0052065,0.12507,0.19981,0,0
3,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.2998,0.12494,0.12381,0,0
3,GO DNA BIOSYNTHETIC PROCESS,0.00076864,0.12492,0.16739,0,0
3,GO BLOOD VESSEL MORPHOGENESIS,0.2998,0.12482,0.13712,0,0
3,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.19156,0.12481,0.14938,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.2577,0.12481,0.16242,0,0
3,GO CELLULAR RESPONSE TO FATTY ACID,0.098083,0.12471,0.13711,0,0
3,GO RENAL FILTRATION,0.15197,0.12434,0.23259,0,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.79394,0.12394,0.075379,0,0
3,GO STEROL BIOSYNTHETIC PROCESS,0.08588,0.12376,0.12043,0,0
3,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.11524,0.12358,0.21814,0,0
3,GO OSSIFICATION,0.11524,0.12342,0.14742,0,0
3,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.20256,0.12338,0.16671,0,0
3,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.20256,0.12331,0.16638,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.197,0.12326,0.12118,0,0
3,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.017954,0.12324,0.20701,0,0
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.30724,0.12319,0.10768,0,0
3,GO GLAND DEVELOPMENT,0.0034935,0.12315,0.20731,0,0
3,GO BONE MORPHOGENESIS,0.18624,0.123,0.14513,0,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0017696,0.12277,0.17858,0,0
3,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.35442,0.12271,0.14498,0,0
3,GO UTERUS DEVELOPMENT,0.067497,0.12268,0.19489,0,0
3,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.12273,0.12261,0.1519,0,0
3,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.01266,0.12244,0.18147,0,0
3,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.022172,0.12212,0.17567,0,0
3,GO FLUID TRANSPORT,0.41494,0.12203,0.10193,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.043559,0.12198,0.13209,0,0
3,GO ERAD PATHWAY,0.0049572,0.12195,0.19996,0,0
3,GO POSITIVE REGULATION OF PROTEIN BINDING,0.024086,0.12179,0.19404,0,0
3,GO NEGATIVE REGULATION OF CELL DIVISION,0.035953,0.12174,0.21475,0,0
3,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.68646,0.1213,0.040772,0,0
3,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.077559,0.12127,0.17362,0,0
3,GO BONE GROWTH,0.10134,0.12125,0.19106,0,0
3,GO PROTEIN LOCALIZATION TO ORGANELLE,0.00011593,0.12125,0.16175,0,0
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0017696,0.12113,0.18847,0,0
3,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.37964,0.12112,0.069443,0,0
3,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.35442,0.12072,0.12213,0,0
3,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.55277,0.12063,0.097522,0,0
3,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.39705,0.12053,0.069023,0,0
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.197,0.12049,0.10537,0,0
3,GO NCRNA EXPORT FROM NUCLEUS,0.011063,0.12019,0.19626,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.0017696,0.12004,0.19041,0,0
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.048745,0.12003,0.16534,0,0
3,GO ALDEHYDE CATABOLIC PROCESS,0.08881,0.11988,0.10123,0,0
3,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.16602,0.11985,0.15314,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.16123,0.11985,0.21778,0,0
3,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.0012758,0.11981,0.16387,0,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.27821,0.11969,0.12474,0,0
3,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.094909,0.1195,0.13398,0,0
3,GO RESPONSE TO ACIDIC PH,0.046961,0.11949,0.19631,0,0
3,GO NUCLEAR PORE ORGANIZATION,0.013235,0.11943,0.22413,0,0
3,GO AUTOPHAGOSOME ORGANIZATION,0.0018673,0.1193,0.22431,0,0
3,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.037377,0.11929,0.21998,0,0
3,GO MITOTIC CELL CYCLE ARREST,0.058535,0.11926,0.15244,0,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.006955,0.11899,0.1925,0,0
3,GO REGULATION OF VASOCONSTRICTION,0.058535,0.11896,0.2093,0,0
3,GO BIOMINERALIZATION,0.16123,0.11888,0.14312,0,0
3,GO POSITIVE REGULATION OF JNK CASCADE,0.16602,0.11885,0.1591,0,0
3,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.3148,0.1188,0.13097,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.11894,0.11878,0.16585,0,0
3,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.24463,0.11844,0.12757,0,0
3,GO ORGANELLE FUSION,0.0038653,0.11838,0.22486,0,0
3,GO RESPONSE TO UV C,0.10811,0.1182,0.13516,0,0
3,GO STORE OPERATED CALCIUM ENTRY,0.20256,0.11804,0.12842,0,0
3,GO CELLULAR ION HOMEOSTASIS,0.080256,0.11789,0.14496,0,0
3,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.012106,0.11776,0.19644,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.197,0.11759,0.143,0,0
3,GO ENDOTHELIAL CELL DEVELOPMENT,0.13885,0.11752,0.17991,0,0
3,GO HYPOTONIC RESPONSE,0.17591,0.11739,0.15185,0,0
3,GO FOREBRAIN NEURON DIFFERENTIATION,0.019548,0.11725,0.22573,0,0
3,GO MITOCHONDRIAL TRANSPORT,0.00014062,0.11715,0.16,0,0
3,GO ENDOTHELIAL CELL MORPHOGENESIS,0.27821,0.11706,0.17376,0,0
3,GO POSITIVE REGULATION OF URINE VOLUME,0.10134,0.11702,0.18983,0,0
3,GO BRANCHING MORPHOGENESIS OF A NERVE,0.14312,0.11698,0.16723,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0019699,0.11665,0.19031,0,0
3,GO REGULATION OF MESODERM DEVELOPMENT,0.058535,0.11657,0.15961,0,0
3,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.41494,0.11629,0.11356,0,0
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.1475,0.116,0.16628,0,0
3,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.19156,0.11598,0.12976,0,0
3,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.11894,0.11565,0.19203,0,0
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.56341,0.11563,0.08177,0,0
3,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.13467,0.11557,0.08636,0,0
3,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.00072571,0.11556,0.15711,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.13885,0.11532,0.12402,0,0
3,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.026142,0.11524,0.1717,0,0
3,GO AUTOPHAGY OF NUCLEUS,0.035953,0.11522,0.15182,0,0
3,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.1475,0.1151,0.18015,0,0
3,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.052482,0.11498,0.24646,0,0
3,GO RESPONSE TO FATTY ACID,0.16123,0.11496,0.12914,0,0
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.30724,0.1149,0.12883,0,0
3,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.14312,0.11488,0.16616,0,0
3,GO REGULATION OF FILOPODIUM ASSEMBLY,0.056456,0.11481,0.17417,0,0
3,GO RRNA MODIFICATION,0.046961,0.11481,0.11175,0,0
3,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.060677,0.11464,0.23321,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.00086166,0.11461,0.18898,0,0
3,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.00045436,0.11459,0.1947,0,0
3,GO T CELL DIFFERENTIATION IN THYMUS,0.55277,0.11457,0.072474,0,0
3,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.39705,0.11451,0.14701,0,0
3,GO PROTEIN REFOLDING,0.39705,0.11431,0.085936,0,0
3,GO RESPONSE TO ACTIVITY,0.022172,0.1143,0.14479,0,0
3,GO EMBRYONIC HEMOPOIESIS,0.14312,0.11417,0.17916,0,0
3,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.5959,0.11414,0.076707,0,0
3,GO REGULATION OF PEPTIDE SECRETION,0.018736,0.11409,0.18037,0,0
3,GO METAL ION HOMEOSTASIS,0.077559,0.11404,0.149,0,0
3,GO VASCULATURE DEVELOPMENT,0.26442,0.11401,0.14309,0,0
3,GO REGULATION OF LIPID LOCALIZATION,0.08588,0.11398,0.14625,0,0
3,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.033245,0.11391,0.15461,0,0
3,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.10811,0.11385,0.16167,0,0
3,GO HEMIDESMOSOME ASSEMBLY,0.50109,0.11383,0.15781,0,0
3,GO RESPONSE TO WOUNDING,0.21989,0.1133,0.14508,0,0
3,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.15655,0.11306,0.1301,0,0
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.08881,0.11294,0.21473,0,0
3,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.44264,0.11285,0.13244,0,0
3,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.18102,0.11281,0.11175,0,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.25111,0.11273,0.15258,0,0
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.026142,0.11267,0.10833,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.10811,0.11261,0.14171,0,0
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0027019,0.11253,0.16471,0,0
3,GO VIRAL RELEASE FROM HOST CELL,0.026142,0.11253,0.13457,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.4521,0.11234,0.082287,0,0
3,GO POSITIVE REGULATION OF SECRETION,0.038848,0.11233,0.17047,0,0
3,GO NK T CELL DIFFERENTIATION,1,0.11229,0.0083281,0,0
3,GO HEPARIN METABOLIC PROCESS,0.080256,0.11215,0.25406,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.08881,0.11196,0.19443,0,0
3,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0014241,0.11195,0.20183,0,0
3,GO REGULATION OF DNA BINDING,0.072385,0.1118,0.14123,0,0
3,GO APOPTOTIC DNA FRAGMENTATION,0.034576,0.11165,0.12528,0,0
3,GO THYMUS DEVELOPMENT,0.0029965,0.11157,0.19365,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.11524,0.1115,0.16158,0,0
3,GO ERROR FREE TRANSLESION SYNTHESIS,0.13467,0.11144,0.081548,0,0
3,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.27126,0.11133,0.18281,0,0
3,GO NCRNA 3 END PROCESSING,0.0076456,0.11132,0.12498,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.19156,0.11127,0.12859,0,0
3,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.019548,0.11101,0.18724,0,0
3,GO PEPTIDYL ARGININE MODIFICATION,0.025096,0.11093,0.15583,0,0
3,GO MYOBLAST DIFFERENTIATION,0.16602,0.11088,0.12908,0,0
3,GO HEART TRABECULA FORMATION,0.33029,0.11081,0.075236,0,0
3,GO PROTEIN KINASE B SIGNALING,0.23827,0.11071,0.12766,0,0
3,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.091819,0.11064,0.14955,0,0
3,GO REGULATION OF ISOTYPE SWITCHING,0.36271,0.11061,0.12931,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.018736,0.11057,0.13356,0,0
3,GO BLASTOCYST DEVELOPMENT,0.00091199,0.11049,0.15394,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.016475,0.11038,0.15685,0,0
3,GO TRIGLYCERIDE METABOLIC PROCESS,0.10811,0.11037,0.12608,0,0
3,GO BLOOD VESSEL REMODELING,0.34626,0.11033,0.14142,0,0
3,GO CYTOKINETIC PROCESS,0.0057394,0.11032,0.16843,0,0
3,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.10811,0.11028,0.10304,0,0
3,GO GLIOGENESIS,0.025096,0.11022,0.18325,0,0
3,GO BRONCHUS DEVELOPMENT,0.10468,0.1102,0.25381,0,0
3,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.062884,0.11016,0.1551,0,0
3,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.12273,0.10978,0.1532,0,0
3,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.50109,0.1096,0.075461,0,0
3,GO MULTI ORGANISM LOCALIZATION,0.015776,0.10959,0.14296,0,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.49108,0.10959,0.11902,0,0
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.10468,0.10958,0.14098,0,0
3,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.026142,0.10954,0.18217,0,0
3,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.2259,0.1095,0.18445,0,0
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.27821,0.10948,0.13706,0,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.197,0.10946,0.14578,0,0
3,GO CELLULAR SENESCENCE,0.0083971,0.10937,0.16215,0,0
3,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.10134,0.10937,0.16268,0,0
3,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.20256,0.10937,0.14925,0,0
3,GO TRNA TRANSPORT,0.027226,0.10934,0.17879,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.68646,0.10892,0.072663,0,0
3,GO GABAERGIC NEURON DIFFERENTIATION,0.10811,0.10887,0.24577,0,0
3,GO KERATINOCYTE DEVELOPMENT,0.1475,0.10867,0.18688,0,0
3,GO DENDRITIC SPINE MAINTENANCE,0.026142,0.10852,0.23015,0,0
3,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.72171,0.10829,0.022344,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0096484,0.10807,0.17243,0,0
3,GO RESPONSE TO SALT STRESS,0.077559,0.10802,0.17857,0,0
3,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.043559,0.10797,0.18261,0,0
3,GO INACTIVATION OF MAPK ACTIVITY,0.10468,0.10787,0.17469,0,0
3,GO GAMMA DELTA T CELL DIFFERENTIATION,0.29248,0.10786,0.16049,0,0
3,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.40594,0.1076,0.13397,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.046961,0.10753,0.1371,0,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.60692,0.10753,0.07351,0,0
3,GO REGULATION OF LIPID STORAGE,0.1306,0.10741,0.16489,0,0
3,GO REGULATION OF AUTOPHAGY,0.00045436,0.10739,0.21419,0,0
3,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.50109,0.10732,0.088216,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.11163,0.10694,0.12731,0,0
3,GO REGULATION OF DNA METHYLATION,0.214,0.10688,0.09047,0,0
3,GO SNRNA METABOLIC PROCESS,0.0038653,0.10677,0.14396,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.0015882,0.10655,0.15317,0,0
3,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.25111,0.10653,0.14978,0,0
3,GO REGULATION OF MRNA CATABOLIC PROCESS,0.0034935,0.10641,0.14952,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.2577,0.10616,0.15516,0,0
3,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.12662,0.10604,0.23146,0,0
3,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.38829,0.10593,0.092291,0,0
3,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.060677,0.10587,0.10353,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.24463,0.10583,0.091237,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.35442,0.10581,0.11336,0,0
3,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.077559,0.1057,0.19703,0,0
3,GO RIG I SIGNALING PATHWAY,0.11163,0.10558,0.13545,0,0
3,GO BEHAVIORAL RESPONSE TO PAIN,0.15197,0.10543,0.18255,0,0
3,GO MATURATION OF 5 8S RRNA,0.08303,0.10543,0.10382,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.030713,0.10542,0.17693,0,0
3,GO PITUITARY GLAND DEVELOPMENT,0.052482,0.10524,0.23915,0,0
3,GO KERATINOCYTE PROLIFERATION,0.24463,0.1049,0.13481,0,0
3,GO INTERFERON BETA PRODUCTION,0.35442,0.1049,0.11899,0,0
3,GO MEMBRANE FUSION,0.020391,0.1048,0.20196,0,0
3,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.27821,0.10473,0.17684,0,0
3,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.13467,0.10465,0.16112,0,0
3,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00035748,0.10448,0.20771,0,0
3,GO GLAND MORPHOGENESIS,0.16123,0.10443,0.16173,0,0
3,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.024086,0.10419,0.16076,0,0
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.08303,0.10408,0.10677,0,0
3,GO ACYLGLYCEROL HOMEOSTASIS,0.20256,0.10391,0.1211,0,0
3,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.015776,0.10369,0.1615,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE,0.2259,0.10367,0.096914,0,0
3,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.15655,0.10361,0.17214,0,0
3,GO RESPONSE TO LIPID,0.2259,0.10334,0.11756,0,0
3,GO ICOSANOID METABOLIC PROCESS,0.30724,0.10328,0.091969,0,0
3,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.51122,0.10327,0.07657,0,0
3,GO CARTILAGE DEVELOPMENT,0.08881,0.10304,0.1563,0,0
3,GO CELL AGING,0.0040644,0.1029,0.16283,0,0
3,GO RELAXATION OF MUSCLE,0.11524,0.10284,0.1981,0,0
3,GO POSITIVE REGULATION OF LIPID STORAGE,0.13885,0.10284,0.18511,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.1475,0.10282,0.15161,0,0
3,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.012106,0.10281,0.15051,0,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.13467,0.1027,0.21953,0,0
3,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.17591,0.10245,0.12799,0,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.11163,0.10232,0.15688,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.18624,0.10229,0.142,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.094909,0.10216,0.18342,0,0
3,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.0040644,0.1017,0.15137,0,0
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.0063209,0.10151,0.12824,0,0
3,GO ENDODERM DEVELOPMENT,0.197,0.10136,0.16703,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.022172,0.10134,0.17837,0,0
3,GO REGULATION OF METAL ION TRANSPORT,0.017954,0.10132,0.21087,0,0
3,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0057394,0.10124,0.13301,0,0
3,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.25111,0.1012,0.11703,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.069906,0.10113,0.13766,0,0
3,GO BIOLOGICAL ADHESION,0.11163,0.10092,0.17606,0,0
3,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.13467,0.10074,0.11682,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.28529,0.10067,0.11254,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.1475,0.10035,0.12281,0,0
3,GO SULFUR COMPOUND CATABOLIC PROCESS,0.11524,0.10019,0.16369,0,0
3,GO TRACHEA MORPHOGENESIS,0.094909,0.10001,0.19292,0,0
3,GO RESPONSE TO IONIZING RADIATION,0.080256,0.099983,0.12893,0,0
3,GO IMP METABOLIC PROCESS,0.51122,0.099904,0.066719,0,0
3,GO POSITIVE REGULATION OF WOUND HEALING,0.37111,0.099821,0.1089,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.08588,0.099816,0.1604,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.56341,0.099706,0.075927,0,0
3,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.10811,0.099563,0.17303,0,0
3,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.46168,0.099451,0.10723,0,0
3,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.37964,0.099384,0.11746,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.094909,0.099361,0.15388,0,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0063209,0.099348,0.1647,0,0
3,GO PLATELET ACTIVATION,0.37964,0.099189,0.12234,0,0
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.098083,0.09911,0.12639,0,0
3,GO KERATINOCYTE MIGRATION,0.197,0.099011,0.15387,0,0
3,GO REGULATION OF PROTEIN FOLDING,0.0044907,0.098842,0.19411,0,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.046961,0.098835,0.11323,0,0
3,GO ORGANELLE MEMBRANE FUSION,0.006955,0.098815,0.22847,0,0
3,GO REGULATION OF AMYLOID BETA CLEARANCE,0.41494,0.098719,0.092161,0,0
3,GO REGULATION OF LIPID TRANSPORT,0.077559,0.098531,0.14327,0,0
3,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.36271,0.098474,0.091538,0,0
3,GO RESPONSE TO RETINOIC ACID,0.18102,0.098298,0.13595,0,0
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.94321,0.098281,0.0032274,0,0
3,GO NCRNA METABOLIC PROCESS,0.011574,0.098271,0.11382,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.10811,0.098036,0.16167,0,0
3,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.37111,0.09771,0.15484,0,0
3,GO LYSOSOME LOCALIZATION,0.19156,0.097688,0.13556,0,0
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.20822,0.097646,0.11879,0,0
3,GO RETINAL CONE CELL DIFFERENTIATION,0.2998,0.097571,0.11551,0,0
3,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0013481,0.097313,0.16189,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.19156,0.096806,0.13112,0,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.29248,0.096739,0.09941,0,0
3,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.54223,0.096634,0.071265,0,0
3,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.10134,0.096327,0.24405,0,0
3,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.023112,0.096318,0.16774,0,0
3,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.058535,0.096064,0.15346,0,0
3,GO BRANCH ELONGATION OF AN EPITHELIUM,0.37964,0.096025,0.087149,0,0
3,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.10468,0.095972,0.18281,0,0
3,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.08303,0.095925,0.12744,0,0
3,GO MICROVILLUS ORGANIZATION,0.19156,0.095612,0.11599,0,0
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.11163,0.095427,0.17815,0,0
3,GO REGULATION OF MEMBRANE PERMEABILITY,0.045233,0.095235,0.12588,0,0
3,GO VACUOLE ORGANIZATION,0.0044907,0.095201,0.20474,0,0
3,GO REGULATION OF MAP KINASE ACTIVITY,0.045233,0.095191,0.18756,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.067497,0.094797,0.11027,0,0
3,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.0016767,0.09469,0.14288,0,0
3,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.57414,0.094612,0.064819,0,0
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.2259,0.094539,0.12215,0,0
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.38829,0.094467,0.13094,0,0
3,GO CALCIUM MEDIATED SIGNALING,0.12662,0.094353,0.13531,0,0
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.27126,0.094198,0.10609,0,0
3,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.15655,0.094169,0.16443,0,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.44264,0.094012,0.07958,0,0
3,GO RESPONSE TO X RAY,0.214,0.093834,0.11581,0,0
3,GO WOUND HEALING,0.27821,0.093615,0.13804,0,0
3,GO TISSUE HOMEOSTASIS,0.091819,0.093613,0.16177,0,0
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.13467,0.093563,0.11683,0,0
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.12662,0.093542,0.17439,0,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.214,0.093445,0.15974,0,0
3,GO PIGMENT GRANULE ORGANIZATION,0.043559,0.093405,0.168,0,0
3,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.49108,0.093217,0.10387,0,0
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.27126,0.093071,0.1072,0,0
3,GO ENDOTHELIAL CELL MIGRATION,0.214,0.093043,0.1525,0,0
3,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.028348,0.093003,0.16573,0,0
3,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.12273,0.092734,0.16282,0,0
3,GO RRNA METHYLATION,0.026142,0.092694,0.12704,0,0
3,GO REGULATION OF BIOMINERALIZATION,0.43329,0.092692,0.10494,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.00017019,0.092632,0.15608,0,0
3,GO TERPENOID BIOSYNTHETIC PROCESS,0.15655,0.09248,0.094041,0,0
3,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.28529,0.092473,0.084068,0,0
3,GO PHAGOSOME MATURATION,0.12273,0.092468,0.14238,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.21989,0.092443,0.11141,0,0
3,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.42405,0.09232,0.10734,0,0
3,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.017954,0.092234,0.1731,0,0
3,GO OVULATION,0.50109,0.092134,0.071108,0,0
3,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.094909,0.092014,0.12086,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.49108,0.091986,0.094086,0,0
3,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.26442,0.091984,0.11051,0,0
3,GO MUSCLE CELL FATE COMMITMENT,0.37111,0.09191,0.12542,0,0
3,GO RUFFLE ASSEMBLY,0.21989,0.091902,0.12491,0,0
3,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.20256,0.091859,0.14439,0,0
3,GO REGULATION OF GASTRULATION,0.43329,0.091826,0.093915,0,0
3,GO SKIN MORPHOGENESIS,0.48117,0.091762,0.13753,0,0
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.27821,0.091719,0.064779,0,0
3,GO OSTEOBLAST DIFFERENTIATION,0.20822,0.091674,0.12099,0,0
3,GO NCRNA PROCESSING,0.031957,0.091629,0.10327,0,0
3,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.052482,0.091408,0.19846,0,0
3,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.23827,0.091353,0.11999,0,0
3,GO REGULATION OF KERATINOCYTE MIGRATION,0.20822,0.091277,0.18817,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0063209,0.09119,0.18197,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.062884,0.091108,0.21781,0,0
3,GO BONE CELL DEVELOPMENT,0.39705,0.091055,0.13237,0,0
3,GO RESPONSE TO COLD,0.034576,0.090878,0.18283,0,0
3,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.10468,0.090851,0.19856,0,0
3,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.66333,0.090843,-0.091498,0,0
3,GO CELL CELL ADHESION,0.15655,0.090631,0.15687,0,0
3,GO GASTRULATION,0.077559,0.090613,0.17514,0,0
3,GO REGULATION OF RESPONSE TO WOUNDING,0.33029,0.090481,0.11776,0,0
3,GO CELLULAR RESPONSE TO CAMP,0.074935,0.090481,0.14535,0,0
3,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.080256,0.090341,0.15683,0,0
3,GO CELLULAR RESPONSE TO IRON ION,0.5959,0.090218,0.075806,0,0
3,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.21989,0.090131,0.090538,0,0
3,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.010572,0.090054,0.16607,0,0
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.23203,0.089981,0.067187,0,0
3,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.37964,0.08993,0.13701,0,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.050584,0.0896,0.14602,0,0
3,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.24463,0.089577,0.13028,0,0
3,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.014457,0.089455,0.20811,0,0
3,GO SECRETION BY TISSUE,0.27126,0.089339,0.086343,0,0
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.46168,0.089328,0.099173,0,0
3,GO VITAMIN CATABOLIC PROCESS,0.20256,0.08916,0.11585,0,0
3,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.16602,0.088987,0.15227,0,0
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.28529,0.088816,0.096372,0,0
3,GO MESODERMAL CELL FATE SPECIFICATION,0.23203,0.088775,0.084063,0,0
3,GO REGULATION OF BONE MINERALIZATION,0.55277,0.0887,0.087086,0,0
3,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.66333,0.088646,0.078854,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.11163,0.088631,0.10785,0,0
3,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.16123,0.088435,0.15624,0,0
3,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.15655,0.088373,0.081972,0,0
3,GO NEPHRIC DUCT MORPHOGENESIS,0.24463,0.088368,0.14588,0,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.056456,0.088367,0.15265,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.33821,0.088347,0.10329,0,0
3,GO REGULATION OF VASCULOGENESIS,0.2259,0.088231,0.13349,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.013834,0.087986,0.17799,0,0
3,GO PHOSPHOLIPID HOMEOSTASIS,0.3148,0.087806,0.11471,0,0
3,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.36271,0.087514,0.13424,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.18624,0.087504,0.11798,0,0
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.19156,0.08738,0.1183,0,0
3,GO RESPONSE TO DEXAMETHASONE,0.33029,0.087338,0.085326,0,0
3,GO ACETYL COA BIOSYNTHETIC PROCESS,0.054439,0.087272,0.13672,0,0
3,GO PLASMA MEMBRANE FUSION,0.41494,0.087256,0.074494,0,0
3,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.33029,0.087158,0.10295,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.043559,0.087067,0.1192,0,0
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.08303,0.087049,0.087234,0,0
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.034576,0.086996,0.15109,0,0
3,GO GLIAL CELL APOPTOTIC PROCESS,0.2577,0.08698,0.12016,0,0
3,GO TYPE I INTERFERON PRODUCTION,0.46168,0.086963,0.089255,0,0
3,GO CELLULAR RESPONSE TO LIPID,0.25111,0.086942,0.1222,0,0
3,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.2577,0.086853,0.14311,0,0
3,GO REGULATION OF VASCULATURE DEVELOPMENT,0.57414,0.086613,0.10342,0,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.1475,0.086603,0.10278,0,0
3,GO CELLULAR HYPEROSMOTIC RESPONSE,0.14312,0.086355,0.13856,0,0
3,GO MYOBLAST PROLIFERATION,0.074935,0.086251,0.2258,0,0
3,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.1306,0.086204,0.13068,0,0
3,GO RESPONSE TO ETHANOL,0.020391,0.086185,0.16047,0,0
3,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.098083,0.08617,0.15122,0,0
3,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.15197,0.086166,0.18209,0,0
3,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.53179,0.085965,0.068061,0,0
3,GO BONE MINERALIZATION,0.36271,0.085865,0.113,0,0
3,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.38829,0.085685,0.11496,0,0
3,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.1475,0.08568,0.10629,0,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.20256,0.085659,0.1288,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.60692,0.085584,0.109,0,0
3,GO RESPONSE TO TESTOSTERONE,0.26442,0.085271,0.08602,0,0
3,GO REGULATION OF OSSIFICATION,0.18102,0.085091,0.14475,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.4521,0.084983,0.075486,0,0
3,GO CARDIAC CELL FATE COMMITMENT,0.27821,0.084975,0.14157,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.098083,0.084936,0.12381,0,0
3,GO RESPONSE TO ESTROGEN,0.20256,0.084891,0.12627,0,0
3,GO REGULATION OF PROTEOLYSIS,0.20822,0.084809,0.11365,0,0
3,GO NEURON REMODELING,0.27821,0.084772,0.18462,0,0
3,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.13467,0.08471,0.1876,0,0
3,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.18624,0.084467,0.15739,0,0
3,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.098083,0.084352,0.2293,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.32248,0.084289,0.12516,0,0
3,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.18102,0.084233,0.090048,0,0
3,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.038848,0.083643,0.17809,0,0
3,GO SNORNA METABOLIC PROCESS,0.065157,0.083524,0.13202,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.1475,0.083396,0.16843,0,0
3,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.08303,0.083329,0.19455,0,0
3,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.10468,0.083329,0.17797,0,0
3,GO OSTEOBLAST PROLIFERATION,0.58498,0.083256,0.11457,0,0
3,GO PROTEIN INSERTION INTO MEMBRANE,0.0047188,0.083214,0.12279,0,0
3,GO CORNIFICATION,0.49108,0.083151,0.041766,0,0
3,GO ENDOTHELIAL CELL CHEMOTAXIS,0.214,0.083051,0.17103,0,0
3,GO RESPONSE TO MECHANICAL STIMULUS,0.214,0.083012,0.13987,0,0
3,GO SERTOLI CELL DEVELOPMENT,0.1475,0.082857,0.16911,0,0
3,GO LUNG CELL DIFFERENTIATION,0.10134,0.082827,0.23094,0,0
3,GO HEPATOCYTE DIFFERENTIATION,0.66333,0.082614,0.01833,0,0
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.57414,0.082521,0.11857,0,0
3,GO VIRAL BUDDING,0.030713,0.082094,0.10252,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.20822,0.082059,0.11346,0,0
3,GO POSITIVE REGULATION OF OSSIFICATION,0.23827,0.082005,0.13586,0,0
3,GO RECEPTOR BIOSYNTHETIC PROCESS,0.39705,0.081658,0.081144,0,0
3,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.18102,0.081565,0.15447,0,0
3,GO REGULATION OF LIPID KINASE ACTIVITY,0.34626,0.081469,0.10308,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.23203,0.081273,0.15345,0,0
3,GO ARACHIDONIC ACID SECRETION,0.25111,0.081265,0.090893,0,0
3,GO HYPOTHALAMUS DEVELOPMENT,0.080256,0.081152,0.17673,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.37111,0.080986,0.083256,0,0
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.27821,0.080795,0.090125,0,0
3,GO HORMONE CATABOLIC PROCESS,0.26442,0.080563,0.09789,0,0
3,GO REGULATION OF MITOCHONDRIAL FUSION,0.072385,0.080342,0.16496,0,0
3,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.214,0.08029,0.11255,0,0
3,GO SECRETION,0.10811,0.080236,0.14175,0,0
3,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.098083,0.080165,0.1841,0,0
3,GO MAINTENANCE OF LOCATION,0.1306,0.079901,0.13843,0,0
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.10134,0.079835,0.12506,0,0
3,GO REGULATION OF CELL SHAPE,0.40594,0.079794,0.13689,0,0
3,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.08881,0.079785,0.11432,0,0
3,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.16123,0.079641,0.14487,0,0
3,GO FATTY ACID TRANSPORT,0.13885,0.079482,0.12521,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.10134,0.079363,0.15533,0,0
3,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.027226,0.079268,0.080567,0,0
3,GO FEMALE GENITALIA DEVELOPMENT,0.27126,0.079181,0.10937,0,0
3,GO RESPONSE TO LITHIUM ION,0.30724,0.079038,0.12356,0,0
3,GO RESPONSE TO STEROL DEPLETION,0.08881,0.078931,0.15771,0,0
3,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.21989,0.078772,0.12145,0,0
3,GO HOMOCYSTEINE METABOLIC PROCESS,0.35442,0.07872,0.10052,0,0
3,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.27126,0.078692,0.10978,0,0
3,GO RESPONSE TO NUTRIENT,0.27126,0.078594,0.11175,0,0
3,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.17591,0.078487,0.18238,0,0
3,GO VIRAL LATENCY,0.33821,0.07823,0.074357,0,0
3,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.20256,0.07815,0.14504,0,0
3,GO ORGAN INDUCTION,0.214,0.077977,0.099007,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.48117,0.077919,0.10443,0,0
3,GO AMINO SUGAR METABOLIC PROCESS,0.26442,0.077816,0.12378,0,0
3,GO ENDOTHELIAL CELL PROLIFERATION,0.2259,0.077588,0.13596,0,0
3,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.10134,0.077459,0.10718,0,0
3,GO MYELOID CELL HOMEOSTASIS,0.20256,0.077347,0.11911,0,0
3,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.37964,0.077263,0.10383,0,0
3,GO REGULATION OF LIPASE ACTIVITY,0.76963,0.077131,0.052251,0,0
3,GO MULTIVESICULAR BODY ORGANIZATION,0.040368,0.077119,0.096585,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.2259,0.077026,0.17995,0,0
3,GO REGULATION OF STEM CELL DIFFERENTIATION,0.2577,0.077014,0.064418,0,0
3,GO RRNA METABOLIC PROCESS,0.10811,0.07681,0.075873,0,0
3,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.37964,0.076732,0.095177,0,0
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.091819,0.076492,0.098499,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.26442,0.076277,0.15262,0,0
3,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.18624,0.076211,0.079635,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.35442,0.076207,0.1035,0,0
3,GO SEQUESTERING OF ACTIN MONOMERS,0.56341,0.076178,0.016039,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.197,0.076114,0.12892,0,0
3,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.24463,0.075959,0.12286,0,0
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.64051,0.075863,0.053807,0,0
3,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.53179,0.075827,0.053491,0,0
3,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.12662,0.075705,0.094989,0,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.60692,0.075641,0.070919,0,0
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.64051,0.075596,0.098708,0,0
3,GO PLACENTA DEVELOPMENT,0.10468,0.075596,0.14327,0,0
3,GO CELLULAR RESPONSE TO DSRNA,0.52145,0.075564,0.087372,0,0
3,GO REGULATION OF WOUND HEALING,0.54223,0.075349,0.085418,0,0
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.39705,0.075291,0.10535,0,0
3,GO PODOSOME ASSEMBLY,0.44264,0.075105,0.11292,0,0
3,GO FRUCTOSE METABOLIC PROCESS,0.1475,0.075089,0.12494,0,0
3,GO PROTEIN MATURATION,0.14312,0.075008,0.11156,0,0
3,GO HYALURONAN METABOLIC PROCESS,0.17591,0.074956,0.19056,0,0
3,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.214,0.074933,0.12646,0,0
3,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.080256,0.074839,0.10936,0,0
3,GO REGULATION OF LIPID CATABOLIC PROCESS,0.197,0.074825,0.11094,0,0
3,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.52145,0.074698,0.040935,0,0
3,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.37964,0.074478,0.1287,0,0
3,GO KERATINOCYTE DIFFERENTIATION,0.18624,0.074377,0.086702,0,0
3,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.42405,0.074328,0.11854,0,0
3,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.016475,0.074311,0.081625,0,0
3,GO MYELOID CELL DEVELOPMENT,0.17591,0.074202,0.15109,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.32248,0.074095,0.084747,0,0
3,GO SNORNA 3 END PROCESSING,0.08588,0.07409,0.12767,0,0
3,GO POSITIVE REGULATION OF DNA BINDING,0.19156,0.074003,0.11064,0,0
3,GO SKELETAL MUSCLE TISSUE REGENERATION,0.33821,0.073944,0.080095,0,0
3,GO REGULATION OF CELLULAR RESPIRATION,0.11894,0.073833,0.092892,0,0
3,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.41494,0.073814,0.11216,0,0
3,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.23827,0.073726,0.1209,0,0
3,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.054439,0.07361,0.1671,0,0
3,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.18102,0.073589,0.16839,0,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.077559,0.073489,0.12824,0,0
3,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.52145,0.073399,0.0627,0,0
3,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.21989,0.073366,0.12202,0,0
3,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.52145,0.072927,0.10547,0,0
3,GO NEGATIVE REGULATION OF CELL DEATH,0.25111,0.07291,0.10846,0,0
3,GO PHAGOSOME ACIDIFICATION,0.16602,0.072871,0.12272,0,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.47137,0.07286,0.12038,0,0
3,GO MITOCHONDRIAL DEPOLARIZATION,0.42405,0.072816,0.077744,0,0
3,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.47137,0.072816,0.11009,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.24463,0.07281,0.13689,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.214,0.072728,0.12953,0,0
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.41494,0.072683,0.08637,0,0
3,GO MESODERMAL CELL FATE COMMITMENT,0.52145,0.072585,0.042915,0,0
3,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.072385,0.072547,0.10802,0,0
3,GO LUNG MORPHOGENESIS,0.2259,0.072522,0.15463,0,0
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.15197,0.072221,0.14491,0,0
3,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.40594,0.071944,0.10376,0,0
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.51122,0.07173,0.070327,0,0
3,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.21989,0.071536,0.11662,0,0
3,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.48117,0.071458,0.13006,0,0
3,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.33821,0.071264,0.081917,0,0
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.78176,0.071252,0.049878,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.93062,0.071249,0.024184,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.27126,0.071132,0.079118,0,0
3,GO RETINA HOMEOSTASIS,0.013235,0.071107,0.20296,0,0
3,GO REGULATION OF MRNA BINDING,0.214,0.071043,0.10061,0,0
3,GO MULTI ORGANISM CELLULAR PROCESS,0.56341,0.070907,0.086807,0,0
3,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.39705,0.070782,0.11228,0,0
3,GO CELLULAR RESPONSE TO AMYLOID BETA,0.26442,0.070765,0.14088,0,0
3,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.21989,0.070742,0.15282,0,0
3,GO TAXIS,0.25111,0.070668,0.14117,0,0
3,GO POSITIVE REGULATION OF MYELINATION,0.18102,0.070588,0.17471,0,0
3,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.56341,0.070582,0.062503,0,0
3,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.33029,0.070493,0.12245,0,0
3,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.79394,0.070446,0.032882,0,0
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.18624,0.070322,0.10414,0,0
3,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.08588,0.070282,0.19294,0,0
3,GO ORGANELLE INHERITANCE,0.038848,0.070256,0.14357,0,0
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.08303,0.070099,0.12895,0,0
3,GO RESPONSE TO SALT,0.27821,0.070054,0.069656,0,0
3,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.1306,0.069874,0.083932,0,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.17091,0.0696,0.13613,0,0
3,GO MUSCLE CELL MIGRATION,0.214,0.069405,0.14012,0,0
3,GO PEPTIDYL PROLINE MODIFICATION,0.038848,0.069329,0.11423,0,0
3,GO RETINOIC ACID METABOLIC PROCESS,0.15197,0.069326,0.14693,0,0
3,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.043559,0.069303,0.11123,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.51122,0.069266,0.10604,0,0
3,GO ATP BIOSYNTHETIC PROCESS,0.55277,0.069072,0.038572,0,0
3,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.37111,0.068996,0.047127,0,0
3,GO NEGATIVE REGULATION OF CELL ADHESION,0.40594,0.068956,0.12015,0,0
3,GO RESPONSE TO INTERLEUKIN 2,0.98106,0.068867,0.035596,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.98106,0.068791,0.028142,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.013834,0.068634,0.15256,0,0
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.08881,0.068632,0.1234,0,0
3,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.24463,0.068606,0.17054,0,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.067497,0.068552,0.09069,0,0
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.19156,0.06844,0.10374,0,0
3,GO PROTEIN DENEDDYLATION,0.56341,0.068123,0.040072,0,0
3,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.26442,0.068118,0.1041,0,0
3,GO POSITIVE REGULATION OF TRANSLATION,0.072385,0.068076,0.088334,0,0
3,GO REGULATION OF CELL DEATH,0.1306,0.067879,0.12703,0,0
3,GO MULTIVESICULAR BODY SORTING PATHWAY,0.16123,0.067845,0.085767,0,0
3,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.069906,0.067837,0.099304,0,0
3,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.1306,0.06779,0.12028,0,0
3,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.26442,0.06775,0.059796,0,0
3,GO COAGULATION,0.35442,0.067666,0.11307,0,0
3,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.2998,0.06759,0.12013,0,0
3,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.2998,0.067575,0.096834,0,0
3,GO NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.69814,0.067012,0.047619,0,0
3,GO RESPONSE TO NITROSATIVE STRESS,0.16123,0.06672,0.076039,0,0
3,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.37111,0.06634,0.12961,0,0
3,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.95582,0.066278,0.0076475,0,0
3,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.18624,0.06617,0.14078,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.53179,0.065904,0.034651,0,0
3,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.43329,0.065893,0.09286,0,0
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.55277,0.065864,0.1015,0,0
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.36271,0.065861,0.061687,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.38829,0.065851,0.094556,0,0
3,GO POSITIVE REGULATION OF CELL AGING,0.55277,0.065837,0.019173,0,0
3,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.16602,0.065608,0.092652,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.034576,0.06559,0.13326,0,0
3,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.08303,0.065456,0.11289,0,0
3,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.49108,0.065454,0.084191,0,0
3,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.24463,0.06544,0.12942,0,0
3,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.47137,0.065437,0.12125,0,0
3,GO LINOLEIC ACID METABOLIC PROCESS,0.39705,0.065258,0.086376,0,0
3,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.23203,0.065053,0.13511,0,0
3,GO PSEUDOURIDINE SYNTHESIS,0.16123,0.065027,0.059928,0,0
3,GO CYTOCHROME COMPLEX ASSEMBLY,0.4521,0.064987,0.028861,0,0
3,GO IMMUNE SYSTEM DEVELOPMENT,0.43329,0.06449,0.084424,0,0
3,GO NEGATIVE REGULATION OF WOUND HEALING,0.40594,0.064473,0.10048,0,0
3,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.2259,0.064443,0.11431,0,0
3,GO RESPONSE TO XENOBIOTIC STIMULUS,0.13885,0.064438,0.14653,0,0
3,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.83078,0.064438,0.06877,0,0
3,GO ENGULFMENT OF APOPTOTIC CELL,0.10811,0.064102,0.17764,0,0
3,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.43329,0.063765,0.10548,0,0
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.34626,0.06332,0.10848,0,0
3,GO REGULATION OF NECROTIC CELL DEATH,0.39705,0.063305,0.081177,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.4521,0.06325,0.061648,0,0
3,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.052482,0.063075,0.15315,0,0
3,GO REGULATION OF ANOIKIS,0.23203,0.062951,0.14747,0,0
3,GO BLASTOCYST FORMATION,0.17591,0.062924,0.081727,0,0
3,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.37964,0.062872,0.11921,0,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.38829,0.06284,0.099668,0,0
3,GO TOXIN METABOLIC PROCESS,0.080256,0.062829,0.17618,0,0
3,GO REGULATION OF MAPK CASCADE,0.20256,0.062713,0.13954,0,0
3,GO RESPONSE TO ANTIBIOTIC,0.43329,0.062652,0.079357,0,0
3,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.65188,0.062569,0.08457,0,0
3,GO PROTEIN OXIDATION,0.51122,0.062511,0.039948,0,0
3,GO OLFACTORY LOBE DEVELOPMENT,0.34626,0.062459,0.11222,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.1306,0.06239,0.064467,0,0
3,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.50109,0.062258,0.10992,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.20256,0.061785,0.075063,0,0
3,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.12273,0.061627,0.13388,0,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.52145,0.061594,0.11025,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.037377,0.061555,0.097478,0,0
3,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.79394,0.061554,0.044358,0,0
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.23827,0.061418,0.088669,0,0
3,GO GLUTAMINE METABOLIC PROCESS,0.28529,0.061235,0.091723,0,0
3,GO PROTEIN N LINKED GLYCOSYLATION,0.1475,0.061233,0.093257,0,0
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.51122,0.06115,0.098214,0,0
3,GO GTP BIOSYNTHETIC PROCESS,0.43329,0.061099,0.062284,0,0
3,GO RESPONSE TO FLUID SHEAR STRESS,0.53179,0.061043,0.10874,0,0
3,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.10468,0.060845,0.13151,0,0
3,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.33029,0.060715,0.098441,0,0
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.3148,0.06065,0.11379,0,0
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.66333,0.060649,0.097272,0,0
3,GO LIPID STORAGE,0.15197,0.060612,0.13807,0,0
3,GO MAINTENANCE OF LOCATION IN CELL,0.23827,0.060611,0.11829,0,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.67486,0.060414,0.073362,0,0
3,GO GRANULOCYTE DIFFERENTIATION,0.56341,0.060227,0.066298,0,0
3,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.25111,0.060226,0.10302,0,0
3,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.74555,0.060198,0.10265,0,0
3,GO POSITIVE REGULATION OF MAPK CASCADE,0.3148,0.0601,0.11967,0,0
3,GO LIPID EXPORT FROM CELL,0.37964,0.05995,0.066564,0,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.27126,0.059853,0.13015,0,0
3,GO ACTIN FILAMENT SEVERING,0.91805,0.059752,0.054243,0,0
3,GO NUCLEAR ENVELOPE REASSEMBLY,0.08881,0.059553,0.11219,0,0
3,GO HEAT GENERATION,0.47137,0.059494,0.078758,0,0
3,GO POSITIVE REGULATION OF CELL DEATH,0.13885,0.059364,0.13072,0,0
3,GO RESPONSE TO MUSCLE ACTIVITY,0.1306,0.059266,0.10985,0,0
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.20256,0.059092,0.10904,0,0
3,GO HYALURONAN CATABOLIC PROCESS,0.61803,0.059078,0.064964,0,0
3,GO CELLULAR RESPONSE TO MANGANESE ION,0.26442,0.05906,0.12151,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.052482,0.059044,0.11161,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.15197,0.059019,0.097869,0,0
3,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.27821,0.059002,0.12261,0,0
3,GO KIDNEY MESENCHYME DEVELOPMENT,0.37964,0.058218,0.10135,0,0
3,GO REGULATION OF RNA BINDING,0.067497,0.057996,0.13003,0,0
3,GO COPPER ION TRANSPORT,0.99368,0.057968,-0.0029023,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.027226,0.057781,0.10663,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.32248,0.05772,0.081859,0,0
3,GO SEQUESTERING OF CALCIUM ION,0.32248,0.057686,0.12183,0,0
3,GO AMINOGLYCAN CATABOLIC PROCESS,0.50109,0.05765,0.10176,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.18624,0.057628,0.11718,0,0
3,GO CERAMIDE CATABOLIC PROCESS,0.64051,0.057381,0.11237,0,0
3,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.99368,0.057358,0.060387,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.0042727,0.057302,0.092207,0,0
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.08588,0.057269,0.05708,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.2998,0.057184,0.10136,0,0
3,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.2259,0.056954,0.1055,0,0
3,GO FATTY ACID DERIVATIVE TRANSPORT,0.39705,0.056821,0.079145,0,0
3,GO NADPH REGENERATION,0.35442,0.056814,0.082453,0,0
3,GO INTESTINAL ABSORPTION,0.54223,0.056712,0.073872,0,0
3,GO RESPONSE TO GROWTH HORMONE,0.47137,0.056596,0.094783,0,0
3,GO FIBROBLAST PROLIFERATION,0.43329,0.056314,0.11535,0,0
3,GO MAST CELL MIGRATION,0.43329,0.056301,0.091469,0,0
3,GO MUSCLE FILAMENT SLIDING,0.20256,0.056275,0.11373,0,0
3,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.37964,0.05627,0.067722,0,0
3,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.08303,0.056247,0.15138,0,0
3,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.197,0.056247,0.10549,0,0
3,GO CHOLESTEROL STORAGE,0.42405,0.05623,0.12078,0,0
3,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.60692,0.055874,0.098789,0,0
3,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.21989,0.055795,0.064837,0,0
3,GO IMP BIOSYNTHETIC PROCESS,0.75756,0.055732,0.029567,0,0
3,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.13885,0.055559,0.088956,0,0
3,GO RESPONSE TO OXYGEN LEVELS,0.19156,0.055544,0.10124,0,0
3,GO LYTIC VACUOLE ORGANIZATION,0.074935,0.055535,0.16572,0,0
3,GO CARDIOLIPIN METABOLIC PROCESS,0.18624,0.055423,0.086287,0,0
3,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.76963,0.055334,0.046369,0,0
3,GO MUSCLE CELL PROLIFERATION,0.48117,0.055281,0.096669,0,0
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.33029,0.055271,0.086522,0,0
3,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.21989,0.055269,0.14195,0,0
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.48117,0.055213,0.089906,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.024086,0.055069,0.10488,0,0
3,GO POLYSACCHARIDE CATABOLIC PROCESS,0.2577,0.054941,0.10962,0,0
3,GO LIVER REGENERATION,0.32248,0.054854,0.095734,0,0
3,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.72171,0.054824,0.059154,0,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.30724,0.054804,0.10154,0,0
3,GO MITOTIC CYTOKINETIC PROCESS,0.027226,0.054713,0.11491,0,0
3,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.18102,0.054346,0.15878,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.23203,0.054286,0.21692,0,0
3,GO EPIBOLY,0.32248,0.054281,0.15256,0,0
3,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.43329,0.05422,0.064479,0,0
3,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.38829,0.05417,0.077682,0,0
3,GO REGULATION OF TELOMERASE ACTIVITY,0.17091,0.053917,0.10986,0,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.64051,0.053815,0.080618,0,0
3,GO INDOLALKYLAMINE METABOLIC PROCESS,0.19156,0.053724,0.1482,0,0
3,GO ER OVERLOAD RESPONSE,0.27126,0.053711,0.093299,0,0
3,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.51122,0.05365,0.089106,0,0
3,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.60692,0.05357,0.066763,0,0
3,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.56341,0.053448,0.08021,0,0
3,GO POSITIVE CHEMOTAXIS,0.85555,0.053429,0.061979,0,0
3,GO PEPTIDE CATABOLIC PROCESS,0.18624,0.053298,0.14437,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.38829,0.052952,0.11058,0,0
3,GO CARTILAGE MORPHOGENESIS,0.26442,0.052742,0.13407,0,0
3,GO VIRAL GENOME REPLICATION,0.46168,0.052701,0.071963,0,0
3,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.34626,0.052654,0.096472,0,0
3,GO RIBOSOME BIOGENESIS,0.33821,0.052619,0.045721,0,0
3,GO MYELOID CELL DIFFERENTIATION,0.41494,0.052543,0.093745,0,0
3,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.49108,0.052514,0.063864,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.39705,0.052456,0.078462,0,0
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.43329,0.052388,0.092364,0,0
3,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.15655,0.052349,0.15334,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.27126,0.052265,0.09536,0,0
3,GO NUCLEOTIDE SALVAGE,0.80618,0.052228,0.02293,0,0
3,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.47137,0.052133,0.093854,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.040368,0.052126,0.11113,0,0
3,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.19156,0.052024,0.13974,0,0
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.23203,0.05202,0.10642,0,0
3,GO MITOCHONDRIAL TRANSCRIPTION,0.197,0.052004,0.088615,0,0
3,GO P38MAPK CASCADE,0.56341,0.051957,0.099277,0,0
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.94321,0.051831,0.022842,0,0
3,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.76963,0.05146,0.034246,0,0
3,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.24463,0.051303,0.080889,0,0
3,GO PHOSPHATE ION TRANSPORT,0.44264,0.050968,0.089158,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.57414,0.050842,0.075307,0,0
3,GO PROTEIN PROCESSING,0.40594,0.050697,0.093853,0,0
3,GO RESPONSE TO VITAMIN,0.62923,0.049969,0.076368,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.28529,0.049919,0.14757,0,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.4521,0.049748,0.092846,0,0
3,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.11894,0.049642,0.077942,0,0
3,GO REGULATION OF PLATELET AGGREGATION,0.5959,0.049574,0.074989,0,0
3,GO REGULATION OF CELL FATE SPECIFICATION,0.52145,0.049546,0.1,0,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS,0.36271,0.049527,0.094317,0,0
3,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.27126,0.049482,0.075917,0,0
3,GO AEROBIC RESPIRATION,0.29248,0.049411,0.039191,0,0
3,GO REGULATION OF ODONTOGENESIS,0.56341,0.049247,0.055815,0,0
3,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.81845,0.049213,0.044217,0,0
3,GO SLEEP,0.1475,0.049105,0.10017,0,0
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.20256,0.049104,0.11038,0,0
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.78176,0.048704,0.078701,0,0
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.69814,0.048676,0.036255,0,0
3,GO GLIAL CELL MIGRATION,0.36271,0.048639,0.11996,0,0
3,GO CARDIOBLAST DIFFERENTIATION,0.23827,0.048611,0.14675,0,0
3,GO FIBROBLAST APOPTOTIC PROCESS,0.34626,0.048476,0.099402,0,0
3,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.34626,0.048464,0.082812,0,0
3,GO PEPTIDYL TYROSINE MODIFICATION,0.40594,0.048446,0.12737,0,0
3,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.37111,0.048183,0.10858,0,0
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.197,0.048144,0.12927,0,0
3,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.32248,0.0479,0.06679,0,0
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.80618,0.047798,0.038685,0,0
3,GO PROGRAMMED NECROTIC CELL DEATH,0.57414,0.047792,0.060413,0,0
3,GO FATTY ACID BIOSYNTHETIC PROCESS,0.34626,0.04758,0.076852,0,0
3,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.2998,0.047464,0.096819,0,0
3,GO POSITIVE REGULATION OF ERAD PATHWAY,0.58498,0.047058,0.079806,0,0
3,GO SMOOTH MUSCLE CELL MIGRATION,0.34626,0.046877,0.14854,0,0
3,GO MIDBODY ABSCISSION,0.18102,0.046876,0.077313,0,0
3,GO SYNCYTIUM FORMATION,0.56341,0.046831,0.091955,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.23827,0.046705,0.11827,0,0
3,GO T CELL HOMEOSTASIS,0.65188,0.046438,0.043616,0,0
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.62923,0.046343,0.067771,0,0
3,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.78176,0.046312,0.046228,0,0
3,GO REGULATION OF CALCIUM ION TRANSPORT,0.08881,0.04613,0.17135,0,0
3,GO BONE TRABECULA MORPHOGENESIS,0.65188,0.046109,0.089355,0,0
3,GO REGULATION OF VIRAL TRANSCRIPTION,0.2259,0.045966,0.082191,0,0
3,GO GAS TRANSPORT,0.42405,0.045831,0.10477,0,0
3,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.7336,0.045626,0.029102,0,0
3,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.64051,0.045624,0.068113,0,0
3,GO AMINE CATABOLIC PROCESS,0.48117,0.045573,0.0774,0,0
3,GO PORE COMPLEX ASSEMBLY,0.42405,0.045498,0.076173,0,0
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.2259,0.045497,0.10993,0,0
3,GO EXOCYTOSIS,0.43329,0.045269,0.10166,0,0
3,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.24463,0.045202,0.089881,0,0
3,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.49108,0.044984,0.12272,0,0
3,GO REGULATION OF PEPTIDASE ACTIVITY,0.76963,0.044931,0.060869,0,0
3,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.16602,0.044868,0.12119,0,0
3,GO LUNG EPITHELIUM DEVELOPMENT,0.11163,0.044783,0.20652,0,0
3,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.29248,0.04467,0.13297,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.23827,0.044458,0.17332,0,0
3,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.1306,0.04439,0.15308,0,0
3,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.55277,0.044294,0.047714,0,0
3,GO AMINE METABOLIC PROCESS,0.056456,0.04429,0.1151,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.050584,0.044175,0.052674,0,0
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.40594,0.044066,0.079136,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION,0.11524,0.043719,0.092887,0,0
3,GO HOMOTYPIC CELL CELL ADHESION,0.53179,0.043649,0.10085,0,0
3,GO REGULATION OF RESPONSE TO STRESS,0.18102,0.043599,0.11415,0,0
3,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.57414,0.04357,0.066189,0,0
3,GO REGULATION OF DEOXYRIBONUCLEASE ACTIVITY,0.96843,0.04349,-0.031916,0,0
3,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.25111,0.043229,0.077703,0,0
3,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.074935,0.043095,0.10955,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.93062,0.04309,0.038434,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.66333,0.043089,0.02769,0,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.60692,0.042735,0.085117,0,0
3,GO IMMUNOLOGICAL MEMORY PROCESS,0.91805,0.04261,0.0025568,0,0
3,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.17591,0.042604,0.11648,0,0
3,GO REGULATION OF POSITIVE CHEMOTAXIS,0.38829,0.042526,0.087786,0,0
3,GO STEROID CATABOLIC PROCESS,0.80618,0.042053,-0.0038479,0,0
3,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.53179,0.041974,0.064748,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.90549,0.041896,0.047437,0,0
3,GO NEUTRAL AMINO ACID TRANSPORT,0.16123,0.041334,0.12813,0,0
3,GO POSITIVE REGULATION OF VIRAL PROCESS,0.42405,0.040972,0.080203,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.23827,0.040816,0.075878,0,0
3,GO APOPTOTIC SIGNALING PATHWAY,0.43329,0.040627,0.089828,0,0
3,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.34626,0.040608,0.089258,0,0
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.23203,0.040575,0.059731,0,0
3,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.28529,0.040418,0.11544,0,0
3,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.15655,0.040348,0.14139,0,0
3,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.077559,0.040274,0.14701,0,0
3,GO PHAGOLYSOSOME ASSEMBLY,0.16602,0.040169,0.18614,0,0
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.30724,0.040167,0.092685,0,0
3,GO CELLULAR RESPONSE TO DRUG,0.20822,0.040138,0.11249,0,0
3,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.37111,0.040121,0.11952,0,0
3,GO CHONDROCYTE DEVELOPMENT,0.35442,0.040098,0.11984,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.37964,0.03934,0.093408,0,0
3,GO HEMOGLOBIN METABOLIC PROCESS,0.4521,0.039207,0.10081,0,0
3,GO ENDODERMAL CELL FATE COMMITMENT,0.67486,0.039199,0.050331,0,0
3,GO ETHANOL METABOLIC PROCESS,0.48117,0.039021,0.077652,0,0
3,GO FORMATION OF PRIMARY GERM LAYER,0.29248,0.03899,0.14205,0,0
3,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.32248,0.038944,0.075791,0,0
3,GO INTERACTION WITH HOST,0.53179,0.038762,0.086361,0,0
3,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.93062,0.038385,0.030673,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.50109,0.038278,0.091417,0,0
3,GO RESPONSE TO NITRIC OXIDE,0.94321,0.038212,0.02153,0,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.60692,0.038167,0.092481,0,0
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.53179,0.037982,0.08852,0,0
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.78176,0.037883,0.053279,0,0
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.81845,0.037845,0.045491,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.78176,0.037784,0.047462,0,0
3,GO GLIAL CELL PROLIFERATION,0.52145,0.037567,0.09461,0,0
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.57414,0.037555,0.091788,0,0
3,GO RESPONSE TO TOXIC SUBSTANCE,0.11894,0.037231,0.10517,0,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.46168,0.036959,0.047149,0,0
3,GO POSITIVE REGULATION OF BONE RESORPTION,0.4521,0.036927,0.13761,0,0
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.54223,0.036917,0.099268,0,0
3,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.76963,0.036813,0.081381,0,0
3,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.13467,0.036769,0.14994,0,0
3,GO NUCLEOSIDE METABOLIC PROCESS,0.2577,0.036551,0.062433,0,0
3,GO VIRAL TRANSLATION,0.074935,0.036415,0.10346,0,0
3,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.46168,0.036409,0.047667,0,0
3,GO REGULATION OF RECEPTOR BINDING,0.26442,0.036354,0.15602,0,0
3,GO ANDROGEN METABOLIC PROCESS,0.52145,0.036335,0.04175,0,0
3,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.95582,0.036012,0.037537,0,0
3,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.74555,0.035986,0.02516,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.55277,0.035913,0.056995,0,0
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.62923,0.035832,0.07919,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.67486,0.035445,0.040313,0,0
3,GO MATURATION OF SSU RRNA,0.27821,0.035026,0.072141,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.58498,0.03498,0.079504,0,0
3,GO REGULATION OF HEMOPOIESIS,0.74555,0.034923,0.054294,0,0
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.12273,0.034807,0.090524,0,0
3,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.36271,0.034709,0.063482,0,0
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.7336,0.034708,0.042701,0,0
3,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.86799,0.034683,-0.014694,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.25111,0.034646,0.13297,0,0
3,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.66333,0.034613,0.02401,0,0
3,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.44264,0.03455,0.073607,0,0
3,GO MUCUS SECRETION,0.47137,0.034538,-0.12091,0,0
3,GO ETHER BIOSYNTHETIC PROCESS,0.76963,0.034511,0.029166,0,0
3,GO HYALURONAN BIOSYNTHETIC PROCESS,0.27821,0.03448,0.18068,0,0
3,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.68646,0.034419,0.050451,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.79394,0.034239,0.064107,0,0
3,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.96843,0.034226,-0.020261,0,0
3,GO NUCLEOSIDE SALVAGE,0.48117,0.034217,0.041837,0,0
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.26442,0.034095,0.13621,0,0
3,GO MONONUCLEAR CELL DIFFERENTIATION,0.95582,0.034038,0.016369,0,0
3,GO EXTRACELLULAR VESICLE BIOGENESIS,0.43329,0.034033,0.085623,0,0
3,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.39705,0.033995,0.1443,0,0
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.56341,0.033967,0.066473,0,0
3,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.68646,0.033889,0.066494,0,0
3,GO REGULATION OF MICROVILLUS ORGANIZATION,0.48117,0.033837,0.09737,0,0
3,GO HEME METABOLIC PROCESS,0.35442,0.033723,0.074143,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.62923,0.033513,0.1089,0,0
3,GO RNA CATABOLIC PROCESS,0.2998,0.033506,0.039392,0,0
3,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.72171,0.033502,0.067666,0,0
3,GO DE NOVO PROTEIN FOLDING,0.38829,0.033351,0.082194,0,0
3,GO PROTEIN ACTIVATION CASCADE,0.85555,0.033222,0.021006,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.30724,0.033201,0.11909,0,0
3,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.65188,0.033064,0.052792,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.37964,0.032878,0.071599,0,0
3,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.95582,0.032874,2.4398e-05,0,0
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.90549,0.032723,0.046539,0,0
3,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.94321,0.032702,0.027627,0,0
3,GO MAST CELL MEDIATED IMMUNITY,0.99368,0.032628,0.011444,0,0
3,GO IRON ION TRANSPORT,0.13885,0.032627,0.13775,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.39705,0.032448,0.16195,0,0
3,GO SIGNAL PEPTIDE PROCESSING,0.56341,0.032281,0.071338,0,0
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.65188,0.032274,0.049559,0,0
3,GO CELL RECOGNITION,0.2259,0.032117,0.12863,0,0
3,GO REGULATION OF LIGASE ACTIVITY,0.41494,0.031918,0.061997,0,0
3,GO CORTICAL CYTOSKELETON ORGANIZATION,0.68646,0.031842,0.082695,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.95582,0.031717,-0.0045317,0,0
3,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.93062,0.031657,-0.014403,0,0
3,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.28529,0.031608,0.11274,0,0
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.98106,0.03148,0.0088791,0,0
3,GO URONIC ACID METABOLIC PROCESS,0.69814,0.031479,0.023892,0,0
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.49108,0.031436,0.10107,0,0
3,GO FATTY ACID HOMEOSTASIS,0.21989,0.031366,0.14432,0,0
3,GO RESPONSE TO ATP,0.091819,0.031241,0.14984,0,0
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.41494,0.031218,0.043832,0,0
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.62923,0.030696,-0.075051,0,0
3,GO REPLACEMENT OSSIFICATION,0.74555,0.030555,0.060811,0,0
3,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.5959,0.030448,0.071597,0,0
3,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.4521,0.030315,0.089499,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.24463,0.030254,0.063118,0,0
3,GO RUFFLE ORGANIZATION,0.80618,0.030245,0.065422,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.46168,0.03023,0.057159,0,0
3,GO RNA 5 END PROCESSING,0.37964,0.030059,0.043094,0,0
3,GO REGULATION OF VACUOLE ORGANIZATION,0.077559,0.030023,0.17234,0,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.99368,0.029934,0.0091799,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.80618,0.029587,0.060051,0,0
3,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.30724,0.029524,0.17509,0,0
3,GO REPLICATIVE SENESCENCE,0.99368,0.029468,0.014859,0,0
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.20256,0.029447,0.16787,0,0
3,GO PLATELET DEGRANULATION,0.81845,0.029232,0.055932,0,0
3,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.55277,0.029164,0.054044,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.26442,0.029129,0.061144,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.69814,0.028914,0.053477,0,0
3,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.214,0.028875,0.082942,0,0
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.98106,0.028714,0.023845,0,0
3,GO NATURAL KILLER CELL DIFFERENTIATION,0.50109,0.028713,0.087228,0,0
3,GO I KAPPAB PHOSPHORYLATION,0.72171,0.028622,0.048199,0,0
3,GO REGULATION OF CELL ADHESION,0.75756,0.028518,0.079668,0,0
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.14312,0.02817,0.09275,0,0
3,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.42405,0.027905,0.11456,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.69814,0.027854,0.013934,0,0
3,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.86799,0.027762,-0.031257,0,0
3,GO GLUTATHIONE METABOLIC PROCESS,0.55277,0.027603,0.042445,0,0
3,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.79394,0.027433,0.06022,0,0
3,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.93062,0.027331,0.043901,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.43329,0.027209,0.09325,0,0
3,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.65188,0.02712,0.086696,0,0
3,GO VIRAL LIFE CYCLE,0.68646,0.027016,0.070475,0,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.72171,0.027004,0.073913,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.98106,0.026952,0.0049324,0,0
3,GO RESPONSE TO HYDROGEN PEROXIDE,0.66333,0.026715,0.065998,0,0
3,GO RESPONSE TO ANGIOTENSIN,0.64051,0.026366,0.0065948,0,0
3,GO NEGATIVE REGULATION OF ANOIKIS,0.4521,0.026207,0.13443,0,0
3,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.5959,0.026006,0.098665,0,0
3,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.49108,0.025888,0.078743,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.57414,0.025645,0.035577,0,0
3,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.56341,0.025564,0.063459,0,0
3,GO MEMBRANE PROTEIN PROTEOLYSIS,0.66333,0.025464,0.097462,0,0
3,GO RESPONSE TO VIRUS,0.81845,0.025384,-0.013307,0,0
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.72171,0.025145,0.057503,0,0
3,GO RESPONSE TO INTERLEUKIN 18,0.80618,0.024625,0.049351,0,0
3,GO POSITIVE REGULATION OF VASCULOGENESIS,0.2998,0.024439,0.12895,0,0
3,GO CELLULAR RESPONSE TO VIRUS,0.50109,0.024078,0.070094,0,0
3,GO ELASTIC FIBER ASSEMBLY,0.5959,0.024044,0.14376,0,0
3,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.75756,0.024034,0.031365,0,0
3,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.42405,0.0239,0.0874,0,0
3,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.44264,0.02375,0.0863,0,0
3,GO INTERFERON ALPHA PRODUCTION,0.85555,0.023734,0.020474,0,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.7336,0.023385,0.068289,0,0
3,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.33029,0.023124,0.12894,0,0
3,GO REGULATION OF VIRAL GENOME REPLICATION,0.69814,0.023122,0.04964,0,0
3,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.67486,0.023006,0.088567,0,0
3,GO ER NUCLEUS SIGNALING PATHWAY,0.47137,0.022899,0.080442,0,0
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.56341,0.022741,0.060698,0,0
3,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.84314,0.022697,0.036915,0,0
3,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.58498,0.022565,-0.059855,0,0
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.50109,0.022233,0.045829,0,0
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.96843,0.022075,0.011441,0,0
3,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.7336,0.022073,0.096518,0,0
3,GO POSITIVE REGULATION OF HEMOPOIESIS,0.94321,0.021862,0.013529,0,0
3,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.55277,0.021829,0.058705,0,0
3,GO PROTEIN NEDDYLATION,0.88046,0.021772,0.019246,0,0
3,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.20822,0.021649,0.077021,0,0
3,GO MATERNAL PLACENTA DEVELOPMENT,0.56341,0.02159,0.086217,0,0
3,GO PROSTANOID METABOLIC PROCESS,0.89296,0.021498,-0.01922,0,0
3,GO POSITIVE REGULATION OF CELL ADHESION,0.88046,0.021399,-0.0013585,0,0
3,GO VITAMIN METABOLIC PROCESS,0.44264,0.021025,0.073314,0,0
3,GO SYMBIOTIC PROCESS,0.33821,0.020947,0.07143,0,0
3,GO VACUOLAR ACIDIFICATION,0.44264,0.020665,0.07642,0,0
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.49108,0.020625,0.081562,0,0
3,GO LEUKOCYTE DIFFERENTIATION,1,0.020602,0.011348,0,0
3,GO ZINC ION TRANSPORT,0.11524,0.020594,0.11943,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.27821,0.020544,0.13327,0,0
3,GO REGULATION OF GLIOGENESIS,0.51122,0.020491,0.085611,0,0
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.68646,0.020431,0.073579,0,0
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.98106,0.020377,-0.0048552,0,0
3,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.32248,0.020167,0.092082,0,0
3,GO MAST CELL ACTIVATION,0.90549,0.020158,-0.013738,0,0
3,GO LYMPHOCYTE DIFFERENTIATION,0.95582,0.020111,0.011604,0,0
3,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.96843,0.020026,0.045225,0,0
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.5959,0.019511,0.033578,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.23203,0.019486,0.067526,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.81845,0.019393,0.017559,0,0
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.88046,0.019328,0.040625,0,0
3,GO REGULATION OF GLIAL CELL PROLIFERATION,0.64051,0.019178,0.062175,0,0
3,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.47137,0.019176,0.084487,0,0
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.83078,0.019168,0.01064,0,0
3,GO CELL ACTIVATION,0.89296,0.019007,-0.0005681,0,0
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.76963,0.019002,0.053909,0,0
3,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.33821,0.018956,0.12996,0,0
3,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.76963,0.018698,0.055513,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.37111,0.018522,0.12288,0,0
3,GO T CELL DIFFERENTIATION,0.98106,0.01832,-0.011036,0,0
3,GO RENAL ABSORPTION,0.35442,0.017709,0.13537,0,0
3,GO GAMMA DELTA T CELL ACTIVATION,0.79394,0.017602,-0.035449,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.53179,0.017571,0.071365,0,0
3,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.29248,0.017477,0.14637,0,0
3,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.79394,0.017445,-0.0053154,0,0
3,GO TETRAHYDROFOLATE INTERCONVERSION,0.85555,0.017267,0.028374,0,0
3,GO ETHER METABOLIC PROCESS,0.23827,0.017133,0.12816,0,0
3,GO REGULATION OF PODOSOME ASSEMBLY,0.53179,0.017099,0.088517,0,0
3,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.40594,0.016976,0.13473,0,0
3,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.66333,0.016894,0.064613,0,0
3,GO NEGATIVE REGULATION OF GENE SILENCING,0.33029,0.016569,0.087096,0,0
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.80618,0.016519,-0.0068765,0,0
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.76963,0.016239,0.064008,0,0
3,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.81845,0.016182,0.016947,0,0
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.70989,0.016041,0.066006,0,0
3,GO RESPONSE TO MAGNESIUM ION,0.40594,0.015915,0.13671,0,0
3,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.90549,0.015714,-0.014138,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.80618,0.015681,-0.058598,0,0
3,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.99368,0.015461,-0.016023,0,0
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.69814,0.015422,-0.015099,0,0
3,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.89296,0.015309,0.044535,0,0
3,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.3148,0.015259,0.089093,0,0
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.7336,0.015187,-0.0089018,0,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.76963,0.014822,0.071117,0,0
3,GO INTERMEDIATE FILAMENT ORGANIZATION,0.34626,0.014732,0.081817,0,0
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.55277,0.014477,0.039441,0,0
3,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.57414,0.014459,0.078621,0,0
3,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.70989,0.014389,0.028977,0,0
3,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.95582,0.014053,0.047613,0,0
3,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.80618,0.013972,0.057267,0,0
3,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.75756,0.013786,0.05494,0,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.75756,0.013659,0.051794,0,0
3,GO REGULATION OF PROSTAGLANDIN SECRETION,0.81845,0.01361,0.03604,0,0
3,GO B CELL DIFFERENTIATION,0.90549,0.013544,0.038214,0,0
3,GO TELOMERASE RNA LOCALIZATION,0.88046,0.013537,0.020883,0,0
3,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.32248,0.013471,0.082921,0,0
3,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.64051,0.013273,0.062863,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.46168,0.01284,0.10051,0,0
3,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.80618,0.012663,0.011985,0,0
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.88046,0.012479,0.058664,0,0
3,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.74555,0.01212,-0.036385,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.78176,0.011904,0.081448,0,0
3,GO MYOBLAST FUSION,0.58498,0.011675,0.095481,0,0
3,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.67486,0.011557,0.078301,0,0
3,GO CELLULAR OXIDANT DETOXIFICATION,0.96843,0.011537,-0.00034079,0,0
3,GO GLYCOPROTEIN CATABOLIC PROCESS,0.85555,0.011436,0.10635,0,0
3,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.47137,0.011214,0.063239,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.74555,0.010892,-0.067458,0,0
3,GO VIRION ASSEMBLY,0.56341,0.010842,0.046936,0,0
3,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.93062,0.010594,0.04021,0,0
3,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.29248,0.01051,0.062218,0,0
3,GO CELLULAR RESPONSE TO X RAY,0.81845,0.010419,0.019071,0,0
3,GO REGULATION OF HEAT GENERATION,0.83078,0.010144,0.048195,0,0
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.69814,0.010056,0.058025,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.54223,0.0096133,0.077991,0,0
3,GO POSITIVE REGULATION OF GLIOGENESIS,0.96843,0.0095531,0.028792,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,1,0.009535,0.014156,0,0
3,GO RELAXATION OF CARDIAC MUSCLE,0.32248,0.0091971,0.2051,0,0
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.4521,0.0090215,0.097042,0,0
3,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.75756,0.0089883,-0.06979,0,0
3,GO KERATAN SULFATE METABOLIC PROCESS,0.33029,0.0089546,0.14091,0,0
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.70989,0.0088147,-0.050021,0,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.74555,0.0083805,-0.0093651,0,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.99368,0.0082582,0.016919,0,0
3,GO PROTEIN HYDROXYLATION,0.47137,0.00821,0.098432,0,0
3,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.44264,0.0081918,-0.17102,0,0
3,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.33821,0.0080483,0.11076,0,0
3,GO REGULATION OF INNATE IMMUNE RESPONSE,0.94321,0.0080039,-0.0043709,0,0
3,GO CELL ADHESION MOLECULE PRODUCTION,0.70989,0.0078584,-0.0045875,0,0
3,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.81845,0.0075855,0.049558,0,0
3,GO PEPTIDYL ASPARAGINE MODIFICATION,0.85555,0.0074997,0.015604,0,0
3,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.39705,0.0072787,0.1262,0,0
3,GO RESPONSE TO DSRNA,0.95582,0.0070829,0.039275,0,0
3,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.53179,0.0070651,0.062543,0,0
3,GO GLYCOSIDE METABOLIC PROCESS,0.52145,0.0069413,0.12702,0,0
3,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.98106,0.0068927,0.018572,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.69814,0.0068324,-0.097079,0,0
3,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.33821,0.0064774,0.15299,0,0
3,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.80618,0.0064389,0.050553,0,0
3,GO ERK1 AND ERK2 CASCADE,0.88046,0.0064387,0.046538,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.93062,0.0063564,0.04457,0,0
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.74555,0.0051964,-0.063485,0,0
3,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.95582,0.0051392,0.029482,0,0
3,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.74555,0.005087,0.083402,0,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.80618,0.0050014,0.039334,0,0
3,GO B CELL ACTIVATION,0.93062,0.0050012,-0.0031304,0,0
3,GO RESPONSE TO AMYLOID BETA,0.51122,0.0047079,0.11867,0,0
3,GO RESPONSE TO GAMMA RADIATION,0.84314,0.0045777,0.042966,0,0
3,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.95582,0.0044443,0.021613,0,0
3,GO REGULATION OF RESPONSE TO TUMOR CELL,0.98106,0.0043966,-0.0036121,0,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.85555,0.0041841,0.061756,0,0
3,GO REGULATION OF RELAXATION OF MUSCLE,0.44264,0.0040978,0.2165,0,0
3,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.76963,0.0040604,0.066793,0,0
3,GO ALDITOL METABOLIC PROCESS,0.80618,0.0040152,0.03062,0,0
3,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.57414,0.0037462,0.092322,0,0
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.89296,0.0036425,0.061062,0,0
3,GO REGULATION OF CELL CELL ADHESION,0.85555,0.0034834,-0.016781,0,0
3,GO ASTROCYTE DIFFERENTIATION,0.88046,0.002995,0.057306,0,0
3,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.75756,0.0027882,0.043141,0,0
3,GO DEFENSE RESPONSE TO VIRUS,0.85555,0.0026987,-0.0036466,0,0
3,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.56341,0.0026934,0.039782,0,0
3,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.41494,0.0021792,0.17418,0,0
3,GO PROTEIN TRIMERIZATION,0.98106,0.0021475,0.019729,0,0
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.44264,0.0020803,0.11673,0,0
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.91805,0.0018667,0.053654,0,0
3,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.51122,0.0018587,-0.014907,0,0
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.48117,0.0018014,-0.05005,0,0
3,GO MEMBRANE LIPID CATABOLIC PROCESS,0.84314,0.0016607,0.074126,0,0
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.78176,0.0015178,0.052167,0,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.80618,0.001467,0.07644,0,0
3,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.70989,0.0014124,0.067799,0,0
3,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.50109,0.0013306,0.12828,0,0
3,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.33821,0.001305,0.077025,0,0
3,GO PHAGOCYTOSIS RECOGNITION,0.85555,0.0011863,-0.014301,0,0
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.93062,0.0011714,-0.00037601,0,0
3,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.47137,0.000768,0.050801,0,0
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.83078,0.00065535,0.026062,0,0
3,GO SMOOTH MUSCLE CELL PROLIFERATION,0.79394,0.00063542,0.067627,0,0
3,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.83078,0.00047176,-0.036407,0,0
3,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.93062,0.00046757,0.061136,0,0
3,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.62923,4.6442e-05,0.047669,0,0
3,GO CELLULAR RESPONSE TO ETHANOL,0.70989,2.7738e-05,0.076246,0,0
3,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.84314,-0.00010976,0.038215,0,0
3,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.69814,-0.00014641,0.082118,0,0
3,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.81845,-0.00042236,-0.035955,0,0
3,GO REGULATION OF CELL FATE COMMITMENT,0.76963,-0.00075147,0.064268,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.68646,-0.00077863,-0.069532,0,0
3,GO NECROTIC CELL DEATH,0.86799,-0.001005,0.033141,0,0
3,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.75756,-0.0011135,0.068916,0,0
3,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.99368,-0.0011511,0.015862,0,0
3,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.84314,-0.0013232,0.0087401,0,0
3,GO TRANSLATIONAL ELONGATION,0.67486,-0.001379,0.014055,0,0
3,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.29248,-0.0013925,0.13731,0,0
3,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.65188,-0.0017615,0.068189,0,0
3,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.65188,-0.0018985,0.039338,0,0
3,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.88046,-0.0019248,0.016887,0,0
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.81845,-0.0019612,0.0034178,0,0
3,GO VASODILATION,0.53179,-0.0020331,0.059095,0,0
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.90549,-0.0023708,-0.0039763,0,0
3,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.79394,-0.0028276,-0.048376,0,0
3,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.83078,-0.0028376,0.0042896,0,0
3,GO DEFENSE RESPONSE,0.81845,-0.0033051,-0.0047234,0,0
3,GO PHAGOCYTOSIS,0.80618,-0.0033438,-0.0072897,0,0
3,GO MITOCHONDRIAL GENE EXPRESSION,0.76963,-0.0033744,0.017075,0,0
3,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.56341,-0.003412,-0.06679,0,0
3,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.89296,-0.0038325,-0.0025185,0,0
3,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.72171,-0.0041849,0.055773,0,0
3,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.75756,-0.0042686,0.050931,0,0
3,GO B CELL APOPTOTIC PROCESS,0.74555,-0.0044992,-0.00084394,0,0
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.94321,-0.0045965,0.0043332,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.7336,-0.0047,0.033621,0,0
3,GO REGULATION OF VIRAL LIFE CYCLE,0.99368,-0.0047827,0.031295,0,0
3,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.40594,-0.0048173,0.1232,0,0
3,GO PLATELET AGGREGATION,0.72171,-0.0048446,0.079061,0,0
3,GO MATURATION OF LSU RRNA,0.86799,-0.0050454,-0.014973,0,0
3,GO MACROPHAGE DIFFERENTIATION,0.79394,-0.0051103,-0.014343,0,0
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.95582,-0.0052591,0.00062865,0,0
3,GO OPSONIZATION,0.83078,-0.0055446,0.0016705,0,0
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.86799,-0.0055962,0.06083,0,0
3,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.80618,-0.0056442,-0.03695,0,0
3,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.50109,-0.0057414,0.092766,0,0
3,GO PYROPTOSIS,0.61803,-0.0058891,0.049129,0,0
3,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.81845,-0.0060627,-0.026871,0,0
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.81845,-0.0061394,0.033449,0,0
3,GO STEROID ESTERIFICATION,0.65188,-0.0061456,0.055532,0,0
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.75756,-0.0061704,0.0020039,0,0
3,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.70989,-0.0064628,0.11207,0,0
3,GO ANIMAL ORGAN REGENERATION,0.7336,-0.0065829,0.060681,0,0
3,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.91805,-0.0067443,-0.0027927,0,0
3,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.54223,-0.0068355,0.05227,0,0
3,GO RESPONSE TO CYTOKINE,0.76963,-0.0068365,0.0098254,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.50109,-0.0068976,0.075889,0,0
3,GO REGULATION OF SYMBIOTIC PROCESS,0.94321,-0.0069772,0.031399,0,0
3,GO LAMELLIPODIUM MORPHOGENESIS,0.48117,-0.0070631,0.11916,0,0
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.54223,-0.0070633,0.041398,0,0
3,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.62923,-0.0071619,0.091845,0,0
3,GO TISSUE REMODELING,0.90549,-0.0075408,0.082542,0,0
3,GO FOLIC ACID METABOLIC PROCESS,0.41494,-0.0077452,0.071694,0,0
3,GO RESPONSE TO BIOTIC STIMULUS,0.78176,-0.0078519,-0.015297,0,0
3,GO RESPONSE TO INTERLEUKIN 4,0.7336,-0.0081579,-0.0095049,0,0
3,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.70989,-0.0082233,0.05483,0,0
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.90549,-0.0085797,-0.013641,0,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.37964,-0.0087275,0.15593,0,0
3,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.74555,-0.008851,-0.043322,0,0
3,GO REGULATION OF B CELL DIFFERENTIATION,0.95582,-0.0090359,-0.048518,0,0
3,GO BARBED END ACTIN FILAMENT CAPPING,0.80618,-0.0090408,0.063201,0,0
3,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.88046,-0.0090632,0.082637,0,0
3,GO MEMBRANE RAFT ORGANIZATION,0.91805,-0.0095865,0.0096595,0,0
3,GO REGULATION OF CELL ACTIVATION,0.7336,-0.0096692,-0.045598,0,0
3,GO COLLAGEN FIBRIL ORGANIZATION,0.99368,-0.0097107,0.044652,0,0
3,GO TRABECULA FORMATION,0.98106,-0.0098694,0.024536,0,0
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.94321,-0.010176,0.00092536,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.96843,-0.010184,0.011048,0,0
3,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.54223,-0.010381,0.11775,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.94321,-0.010488,0.01599,0,0
3,GO GLYCEROL ETHER METABOLIC PROCESS,0.42405,-0.010598,0.095223,0,0
3,GO LYMPHOCYTE ACTIVATION,0.88046,-0.010654,-0.018371,0,0
3,GO FOREBRAIN NEURON FATE COMMITMENT,0.62923,-0.010665,0.17496,0,0
3,GO NEGATIVE REGULATION OF LIPID STORAGE,0.52145,-0.010834,0.096141,0,0
3,GO NEGATIVE REGULATION OF COAGULATION,0.89296,-0.010854,-0.0015061,0,0
3,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.95582,-0.01106,0.051406,0,0
3,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.95582,-0.011202,0.048338,0,0
3,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.55277,-0.011232,0.10638,0,0
3,GO CELLULAR COPPER ION HOMEOSTASIS,0.64051,-0.011259,-0.01288,0,0
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.99368,-0.011512,0.015387,0,0
3,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.95582,-0.011521,0.039543,0,0
3,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.5959,-0.011724,0.052154,0,0
3,GO RESPONSE TO TYPE I INTERFERON,0.64051,-0.01199,-0.04567,0,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.88046,-0.012348,0.00051533,0,0
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.62923,-0.012752,0.061157,0,0
3,GO IRON ION HOMEOSTASIS,0.38829,-0.012809,0.089884,0,0
3,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.84314,-0.013106,0.051348,0,0
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.83078,-0.013649,0.0016625,0,0
3,GO ELECTRON TRANSPORT CHAIN,0.60692,-0.013807,-0.013912,0,0
3,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.91805,-0.013909,0.043822,0,0
3,GO REGULATION OF GLOMERULAR FILTRATION,0.67486,-0.014084,0.091611,0,0
3,GO AUTOPHAGIC CELL DEATH,0.34626,-0.014153,-0.033022,0,0
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.95582,-0.014186,0.00099802,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.98106,-0.014239,0.046192,0,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.80618,-0.014439,0.027763,0,0
3,GO NIK NF KAPPAB SIGNALING,0.91805,-0.014879,0.0013017,0,0
3,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.96843,-0.015015,0.037763,0,0
3,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.81845,-0.015082,-0.014384,0,0
3,GO CYTOKINE PRODUCTION,0.84314,-0.015226,-0.0011563,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.86799,-0.015227,0.01659,0,0
3,GO GAP JUNCTION ASSEMBLY,0.74555,-0.015261,0.070797,0,0
3,GO PSEUDOPODIUM ORGANIZATION,0.80618,-0.015676,0.00034567,0,0
3,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.61803,-0.015681,0.03739,0,0
3,GO GERMINAL CENTER FORMATION,0.70989,-0.016135,-0.089946,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.83078,-0.016142,0.077893,0,0
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.89296,-0.016351,0.018627,0,0
3,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.81845,-0.016367,0.012172,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.67486,-0.016373,0.034448,0,0
3,GO POLYAMINE BIOSYNTHETIC PROCESS,0.32248,-0.0165,-0.026566,0,0
3,GO MITOCHONDRIAL TRANSLATION,0.78176,-0.016511,-0.004443,0,0
3,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.81845,-0.016937,0.021815,0,0
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.93062,-0.01699,0.0046271,0,0
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.66333,-0.017387,0.053077,0,0
3,GO RESPONSE TO MANGANESE ION,0.86799,-0.017432,0.054096,0,0
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.95582,-0.017631,0.037947,0,0
3,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.69814,-0.01811,0.069085,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.66333,-0.018292,-0.025185,0,0
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.66333,-0.018303,-0.04328,0,0
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.86799,-0.018522,-0.016079,0,0
3,GO ACTIVATION OF IMMUNE RESPONSE,0.75756,-0.018539,-0.024341,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.75756,-0.018679,-0.040613,0,0
3,GO RESPONSE TO ZINC ION,0.80618,-0.018834,-0.023414,0,0
3,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.79394,-0.01889,-0.025707,0,0
3,GO ARGININE METABOLIC PROCESS,0.88046,-0.018949,0.032316,0,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.67486,-0.019004,-0.038607,0,0
3,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.67486,-0.019084,0.019822,0,0
3,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.84314,-0.019157,0.020655,0,0
3,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.68646,-0.019365,-0.0038599,0,0
3,GO COPPER ION HOMEOSTASIS,0.93062,-0.019579,0.026527,0,0
3,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.67486,-0.019666,-0.043599,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.98106,-0.020426,-0.0057823,0,0
3,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.62923,-0.0206,0.098093,0,0
3,GO POLYAMINE METABOLIC PROCESS,0.88046,-0.020619,0.042544,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.84314,-0.02089,0.014242,0,0
3,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.90549,-0.02097,0.01162,0,0
3,GO B CELL MEDIATED IMMUNITY,0.61803,-0.021136,-0.072414,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.72171,-0.021585,0.042298,0,0
3,GO SUPEROXIDE METABOLIC PROCESS,0.89296,-0.021792,0.01806,0,0
3,GO L ASCORBIC ACID METABOLIC PROCESS,0.67486,-0.021875,0.0525,0,0
3,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.52145,-0.02189,-0.15056,0,0
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.7336,-0.021994,-0.029689,0,0
3,GO REGULATION OF DEFENSE RESPONSE,0.85555,-0.022001,0.0073484,0,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.84314,-0.022052,0.029026,0,0
3,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.66333,-0.023418,-0.028824,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.91805,-0.023556,0.045962,0,0
3,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.94321,-0.023586,0.009662,0,0
3,GO OXIDATIVE PHOSPHORYLATION,0.52145,-0.023619,-0.017951,0,0
3,GO REGULATION OF CELLULAR EXTRAVASATION,0.70989,-0.023817,-0.04302,0,0
3,GO REGULATION OF TISSUE REMODELING,0.80618,-0.023836,0.069688,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.76963,-0.023884,0.0077863,0,0
3,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.81845,-0.023965,0.04373,0,0
3,GO ACTIVATED T CELL PROLIFERATION,0.70989,-0.024431,-0.04098,0,0
3,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.91805,-0.024894,-0.02382,0,0
3,GO MACROMOLECULE DEPALMITOYLATION,0.7336,-0.024942,0.027225,0,0
3,GO FOAM CELL DIFFERENTIATION,0.85555,-0.025099,0.043915,0,0
3,GO T CELL APOPTOTIC PROCESS,0.39705,-0.025133,-0.12782,0,0
3,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.79394,-0.025159,-0.00681,0,0
3,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.75756,-0.025508,-0.023401,0,0
3,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.84314,-0.025509,0.11306,0,0
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.79394,-0.025569,0.035481,0,0
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.68646,-0.025943,-0.075178,0,0
3,GO REGULATION OF CHEMOTAXIS,0.83078,-0.026164,0.01289,0,0
3,GO RESPONSE TO HYPEROXIA,0.72171,-0.026184,0.017662,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.5959,-0.026277,-0.11641,0,0
3,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.94321,-0.026318,-0.034258,0,0
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.84314,-0.026432,0.032962,0,0
3,GO TRANSLATIONAL TERMINATION,0.64051,-0.026484,-0.012925,0,0
3,GO IMMUNE EFFECTOR PROCESS,0.76963,-0.026696,-0.026202,0,0
3,GO CELLULAR IRON ION HOMEOSTASIS,0.58498,-0.026799,0.069428,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.99368,-0.026824,0.039894,0,0
3,GO MEMBRANE INVAGINATION,0.86799,-0.026876,0.008238,0,0
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.99368,-0.027237,0.015846,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.78176,-0.02752,-0.052363,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.94321,-0.027684,0.034093,0,0
3,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.57414,-0.027773,-0.061456,0,0
3,GO INNATE IMMUNE RESPONSE,0.62923,-0.027774,-0.055406,0,0
3,GO HEPATOCYTE APOPTOTIC PROCESS,0.94321,-0.028037,0.039168,0,0
3,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.86799,-0.028276,-0.0058822,0,0
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.75756,-0.028372,0.064868,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.72171,-0.028611,0.0019832,0,0
3,GO RESPONSE TO TUMOR CELL,0.69814,-0.02864,-0.031964,0,0
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.74555,-0.028771,-0.028463,0,0
3,GO POSITIVE REGULATION OF TISSUE REMODELING,0.90549,-0.028825,0.083389,0,0
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.95582,-0.028929,-0.015192,0,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.90549,-0.029292,0.019915,0,0
3,GO NATURAL KILLER CELL ACTIVATION,0.61803,-0.029366,-0.07282,0,0
3,GO PROTEIN CONTAINING COMPLEX REMODELING,0.84314,-0.02937,-0.014986,0,0
3,GO GTP METABOLIC PROCESS,1,-0.029536,0.027095,0,0
3,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.83078,-0.029981,0.047635,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.81845,-0.030005,0.011855,0,0
3,GO TRNA 5 LEADER REMOVAL,0.3148,-0.03016,-0.042639,0,0
3,GO CYTOPLASMIC TRANSLATION,0.26442,-0.030452,-0.061,0,0
3,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.44264,-0.030506,0.12107,0,0
3,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.88046,-0.030754,0.05401,0,0
3,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.79394,-0.030789,-0.0095073,0,0
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.85555,-0.031019,0.010439,0,0
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.60692,-0.031117,-0.0046995,0,0
3,GO REGULATION OF MAST CELL ACTIVATION,0.66333,-0.031872,-0.051373,0,0
3,GO NEUTROPHIL HOMEOSTASIS,0.81845,-0.032135,0.009514,0,0
3,GO REGULATION OF PROTEIN MATURATION,0.81845,-0.032222,0.019016,0,0
3,GO RESPONSE TO VITAMIN D,0.95582,-0.03228,0.018654,0,0
3,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.75756,-0.032299,0.062944,0,0
3,GO MOVEMENT IN HOST ENVIRONMENT,0.90549,-0.032341,0.046018,0,0
3,GO RESPONSE TO THYROID HORMONE,0.90549,-0.03251,0.0093163,0,0
3,GO VAGINA DEVELOPMENT,0.54223,-0.032536,0.10939,0,0
3,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.57414,-0.032614,-0.048171,0,0
3,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.99368,-0.03295,0.014486,0,0
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.93062,-0.033124,-0.00074052,0,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.83078,-0.033134,-0.0017756,0,0
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.68646,-0.033325,-0.045233,0,0
3,GO MODULATION BY HOST OF VIRAL PROCESS,0.83078,-0.033368,0.020538,0,0
3,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.68646,-0.033667,0.081324,0,0
3,GO LIVER MORPHOGENESIS,0.83078,-0.033868,0.017618,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.88046,-0.034164,0.038393,0,0
3,GO WATER TRANSPORT,0.67486,-0.034185,0.078436,0,0
3,GO OSTEOCLAST DIFFERENTIATION,0.81845,-0.034676,0.0011671,0,0
3,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.61803,-0.034948,-0.087791,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.5959,-0.035014,-0.033889,0,0
3,GO EMBRYO IMPLANTATION,0.37111,-0.035227,-0.02236,0,0
3,GO LEUKOTRIENE METABOLIC PROCESS,0.95582,-0.03551,0.020612,0,0
3,GO POSITIVE REGULATION OF HEAT GENERATION,0.74555,-0.035605,0.013551,0,0
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.94321,-0.035721,-0.00079927,0,0
3,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.57414,-0.035936,0.10131,0,0
3,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.84314,-0.036046,0.019935,0,0
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.65188,-0.036111,-0.012973,0,0
3,GO T CELL ACTIVATION,0.78176,-0.036235,-0.052095,0,0
3,GO AMP METABOLIC PROCESS,0.86799,-0.036453,0.015994,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.62923,-0.036638,-0.027082,0,0
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.99368,-0.03684,0.034699,0,0
3,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.83078,-0.037041,-0.007827,0,0
3,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.70989,-0.037139,-0.031434,0,0
3,GO LEUKOCYTE MEDIATED IMMUNITY,0.5959,-0.03751,-0.05265,0,0
3,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.81845,-0.037512,-0.020539,0,0
3,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.51122,-0.03786,-0.067197,0,0
3,GO BONE REMODELING,0.99368,-0.037915,0.07978,0,0
3,GO OSTEOCLAST DEVELOPMENT,0.85555,-0.03839,0.016981,0,0
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.55277,-0.038497,-0.028923,0,0
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.34626,-0.038724,-0.081366,0,0
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.38829,-0.038763,-0.04151,0,0
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.49108,-0.038937,-0.13879,0,0
3,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.55277,-0.038951,-0.042791,0,0
3,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.64051,-0.039094,-0.028737,0,0
3,GO FC RECEPTOR SIGNALING PATHWAY,0.81845,-0.039195,0.039977,0,0
3,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.60692,-0.039366,-0.064694,0,0
3,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.7336,-0.039527,0.040141,0,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.54223,-0.039667,-0.055615,0,0
3,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.66333,-0.040059,0.00081489,0,0
3,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.7336,-0.040902,0.088114,0,0
3,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.62923,-0.041079,-0.03354,0,0
3,GO CELLULAR RESPONSE TO LITHIUM ION,0.86799,-0.041119,0.0057113,0,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.95582,-0.041168,0.042345,0,0
3,GO REGULATORY T CELL DIFFERENTIATION,0.69814,-0.041464,-0.087611,0,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.7336,-0.041712,-0.027985,0,0
3,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.66333,-0.041866,-0.027118,0,0
3,GO IMMUNOGLOBULIN PRODUCTION,0.80618,-0.042123,-0.014674,0,0
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.58498,-0.042671,-0.07159,0,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.85555,-0.043067,-0.0038253,0,0
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.72171,-0.043109,-0.043941,0,0
3,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.80618,-0.043173,-0.021912,0,0
3,GO MYELOID LEUKOCYTE ACTIVATION,0.52145,-0.043385,-0.061423,0,0
3,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.72171,-0.043563,-0.073213,0,0
3,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.89296,-0.043573,0.013472,0,0
3,GO REGULATION OF FIBRINOLYSIS,0.66333,-0.043656,-0.057307,0,0
3,GO RESPONSE TO CADMIUM ION,0.43329,-0.043698,-0.028174,0,0
3,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.85555,-0.0439,0.0040928,0,0
3,GO B CELL HOMEOSTASIS,0.96843,-0.044049,0.0070104,0,0
3,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.66333,-0.044117,-0.011799,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.80618,-0.044257,-0.060653,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.7336,-0.044301,-0.041902,0,0
3,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.46168,-0.044409,-0.10767,0,0
3,GO NUCLEOBASE METABOLIC PROCESS,0.66333,-0.044715,-0.012319,0,0
3,GO REGULATION OF NUCLEASE ACTIVITY,0.53179,-0.045389,-0.028986,0,0
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.098083,-0.045493,-0.10085,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.72171,-0.045613,0.0037129,0,0
3,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.75756,-0.045675,-0.00675,0,0
3,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.42405,-0.046169,-0.06611,0,0
3,GO REGULATION OF EXOSOMAL SECRETION,0.85555,-0.046597,0.063201,0,0
3,GO T CELL RECEPTOR SIGNALING PATHWAY,0.76963,-0.046598,-0.023452,0,0
3,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.84314,-0.046745,-0.033119,0,0
3,GO BONE RESORPTION,0.99368,-0.046818,0.037409,0,0
3,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.34626,-0.047071,-0.11739,0,0
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.61803,-0.047161,-0.028419,0,0
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.32248,-0.047601,-0.067582,0,0
3,GO PROTEASOME ASSEMBLY,0.42405,-0.047733,-0.031926,0,0
3,GO ENDODERM FORMATION,0.79394,-0.047933,0.091911,0,0
3,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.78176,-0.048002,-0.051868,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.7336,-0.048029,0.056925,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.67486,-0.048328,-0.036936,0,0
3,GO PEPTIDE CROSS LINKING,0.55277,-0.048538,-0.07571,0,0
3,GO REGULATION OF IMMUNE RESPONSE,0.70989,-0.048853,-0.046127,0,0
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.67486,-0.049504,-0.039991,0,0
3,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.74555,-0.049874,-0.050982,0,0
3,GO PROTEIN TARGETING TO MEMBRANE,0.13885,-0.049897,-0.059235,0,0
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.5959,-0.049944,-0.064375,0,0
3,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.33029,-0.050016,-0.1841,0,0
3,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.94321,-0.050171,0.033682,0,0
3,GO DETECTION OF OTHER ORGANISM,0.44264,-0.050591,-0.12488,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.91805,-0.050622,0.013493,0,0
3,GO GLYCOLIPID CATABOLIC PROCESS,0.62923,-0.050673,-0.003805,0,0
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.72171,-0.050717,-0.066489,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.53179,-0.050904,-0.028906,0,0
3,GO RESPONSE TO INTERLEUKIN 6,0.70989,-0.051237,0.012903,0,0
3,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.50109,-0.051369,-0.047566,0,0
3,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.85555,-0.051664,0.025435,0,0
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.17591,-0.052061,-0.063242,0,0
3,GO VASCULAR WOUND HEALING,0.90549,-0.052192,0.041042,0,0
3,GO COLLAGEN BIOSYNTHETIC PROCESS,0.94321,-0.052866,0.050986,0,0
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.91805,-0.053397,0.01273,0,0
3,GO DNA DEAMINATION,0.69814,-0.053414,-0.030305,0,0
3,GO PROSTAGLANDIN TRANSPORT,0.81845,-0.05369,0.05938,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.94321,-0.053704,0.011543,0,0
3,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.38829,-0.05409,-0.040241,0,0
3,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.68646,-0.054354,-0.048345,0,0
3,GO MACROPHAGE CYTOKINE PRODUCTION,0.85555,-0.054415,0.056117,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.54223,-0.054544,-0.078074,0,0
3,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.57414,-0.054637,-0.037062,0,0
3,GO LYMPHOCYTE HOMEOSTASIS,0.90549,-0.054662,-0.015758,0,0
3,GO T CELL PROLIFERATION,0.48117,-0.055489,-0.10965,0,0
3,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.83078,-0.055767,0.014368,0,0
3,GO ALPHA BETA T CELL DIFFERENTIATION,0.61803,-0.055901,-0.086172,0,0
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.68646,-0.055965,-0.032301,0,0
3,GO TRNA 5 END PROCESSING,0.3148,-0.056088,-0.024208,0,0
3,GO ALPHA BETA T CELL ACTIVATION,0.67486,-0.056206,-0.090444,0,0
3,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.58498,-0.056609,-0.0997,0,0
3,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.93062,-0.056982,0.035412,0,0
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.42405,-0.057165,-0.14286,0,0
3,GO B CELL RECEPTOR SIGNALING PATHWAY,0.61803,-0.057412,-0.12961,0,0
3,GO ENTRY INTO HOST,0.99368,-0.057595,0.030348,0,0
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.2577,-0.057602,-0.12215,0,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.7336,-0.057914,-0.042633,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.61803,-0.05806,-0.096849,0,0
3,GO REGULATION OF COAGULATION,0.74555,-0.058447,-0.021845,0,0
3,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.94321,-0.058476,-0.037677,0,0
3,GO REGULATION OF T CELL DIFFERENTIATION,0.93062,-0.058696,-0.019822,0,0
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.69814,-0.058842,-0.054403,0,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.51122,-0.058881,-0.10242,0,0
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.69814,-0.058901,-0.078732,0,0
3,GO NUCLEOSIDE CATABOLIC PROCESS,0.36271,-0.05903,-0.052897,0,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.57414,-0.059207,-0.014193,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.89296,-0.059233,0.03583,0,0
3,GO REGULATION OF CALCIUM ION IMPORT,0.76963,-0.059951,0.061842,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.68646,-0.060102,-0.036522,0,0
3,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.5959,-0.060282,-0.062949,0,0
3,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.62923,-0.060382,-0.0027002,0,0
3,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.86799,-0.06054,0.049613,0,0
3,GO APOPTOTIC CELL CLEARANCE,0.7336,-0.060554,-0.031457,0,0
3,GO MACROPHAGE MIGRATION,0.2998,-0.060649,-0.13472,0,0
3,GO REGULATION OF BONE REMODELING,0.99368,-0.060698,0.043101,0,0
3,GO INTERLEUKIN 13 PRODUCTION,0.79394,-0.061042,-0.039065,0,0
3,GO CELL CELL RECOGNITION,0.64051,-0.061156,-0.011209,0,0
3,GO IRON ION TRANSMEMBRANE TRANSPORT,0.38829,-0.061168,-0.057014,0,0
3,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.56341,-0.061231,-0.041455,0,0
3,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.54223,-0.061522,-0.074133,0,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.3148,-0.061603,-0.046291,0,0
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.70989,-0.06185,-0.075736,0,0
3,GO CELLULAR RESPONSE TO INTERFERON BETA,0.56341,-0.061937,-0.04447,0,0
3,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.90549,-0.061953,0.034051,0,0
3,GO INTERLEUKIN 6 PRODUCTION,0.53179,-0.06198,-0.06309,0,0
3,GO REGULATION OF B CELL ACTIVATION,0.65188,-0.062014,-0.087558,0,0
3,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.94321,-0.062669,0.032976,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.27821,-0.062701,-0.20276,0,0
3,GO INTERLEUKIN 4 PRODUCTION,0.25111,-0.062776,-0.18423,0,0
3,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.75756,-0.062912,-0.12326,0,0
3,GO LYMPHOCYTE APOPTOTIC PROCESS,0.47137,-0.062958,-0.099458,0,0
3,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.55277,-0.063019,-0.037277,0,0
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.76963,-0.063047,-0.056616,0,0
3,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.86799,-0.063055,-0.010341,0,0
3,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.93062,-0.063707,0.03417,0,0
3,GO REGULATION OF LYSOSOMAL LUMEN PH,0.47137,-0.063927,-0.039495,0,0
3,GO NEUTROPHIL EXTRAVASATION,0.78176,-0.064019,-0.030936,0,0
3,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.67486,-0.064551,-0.035397,0,0
3,GO LYMPHOCYTE MEDIATED IMMUNITY,0.57414,-0.065024,-0.099898,0,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.47137,-0.065067,-0.025702,0,0
3,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.13885,-0.065117,-0.086846,0,0
3,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.53179,-0.065451,-0.076469,0,0
3,GO POSITIVE REGULATION OF CELL ACTIVATION,0.54223,-0.066212,-0.10141,0,0
3,GO IMMUNE RESPONSE TO TUMOR CELL,0.43329,-0.066379,-0.09961,0,0
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.35442,-0.066549,-0.040182,0,0
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.50109,-0.066635,-0.065401,0,0
3,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.62923,-0.066681,-0.050205,0,0
3,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.72171,-0.066923,0.012962,0,0
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.069906,-0.067004,-0.12416,0,0
3,GO LEUKOCYTE APOPTOTIC PROCESS,0.40594,-0.067011,-0.11829,0,0
3,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.75756,-0.067083,-0.0038579,0,0
3,GO INTERACTION WITH SYMBIONT,0.75756,-0.067282,-0.003953,0,0
3,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.88046,-0.067294,0.033218,0,0
3,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.49108,-0.067695,-0.12403,0,0
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.69814,-0.067952,-0.07089,0,0
3,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.42405,-0.068003,-0.12818,0,0
3,GO DETOXIFICATION,0.41494,-0.068599,-0.030774,0,0
3,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.50109,-0.068945,-0.032393,0,0
3,GO LIPOPROTEIN CATABOLIC PROCESS,0.37964,-0.068992,-0.057846,0,0
3,GO PLASMINOGEN ACTIVATION,0.20822,-0.069224,-0.16375,0,0
3,GO RESPONSE TO BACTERIUM,0.60692,-0.069282,-0.049747,0,0
3,GO CD40 SIGNALING PATHWAY,0.46168,-0.069639,-0.10378,0,0
3,GO RIBOSOME ASSEMBLY,0.067497,-0.06973,-0.095794,0,0
3,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.90549,-0.069745,0.039293,0,0
3,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.56341,-0.069745,-0.059745,0,0
3,GO VITAMIN D METABOLIC PROCESS,0.4521,-0.069761,-0.082767,0,0
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.93062,-0.069914,0.05637,0,0
3,GO ICOSANOID BIOSYNTHETIC PROCESS,0.41494,-0.070095,-0.082741,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.98106,-0.070797,-0.0077579,0,0
3,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.65188,-0.070819,-0.054539,0,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.42405,-0.07148,-0.028608,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.46168,-0.072341,-0.084044,0,0
3,GO REGULATION OF PHAGOCYTOSIS,0.5959,-0.072839,-0.062519,0,0
3,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.62923,-0.072941,-0.038443,0,0
3,GO MACROPHAGE ACTIVATION,0.40594,-0.073125,-0.12738,0,0
3,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.99368,-0.073438,0.040594,0,0
3,GO POSITIVE REGULATION OF COAGULATION,0.49108,-0.073809,-0.047306,0,0
3,GO INFLAMMATORY RESPONSE,0.58498,-0.073812,-0.045262,0,0
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.53179,-0.073833,-0.09998,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.69814,-0.074007,-0.071213,0,0
3,GO VIRAL GENE EXPRESSION,0.091819,-0.074472,-0.089201,0,0
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.46168,-0.074574,-0.050466,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.70989,-0.074621,0.047271,0,0
3,GO REGULATION OF MACROPHAGE MIGRATION,0.43329,-0.075006,-0.097282,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.95582,-0.075185,-0.028466,0,0
3,GO LEUKOCYTE TETHERING OR ROLLING,0.54223,-0.075656,-0.10425,0,0
3,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.60692,-0.075659,0.0065157,0,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.67486,-0.075767,0.016254,0,0
3,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.53179,-0.076027,-0.12798,0,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.62923,-0.076145,0.00087423,0,0
3,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.51122,-0.076327,-0.082337,0,0
3,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.44264,-0.076484,-0.041404,0,0
3,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.64051,-0.076975,-0.044328,0,0
3,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,0.26442,-0.077151,-0.1724,0,0
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.56341,-0.077281,-0.090185,0,0
3,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.30724,-0.077891,-0.027795,0,0
3,GO GLYCINE METABOLIC PROCESS,0.28529,-0.078214,-0.13799,0,0
3,GO REGULATION OF INFLAMMATORY RESPONSE,0.55277,-0.078586,-0.036727,0,0
3,GO RESPONSE TO INTERLEUKIN 7,0.64051,-0.078592,-0.006701,0,0
3,GO POSITIVE REGULATION OF CHEMOTAXIS,0.50109,-0.078894,-0.044649,0,0
3,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.86799,-0.079042,-0.0011173,0,0
3,GO CYTIDINE TO URIDINE EDITING,0.55277,-0.079534,-0.067043,0,0
3,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,0.3148,-0.079711,-0.15309,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.83078,-0.080729,0.032194,0,0
3,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.23827,-0.080803,-0.05855,0,0
3,GO SUPEROXIDE ANION GENERATION,0.57414,-0.080974,-0.059083,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.7336,-0.081285,0.030752,0,0
3,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.2998,-0.081659,-0.10103,0,0
3,GO ASTROCYTE DEVELOPMENT,0.61803,-0.081985,-0.018343,0,0
3,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.27126,-0.082533,-0.0096255,0,0
3,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.95582,-0.08283,0.026366,0,0
3,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.44264,-0.082877,-0.10342,0,0
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.16123,-0.08337,-0.06099,0,0
3,GO LYMPH NODE DEVELOPMENT,0.86799,-0.083431,-0.026243,0,0
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.70989,-0.084099,-0.014143,0,0
3,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.25111,-0.084573,-0.1061,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION,0.47137,-0.084577,-0.051864,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.62923,-0.084749,-0.09311,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.53179,-0.08508,-0.0057704,0,0
3,GO REGULATION OF T CELL ACTIVATION,0.65188,-0.085471,-0.079217,0,0
3,GO TUMOR NECROSIS FACTOR SECRETION,0.66333,-0.086001,-0.025537,0,0
3,GO REGULATION OF INTEGRIN ACTIVATION,0.52145,-0.086208,-0.074025,0,0
3,GO REGULATION OF MEMBRANE INVAGINATION,0.79394,-0.086256,-0.022114,0,0
3,GO TRANSITION METAL ION HOMEOSTASIS,0.78176,-0.086524,0.011561,0,0
3,GO LEUKOCYTE PROLIFERATION,0.54223,-0.087082,-0.098935,0,0
3,GO NAD BIOSYNTHETIC PROCESS,0.75756,-0.08719,-0.047792,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.51122,-0.087298,-0.004574,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.5959,-0.0874,-0.025902,0,0
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.7336,-0.087801,-0.035553,0,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.66333,-0.088394,-0.01786,0,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.36271,-0.08874,-0.1222,0,0
3,GO FEVER GENERATION,0.68646,-0.08888,-0.026968,0,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.49108,-0.089078,-0.11029,0,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.42405,-0.089175,-0.12412,0,0
3,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.52145,-0.089455,-0.095689,0,0
3,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.23827,-0.089787,-0.061347,0,0
3,GO ETHANOL OXIDATION,0.76963,-0.089973,-0.052981,0,0
3,GO T CELL MEDIATED IMMUNITY,0.34626,-0.090216,-0.144,0,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.36271,-0.091068,-0.022934,0,0
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.65188,-0.09144,-0.080006,0,0
3,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.33821,-0.091611,-0.16652,0,0
3,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.78176,-0.091996,-0.012848,0,0
3,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.55277,-0.092215,-0.055911,0,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.42405,-0.092363,-0.12016,0,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.58498,-0.092514,-0.05615,0,0
3,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,0.32248,-0.09266,-0.18314,0,0
3,GO CELLULAR EXTRAVASATION,0.58498,-0.092798,-0.072053,0,0
3,GO INTEGRIN ACTIVATION,0.44264,-0.093134,-0.091153,0,0
3,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.55277,-0.093434,-0.092962,0,0
3,GO PEPTIDYL PROLINE HYDROXYLATION,0.83078,-0.093442,-0.0054618,0,0
3,GO TRANSLATIONAL INITIATION,0.041938,-0.093493,-0.1252,0,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.4521,-0.093893,-0.13197,0,0
3,GO PROTEIN NITROSYLATION,0.214,-0.095135,-0.11145,0,0
3,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.23203,-0.096031,-0.096245,0,0
3,GO TONIC SMOOTH MUSCLE CONTRACTION,0.37111,-0.096606,-0.079473,0,0
3,GO REGULATION OF GLIAL CELL MIGRATION,0.43329,-0.096616,-0.097559,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.65188,-0.096695,-0.070062,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.19156,-0.096946,-0.15994,0,0
3,GO INTERLEUKIN 2 PRODUCTION,0.35442,-0.097188,-0.15614,0,0
3,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.62923,-0.097404,-0.08,0,0
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.61803,-0.097476,-0.040028,0,0
3,GO ADAPTIVE IMMUNE RESPONSE,0.47137,-0.097956,-0.14018,0,0
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.61803,-0.098115,-0.037875,0,0
3,GO GLIAL CELL ACTIVATION,0.32248,-0.098356,-0.16454,0,0
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.55277,-0.098461,-0.10058,0,0
3,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.2998,-0.098978,-0.18709,0,0
3,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.33821,-0.099028,-0.10857,0,0
3,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.54223,-0.099186,-0.014424,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.55277,-0.099521,-0.076203,0,0
3,GO REGULATION OF PLATELET ACTIVATION,0.61803,-0.10015,-0.05916,0,0
3,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.52145,-0.10043,-0.046194,0,0
3,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.66333,-0.10188,-0.018558,0,0
3,GO HETEROTYPIC CELL CELL ADHESION,0.50109,-0.10199,-0.040428,0,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.7336,-0.10201,-0.04584,0,0
3,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.86799,-0.10213,0.0015078,0,0
3,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.48117,-0.10213,-0.08074,0,0
3,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.51122,-0.10257,-0.090408,0,0
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.27126,-0.10286,-0.20754,0,0
3,GO T CELL CYTOKINE PRODUCTION,0.37111,-0.10294,-0.12129,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.67486,-0.10302,-0.0696,0,0
3,GO RESPONSE TO INTERLEUKIN 12,0.19156,-0.10407,-0.086708,0,0
3,GO GALACTOSE METABOLIC PROCESS,0.7336,-0.10453,0.060647,0,0
3,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.36271,-0.1047,-0.066126,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.32248,-0.10484,-0.17796,0,0
3,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.26442,-0.10533,-0.092428,0,0
3,GO LEUKOCYTE HOMEOSTASIS,0.80618,-0.10535,-0.021338,0,0
3,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.40594,-0.10598,-0.1114,0,0
3,GO THYMOCYTE APOPTOTIC PROCESS,0.88046,-0.10598,0.0091008,0,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.40594,-0.106,-0.12377,0,0
3,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.4521,-0.10633,-0.11817,0,0
3,GO LEUKOCYTE CELL CELL ADHESION,0.51122,-0.10638,-0.10238,0,0
3,GO ZYMOGEN ACTIVATION,0.5959,-0.10662,-0.035978,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.2577,-0.10662,-0.15199,0,0
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.38829,-0.10676,-0.1363,0,0
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.36271,-0.10681,-0.14362,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.44264,-0.10727,-0.11922,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.49108,-0.10774,-0.11431,0,0
3,GO REGULATION OF LEUKOCYTE MIGRATION,0.37964,-0.10791,-0.1078,0,0
3,GO ACUTE PHASE RESPONSE,0.27126,-0.10869,-0.10081,0,0
3,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.42405,-0.1093,-0.03966,0,0
3,GO REGULATION OF MYOBLAST FUSION,0.56341,-0.10974,-0.068125,0,0
3,GO AMYLOID BETA CLEARANCE,0.93062,-0.11042,0.016909,0,0
3,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.34626,-0.11078,-0.14841,0,0
3,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.33029,-0.11106,-0.11643,0,0
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.54223,-0.11117,-0.1148,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.5959,-0.11138,-0.011619,0,0
3,GO T CELL LINEAGE COMMITMENT,0.48117,-0.11178,-0.08321,0,0
3,GO CELLULAR RESPONSE TO CADMIUM ION,0.1306,-0.11264,-0.11383,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.55277,-0.11265,-0.11755,0,0
3,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.61803,-0.11295,-0.044384,0,0
3,GO PROSTAGLANDIN SECRETION,0.90549,-0.11363,0.0010759,0,0
3,GO CHEMOKINE SECRETION,0.23203,-0.11427,-0.18765,0,0
3,GO NEUROINFLAMMATORY RESPONSE,0.33029,-0.11473,-0.15868,0,0
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.58498,-0.11507,-0.061747,0,0
3,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.36271,-0.11619,-0.1611,0,0
3,GO REGULATION OF BONE DEVELOPMENT,0.98106,-0.11666,0.0081844,0,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.40594,-0.11688,-0.14271,0,0
3,GO COLLAGEN METABOLIC PROCESS,0.69814,-0.11692,0.021178,0,0
3,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.34626,-0.11698,-0.098185,0,0
3,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.67486,-0.11851,-0.021924,0,0
3,GO AMINO SUGAR CATABOLIC PROCESS,0.44264,-0.1186,-0.12421,0,0
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.29248,-0.12058,-0.090412,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,0.74555,-0.121,-0.055454,0,0
3,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.34626,-0.12131,-0.13644,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.30724,-0.12153,-0.11138,0,0
3,GO MACROPHAGE CHEMOTAXIS,0.23203,-0.12154,-0.12482,0,0
3,GO DEFENSE RESPONSE TO BACTERIUM,0.32248,-0.12155,-0.10144,0,0
3,GO RESPONSE TO INTERLEUKIN 1,0.3148,-0.12159,-0.081915,0,0
3,GO ENDODERMAL CELL DIFFERENTIATION,1,-0.12241,0.068669,0,0
3,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.60692,-0.1225,-0.067509,0,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.44264,-0.12265,-0.025741,0,0
3,GO LEUKOCYTE MIGRATION,0.42405,-0.12266,-0.074009,0,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.49108,-0.12295,-0.062226,0,0
3,GO THYMIC T CELL SELECTION,0.58498,-0.12315,-0.12158,0,0
3,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.40594,-0.12325,-0.054129,0,0
3,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.10134,-0.12344,-0.17975,0,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.53179,-0.1235,-0.073211,0,0
3,GO CELL CHEMOTAXIS,0.4521,-0.12389,-0.078752,0,0
3,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.57414,-0.12395,-0.070565,0,0
3,GO RESPONSE TO COPPER ION,0.077559,-0.12433,-0.12199,0,0
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.33821,-0.12523,-0.10643,0,0
3,GO RESPONSE TO INTERFERON GAMMA,0.28529,-0.12536,-0.17027,0,0
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.08303,-0.12558,-0.14588,0,0
3,GO LYMPHOCYTE COSTIMULATION,0.57414,-0.12565,-0.11321,0,0
3,GO LABYRINTHINE LAYER MORPHOGENESIS,0.96843,-0.12571,0.03077,0,0
3,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.37111,-0.12591,-0.086571,0,0
3,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.30724,-0.1264,-0.059117,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.15655,-0.1268,-0.10938,0,0
3,GO CYTOKINE SECRETION,0.4521,-0.12703,-0.080827,0,0
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.33821,-0.12731,-0.15816,0,0
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.36271,-0.12736,-0.09474,0,0
3,GO INTERLEUKIN 1 PRODUCTION,0.24463,-0.12787,-0.16649,0,0
3,GO DETECTION OF BIOTIC STIMULUS,0.44264,-0.12883,-0.10692,0,0
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.37111,-0.12897,-0.055171,0,0
3,GO RESPONSE TO INTERLEUKIN 15,0.50109,-0.1298,-0.11669,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.26442,-0.13033,-0.16903,0,0
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.054439,-0.13049,-0.19751,0,0
3,GO RESPIRATORY BURST,0.29248,-0.13061,-0.158,0,0
3,GO T CELL SELECTION,0.58498,-0.1308,-0.1239,0,0
3,GO COMPLEMENT ACTIVATION,0.33821,-0.13209,-0.14659,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.42405,-0.13319,-0.080034,0,0
3,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.50109,-0.1333,-0.11238,0,0
3,GO CELL REDOX HOMEOSTASIS,0.12273,-0.13339,-0.083725,0,0
3,GO MATURE B CELL DIFFERENTIATION,0.79394,-0.13341,-0.065753,0,0
3,GO SEQUESTERING OF METAL ION,0.20822,-0.134,-0.13408,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.44264,-0.13411,-0.093069,0,0
3,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.64051,-0.13471,-0.05695,0,0
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.66333,-0.13497,-0.03629,0,0
3,GO REGULATION OF MACROPHAGE ACTIVATION,0.34626,-0.13499,-0.1362,0,0
3,GO CELL ADHESION MEDIATED BY INTEGRIN,0.35442,-0.13519,-0.067665,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.20822,-0.13521,-0.14333,0,0
3,GO T CELL EXTRAVASATION,0.37111,-0.13607,-0.12212,0,0
3,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.046961,-0.1366,-0.12885,0,0
3,GO CELLULAR RESPONSE TO COPPER ION,0.16602,-0.13737,-0.18654,0,0
3,GO CYTOKINE METABOLIC PROCESS,0.2998,-0.13752,-0.14223,0,0
3,GO INTERFERON GAMMA PRODUCTION,0.29248,-0.13793,-0.17489,0,0
3,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.25111,-0.13845,-0.20591,0,0
3,GO REGULATION OF B CELL PROLIFERATION,0.37964,-0.1395,-0.16783,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.2998,-0.14056,-0.14571,0,0
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.27126,-0.14092,-0.17745,0,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.11524,-0.1411,-0.13851,0,0
3,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.37964,-0.14169,-0.1407,0,0
3,GO VITAMIN BIOSYNTHETIC PROCESS,0.38829,-0.1422,-0.080885,0,0
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.68646,-0.14234,-0.088715,0,0
3,GO INTERLEUKIN 1 BETA PRODUCTION,0.24463,-0.14257,-0.1752,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.29248,-0.14295,-0.14023,0,0
3,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.29248,-0.14327,-0.18748,0,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.32248,-0.14393,-0.12286,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.44264,-0.14418,-0.13753,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.40594,-0.1448,-0.093557,0,0
3,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.1306,-0.14551,-0.14265,0,0
3,GO RESPONSE TO INTERFERON ALPHA,0.34626,-0.14584,-0.096942,0,0
3,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.27126,-0.14611,-0.14306,0,0
3,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.2577,-0.14643,-0.12537,0,0
3,GO MYELOID CELL APOPTOTIC PROCESS,0.50109,-0.14698,-0.052274,0,0
3,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.18102,-0.14742,-0.10225,0,0
3,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.37964,-0.14773,-0.072149,0,0
3,GO ACUTE INFLAMMATORY RESPONSE,0.3148,-0.14774,-0.11058,0,0
3,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.38829,-0.14828,-0.10999,0,0
3,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,0.49108,-0.14863,-0.12213,0,0
3,GO FIBRINOLYSIS,0.33821,-0.1494,-0.13106,0,0
3,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.37964,-0.14952,-0.15217,0,0
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.37964,-0.14957,-0.090673,0,0
3,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.81845,-0.15007,0.0015258,0,0
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.43329,-0.15074,-0.1273,0,0
3,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.34626,-0.15152,-0.091055,0,0
3,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.30724,-0.15204,-0.12284,0,0
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.81845,-0.15212,-0.018097,0,0
3,GO T HELPER 1 CELL DIFFERENTIATION,0.3148,-0.15319,-0.18877,0,0
3,GO T HELPER 2 CELL DIFFERENTIATION,0.42405,-0.15397,-0.13209,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.2577,-0.15405,-0.15241,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.18624,-0.15406,-0.16376,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.37111,-0.15495,-0.15912,0,0
3,GO RESPONSE TO PROTOZOAN,0.43329,-0.15498,-0.16066,0,0
3,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.58498,-0.15507,-0.03325,0,0
3,GO CELLULAR RESPONSE TO ZINC ION,0.18624,-0.15517,-0.18172,0,0
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.27821,-0.15614,-0.17484,0,0
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.27126,-0.15651,-0.18133,0,0
3,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.25111,-0.15651,-0.22399,0,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.27821,-0.15689,-0.15236,0,0
3,GO LYMPHOCYTE MIGRATION,0.27821,-0.15725,-0.18581,0,0
3,GO BLEB ASSEMBLY,0.35442,-0.15729,-0.093888,0,0
3,GO DECIDUALIZATION,0.62923,-0.15763,-0.037262,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.64051,-0.15796,-0.083775,0,0
3,GO REGULATION OF NEUTROPHIL ACTIVATION,0.33029,-0.15854,-0.19067,0,0
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.28529,-0.15863,-0.13805,0,0
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.19156,-0.15927,-0.1484,0,0
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.41494,-0.1605,-0.066507,0,0
3,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.47137,-0.16087,-0.11725,0,0
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.35442,-0.1612,-0.099742,0,0
3,GO ZYMOGEN INHIBITION,0.2998,-0.16233,-0.10784,0,0
3,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.18624,-0.16235,-0.17393,0,0
3,GO RESPONSE TO INTERFERON BETA,0.16602,-0.16248,-0.17643,0,0
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.3148,-0.16253,-0.16352,0,0
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.3148,-0.16268,-0.14469,0,0
3,GO XENOBIOTIC CATABOLIC PROCESS,0.95582,-0.1629,0.013293,0,0
3,GO CHEMOKINE PRODUCTION,0.28529,-0.16306,-0.10942,0,0
3,GO VITAMIN D BIOSYNTHETIC PROCESS,0.25111,-0.16376,-0.16785,0,0
3,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.41494,-0.16389,-0.12071,0,0
3,GO MACROPHAGE APOPTOTIC PROCESS,0.214,-0.165,-0.14887,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.14312,-0.16539,-0.078063,0,0
3,GO REGULATION OF NEUTROPHIL MIGRATION,0.33029,-0.16649,-0.14168,0,0
3,GO MYELOID LEUKOCYTE MIGRATION,0.197,-0.16689,-0.16694,0,0
3,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.21989,-0.16709,-0.15297,0,0
3,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.15655,-0.16772,-0.1555,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.11163,-0.16844,-0.17659,0,0
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.41494,-0.16852,-0.11842,0,0
3,GO LEUKOCYTE CHEMOTAXIS,0.28529,-0.16876,-0.14969,0,0
3,GO ANTIBACTERIAL HUMORAL RESPONSE,0.70989,-0.1699,-0.034594,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.15197,-0.17076,-0.14024,0,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.39705,-0.17127,-0.12095,0,0
3,GO ALPHA BETA T CELL PROLIFERATION,0.3148,-0.17219,-0.16506,0,0
3,GO ZINC ION HOMEOSTASIS,0.041938,-0.17238,-0.18267,0,0
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.16123,-0.17256,-0.14813,0,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.53179,-0.17266,-0.075441,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.38829,-0.17274,-0.15514,0,0
3,GO COLLAGEN CATABOLIC PROCESS,0.46168,-0.17274,-0.05207,0,0
3,GO L SERINE METABOLIC PROCESS,0.29248,-0.17327,-0.11439,0,0
3,GO CELL KILLING,0.2259,-0.17357,-0.17774,0,0
3,GO INTERLEUKIN 8 PRODUCTION,0.23203,-0.17418,-0.16013,0,0
3,GO CELL JUNCTION DISASSEMBLY,0.41494,-0.17457,-0.094006,0,0
3,GO REGULATION OF LYMPHOCYTE MIGRATION,0.2998,-0.17488,-0.1403,0,0
3,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.38829,-0.17516,-0.093424,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.41494,-0.17559,-0.15929,0,0
3,GO ASTROCYTE ACTIVATION,0.57414,-0.17595,-0.064223,0,0
3,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.21989,-0.17619,-0.24436,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.27126,-0.17771,-0.14531,0,0
3,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.57414,-0.17832,-0.044461,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.20256,-0.17909,-0.23047,0,0
3,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.35442,-0.17932,-0.11666,0,0
3,GO HUMORAL IMMUNE RESPONSE,0.28529,-0.17952,-0.14162,0,0
3,GO DENDRITIC CELL DIFFERENTIATION,0.28529,-0.18001,-0.21136,0,0
3,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.33029,-0.18115,-0.16451,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.24463,-0.18155,-0.11545,0,0
3,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.23827,-0.18296,-0.15627,0,0
3,GO TROPHOBLAST CELL MIGRATION,0.35442,-0.18364,-0.04695,0,0
3,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.42405,-0.18545,-0.14634,0,0
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.33029,-0.18572,-0.10279,0,0
3,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.23203,-0.186,-0.15457,0,0
3,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.52145,-0.18637,-0.055005,0,0
3,GO B CELL PROLIFERATION,0.42405,-0.18672,-0.17684,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.37111,-0.18832,-0.10059,0,0
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.33029,-0.18865,-0.18541,0,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.2998,-0.18961,-0.18862,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.20822,-0.19171,-0.23457,0,0
3,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.065157,-0.19226,-0.15246,0,0
3,GO MYELOID DENDRITIC CELL ACTIVATION,0.2577,-0.19248,-0.2087,0,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.15197,-0.19261,-0.25281,0,0
3,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.214,-0.19293,-0.17445,0,0
3,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.21989,-0.19294,-0.13599,0,0
3,GO POSITIVE T CELL SELECTION,0.37964,-0.19312,-0.17366,0,0
3,GO CELLULAR DEFENSE RESPONSE,0.197,-0.19396,-0.24413,0,0
3,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.21989,-0.19643,-0.21191,0,0
3,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.15655,-0.19659,-0.23976,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.17091,-0.1976,-0.17517,0,0
3,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.19156,-0.19876,-0.24336,0,0
3,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.11524,-0.19914,-0.21672,0,0
3,GO HISTAMINE TRANSPORT,0.76963,-0.19995,-0.03262,0,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.2998,-0.20228,-0.14193,0,0
3,GO T CELL MIGRATION,0.1475,-0.20336,-0.2212,0,0
3,GO KILLING OF CELLS OF OTHER ORGANISM,0.11163,-0.20396,-0.15141,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.14312,-0.20557,-0.23114,0,0
3,GO RESPONSE TO FUNGUS,0.1475,-0.20662,-0.16641,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.13467,-0.2067,-0.19411,0,0
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.16123,-0.20685,-0.24488,0,0
3,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.27126,-0.20707,-0.17189,0,0
3,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.18624,-0.20784,-0.22539,0,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.23827,-0.20855,-0.19524,0,0
3,GO POSITIVE REGULATION OF CELL KILLING,0.24463,-0.2095,-0.18754,0,0
3,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.15655,-0.2115,-0.13219,0,0
3,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.197,-0.21182,-0.17518,0,0
3,GO REGULATION OF CELL KILLING,0.24463,-0.21191,-0.17958,0,0
3,GO REGULATION OF T CELL MIGRATION,0.28529,-0.21292,-0.15122,0,0
3,GO IMMUNOGLOBULIN SECRETION,0.2577,-0.21377,-0.16869,0,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.51122,-0.2143,-0.093504,0,0
3,GO NEGATIVE T CELL SELECTION,0.29248,-0.21525,-0.23117,0,0
3,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.13885,-0.21601,-0.25477,0,0
3,GO PROSTANOID BIOSYNTHETIC PROCESS,0.17591,-0.21652,-0.16654,0,0
3,GO GRANULOCYTE MIGRATION,0.12273,-0.21666,-0.22179,0,0
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.36271,-0.21705,-0.14767,0,0
3,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.16602,-0.21892,-0.16843,0,0
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.24463,-0.21912,-0.18175,0,0
3,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.29248,-0.22015,-0.21355,0,0
3,GO INFLAMMATORY RESPONSE TO WOUNDING,0.35442,-0.22187,-0.14449,0,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.33029,-0.22368,-0.20966,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.35442,-0.22396,-0.12551,0,0
3,GO NEGATIVE REGULATION OF BONE REMODELING,0.1475,-0.22531,-0.20508,0,0
3,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.14312,-0.22868,-0.24723,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.39705,-0.23049,-0.16864,0,0
3,GO RESPONSE TO LIPOTEICHOIC ACID,0.29248,-0.23157,-0.13981,0,0
3,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.30724,-0.23231,-0.1735,0,0
3,GO ANTIMICROBIAL HUMORAL RESPONSE,0.21989,-0.23285,-0.13258,0,0
3,GO REGULATION OF PLASMINOGEN ACTIVATION,0.12273,-0.23297,-0.20657,0,0
3,GO GRANULOCYTE CHEMOTAXIS,0.10811,-0.23335,-0.23414,0,0
3,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.23203,-0.23467,-0.24529,0,0
3,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.18102,-0.23485,-0.21737,0,0
3,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.13885,-0.23555,-0.19952,0,0
3,GO NEGATIVE REGULATION OF CELL KILLING,0.16123,-0.23715,-0.23806,0,0
3,GO INTERLEUKIN 12 PRODUCTION,0.34626,-0.23749,-0.19594,0,0
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.24463,-0.2383,-0.16053,0,0
3,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.14312,-0.23906,-0.18071,0,0
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.16123,-0.23917,-0.23274,0,0
3,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.18102,-0.24065,-0.23121,0,0
3,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.4521,-0.24265,-0.18582,0,0
3,GO POSITIVE THYMIC T CELL SELECTION,0.33821,-0.24341,-0.21213,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.27126,-0.24467,-0.22996,0,0
3,GO T CELL MEDIATED CYTOTOXICITY,0.11524,-0.24492,-0.26517,0,0
3,GO TYPE 2 IMMUNE RESPONSE,0.26442,-0.24505,-0.19475,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.11524,-0.2459,-0.28574,0,0
3,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.2259,-0.25159,-0.2088,0,0
3,GO RESPONSE TO CHEMOKINE,0.15197,-0.25464,-0.25958,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.33821,-0.25562,-0.18261,0,0
3,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.10134,-0.25909,-0.29148,0,0
3,GO POSITIVE REGULATION OF T CELL MIGRATION,0.094909,-0.26102,-0.25607,0,0
3,GO NEUTROPHIL MIGRATION,0.10134,-0.26151,-0.26078,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.3148,-0.26183,-0.20912,0,0
3,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.34626,-0.26221,-0.14303,0,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.08588,-0.2634,-0.29995,0,0
3,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.094909,-0.26503,-0.29543,0,0
3,GO KERATAN SULFATE CATABOLIC PROCESS,0.79394,-0.26524,-0.028967,0,0
3,GO T HELPER CELL LINEAGE COMMITMENT,0.214,-0.26589,-0.22568,0,0
3,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.13467,-0.2683,-0.22413,0,0
3,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.13885,-0.27354,-0.20347,0,0
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.10134,-0.27589,-0.29251,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.16123,-0.27619,-0.22207,0,0
3,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.214,-0.2779,-0.22465,0,0
3,GO HISTAMINE SECRETION,0.21989,-0.27908,-0.13353,0,0
3,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.2577,-0.28098,-0.16804,0,0
3,GO HYPERSENSITIVITY,0.091819,-0.28335,-0.37758,0,0
3,GO CYCLOOXYGENASE PATHWAY,0.15197,-0.28496,-0.22569,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.20822,-0.286,-0.2262,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.091819,-0.28624,-0.24782,0,0
3,GO NEUTROPHIL CHEMOTAXIS,0.072385,-0.28668,-0.28767,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.11524,-0.28919,-0.24768,0,0
3,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.072385,-0.29111,-0.30414,0,0
3,GO INTERLEUKIN 10 PRODUCTION,0.094909,-0.29293,-0.26955,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.10811,-0.29738,-0.27025,0,0
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.1475,-0.30028,-0.18333,0,0
3,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,0.074935,-0.30192,-0.33232,0,0
3,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.197,-0.30495,-0.27357,0,0
3,GO DENDRITIC CELL MIGRATION,0.098083,-0.31567,-0.30044,0,0
3,GO REGULATION OF TOLERANCE INDUCTION,0.28529,-0.32534,-0.29808,0,0
3,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.091819,-0.32877,-0.31429,0,0
3,GO SYNAPSE PRUNING,0.077559,-0.3322,-0.38161,0,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.17091,-0.33805,-0.22781,0,0
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.08588,-0.33964,-0.33369,0,0
3,GO TOLERANCE INDUCTION,0.18624,-0.34858,-0.35432,0,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.197,-0.35039,-0.3049,0,0
3,GO LYMPHOCYTE CHEMOTAXIS,0.077559,-0.35108,-0.34509,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.091819,-0.35172,-0.31709,0,0
3,GO DENDRITIC CELL CHEMOTAXIS,0.10468,-0.358,-0.32362,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.091819,-0.36228,-0.36661,0,0
3,GO T CELL TOLERANCE INDUCTION,0.214,-0.37322,-0.33191,0,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.10811,-0.38456,-0.32862,0,0
3,GO DETOXIFICATION OF INORGANIC COMPOUND,0.024086,-0.4006,-0.48005,0,0
3,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.20256,-0.44278,-0.34501,0,0
